Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.9628900589026019,2.697546816945912,0.0,0.0,0.0,77/87,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;SEC61B;RPL10;RPS6;RPL10A
prerank,cytoplasmic translation (GO:0002181),0.9556673729639734,2.680049587306557,0.0,0.0,0.0,75/91,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,protein targeting to ER (GO:0045047),0.9445072916847548,2.679050938459467,0.0,0.0,0.0,76/99,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.9523067016972429,2.6687638317312072,0.0,0.0,0.0,77/91,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;SSR2;RPS6;RPL10A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.9336165796022624,2.6435871458850118,0.0,0.0,0.0,78/110,2.78%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH
prerank,peptide biosynthetic process (GO:0043043),0.8966317506110989,2.6025007982641446,0.0,0.0,0.0,82/153,2.38%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.8700622108533368,2.5260501355858382,0.0,0.0,0.0,79/168,2.90%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D
prerank,translation (GO:0006412),0.8454623407974,2.4842027891324903,0.0,0.0,0.0,87/208,2.38%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;LARS2;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;MRPS34;RPS6;RPL10A;EEF1G
prerank,rRNA metabolic process (GO:0016072),0.8505755581063958,2.4730442442057967,0.0,0.0,0.0,59/160,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,rRNA processing (GO:0006364),0.8338617499224302,2.4301258325046016,0.0,0.0,0.0,59/172,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ribosome biogenesis (GO:0042254),0.8089955228618559,2.366027668345,0.0,0.0,0.0,59/187,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.7931135825534714,2.349426935475317,0.0,0.0,0.0,94/306,3.75%,RPLP1;RPL41;APOE;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;PTMS;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;EEF1G;EIF4G2;POLR2D;MRPL43;POLR2F;EEF1D
prerank,ncRNA processing (GO:0034470),0.801433896700849,2.341649714879918,0.0,0.0,0.0,59/200,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ribosome assembly (GO:0042255),0.8479180059370105,2.271185567710448,0.0,0.0,0.0,18/47,3.10%,RPSA;RPL11;RPS15;RPS14;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPS28;RPL10;NPM1;RPS27L
prerank,cellular protein metabolic process (GO:0044267),0.7512525232721773,2.2435175669944956,0.0,0.0,0.0,127/396,7.48%,RPLP1;RPL41;APOE;CST3;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;SFTPA1;SFTPA2;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;IGFBP6;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;SPARCL1;RPL7A;RPL14;RPL31;SPP1;RPL36A;LGALS1;RPS28;MRPL34;RPL35;RPL4;RPL10;C3;LAMC1;LAMB2;RPS6;LGMN;RPL10A;PNPLA2;CKAP4;RPN1;IGFBP3;MFGE8;MRPL43;IGFBP4;HSP90B1;IGFBP5;CHEK2;RPN2;SHISA5;MRPL35;UBE2G2;UBL5;PDIA6;MRPL55;PSENEN;EEF1A2;CPE;LOX;CDC34;MRPL28;PENK;FN1;OMA1;SFTPB;UBA52;SPCS1;MRPL41;MRPL27;P4HB;MRPS11
prerank,gene expression (GO:0010467),0.7454423459628841,2.213007403209204,0.0,0.0,0.0,91/348,3.45%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;MRPL43;POLR2F
prerank,response to copper ion (GO:0046688),0.9272326133007222,2.1878219769994356,0.0,0.0,0.0,12/20,2.47%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;ATP5F1D;MT3;MT2A;PRNP
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.6531730740386694,-2.1585042382391166,0.0,0.046378577761173226,0.035,16/26,19.27%,SETD5;TET2;SETD2;OGT;TET3;KMT2A;KMT5C;KMT5B;KMT2D;WDR82;SETD4;PRDM9;SETD1B;SETD3;VCPKMT;BEND3
prerank,ribosomal small subunit biogenesis (GO:0042274),0.8376405136104079,2.1465118335965405,0.0,0.0,0.0,19/39,7.48%,RPS24;RPSA;RPS15;RPS16;RPS14;RPS5;RPS7;RPS19;RPS27;RPS25;RPS17;RPS28;RPS6;NPM1;RPS27L;LSM6;EMG1;SRFBP1;MRPS11
prerank,response to cadmium ion (GO:0046686),0.8867210368666416,2.145373517914694,0.0,0.0,0.0,12/26,2.16%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;MT2A;MAPK3;AKT1
prerank,ribosomal large subunit assembly (GO:0000027),0.8715889369965667,2.1433485420615037,0.0,0.0,0.0,10/24,4.50%,RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPL10;DDX28
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.78600899369279,2.140558308292512,0.0,0.0,0.0,19/57,4.99%,RPL26;RPS24;RPL35A;RPL11;RPS15;RPS16;RPL38;RPS7;RPS19;RPL5;RPS25;RPL7;RPS17;RPL14;RPS28;RPS6;NPM1;EMG1;LTO1
prerank,cellular response to cadmium ion (GO:0071276),0.8870841680900852,2.135537972617194,0.0,0.0,0.0,12/24,2.16%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;MT2A;MAPK3;AKT1
prerank,response to zinc ion (GO:0010043),0.8677844853854768,2.132503854190344,0.0,0.0,0.0,11/25,1.88%,CRIP1;MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;MT2A
prerank,ribosomal large subunit biogenesis (GO:0042273),0.7759308834648879,2.106899556467324,0.0,0.0,0.0,16/54,3.04%,RPL26;RPL35A;RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL7;RPL23A;RPL7A;RPL14;RPL10;RPL10A;NPM1
prerank,cellular response to copper ion (GO:0071280),0.9349785239595213,2.1043784769856146,0.0,0.0,0.0,11/16,2.47%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;MT2A;PRNP
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.7492907519765921,2.0807200006344484,0.0,0.0,0.0,45/69,15.83%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;COX7B
prerank,aerobic electron transport chain (GO:0019646),0.7516584828518424,2.0805332785737414,0.0,0.0,0.0,45/68,15.83%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;COX7B
prerank,cellular zinc ion homeostasis (GO:0006882),0.8418087314430208,2.0786430836515173,0.0,0.0,0.0,11/26,1.88%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;SLC30A1;MT2A
prerank,zinc ion homeostasis (GO:0055069),0.8259614636846285,2.0730960291550318,0.0,0.0,0.0,11/28,1.88%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;SLC30A1;MT2A
prerank,negative regulation of peptidase activity (GO:0010466),0.7725649163660517,2.050375834805102,0.0,0.0,0.0,20/47,12.85%,CST3;GAPDH;VTN;PARK7;UBXN1;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINF1;SERPINE2;AGT;ECM1;SPOCK1;CSTB;SPOCK3;TIMP1;SERPING1;TIMP3;SERPINA9
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.8975015616471607,2.033405125923212,0.0,0.0,0.0,11/16,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,androgen receptor signaling pathway (GO:0030521),-0.7839933094397945,-2.018927216993835,0.0,0.23019611157070125,0.307,8/11,13.24%,ZMIZ1;ARID1A;KDM3A;PMEPA1;DDX17;RNF14;AR;PLPP1
prerank,negative regulation of viral life cycle (GO:1903901),0.8987266746769194,2.01549047827443,0.0,6.0708196959260474e-05,0.002,6/15,0.98%,IFITM3;PPIA;LY6E;IFITM2;GSN;IFITM1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.8866821867214821,2.011010468906131,0.0,5.886855462716166e-05,0.002,11/17,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,cellular response to zinc ion (GO:0071294),0.8977467759090829,2.0010563837587716,0.0,5.713712654989221e-05,0.002,10/15,1.88%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;MT3;MT2A
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6151446844560866,-1.993967420680179,0.0,0.2070068226901147,0.378,12/24,16.29%,SMAD6;PARVA;ACVR1;BMPR1A;ROBO1;NRP1;ZFPM2;FGFR2;NRP2;SMAD4;BMP4;BMPR2
prerank,embryonic limb morphogenesis (GO:0030326),-0.5680365393812676,-1.9909948421284898,0.0,0.1623250221641063,0.387,10/34,5.80%,CACNA1C;AFF3;CREBBP;GLI3;FBXW4;NIPBL;SKI;LRP6;RARG;WDPCP
prerank,retina homeostasis (GO:0001895),0.840982258889497,1.9820671114462036,0.0,0.00022201854887958115,0.008,6/23,1.79%,POTEF;ACTB;ACTG1;B2M;HSPB1;SOD1
prerank,ribosomal small subunit assembly (GO:0000028),0.8924918801620007,1.9802984876749714,0.0,0.00021585136696625944,0.008,8/16,3.10%,RPSA;RPS15;RPS14;RPS5;RPS19;RPS27;RPS28;RPS27L
prerank,inner mitochondrial membrane organization (GO:0007007),0.7484124017637209,1.9743804069538733,0.0,0.000262521932796802,0.01,18/47,5.54%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;TIMM8B;ATP5MC1;TIMM13;ATP5MG;NDUFA13;ATP5PF;ATP5ME;ATP5F1A;MICOS13;ROMO1;GHITM;TIMM10B
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.7580509822941582,1.9649049118740152,0.0,0.00038342019132164503,0.015,30/38,18.06%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,cristae formation (GO:0042407),0.8019452922497885,1.9619953556710141,0.0,0.00037358890436467977,0.015,12/27,3.31%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A;MICOS13
prerank,negative regulation of viral entry into host cell (GO:0046597),0.9129081506914147,1.9614939664126838,0.0,0.0003642491817555628,0.015,5/12,0.98%,IFITM3;LY6E;IFITM2;GSN;IFITM1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.6968451339320186,1.9597816310055318,0.0,0.00035536505537128076,0.015,26/91,7.01%,FTH1;FTL;MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;ATOX1;MT3;BOLA2;SLC30A1;HMOX1;SOD1;TMPRSS6;MT2A;PRNP;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;SLC39A10;TFRC;SLC39A7
prerank,negative regulation of hippo signaling (GO:0035331),-0.7429655762415137,-1.9551198861755625,0.0,0.18981281337377728,0.504,6/12,17.31%,WWC2;VGLL4;DLG5;MARK3;LIMD1;MAPK14
prerank,regulation of viral entry into host cell (GO:0046596),0.7793373395345977,1.9505747285092454,0.0,0.000439411711324171,0.019,7/30,1.44%,IFITM3;CD74;LY6E;IFITM2;GSN;IFITM1;LGALS1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.8627633284315636,1.9479424379241257,0.0,0.0004743710274025934,0.021,9/17,3.20%,COX4I1;COX6C;COX6B1;COX7C;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.7769186683786866,1.9457017016902827,0.0,0.0004856655756740838,0.022,5/29,0.50%,RPS8;RPS16;RPS14;RPS21;RPS19
prerank,regulation of complement activation (GO:0030449),0.7542979432864131,1.9452734529693303,0.0,0.0004964581440223966,0.023,9/40,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7439813413061017,-1.9366471356290205,0.0,0.19776881329866147,0.584,3/11,6.50%,AFDN;RAPGEF2;RAPGEF6
prerank,regulation of humoral immune response (GO:0002920),0.7424774433761506,1.936535784548221,0.0,0.0006334768378357614,0.029,9/44,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,limb morphogenesis (GO:0035108),-0.6489760264700727,-1.9354093662474414,0.004878048780487805,0.17242488665913533,0.587,7/20,7.84%,GLI3;FBXW4;NIPBL;SKI;LRP6;PCSK5;IQCE
prerank,ribonucleoprotein complex assembly (GO:0022618),0.6660293924617083,1.935102267310659,0.0,0.0006199986072435111,0.029,33/132,7.48%,RPSA;RPL11;RPS15;RPS14;RPL38;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;HSP90AA1;HSP90AB1;SNRPG;RPS28;RPL10;GEMIN7;POLR2D;RPS27L;DDX39B;SNRPD2;LSM4;SNRPE;PUF60;SNRPF;SRSF9;STRAP;XAB2;MRPS11
prerank,glycolytic process (GO:0006096),0.7892042132225722,1.9329397386570675,0.0,0.0006273180352456914,0.03,11/28,6.42%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;PGK1
prerank,regulation of immune effector process (GO:0002697),0.7475025043552476,1.9299668429557337,0.0,0.0006541617958059087,0.032,9/41,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7506002307789846,-1.9278335457616507,0.0037174721189591076,0.16359760509047996,0.615,10/11,22.76%,TET2;OGT;TET3;KMT2A;KMT2D;WDR82;PRDM9;SETD1B;BEND3;CTR9
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.8472502865756291,1.9199459880488774,0.0,0.0008741980362133506,0.043,4/16,1.69%,TPT1;RPS3;CLU;CXCL12
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.8020343903398627,1.9102134690313788,0.0,0.001085605404447952,0.053,7/22,3.46%,RPL23;RPS15;RPL37;RPS7;RPS20;UBB;EIF5A
prerank,translational elongation (GO:0006414),0.6695260413944724,1.9092027579451838,0.0,0.0010834078226575714,0.054,54/101,21.66%,EEF1A1;MRPL23;MRPL13;MRPS12;EEF2;RACK1;EEF1B2;MRPL34;AURKAIP1;MRPS34;EEF1G;MRPL43;EEF1D;MRPL35;MRPL55;MRPL4;EEF1A2;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35
prerank,catecholamine metabolic process (GO:0006584),-0.6927865831505307,-1.9054373897137988,0.007662835249042145,0.1853886238420881,0.703,3/14,6.77%,SNCAIP;PRKN;ATP7A
prerank,negative regulation of endopeptidase activity (GO:0010951),0.724434390255697,1.9025657549185748,0.0,0.0012645631970381803,0.063,17/47,12.85%,GAPDH;VTN;MT3;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINF1;SERPINE2;AGT;SORL1;SPOCK1;SPOCK3;TIMP1;SERPING1;TIMP3;SERPINA9
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8279307682472176,1.8980466911532108,0.0,0.0013850462713668316,0.068,7/17,7.41%,PPIA;HSPB1;SOD1;AKT1;TREM2;BAG5;P4HB
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6982800626758432,-1.885773572429308,0.0,0.20270832036103031,0.775,8/13,14.11%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,substantia nigra development (GO:0021762),0.7471068798901283,1.8845006897898626,0.0,0.002013304568248929,0.101,15/37,5.43%,ACTB;CALM1;S100A1;MBP;PLP1;COX6B1;CKB;DYNLL1;ATP5PF;HSPA5;CNP;CALM3;NDRG2;YWHAH;YWHAE
prerank,eye morphogenesis (GO:0048592),-0.6255560758687944,-1.8842762095197447,0.0,0.18746817573973126,0.784,14/19,19.09%,COL5A2;FBN1;COL5A1;NIPBL;SHROOM2;SKI;RARG;EFEMP1;STAT3;IFT122;MFAP5;NF1;NKD1;AGTPBP1
prerank,negative regulation of cell activation (GO:0050866),0.8708889250359702,1.8806243639299747,0.0,0.0022375306879270284,0.114,6/14,4.06%,APOE;THBD;TREM2;GPER1;PDGFB;NR1D1
prerank,pyruvate metabolic process (GO:0006090),0.7035205973603671,1.874728238562195,0.0,0.002675420890555479,0.133,14/52,6.70%,BSG;ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;GLO1;PKM;ENO1;LDHA;PGK1;SDS
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8769363413541935,1.8719463782264998,0.0,0.0028470050987791113,0.145,6/12,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,eye development (GO:0001654),-0.4803756647783773,-1.8650591005550483,0.0,0.2080437421116043,0.838,14/54,7.79%,PBX1;CACNA1C;COL5A2;FBN1;COL5A1;SMOC1;PBX3;NIPBL;SHROOM2;SKI;LAMA1;EFEMP1;SIPA1L3;CEP290
prerank,response to interferon-beta (GO:0035456),0.7893566601696406,1.864881067494407,0.0,0.0031774052916982427,0.162,7/22,6.18%,IFITM3;IFITM2;IFITM1;NDUFA13;SHFL;UBE2G2;CDC34
prerank,mitochondrial translational elongation (GO:0070125),0.6616497766388159,1.864378496923317,0.0,0.003173015094404014,0.164,49/88,22.71%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.8412808518566984,1.8618998773908313,0.0,0.0032802330684872536,0.172,5/15,6.65%,APOE;PLTP;APOC1;ABCG1;LIPG
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.7617593680061876,1.8615733067650593,0.0,0.0032429927149850105,0.173,7/24,5.15%,APOE;UBB;GPX1;PSME1;PSME2;PINK1;ATP5IF1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.6830405416589538,1.8604438891359452,0.0,0.0032327114880806203,0.178,38/56,22.69%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2;NDUFA12;NDUFAF3;NDUFAF2;NDUFA10;NDUFAB1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.6830405416589538,1.8604438891359452,0.0,0.0032327114880806203,0.178,38/56,22.69%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2;NDUFA12;NDUFAF3;NDUFAF2;NDUFA10;NDUFAB1
prerank,cellular response to interleukin-12 (GO:0071349),0.6914402448618132,1.8584521722763296,0.0011086474501108647,0.0033174694707583567,0.184,15/48,8.93%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;SIRPA;AIP;MSN;GSTO1;P4HB;LCP1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.7425643031661878,1.8541985160643562,0.0,0.003752870357481556,0.207,9/32,8.39%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1;ROMO1;ANG;S100A9;CXCL10
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.6872882826251151,1.8463587943966717,0.0,0.004465223800227397,0.239,14/56,6.79%,SFTPA1;SFTPA2;RPS27A;CTSB;UBC;UBB;S100A1;CTSL;CTSS;LGMN;HSP90B1;S100A9;S100A8;UBA52
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.7300389027260733,1.8458344686396808,0.0,0.004513832997441484,0.243,7/30,4.88%,TPT1;RPS3;CD74;CLU;CXCL12;DDX39B;MIF
prerank,regulation of amyloid fibril formation (GO:1905906),0.8300788221820428,1.8440524740285482,0.0,0.004673651336921617,0.252,6/15,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7682144009053709,1.8411008062882483,0.0,0.004842779597435863,0.264,4/21,0.52%,RPL23;RPL11;RPS7;RPL5
prerank,aggrephagy (GO:0035973),0.7550719792283557,1.8380941616528246,0.002430133657351154,0.005157631606454354,0.283,7/27,1.79%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1
prerank,neutrophil activation involved in immune response (GO:0002283),0.6097037968815381,1.836566666408965,0.0,0.005409774884591878,0.297,160/428,18.27%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A9;S100A8;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;MAGT1;CD300A;TMBIM1;GCA;SYK;SLC2A3;CTSC;LAMP2
prerank,neutrophil degranulation (GO:0043312),0.6094571342641997,1.8362853391816447,0.0,0.005362280191689198,0.297,159/425,18.27%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A9;S100A8;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;MAGT1;CD300A;TMBIM1;GCA;SLC2A3;CTSC;LAMP2
prerank,regulation of membrane depolarization (GO:0003254),-0.6153214428557001,-1.8360698572517762,0.00425531914893617,0.2539074857544155,0.918,5/18,8.88%,LRRK2;CAMK2D;FHL1;PTPN3;SMAD7
prerank,glucose catabolic process to pyruvate (GO:0061718),0.7543902812842356,1.8353193967312358,0.0012422360248447205,0.00537469903745986,0.305,9/24,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,canonical glycolysis (GO:0061621),0.7543902812842356,1.8353193967312358,0.0012422360248447205,0.00537469903745986,0.305,9/24,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,mitochondrial translational termination (GO:0070126),0.65331549931728,1.8351900352476307,0.0,0.005342321332414921,0.305,47/88,22.71%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;CHCHD1;MRPL17;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,negative regulation of hemostasis (GO:1900047),0.8822317439631532,1.8315088861387963,0.0014184397163120568,0.005663995934484769,0.321,5/12,2.99%,APOE;VTN;THBD;SERPINE2;CD34
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6855385364464192,1.830173630925255,0.0011160714285714285,0.005840439871567827,0.334,14/46,8.93%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;AIP;MSN;GSTO1;P4HB;LCP1
prerank,regulation of glucose import (GO:0046324),-0.5416772452816302,-1.8292634537724917,0.0,0.2519310199640037,0.926,15/30,16.95%,PRKAG2;SORBS1;PID1;OSBPL8;APPL2;IRS1;GRB10;INSR;IGF1;ENPP1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,amyloid fibril formation (GO:1990000),0.6864941406352212,1.8286534839913722,0.0,0.005975530880445688,0.343,16/51,8.71%,CST3;RPS27A;UBC;B2M;UBB;GSN;H3-3A;ITM2B;MFGE8;FKBP1A;SORL1;PSENEN;TTR;UBA52;CALB1;MAPT
prerank,neutrophil mediated immunity (GO:0002446),0.6064900606889617,1.8279799975943387,0.0,0.0060101114989667866,0.351,160/432,18.27%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A9;S100A8;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;ADAM17;MAGT1;CD300A;TMBIM1;GCA;SLC2A3;CTSC;LAMP2
prerank,postsynaptic membrane organization (GO:0001941),0.795691407033109,1.827702093867624,0.0,0.005947904334181371,0.351,8/17,6.40%,APOE;NRXN1;NLGN1;SHISA7;LRP4;LHFPL4;MUSK;GPHN
prerank,cellular glucan metabolic process (GO:0006073),-0.6999921939170394,-1.8275974085534508,0.010169491525423728,0.23860458542496274,0.929,5/11,13.55%,PRKAG2;PHKB;PHKA1;GBE1;GSK3B
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5934870932562148,-1.8275351443511105,0.0,0.22369179883590257,0.929,10/21,15.76%,SAMD4A;CNOT4;PAN3;CNOT1;PARN;TUT7;CNOT10;CNOT7;TNKS1BP1;TUT4
prerank,negative regulation of lipid catabolic process (GO:0050995),0.8034630139792887,1.8271219754929569,0.0,0.005922750922854679,0.353,7/17,8.69%,AKT1;APOC1;TNF;SORL1;BSCL2;PDE3B;MFSD2A
prerank,modulation by symbiont of host process (GO:0044003),0.9009847576523533,1.825064924057595,0.0,0.00614396210190106,0.366,8/10,6.79%,RPS27A;UBC;B2M;UBB;MRC1;ENO1;PGK1;UBA52
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.7488724971466156,1.8222776265663183,0.0012531328320802004,0.006625866068124999,0.394,9/25,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,platelet aggregation (GO:0070527),0.7238090057589438,1.8219290256304619,0.0,0.0066279066797874965,0.396,13/33,12.51%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,reverse cholesterol transport (GO:0043691),0.8566499538001314,1.8214188749114977,0.0013297872340425532,0.006607310738821837,0.4,4/13,6.65%,APOE;CLU;ABCG1;LIPG
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.806722620963646,1.8180360106354292,0.0,0.007145424561641691,0.427,6/15,5.97%,RPL23;RPL11;RPS7;RPL5;PARK7;BAG5
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7951524107700146,1.8172695537459553,0.0,0.007229794365148292,0.435,8/18,10.02%,LAPTM5;PRNP;CD34;HOMER2;PTPRC;TNFAIP3;NAV3;ZFP36
prerank,regulation of endopeptidase activity (GO:0052548),0.6687785273765697,1.8170657691646654,0.0,0.007214043719563356,0.436,22/59,12.85%,GAPDH;VTN;PSME1;TIMP2;SERPINH1;AKT1;SPOCK2;PSME2;SERPINF1;PSMB8;SERPINE2;AGT;PSENEN;SPOCK1;VSIR;SPOCK3;TIMP1;ATP13A2;SERPING1;PSMB9;TIMP3;SERPINA9
prerank,vascular process in circulatory system (GO:0003018),-0.6632937947351847,-1.816890679505376,0.010638297872340425,0.21882141973496635,0.943,3/13,5.09%,ROCK2;ROCK1;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.6632937947351847,-1.816890679505376,0.010638297872340425,0.21882141973496635,0.943,3/13,5.09%,ROCK2;ROCK1;AGTR1
prerank,cellular component disassembly (GO:0022411),0.6691703201629068,1.8153144979099447,0.0,0.00733894647685282,0.442,15/53,11.31%,BSG;GSN;CTSL;CAPNS1;CTSS;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1;MMP3
prerank,extracellular matrix disassembly (GO:0022617),0.6671639131134772,1.8111841166979026,0.0,0.008005476522100282,0.473,15/53,11.31%,BSG;GSN;CTSL;CAPNS1;CTSS;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1;MMP3
prerank,regulation of hippo signaling (GO:0035330),-0.6187099190287925,-1.8096988986043723,0.011811023622047244,0.22111686496148572,0.953,8/17,17.31%,WWC2;VGLL4;DLG5;MOB3B;MARK3;NF2;LIMD1;MAPK14
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6489832970867648,1.8036868156958938,0.0,0.009206530043213066,0.515,29/67,16.21%,B2M;PSMB4;CALR;PSME1;PSMB6;PSME2;PSMB8;CYBA;PSMD2;TAPBP;PSMD1;PSMC3;PSMD6;TAP2;CYBB;PSMA7;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,regulation of tau-protein kinase activity (GO:1902947),0.88580007444324,1.803656580630988,0.001388888888888889,0.00910753509651185,0.515,6/10,9.30%,CLU;HSP90AA1;HSP90AB1;C5AR1;SORL1;EGR1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.7611581489081375,1.8034734253305997,0.0,0.009062312975875989,0.516,6/22,5.48%,APOD;APOC1;GPER1;TNF;BSCL2;PDE3B
prerank,negative regulation of platelet activation (GO:0010544),0.7974354495340217,1.8029000636337678,0.001288659793814433,0.009110063745802286,0.521,4/16,3.89%,APOE;THBD;SERPINE2;PDGFB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.6456626099868827,1.8009251207653023,0.0,0.009399652495858828,0.534,30/70,16.21%,B2M;PSMB4;CALR;PSME1;PSMB6;PSME2;PSMB8;CYBA;PSMD2;FCER1G;TAPBP;PSMD1;PSMC3;PSMD6;TAP2;CYBB;PSMA7;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,translational termination (GO:0006415),0.6367315832583835,1.798830341091012,0.0,0.009693284067062127,0.546,49/95,22.90%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;TRMT112;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;CHCHD1;MRPL17;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38;ETF1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6221091813252345,-1.7987027967111577,0.0,0.23042234853538995,0.965,10/16,24.58%,PARP9;KMT5C;PARP3;KMT5B;SHLD1;KDM4D;SMCHD1;SHLD2;SHLD3;PRKDC
prerank,alcohol catabolic process (GO:0046164),0.8809167064643149,1.7982126661175661,0.0029239766081871343,0.009812426937088631,0.553,3/10,2.26%,APOE;MT3;SNX17
prerank,platelet degranulation (GO:0002576),0.6247428445587813,1.7933684610590244,0.0,0.010723888367914616,0.584,38/118,15.48%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;ANXA5;PDGFB;TUBA4A;LGALS3BP;ECM1;FLNA;RARRES2;MANF;ENDOD1;FN1;LEFTY2;APLP2;CLEC3B;TIMP1;SERPING1;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;IGF2;PDGFA
prerank,positive regulation of peptidase activity (GO:0010952),0.7520712798725128,1.7869173160132417,0.0,0.012093072834284685,0.635,13/20,19.19%,GRN;NDUFA13;PSME1;RCN3;PSME2;PINK1;PSENEN;VCP;VSIR;CTSH;APH1B;PRELID1;DDRGK1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.6145370864978089,-1.7866270418261079,0.004310344827586207,0.24368953053606002,0.976,11/18,18.12%,ASH1L;SETD2;EHMT1;KMT2A;KMT2D;SETD7;EHMT2;SETD4;PRDM9;SETD1B;SETD3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.7351502946546093,1.7862014340251127,0.0012422360248447205,0.012175299382245345,0.64,7/25,6.46%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;GABARAPL2;HIPK2
prerank,protein localization to vacuole (GO:0072665),0.8336085127005383,1.7860004446403395,0.004285714285714286,0.012113070828577148,0.641,8/13,10.01%,CD81;LAMTOR4;LAMTOR5;GLMP;RTN4;ATP13A2;RNF128;MFSD1
prerank,microglial cell activation (GO:0001774),0.7573816513319525,1.7842570552292858,0.0012578616352201257,0.012457557776028439,0.65,12/21,14.98%,CLU;C1QA;TYROBP;GRN;ITGB2;TREM2;TNF;C5AR1;MAPT;AIF1;CX3CR1;IFNGR1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8330304584091164,1.7824442362142014,0.0,0.012786080251881167,0.66,2/12,0.25%,ACTB;ACTG1
prerank,carbohydrate catabolic process (GO:0016052),0.6990326444740551,1.781343303628019,0.0,0.0129325804722356,0.668,12/38,6.42%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;MAN2B2;PGK1
prerank,positive regulation of cellular component movement (GO:0051272),0.726792705594728,1.7790416072087682,0.002466091245376079,0.013433693093173712,0.679,12/24,17.48%,RPS19;CAVIN1;CCL19;SPOCK2;TUBB2B;NTN1;PHPT1;CSF1R;STK11;TRIM32;TWIST1;ADAM17
prerank,mitochondrial translation (GO:0032543),0.6229007856751989,1.777632776313964,0.0,0.01364402542501211,0.69,51/104,22.71%,MRPL23;MRPL13;MRPS12;LARS2;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;NDUFA7;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.7213697750174014,1.7725678307479487,0.0,0.015037645231982743,0.729,9/26,5.97%,PPIA;HSPB1;PARK7;ATF4;AKT1;TXN;PINK1;GPR37L1;BAG5
prerank,maturation of SSU-rRNA (GO:0030490),0.697247297866215,1.7723519842358133,0.0,0.014935330363848889,0.73,9/34,10.07%,RPS8;RPS16;RPS14;RPS19;RPS28;LSM6;SRFBP1;MRPS11;WDR3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.698742573909555,1.7697117815816148,0.0,0.01573556465184031,0.755,12/35,9.28%,CLU;B2M;VTN;C3;CCL19;APOC1;HNRNPK;RAC1;FLOT1;SNAP91;LRPAP1;ARF6
prerank,positive regulation of lipid transport (GO:0032370),0.8356178586695293,1.7673253522185755,0.0014005602240896359,0.016328864219961086,0.77,3/12,1.34%,APOE;DBI;SPP1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6566933523175498,1.7658412003562938,0.0010799136069114472,0.016634045966837364,0.779,14/54,9.82%,TMSB4X;APOE;ATP5F1B;HSPB1;AKT1;ATP5F1A;CSNK2B;TNF;PDGFB;ACVRL1;VASH1;KDR;GATA2;HMGB1
prerank,regulation of phagocytosis (GO:0050764),0.6597133087699449,1.7650925904699648,0.0,0.01680488850341299,0.782,20/53,13.55%,RACK1;CALR;CYBA;TREM2;DOCK2;TGM2;TNF;PTPRC;FCER1G;LMAN2;CAMK1D;SIRPA;IL2RB;SPACA3;SYT11;GATA2;HCK;IL2RG;SLC11A1;GAS6
prerank,toll-like receptor signaling pathway (GO:0002224),0.6214835370205769,1.762451725639975,0.0,0.017381715339914575,0.799,26/84,15.58%,SFTPA1;SFTPA2;RPS27A;CTSB;UBC;UBB;S100A1;CTSL;CTSS;LGMN;ITGB2;HSP90B1;S100A9;S100A8;TIRAP;UBA52;HSPD1;TICAM2;HMGB1;RIPK2;TLR6;TRAF3;TRIL;UNC93B1;TLR5;TLR1
prerank,pre-replicative complex assembly (GO:0036388),0.6412692973247652,1.7561952627069715,0.0,0.01952797932101707,0.836,24/64,16.21%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;UBA52;PSMA7;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5
prerank,skeletal system morphogenesis (GO:0048705),-0.4680428619475735,-1.7561915460355957,0.0,0.2981186184692709,0.988,11/42,8.39%,WWOX;HOXB3;ANKRD11;HOXA3;LRP5;SKI;LRP6;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5809186623750745,-1.756135625255532,0.0,0.2852061213542349,0.988,8/21,14.11%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,negative regulation of coagulation (GO:0050819),0.8149426440537193,1.756037039289194,0.0041265474552957355,0.019409875938147,0.836,7/14,10.54%,APOE;VTN;THBD;SERPINE2;CD34;HS3ST5;PROCR
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7058175829860067,-1.7513770645963926,0.018050541516245487,0.28350319637546445,0.99,5/10,15.41%,RAPGEF2;RAPGEF1;NGF;KIDINS220;BDNF
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7252116493161882,1.750659309554873,0.0,0.021485512988795363,0.858,5/24,4.88%,TPT1;CD74;CLU;CXCL12;MIF
prerank,regulation of peptidase activity (GO:0052547),0.7602074097506514,1.7495608901951518,0.0013280212483399733,0.02183848766548041,0.869,8/19,9.60%,CST3;NDUFA13;RCN3;PSMB8;PINK1;ECM1;CSTB;ATP13A2
prerank,neuron cell-cell adhesion (GO:0007158),0.7985291470076912,1.7488238715004336,0.001336898395721925,0.021948819041808593,0.87,8/14,12.53%,NRXN1;NLGN1;CNTN4;NINJ2;NRXN3;CDK5R1;NCAM2;NRXN2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.686180320402278,1.7467944110168792,0.0011806375442739079,0.022640110252673536,0.881,17/37,17.16%,RPS3;RPS7;RACK1;UBB;SOD1;EIF5A;S100A9;S100A8;NUPR1;BAX;MSX1;PMAIP1;BBC3;BAD;CAV1;BCAP31;DNM1L
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.6055081701394823,1.7427391463717674,0.0,0.024090618059469836,0.9,23/107,9.60%,TPT1;MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;CALR;MT3;SLC30A1;CXCL12;MT2A;CCL19;SLC24A4;SLC24A2;SLC39A10;DRD5;SLC39A7;TMCO1;HTR2C;ATP13A2
prerank,DNA methylation or demethylation (GO:0044728),-0.5792684475698513,-1.73713061065851,0.0,0.2918021773397644,0.992,8/19,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,DNA alkylation (GO:0006305),-0.5792684475698513,-1.73713061065851,0.0,0.2918021773397644,0.992,8/19,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.8543775884398028,1.7364580015964106,0.001447178002894356,0.026958420315286023,0.922,7/10,8.07%,ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5F1A;ATP5MC2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6807037826589362,-1.7349489044037403,0.003676470588235294,0.2861478645969405,0.992,5/11,6.97%,PARP4;PARP9;PARP12;PARP16;PARP3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6825189933202163,-1.7348243624023376,0.010869565217391304,0.27645349095793414,0.992,5/11,7.78%,MLLT3;DAB2;PLEKHA4;WNT5B;RSPO3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.605240482677106,1.7345966603200018,0.0,0.027639504306655176,0.926,28/110,11.61%,APOE;RPS3;HSPA8;GFAP;CLU;RACK1;GSN;HSP90AA1;PARK7;HSPA5;NRG1;CRYAB;PINK1;TNF;RHOC;LGALS3;SORL1;TIRAP;VCP;TFRC;SAR1A;MTLN;HCK;PIH1D1;MMP3;BAX;SVIP;WARS1
prerank,neutrophil chemotaxis (GO:0030593),0.6508394566860097,1.7341361797184616,0.0,0.027628104603266024,0.928,18/53,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A9;S100A8;CXCL10;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6641922784929548,1.7322749131372925,0.0023094688221709007,0.02834732832094492,0.935,7/40,3.00%,CLU;CD63;B2M;VTN;C3;CCL19;HNRNPK
prerank,gluconeogenesis (GO:0006094),0.6790087520551964,1.7310572771297192,0.001142857142857143,0.028638851009987636,0.939,12/39,9.20%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.6739026959976472,1.7307570267661703,0.0035087719298245615,0.02858925861212165,0.94,10/37,6.46%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;HIPK2
prerank,immunoglobulin mediated immune response (GO:0016064),0.8557676171492666,1.726280880928372,0.0,0.03067281651366635,0.954,3/10,4.09%,CD74;CD81;FCER1G
prerank,histone H3-K9 demethylation (GO:0033169),-0.6695875000508171,-1.7241921465242984,0.010452961672473868,0.2900123849069159,0.995,7/11,14.04%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,protein localization to lysosome (GO:0061462),0.6957354542913481,1.7235247542060632,0.0012224938875305623,0.03197863100601293,0.958,14/28,19.09%,CD81;LAPTM5;LAMTOR4;LAMTOR5;GLMP;RTN4;SORL1;ATP13A2;RNF128;MFSD1;M6PR;NCOA4;VPS4A;SNX16
prerank,homotypic cell-cell adhesion (GO:0034109),0.6658224296865007,1.7223560239551505,0.0,0.03242004512076691,0.96,13/39,12.51%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,mitochondrial transport (GO:0006839),0.637415299064528,1.7217852359342003,0.002185792349726776,0.03243949455838345,0.961,20/53,16.83%,TSPO;HSP90AA1;TIMM8B;TIMM13;TOMM5;SLC25A5;TOMM7;SLC25A4;SLC25A13;AIP;TIMM10B;TMEM14A;GDAP1;PMAIP1;TMEM14C;SPG7;ABCB10;BAD;MFF;BCAP31
prerank,response to metal ion (GO:0010038),0.6236994379212036,1.721607199155627,0.0,0.03231147792098336,0.962,14/67,8.71%,CRIP1;MT1X;MT1A;CALM1;ATP5F1D;PPP1CA;MT3;MT2A;CALM3;SLC25A13;GPHN;NDRG1;HVCN1;MAPT
prerank,positive regulation of locomotion (GO:0040017),0.6965915820633122,1.7201780497050276,0.0024691358024691358,0.03303256238757715,0.965,17/27,21.84%,CAVIN1;CCL19;SPOCK2;TREM2;PDGFB;RARRES2;NTN1;P2RY12;PHPT1;CSF1R;AIF1;F2RL1;TRIM32;TWIST1;STX4;TGFB1;PPM1F
prerank,negative regulation of blood coagulation (GO:0030195),0.6756071289387998,1.7193814624398769,0.001160092807424594,0.033184731424417246,0.967,7/38,3.89%,APOE;VTN;THBD;A2M;SERPINE2;CD34;PDGFB
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.7464264086070139,1.719074415971225,0.0038314176245210726,0.033032454191403236,0.968,6/18,5.97%,PPIA;HSPB1;PARK7;AKT1;PINK1;BAG5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.6052438661733891,1.7184414181497154,0.0,0.033089538413206325,0.969,38/87,18.06%,UQCC2;NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;COX17;NDUFA3;COA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;OMA1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.7667983055218962,1.715262392201677,0.0025380710659898475,0.03465596107875797,0.975,7/17,4.82%,APOE;CLU;PRNP;NTRK2;RTN4;PIN1;SORL1
prerank,neutrophil migration (GO:1990266),0.6377776384717792,1.7141118478762405,0.0,0.03515092586835325,0.978,19/58,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A9;S100A8;CXCL10;PECAM1;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,hydrogen peroxide metabolic process (GO:0042743),0.7445547461601232,1.7099803450857025,0.005148005148005148,0.03751853922005979,0.985,9/19,9.70%,GPX1;PARK7;SOD1;CYBA;PRDX5;PRDX4;PRDX2;GPX3;PRDX1
prerank,regulated exocytosis (GO:0045055),0.583857154558455,1.7091392985076046,0.0,0.03780559602640118,0.986,65/173,20.16%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;SNAP25;ANXA5;PDGFB;TUBA4A;LGALS3BP;DNAJC5;ECM1;SYNGR2;FLNA;RARRES2;MANF;ENDOD1;SYT1;FN1;RIMS2;LEFTY2;SYNGR1;RIMS1;APLP2;SDF4;SYT12;SYT11;CLEC3B;TIMP1;VAMP2;SERPING1;SYT6;SYT4;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;RAB26;IGF2;SYT10;PDGFA;CDK5;SYT2;SCCPDH;SCG3;SCIN;LAMP2;SNCA;RAB31;HGF;TGFB1;CYB5R1;QSOX1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5591102266119204,-1.7071025818425862,0.01020408163265306,0.3070984346483351,0.997,7/20,11.38%,ZBTB20;ARNT;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,positive regulation of glycolytic process (GO:0045821),-0.5591102266119204,-1.7071025818425862,0.01020408163265306,0.3070984346483351,0.997,7/20,11.38%,ZBTB20;ARNT;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,cholesterol efflux (GO:0033344),0.7343881042280361,1.7057870007807412,0.0037128712871287127,0.040017465660861735,0.99,4/20,5.54%,APOE;NPC2;APOC1;ABCG1
prerank,positive regulation of phospholipid transport (GO:2001140),0.825919386328525,1.7032718764173604,0.0013850415512465374,0.04143206185715387,0.991,3/10,3.73%,APOE;DBI;TMEM30A
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.6295428655945523,1.7024932123378236,0.0,0.04172648435476778,0.992,15/53,10.18%,APOE;UBB;GPX1;HSP90AB1;PSME1;PSME2;TREM2;PINK1;GABARAPL2;PSMC3;FOXF2;NUPR1;XPO1;ALAD;ECSCR
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7638297564260074,1.7000208517928124,0.004016064257028112,0.04312980126194572,0.995,4/15,8.38%,TMSB4X;HSPB1;LGMN;KDR
prerank,cellular response to metal ion (GO:0071248),0.5889388090481804,1.6998683492660744,0.0,0.04294623456064208,0.995,41/123,16.40%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;B2M;MT3;MT2A;MAPK3;LGMN;AKT1;NLGN1;PRNP;ANK3;DLG2;SYT1;AQP1;HVCN1;SYT12;SYT11;JUN;ATP13A2;SYT6;SYT4;SMPD1;WNT5A;GLRA2;TRPM2;GLRA1;ALOX5AP;CPNE5;SYT10;CPNE6;NCF1;KCNA1;DMTN;ADCY8;SYT2
prerank,positive regulation of endocytosis (GO:0045807),0.6459836562225132,1.6983094688800375,0.001128668171557562,0.04381634906013035,0.995,11/45,5.06%,APOE;CLU;B2M;VTN;CD151;C3;CCL19;NLGN1;TREM2;HNRNPK;FLOT1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.7048277212278016,1.6982610336368078,0.0037128712871287127,0.04354470943798928,0.995,9/23,10.13%,RPS27A;UBC;UBB;COPS7A;COPS6;PARP1;UBA52;RBX1;DDB1
prerank,response to interferon-alpha (GO:0035455),0.7608059077319017,1.6973999491664877,0.003896103896103896,0.04386741497034561,0.995,7/16,14.08%,IFITM3;IFITM2;IFITM1;BST2;GAS6;PDE12;RO60
prerank,negative regulation of secretion by cell (GO:1903531),0.662282231777005,1.697321784228954,0.002290950744558992,0.04359907879339963,0.995,18/38,21.22%,APOE;SLC30A1;TRH;IL1RAPL1;GRM7;SYT11;VAMP3;DPH3;SYT4;CHGA;IL11;VAMP8;LILRB1;TNFRSF1A;SNCA;NOTCH1;ERP29;RSAD2
prerank,response to interferon-gamma (GO:0034341),0.6072144465151154,1.6961343149287451,0.001075268817204301,0.04415023859927871,0.995,22/67,19.11%,IFITM3;CD74;IFITM2;GAPDH;IFITM1;RPL13A;CCL19;AQP4;SHFL;SIRPA;CXCL16;IRF8;WNT5A;AIF1;SLC11A1;BST2;PDE12;CCL2;CCL3;CCL8;EPRS1;SNCA
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.6452831377014334,1.6959257917973465,0.003409090909090909,0.043992938702451106,0.995,18/46,16.83%,TSPO;TIMM8B;TIMM13;AKT1;TOMM5;TOMM7;PINK1;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;GDAP1;TIMM50;TOMM20L;MFF;BCAP31
prerank,inositol lipid-mediated signaling (GO:0048017),-0.44443843239926645,-1.6958608485039937,0.0,0.3225644223099891,1.0,13/50,10.41%,GAB2;PLCE1;PI4KA;PITPNM2;OGT;ADAP2;IRS1;PLCL1;PLCD3;IGF1;PDGFRB;TNFAIP8L3;NGF
prerank,response to unfolded protein (GO:0006986),0.6336260063719612,1.695558158585578,0.0,0.043965515271548634,0.995,24/48,21.15%,HSPA8;HSP90AA1;HSPB1;HSP90AB1;HSPA5;SERPINH1;TMBIM6;HSPE1;HSPA1B;HSPD1;HSPB8;HSPB2;DNAJA1;BAX;DNAJB2;HSPA1A;DNAJB1;DAB2IP;HERPUD1;HSPA4L;HSPA2;HSPA9;BAK1;DDIT3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6018724850521285,1.695192317649025,0.0,0.04393210174725044,0.995,32/86,16.57%,RPS27A;UBC;UBB;PSMB4;ELOB;HMOX1;PSME1;ATF4;KLF2;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;UBA52;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;HSPA1A;PSMB10;EGLN2;DNAJB1;PSMB1;PSMB5;VHL
prerank,granulocyte chemotaxis (GO:0071621),0.6345005990465012,1.6929177087397271,0.0,0.04522997198907603,0.998,18/55,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A9;S100A8;CXCL10;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,negative regulation of protein binding (GO:0032091),0.6176477377658025,1.6911368337989603,0.0,0.04626042941453015,0.998,21/71,12.09%,ACTB;RACK1;B2M;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;ADAM15;PDGFB;PIN1;SORL1;TLE5;LRPAP1;IFIT1;MAP2;CAMK1;BAX;DNAJB2;DDX11
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6622617891952746,1.6910078858924247,0.003444316877152698,0.04607596487164384,0.998,8/33,9.85%,RPS3;CD81;LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.7049895786275325,1.6908489901320096,0.001226993865030675,0.04590003701816595,0.998,5/26,3.71%,APOE;S100A1;PARK7;AKT1;TNF
prerank,lipoprotein catabolic process (GO:0042159),0.8101625876819343,1.6870079625548362,0.0028653295128939827,0.048345241608873345,0.998,3/11,3.56%,APOE;CTSD;LYPLA2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.5454763647570676,-1.6859242763572868,0.004629629629629629,0.33736730400995335,1.0,10/20,19.22%,TNRC6B;TNRC6A;TNRC6C;CNOT1;MOV10;CNOT7;LIMD1;AGO2;CELF1;AGO4
prerank,positive regulation of transport (GO:0051050),0.6004764460051631,1.6844626459529781,0.0,0.05023431482727032,0.998,26/85,13.79%,APOE;ACTB;CHCHD10;CALR;CD151;CCL19;CYBA;TREM2;DOCK2;TNF;FCER1G;LMAN2;CAMK1D;FLOT1;SIRPA;IL2RB;MLC1;SPACA3;SGK1;GATA2;SMPD1;BAX;IL2RG;SLC11A1;GAS6;CLIP3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6724126907868149,-1.68173590363222,0.026058631921824105,0.33829080249326354,1.0,3/10,5.44%,HDAC4;PIAS1;SAE1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7497441552224748,1.6793728373512748,0.005194805194805195,0.05415171168766034,0.998,5/16,6.51%,APOE;CLU;TREM2;TNF;LRPAP1
prerank,protein targeting to mitochondrion (GO:0006626),0.6298873539377167,1.6790151155683004,0.002244668911335578,0.05408082261295014,0.998,20/52,16.83%,TSPO;HSP90AA1;TIMM8B;TIMM13;NDUFA13;TOMM5;TOMM7;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;PMPCB;GDAP1;TIMM50;TOMM20L;TIMM29;MFF;BCAP31
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7971437687552188,1.678604447940816,0.004043126684636119,0.05411273852418032,0.998,5/13,12.49%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,defense response to Gram-positive bacterium (GO:0050830),0.6390956531375135,1.674732111572291,0.0,0.05692119728636623,0.999,8/40,5.68%,RPL39;MBL2;MPEG1;PGLYRP1;ROMO1;ANG;TIRAP;RARRES2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.820287583397229,1.674476320769321,0.01,0.05677549034648495,0.999,2/10,2.16%,APOD;AKT1
prerank,positive regulation of phagocytosis (GO:0050766),0.6279614289945099,1.6740123633237616,0.0,0.056825815781599155,0.999,21/47,15.66%,CALR;C4B;C3;CYBA;TREM2;DOCK2;TNF;PTPRC;FCER1G;LMAN2;CAMK1D;SIRPA;IL2RB;SPACA3;GATA2;IL2RG;SLC11A1;GAS6;CCL2;F2RL1;CD300LF
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.49677561000373455,-1.673199198114415,0.0111731843575419,0.3506026561346391,1.0,8/27,7.96%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;PRKN;ARHGEF18;PPFIA1;MET
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.7314743876127238,1.6707494993761551,0.003911342894393742,0.05942674200657824,0.999,7/18,9.92%,APOE;CD81;HSP90AA1;ATP5IF1;MSN;PTTG1IP;RNF128
prerank,nuclear migration (GO:0007097),-0.6118281145573399,-1.6706810543198363,0.024096385542168676,0.34655103938209997,1.0,7/13,11.78%,SYNE2;SYNE3;PAFAH1B1;DOCK7;PCM1;FBXW11;CLMN
prerank,intermediate filament organization (GO:0045109),0.7429794500004483,1.6701648346107583,0.007822685788787484,0.05966997773461587,0.999,6/17,13.89%,GFAP;VIM;NEFL;KRT9;EPPK1;DES
prerank,hexose biosynthetic process (GO:0019319),0.6479812487215176,1.670003940557137,0.002257336343115124,0.05944199742268161,0.999,12/42,9.20%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,regulation of B cell proliferation (GO:0030888),0.6347372668375815,1.668215444473723,0.004592422502870264,0.060728313284880105,0.999,15/44,20.07%,CD74;CD81;TYROBP;PTPRC;MIF;TIRAP;TFRC;IL2;CD22;CTLA4;VAV3;IKZF3;CD300A;GPR183;MEF2C
prerank,regulation of leukocyte migration (GO:0002685),0.7543167737717787,1.6680665093861051,0.002628120893561104,0.060428225039166,0.999,4/16,6.43%,CD81;HMOX1;RAC1;RHOG
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5735480905266054,-1.6664554083038232,0.02032520325203252,0.3471514505458946,1.0,6/17,11.61%,PBX1;CREBBP;MAML2;KAT2B;MAML1;RBPJ
prerank,negative regulation of mitochondrion organization (GO:0010823),0.6658916644918359,1.6662408753613878,0.0,0.06189821962714024,0.999,14/33,13.09%,CLU;GPX1;AKT1;VAT1;SLC25A5;PINK1;FZD9;GHITM;TMEM14A;TFRC;OMA1;MAPT;ACAA2;HSPA1A
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.49323339047213904,-1.6657969001764084,0.0,0.33986150340135735,1.0,13/29,19.40%,FER;GHR;STAT5B;IL31RA;PIAS1;IL15;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2
prerank,glucose metabolic process (GO:0006006),0.6182276202370648,1.6651943468640191,0.0,0.06256615014992062,0.999,23/58,20.39%,ALDOA;APOD;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;OMA1;SLC25A11;GAA;DCXR;SLC25A1;ENO3;PPARGC1A;G6PC3;AKR1A1;TFAP2B;GOT1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.6169032092320004,1.6642668869779238,0.0011061946902654867,0.06319267114695737,0.999,24/53,20.35%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;BCKDK;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;OAZ2;PSMA4
prerank,regulation of neuron death (GO:1901214),0.591060012118575,1.6636013229228301,0.0,0.06347704897689661,0.999,34/82,20.07%,CLU;UBB;C1QA;CTSZ;TYROBP;GPNMB;PARK7;DCC;AKT1;PRNP;ITGB2;CD34;GRID2;NENF;SORL1;MAPT;FAIM2;DHCR24;TRIM2;EGR1;ATP13A2;CHGA;WNT5A;EGLN2;EPHB1;CDK5;PPARGC1A;GRM4;GRIN2B;AKT1S1;NSMF;SNCA;DDIT4;MEF2C
prerank,DNA methylation (GO:0006306),-0.5217780087384686,-1.6614279465955248,0.009852216748768473,0.3412987645501722,1.0,8/23,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.8190096476878186,1.659699483358614,0.00411522633744856,0.06705515222535549,0.999,6/10,8.96%,RPS27A;UBC;UBB;UBA52;ISG15;NEDD8
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6318765759546648,1.6569025214134645,0.0022650056625141564,0.06957711264230879,0.999,8/40,6.83%,RPL23;RPL11;RPS7;RPL5;CLU;LAPTM5;HIPK2;FOXF2
prerank,positive regulation of B cell proliferation (GO:0030890),0.6715467783655711,1.653965154375624,0.002442002442002442,0.07244923084801416,0.999,7/29,8.64%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2
prerank,protein targeting to lysosome (GO:0006622),0.7089330399609296,1.652848627978091,0.007633587786259542,0.07322090667859389,0.999,9/20,19.09%,HSPA8;CLU;LAPTM5;SORL1;M6PR;LAMP2;NCOA4;VPS4A;SNX16
prerank,regulation of plasminogen activation (GO:0010755),0.7893520028519418,1.652623141556524,0.006896551724137931,0.07305604072961105,0.999,4/12,8.76%,CTSZ;SERPINE2;ENO1;CLEC3B
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7250010461584429,1.652373027181462,0.009114583333333334,0.07289840290867997,0.999,6/17,9.85%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4930798474135749,-1.6519541665695634,0.0,0.35654945634931223,1.0,11/28,15.34%,PID1;APPL2;TNS2;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;PRKCB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.7270561954409596,1.6497445863392386,0.006297229219143577,0.07515205217392121,0.999,7/19,4.82%,APOE;CLU;PRNP;NTRK2;RTN4;PIN1;SORL1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.6150413914156132,1.648407294543184,0.0011160714285714285,0.07610005981908528,0.999,28/50,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;OAZ2;PSMA4;PSMC1;PSMD9;PSMB2;PSMD4;PSMD10
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7991918109137992,1.648222087283189,0.00410958904109589,0.07585937057414213,0.999,3/11,1.42%,ITM2A;ITM2C;ITM2B
prerank,ATP transport (GO:0015867),0.7888762068560169,1.6481420099919868,0.00684931506849315,0.07553683393826592,0.999,2/10,4.33%,SLC25A5;SLC25A4
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.7433394718489753,1.6458500667491893,0.007978723404255319,0.07769074079188559,0.999,4/16,3.71%,APOE;S100A1;AKT1;TNF
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.8000084695527683,1.6449163837679306,0.008174386920980926,0.07822871315696531,0.999,5/11,12.49%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,chemical synaptic transmission (GO:0007268),0.549960454372759,1.6438657746102134,0.0,0.07904142315542816,1.0,121/284,23.37%,APOE;HSPA8;CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;SLC17A8;ASIC2;NRXN1;CNP;GABRB1;NLGN1;NSG1;SNAP25;CHRNA9;DLGAP2;GRM5;GRIA2;SLC1A4;SLC1A2;DLGAP1;GRID2;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;DNAJC5;GRIK5;GRIK2;GRIN1;CACNA1A;SYT1;PENK;DRD5;GABRA2;AMPH;RIMS1;SYPL1;RAPSN;SLC12A5;GRM7;GRIA4;GRIN2A;PDYN;PRKAR1A;ERC2;SYN2;HTR2C;SLC6A5;SLC6A2;CRH;VAMP2;PTPRN2;CAMK1;KIF5A;GRID1;GRM1;SLC17A7;PRKAR1B;HAP1;CHRM3;GLRA2;SLC17A6;GRIA1;GLRA1;GABRA3;GABRB3;SYN1;CHRM2;SLC1A1;NRXN2;CHRNA4;CHAT;HCRT;CBLN2;SDCBP;LIN7C;NAAA;PPFIA3;SYT10;CDK5;CPNE6;KCNK3;DOC2A;KCNA1;GABRB2;NAPA;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;GLRA3;SNCA;UNC119;STAC3;GABBR2;UTS2;GAD1;SST;CACNB4;RIMBP2;NPY5R;GRIA3;GRIK1;CHRNA3;SLC32A1;CACNA1E;HTR3B;SYT5;SLC5A7
prerank,regulation of protein neddylation (GO:2000434),0.7970964485165082,1.6424241894619716,0.009722222222222222,0.08013998664128417,1.0,4/10,4.55%,RPL11;RPL5;COPS9;EPAS1
prerank,B cell mediated immunity (GO:0019724),0.8024386268417693,1.64233698372209,0.0,0.07979305532186058,1.0,2/10,4.09%,CD74;FCER1G
prerank,cellular response to interferon-beta (GO:0035458),0.7629883687602987,1.6423335486784574,0.006747638326585695,0.07937820414201577,1.0,4/14,6.18%,IFITM2;NDUFA13;UBE2G2;CDC34
prerank,negative regulation of protein metabolic process (GO:0051248),0.6118686302725465,1.6420847843218693,0.0022026431718061676,0.07926774165478474,1.0,11/48,5.34%,APOE;CLU;PFDN5;HSP90AB1;PRNP;TREM2;CRYAB;PFDN6;CD84;PIN1;FLNA
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.6960357692613041,1.6397881543917376,0.007741935483870968,0.08145522327008772,1.0,9/20,14.87%,CLU;HSP90AA1;HSP90AB1;PFDN6;CCT2;HSPD1;PSMG3;HSPA1A;PTGES3
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.459078451182725,-1.6385453169485324,0.007246376811594203,0.38176108297522543,1.0,14/35,13.79%,NR3C2;RBFOX2;ZMIZ1;UBR5;YAP1;ARID1A;KDM3A;PMEPA1;ESR1;DDX17;RNF14;AR;PLPP1;PPARGC1B
prerank,histone lysine demethylation (GO:0070076),-0.5125471574918302,-1.6384127836482507,0.004784688995215311,0.37326405876428553,1.0,10/25,14.04%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;KDM3A;KDM5C;KDM4C;PHF8;KDM4D
prerank,response to reactive oxygen species (GO:0000302),0.6076414513380832,1.637871531562028,0.0011013215859030838,0.08322244517457666,1.0,19/54,15.91%,APOE;RPS3;APOD;GPX1;HMOX1;SOD1;MAPK3;AKT1;PTPRN;PRDX5;ROMO1;HYAL2;MAPT;JUN;PJVK;CAT;HP;GLRX2;NCF1
prerank,negative regulation of wound healing (GO:0061045),0.6552542949036165,1.6374678283956008,0.010882708585247884,0.08320903301162472,1.0,8/28,9.80%,APOE;VTN;THBD;SERPINE2;CD34;TNF;CLASP1;EPPK1
prerank,cellular iron ion homeostasis (GO:0006879),0.6092095466422004,1.6361282163926214,0.0010869565217391304,0.0842019578584073,1.0,17/55,12.88%,FTH1;FTL;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,maintenance of blood-brain barrier (GO:0035633),0.6635352819271881,1.6345994653760754,0.0072992700729927005,0.08555147788634396,1.0,12/30,14.81%,ACTB;ACTG1;CLDN5;MBP;LAMC1;ESAM;MFSD2A;PECAM1;SLC1A1;LSR;GJA1;JAM3
prerank,positive regulation of cation channel activity (GO:2001259),0.6308519221999227,1.6336338184248107,0.003432494279176201,0.08639423570519081,1.0,15/40,19.59%,TMSB4X;CALM1;CTSS;AKAP6;CALM3;ANK3;GSTO1;P2RY6;HAP1;GSTM2;CCL2;LRRC55;CCR2;CALM2;STAC3
prerank,actin filament bundle organization (GO:0061572),-0.466799234275314,-1.6323057505088732,0.015748031496062992,0.3799465675579268,1.0,9/33,4.65%,CALD1;DPYSL3;PAWR;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,regulation of interleukin-2 production (GO:0032663),0.6214477098659008,1.6315920792967054,0.0022497187851518562,0.08848434331750957,1.0,11/43,11.48%,RPS3;LAPTM5;PDE4B;PRNP;CD34;HOMER2;PTPRC;TNFAIP3;NAV3;ZFP36;PNP
prerank,iron ion homeostasis (GO:0055072),0.6047258536920729,1.6310806061098344,0.003260869565217391,0.08858149615410324,1.0,18/58,12.88%,FTH1;FTL;B2M;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5940425463452698,1.6295716685070276,0.001091703056768559,0.08991126802454312,1.0,21/62,17.03%,TPT1;PPIA;CLU;HSPB1;CXCL12;NDUFA13;PARK7;AKT1;TMBIM6;PINK1;ENO1;BAG5;CREB3;PTTG1IP;DNAJA1;SYVN1;HSPA1A;YBX3;HERPUD1;TRIM32;NDUFS3
prerank,negative regulation of viral process (GO:0048525),0.6033319030606469,1.6291572572278565,0.001098901098901099,0.08997136007860787,1.0,22/57,22.30%,IFITM3;PPIA;IFITM2;IFITM1;MBL2;SHFL;TNF;ISG15;TRIM28;PROX1;IFIT1;ZFP36;BANF1;BST2;HEXIM1;TRIM32;OAS3;TRIM13;FAM111A;RSAD2;ISG20;TNIP1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7549782542681979,1.628376812455378,0.01349527665317139,0.09048286274712111,1.0,5/13,9.63%,BGN;HEXB;BCAN;HEXA;DCN
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.5812757400492545,1.6282658901255715,0.0,0.09018546571729193,1.0,16/84,4.82%,APOE;MRPL13;RPS3;CLU;RACK1;GAPDH;RPL13A;CALR;PRNP;IGFBP5;NTRK2;NCL;ORMDL3;RTN4;PIN1;SORL1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6377915740216672,1.6281921216599473,0.004592422502870264,0.08983384721806802,1.0,13/37,10.00%,GRM5;GRIA2;GRID2;HOMER2;GRIK2;GRIN1;GRIN3A;GRM8;GRM7;GRIA4;GRIN2A;CDK5R1;GRM1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7879858530392619,1.6281563312323135,0.006993006993006993,0.08943353893510567,1.0,7/11,13.89%,GPX1;PRDX5;PRDX4;PRDX2;GPX3;PRDX1;CAT
prerank,regulation of oxidative phosphorylation (GO:0002082),0.7374615216415858,1.6274127651065795,0.015006821282401092,0.08989528349734376,1.0,9/16,13.84%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;NUPR1;MLXIPL;AK4;PDE12
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.7920913988729409,1.627274275583109,0.006983240223463687,0.08958770213303968,1.0,8/11,14.56%,UQCR11;UQCR10;CYC1;UQCRH;UQCRQ;UQCRC1;UQCRB;UQCRFS1
prerank,keratan sulfate catabolic process (GO:0042340),0.7784935312684891,1.6266532181762337,0.009523809523809525,0.08992284928057843,1.0,4/11,2.91%,HEXB;FMOD;LUM;HEXA
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5455378145439344,1.625554977152885,0.0,0.09072883606037764,1.0,95/224,23.29%,CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;ASIC2;NRXN1;CNP;GABRB1;NLGN1;SNAP25;CHRNA9;GRM5;GRIA2;SLC1A2;DLGAP1;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;GRIK2;GRIN1;CACNA1A;SYT1;PENK;DRD5;GABRA2;AMPH;SYPL1;RAPSN;SLC12A5;GRM7;GRIA4;GRIN2A;PDYN;PRKAR1A;SYN2;HTR2C;SLC6A5;SLC6A2;CRH;CAMK1;KIF5A;GRM1;PRKAR1B;HAP1;CHRM3;GLRA2;GRIA1;GLRA1;GABRA3;GABRB3;SYN1;CHRM2;SLC1A1;NRXN2;CHRNA4;HCRT;SDCBP;SYT10;CDK5;CPNE6;KCNK3;DOC2A;KCNA1;GABRB2;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;GLRA3;SNCA;UNC119;GABBR2;UTS2;GAD1;SST;CACNB4;NPY5R;GRIA3;GRIK1;CHRNA3;CACNA1E;HTR3B;SYT5
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6360898368532959,-1.624347440017712,0.030303030303030304,0.39306101740054183,1.0,3/12,3.12%,FBXW4;SKI;LRP6
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.668357002833325,1.6205392896315423,0.010882708585247884,0.09649018642035297,1.0,13/25,20.87%,HSPA8;HSPA5;SDF2L1;HSPE1;HSPA1B;BAG1;SDF2;HSPA1A;PTGES3;DNAJB1;ERO1A;HSPA2;HSPA9
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5829189262479123,1.620005864083228,0.0032085561497326204,0.09674182059517412,1.0,33/74,21.65%,RPS27A;UBC;UBB;PSMB4;ELOB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;UBA52;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;EGLN2;PSMB1;PSMB5;VHL;PSMA6;NOTCH1;CITED2;PSMA4;SIRT2;ELOC
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6471918264009354,1.6177219450396747,0.007272727272727273,0.09946980799890903,1.0,17/32,21.19%,PPIA;CALM1;HSP90AB1;CALM3;PPP1R15B;PIN1;DUSP26;SMPD1;DLC1;CDH5;CD300A;PPP1R15A;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7596060821423101,1.6172900986481895,0.011379800853485065,0.09955004241281923,1.0,4/11,10.04%,GSN;PARK7;ST18;PIH1D1
prerank,defense response to bacterium (GO:0042742),0.5668959263877389,1.6167566445744068,0.0,0.09973846130712444,1.0,28/105,18.13%,RPL30;RPL39;RPS19;MBL2;MPEG1;PGLYRP1;TREM2;ROMO1;FCER1G;ANG;S100A9;S100A8;TIRAP;RARRES2;ISG15;CEBPB;AQP1;ADGRB1;STAB1;CHGA;LYZL4;LCN2;SLC11A1;TLR6;ADAM17;NOS2;SYK;OAS3
prerank,error-free translesion synthesis (GO:0070987),0.6897399201949838,1.616571714530822,0.006180469715698393,0.0995230415490641,1.0,8/22,13.25%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;PCNA;RFC2
prerank,neurotransmitter transport (GO:0006836),0.5804991247063204,1.6157116328605914,0.0010799136069114472,0.10026745685930598,1.0,30/73,15.30%,HSPA8;SLC17A8;NRXN1;SNAP25;SLC1A2;DNAJC5;SYT1;GLUL;GABRA2;RIMS1;PPFIA4;PPFIA2;SYN2;SLC6A2;VAMP2;PTPRN2;SLC6A16;SLC17A7;SLC29A1;SLC17A6;SYN1;SLC1A1;NRXN2;CHAT;GLS2;GLS;SLC29A2;LIN7C;NAAA;PPFIA3
prerank,negative regulation of transposition (GO:0010529),-0.5707221625825429,-1.6153924354331808,0.02564102564102564,0.40767901036894716,1.0,7/16,16.08%,UBR2;TUT7;MOV10;MYBL1;TEX15;TUT4;SIRT7
prerank,regulation of neuron apoptotic process (GO:0043523),0.5739241675295416,1.614169920373826,0.0,0.10191367582440128,1.0,43/96,21.81%,APOE;MDK;GRN;MT3;PARK7;SOD1;ATF4;LGMN;PRNP;FOXQ1;TREM2;PINK1;GRID2;TNF;FZD9;NTRK2;CTNNB1;FAIM2;NUPR1;TRIM2;CDK5R1;SET;BAX;WFS1;EGLN2;CCL2;PTPRZ1;CDK5;TYRO3;CCL3;BACE1;PPARGC1A;GRM4;AGAP2;ERBB3;AKT1S1;NSMF;TFAP2B;POU4F1;MEF2C;CRLF1;DDIT3;MAG
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7698314743118766,1.6113009341983795,0.012482662968099861,0.10499733294275031,1.0,4/11,3.08%,RACK1;PARK7;ATF4;PINK1
prerank,cellular response to hypoxia (GO:0071456),0.5545686725543771,1.6098083784945185,0.0,0.10662466154525088,1.0,54/126,21.65%,RPS27A;UBC;UBB;PSMB4;ELOB;MT3;HMOX1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PINK1;KCND2;PSMD1;ZFP36L1;EPAS1;PSMC3;PSMD6;PGK1;HIPK2;UBA52;PSMA7;NDRG1;BNIP3L;P4HB;FMN2;AQP1;PSMD5;RBX1;AK4;PSMB9;PSMD13;PSMB3;ACAA2;PMAIP1;PSMB11;PSMB10;EGLN2;BAD;PSMB1;PSMB5;VHL;LMNA;TWIST1;NOP53;PSMA6;SFRP1;PSMA4;MYC;SIRT2;HYOU1;STUB1;ELOC
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7308392232081342,1.609400565748189,0.009433962264150943,0.10674046324996954,1.0,3/15,2.14%,TMSB4X;HSPB1;LGMN
prerank,'de novo' posttranslational protein folding (GO:0051084),0.6458596883721912,1.6077966729043278,0.007142857142857143,0.10857812109911823,1.0,12/30,16.17%,HSPA8;HSPA5;SDF2L1;HSPE1;CCT2;HSPA1B;BAG1;SDF2;HSPA1A;PTGES3;DNAJB1;ERO1A
prerank,actin filament bundle assembly (GO:0051017),-0.4590956657711585,-1.607733903687647,0.014388489208633094,0.41964497852302285,1.0,9/33,4.65%,CALD1;DPYSL3;PAWR;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,regulation of platelet activation (GO:0010543),0.6858212690887509,1.6069117831532955,0.012626262626262626,0.10927912989221544,1.0,4/21,4.09%,APOE;THBD;PDGFB;FCER1G
prerank,histone H3-K36 demethylation (GO:0070544),-0.629561708188737,-1.6057194199533606,0.04838709677419355,0.4160834729295085,1.0,4/10,13.40%,KDM2A;KDM7A;KDM4C;PHF8
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8004345851018968,1.6053045131472865,0.007429420505200594,0.11114119129058225,1.0,1/10,0.03%,APOE
prerank,defense response to fungus (GO:0050832),0.7113082821348541,1.605079770547764,0.01706036745406824,0.11089219434565485,1.0,7/17,14.23%,GAPDH;S100A9;S100A8;RARRES2;CLEC6A;CLEC4D;CX3CR1
prerank,heme biosynthetic process (GO:0006783),0.6741625091624273,1.604998592237547,0.01910828025477707,0.11048136366801023,1.0,10/22,16.26%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7274707282518963,1.6044841886234633,0.020253164556962026,0.11068447407375821,1.0,2/14,1.05%,RPS3;CD81
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4893506146800537,-1.6041413267435793,0.01507537688442211,0.41191624018676165,1.0,7/24,7.96%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ARHGEF18;PPFIA1;MET
prerank,positive regulation of neuron death (GO:1901216),0.6036720938457542,1.603404398239412,0.009009009009009009,0.11163889752719687,1.0,25/46,22.12%,CLU;C1QA;TYROBP;GRN;ATF4;PRNP;ITGB2;TNF;CTNNB1;MAPT;NUPR1;EGR1;CDK5R1;WNT5A;BAX;TLR6;CDK5;CCL3;BACE1;GRIN2B;SNCA;TFAP2B;DDIT4;DDIT3;REST
prerank,positive regulation of chemotaxis (GO:0050921),0.6057621815581787,1.601496971523828,0.004489337822671156,0.11388005704687659,1.0,19/43,19.83%,TMSB4X;MDK;HSPB1;LGMN;CCL19;TREM2;PDGFB;DSCAM;RARRES2;KDR;P2RY12;AIF1;F2RL1;ADAM17;CCR2;STX4;EDN3;IL6;TGFB1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7304037247048761,1.6005802218348892,0.02091503267973856,0.11475704934377584,1.0,3/14,5.28%,TYROBP;TNF;ATP6AP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.7461131351482667,1.6005672118466245,0.01532033426183844,0.11428766790340915,1.0,4/12,10.15%,RPL26;CD74;MIF;TAF9
prerank,protein stabilization (GO:0050821),0.5456842035732864,1.5998551841694904,0.0,0.11490721373546049,1.0,56/168,18.27%,RPL23;RPL11;RPS7;RPL5;CLU;GAPDH;LAMP1;TYROBP;HSP90AA1;HSP90AB1;GRN;CALR;MT3;PPIB;PARK7;CRYAB;PINK1;CCT2;CHEK2;GLMP;RTN4;PIN1;HSPA1B;FLOT1;FLNA;BAG5;PFN1;BAG1;DNLZ;CCT7;ATP1B2;HSPD1;TSPAN1;CCT8;MFSD1;TAF9;MTMR9;CDC37;SOX17;MSX1;WFS1;SYVN1;NCLN;HSPA1A;FBXW7;WNT10B;PTGES3;ATP1B1;GOLGA7;PEX6;VHL;PFN2;PPARGC1A;ATP1B3;NOP53;LAMP2
prerank,kinetochore organization (GO:0051383),-0.5992664015446935,-1.5998454118125025,0.02768166089965398,0.41516791560823263,1.0,8/13,26.50%,POGZ;CENPC;CENPT;CENPE;CENPH;NDC80;MIS12;NUF2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5668474246295498,1.5990582286869972,0.0010570824524312897,0.11542930966667661,1.0,24/84,13.59%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;ECRG4;PSMD6;UBA52;PSMA7;PSMD5;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXO5;FBXO31;PSMB10
prerank,positive regulation of chemokine production (GO:0032722),0.6052073102909082,1.5985359365291025,0.006928406466512702,0.11573014632007071,1.0,23/44,25.85%,CD74;MBP;HMOX1;TNF;TIRAP;LPL;EGR1;HMGB1;CSF1R;WNT5A;AIF1;F2RL1;TWIST1;ADCYAP1;ADAM17;SYK;OAS3;IL6;PYCARD;APP;AGER;IL33;TLR7
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6385083703854905,1.5971678784787595,0.010804321728691477,0.11729861399485692,1.0,15/32,20.40%,CALM1;AKAP6;CALM3;GPER1;APLNR;GSTO1;P2RY6;THY1;CXCL10;HAP1;GSTM2;TRPC1;CALM2;SNCA;CAPN3
prerank,error-prone translesion synthesis (GO:0042276),0.6919255515681524,1.5969703522886152,0.010922330097087379,0.11712187023234755,1.0,7/21,13.25%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2
prerank,lipid catabolic process (GO:0016042),0.6979628845761994,1.59689042821909,0.015209125475285171,0.11673671799020371,1.0,5/18,8.93%,MT3;PLAAT3;LIPG;LIPE;LPL
prerank,aerobic respiration (GO:0009060),0.6908673382978339,1.5962583238466868,0.00639386189258312,0.1172195875937086,1.0,9/20,14.09%,ATP5F1D;UQCR10;NDUFS7;UQCRH;SDHB;UQCRC1;BLOC1S1;UQCRB;NDUFS8
prerank,cell-cell junction assembly (GO:0007043),0.5827099073191573,1.596141482714229,0.0021598272138228943,0.11689439847442946,1.0,22/63,16.80%,ACTB;ACTG1;CLDN5;RAMP2;GJA4;GJB2;RHOC;CDH20;CTNNB1;CLDN11;CDH18;RHOA;CDH12;GJA1;CDH19;DCHS1;JAM3;CDH7;CDH24;EPB41L3;CDH10;CDH5
prerank,regulation of mRNA catabolic process (GO:0061013),0.5520157192515177,1.5946983007828759,0.0,0.11844143825832487,1.0,37/121,13.60%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;YWHAB;PSMD1;ZFP36L1;PSMC3;ZFP36L2;PRR5L;PSMD6;PCBP4;UBA52;PSMA7;PSMD5;XPO1;SET;ZFP36;PSMB9;EXOSC2;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;HSPA1A;PSMB10;YWHAZ
prerank,triglyceride catabolic process (GO:0019433),0.6866497209351372,1.5939255659944167,0.011553273427471117,0.11906901030276287,1.0,7/19,23.46%,PNPLA2;FABP5;LIPG;LPL;FABP7;FABP4;FABP3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4409585823636809,-1.5938505254643585,0.0,0.42220342350195844,1.0,13/39,14.26%,TSPAN5;ZMIZ1;CREBBP;MAML2;ROBO1;YAP1;KAT2B;STAT3;MAML1;AAK1;RBPJ;JAG1;PRKCI
prerank,cellular response to heat (GO:0034605),0.6252586924667051,1.593762623671854,0.008215962441314555,0.11878049942482094,1.0,11/35,13.09%,HSP90AA1;HSP90AB1;HSBP1;HMOX1;POLR2D;HSPA1B;YWHAE;VCP;MAPT;PDCD6;HSPA1A
prerank,zymogen activation (GO:0031638),0.6173363170596999,1.5936155487645025,0.010285714285714285,0.11847831787394714,1.0,18/39,18.82%,CTSL;LGMN;CD5L;PGK1;OMA1;F9;KLK1;GRIN2A;VSIR;PLAT;RIPK2;CTSH;BAD;HPR;HP;PLAU;MMP14;PRSS12
prerank,negative regulation of RNA splicing (GO:0033119),0.6941809994626871,1.593405299732385,0.011568123393316195,0.1182665628598281,1.0,5/19,7.06%,RPS13;RPS26;TMBIM6;PCBP4;SRSF9
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7005787206293652,1.5933925607201445,0.014435695538057743,0.11778982556246281,1.0,5/17,4.03%,CALM1;HSP90AB1;CALM3;PPP1R15B;PTPRC
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.6782033525151683,1.5920652420381318,0.015151515151515152,0.11917242072805946,1.0,10/23,15.08%,HSP90AA1;TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B;BAX;PMAIP1;BAD;TIMM29
prerank,negative regulation of receptor binding (GO:1900121),0.7861919822569017,1.5920358467798466,0.020437956204379562,0.11871956799831446,1.0,2/10,3.42%,B2M;ADAM15
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5797067711350083,1.5918976560743487,0.0,0.11798931828372397,1.0,22/78,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5797067711350083,1.5918976560743487,0.0,0.11798931828372397,1.0,22/78,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,macrophage migration (GO:1905517),0.7268903146321424,1.5917657764106388,0.024896265560165973,0.11764029530605094,1.0,6/13,19.15%,LGALS3;P2RY12;CCL2;CCL3;CCR2;CXCL17
prerank,positive regulation of leukocyte migration (GO:0002687),0.6430657548728622,1.5916752348419783,0.0186799501867995,0.1173057204860155,1.0,11/27,19.67%,MDK;TNF;LGALS3;THY1;AIF1;F2RL1;JAM3;ADAM17;PLVAP;EDN3;IL6
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6867408526757299,1.590506632134138,0.02165605095541401,0.11854883860717037,1.0,11/20,22.37%,GNA11;LY6H;CDK5R1;RGS10;CHRM3;CHRM2;LYPD1;CHRM5;GRK2;AGRN;CHRNA3
prerank,regulation of lipid catabolic process (GO:0050994),0.6921968600523486,1.5895595536087954,0.013140604467805518,0.11944289570625799,1.0,5/19,5.68%,APOC1;TNF;BSCL2;PDE3B;RARRES2
prerank,negative regulation of axonogenesis (GO:0050771),0.6433580315986649,1.5884506180173774,0.0166270783847981,0.12054872261336406,1.0,10/27,15.84%,ARHGDIA;MT3;DCC;RTN4;LRP4;THY1;MAP2;GDI1;RHOA;FGF13
prerank,T cell activation involved in immune response (GO:0002286),0.7560333563780393,1.5884036160020933,0.019444444444444445,0.12014677997266428,1.0,7/12,14.62%,CD74;MDK;FCER1G;LCP1;SLC11A1;LILRB1;F2RL1
prerank,cellular respiration (GO:0045333),0.6094793948143584,1.5883189337010142,0.00558659217877095,0.119793699524504,1.0,20/41,23.79%,ATP5F1D;UQCR10;NDUFS7;UQCRH;ETFB;SLC25A13;NDUFA5;MTLN;SDHB;UQCRC1;BLOC1S1;UQCRB;NDUFS8;UQCRFS1;PPARGC1A;CYCS;SDHA;COQ10A;MTFR1L;SLC25A14
prerank,selective autophagy (GO:0061912),0.5901197107947315,1.5871027021042687,0.003293084522502744,0.12108629309755498,1.0,11/56,7.70%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1;MAP1LC3B;AUP1;UBA52;UFC1
prerank,mitochondrial gene expression (GO:0140053),0.6030340806680901,1.5869011586284136,0.013559322033898305,0.12090994110030827,1.0,16/42,19.36%,MRPL23;MRPS12;LARS2;MRPS34;MRPS11;MRPS14;MRPL51;MRPL57;MRPL2;NDUFA7;MRPS24;MRPL12;MRPS2;MRPS6;MRPS16;MRPS21
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6970773889024403,1.5865840548107835,0.02099737532808399,0.12088555014976089,1.0,8/18,19.89%,GNA11;CDK5R1;RGS10;CHRM3;CHRM2;CHRM5;GRK2;AGRN
prerank,negative regulation of neuron death (GO:1901215),0.5606967728434775,1.5857906566520632,0.0,0.12160765989813002,1.0,17/93,4.82%,APOE;MDK;GRN;GPNMB;MT3;PARK7;SOD1;ATF4;LGMN;AKT1;FOXQ1;CD34;PINK1;FZD9;NTRK2;NENF;SORL1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6097491101195123,1.5852730095718568,0.011682242990654205,0.12199919260932984,1.0,8/36,8.89%,APOE;CALM1;S100A1;HSP90AA1;AKT1;TNF;CYGB;SPR
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6004008118043278,1.5852408426509503,0.006756756756756757,0.1215652569302218,1.0,10/42,12.88%,RPL30;RPS19;MPEG1;TREM2;ROMO1;RARRES2;AQP1;ADGRB1;CHGA;SLC11A1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.7034449191602344,1.5848119163466572,0.013245033112582781,0.12175747203273479,1.0,8/16,9.83%,TMSB4X;TREM2;PINK1;ENO1;PARP1;VCP;AK4;DNAJC30
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5511500244844681,1.5836826393276175,0.0010460251046025104,0.12315223285819257,1.0,26/88,17.56%,APOE;CST3;MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;AKT1;SERPINE2;IGFBP5;NCL;CSTB;NELL1;YBX1;PCIF1;ATRAID;PLAT;CAMK2N1;CDK5;ENC1;EIF4A3;DAB2IP;EIF4ENIF1;CLN8;NANOS2
prerank,regulation of blood coagulation (GO:0030193),0.6513539406963229,1.5830162298429762,0.018292682926829267,0.12361660614771108,1.0,5/27,2.99%,APOE;VTN;THBD;SERPINE2;CD34
prerank,positive regulation of translation (GO:0045727),0.560903916631466,1.5826098728237128,0.0,0.12372193087775867,1.0,17/94,6.54%,RPL26;RPS9;RPS4X;RPL5;EEF2;VIM;UQCC2;EIF3D;POLR2D;NPM1;RPS27L;EIF5A;EIF5AL1;COA3;PKM;UHMK1;EIF3C
prerank,muscle filament sliding (GO:0030049),0.6070260594805672,1.5820241076260393,0.011627906976744186,0.12358460877321571,1.0,8/38,15.84%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,actin-myosin filament sliding (GO:0033275),0.6070260594805672,1.5820241076260393,0.011627906976744186,0.12358460877321571,1.0,8/38,15.84%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,regulation of cholesterol esterification (GO:0010872),0.7908184167265464,1.5809057810999305,0.02014388489208633,0.12482330168817496,1.0,5/10,9.19%,APOE;APOC1;AGT;ABCG1;STARD4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5664435253601321,-1.5808919222729183,0.03187250996015936,0.44715070667874335,1.0,4/15,3.12%,EDA;ANKRD11;GLI2;LRP6
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4810536251453189,-1.5807651980227146,0.03508771929824561,0.4387256830616049,1.0,11/25,19.40%,GHR;STAT5B;IL31RA;PIAS1;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7719690986705194,1.5770069676390428,0.010043041606886656,0.12997130309595034,1.0,8/11,19.10%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;SRI;FKBP1B;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7719690986705194,1.5770069676390428,0.010043041606886656,0.12997130309595034,1.0,8/11,19.10%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;SRI;FKBP1B;CALM2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5733682187872424,1.5767584216223098,0.0010482180293501049,0.12983937622725966,1.0,22/79,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6083287933036448,1.5767112762193207,0.004555808656036446,0.1294191627059152,1.0,20/38,19.75%,PRNP;GRM5;AGT;PDGFB;PTPRC;HYAL2;PTK6;THY1;LILRA5;FCGR1A;CSF1R;DOK7;SRCIN1;GAS6;LRP8;CAV1;CASS4;ERBB3;UNC119;EFNA1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6925272555560714,1.5765788047458513,0.02176696542893726,0.12914790524408712,1.0,6/18,12.22%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,positive regulation of phosphatase activity (GO:0010922),0.6738140632412509,1.5761311853237538,0.010012515644555695,0.12931111827637629,1.0,10/21,20.07%,CALM1;HSP90AB1;CALM3;PPP1R15B;MTMR9;BMP2;CD300A;PPP1R15A;CALM2;MEF2C
prerank,sulfur compound catabolic process (GO:0044273),0.6088506244312983,1.575603140359124,0.010238907849829351,0.12967447476161917,1.0,22/38,30.60%,BGN;HEXB;BCAN;FMOD;LUM;HEXA;MPST;DCN;ACAT1;TXN2;TST;VCAN;ACAN;PRELP;ADO;CSPG5;CHAC2;GLB1;GGT5;GGT7;IDS;GNS
prerank,regulation of calcium ion import (GO:0090279),0.6656831561343529,1.5741980038683627,0.019083969465648856,0.13139717343019994,1.0,11/21,20.23%,SLC30A1;CXCL12;PRNP;PDGFB;LGALS3;CTNNB1;PLN;CCL2;CCL3;PSEN2;SPHK2
prerank,positive regulation of cellular component organization (GO:0051130),0.5481639835974829,1.574053162305258,0.0,0.13109113271480105,1.0,30/107,11.61%,APOE;RPS3;CLU;RACK1;GPX1;CD151;PARK7;CCL19;NRXN1;NRG1;TREM2;TNF;TMEM30A;RHOC;LGALS3;LRP4;FLOT1;TIRAP;VCP;TFRC;LMAN1;SURF4;MTLN;CAMK1;PIH1D1;SMPD1;TMED9;MMP3;BAX;WARS1
prerank,acylglycerol homeostasis (GO:0055090),0.6817644133688984,1.5721163398907092,0.017789072426937738,0.13380960109057832,1.0,4/20,9.13%,APOE;MTLN;LPL;MLXIPL
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.4876060517973061,-1.5712138128521458,0.015228426395939087,0.4577029912969903,1.0,8/23,11.38%,ZBTB20;ARNT;NFKB1;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,ganglioside metabolic process (GO:0001573),0.6749651837102796,1.5710891069753241,0.01683937823834197,0.13495584498516258,1.0,9/20,16.06%,GM2A;HEXB;HEXA;B4GALNT1;CLN6;ST8SIA4;ST6GALNAC3;ABCA2;NEU1
prerank,positive regulation of response to wounding (GO:1903036),0.6437482364657419,1.5696685423759393,0.01877346683354193,0.13663507163625097,1.0,4/24,1.29%,ACTG1;VTN;MDK;GRN
prerank,neurotransmitter secretion (GO:0007269),0.5856322196703633,1.5695256586029604,0.007945516458569807,0.13640462122188624,1.0,27/44,29.01%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;LIN7C;NAAA;PPFIA3;SYT10;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.647079125061055,1.5693484214149631,0.020050125313283207,0.13620336070127867,1.0,10/24,16.26%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5504703810929832,1.5693124414609516,0.0010471204188481676,0.13578042525559542,1.0,36/94,20.79%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TOLLIP;PSMD1;PSMC3;ST18;PSMD6;UBA52;PSMA7;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;RIPK2;PSMB10;UBE2V1;PSMB1;PSMB5;SQSTM1;TAB1;PSMA6;SKP1;IL1RAP;PSMA4;NFKBIA
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4573029621195103,-1.5680904207172566,0.012578616352201259,0.4585278629694313,1.0,9/31,10.62%,RANBP3L;SMAD6;CRIM1;SUFU;LRP5;SKI;CDK6;PPARG;TRPM4
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6555991356258161,1.5677317503856592,0.0199501246882793,0.1377819557466934,1.0,8/24,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,epithelial cell differentiation (GO:0030855),0.5604564791697074,1.567184643598108,0.0,0.1380926161064037,1.0,18/88,11.93%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;AKT1;ERBB4;TOLLIP;LGALS3;PGK1;EDF1;PROX1;BASP1;KDR;DNPH1;PIH1D1;KDM6B;PCNA
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.646397800096215,1.5666709688758573,0.012484394506866416,0.13839431149051215,1.0,10/25,16.45%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF;KLF4;DDAH1;TLR6;DDAH2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6939396654006078,1.5660312656894024,0.02607561929595828,0.13882928163171368,1.0,10/18,17.76%,APOE;NSG1;PSENEN;ABCG1;KLK6;ACHE;BACE1;PSEN2;ADAM17;APH1B
prerank,digestive tract development (GO:0048565),-0.45388063454409655,-1.5651009582476716,0.02112676056338028,0.4590142343564808,1.0,10/32,10.39%,RARB;SMO;GLI3;GLI2;NIPBL;COBL;CLMP;PCSK5;FGFR2;PKD1
prerank,protein-containing complex disassembly (GO:0032984),0.5850144508825325,1.5646208912704136,0.005611672278338945,0.14071485519634808,1.0,10/54,5.80%,RPL23;HSPA8;GABARAP;PPP1CA;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;CTNNB1;VCP
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.713977494257146,1.5639498939132719,0.015384615384615385,0.14140430518865088,1.0,5/14,8.58%,GRN;TREM2;PTPRC;NR1D1;SYT11
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5546548089810723,-1.5634528036025972,0.045871559633027525,0.45600888195055994,1.0,4/16,8.25%,PDS5A;NIPBL;PDS5B;POGZ
prerank,embryonic eye morphogenesis (GO:0048048),-0.614420548575325,-1.5620896063361944,0.05263157894736842,0.45128320851051745,1.0,4/11,5.77%,FBN1;LRP6;RARG;EFEMP1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5914620911532088,1.5616297792907146,0.007865168539325843,0.14478528165285254,1.0,11/48,9.82%,TMSB4X;ATP5F1B;HSPB1;HMOX1;AKT1;ATP5F1A;PDGFB;KDR;JCAD;GATA2;HMGB1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5310870820109572,-1.5605141322360625,0.05333333333333334,0.4472275721789165,1.0,5/17,9.60%,PRKAG2;PPARA;NCOR1;PRKAA2;PPARG
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6550736119437199,1.5600096745474439,0.019417475728155338,0.1468212097017199,1.0,8/24,16.32%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2;POLD4
prerank,negative regulation of growth (GO:0045926),0.5369891665039311,1.5590349465303515,0.0010224948875255625,0.1478319441680271,1.0,44/121,20.23%,MT1H;MT1M;MT1X;MT1A;MT1B;MT1E;MT1F;MT1G;RACK1;MT3;NDUFA13;MT2A;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;ING1;DACT3;SLIT3;NDUFS3;SCGB3A1;CCAR2;INHBA;NOTCH1;TGFB1;ING5;OSGIN1;SFRP1;SPHK2
prerank,natural killer cell mediated immunity (GO:0002228),0.6979260591695013,1.5585469987967815,0.016238159675236806,0.1481163976487535,1.0,2/15,1.46%,TUBB;TUBB4B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.638871262038151,1.5578855931384716,0.015476190476190477,0.14869295849515518,1.0,5/27,6.79%,RPS27A;UBC;UBB;MAPK3;UBA52
prerank,regulation of aerobic respiration (GO:1903715),0.7050456888990286,1.5575435220318754,0.027359781121751026,0.14880463973856858,1.0,6/15,9.44%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;AK4
prerank,regulation of cellular component biogenesis (GO:0044087),0.6067904006909517,1.557122473155236,0.0220162224797219,0.1489680707655453,1.0,9/39,6.44%,APOE;HSPA8;GFAP;HSP90AA1;CCL19;PINK1;AGT;BAG5;MSN
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6995647987796796,1.556537757298362,0.023004059539918808,0.14946726019836346,1.0,2/16,7.11%,CLDN5;CLDN11
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6138781771337914,1.5562812979086063,0.020023557126030624,0.1493600917725741,1.0,8/33,6.09%,APOD;HMOX1;IGFBP3;GPER1;IGFBP5;ANG;NDRG4;TNFAIP3
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7150136695996294,1.5558235089767185,0.0203527815468114,0.1496174832993017,1.0,5/13,5.80%,TMSB4X;TREM2;PINK1;ENO1;VCP
prerank,gastrulation (GO:0007369),-0.5477392605830729,-1.5556168488511808,0.05194805194805195,0.4525506198738044,1.0,5/15,13.79%,LRP5;GPC3;TASOR;NPHP3;SMAD2
prerank,cellular response to peptide (GO:1901653),0.5759823926841807,1.5541508691391064,0.012276785714285714,0.15188381436580844,1.0,20/56,16.62%,RPL23;VIM;LGMN;PRNP;TREM2;GRM5;GPER1;ZFP36L1;GRIN1;CACNA1A;ATP1A3;GRIN2A;CHMP5;DDX11;GJA1;RIPK2;TLR6;CDK5;CAV1;VCAM1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.6420169464718591,1.5540990141646551,0.022974607013301087,0.15146957336206074,1.0,11/24,16.80%,CLU;RACK1;PARK7;UBXN1;TMBIM6;CREB3;WFS1;SYVN1;HSPA1A;NR1H2;HERPUD1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.651653372627352,1.5539034948426564,0.020506634499396863,0.15129608397158212,1.0,7/24,7.53%,B2M;CALR;CANX;FCER1G;TAPBP;TAP2;PDIA3
prerank,regulation of leukocyte activation (GO:0002694),0.7148114664249535,1.5537143982516386,0.021505376344086023,0.1511461797191906,1.0,4/14,9.11%,CD74;GPER1;MIF;GPR137B
prerank,neuron maturation (GO:0042551),0.6846014466879402,1.5530335860681779,0.021822849807445442,0.15181841992206638,1.0,6/18,12.93%,MTCH1;C1QA;C3;ADGRB3;B4GALT6;CLN5
prerank,protein catabolic process (GO:0030163),0.5708685994489872,1.5514355156369557,0.008648648648648649,0.1541040756806114,1.0,15/59,12.96%,APOE;HSPA8;CTSD;HSP90AA1;USE1;NR1D1;CHEK2;UBE2G2;VCP;PRPF19;FBXO27;DDB1;PMAIP1;CLN5;CLN6
prerank,cholesterol transport (GO:0030301),0.5932349252262372,1.5513195138218638,0.005567928730512249,0.15380997038750147,1.0,8/45,9.19%,APOE;CLU;NPC2;APOC1;ABCG1;LIPG;TSPO2;STARD4
prerank,positive regulation of superoxide anion generation (GO:0032930),0.7248087671687345,1.5507006604437583,0.01912568306010929,0.15442583333876667,1.0,7/13,19.83%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,negative regulation of translational initiation (GO:0045947),-0.5875656348737517,-1.5487235732227775,0.04184100418410042,0.46389889609407664,1.0,7/13,21.61%,EIF2AK4;LARP1;RBM4;PAIP2;AGO2;FMR1;TPR
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7297475038906738,1.5484599810134616,0.019525801952580194,0.15803999346594388,1.0,3/12,1.67%,CTSB;CTSL;CTSS
prerank,protein insertion into ER membrane (GO:0045048),0.5966110891469311,1.5483413698788777,0.010465116279069767,0.1577328624995092,1.0,17/37,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;EMC6;SEC61G;EMC3;EMC10;VAMP2;EMC4;SERP1;SGTA;TRAM1L1;EMC8;VAPA;TRAM1;CYB5A
prerank,positive regulation of tissue remodeling (GO:0034105),-0.633969679318074,-1.548278956190406,0.04950495049504951,0.45766625315703935,1.0,4/10,5.46%,ROCK2;ROCK1;IL18;IL15
prerank,protein K63-linked ubiquitination (GO:0070534),-0.4240243047376089,-1.548023373706995,0.007194244604316547,0.45099609114022077,1.0,13/41,11.10%,UBE2E2;HECTD1;RNF152;PRKN;TRAF3IP2;ARIH2;TRAF5;RNF135;TRIM5;RNF8;ZFP91;ITCH;RNF115
prerank,signal release from synapse (GO:0099643),0.5803750065985023,1.5478221189059738,0.010273972602739725,0.15806691158729358,1.0,26/43,29.01%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;LIN7C;NAAA;PPFIA3;SYT10;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7534007446740923,1.5475300016914446,0.031073446327683617,0.15806150131005806,1.0,3/10,2.58%,CALM1;PDE4B;CALM3
prerank,regulation of superoxide anion generation (GO:0032928),0.7115078618374775,1.5469599311036706,0.017543859649122806,0.15841726165497277,1.0,7/14,19.83%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,response to ethanol (GO:0045471),0.7229046397609294,1.5468516980401879,0.024,0.15813147012171636,1.0,7/14,11.81%,SOD1;GRIN1;GRIN3A;GRIN2A;SDF4;GLRA2;GLRA1
prerank,anterograde axonal transport (GO:0008089),0.6022635513319375,1.5464497500341334,0.012585812356979404,0.1583269776697513,1.0,12/37,12.70%,HSPB1;SOD1;BLOC1S4;MAP1A;DLG2;NEFL;AP3B2;KIF5A;BLOC1S1;BLOC1S3;HAP1;BLOC1S5
prerank,positive regulation of dephosphorylation (GO:0035306),0.6293203944901153,1.5458529382883683,0.02303030303030303,0.1588542717233403,1.0,14/27,21.19%,PPIA;CALM1;CALM3;PIN1;SMPD1;MTMR9;BMP2;DLC1;CDH5;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.6765762601404299,1.5447053480385078,0.02531645569620253,0.16032189512932396,1.0,5/18,10.12%,LAPTM5;GPNMB;AKT1;DUSP3;FGL1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.561703307727867,1.5435918807291784,0.006362672322375398,0.16194878656846906,1.0,24/69,20.74%,APOE;MDK;GRN;MT3;PARK7;SOD1;LGMN;FOXQ1;PINK1;FZD9;NTRK2;SET;WFS1;CX3CR1;CCL2;PTPRZ1;NONO;TYRO3;PPARGC1A;AGAP2;ERBB3;POU4F1;MEF2C;CRLF1
prerank,glycine transport (GO:0015816),0.7583744994230821,1.5431809993452834,0.030683403068340307,0.16212983076229365,1.0,3/10,9.06%,SLC38A5;SLC6A17;SLC6A5
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7514089311847738,1.541942243051941,0.03076923076923077,0.1637560793714873,1.0,5/10,13.39%,TYROBP;HSP90AB1;FN1;CD24;LILRB1
prerank,myelin maintenance (GO:0043217),0.7552547753340647,1.541036861976553,0.023809523809523808,0.1647468694981931,1.0,7/10,16.64%,CLU;SOD1;MYRF;CXCR4;DEGS1;EPB41L3;PRX
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5725059280799752,1.540992431313823,0.010976948408342482,0.1643123141724512,1.0,14/53,17.09%,MTNR1A;MTNR1B;NPY1R;AGT;SSTR4;HTR2C;VIPR1;MC1R;CHRM3;CHRM2;CCL2;HTR7;PTGIR;CHRM5
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.7490584863920948,1.5406403158801245,0.015193370165745856,0.1644143884257159,1.0,5/11,5.54%,TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6606113277098126,1.5405444226868703,0.015483870967741935,0.16407978414816937,1.0,6/19,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,proton transmembrane transport (GO:1902600),0.6091443144286475,1.540319278025778,0.011655011655011656,0.16399007811696328,1.0,11/36,13.03%,ATP5MF;ATP6V0C;ATP5F1B;ATP6V1F;UCP2;ATP6V0E2;ATP1A3;HVCN1;ATP1A4;ATP1A1;SLC25A27
prerank,mitochondrion localization (GO:0051646),-0.5127798015285328,-1.5397507541530235,0.04128440366972477,0.46590450474135614,1.0,6/19,8.33%,LRRK2;TRAK1;MFN1;MARK1;BRAT1;MEF2A
prerank,transition metal ion homeostasis (GO:0055076),0.6246531356613849,1.5386808575082644,0.025830258302583026,0.1662111979074635,1.0,5/28,1.87%,FTL;B2M;MT3;HMOX1;TMPRSS6
prerank,regulation of B cell activation (GO:0050864),0.6320801440635478,1.537365007673623,0.018963337547408345,0.1680611459870963,1.0,9/25,21.39%,LAPTM5;ZFP36L1;ZFP36L2;TNFAIP3;CD22;IKZF3;SH3KBP1;IL6;BANK1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4680910969601293,-1.5373564407767268,0.00684931506849315,0.46463416622931475,1.0,15/29,19.58%,SMAD3;DICER1;DROSHA;SMAD1;ZC3H7A;TUT7;ZC3H7B;SMAD2;PUM2;SRRT;TARBP2;TUT4;AGO2;AGO4;ADAR
prerank,negative regulation of proteolysis (GO:0045861),0.5977299927261466,1.5370687371791152,0.021479713603818614,0.16810266824799847,1.0,13/34,12.44%,CST3;TIMP2;AKT1;PRNP;SERPINE2;TMEM59;ECM1;CSTB;TIMP1;GAS1;PLAT;CAMK2N1;TIMP3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.6142144583889739,-1.5349212678677682,0.05185185185185185,0.4642034458542344,1.0,5/10,17.24%,RAPGEF2;ATP7A;GIPC1;APPL1;CTNS
prerank,response to thyroid hormone (GO:0097066),0.7182521027820433,1.5348554431033137,0.023776223776223775,0.1716057852387915,1.0,3/13,1.67%,CTSB;CTSL;CTSS
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.709327895074819,1.534742353093789,0.03773584905660377,0.17124361532065777,1.0,4/13,3.67%,RACK1;PARK7;TXN;GPR37L1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6196089340859161,1.5346908205675438,0.017985611510791366,0.1708277152448291,1.0,11/28,14.56%,RPS3;RAC1;HSPA1B;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;HSPA1A;ARL2
prerank,peptide cross-linking (GO:0018149),0.6432994178120289,1.5346304162315747,0.010817307692307692,0.1704260663011969,1.0,6/25,13.69%,F13A1;TGM2;FN1;EPB42;COL3A1;EVPL
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5673636503657126,-1.5340220513139506,0.034482758620689655,0.4595352649418243,1.0,8/14,22.35%,GHR;STAT5B;PXN;STAT3;PTK2;STAT5A;STAT6;PIK3R1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6292985855543192,1.5335654353311061,0.021144278606965175,0.17196657353597164,1.0,6/26,3.71%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.45749922450582164,-1.5329613936302666,0.01,0.4550908494912357,1.0,10/27,15.34%,PID1;TNS2;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;PRKCB
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5643911329894404,-1.5327360312448148,0.04609929078014184,0.44889738912670724,1.0,7/13,22.20%,RANBP2;CBLB;KPNA4;KPNA2;NUP35;KPNA3;KPNA6
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6019566701007908,-1.5326473101639464,0.06060606060606061,0.4426375396082281,1.0,5/11,18.78%,PDK1;STK24;PRODH;GSKIP;MAP3K5
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6453979767217075,1.5323837842563457,0.03754693366708386,0.17370784602127948,1.0,5/22,6.25%,TMSB4X;TMSB10;GSN;MYADM;PFN1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6339274212706496,1.5321984717715305,0.028290282902829027,0.17347858035994276,1.0,9/28,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;OTULIN;AAMP;RIPK2;UBE2V1
prerank,axon development (GO:0061564),0.5471686069193465,1.5319911077369142,0.005230125523012552,0.17337536177571244,1.0,25/78,16.84%,ACTB;S100A6;PLP1;DCC;S100B;CTNNA2;ANK3;MAP1A;CNTN4;RTN4;NEFH;NRCAM;GRM7;MAPT;CDK5R1;PAK3;ADGRB1;APBB1;SHTN1;CCK;DSCAML1;SPTBN4;CDK5;GAP43;BRSK2
prerank,histone modification (GO:0016570),-0.3399123752680077,-1.5318207081791522,0.0,0.4382048408187228,1.0,32/109,14.95%,EYA2;NSD1;EYA1;PRDM5;KAT6B;CREBBP;USP3;MIDEAS;BAZ2A;HDAC4;MTA3;EHMT1;TBL1X;HUWE1;RCOR1;UFL1;EYA4;BAZ1B;USP16;NSD3;MIER1;USP36;TBL1XR1;EYA3;RCOR3;BRD8;PHF20L1;KAT6A;SIRT1;EHMT2;CARM1;EZH2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6315678513619456,1.5305761240556306,0.022332506203473945,0.17553630607444068,1.0,12/26,16.41%,CYBA;RTN4;FLOT1;TIRAP;SLC15A4;TICAM2;HMGB1;NINJ1;F2RL1;TLR5;TLR1;CAV1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6420893145807021,1.5295807614654418,0.016331658291457288,0.1767822695453665,1.0,7/22,9.85%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;CD22;PHPT1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5981130316025786,1.5291376785183692,0.01633605600933489,0.17716735349294235,1.0,13/34,20.23%,LAPTM5;RBP4;SLC7A5;PTPRC;IL2;VAMP3;WNT5A;F2RL1;DNAJB9;STX4;CD86;IL6;SPHK2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6662402388927379,1.5289702390363558,0.03534031413612566,0.1769742435487303,1.0,6/17,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,protein autoubiquitination (GO:0051865),-0.3838347078884276,-1.5285846443634494,0.021505376344086023,0.4399353032357528,1.0,19/61,15.26%,RNF220;CNOT4;PRKN;SH3RF1;SH3RF3;RNF146;RNF213;RNF8;UHRF2;DDB2;RNF41;SH3RF2;NFX1;ITCH;RNF115;ERCC8;WWP2;RNF185;MDM2
prerank,negative regulation of axon extension (GO:0030517),0.6135068299687185,1.5276692561657417,0.013033175355450236,0.1787877826872677,1.0,9/30,13.41%,MT3;SEMA3F;SEMA7A;RTN4;SEMA4C;SEMA6D;MAP2;SEMA4A;SEMA4G
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6308059929642865,1.5274224501832985,0.029055690072639227,0.17875911358945923,1.0,8/26,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,positive regulation of neutrophil migration (GO:1902624),0.6574689653128416,1.5259017521374512,0.03479381443298969,0.18108793628643027,1.0,6/18,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6901056911508807,1.5257144111083387,0.026923076923076925,0.1808516656517435,1.0,5/17,8.35%,APOE;SOD1;RAN;ABCG1;SEC14L2
prerank,phospholipid transport (GO:0015914),0.5662296476942468,1.5252163419322096,0.005567928730512249,0.1813113834022341,1.0,11/52,10.95%,APOE;PLTP;NPC2;APOC1;TMEM30A;SCP2;ATP8B4;ABCG1;ATP8A2;MFSD2A;ATP8A1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4064358389943351,-1.524720817702083,0.009523809523809525,0.44358155979300984,1.0,16/51,11.55%,FBN1;SMAD6;BMPR1A;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;CHRDL1
prerank,epiboly involved in wound healing (GO:0090505),0.6754053761767591,1.5241228811556367,0.034346103038309116,0.18280170723111253,1.0,7/16,17.95%,CD151;RHOC;MRTFA;FLNA;LCP1;RHOA;TMEFF2
prerank,transition metal ion transport (GO:0000041),0.6036062790304945,1.5230614548859638,0.014018691588785047,0.18429464573325,1.0,12/35,15.52%,FTH1;ATOX1;MT3;SLC30A1;COX17;TFRC;TTYH1;TRPC7;SLC11A1;TRPC1;SLC31A1;HEPH
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6569401669933014,1.5220081694062444,0.02702702702702703,0.18583216468170258,1.0,13/22,20.35%,PSMB4;PSMB6;PSMB8;PSMA7;PSMB9;PSMB3;PSMB11;PSMB10;PSMB1;ENC1;PSMB5;PSMA6;PSMA4
prerank,long-term memory (GO:0007616),0.6594444663620254,1.5217141700095338,0.02788339670468948,0.18582848868766363,1.0,4/19,7.77%,APOE;PRNP;CALB1;SGK1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5873639120752506,1.521149736164374,0.017523364485981307,0.18633137321377782,1.0,15/38,16.45%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;CD34;TNF;RAC1;SIRPA;KLF4;DDAH1;CX3CR1;TLR6;CAV1;DDAH2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5812178403443514,1.520701986167975,0.018285714285714287,0.1866232417244539,1.0,13/41,16.90%,GPX4;SCD5;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;SCD;FADS3;DEGS1;FAAH
prerank,dendrite self-avoidance (GO:0070593),0.6986187978569521,1.520666032861701,0.014473684210526316,0.18613582878057106,1.0,8/16,15.44%,BSG;DSCAM;CNTN4;ROBO4;EMB;TNN;IGSF9;DSCAML1
prerank,dendritic cell differentiation (GO:0097028),0.6357376323900424,1.5202032443797868,0.03626943005181347,0.18644867017937963,1.0,10/22,19.95%,CCL19;TREM2;IRF8;TRPM2;LILRB1;GAS6;F2RL1;BATF3;FLT3;BATF2
prerank,dopamine metabolic process (GO:0042417),-0.5118810569127026,-1.5199816706992664,0.02145922746781116,0.44943677560476725,1.0,4/18,6.77%,SNCAIP;MOXD1;PRKN;ATP7A
prerank,positive regulation of DNA replication (GO:0045740),-0.5210623934271602,-1.5198540615715488,0.021834061135371178,0.44357731360373265,1.0,7/16,13.82%,EGFR;GLI2;KAT7;BRPF3;BCAR3;ATAD5;STN1
prerank,gene silencing by miRNA (GO:0035195),-0.43847526135939224,-1.5193402851432516,0.01282051282051282,0.43902037121048143,1.0,16/32,19.58%,TNRC6B;TNRC6A;TNRC6C;CNOT1;DICER1;ZC3H7A;MOV10;RBM4;ZC3H7B;CNOT7;PUM2;TARBP2;LIMD1;AGO2;AGO4;ADAR
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6893195099504004,1.518347524359743,0.03443708609271523,0.18953339859734214,1.0,7/16,21.10%,APOE;AGT;DDAH1;MAFA;DDAH2;NOS2;KCNC2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5470683549402915,1.518145665363789,0.004273504273504274,0.18937116028656814,1.0,30/68,25.86%,CD74;MBP;TYROBP;CYBA;TNF;TIRAP;HYAL2;HSPD1;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;AIF1;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;IL6;SPHK2;TMEM106A;PYCARD;APP;AGER;LBP;IL33;TLR7;POU2F2
prerank,response to axon injury (GO:0048678),0.6558861463772436,1.516509801318999,0.0247074122236671,0.19210741258396108,1.0,4/18,2.84%,APOD;TYROBP;SOD1;TREM2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.566404241604923,1.5155620678801012,0.016648168701442843,0.19344769278254234,1.0,20/54,16.86%,RPS3;RPL11;RPL5;PARK7;UBXN1;AKT1;COPS9;HSPA1B;CTNNB1;BAG5;TNFAIP3;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;ARRB2;CAV1;SQSTM1
prerank,acylglycerol catabolic process (GO:0046464),0.6016448452435571,1.5140660084420339,0.022592152199762187,0.19591504449293037,1.0,12/30,25.29%,PNPLA2;LYPLA2;FABP5;LIPG;LIPE;LPL;FAAH;FABP7;FABP4;FABP3;ABHD16A;ABHD12
prerank,cellular response to interleukin-1 (GO:0071347),0.5171604392996343,1.513432582980513,0.002034587995930824,0.19659145595875466,1.0,48/143,20.94%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;CCL19;PSMB6;PSME2;PSMB8;PSMD2;TOLLIP;NR1D1;PSMD1;PSMC3;SIRPA;ST18;PSMD6;HYAL2;UBA52;PSMA7;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;RIPK2;PSMB10;UBE2V1;CCL2;MAPK11;PSMB1;PSMB5;DAB2IP;CCL3;SQSTM1;CCL8;TAB1;PSMA6;SKP1;SFRP1;IL1RAP;PSMA4;NFKBIA;PYCARD
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.6441034095512301,1.513090051262302,0.03258145363408521,0.1966932053191023,1.0,7/22,10.13%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,energy reserve metabolic process (GO:0006112),-0.4997746183978368,-1.512893523718324,0.021929824561403508,0.4495417792428482,1.0,5/19,4.38%,PRKAG2;PID1;PHKB;PHKA1;LEPR
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6685079517896795,1.5128071571970494,0.031578947368421054,0.19668916186382973,1.0,4/16,9.25%,TUBB;TUBB4B;CORO1A;VAMP2
prerank,regulation of stress fiber assembly (GO:0051492),-0.37538633672132826,-1.5124889130085348,0.0,0.4448494498530524,1.0,20/74,6.21%,ROCK2;PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ABL1;ASAP3;ALMS1;SLC9A1;LPAR1;ROCK1;PPM1E;NRP1;SORBS3;ARHGEF18;ARHGEF10L;CARMIL1;TGFBR1;PPFIA1;PXN
prerank,pulmonary valve morphogenesis (GO:0003184),-0.52717643814033,-1.5124269801463504,0.06550218340611354,0.43933478258192055,1.0,8/17,14.92%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;JAG1;BMP4;HEY2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5457294171424985,1.5114481833104816,0.012779552715654952,0.19894799260577148,1.0,18/71,10.13%,RPS27A;CTSB;UBC;UBB;CTSL;CTSZ;CTSS;LGMN;NR1D1;VCP;TNFAIP3;OMA1;UBA52;ISG15;PRPF19;NEDD8;OTUD7A;DDB1
prerank,morphogenesis of an epithelium (GO:0002009),0.6178202918288538,1.5110450863102332,0.029339853300733496,0.19927583043418332,1.0,2/25,0.25%,ACTB;ACTG1
prerank,protein localization to cell-cell junction (GO:0150105),0.6687628064322952,1.5109604700551142,0.04993429697766097,0.19889276349464996,1.0,2/15,0.25%,ACTB;ACTG1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5425879316710259,1.510240331368235,0.007454739084132056,0.19990742272554016,1.0,28/69,20.94%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;TIRAP;DDT;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;IL6;SPHK2;TMEM106A;PYCARD
prerank,autophagosome maturation (GO:0097352),0.6071509079697313,1.5089575351200932,0.022727272727272728,0.20178406726294465,1.0,7/32,5.80%,CALM1;GABARAP;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;VCP
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7282232655661935,1.50844085842567,0.03276353276353276,0.20226776967213272,1.0,7/11,15.58%,CYBA;TREM2;TIRAP;TNFAIP3;TLR6;F2RL1;TLR1
prerank,regulation of fibroblast proliferation (GO:0048145),0.5772430410142159,1.5082950900243166,0.016930022573363433,0.20200511933378076,1.0,18/45,20.52%,FTH1;CD74;S100A6;AGT;PDGFB;MIF;CTNNB1;FN1;AQP1;WNT5A;GAS6;PDGFA;DAB2IP;TRIM32;CD300A;DDR2;SFRP1;MYC
prerank,negative regulation of immune system process (GO:0002683),0.6677249820809266,1.5082270296366243,0.041025641025641026,0.2016303985094742,1.0,4/16,13.00%,HMOX1;GPER1;COL3A1;SOX9
prerank,negative regulation of neuron projection development (GO:0010977),0.556967724988313,1.5081855236934045,0.013172338090010977,0.2011392536738884,1.0,12/56,8.34%,APOE;ARHGDIA;ITM2C;MT3;DCC;NLGN1;RTN4;LRP4;SPOCK1;BAG5;CRMP1;THY1
prerank,histone mRNA catabolic process (GO:0071044),-0.5104802799358115,-1.5077713824166186,0.0625,0.44581568959374146,1.0,8/15,21.79%,TENT4B;XRN1;TUT7;TUT1;ATM;TUT4;TENT2;LSM1
prerank,regulation of protein binding (GO:0043393),0.5241054360356314,1.507462783182473,0.002061855670103093,0.20213401259555364,1.0,31/114,14.55%,ACTB;RPL11;RACK1;CLDN5;B2M;VTN;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;RAN;PDGFB;FKBP1A;PIN1;SORL1;FLOT1;TLE5;ADD2;HIPK2;LRPAP1;IFIT1;CAMK1;BAX;DNAJB2;DDX11;BMP2;RIPK2;HDAC5;TIAM1
prerank,spliceosomal snRNP assembly (GO:0000387),0.5849175323273107,1.5071279396291797,0.015011547344110854,0.2022358583685656,1.0,13/38,18.55%,SNRPG;GEMIN7;SNRPD2;LSM4;SNRPE;SNRPF;STRAP;CD2BP2;PRPF19;PRPF8;SNRPB;PRPF31;SNRPD3
prerank,water transport (GO:0006833),0.7105720870649548,1.506870005779667,0.03611111111111111,0.20217004584794238,1.0,2/12,8.40%,AQP4;AQP1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5802508751089539,1.506286191500628,0.018223234624145785,0.2028623807538166,1.0,22/41,23.07%,PRNP;GRM5;AGT;PDGFB;NTRK2;DOCK3;LILRA5;FCGR1A;CSF1R;DOK7;FBXW7;SRCIN1;GAS6;LRP8;NCF1;CASS4;ADAM17;ERBB3;UNC119;EFNA1;TGFA;PTPN1
prerank,regulation of microtubule-based movement (GO:0060632),0.7202801977072686,1.5059415822459612,0.04061624649859944,0.20305236204773738,1.0,4/11,11.11%,LAMP1;NEFH;MAP2;HAP1
prerank,cellular response to purine-containing compound (GO:0071415),0.7461423009320413,1.5055267701134736,0.030882352941176472,0.2033190366001984,1.0,6/10,15.89%,P2RY6;P2RY1;GSTM2;TRPM2;SLC8A1;RYR2
prerank,synaptic vesicle cycle (GO:0099504),0.6069890640753598,1.5049640462814298,0.02342786683107275,0.20380387551106283,1.0,17/30,28.13%,SLC17A8;NLGN1;SNAP25;DNAJC5;RIMS1;VAMP2;SLC17A7;SLC17A6;SYNDIG1;SYT10;CDK5;SNCA;SLC32A1;WNT7A;PIP5K1C;CPLX1;PCLO
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5338545840573166,1.5039273141634486,0.007391763463569166,0.20534249716524564,1.0,43/85,26.32%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;AP2M1;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;ARHGEF19;PSMA6;PSMA4;FZD2;FZD1;AP2A1;PSMC1;PARD6A;WNT7A;PSMD9;CELSR3;PSMB2;PSMD4;PSMD10;FZD3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.6349174150228654,1.5037243463922003,0.03482587064676617,0.20523353543882394,1.0,6/22,12.22%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6890365628620714,1.502850033988518,0.02029769959404601,0.20647322307668184,1.0,6/16,13.45%,IGFBP6;IGFBP3;IGFBP4;IGFBP5;IGFBP2;BMP2
prerank,regulation of interleukin-8 production (GO:0032677),0.5426157999553012,1.5019319156761288,0.009761388286334056,0.20783163663859328,1.0,22/69,21.15%,TMSB4X;CD74;PARK7;TNF;LAMTOR5;PTPRC;HSPA1B;TIRAP;HYAL2;HMGB1;KLF4;HSPA1A;TLR6;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3
prerank,negative regulation of inclusion body assembly (GO:0090084),0.7426603712216471,1.5015090435170075,0.05322128851540616,0.20817844573658087,1.0,8/10,20.71%,SORL1;HSPA1B;DNAJB2;HSPA1A;SACS;DNAJB1;DNAJA4;HSPA2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5388554533223914,1.5010677209760064,0.0021344717182497333,0.20859463612787152,1.0,29/73,20.94%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;TIRAP;DDT;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;CD86;IL6;SPHK2;TMEM106A;PYCARD
prerank,regulation of mRNA stability (GO:0043488),0.5158300713713492,1.5006218171563672,0.0,0.2090162615391921,1.0,55/145,20.35%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;NPM1;YWHAB;PSMD1;ZFP36L1;MEX3D;PSMC3;ZFP36L2;PSMD6;PCBP4;UBA52;PSMA7;PSMD5;YBX1;XPO1;SET;ZFP36;PSMB9;EXOSC2;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;SLC11A1;HSPA1A;PSMB10;YWHAZ;HNRNPU;PDE12;CIRBP;YTHDF1;PSMB1;PSMB5;PCID2;EIF4ENIF1;TBRG4;ANP32A;EXOSC9;PSMA6;CARHSP1;SERBP1;PSMA4
prerank,regulation of translation (GO:0006417),0.5109048174333553,1.5005535570559934,0.0,0.20856048114533268,1.0,24/173,4.47%,RPL26;MRPL13;RPS3;RPS4X;RPL5;EEF2;VIM;RACK1;GAPDH;RPL13A;HSPB1;CALR;EIF1;RPL10;EIF4G2;EIF3D;GRM5;SHFL;NPM1;RPS27L;EIF1B;METAP1;IGFBP5;NCL
prerank,regulation of transport (GO:0051049),0.5806136523713266,1.499614415595948,0.029691211401425176,0.21000936373564014,1.0,15/36,20.21%,ACTB;ACTG1;PINK1;REEP5;REEP6;VAMP2;DNAJA1;RSC1A1;CDK5;EPB41;ICA1;TMEM102;ICA1L;SNCA;TRAT1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6200045502348632,1.4995316881511214,0.020833333333333332,0.2096414461627353,1.0,11/26,19.10%,CALM1;CALM3;FKBP1A;YWHAE;GSTO1;PLN;GSTM2;CBARP;SRI;FKBP1B;CALM2
prerank,acylglycerol metabolic process (GO:0006639),0.5827108662156594,1.4987300685182734,0.011764705882352941,0.21079391924024768,1.0,8/37,9.18%,APOE;PNPLA2;APOC1;LYPLA2;PLAAT3;DGKH;LPL;DGKI
prerank,intraciliary retrograde transport (GO:0035721),-0.573505234263616,-1.4986044874633435,0.03678929765886288,0.4631494861485455,1.0,7/12,17.04%,DYNC2H1;WDR35;IFT140;IFT122;WDR19;DYNC2I2;DYNC2LI1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5086860237610094,-1.4984284506714356,0.06060606060606061,0.45780865286563704,1.0,9/18,21.30%,BIRC2;BIRC3;SEC14L1;ANKRD17;DDX60;NPLOC4;PUM2;DHX58;GPATCH3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6774822344253836,1.4978887525046882,0.03811944091486658,0.21185283165680072,1.0,4/15,5.38%,CLU;GPX1;AKT1;GHITM
prerank,lipoprotein biosynthetic process (GO:0042158),0.7275876289934042,1.497840441171806,0.04419889502762431,0.2114081026449681,1.0,1/11,0.03%,APOE
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7255949506477857,1.4978196829927237,0.06142857142857143,0.21037889995670309,1.0,3/10,12.78%,MBP;MYADM;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7255949506477857,1.4978196829927237,0.06142857142857143,0.21037889995670309,1.0,3/10,12.78%,MBP;MYADM;KLF4
prerank,negative regulation of T cell activation (GO:0050868),0.5842635141968264,1.4977845387465947,0.01179245283018868,0.2099091220004013,1.0,8/35,13.39%,LAPTM5;GPNMB;LGALS3;DUSP3;CEBPB;FGL1;SDC4;LILRB1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7193063131424273,1.4972778956087485,0.03698435277382646,0.21056630391630315,1.0,6/11,14.41%,CXCL12;CCL19;HCLS1;LILRB1;GAS6;IRF7
prerank,response to hydrogen peroxide (GO:0042542),0.5703468293690632,1.4969987214832057,0.009933774834437087,0.21057423932082162,1.0,14/45,15.71%,RPS3;GPX1;HMOX1;PARK7;SOD1;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2;CAT;HP;GLRX2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6896058984115079,1.4967506888575226,0.0340599455040872,0.2105354122881638,1.0,5/14,13.39%,CD74;LAPTM5;SEMA7A;WNT5A;LILRB1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5952361313574351,1.4967307268549799,0.03210463733650416,0.21004790862259842,1.0,11/29,13.55%,CALR;CXCL12;LGMN;TNF;LGALS3;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;GAS6
prerank,positive regulation of inflammatory response (GO:0050729),0.5312249842889628,1.4965711778454251,0.006376195536663124,0.20985156889453987,1.0,36/86,26.21%,RPS19;CD81;MDK;GRN;AGT;TNF;S100A9;S100A8;DDT;HYAL2;FEM1A;CEBPA;IL2;LPL;NUPR1;LILRA5;KARS1;NINJ1;PLA2G7;WNT5A;VAMP8;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;IL6;NFKBIA;TNIP1;APP;PLA2G3;LBP;PDE2A;IL33;TLR7;CX3CL1
prerank,response to nitric oxide (GO:0071731),0.6922131004199301,1.4963239182619148,0.04005524861878453,0.20988806619872805,1.0,5/13,11.31%,MT3;CCL19;TXN;AQP1;MMP3
prerank,negative regulation of macrophage activation (GO:0043031),0.6748658679093866,1.496179968404419,0.025503355704697986,0.2096346853033703,1.0,5/16,8.58%,GRN;PTPRC;NR1D1;LRFN5;SYT11
prerank,regulation of T cell migration (GO:2000404),0.6504570318326193,1.496123815923276,0.04155495978552279,0.20921501668888176,1.0,9/18,24.37%,APOD;CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,glutathione derivative metabolic process (GO:1901685),0.631558839281644,1.4957966492875847,0.04539559014267185,0.20886519249959776,1.0,9/20,20.12%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;AKR1A1;ESD
prerank,glutathione derivative biosynthetic process (GO:1901687),0.631558839281644,1.4957966492875847,0.04539559014267185,0.20886519249959776,1.0,9/20,20.12%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;AKR1A1;ESD
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5977663217774395,1.4947323710621703,0.03832335329341317,0.21061255252383518,1.0,13/30,19.19%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;TAF9;SVIP;SDCBP;SGTA;NOP53;CCAR2;DDRGK1
prerank,innate immune response (GO:0045087),0.5067697472301759,1.4943591604530906,0.0,0.21082694554311412,1.0,55/217,18.48%,IFITM3;RPL39;CD74;IFITM2;B2M;IFITM1;MBL2;TYROBP;C3;PGLYRP1;S100B;CYBA;TREM2;SHFL;ADAM15;FCER1G;SERINC3;ANG;RARRES2;CYBB;RNF187;PPP1R14B;MFAP4;ISG15;CXCL16;CORO1A;TRIM28;CLEC6A;PTK6;CAPZA2;OTULIN;CXCL10;IFIT1;TRIM59;HMGB1;HCK;SMPD1;CHGA;LCN2;SLC11A1;BST2;MSRB1;RIPK2;CLEC4D;CX3CR1;IRF7;SERINC5;NCF1;ATAD3A;PIK3CD;TRIM32;NOS2;SYK;SRMS;SLA
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6862571790529143,1.493778124269146,0.06027397260273973,0.2114815759594536,1.0,4/13,3.73%,TYROBP;HSP90AB1;TNF;MAP1A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5894106577516521,-1.493480978956173,0.057034220532319393,0.4645720890133941,1.0,8/11,39.06%,SMAD7;RC3H2;SOCS5;ANXA1;JAK3;IL4;FOXP3;TBX21
prerank,central nervous system myelination (GO:0022010),0.7061862835364388,1.4929869858713505,0.04986149584487535,0.21261146984731266,1.0,6/11,16.01%,CLU;PLP1;B4GALT6;MYRF;TENM4;ABCA2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6393623643239552,1.4904797471894928,0.03827160493827161,0.2170412012212688,1.0,5/21,5.60%,RPS3;CD81;NFAM1;PTPRC;SLC39A10
prerank,positive regulation of ATPase activity (GO:0032781),0.5800796707230934,1.4901311010090696,0.021003500583430573,0.21721869014744646,1.0,16/41,18.89%,DYNLL2;DYNLL1;GABARAPL2;PFN1;ATP1B2;DNAJB2;VMP1;HNRNPU;DNAJB1;ATP1B1;RYR2;PFN2;DNAJB11;ATP1B3;AHSA1;DNAJC10
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6253567178017096,1.4900614464266937,0.04,0.2168395862441184,1.0,10/23,25.30%,LAPTM5;PRNP;VSIR;HMGB1;LILRB1;GAS6;INHBA;DDIT3;C1QBP;INHA
prerank,macrophage chemotaxis (GO:0048246),0.7142080391170592,1.4899181459976236,0.05890804597701149,0.21661869225248703,1.0,4/10,19.15%,LGALS3;CCL2;CCL3;CXCL17
prerank,respiratory electron transport chain (GO:0022904),0.6867321076073669,1.4897466626202416,0.0340599455040872,0.216417779859868,1.0,11/14,27.44%,ETFB;SLC25A13;NDUFA5;SDHB;SLC25A22;UQCRFS1;PPARGC1A;SLC25A18;SDHA;GPD2;SLC25A12
prerank,positive regulation of cellular respiration (GO:1901857),0.7158360879257074,1.4896555592274543,0.035211267605633804,0.21608110197697475,1.0,7/11,20.09%,PARK7;PINK1;VCP;NUPR1;ISCU;PRELID1;IL10RB
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6369135030669896,1.4896404287820872,0.038461538461538464,0.21557671831410263,1.0,3/21,2.84%,APOE;PLTP;TREM2
prerank,response to UV-B (GO:0010224),0.7075173979720227,1.4884539951633395,0.0392156862745098,0.2175805241125,1.0,4/12,14.18%,CRIP1;HYAL2;MFAP4;STK11
prerank,macrophage activation involved in immune response (GO:0002281),0.6860723953298642,1.488238783721549,0.06199460916442048,0.2175243450911919,1.0,3/13,2.84%,TYROBP;GRN;TREM2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5518381730771983,1.488052655846226,0.014444444444444444,0.21738204372719805,1.0,24/55,21.42%,RPS3;RACK1;AGT;GPER1;TNF;S100A9;S100A8;HYAL2;TNFSF12;NUPR1;BAX;PMAIP1;BBC3;BAD;DAB2IP;CAV1;BCAP31;DNM1L;LTBR;TNFRSF12A;ING5;PYCARD;DDIT3;FIS1
prerank,regulation of dendritic spine development (GO:0060998),0.6490291174600445,1.4873631853079472,0.04068241469816273,0.21835384522428913,1.0,6/19,9.68%,APOE;NLGN1;GRIN3A;PPFIA2;ARF6;CAMK1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6540929075626641,1.4871246410557524,0.02911392405063291,0.21834966580210338,1.0,4/20,8.35%,APOE;ACADVL;RAN;SEC14L2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6158497008901419,1.4864296752957573,0.028117359413202935,0.21923570003376502,1.0,10/27,15.48%,CD74;S100A6;AGT;PDGFB;MIF;FN1;AQP1;WNT5A;GAS6;PDGFA
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6222617290112894,1.4863712362065753,0.03198031980319803,0.21887791149022207,1.0,11/24,19.10%,CALM1;AKAP6;CALM3;FKBP1A;GSTO1;GSTM2;JPH4;SRI;FKBP1B;SELENON;CALM2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5843589173506407,1.4860675681617148,0.033532934131736525,0.21890712503542548,1.0,8/35,4.63%,CALM1;HSP90AB1;CALM3;CSNK2B;PPP1R15B;HSP90B1;FKBP1A;PPP1R1B
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5827791952342289,-1.4854722143413746,0.07446808510638298,0.4784366653852443,1.0,4/11,8.88%,TGFBR3;ACVR1;TGFBR1;SMAD7
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5786012228986662,-1.4849593228345035,0.059800664451827246,0.4742896366865625,1.0,5/10,13.42%,CREBBP;KAT7;KAT2B;ESCO1;SIRT1
prerank,negative regulation of binding (GO:0051100),0.5311016472457213,1.484894794359492,0.0136986301369863,0.22094561267550225,1.0,21/81,12.09%,ACTB;RACK1;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;PDGFB;PIN1;SORL1;TLE5;LRPAP1;PLN;IFIT1;JUN;CAMK1;SUMO3;BAX;DNAJB2;DDX11
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.6191171378720864,1.4844473368607856,0.04779411764705882,0.22135557682389903,1.0,19/25,32.42%,TMEM50A;CHMP2B;VCP;LEPROT;CHMP5;CHMP6;SORT1;UBXN6;CHMP1B;CHMP7;LYST;CHMP1A;LAPTM4B;CHMP4C;LEPROTL1;MVB12A;TMEM50B;CHMP4A;CHMP4B
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5604211868331166,-1.4843008345314417,0.07773851590106007,0.47067935100636293,1.0,5/12,10.73%,NFIB;PAFAH1B1;GLI2;EPHA4;EPHB2
prerank,cellular response to chemical stress (GO:0062197),0.5240420522885935,1.4842429429923485,0.005241090146750524,0.22125274197454245,1.0,35/96,21.52%,PPIA;GPX1;MT3;CHCHD2;PARK7;SOD1;ATF4;CYBA;PRDX5;PRDX6;PINK1;PRDX2;HSPA1B;PARP1;PRR5L;PYCR2;CYBB;ATP13A2;GPX3;PRDX1;GPX7;ERMP1;AIF1;HSPA1A;CAT;NCF1;ERO1A;CAV1;PPARGC1A;STX4;SNCA;SOD3;SIRT2;SELENOS;CYCS
prerank,negative regulation of cartilage development (GO:0061037),-0.5364484064830843,-1.4837708978915365,0.06072874493927125,0.4666137396703405,1.0,8/13,21.56%,ADAMTS12;TGFBR1;EFEMP1;WNT11;CHADL;WNT9A;ADAMTS7;PTPN11
prerank,receptor-mediated endocytosis (GO:0006898),0.5133309623769332,1.483745757103527,0.0020387359836901123,0.22168748004345776,1.0,44/132,19.75%,APOE;SPARC;CTSL;CD81;RAMP2;HSP90AA1;CALR;MRC1;ITGB2;LRP1B;CANX;HSP90B1;FCER1G;SORL1;CAV2;DNM3;SNAP91;AP2M1;TFRC;CD163;CXCL16;CLTC;AP2S1;FCGR1A;STAB1;LRP3;FNBP1L;FCHO1;RAMP3;MSR1;LILRB1;CLTA;M6PR;HPR;HP;ARRB2;DLL1;CAV1;TMEM108;SYK;SNCA;GRK2;RAB31;HSPG2
prerank,regulation of receptor binding (GO:1900120),0.7382763004011779,1.483671618332506,0.02582496413199426,0.22134265614348206,1.0,2/10,3.42%,B2M;ADAM15
prerank,neuron remodeling (GO:0016322),0.7329679972950093,1.4836337568248235,0.037037037037037035,0.22090845613518323,1.0,3/10,4.22%,C1QA;C3;ADGRB3
prerank,hexose metabolic process (GO:0019318),0.5726374362145774,1.4834667544452704,0.03178206583427923,0.22070550109488146,1.0,11/39,10.95%,ALDOA;APOD;ALDOC;OMA1;GALT;PMM1;FUOM;CHST1;GAA;DCXR;FUCA1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5589305608153415,-1.4827007044979195,0.07380073800738007,0.4536686639099252,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5589305608153415,-1.4827007044979195,0.07380073800738007,0.4536686639099252,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5589305608153415,-1.4827007044979195,0.07380073800738007,0.4536686639099252,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,heart process (GO:0003015),0.6837284649993502,1.4825531471435334,0.04755434782608696,0.22203181047705206,1.0,6/14,20.40%,GPX1;SOD1;SGCZ;RAMP3;SGCG;PPCS
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6555963836175753,1.4802640578826423,0.03647798742138365,0.22625916770345697,1.0,9/18,11.36%,SLC17A8;GRIA2;SLC1A4;GRID2;GRIK5;GRIK2;GRID1;SLC17A7;SLC17A6
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6560515814737834,1.4802635763321292,0.0563564875491481,0.2257364581058883,1.0,1/17,0.01%,TMSB4X
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5778467752083379,1.4794862079268558,0.031990521327014215,0.22682381145371097,1.0,13/35,17.61%,NLGN1;PCDHGB4;CDH20;SELL;CDH18;CDH12;CDH19;DCHS1;CDH7;CDH24;CDH10;CDH5;PCDHB14
prerank,regulation of tissue remodeling (GO:0034103),0.644588674255796,1.4794760265460853,0.042105263157894736,0.2263156717461029,1.0,3/18,1.42%,CST3;MDK;GPNMB
prerank,positive regulation of ERAD pathway (GO:1904294),0.6902343979117218,1.4790599708453063,0.046357615894039736,0.22666706224674735,1.0,8/13,21.24%,UBQLN2;RNFT1;SGTA;CAV1;HERPUD1;BCAP31;TMEM259;USP13
prerank,cell junction maintenance (GO:0034331),0.6829016129141933,1.4789619334008768,0.03713527851458886,0.22634918655140468,1.0,6/14,14.62%,CHCHD10;MYADM;CSF1R;DCTN1;CBLN2;F2RL1
prerank,negative regulation of viral genome replication (GO:0045071),0.572041496051788,1.4785731064534962,0.02828054298642534,0.22658972493685955,1.0,10/40,13.02%,IFITM3;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;BANF1;BST2
prerank,cellular protein-containing complex assembly (GO:0034622),0.5035650185493675,1.4785064172683795,0.0030425963488843813,0.22619568562230266,1.0,46/159,15.73%,RPL38;CLU;GPX4;HSP90AA1;HSP90AB1;FMOD;NSG1;CYBA;NRG1;HIGD2A;COX7A2L;CSNK2B;PFDN6;CCT2;MID1IP1;FKBP1A;RTN4;COX7A2;POMP;AP2M1;EID2;DNAAF3;OMA1;HSPD1;CLTC;MAPT;VAMP3;VAMP2;AP2S1;HIGD1B;PSMG3;PSMD13;FCHO1;VAMP8;ANLN;HSPA1A;NSG2;VBP1;OTUD6B;TIAM1;ARL2;PTGES3;CLTA;PDE4DIP;MAPK8IP2;TBCA
prerank,hemidesmosome assembly (GO:0031581),0.7277804492737805,1.4784387361932962,0.04460431654676259,0.22579457496990035,1.0,4/11,9.48%,CD151;LAMC1;PLEC;LAMC2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.45226995974275763,-1.478170713294245,0.02197802197802198,0.46060589138583075,1.0,12/25,16.73%,SULF1;ZNF423;BMPR1A;FOXD1;SMAD4;RBPJ;NUMA1;BMP4;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,protein-DNA complex assembly (GO:0065004),0.5143727521024345,1.4774302543317201,0.007186858316221766,0.22729370201490479,1.0,34/116,16.76%,RPS27A;UBC;UBB;PSMB4;H3-3A;PSME1;PSMB6;PSME2;PSMB8;PSMD2;NPM1;PSMD1;PSMC3;MCM5;PARP1;PSMD6;RPA2;UBA52;BRD2;PSMA7;GMNN;PSMD5;RBX1;DDB1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;PSMB10;PSMB1;PSMB5;NAP1L2;CETN2
prerank,protein kinase B signaling (GO:0043491),0.6173171725734267,1.4767744817216202,0.029593094944512947,0.22822087672164748,1.0,12/23,21.36%,MT3;AKT1;TNF;ZFP36L1;KDR;GAS6;CCL2;TYRO3;CCL3;TGFB1;THEM4;SIRT2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.4112004967842729,-1.4762398761742903,0.020833333333333332,0.4604419455512242,1.0,10/36,14.95%,MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,limb development (GO:0060173),-0.4417881806747632,-1.4759309589461793,0.03954802259887006,0.45629782590002643,1.0,8/28,13.22%,SMOC1;GLI3;KREMEN1;KAT2B;PCSK5;IQCE;INTU;IFT122
prerank,regulation of proteolysis (GO:0030162),0.5491816378802906,1.4757655645733851,0.025274725274725275,0.2298773006891282,1.0,21/48,21.57%,CST3;AURKAIP1;AKT1;SERPINE2;LTBP4;PRSS37;CSTB;GSAP;NEDD8;PLAT;CAMK2N1;CLN6;TRAF3;BAD;CDK5;CAV1;TRIM32;CLN8;CAPN3;BAK1;STUB1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6146791541713378,1.4756988921634886,0.04438964241676942,0.22949126878764206,1.0,13/24,16.60%,TYROBP;GRN;ATF4;PRNP;TNF;CTNNB1;NUPR1;CDK5R1;BAX;FBXW7;CDK5;CCL3;BACE1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6741831673131181,1.4755808124444763,0.036211699164345405,0.2292801967614594,1.0,9/15,18.67%,TYROBP;TREM2;FLOT1;CD53;CAMK1;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,protein O-linked glycosylation (GO:0006493),-0.34324502739143126,-1.4752632927932796,0.0,0.4528388277074428,1.0,18/96,7.40%,TMTC1;GXYLT2;LARGE1;ST3GAL4;TMTC4;PLOD2;TRAK1;TET2;OGA;OGT;ST3GAL3;GALNT11;TET3;B3GNT2;PGM3;ST6GAL1;GALNT12;CRPPA
prerank,negative regulation of bone remodeling (GO:0046851),0.7236613011807678,1.4751622812087892,0.04845222072678331,0.22961480852072286,1.0,6/11,20.17%,TNFAIP3;P2RX7;GPR137B;TMEM119;IL6;SFRP1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6029146000658313,1.4747654967510853,0.03970223325062035,0.22992608874058856,1.0,9/26,14.56%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;ARL2
prerank,positive regulation of leukocyte activation (GO:0002696),0.6409581236843249,1.4746050316537496,0.05269922879177378,0.22970675005862168,1.0,10/18,25.77%,SPACA3;HSPD1;CEBPA;KARS1;WNT5A;CLEC4D;TLR6;CRLF2;LBP;IL33
prerank,positive regulation of macrophage activation (GO:0043032),0.6596293544880325,1.4729801167173269,0.043243243243243246,0.23251320922909455,1.0,8/17,16.36%,TREM2;SPACA3;HSPD1;CEBPA;KARS1;WNT5A;TLR6;CCL3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.524253548492668,1.472548794877012,0.006263048016701462,0.2329395198825738,1.0,22/84,11.65%,TMSB4X;SPARC;ATP5F1B;HSPB1;GRN;CALR;RHOB;LGMN;AKT1;ATP5F1A;AGT;PDGFB;RAC1;EMC10;PROX1;KDR;GATA2;HMGB1;PDCD6;WNT5A;AAMP;FLT4
prerank,regulation of interleukin-6 production (GO:0032675),0.5150537908372439,1.4716055920499638,0.0030959752321981426,0.2344693886586187,1.0,38/96,26.21%,CD74;MBP;TYROBP;CYBA;TREM2;TNF;TIRAP;SIRPA;HYAL2;TNFAIP3;HSPD1;SYT11;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;AIF1;GAS6;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;IL6;SPHK2;TMEM106A;PTPN6;PYCARD;SELENOS;APP;AGER;LBP;IL33;TLR7;POU2F2;CX3CL1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6111470124185626,1.471181233028769,0.05263157894736842,0.2348074340132363,1.0,5/24,7.08%,MT3;HSPA5;ATF4;KLF2;CEBPB
prerank,fatty acid biosynthetic process (GO:0006633),0.5292531731706143,1.4710408791713157,0.020474137931034482,0.23462708564937776,1.0,25/63,28.16%,GPX4;SCD5;FADS1;LIPG;ELOVL1;ELOVL2;TECRL;LPL;OXSM;ELOVL7;SCD;ACOT7;FADS3;DEGS1;LTC4S;ASAH2;ACSM5;NDUFAB1;CYP2E1;ELOVL6;ACLY;HACD4;XBP1;GSTM4;HSD17B8
prerank,cellular response to unfolded protein (GO:0034620),0.5982310028178902,1.4706022032891928,0.038600723763570564,0.23502345729722054,1.0,16/26,26.57%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPD1;HSPB8;BAX;HSPA1A;ABCB10;DAB2IP;HSPA2;HSPA9;BAK1;PTPN1;HSPA14;TM7SF3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6682650322874586,1.4703101764538495,0.04341926729986431,0.23518435910225394,1.0,10/15,27.18%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6818755553773747,1.4702628740703791,0.047182175622542594,0.23476474869225344,1.0,2/13,1.79%,APOE;SOD1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3904612466614077,-1.4698720959756526,0.027777777777777776,0.4615234079648458,1.0,15/47,11.35%,GOLGA4;VAMP5;MACF1;EXOC4;SPTBN1;RABEP1;EXOC2;BLZF1;RAB10;ARL3;ARFGEF2;GGA2;OPTN;KIF13A;EXOC6B
prerank,copper ion homeostasis (GO:0055070),0.6557791632594582,1.4685188274064513,0.04263565891472868,0.23809995011717616,1.0,6/17,15.43%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6990759672031235,1.4658291204421061,0.05131761442441054,0.24338874711445826,1.0,8/13,19.10%,CALM1;CALM3;ANK3;IRX3;SLC8A1;CAV1;SRI;CALM2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.39414810193156524,-1.465591027311681,0.026785714285714284,0.46764371322010717,1.0,22/43,27.58%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;PABIR1;ATM;RAD17;ORC1;NAE1;TAOK1;CHFR;CLSPN;INTS3;CDC14B;ABRAXAS1;HUS1B;PLK1;CDK1;BRCC3;TICRR
prerank,cell junction assembly (GO:0034329),0.5128627299298757,1.4654820979823544,0.009365244536940686,0.24358519752539473,1.0,33/100,19.07%,ACTB;ACTG1;CLDN5;GJA4;NRXN1;SPOCK2;NLGN1;DSCAM;CDH20;FLNA;ADGRL3;DNM3;FN1;KIRREL3;CDH18;NRCAM;DNER;NRXN2;RHOA;CDH12;VMP1;CDH19;DCHS1;CDH7;ACHE;CDH24;CDK5;CDH10;CDH5;PCDHB14;GPM6A;CTNND2;FBLIM1
prerank,heart contraction (GO:0060047),0.5579207013444417,1.4652876165663868,0.0367816091954023,0.2434393396040409,1.0,12/41,19.17%,GPX1;SOD1;SGCZ;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;SGCG;GRK2
prerank,apoptotic cell clearance (GO:0043277),0.5898565031961369,1.4642490542462179,0.03048065650644783,0.245238895721754,1.0,12/30,20.23%,TYROBP;TREM2;TGM2;RAC1;RHOG;XKR4;HMGB1;ADGRB1;GAS6;TYRO3;RAC2;XKR6
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5385878952652046,1.4639599771406506,0.03135498320268757,0.24532868657811477,1.0,20/51,21.29%,TYROBP;HSPB1;CCL19;S100A13;TNF;P2RX7;LPL;EGR1;LILRA5;HMGB1;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;TMED10
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6707666443786279,1.4632162734355225,0.07432432432432433,0.24632410175848204,1.0,5/13,14.84%,RPS15;NPM1;RAN;XPO1;NUP88
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5755903355537831,1.462396374213014,0.03751465416178194,0.2476179603488783,1.0,9/36,10.15%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;GABARAPL2;BAG5;ALAD;TAF9
prerank,positive regulation of cholesterol transport (GO:0032376),0.5984358844565882,1.4619195627018544,0.034610630407911,0.24820762673499866,1.0,5/27,6.65%,APOE;PLTP;TREM2;SCP2;LIPG
prerank,lipid droplet organization (GO:0034389),0.6292810366353544,1.4617049042496701,0.04314720812182741,0.24814998853623227,1.0,6/22,7.34%,PPIA;CDS1;AUP1;BSCL2;TSPO2;HSD17B13
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5274227974480807,1.4615699830287445,0.010604453870625663,0.2479045986660168,1.0,19/72,13.25%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5825249289784991,1.4613981876166813,0.04156769596199525,0.2477540600437651,1.0,9/31,17.99%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;HMGB1;RIPK2;MAPK11;SYK
prerank,regulation of autophagosome maturation (GO:1901096),-0.5346519830534779,-1.4608490131335101,0.07662835249042145,0.4746027324859084,1.0,7/13,22.91%,CLEC16A;UVRAG;CLN3;TMEM39A;RUBCN;ADRB2;PHF23
prerank,cellular copper ion homeostasis (GO:0006878),0.68099537535308,1.4608275313007115,0.05466666666666667,0.24854221826627257,1.0,6/14,15.43%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,regulation of establishment of planar polarity (GO:0090175),0.5157481072881757,1.4603133738516232,0.017875920084121977,0.24913813834515242,1.0,43/88,26.32%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;AP2M1;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;ARHGEF19;PSMA6;PSMA4;FZD2;FZD1;AP2A1;PSMC1;PARD6A;WNT7A;PSMD9;CELSR3;PSMB2;PSMD4;PSMD10;FZD3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5892013924031276,-1.4601152257356127,0.09342560553633218,0.4666021969680604,1.0,6/10,17.91%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,DNA dealkylation (GO:0035510),-0.5892013924031276,-1.4601152257356127,0.09342560553633218,0.4666021969680604,1.0,6/10,17.91%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.3800845902065762,-1.4600428932062894,0.02912621359223301,0.4620718612125758,1.0,22/50,15.34%,FBXL17;CREBBP;SMO;DCDC2;GLI3;SUFU;GPC3;TTC23;HERC4;DLG5;FGFR2;BTRC;ZIC1;TULP3;INTU;IFT122;RORA;WDR11;GAS8;EVC;UCHL5;KIF7
prerank,negative regulation of MAPK cascade (GO:0043409),0.5159947604488873,1.4600047182147482,0.005208333333333333,0.24930901920221396,1.0,21/87,13.40%,APOE;PPIA;AGT;PEBP1;GPER1;PTPRC;PIN1;SORL1;UCHL1;DUSP3;SIRPA;RGS2;HYAL2;DUSP26;P2RX7;SMPD1;CAMK2N1;PTPRR;TIMP3;CNKSR3;SPRY1
prerank,positive regulation of T cell migration (GO:2000406),0.6234301933483128,1.4598536572212222,0.048223350253807105,0.24915057364485324,1.0,12/20,26.20%,CXCL12;CXCL10;WNT5A;AIF1;RHOA;DOCK8;TMEM102;ADAM17;CCR2;PYCARD;APP;OXSR1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5895749292182666,1.4583658191520974,0.0498220640569395,0.25184080157183764,1.0,9/30,15.42%,RPS3;PRNP;IL2;PRKAR1A;CD24;ICOSLG;HMGB1;IGFBP2;IGF2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.5224900796123721,1.4582862900230134,0.008438818565400843,0.25146364133016524,1.0,22/80,16.13%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;RACK1;EIF3D;NPM1;RPS27L;TNF;ABCG1;EIF3C;GSAP;PCIF1;ZCCHC4;TNFRSF1A;IFNGR1;CIRBP;YTHDF1;ABCA2;EIF4A3
prerank,regulation of steroid metabolic process (GO:0019218),0.6171492759734921,1.4580707721230364,0.039119804400977995,0.251410483860681,1.0,3/23,5.54%,APOE;ACADVL;ABCG1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6243009153353835,1.4574692224223897,0.04584882280049566,0.2521485503138958,1.0,6/21,10.71%,MDK;MAPK3;MIF;DDT;RARRES2;CSF1R
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5308827600679705,1.4564102004412063,0.025974025974025976,0.25405933103893963,1.0,22/61,16.41%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;NCOR2;ODC1;PSMB10;PSMB1;PSMB5;CAV1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5621802713659938,1.4563722147569016,0.03737259343148358,0.253625582919984,1.0,16/40,20.94%,CLU;GPX1;AKT1;PINK1;GPER1;GHITM;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PRELID1;HGF;PYCARD
prerank,regulation of viral genome replication (GO:0045069),0.5369024832757092,1.4560358210944329,0.02600216684723727,0.25382288054946545,1.0,23/56,24.08%,IFITM3;PPIA;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;DDB1;BANF1;PABPC1;BST2;PDE12;OAS3;RAD23A;FAM111A;RSAD2;ISG20;TNIP1;VAPB;CD28;BTBD17
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6290781650634888,1.455976586401836,0.05680317040951123,0.25343005133972113,1.0,11/19,21.42%,PRNP;GRM5;PTPRC;KDR;TRPM2;RYR2;DMTN;VCAM1;BCAP31;FKBP1B;FIS1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.4072887034406448,-1.4555194490638383,0.02040816326530612,0.4683783879949119,1.0,11/36,11.01%,AFDN;GOLGA4;VAMP5;MACF1;SPTBN1;GORASP2;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,endothelial cell differentiation (GO:0045446),0.683341374251458,1.4554400927579185,0.05631868131868132,0.2541663364902463,1.0,7/12,13.18%,SOX18;ACVRL1;EDF1;PROX1;KDR;KDM6B;TIE1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.6189777310808946,1.4552880612971135,0.03615960099750624,0.2539767891921968,1.0,8/22,10.83%,APOE;HSPA8;GPX1;PARK7;MAP1A;MAPT;MAP2;AEBP1
prerank,myeloid cell differentiation (GO:0030099),0.5525856653987222,1.4550998826357107,0.025056947608200455,0.2538708254114059,1.0,11/47,11.15%,RPS14;RPS19;SLC25A5;HCLS1;SPI1;ATP5IF1;TIRAP;HIPK2;CEBPA;IKZF1;IL11
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3682051921134111,-1.4548738772994734,0.013888888888888888,0.46542095567334335,1.0,16/63,9.64%,AUTS2;MCU;SIPA1L1;PHACTR1;FER;PARVA;GAB1;NRP1;PTK7;RICTOR;MYH9;MKLN1;CDC42BPB;PDLIM4;NRK;PIP5K1A
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5501196804827821,-1.4546958799806469,0.10943396226415095,0.46134596720822724,1.0,10/13,25.90%,RNF152;SESN1;ATM;ITFG2;SPAAR;CASTOR2;CASTOR1;KPTN;SESN2;SESN3
prerank,gas transport (GO:0015669),0.7229355565178472,1.4546321136955833,0.0524822695035461,0.25435172738290523,1.0,6/10,22.18%,CA2;IPCEF1;CYGB;AQP1;MYC;MB
prerank,regulation of microglial cell activation (GO:1903978),0.6634222561397407,1.4539935071570607,0.04456824512534819,0.2552549669713641,1.0,5/15,8.58%,GRN;TREM2;PTPRC;NR1D1;SYT11
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6774259025452611,1.453989679291823,0.07228915662650602,0.2547295875585128,1.0,4/13,6.98%,CD81;TMEM30A;SORL1;SAR1A
prerank,muscle organ development (GO:0007517),-0.375423924115012,-1.4535437433108331,0.030612244897959183,0.45962345675653826,1.0,11/54,8.33%,LAMA2;LARGE1;TCF12;VAMP5;MRAS;ITGA11;CHD2;FHL1;UTRN;IGF1;MEF2A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5834620299230413,-1.452614464120312,0.08411214953271028,0.45752075397420044,1.0,5/10,15.34%,PID1;APPL2;GRB10;ENPP1;PRKCB
prerank,phospholipid homeostasis (GO:0055091),0.7014871035989277,1.4525634408440684,0.058265582655826556,0.25735669198049943,1.0,3/11,6.65%,RCN3;ABCG1;LIPG
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5340189967043708,1.452352637845417,0.022396416573348264,0.25733480189914537,1.0,16/57,18.03%,PSAP;MTNR1A;GNAI2;NPY1R;GPR37L1;FLNA;GRM8;GRM7;P2RY12;GNAI1;CHRM3;CHRM2;ADCY4;ADCY8;CHRM5;GRM4
prerank,cellular response to ATP (GO:0071318),0.6657252359971806,1.452324811257456,0.056833558863328824,0.2568722128356861,1.0,4/14,9.31%,HSP90B1;P2RX7;P2RY1;P2RY12
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.548877784041138,1.4520688146824292,0.02828054298642534,0.25690713736815435,1.0,22/50,27.26%,ACTB;HSP90AB1;CCNI;CCND2;SERTAD1;CDKN1C;CCND1;CDK5R1;CDC37;CAMK2N1;CCNG1;CDK5R2;CCNJL;CDC25A;GADD45A;BLM;CCNA2;CDKN2B;CCNG2;CCNH;CDKN1A;CNPPD1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5900418315007543,1.4511845542253023,0.05128205128205128,0.2583025772167955,1.0,9/30,15.66%,RPS27A;UBC;UBB;UBA52;TICAM2;TLR6;IRF7;TRAF3;CD300LF
prerank,leukocyte tethering or rolling (GO:0050901),0.6309823101161767,1.4508910095794574,0.06729475100942127,0.2583919270348618,1.0,8/17,16.62%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7152544457988393,1.4500180190899863,0.0617816091954023,0.259879550629643,1.0,4/10,14.24%,AKT1;TREM2;CD68;TLR6
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6717187820475916,1.4497273534116117,0.060927152317880796,0.26007589002377945,1.0,4/13,6.98%,CD81;TMEM30A;SORL1;SAR1A
prerank,regulation of macrophage activation (GO:0043030),0.5849105131408612,1.44951143276613,0.05054151624548736,0.2600763785806507,1.0,10/30,14.24%,CD74;LRFN5;MIF;SPACA3;HSPD1;CEBPA;GPR137B;KARS1;WNT5A;TLR6
prerank,regulation of protein metabolic process (GO:0051246),0.5539491153139585,1.448811018325531,0.03615819209039548,0.2610167361926448,1.0,12/44,12.78%,APOE;HSP90AB1;KLF2;LTBP4;FKBP1A;CHEK2;GSAP;NEDD8;CHMP6;WFS1;ODC1;KLF4
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5704930993949188,1.4488083953141786,0.046948356807511735,0.2604933542251904,1.0,12/32,20.40%,AKAP6;GPER1;APLNR;GRIN1;P2RX7;THY1;CXCL10;RAMP3;TRPC1;CAV1;SNCA;CAPN3
prerank,positive regulation of nervous system development (GO:0051962),0.5552499533912597,1.4483866063493116,0.03468208092485549,0.26098453872786076,1.0,19/42,20.87%,NRXN1;NLGN1;SERPINF1;TGM2;GPER1;GRID2;IL1RAPL1;PTPRD;SNW1;SYNDIG1;LRRC4B;CX3CR1;EPHB1;CLSTN2;CLSTN1;TRIM32;SOX11;IL1RAP;CLSTN3
prerank,cellular response to type I interferon (GO:0071357),0.556950763182967,1.448294995954386,0.02702702702702703,0.2601685132851995,1.0,16/41,22.14%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;BST2;IRF7;OAS3;RSAD2;IRF9;IFI27;IRF5;ISG20
prerank,type I interferon signaling pathway (GO:0060337),0.556950763182967,1.448294995954386,0.02702702702702703,0.2601685132851995,1.0,16/41,22.14%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;BST2;IRF7;OAS3;RSAD2;IRF9;IFI27;IRF5;ISG20
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6292982589404278,1.4482725601996023,0.0594059405940594,0.2596957973843949,1.0,4/19,15.62%,APOE;RAPSN;CHRNA4;ACHE
prerank,activation of protein kinase B activity (GO:0032148),0.584977648107795,1.4480410655127485,0.039806996381182146,0.2597048099359595,1.0,9/29,4.35%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;PDGFB;ANG
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6739269988313885,1.4477715833013258,0.07442489851150202,0.25975643977340546,1.0,5/12,9.00%,SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4
prerank,fatty acid transport (GO:0015908),0.6474255777605327,1.4476906294690666,0.06431273644388398,0.2594421635405731,1.0,3/17,8.69%,APOE;FABP5;MFSD2A
prerank,triglyceride homeostasis (GO:0070328),0.5988196007992775,1.4473678393875722,0.04567901234567901,0.2596698381523593,1.0,4/26,9.13%,APOE;MTLN;LPL;MLXIPL
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.49451453000256873,-1.4466900113043097,0.08260869565217391,0.4678795893537174,1.0,8/17,14.92%,NOTCH2;ACVR1;BMPR1A;GALNT11;RBPJ;JAG1;BMP4;HEY2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5333805535176006,1.4464187278670368,0.029867256637168143,0.26130157042309243,1.0,21/55,16.21%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;GPR132;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;ATF5;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5118937798616053,-1.4454438440955346,0.0851063829787234,0.4665497103407116,1.0,6/15,8.33%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5940876544676559,1.4449125090282373,0.04926108374384237,0.2641578343221847,1.0,9/29,15.66%,RPS27A;UBC;UBB;UBA52;TICAM2;TLR6;IRF7;TRAF3;CD300LF
prerank,carbohydrate derivative transport (GO:1901264),0.6370614704718467,1.444742329876134,0.05419354838709677,0.263983235713631,1.0,9/18,15.77%,PLTP;NPC2;ABCG1;MFSD2A;SLC15A4;SLC29A1;SLC29A2;SLC15A2;SLC25A19
prerank,cellular response to oxidative stress (GO:0034599),0.5037121657768481,1.4444329427687992,0.008264462809917356,0.2641618405154623,1.0,32/118,13.89%,RPS3;PPIA;GPX1;MT3;CHCHD2;HMOX1;PARK7;SOD1;MAPK3;ATF4;AKT1;CYBA;PRDX5;PRDX6;PINK1;PRDX2;ROMO1;HSPA1B;PARP1;PRR5L;PYCR2;CYBB;MAPT;JUN;ATP13A2;GPX3;PRDX1;GPX7;ERMP1;AIF1;HSPA1A;CAT
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6299623957018147,1.443370415529373,0.04884318766066838,0.266091197531922,1.0,8/18,16.69%,CHCHD10;SLC25A5;FZD9;TMEM14A;BAX;ACAA2;HSPA1A;TMEM102
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.6170580285274064,1.443172040338982,0.050505050505050504,0.2660302367089246,1.0,13/21,31.54%,MDK;NES;FZD9;CTNNB1;PROX1;CX3CR1;TOX;NAP1L1;CX3CL1;FZD3;DLL4;DRD2;DISP3
prerank,histone H3 deacetylation (GO:0070932),-0.5048175716549244,-1.4419601187583533,0.100418410041841,0.47072089204330964,1.0,6/15,16.08%,HDAC4;PER2;HDAC8;SMARCAD1;SIRT1;SIRT7
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5328889170865735,1.4415105084242106,0.022172949002217297,0.26946249795106164,1.0,19/51,19.67%,MDK;CALR;CXCL12;MAPK3;LGMN;RARRES2;CXCL10;CREB3;HMGB1;PLA2G7;CSF1R;AIF1;GAS6;F2RL1;ADAM17;CCR2;EDN3;CXCL17;IL6
prerank,macrophage activation (GO:0042116),0.5636441581413124,1.4412787929232904,0.04032258064516129,0.2694465010464855,1.0,18/34,24.75%,CLU;C1QA;ITGB2;TREM2;TNF;C5AR1;CD93;MAPT;AIF1;SLC11A1;IFNGR1;TLR1;SYK;SNCA;TMEM106A;APP;AGER;LBP
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.47047454806166034,-1.4412745263018067,0.06280193236714976,0.46821625150355173,1.0,9/20,19.97%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,global genome nucleotide-excision repair (GO:0070911),0.5996304049463818,1.4410917322677808,0.06463414634146342,0.26938882974440836,1.0,7/26,10.13%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,regulation of immunoglobulin production (GO:0002637),0.5984004205316866,1.4410175916024277,0.05422446406052964,0.26905872892344235,1.0,9/23,19.67%,RBP4;PTPRC;IL2;CD22;VAMP3;DNAJB9;STX4;CD86;IL6
prerank,positive regulation of synaptic transmission (GO:0050806),0.5153257215620337,1.440789490355686,0.018008474576271187,0.26905872892344235,1.0,35/72,24.49%,LGMN;NRXN1;NLGN1;GPER1;SLC24A2;TNF;MPP2;SHISA7;GRIK2;FLOT1;SYT1;LGI1;RIMS2;RIMS1;GRIN2A;VAMP2;HAP1;CCL2;ADRA1A;ADCY8;CACNG8;CLSTN2;SQSTM1;CLSTN1;GRIN2B;CCR2;KCTD13;CACNG5;STX4;ZDHHC12;CLSTN3;STX1B;CACNG2;APP;AGER
prerank,positive regulation of T cell proliferation (GO:0042102),0.5297700756781477,1.4401858172841235,0.03482045701849837,0.27002251575516845,1.0,22/55,24.66%,RPS3;CCL19;PTPRC;TFRC;IL2;CD24;ICOSLG;HMGB1;PNP;AIF1;IGFBP2;IGF2;VCAM1;SYK;CCR2;CD86;IL6;PYCARD;IL12RB1;CD28;AGER;CD276
prerank,positive regulation of protein binding (GO:0032092),0.528406110953863,1.4401604031455155,0.025302530253025302,0.2695632187462356,1.0,11/56,6.46%,APOE;RPL11;CLDN5;B2M;VTN;RAN;FKBP1A;PIN1;FLOT1;ADD2;HIPK2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6001213836968965,1.4393824902489865,0.05953827460510328,0.27082102799494057,1.0,7/23,18.47%,TUBB;TUBA1A;TUBA1B;KIF5A;CCDC88A;HOOK1;KIF5C
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5844681188917975,-1.4392701615104915,0.10622710622710622,0.46928603409269487,1.0,5/10,16.18%,CAMK2D;PRKCE;ATP1A2;HECW2;STK39
prerank,cellular response to superoxide (GO:0071451),0.7064813415855363,1.4391023507921588,0.06349206349206349,0.27087763088639166,1.0,4/10,9.70%,MT3;SOD1;PRDX2;PRDX1
prerank,regulation of macrophage migration (GO:1905521),0.708537900769125,1.4381061358014393,0.06950354609929078,0.27265022117669313,1.0,3/10,14.23%,CD81;P2RY12;CX3CR1
prerank,DNA-dependent DNA replication (GO:0006261),0.5015748745543989,1.4380742459867166,0.005070993914807302,0.272215555165324,1.0,47/128,26.19%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;RPA2;CDC34;UBA52;PSMA7;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;POLE4;PSMB11;RFC2;PSMB10;RECQL5;PSMB1;PSMB5;POLD4;PSMA6;RFC4;PSMA4;GINS3;POLG;BLM;CDC45;PSMC1;PSMD9;POLD1;PNKP;RPA3;RPAIN;PSMB2;PSMD4;RAD51;PSMD10
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6090809778085929,1.438045845077862,0.060225846925972396,0.271760185426904,1.0,6/21,10.12%,LAPTM5;GPNMB;LGALS3;DUSP3;TNFAIP3;FGL1
prerank,negative regulation of neurogenesis (GO:0050768),0.5629829371641715,1.4376703775038806,0.0562874251497006,0.27215507956682045,1.0,16/34,23.14%,ARHGDIA;B2M;TNF;RTN4;SORL1;YWHAH;LRP4;THY1;GDI1;RHOA;NOTCH1;IL6;MAG;REST;WNT7A;PTN
prerank,cardiac conduction system development (GO:0003161),-0.4467423731741752,-1.4376068179432868,0.06593406593406594,0.4692771657546296,1.0,9/24,14.92%,NOTCH2;BMPR1A;SMAD1;MAML1;SMAD4;GJB6;CACNA1G;BMP4;HEY2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6731120806045443,1.4367285618401762,0.0681198910081744,0.27386709670707604,1.0,7/12,24.00%,APOC1;P4HB;MFSD2A;SOAT2;ACSL3;DGAT1;MTTP
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.588700234916648,1.435174051941722,0.055970149253731345,0.27708147934908145,1.0,11/27,19.31%,RPS27A;UBC;UBB;TIRAP;UBA52;HSPD1;TLR6;TLR5;TLR1;TAB1;CD14
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5686100656162049,1.434820088481029,0.045023696682464455,0.2773252195600588,1.0,15/31,26.57%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPB8;BAX;HSPA1A;DAB2IP;HSPA2;HSPA9;BAK1;STUB1;PTPN1;HSPA14;TM7SF3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6320606387893757,1.4342859985865593,0.07255936675461741,0.2779281272502965,1.0,4/16,10.70%,C3;GPER1;KLK6;CHGA
prerank,positive regulation of cellular senescence (GO:2000774),0.7101893330770486,1.433269395964697,0.06666666666666667,0.27979313618236407,1.0,2/10,2.35%,B2M;YPEL3
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5802828905311734,1.432819683513594,0.05896510228640193,0.2803743689081821,1.0,7/28,7.56%,APOE;TYROBP;LGMN;NSG1;SHISA7;FAM107A;CALB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.673583892917896,1.4327855500804643,0.06722689075630252,0.27992698806300725,1.0,9/12,18.13%,CD74;MBP;TNF;TIRAP;LPL;HMGB1;KLF4;F2RL1;OAS3
prerank,camera-type eye development (GO:0043010),-0.4456712114898269,-1.4325861926054484,0.05263157894736842,0.47742114061864277,1.0,7/25,7.79%,CACNA1C;FBN1;SHROOM2;SKI;LAMA1;EFEMP1;CEP290
prerank,steroid catabolic process (GO:0006706),0.7191989507311923,1.4317855725397208,0.060431654676258995,0.2816017296778327,1.0,3/10,6.58%,SPP1;YWHAH;HSD17B6
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6570469622309901,1.4314302767543803,0.05481283422459893,0.28187078802710075,1.0,2/15,3.71%,APOE;TNF
prerank,regulation of immune response (GO:0050776),0.4928815589155518,1.4314277884524587,0.010193679918450561,0.2813446073396488,1.0,33/135,17.99%,B2M;IFITM1;CD81;TYROBP;COL1A1;C3;ITGB2;TREM2;CD34;FKBP1A;TIRAP;SPPL2B;SELL;CD3D;COL3A1;CD22;FGL1;FCGR1A;NPDC1;CD300LG;ELMOD2;COL1A2;LILRB1;IRF7;NCR1;TRAF3;LRP8;PIANP;CD300LF;VCAM1;OSCAR;CD300A;SYK
prerank,postreplication repair (GO:0006301),0.5461419672607996,1.4313769438367636,0.035634743875278395,0.28092974415774247,1.0,11/45,14.04%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15;PCNA;NSMCE1;RFC2;UBE2V1
prerank,regulation of telomere maintenance (GO:0032204),-0.4403524004994797,-1.431147604858388,0.07734806629834254,0.4766934044363793,1.0,8/26,13.31%,SMG6;DHX36;SMG1;HDAC8;PML;YLPM1;TERF2;TINF2
prerank,positive regulation of binding (GO:0051099),0.5093850646310019,1.4306883049578074,0.015906680805938492,0.28200799196922444,1.0,26/84,16.41%,APOE;RPL11;CLDN5;B2M;VTN;TXN;NME1;RAN;FKBP1A;PIN1;FLOT1;HES1;ADD2;HIPK2;GMNN;EDF1;HMGB1;DPH3;DDX11;CLN5;BMP2;RIPK2;STMN1;TIAM1;EPB41;CAV1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6047760898300671,1.4305582211037389,0.06734434561626429,0.28178589036447166,1.0,12/22,19.59%,CALM1;AKAP6;CALM3;GSTO1;P2RY6;HAP1;GSTM2;VMP1;ATP1B1;RYR2;CALM2;STAC3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49943087136906067,1.4304919858914091,0.009278350515463918,0.28142507925329296,1.0,41/112,21.40%,CLU;TYROBP;HSPB1;CCL19;CYBA;CD34;POMC;PTPRC;MIF;TIRAP;SIRPA;DDT;TNFAIP3;SYT11;VSIR;LPL;LILRA5;HMGB1;ZFP36;MC1R;WNT5A;C1QTNF4;LILRB1;GAS6;CX3CR1;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;IL6;SPHK2;TMEM106A;PTPN6;PYCARD;SELENOS
prerank,negative regulation of chemokine production (GO:0032682),0.6579026589945915,1.4300983153447606,0.06712328767123288,0.2817601951148145,1.0,7/14,19.67%,APOD;SIRPA;KLF4;F2RL1;SIGIRR;OAS3;IL6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6896796041452207,1.4295545388473636,0.07060518731988473,0.282520150976327,1.0,5/11,18.77%,TYROBP;ITGB2;SPI1;F2RL1;STX4
prerank,cellular response to interleukin-7 (GO:0098761),-0.4889489826421229,-1.4294452203356713,0.04435483870967742,0.47185291148418285,1.0,6/17,16.38%,BRWD1;STAT5B;IRS1;STAT3;STAT5A;JAK1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4889489826421229,-1.4294452203356713,0.04435483870967742,0.47185291148418285,1.0,6/17,16.38%,BRWD1;STAT5B;IRS1;STAT3;STAT5A;JAK1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4563397100957417,-1.4293540566322103,0.027777777777777776,0.46798591604312595,1.0,7/26,5.49%,FOXP1;STRN3;DAB2;KANK2;PIAS2;CNOT1;NCOR1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.6421099342735895,1.4282114458754092,0.04900662251655629,0.28517309470332236,1.0,10/17,21.42%,CLU;FZD9;BAX;TIMM50;BBC3;BAD;MFF;DNM1L;BAK1;FIS1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5377146901906238,1.4277493768986476,0.03897550111358575,0.2856828817026272,1.0,14/50,13.55%,GPX1;MT3;PARK7;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;PIH1D1;KLF4;GAS6
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5983664437033085,1.4277086194360002,0.07838179519595449,0.2852445890517303,1.0,7/22,17.00%,MBP;TNF;FLOT1;MYADM;THY1;KLF4;SKAP1
prerank,monocyte chemotaxis (GO:0002548),0.5686705134520263,1.4276518536903329,0.04420549581839905,0.2848383798231114,1.0,11/32,21.09%,RPS19;CCL19;PDGFB;LGALS3;CCL2;FOLR2;FLT1;CCL3;CCL8;IL6;PTPRO
prerank,adherens junction organization (GO:0034332),0.5320113376655785,1.4273579284045925,0.03269447576099211,0.2850347114514175,1.0,16/48,16.80%,ACTB;RAMP2;CADM2;ANG;CDH20;CTNNB1;CDH18;CADM3;CDH12;CDH19;DCHS1;JAM3;CDH7;CDH24;CDH10;CDH5
prerank,negative regulation of immune effector process (GO:0002698),0.6654022286549659,1.4264233362347438,0.07152875175315568,0.2867926645763652,1.0,3/13,4.08%,RPS19;GRN;LGALS3
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6450956457607039,1.4258851090366007,0.05992010652463382,0.28752471435301735,1.0,9/15,22.12%,GPER1;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HNRNPU;SSTR2;REST
prerank,translesion synthesis (GO:0019985),0.5507025674977036,1.4252796664184626,0.04406779661016949,0.2883483693521387,1.0,7/42,6.97%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,negative regulation of viral transcription (GO:0032897),0.652992963417465,1.4252441412417396,0.08022130013831259,0.2879277688031967,1.0,5/13,19.64%,IFITM3;ZFP36;HEXIM1;TRIM32;TRIM13
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.5522540182056404,1.4250978909086653,0.04279279279279279,0.28772672105117764,1.0,10/39,13.25%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5817249970723876,1.424901511320561,0.06197854588796186,0.28769979451652855,1.0,8/29,10.13%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.5932757782818617,1.4247935375727327,0.06608478802992519,0.2874274840237557,1.0,9/23,23.36%,GPX4;GSTM1;FADS1;GSTM2;ACOT7;LTC4S;ASAH2;CYP2E1;ELOVL6
prerank,antibacterial humoral response (GO:0019731),0.6534930636854979,1.4243429407970878,0.05569948186528497,0.28795649651410005,1.0,2/16,4.35%,RPL39;ANG
prerank,central nervous system neuron differentiation (GO:0021953),0.5668558375466248,1.4241687547919653,0.04337631887456037,0.287865952375633,1.0,10/33,8.81%,MDGA2;GRID2;NTRK2;KNDC1;CTNNB1;SPOCK1;PROX1;MAPT;MAP2;FAIM2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4485438448191553,-1.4241241410790826,0.05504587155963303,0.47627756863613585,1.0,9/23,13.79%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,glycosphingolipid metabolic process (GO:0006687),0.5355620153178985,1.4232463470156396,0.041128084606345476,0.28932143446042696,1.0,13/42,16.06%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;B4GALT6;SMPD1;CTSA;GLTP;CLN6;ST6GALNAC3;ABCA2;NEU1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5797190634056963,-1.4231101870886067,0.10509554140127389,0.4747399007310589,1.0,5/10,16.26%,MLLT3;HOXB4;UFL1;BATF;TP53
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6124016744939815,1.4229990050452606,0.07711757269279393,0.289354991392768,1.0,6/20,13.41%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4949571968525774,1.422891256570186,0.013360739979445015,0.28909265268827566,1.0,28/113,11.61%,RPS3;CLU;RACK1;HSP90AA1;PARK7;TPPP3;NRG1;IL5;TERF1;RASIP1;TNF;RHOC;LGALS3;PSMC3;PARP1;TIRAP;VCP;RPA2;TFRC;ISG15;MTLN;RBX1;LCP1;PIH1D1;DDB1;MMP3;BAX;WARS1
prerank,receptor clustering (GO:0043113),0.5787467439823822,1.4228064678974022,0.04950495049504951,0.2887526427168739,1.0,10/27,14.33%,NRXN1;NLGN1;ITGB2;DLG2;LRP4;FLNA;MUSK;THY1;NRXN2;LRRC7
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.555993589848693,1.4218044594875185,0.05328798185941043,0.290679130385587,1.0,10/37,13.25%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,amide transport (GO:0042886),0.588786208259873,1.421071898905766,0.04396984924623116,0.29187456655914207,1.0,7/26,15.30%,SLC38A5;PLTP;TAP2;GLTP;SLC14A1;SLC19A1;FOLR2
prerank,fluid transport (GO:0042044),0.6676996737122736,1.4206006096831092,0.07735583684950774,0.2923533003276884,1.0,2/12,8.40%,AQP4;AQP1
prerank,regulation of macrophage cytokine production (GO:0010935),0.6577202399028685,1.420437479558651,0.07476635514018691,0.29217120676578945,1.0,6/13,13.39%,CD74;LAPTM5;SEMA7A;CUEDC2;WNT5A;LILRB1
prerank,vasodilation (GO:0042311),0.6517822056621528,1.420405724211011,0.09274193548387097,0.29173351102336326,1.0,5/13,18.33%,SOD1;KLF2;GPER1;F2RL1;KCNMA1
prerank,maintenance of protein localization in organelle (GO:0072595),0.6224774617925241,1.4187306692688755,0.05620915032679739,0.2951049218964261,1.0,5/19,4.30%,CHCHD10;HSPA5;AKT1;PINK1;ARL2BP
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.5390959029381233,1.4175134706911514,0.05152224824355972,0.2974636953102918,1.0,12/40,11.72%,UBB;PARK7;SOD1;AKT1;PINK1;ATP5IF1;VCP;MTLN;MAPT;TUSC2;BAX;PMAIP1
prerank,peptide hormone secretion (GO:0030072),0.5861088300349742,1.41738208349123,0.07037037037037037,0.2972772766447894,1.0,8/26,19.67%,PARK7;PTPRN;LTBP4;RIMS2;MAFA;ADCYAP1;EDN3;IL6
prerank,positive regulation of synapse assembly (GO:0051965),0.5856397649587782,1.416990709616934,0.06939281288723669,0.2976760357293567,1.0,15/27,23.04%,NRXN1;NLGN1;GRID2;IL1RAPL1;SEMA4A;PTPRD;SYNDIG1;LRRC4B;EPHB1;CLSTN2;CLSTN1;AGRN;IL1RAP;CLSTN3;WNT7A
prerank,regulation of B cell differentiation (GO:0045577),0.6273591673129154,1.41694647356352,0.09067688378033206,0.29723762910919665,1.0,11/17,27.81%,ZFP36L1;ZFP36L2;IKZF3;MMP14;SYK;INHBA;SFRP1;ID2;PPP2R3C;INHA;XBP1
prerank,Rap protein signal transduction (GO:0032486),-0.56765453732115,-1.4167649949722565,0.08148148148148149,0.48549877443460476,1.0,5/10,18.41%,RAPGEF2;RAPGEF1;RAPGEF3;SGSM3;PLK2
prerank,T cell migration (GO:0072678),0.6554915824851076,1.416748707243158,0.07327001356852103,0.29719307019079855,1.0,8/13,24.39%,S1PR1;MSN;CXCL16;CXCL10;CCL3;PIK3CD;GPR183;MYO1G
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6741253847813392,1.416609907288843,0.075,0.29700673069541966,1.0,7/12,24.76%,CCT2;CCT7;CCT8;DKC1;GNL3L;CCT4;CCT3
prerank,peptidyl-proline modification (GO:0018208),0.5834105348280723,1.4164206716933048,0.06796116504854369,0.2969183499955023,1.0,6/25,5.50%,PPIA;PPIB;FKBP1A;PIN1;FKBP10;FKBP7
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.608680641455795,1.41634352158587,0.085219707057257,0.29657977821164044,1.0,8/18,16.62%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,relaxation of cardiac muscle (GO:0055119),0.6658988546207688,1.4162141506574735,0.06693989071038252,0.29636146969251087,1.0,8/13,15.37%,GSN;RGS2;PLN;CHGA;GSTM2;ATP1A1;ATP1B1;SLC8A1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5573809266603942,1.4157131407029668,0.05841121495327103,0.2970592173055751,1.0,13/33,20.94%,APOE;CSNK2B;TNF;ACVRL1;VASH1;HMGB1;KLF4;RHOA;HDAC5;NOTCH1;TGFB1;MEF2C;GADD45A
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5954643199094736,1.4154328130715945,0.07806691449814127,0.2972256371447358,1.0,9/22,20.23%,LAPTM5;SLC7A5;TNF;WNT5A;LILRB1;F2RL1;TRIL;CCR2;SPHK2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.4946915220164994,-1.415105789472525,0.0847457627118644,0.4855919791661761,1.0,9/16,23.30%,SHLD1;FBH1;FANCB;CGAS;SMCHD1;RMI2;SHLD2;SHLD3;POLQ
prerank,glycolipid metabolic process (GO:0006664),0.5281426876353986,1.4144243784376849,0.055872291904218926,0.29919707004802576,1.0,13/47,16.60%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;SMPD1;FUCA1;CTSA;GLTP;ST6GALNAC3;ABCA2;NEU1;SCCPDH
prerank,regulation of amyloid-beta formation (GO:1902003),0.5600231943483824,1.4138314038640323,0.056712962962962965,0.3000230767568544,1.0,10/34,7.88%,APOE;CLU;PRNP;TNF;NTRK2;RTN4;PIN1;SORL1;ABCG1;GSAP
prerank,regulation of protein targeting to membrane (GO:0090313),0.5656834905641893,1.4133543600356933,0.07230392156862746,0.30068095418399937,1.0,11/28,21.42%,PRNP;ITGB2;ANK3;GDI1;HRAS;MTCL1;MIEF2;MFF;DMTN;C2CD5;FIS1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.690043550815116,1.4133263803207856,0.07790368271954674,0.3002305468255464,1.0,7/11,24.76%,TERF1;CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,glutathione metabolic process (GO:0006749),0.5429640720546,1.4128770851557564,0.07424593967517401,0.30081184675168393,1.0,8/38,15.71%,GPX1;PARK7;SOD1;GSTM1;GSTM5;GSTM2;HPGDS;GLRX2
prerank,negative regulation of leukocyte activation (GO:0002695),0.6482647353943705,1.4128710198191519,0.08445040214477212,0.3003074082950526,1.0,4/15,4.43%,GRN;GPER1;CD84;LRFN5
prerank,cellular response to leucine (GO:0071233),-0.5641041712937199,-1.4122708743486216,0.10104529616724739,0.48486694932135654,1.0,8/10,25.90%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,response to leucine (GO:0043201),-0.5641041712937199,-1.4122708743486216,0.10104529616724739,0.48486694932135654,1.0,8/10,25.90%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5142416647223561,1.411578519700807,0.035106382978723406,0.3027053050643666,1.0,17/71,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;FCER1G;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,prostaglandin metabolic process (GO:0006693),0.57327529800489,1.4110701796558742,0.07338308457711443,0.3033946999843523,1.0,7/26,14.87%,CD74;PTGDS;GSTM1;MIF;PRXL2B;HPGDS;PTGES3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.48729768735192763,1.4110476577713926,0.01752577319587629,0.30293181663437435,1.0,41/114,24.17%,TMSB4X;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;EIF5A;TNF;PSMD1;PSMC3;ST18;PSMD6;PSMA7;TNFSF12;PSMD5;PSMB9;PSMD13;TXNDC17;PSMB3;PSMB11;PSMB10;TNFRSF1A;TRAF3;PSMB1;PSMB5;ADAM17;COMMD7;PLVAP;LTBR;TNFRSF12A;PSMA6;PSMA4;NFKBIA;PYCARD;TNFRSF9;PSMC1;PSMD9;RELA;TNFRSF13B;TNFRSF11A
prerank,negative regulation of protein processing (GO:0010955),0.6724561323760568,1.4108215710627159,0.08970976253298153,0.3029220319271328,1.0,5/12,10.76%,CTSZ;PRNP;SERPINE2;TMEM59;GAS1
prerank,lipoxygenase pathway (GO:0019372),0.6514108345500247,1.4099370909276026,0.08636977058029689,0.3045805087168376,1.0,2/14,1.19%,GPX4;GPX1
prerank,response to glucocorticoid (GO:0051384),0.5767466723539518,1.4090612207122988,0.05218446601941747,0.3062034283880746,1.0,14/26,22.12%,TNF;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HSD3B2;HNRNPU;PDCD7;SLIT3;IL6;GOT1;SSTR2;REST
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.48566457465524726,1.4090249457187165,0.01131687242798354,0.3057853233268918,1.0,23/108,11.72%,RPS3;MTCH1;CTSD;RACK1;GSN;LAPTM5;NDUFA13;RPS27L;HSPE1;GPER1;TNF;S100A9;S100A8;ST18;VCP;BEX3;FOXL2;HSPD1;MAPT;HMGB1;PDCD6;BAX;PMAIP1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5614430469681321,1.4088899907145238,0.06009615384615385,0.3056019608593417,1.0,15/34,22.37%,AKT1;GRID2;MPP2;GABRG3;GRIN1;GABRA2;GRIN2A;GLRA1;GABRA3;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5275120194572032,1.4080842703056338,0.04691075514874142,0.3070496707919886,1.0,20/45,25.54%,TYROBP;HSPB1;CCL19;TNF;P2RX7;LPL;EGR1;LILRA5;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;APP;AGER;CASP1
prerank,regulation of viral transcription (GO:0046782),0.5385128425177178,1.4077508759182762,0.06177156177156177,0.30732323945779133,1.0,15/39,21.24%,IFITM3;POLR2E;POLR2D;POLR2F;NELFCD;ZFP36;POLR2G;SUPT4H1;POLR2K;HEXIM1;NELFE;TRIM32;TRIM13;POLR2H;CDK9
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5051065317175697,1.4076209218126121,0.023182297154899896,0.3070871666607158,1.0,22/72,16.80%,APOE;HSPA8;CLU;PFDN5;TREM2;CRYAB;PFDN6;MID1IP1;MYADM;PFN1;CORO1A;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;VBP1;PFDN1;FGF13;PFN2;CDH5
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.49072636453286855,1.4075437679387177,0.02074688796680498,0.30625644603866925,1.0,40/104,25.42%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,cellular response to lectin (GO:1990858),0.49072636453286855,1.4075437679387177,0.02074688796680498,0.30625644603866925,1.0,40/104,25.42%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,positive regulation of interleukin-8 production (GO:0032757),0.525224654283857,1.4074235463498137,0.04581005586592179,0.3059971585930082,1.0,18/49,21.15%,CD74;PARK7;TNF;LAMTOR5;HSPA1B;TIRAP;HYAL2;HMGB1;HSPA1A;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4797563418561896,1.407144621312589,0.009109311740890687,0.30612138977412623,1.0,37/152,17.29%,PSAP;MTNR1A;RAMP2;GNAI2;NPY1R;GPER1;GPR37L1;ADGRB3;GNA11;SCTR;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;GRM8;ADGRG1;RXFP1;CXCL10;VIPR1;P2RY12;ADGRB1;MC1R;GNAI1;GNAO1;ADGRB2;CALCB;RAMP3;CHRM2;ADCY4;PF4;ADGRL4;ADRA1D;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,regulation of interferon-gamma production (GO:0032649),0.5090162874856208,1.4069655701334292,0.03866809881847476,0.3060639970558126,1.0,28/71,28.31%,LAPTM5;PDE4B;PRNP;SLC7A5;SIRPA;ISG15;HSPD1;VSIR;HMGB1;SLC11A1;LILRB1;GAS6;F2RL1;RASGRP1;CCR2;CD14;INHBA;PYCARD;DDIT3;IL12RB1;C1QBP;CD276;INHA;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4234995304882369,-1.406748315823589,0.060240963855421686,0.49460592804718606,1.0,12/27,17.61%,EGFR;TNRC6B;DDX6;STAT3;RIPK1;EIF4G1;BMP4;PUM2;LIMD1;TP53;AGO2;FMR1
prerank,phospholipid catabolic process (GO:0009395),0.5839484016055418,1.4067060895723034,0.07195121951219512,0.3061583637041298,1.0,11/24,18.52%,PRDX6;LIPG;ENPP2;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2;GPCPD1;GDPD1;ENPP6
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5607863628492313,1.4067059016838623,0.06060606060606061,0.3056455356242233,1.0,12/33,15.50%,NRG3;NLGN1;GRID2;GRIK5;GRIK2;FABP5;LRRC4C;CACNA1A;GRID1;ABR;CX3CR1;LRP8
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5104538537516148,1.406402726998809,0.036055143160127257,0.3059059649908892,1.0,17/73,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;FCER1G;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,cellular response to BMP stimulus (GO:0071773),-0.35043486011036856,-1.4054214995386256,0.0,0.4937299872469455,1.0,23/66,16.73%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;RGMA;SMAD4;PDCD4;HIVEP1;BMP4;SMAD2;TGFB3;RUNX2;ACVR2A;BMPR2;ACVR2B
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.489603303323541,1.4051296557088357,0.020768431983385256,0.3086027714222344,1.0,40/105,25.42%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,ceramide catabolic process (GO:0046514),0.6402005007954613,1.4048413365245271,0.09686221009549795,0.30880236186610494,1.0,3/14,2.91%,GM2A;HEXB;HEXA
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5041940113672297,1.4043657624002528,0.027600849256900213,0.30944412461377185,1.0,25/75,16.87%,ACTB;S100A6;DCC;S100B;CTNNA2;ANK3;MAP1A;CNTN4;LRP4;NEFH;NRCAM;MFSD2A;MAP2;PAK3;ADGRB1;APBB1;TMEM106B;SHTN1;CCK;MAPK8IP2;DSCAML1;SPTBN4;CDK5;BRSK2;CDHR1
prerank,atrial septum development (GO:0003283),-0.5249179055005779,-1.4039997774111133,0.07954545454545454,0.4932330728542711,1.0,7/13,19.43%,NOTCH2;ANK2;MDM4;NPHP3;HEY2;BMPR2;DAND5
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5316031686045102,1.4039878910111687,0.04338153503893215,0.3098530237731695,1.0,18/48,20.40%,CALM1;AKAP6;CALM3;GPER1;FKBP1A;APLNR;GSTO1;THY1;CXCL10;GSTM2;JPH4;TRPC1;SRI;FKBP1B;SELENON;CALM2;SNCA;CAPN3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.49901617948611177,1.4039264280376131,0.01867219917012448,0.30950830859426137,1.0,32/88,20.89%,RPS3;CLU;RACK1;PARK7;NRG1;TNF;RHOC;LGALS3;FLOT1;TIRAP;VCP;PFN1;TFRC;MTLN;ATP13A2;PIH1D1;SDC4;CHGA;MMP3;BAX;WARS1;SDCBP;DAB2IP;PFN2;CDH5;CRB3;SYK;VPS4A;TGFB1;CDC42EP2;ERCC1;BAK1
prerank,stem cell differentiation (GO:0048863),-0.38356619611415194,-1.403639942836704,0.04964539007092199,0.49012880978007867,1.0,13/39,18.13%,MLLT3;FBXL17;SETD2;LRP6;HOXB4;JARID2;UFL1;FGFR2;KIT;BATF;TP53;PSMD11;METTL5
prerank,negative regulation of cytokine production (GO:0001818),0.48042019986691364,1.4032182716673214,0.004032258064516129,0.310694098970469,1.0,37/163,16.38%,TMSB4X;APOD;TYROBP;LAPTM5;GPNMB;PRNP;TREM2;CD34;CD84;TNF;HOMER2;PTPRC;RAC1;PIN1;SIRPA;TNFAIP3;FN1;CUEDC2;ISG15;NAV3;SYT11;VSIR;SARS1;LILRA5;HMGB1;ZFP36;SRGN;ATP2B1;KLF4;SLC11A1;LILRB1;GAS6;TLR6;F2RL1;SIGIRR;DLL1;HDAC9
prerank,regulation of interleukin-4 production (GO:0032673),0.6030522240464664,1.403018549963103,0.07380073800738007,0.3106525737796027,1.0,11/21,27.86%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;DDIT3;CD28;PRKCQ;LEF1;ZFPM1
prerank,positive regulation of cell communication (GO:0010647),0.5707255139672208,1.4028020055666655,0.056831922611850064,0.3106945341832114,1.0,15/28,20.87%,ANK3;TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;HCRT;CLSTN2;CLSTN1;NMB;KCTD13;EDN3;SOX11;CLSTN3
prerank,protein deneddylation (GO:0000338),0.6840087173730923,1.402744547828311,0.0836940836940837,0.31031229907460506,1.0,3/10,14.73%,COPS7A;COPS6;COPS8
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5297638354180556,1.402633262973451,0.041340782122905026,0.31008628697898893,1.0,21/49,21.73%,RACK1;NDUFA13;PINK1;S100A9;S100A8;P4HB;NUPR1;BAX;PMAIP1;BBC3;BAD;CAV1;HERPUD1;BCAP31;NDUFS3;DNM1L;RTKN2;PYCARD;DDIT3;FIS1;PTPMT1
prerank,adenine nucleotide transport (GO:0051503),0.615740264155057,1.4025326974672605,0.0975609756097561,0.3098386876716689,1.0,4/17,13.31%,SLC25A5;LRRC8A;SLC25A4;SLC19A1
prerank,cGMP-mediated signaling (GO:0019934),0.6515858593972138,1.4020653558254064,0.09686221009549795,0.31036418804798577,1.0,3/13,8.96%,APOE;AQP1;HTR2C
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4195510415589907,-1.4018575967741265,0.05789473684210526,0.4904673751932667,1.0,7/27,13.32%,KAT6B;CREBBP;KAT7;KAT2B;BRD8;PHF20L1;KAT6A
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5328422612157133,-1.4018056232119138,0.08955223880597014,0.4866855900611228,1.0,2/12,1.11%,PLEKHH2;LIMA1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.5432584722939962,1.401748050021257,0.05717488789237668,0.31060658430885046,1.0,7/42,6.97%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,positive regulation of telomerase activity (GO:0051973),0.5510582338250827,1.4013854965863202,0.060498220640569395,0.31100690266548825,1.0,16/33,23.98%,HSP90AA1;HSP90AB1;MAPK3;CCT2;CTNNB1;KLF4;PTGES3;PARM1;DKC1;MAPK15;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.47771475103801186,-1.40118444213335,0.0995260663507109,0.484332689443807,1.0,6/17,4.47%,ABL1;BAIAP2L1;BCAS3;NRP1;BAIAP2;NTRK3
prerank,regulation of mitochondrial translation (GO:0070129),0.5907729369828147,1.4009109294572089,0.08553459119496855,0.31168004264116345,1.0,10/21,27.39%,UQCC2;COA3;TRUB2;TSFM;SHMT2;RPUSD4;MTG2;C1QBP;TRMT10C;RCC1L
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5027208435670623,1.4007385898970206,0.03858520900321544,0.31160904484821705,1.0,22/72,16.21%,PSMB4;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;TIRAP;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;TLR6;COPS8;PSMB1;PSMB5
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5243954085422298,1.4005425175417283,0.044956140350877194,0.31161566855446093,1.0,21/52,25.06%,CXXC1;ACADVL;HSPA5;CTDSP2;SSR1;PDIA6;WFS1;SYVN1;SERP1;DDX11;KLHDC3;DCTN1;DNAJB11;LMNA;DNAJB9;YIF1A;HYOU1;MYDGF;TLN1;VAPB;DNAJC3
prerank,activin receptor signaling pathway (GO:0032924),-0.5096951141137418,-1.4001546885325669,0.11646586345381527,0.4830159196102676,1.0,6/15,16.73%,SMAD3;ACVR1;TGFBR1;SMAD2;ACVR2A;ACVR2B
prerank,BMP signaling pathway (GO:0030509),-0.35264220575657135,-1.3999289228448013,0.0,0.4798050949960325,1.0,22/62,16.73%,BMP6;TGFBR3;SMAD3;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;RGMA;SMAD4;PDCD4;HIVEP1;BMP4;SMAD2;TGFB3;RUNX2;ACVR2A;BMPR2;ACVR2B
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.593360193867394,1.3995196602588107,0.07115628970775095,0.31361854549153956,1.0,4/22,3.89%,CALM1;GPNMB;CALM3;PDGFB
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5574044176428639,1.3986343774625394,0.07151515151515152,0.3153047968359282,1.0,10/31,19.96%,TYROBP;GPNMB;CEBPB;SDC4;CTLA4;LILRB1;CD300A;SOX11;CD86;LST1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5111101823949067,-1.3982046910029697,0.09375,0.4801836400523334,1.0,7/13,19.29%,LARGE1;OGA;PGM3;MGAT3;RENBP;CHST3;NAGK
prerank,prostaglandin biosynthetic process (GO:0001516),0.5996322296040297,1.3980656990808547,0.09664948453608248,0.31613842683199095,1.0,6/18,14.87%,CD74;PTGDS;MIF;PRXL2B;HPGDS;PTGES3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.47456271923474586,1.3980298508575006,0.004032258064516129,0.3157108696820547,1.0,51/175,20.94%,TMSB4X;RPS3;PSMB4;PSME1;AKT1;CCL19;PSMB6;PSME2;PSMB8;PSMD2;GPER1;EIF5A;TNF;NR1D1;PSMD1;ZFP36L1;PSMC3;ZFP36L2;ST18;PSMD6;HYAL2;PSMA7;TNFSF12;PSMD5;ZFP36;PSMB9;PSMD13;TXNDC17;PSMB3;PSMB11;PSMB10;TNFRSF1A;ERBIN;CCL2;TRAF3;YBX3;PSMB1;PSMB5;DAB2IP;CCL3;ADAM17;CCL8;COMMD7;PLVAP;LTBR;TNFRSF12A;PSMA6;SFRP1;PSMA4;NFKBIA;PYCARD
prerank,detection of calcium ion (GO:0005513),0.6593868449040581,1.3980272833577057,0.09067017082785808,0.31520479192821704,1.0,5/13,19.10%,CALM1;CALM3;SYT1;RYR2;CALM2
prerank,dendritic cell chemotaxis (GO:0002407),0.6463238094371007,1.397185058122832,0.0942622950819672,0.31665082705882186,1.0,7/14,19.49%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,divalent inorganic cation homeostasis (GO:0072507),0.58432824611891,1.3970919070520462,0.06439854191980558,0.3163697394720663,1.0,12/25,19.55%,MT3;ANK3;TMTC2;GRIN1;ATP13A2;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,positive regulation of calcium ion import (GO:0090280),0.6679393026017825,1.3967057513008996,0.0851063829787234,0.3167662119091608,1.0,7/12,20.23%,CXCL12;PDGFB;LGALS3;RAMP3;CCL2;CCL3;SPHK2
prerank,innate immune response in mucosa (GO:0002227),0.6897566324950193,1.3963541067989946,0.10013908205841446,0.31713806429474184,1.0,1/10,0.48%,RPL39
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5243341882274656,1.3962328623954043,0.06331877729257641,0.31692903632156444,1.0,11/46,6.09%,APOD;HMOX1;AKT1;IGFBP3;TNF;PDGFB;IGFBP5;ANG;NDRG4;CTNNB1;TNFAIP3
prerank,negative regulation of neuron differentiation (GO:0045665),0.5829180637839981,1.3960018052025562,0.08679245283018867,0.3169906627833405,1.0,7/22,15.99%,B2M;CALR;CNTN4;HES1;SOX9;HEY1;DLL1
prerank,central nervous system neuron development (GO:0021954),0.6330139744775048,1.3948058106646073,0.10133333333333333,0.3194966868589984,1.0,6/15,10.09%,HSP90AA1;HSP90AB1;NTRK2;MAPT;MAP2;B4GALT6
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6629941070656952,1.3945747811114144,0.0906515580736544,0.3194952536277615,1.0,8/12,24.37%,CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,prostanoid biosynthetic process (GO:0046457),0.6231593239638831,1.3941411454947426,0.10079575596816977,0.32004203251924485,1.0,4/15,9.20%,CD74;PTGDS;MIF;PRXL2B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6144246820367155,1.3941009069845056,0.07750952986022872,0.3196296206126803,1.0,11/17,23.14%,MDK;SERPINE2;HES1;TENM4;BMP2;CXCR4;PTPRZ1;NOTCH1;TGFB1;ID2;PTN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4868527367094044,-1.3927913939217986,0.0776255707762557,0.4891688794832391,1.0,6/16,13.79%,RBFOX2;ARID1A;ESR1;DDX17;AR;PPARGC1B
prerank,insulin secretion (GO:0030073),0.6063088678430523,1.3925604710848412,0.08545918367346939,0.3227497895064419,1.0,6/19,17.29%,PARK7;PTPRN;RIMS2;PTPRN2;MAFA;ADCYAP1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6125880721742031,1.3925399840983292,0.08549222797927461,0.32228675386749467,1.0,4/18,9.73%,TYROBP;DOCK2;FCER1G;KARS1
prerank,regulation of transmembrane transport (GO:0034762),0.5580109063365188,1.3920966326024278,0.06272189349112427,0.322811857251604,1.0,3/31,5.63%,ACTB;SLC2A1;KCNJ10
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6804027076870724,1.3919559938327783,0.09787234042553192,0.32266425834697715,1.0,2/10,2.58%,CALM1;CALM3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.5659072694470877,1.3919099944849829,0.0705596107055961,0.32228767601732194,1.0,10/29,19.74%,PPIA;HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,diol metabolic process (GO:0034311),0.6102113960812582,1.3911119139683004,0.08949416342412451,0.32367319743320727,1.0,9/19,21.11%,CALM1;HSP90AA1;AKT1;SPR;NAAA;SGPP1;SPHK2;SGPP2;ASAH2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.47644582817012177,1.3903316678968876,0.009174311926605505,0.3249323804896897,1.0,43/151,17.61%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;MIF;NDRG4;TIRAP;ATP6AP1;DDT;P2RY6;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;FBXW7;BMP2;GAS6;CCL2;F2RL1;PDGFA;RASGRP1;ARRB2;ADRA1A;CCL3;GATA4;ADCYAP1;CCL8
prerank,negative regulation of cell projection organization (GO:0031345),0.5241386359309174,1.3901677504684673,0.05399325084364454,0.3248113100556836,1.0,9/48,6.92%,APOE;ITM2C;MT3;DCC;PRNP;YWHAH;SPOCK1;BAG5;CRMP1
prerank,positive regulation of macrophage migration (GO:1905523),0.6052523437693997,1.3900350596794742,0.08108108108108109,0.32461309447637116,1.0,8/19,19.15%,MDK;MAPK3;TREM2;RARRES2;P2RY12;CSF1R;CCL3;CXCL17
prerank,negative regulation of secretion (GO:0051048),0.6901509337164904,1.3899717050119231,0.09579100145137881,0.32426676323819387,1.0,4/10,11.89%,CD74;NRG1;VAMP3;VAMP8
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6162551602963958,1.389548897047129,0.0916030534351145,0.32477767812012276,1.0,8/17,25.94%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;CD28;PRKCQ
prerank,iron ion transport (GO:0006826),0.5349624820518497,1.388912739863348,0.06312292358803986,0.32584528983239996,1.0,12/47,12.88%,FTH1;ATP6V0C;ATP6V1F;ATP6V1G1;ATP6AP1;ATP6V0E2;TFRC;TTYH1;CLTC;ATP6V0D2;SLC40A1;SLC11A1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.6032480395053467,1.3885445735322532,0.0922882427307206,0.3262222469610256,1.0,9/18,20.91%,SLC25A5;SLC25A4;ALKBH7;PMAIP1;SPG7;BAD;TMEM102;BAK1;THEM4
prerank,positive regulation of cellular process (GO:0048522),0.4605323899216179,1.3881723949402582,0.0,0.32663423209178644,1.0,168/565,20.96%,RPL23;RPS9;RPS4X;RPS15A;RPS19;CLDN5;CD81;MDK;HSP90AB1;GRN;CALR;H3-3A;GNAI2;MT3;CAPNS1;CXCL12;RPS6;LGMN;AKT1;TSPAN31;S100B;AKAP6;SLC25A5;CYBA;NRG1;EIF4G2;CCND2;TREM2;DOCK2;TGM2;ERBB4;NPM1;COPS9;S100A13;GPER1;COX17;TNF;MAP1A;EMP2;PDGFB;ROMO1;HCLS1;FCER1G;LMAN2;RAC1;NTRK2;ZFP36L1;S100A9;S100A8;CAMK1D;FLOT1;SSR1;SIRPA;IL2RB;GRIN1;SERTAD1;HES1;FN1;FRMD5;MATK;LGI1;RHOG;RNF187;MLC1;SPACA3;ADGRG1;CCND1;CXCL16;P4HB;NAMPT;PTK6;SLC6A6;PAK1;DUSP26;P2RX7;DDX49;MTLN;PROX1;KDR;CCN2;IL2;MFSD2A;MAPT;VIPR1;NUPR1;MLXIPL;TIMP1;LAMC2;GATA2;LILRA5;HCK;DNPH1;ZFP36;KITLG;EXOSC2;FASN;CSF1R;MYRF;TENM4;WNT5A;IL11;RAMP3;CEP131;FLT4;IL2RG;HRAS;NSMCE1;AIF1;SLC11A1;PRMT1;SOX9;FBXO5;RIPK2;GAS6;CTSH;SDCBP;TIAM1;PDF;FOLR2;IGF2;PDGFA;HPR;HP;RYR2;DLL1;IER5;ADRA1D;FLT1;CAV1;CCKBR;EPB41L4B;VHL;TMEM102;CIAO1;TRIM32;LMNA;MMP14;ADAM17;FKBP1B;CNBP;TBRG4;ERBB3;EXOSC9;MAZ;STX4;HMGN5;EDN3;SOX11;PPP3CA;DDRGK1;CD86;RTKN2;TFAP2B;FLT3;NOTCH1;TRIM13;IL6;RAD23A;MAPK15;TGFB1;CITED2;THPO;SFRP1;MYC;CRLF1;PTPN6;PYCARD;CRLF2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5175220614682847,1.387975904756863,0.05066079295154185,0.32660821721610944,1.0,12/49,14.81%,CLU;RPL13A;PARK7;HSPA5;TREM2;CRYAB;SORL1;HMGB1;SVIP;THRA;NLRP2B;JAM3
prerank,regulation of cholesterol efflux (GO:0010874),0.5580022111706487,1.3878539387031832,0.07117008443908324,0.32642290037094074,1.0,3/30,2.84%,APOE;PLTP;TREM2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5565596849494505,1.3877015508698034,0.05957943925233645,0.32626217692934534,1.0,8/33,11.56%,RPS3;PARK7;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2
prerank,positive regulation of cell death (GO:0010942),0.5103388633695823,1.3875866555782221,0.05142231947483589,0.3260629763842749,1.0,20/59,19.98%,CLU;C1QA;TYROBP;MT3;PRNP;ITGB2;TNF;SLC6A6;MAPT;EGR1;WNT5A;MMP3;RAMP3;RIPK2;HPR;HP;GRIN2B;SNCA;TRIM13;DDIT4
prerank,angiogenesis involved in wound healing (GO:0060055),0.6629998708909861,1.3867423166219208,0.0846262341325811,0.3275780633112904,1.0,7/11,24.83%,CD34;KDR;GATA2;MCAM;HPSE;PRCP;SRF
prerank,cellular response to fatty acid (GO:0071398),-0.531644219558248,-1.3863375583623918,0.11400651465798045,0.5012169385739409,1.0,2/12,4.53%,PID1;IRS1
prerank,positive regulation of viral life cycle (GO:1903902),0.5957268200355634,1.3862093497371404,0.07448107448107448,0.32841154533766787,1.0,5/22,10.13%,CD74;LGALS1;CHMP2B;P4HB;DDB1
prerank,regulation of mononuclear cell migration (GO:0071675),0.5886432810815553,1.3860924634343197,0.07458912768647281,0.32822040554726145,1.0,8/23,12.35%,MDK;MAPK3;TNF;LGALS3;RARRES2;MSN;CSF1R;AIF1
prerank,regulation of protein dephosphorylation (GO:0035304),0.5384197485073431,1.384924257632732,0.0743321718931475,0.3305475662558722,1.0,16/37,21.19%,PPIA;CALM1;CALM3;HSP90B1;YWHAB;PIN1;SMPD1;ARPP19;DLC1;CDH5;PPP1R15A;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,triglyceride metabolic process (GO:0006641),0.522596074977414,1.3845475515585437,0.05561735261401557,0.3309517118889032,1.0,8/48,11.20%,APOE;PNPLA2;APOC1;FABP5;PLAAT3;LIPG;LPL;MOGAT2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.653752702933002,1.3844546941008937,0.1009549795361528,0.3306743927534578,1.0,1/13,0.01%,TMSB4X
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5829199940784543,1.3840775904778633,0.07990012484394507,0.3310667300875222,1.0,12/25,22.37%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;GLRA1;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,positive regulation of immune response (GO:0050778),0.5033899744776106,1.3840288438670407,0.04515418502202643,0.3306775488370918,1.0,20/64,23.31%,CD74;CD81;GRN;CYBA;ITGB2;PTPRC;IL2;SLC15A4;KARS1;LILRB1;F2RL1;SKAP1;STX4;NLRP3;SPHK2;PYCARD;RSAD2;POLR3D;AKIRIN2;IL12RB1
prerank,retrograde axonal transport (GO:0008090),0.6218620727536465,1.384010404688256,0.09492847854356307,0.3302185874759096,1.0,6/16,11.11%,SOD1;MAP1A;DLG2;NEFL;KIF5A;HAP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5871687001187107,1.3839840380218613,0.09240506329113925,0.3297861163157842,1.0,8/23,11.75%,SEC61B;HSP90B1;AUP1;VCP;LMAN1;SURF4;TMED9;SYVN1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5672117675816529,1.3839830759593128,0.0927960927960928,0.32928715609550435,1.0,10/27,12.67%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC25A29;SLC6A5;SLC3A2;SLC1A1;SLC25A22
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5303097191585523,-1.3837087241591002,0.11458333333333333,0.5037317968992955,1.0,4/12,5.49%,FOXP1;DAB2;PIAS2;NCOR1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.6417563449044058,1.3834745510862585,0.1062992125984252,0.329977380965495,1.0,4/13,13.55%,CD74;TAF9;WNT5A;GAS6
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.38187381930292896,-1.3834460559186177,0.05737704918032787,0.5005450948002178,1.0,13/43,13.42%,SORBS1;PID1;SIK2;TNS2;OGT;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;SIRT1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5036160380369487,1.3832154317892362,0.05425531914893617,0.33007331399927786,1.0,16/70,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.48548339560475195,1.383058326829066,0.01962809917355372,0.3299532688679313,1.0,37/101,23.89%,RPL26;RPS4X;RPL5;EEF2;VIM;HSP90AA1;AURKAIP1;AKT1;EIF3D;NPM1;RPS27L;AGT;MSN;EIF3C;PTTG1IP;PCIF1;ZCCHC4;KLF4;CLN6;BAD;NR1H2;CIRBP;YTHDF1;EIF4A3;ASPSCR1;TRIM32;INHBA;IL6;TGFB1;CAPN3;NFKBIA;BAK1;STUB1;WNT7A;ELAVL1;PLXNB2;CD28
prerank,protein localization to chromatin (GO:0071168),-0.46530799947416746,-1.3828118415724597,0.07462686567164178,0.4984865355779473,1.0,7/18,12.24%,NIPBL;WAPL;TASOR;ESR1;PPHLN1;MRNIP;LRWD1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5480639471427131,1.382552226076653,0.06715506715506715,0.33064083090801083,1.0,11/31,15.07%,CHCHD10;YWHAB;YWHAH;YWHAE;YWHAG;BAX;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,regulation of cation channel activity (GO:2001257),0.48863255892910523,1.382007349088554,0.032460732984293195,0.33147260679004015,1.0,39/89,25.11%,CALM1;CTSS;NLGN1;GRIA2;ANK3;FKBP1A;DLG2;SHISA7;NEFL;FGF14;AHNAK;GRIN1;GRIA4;GRIN2A;CRH;VAMP2;FGF11;FGF12;GRIA1;JPH4;LRRC7;KCNE5;MAPK8IP2;FGF13;CACNG8;FKBP1B;GRIN2B;CACNG5;SELENON;CALM2;MEF2C;CACNB4;GRIA3;KCNAB1;CACNG2;APP;SHISA6;PRRT1;PRKACA
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3802945940671163,-1.3818142465461845,0.061068702290076333,0.49732499478564823,1.0,10/38,14.95%,MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.46924812696984386,1.381367095680311,0.010080645161290322,0.33258962881500415,1.0,47/184,16.89%,RPS27A;TUBB;UBC;UBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TUBA4A;PSMD1;ZFP36L1;DCTN3;PSMC3;PPP2R1A;ZFP36L2;YWHAE;PSMD6;UBA52;PSMA7;CLASP1;YWHAG;TUBB4A;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;CEP131;PSMB11;DCTN1;ANLN;FBXO5;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6307162606536039,1.3813525463733163,0.11527777777777778,0.3321310817330563,1.0,3/13,11.72%,RPL26;MSX1;PMAIP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5067369365870817,1.3810265045205963,0.05953693495038589,0.3324180628557603,1.0,25/57,22.12%,CTSD;NDUFA13;LGMN;GPER1;TNF;GRIN1;FOXL2;GRIN2A;HMGB1;PDCD6;PMAIP1;RIPK2;BAD;BCAP31;PDCD5;SYK;GRIN2B;NLRP3;MYC;BAK1;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5770207077873293,1.3809384534538407,0.08739076154806492,0.33211818706792734,1.0,9/22,16.24%,TREM2;NR1D1;FLOT1;TIRAP;TNFAIP3;TICAM2;NINJ1;F2RL1;DAB2IP
prerank,protein targeting (GO:0006605),0.48158507864710187,1.3808920674533356,0.01748971193415638,0.33173499669832684,1.0,29/118,15.91%,RPL11;GABARAP;TSPO;NACA;TIMM8B;TIMM13;TOMM5;NLGN1;AKAP6;TOMM7;SRP14;SEC61G;SORL1;AIP;TIMM10B;SPCS1;ICMT;HAP1;CDC37;GDAP1;GOLGA7B;SEC61A1;YIF1B;SPCS2;SDCBP;MFF;GOLGA7;PEX6;NCF1
prerank,cellular response to dsRNA (GO:0071359),0.6277865738336375,1.3808815152272307,0.09042553191489362,0.3312819125292086,1.0,7/15,21.33%,NPM1;FLOT1;PQBP1;IFIT1;PDE12;CAV1;RALB
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5726163552713921,1.380672674565879,0.09401709401709402,0.33131222544166583,1.0,6/23,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4560588501440104,1.3806586122720093,0.0,0.3308582279947086,1.0,155/532,21.23%,TMSB4X;RPS27A;IFITM3;HSPA8;PPIA;UBC;VIM;IFITM2;B2M;UBB;RPLP0;IFITM1;PSMB4;HSP90AA1;F13A1;MT3;BOLA2;CFL1;CXCL12;HMOX1;SOD1;MT2A;MAPK3;TALDO1;PSME1;AKT1;CCL19;PSMB6;PSME2;PSMB8;ITGB2;PSMD2;IL5;POMC;CNN2;CSNK2B;EIF5A;CANX;TNF;HSP90B1;PDGFB;TOLLIP;FCER1G;PSMD1;SPI1;JUNB;MIF;PSMC3;ST18;AIP;PSMD6;IL2RB;CSF3R;S1PR1;FN1;MSN;UBA52;PSMA7;ISG15;CCND1;CCR5;GSTO1;P4HB;CEBPA;CXCL10;TNFSF12;IL2;IFIT1;PSMD5;RBX1;LCP1;TIMP1;EGR1;HCK;FCGR1A;PSMB9;IRF8;CSF1R;PSMD13;TXNDC17;IL11;MMP3;PSMB3;LCN2;IL2RG;IL3RA;MAOA;PSMB11;COL1A2;BST2;VAV1;RIPK2;PSMB10;YWHAZ;TNFRSF1A;RHOU;UBE2V1;NDN;CCL2;PTPRZ1;IRF7;ARF1;PF4;IFNGR1;TRAF3;LRP8;CSF2RB;CD300LF;IL17RB;PSMB1;PSMB5;CCL3;VCAM1;SQSTM1;PIK3CD;TWIST1;ADAM17;NCAM1;NOS2;CCL8;SYK;OAS3;COMMD7;CCR2;SLA;PLVAP;LTBR;TNFRSF12A;STX4;TAB1;IL20RA;PSMA6;MUC1;CD86;SOS1;FLT3;HGF;IL6;IFNGR2;TGFB1;CSF2RA;IL10RB;SKP1;IL1RAP;PSMA4;MYC;CRLF1;NFKBIA;HSPA9;PTPN6;PYCARD;CRLF2;RSAD2;HNRNPF;IRF9
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5821463517839258,1.3806227089296217,0.0794044665012407,0.3304488782883671,1.0,7/24,13.41%,SEMA3F;DSCAM;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6053924610080695,1.3801245972604874,0.09743589743589744,0.3312095111683105,1.0,4/18,3.71%,RPS13;RPS26;TMBIM6;TNF
prerank,regulation of BMP signaling pathway (GO:0030510),-0.34707210926885407,-1.3800275726626243,0.0,0.4984918395136071,1.0,25/73,16.73%,SULF1;SMAD6;ZNF423;BMPR1A;FOXD1;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;RBPJ;ITGA3;NUMA1;BMP4;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,endothelial tube morphogenesis (GO:0061154),0.6664184569502458,1.3797385254978767,0.09612625538020086,0.33163979624341344,1.0,5/10,13.17%,RHOB;CSNK2B;ACVRL1;CTNNB1;RHOA
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5983183526212031,1.3794215145753868,0.08564231738035265,0.3319509840928348,1.0,10/21,20.52%,MT3;MAPK3;ZFP36L1;ZFP36L2;KDR;KARS1;SOX9;CTSH;MAP2K2;MYC
prerank,peptidyl-amino acid modification (GO:0018193),0.6733259355346414,1.37932875311721,0.10926694329183956,0.33169452322662646,1.0,5/10,15.29%,METAP1;FKBP10;FKBP7;METAP2;PDF
prerank,positive regulation of type 2 immune response (GO:0002830),0.6275999169597211,1.379131843791599,0.10540540540540541,0.33171961667811223,1.0,2/14,1.05%,CD74;CD81
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.53634046560958,1.378969996244749,0.08009153318077804,0.3315929998365997,1.0,6/35,7.58%,APOE;SPARC;ATP5F1A;CAV2;ATP5IF1;VASH1
prerank,protein processing (GO:0016485),0.48204383873500495,1.378916892758932,0.028985507246376812,0.3312110667562514,1.0,35/102,18.82%,CTSL;CTSS;LGMN;CD5L;RCE1;CPXM1;CPD;PSENEN;CPE;OMA1;F9;SPCS1;KLK1;KLK6;VSIR;METAP2;PCSK2;SRGN;AEBP1;MYRF;CPXM2;TMEM208;CLN5;SPCS2;CTSH;SPG7;HPR;HP;BACE1;PSEN2;MMP14;ADAM17;APH1B;SEC11C;PRSS12
prerank,carbohydrate biosynthetic process (GO:0016051),-0.449961390082098,-1.3788827111088475,0.07920792079207921,0.49744462962440344,1.0,9/21,19.97%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6091185537754095,1.3785486080761025,0.097911227154047,0.3316019002236858,1.0,10/18,24.49%,RPS3;IL2;CD24;ICOSLG;HMGB1;IGFBP2;IGF2;PYCARD;IL12RB1;AGER
prerank,connective tissue development (GO:0061448),-0.39529857596902346,-1.378189594842393,0.04054054054054054,0.4956124706084677,1.0,11/35,11.14%,SULF1;SOX5;ZBTB16;LRP5;SLC39A13;ATP7A;ITGB8;ARID5B;PKD1;SPTLC2;CREB3L2
prerank,action potential (GO:0001508),0.5332841674128734,1.3780613637868417,0.05423728813559322,0.3323049201813868,1.0,19/44,27.61%,AKAP6;ANK3;GPER1;SCN1A;KCND2;GNA11;YWHAH;KCNE4;KCNA2;CHRNA4;KCNE5;KCNA1;SRI;SCN9A;MYH14;SCN8A;SCN2A;KCNMB4;KCNQ1
prerank,apoptotic mitochondrial changes (GO:0008637),0.5534068547030976,1.3778169053230764,0.07459207459207459,0.3324199540859825,1.0,14/32,21.42%,CLU;ERBB4;FZD9;HSPD1;BAX;TIMM50;BBC3;BAD;MFF;DNM1L;CCAR2;BAK1;THEM4;FIS1
prerank,"phagocytosis, engulfment (GO:0006911)",0.5433789910000282,1.3775940006731275,0.06713780918727916,0.33248778916630384,1.0,11/36,12.35%,GSN;ITGB2;ARHGAP25;RAC1;ELMO1;RHOG;XKR4;ADGRB1;FCGR1A;MSR1;AIF1
prerank,ceramide transport (GO:0035627),0.6458905366663409,1.3765692432846606,0.08640226628895184,0.3345548085579249,1.0,2/12,1.44%,PSAP;PLTP
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6001049511002388,1.3763767110100638,0.08387942332896461,0.33458535140462387,1.0,9/18,22.12%,ZFP36L1;ZFP36L2;FAM107A;SSTR4;AQP1;ZFP36;HNRNPU;SSTR2;REST
prerank,membrane repolarization during action potential (GO:0086011),0.6350322545127735,1.3760994593972442,0.09395973154362416,0.33477133142884086,1.0,5/13,15.24%,YWHAE;KCNE4;ATP1A1;KCNE5;ATP1B1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6016987043912637,1.3759690856824243,0.10103626943005181,0.33458263890195955,1.0,9/17,19.15%,CXCL12;LGMN;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;CCR2;CXCL17
prerank,regulation of smooth muscle cell migration (GO:0014910),0.591096863624193,1.37595645766308,0.1,0.334129457447067,1.0,7/20,5.04%,VTN;S100A11;IGFBP3;PDGFB;IGFBP5;SORL1;NDRG4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.6088669779914175,1.3754503885166336,0.10615989515072084,0.3349558050477309,1.0,6/17,17.59%,EMC6;EMC3;EMC10;EMC4;SGTA;EMC8
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.4224596713263615,-1.3745362991469365,0.06735751295336788,0.501050696086157,1.0,12/25,22.05%,SF3B1;TRA2B;MPHOSPH10;SRRM1;SCAF11;PRPF3;SF3B3;PRPF4;SLU7;DDX23;LSM1;PRPF6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6708665918142901,1.3744672590522367,0.1017191977077364,0.3367960741060263,1.0,2/10,4.96%,ACADVL;ETFB
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.46408553908586503,-1.374325838825164,0.09251101321585903,0.4981355590109386,1.0,7/19,16.99%,NFAT5;PLCE1;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,negative regulation of T cell proliferation (GO:0042130),0.5512781623550674,1.3739088569196256,0.08732057416267942,0.3376428494234754,1.0,6/28,13.39%,GPNMB;PRNP;CEBPB;PRKAR1A;SDC4;LILRB1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6294748793705296,1.3732953078605477,0.1115702479338843,0.33868060619583223,1.0,8/14,26.23%,TIRAP;HNRNPA0;ZFP36;TARDBP;ELAVL4;YBX3;ELAVL1;HNRNPC
prerank,positive regulation of cell division (GO:0051781),-0.3867050835968191,-1.3729245077809864,0.07692307692307693,0.49802982726687794,1.0,9/38,12.16%,SVIL;FGF1;PRKCE;CDC14A;FGFR2;CSPP1;CDC25B;PKP4;GIPC1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5215216707480494,1.372755276071038,0.05555555555555555,0.33950403081055475,1.0,13/44,19.48%,APOE;AGT;SORL1;UCHL1;RGS2;HYAL2;SMPD1;DNAJA1;MAPK8IP1;SPRY1;DAB2IP;CD300A;SPRY3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5677582368286266,1.3722711905323404,0.07804878048780488,0.3402342419374109,1.0,14/27,25.43%,BGN;BCAN;DCN;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;CSGALNACT2;CHSY3;B3GAT1;CHST9;CSPG5
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6190572275873867,1.372270844627403,0.1118508655126498,0.33974539963577666,1.0,8/15,17.44%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2
prerank,regulation of protein ubiquitination (GO:0031396),0.47884223768867407,1.3711658037280734,0.02390852390852391,0.3419768511087243,1.0,32/108,16.86%,RPS3;UBB;HSP90AA1;HSP90AB1;LAPTM5;PARK7;UBXN1;AKT1;PINK1;FKBP1A;HSPA1B;BAG5;TNFAIP3;FAM107A;FOXF2;ISG15;CENPX;PTTG1IP;ADGRB1;DNAJA1;WFS1;VPS28;DNAJB2;NSMCE3;HSPA1A;FBXW7;IVNS1ABP;RIPK2;HSPBP1;ARRB2;CAV1;SQSTM1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.48509968285045835,1.3708051059998287,0.03995793901156677,0.34235526627682256,1.0,29/87,16.21%,PSMB4;GPNMB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;ZFP36L1;PSMC3;ZFP36L2;PSMD6;GPR132;FAM107A;PSMA7;JADE1;PSMD5;RBX1;CDK2AP2;PSMB9;PSMD13;PSMB3;PSMB11;KLF4;FBXO5;PSMB10;CCL2;PSMB1;PSMB5
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6449295015513147,1.3702242963980542,0.10340136054421768,0.3433301271741675,1.0,2/13,1.13%,LAMP1;TYROBP
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5372616428910165,1.3702087543835175,0.08561236623067776,0.34287295834625064,1.0,14/36,21.73%,RPS3;PPIA;TMBIM6;TNF;CX3CR1;MAPK8IP2;DAB2IP;GATA4;MAZ;QARS1;ING5;PYCARD;ASAH2;PTPMT1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.478375991093186,1.3700150122794534,0.034303534303534305,0.3427912156931124,1.0,28/98,20.94%,APOE;CD63;MT3;CHCHD2;AKT1;APOC1;AGT;SLCO1C1;PDGFB;ROMO1;GHITM;VAMP3;STARD4;FASN;DCXR;RAMP3;KLF4;SFRP4;NR1H2;ARRB2;SNCA;PRELID1;CBR1;INHBA;TGFB1;IL10RB;NFKBIA;GADD45A
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5108328666940125,1.369819600732707,0.06548279689234185,0.3427567504537236,1.0,10/47,13.19%,APOE;RPL10;AKT1;GRM5;AGT;METAP1;PCIF1;RBM4B;KLF4;METTL18
prerank,regulation of feeding behavior (GO:0060259),-0.5235906233617575,-1.3696686321350575,0.12686567164179105,0.5033615355319204,1.0,4/11,6.91%,AGRP;LEPR;EIF2AK4;STAT3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5591844425462466,1.3694726201629808,0.0967741935483871,0.34309820413843944,1.0,9/28,20.94%,TYROBP;SIRPA;HSPD1;THY1;CCL2;SH3KBP1;CCR2;IL6;PYCARD
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6460934817996701,1.3694319461299935,0.1226158038147139,0.3427005312985235,1.0,6/12,19.10%,CALM1;CALM3;IRX3;CAV1;SRI;CALM2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4869444694536926,1.3689841872241413,0.04250797024442083,0.34332491764843565,1.0,32/80,22.12%,CTSD;GPX1;MT3;NDUFA13;AKT1;ARL6IP1;GPER1;TNF;LAMTOR5;YWHAE;BEX3;FOXL2;AQP1;DHCR24;HMGB1;PDCD6;PMAIP1;KLF4;GAS6;BAD;BCAP31;PDCD5;SYK;SNCA;NLRP3;HGF;MYC;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5042508323146642,1.368013576515985,0.054945054945054944,0.3452380573230855,1.0,16/63,20.07%,CD74;CD81;CCL19;PTPRC;MIF;TIRAP;TFRC;IL2;PNP;AIF1;VAV3;VCAM1;CD86;GPR183;IL6;MEF2C
prerank,regulation of chemokine production (GO:0032642),0.5356507547612752,1.3672905807220777,0.07075471698113207,0.34659486026359115,1.0,19/36,26.11%,CD74;HMOX1;TREM2;TNF;LPL;EGR1;CSF1R;WNT5A;AIF1;F2RL1;SIGIRR;ADAM17;IL6;PYCARD;APP;AGER;IL33;TLR7;ACKR1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.5008993183999837,-1.3671879487437961,0.124,0.5059750708888433,1.0,4/13,5.44%,ATG10;SENP6;UBA3;SAE1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6664001504501919,1.366803654708293,0.10709117221418235,0.3473661292859434,1.0,6/10,25.01%,APLNR;PDE3B;CDC34;PDE11A;PDE2A;RNF157
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6731923982646086,1.3666838946970554,0.12939521800281295,0.34669818550113235,1.0,6/10,23.50%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6731923982646086,1.3666838946970554,0.12939521800281295,0.34669818550113235,1.0,6/10,23.50%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6358251242132538,1.3665375158924389,0.11428571428571428,0.34656576343903583,1.0,1/13,0.38%,RPS21
prerank,protein autoprocessing (GO:0016540),0.6020842564688887,1.3662826404620514,0.09407216494845361,0.3466820030534415,1.0,4/17,10.97%,CTSL;OMA1;KLK6;MYRF
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6397513776070519,1.3660819230369128,0.11218836565096953,0.34672026461054617,1.0,5/12,15.67%,HSP90AA1;HSP90AB1;B4GALT6;SPTBN4;EPHB1
prerank,interstrand cross-link repair (GO:0036297),0.5127448738869422,1.366010263549766,0.06182212581344902,0.3463965505242715,1.0,8/53,7.60%,RPS27A;UBC;UBB;VCP;NUCKS1;RPA2;UBA52;CENPX
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6388358059701569,1.3659741051255363,0.11972789115646258,0.34600445817149855,1.0,8/13,21.19%,GLUL;DDAH1;GLS2;GLS;NOS2;GLUD1;GAD1;ALDH4A1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4954806711147636,1.3658770123433568,0.05183585313174946,0.34578439362567465,1.0,26/65,21.57%,MT3;HMOX1;PINK1;KCND2;ZFP36L1;EPAS1;PGK1;HIPK2;NDRG1;BNIP3L;P4HB;FMN2;AQP1;AK4;ACAA2;PMAIP1;EGLN2;BAD;LMNA;TWIST1;NOP53;SFRP1;MYC;SIRT2;HYOU1;STUB1
prerank,regulation of primary metabolic process (GO:0080090),0.4709831821884059,1.365800904255967,0.023445463812436288,0.3454999165747279,1.0,28/126,12.63%,APOE;PSAP;PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;CERS2;NR1D1;PSMD1;PSMC3;PSMD6;PSMA7;EDF1;LSS;PSMD5;SIN3B;PSMB9;FASN;PSMD13;SCD;PSMB3;SC5D;PSMB11;NCOR2;ODC1
prerank,positive regulation of cell junction assembly (GO:1901890),0.5054123935329556,1.3657328603151977,0.06120218579234973,0.345171588585212,1.0,28/56,23.80%,CLDN5;NRXN1;NLGN1;S100A10;AGT;GRID2;CNTNAP2;RAC1;FLOT1;IL1RAPL1;THY1;KDR;PTPRD;SYNDIG1;IRX3;LRRC4B;EPHB1;CAV1;CLSTN2;CLSTN1;CRB3;SFRP1;IL1RAP;CLSTN3;COL16A1;PPM1F;WNT7A;TEK
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5450076159596823,-1.365718665602128,0.1258741258741259,0.5060115124594428,1.0,5/10,19.08%,GHR;STAT5B;STAT3;STAT5A;STAT6
prerank,protein K11-linked ubiquitination (GO:0070979),-0.41691854576992854,-1.3648917451743086,0.0784313725490196,0.5046931144921698,1.0,7/27,14.03%,UBE2E2;ANAPC5;ANAPC1;PRKN;ANAPC7;CDC26;CDC27
prerank,B cell proliferation (GO:0042100),0.583991674203721,1.3647563537594565,0.10899873257287707,0.3471826637653245,1.0,5/17,20.07%,PTPRC;CD180;HSPD1;RASGRP1;MEF2C
prerank,response to alcohol (GO:0097305),0.5572488647482555,1.364606620791327,0.0976470588235294,0.3470943943659193,1.0,14/27,19.83%,SOD1;CCL19;GRIN1;GRIN3A;CCR5;GRIN2A;SDF4;GLRA1;HSD3B2;ABCA2;CCL3;SLIT3;GRIN2B;TGFB1
prerank,myoblast fusion (GO:0007520),0.6582625724977871,1.36449953165165,0.0989010989010989,0.34687434422583,1.0,3/12,5.56%,CD81;ADGRB3;ADAM12
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6289697611313563,1.3644014433571126,0.09517601043024772,0.3466266516288181,1.0,5/15,10.00%,GRM5;HOMER2;GRM8;GRM7;GRM1
prerank,monocarboxylic acid transport (GO:0015718),-0.3547900648797433,-1.3643572681093352,0.041666666666666664,0.5024829989704699,1.0,12/51,12.66%,SLCO3A1;SLC6A13;SLC16A12;NCOA1;SLC6A12;SLC16A9;ABCG2;SLCO2A1;ABCB4;SLC16A6;SLC16A13;ATP8B1
prerank,mitochondrion disassembly (GO:0061726),0.5366308009145323,1.3632586835594511,0.08680555555555555,0.3489926996605285,1.0,7/34,5.66%,GABARAP;MAP1LC3B;PINK1;MAP1LC3A;GABARAPL2;GABARAPL1;ATG9A
prerank,regulation of chemotaxis (GO:0050920),0.5501350339681979,1.3632291371369376,0.0883054892601432,0.3485884793664921,1.0,15/30,21.84%,CCL19;TREM2;PDGFB;DUSP3;RARRES2;P2RY12;AIF1;ZSWIM8;CXCR4;F2RL1;YTHDF1;STX4;GPR183;TGFB1;PPM1F
prerank,presynapse organization (GO:0099172),0.660838362230641,1.3630910632224356,0.11927877947295423,0.34841983340635096,1.0,6/10,23.04%,NLGN1;C5AR1;WNT5A;LRRTM3;FZD1;WNT7A
prerank,T cell proliferation (GO:0042098),0.6272914339142138,1.3622915523393115,0.12414733969986358,0.35001369490935824,1.0,5/13,15.62%,MSN;SLC11A1;LILRB1;DOCK8;RASGRP1
prerank,negative regulation of cation channel activity (GO:2001258),0.5612805507035061,1.3620166418066513,0.1022167487684729,0.35021765527487714,1.0,9/26,19.10%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;CBARP;SRI;FKBP1B;CALM2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.46533934442293173,1.3616561853444276,0.023445463812436288,0.35061318674625197,1.0,41/145,16.89%,TUBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TUBA4A;PSMD1;DCTN3;PSMC3;PPP2R1A;YWHAE;PSMD6;GPR132;PSMA7;CCND1;CLASP1;YWHAG;TUBB4A;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;CEP131;PSMB11;DCTN1;FBXO5;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,regulation of protein localization to Cajal body (GO:1904869),0.6554308171654554,1.3610991486581625,0.12642045454545456,0.3509951686068243,1.0,7/11,24.76%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.6554308171654554,1.3610991486581625,0.12642045454545456,0.3509951686068243,1.0,7/11,24.76%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6701108678902961,1.3604216937155424,0.11205673758865248,0.352132124615831,1.0,5/10,17.59%,EMC6;EMC3;EMC10;EMC4;EMC8
prerank,mononuclear cell differentiation (GO:1903131),0.5550279884386801,1.3603432532177773,0.11428571428571428,0.3518567478451249,1.0,11/24,20.15%,MT1G;TREM2;IKZF1;IRF8;CSF1R;TRPM2;LILRB1;GAS6;BATF3;FLT3;PDE1B
prerank,cellular response to organonitrogen compound (GO:0071417),0.4804788083222518,1.3595825115437676,0.03426791277258567,0.3532518049137641,1.0,31/99,20.17%,ACTB;GABRB1;AKAP6;LAMTOR2;LAMTOR4;HSP90B1;LAMTOR5;IGFBP5;ZFP36L1;CTNNB1;P2RY6;P2RX7;AQP1;P2RY1;EGR1;P2RY12;GLRA2;TRPM2;GLRA1;GABRB3;SOX9;LAMTOR3;RRAGC;HCN1;RRAGD;DMTN;GABRB2;HCN3;NSMF;MEF2C;SFRP1
prerank,spermatid development (GO:0007286),-0.4074791329158449,-1.3594799431638165,0.07051282051282051,0.5106957844845903,1.0,18/32,32.44%,CDYL;RNF8;ING2;NECTIN2;RFX2;SYCP3;JAM2;ZMYND15;CIB1;YTHDC2;MKKS;ACRBP;DPY19L2;TDRD5;CCDC63;RSPH1;SOX30;TTC21A
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6414339573548864,1.3593421948575881,0.11007957559681697,0.353387211605337,1.0,7/13,19.19%,RACK1;HSPA5;PPP1R15B;WFS1;PPP1R15A;DNAJB9;DDRGK1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.46630985690988996,1.3592837154613067,0.028600612870275793,0.35303328042019966,1.0,42/124,20.32%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;RAC1;CNTN4;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;ATP1B2;PRDM12;MAPT;MAP2;STMN4;CDK5R1;HMGB1;BLOC1S1;CSF1R;BLOC1S3;BLOC1S5;PRMT1;STMN1;GPRIN2;EHD1;CDK5;NCDN;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;ATCAY;IL6;VAPA;POU4F1;CTTN
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5320086806274681,-1.3592377182305007,0.12323943661971831,0.5078416558687687,1.0,6/11,21.61%,SETD2;IWS1;AKAP8L;CPSF6;KHDRBS1;TPR
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6439782712219111,1.3590760880274149,0.11914893617021277,0.3530617168507008,1.0,2/11,2.84%,AKAP6;TREM2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6115769422866975,1.3590463834285391,0.12084993359893759,0.3526498799061527,1.0,8/15,27.66%,RACK1;TNF;ORMDL3;TNFRSF1A;SPHK2;ORMDL2;PLA2G6;SAMD8
prerank,negative regulation of phagocytosis (GO:0050765),0.6008594206514398,1.3588729876495453,0.11311053984575835,0.3526063696081022,1.0,6/17,17.78%,RACK1;SIRPA;SYT11;HMGB1;CD300LF;CD300A
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.623450329549909,1.3587005102035798,0.12585499316005472,0.3525498332059687,1.0,4/14,9.22%,CD63;EMP2;FLNA;TIMP1
prerank,pulmonary valve development (GO:0003177),-0.4773555246547637,-1.358379061661742,0.0967741935483871,0.5066584315492536,1.0,9/18,16.29%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;JAG1;BMP4;HEY2;BMPR2
prerank,positive regulation of signaling (GO:0023056),0.5316338499131357,1.3582614850376113,0.06674473067915691,0.35312218963397035,1.0,17/37,20.87%,TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;VAMP3;RAMP3;HCRT;CLSTN2;CLSTN1;NMB;KCTD13;EDN3;SOX11;SNCA;CLSTN3
prerank,negative regulation of B cell activation (GO:0050869),0.5868256935951748,1.3577531187161762,0.10592686002522068,0.3539512363777069,1.0,11/21,25.30%,TYROBP;LAPTM5;TNFAIP3;CTLA4;CD300A;INHBA;SFRP1;ID2;BANK1;TNFRSF13B;INHA
prerank,erythrocyte differentiation (GO:0030218),0.5235284986586802,1.3571164055569216,0.06621004566210045,0.3551328069065215,1.0,8/44,9.02%,RPS14;RPS19;SLC25A5;HCLS1;ATP5IF1;HIPK2;TSPO2;IKZF1
prerank,positive regulation of glucose import (GO:0046326),-0.4405796681330426,-1.3568872529342928,0.07766990291262135,0.5071503431788627,1.0,10/21,16.95%,SORBS1;OSBPL8;IRS1;INSR;IGF1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.34724562607340037,-1.3565142665393082,0.05102040816326531,0.5046858720123079,1.0,15/54,11.10%,UBE2E2;TTC3;RNF216;RNF152;UBR5;PRKN;RNF146;ARIH2;UBE2R2;UBE2Q2;RNF8;ZNRF1;TOPORS;ITCH;RNF115
prerank,positive regulation of ruffle assembly (GO:1900029),0.6370538758028418,1.3564729414104209,0.11612021857923498,0.3562824360808444,1.0,5/13,12.02%,NLGN1;PFN1;P2RY12;DEF8;HRAS
prerank,organic substance transport (GO:0071702),0.4700383168900298,1.3551820347184225,0.030706243602865915,0.35910008221131934,1.0,31/120,17.51%,RAMP2;PLTP;GM2A;RCN3;SLC18A1;LRP1B;TXNIP;HSP90B1;ABCB6;ABCG1;CHMP2B;TAP2;RD3;ARRDC1;SCAMP3;MFSD2A;SLC6A2;VAMP2;SLC50A1;ATP8A1;SLC48A1;RAMP3;CMTM6;NME4;SLC19A1;SCAMP2;ARRDC3;CHMP1B;ABCA2;MFSD2B;CLN8
prerank,maturation of LSU-rRNA (GO:0000470),0.5546533725753926,1.3548770638037344,0.097708082026538,0.3593312473892738,1.0,4/26,2.38%,RPL7;RPL7A;RPL35;RPL10A
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5562358686443595,1.3545115021494596,0.0908004778972521,0.3598313176851548,1.0,16/27,25.63%,SYT1;RIMS2;RIMS1;SDF4;SYT12;SYT11;VAMP2;SYT6;SYT4;SYT10;SYT2;DOC2B;SCIN;SYT3;SYT5;SYT17
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6680457288696865,1.3541392332402982,0.12375533428165007,0.3598158601637143,1.0,4/10,20.23%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6680457288696865,1.3541392332402982,0.12375533428165007,0.3598158601637143,1.0,4/10,20.23%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,regulation of intracellular transport (GO:0032386),0.5263007763706957,1.353987423580879,0.08083140877598152,0.35972062584033215,1.0,12/38,11.11%,LAMP1;CRYAB;NEFH;REEP5;MLC1;REEP6;MAP2;LCP1;ATP13A2;DNAJC30;GAS1;HAP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5436375422553281,1.3531708754883762,0.09579439252336448,0.3612833839734464,1.0,11/28,19.19%,CLU;LAPTM5;TREM2;PSMC3;ATP5IF1;NUPR1;ECSCR;FBXW7;DAB2IP;CTSC;DDRGK1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6704869444340322,1.3531599456186496,0.12138728323699421,0.36083723558078723,1.0,6/10,24.76%,CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,relaxation of muscle (GO:0090075),0.6372828682613477,1.3524418713429092,0.10490463215258855,0.36214118649093485,1.0,7/13,15.37%,GSN;RGS2;PLN;GSTM2;ATP1A1;ATP1B1;SLC8A1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5059722876759747,-1.3521267510191963,0.1,0.511662807996168,1.0,6/13,2.52%,ROCK2;AKAP13;ASAP3;ALMS1;SLC9A1;ROCK1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6370687228176903,1.351629250248672,0.12585499316005472,0.36367257481711307,1.0,4/13,8.93%,CD81;ITGB2;FCER1G;LPL
prerank,response to nutrient levels (GO:0031667),0.5959976062019474,1.3515468627446112,0.10613810741687979,0.36339765670113156,1.0,4/17,9.67%,ATF4;SCTR;FAM107A;CD68
prerank,positive regulation of cytokinesis (GO:0032467),-0.39496183365643944,-1.3515055164808065,0.06382978723404255,0.510032991974054,1.0,11/32,21.39%,SVIL;PRKCE;CDC14A;CSPP1;CDC25B;PKP4;GIPC1;CDC14B;RACGAP1;PKN2;KIF23
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5381826103828494,-1.351247743331203,0.10810810810810811,0.5074451610857823,1.0,1/10,0.23%,BMP6
prerank,receptor internalization (GO:0031623),0.5133002855602645,1.350753204393585,0.0773542600896861,0.36486543026085516,1.0,16/44,19.27%,CD81;RAMP2;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;SNCA;GRK2;RAB31
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5934431954309687,1.3506737235709607,0.12532981530343007,0.36457681329470804,1.0,5/17,14.60%,AKAP6;ANK3;VAMP2;KCNE4;KCNE5
prerank,aminoglycan metabolic process (GO:0006022),0.6528913842345831,1.3506440612547437,0.12640449438202248,0.3641644950237412,1.0,6/10,25.18%,B3GAT3;CLN6;XYLT1;B3GAT1;GAL3ST3;CHST9
prerank,regulation of histone methylation (GO:0031060),-0.502775327326129,-1.3505453804708263,0.11191335740072202,0.5059062010375236,1.0,3/13,5.61%,NSD1;JARID2;MTHFR
prerank,MAPK cascade (GO:0000165),0.4518409452660701,1.3503708749448489,0.007,0.3643478525981139,1.0,94/295,20.67%,RPS27A;UBC;CALM1;UBB;MBP;PSMB4;MT3;MAPK3;PSME1;PSMB6;PSME2;PSMB8;NRG1;PSMD2;ERBB4;IL5;RCE1;LAMTOR2;PEBP1;TNF;PDGFB;YWHAB;DLG2;PSMD1;ZFP36L1;NEFL;PSMC3;ZFP36L2;YWHAE;PSMD6;IL2RB;GRIN1;SHC3;UBA52;PSMA7;CCR5;PAK1;KDR;IL2;PSMD5;RBX1;ABHD17A;KARS1;ZFP36;KITLG;ICMT;PSMB9;RASGRP3;PSMD13;PSMB3;IL2RG;IL3RA;HRAS;GFRA1;PSMB11;SOX9;LAMTOR3;PSMB10;KBTBD7;CTSH;CCL2;LRRC7;ARL2;MAPK11;GOLGA7;PDGFA;CSF2RB;RASGRP1;SPTBN4;FGF13;PSMB1;GFRA2;PSMB5;DAB2IP;CCL3;SPTBN2;NCAM1;RASGRF1;ERBB3;GRIN2B;PLVAP;MAP2K2;KLB;PSMA6;SOS1;FLT3;HGF;TGFB1;CSF2RA;MEF2C;SKP1;PSMA4;MYC;BRAP
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6176056068413376,1.350186697196881,0.11936339522546419,0.36435028209937903,1.0,1/14,0.01%,TMSB4X
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5605578781713076,1.3501633871911318,0.09661229611041405,0.36391305005450414,1.0,8/24,10.88%,PEX5L;SCTR;APLNR;PDE3B;CDC34;PRKAR1A;GNAI1;PRKAR1B
prerank,positive regulation of cell aging (GO:0090343),0.6537438961828939,1.3499117411845236,0.11468531468531469,0.3640985679896508,1.0,2/11,2.35%,B2M;YPEL3
prerank,cellular response to gamma radiation (GO:0071480),0.5938346539749484,1.3498899564018636,0.11973684210526316,0.36366536329451626,1.0,4/17,12.02%,RPL26;CRYAB;TMEM109;HRAS
prerank,cholesterol metabolic process (GO:0008203),0.4886774904728702,1.349827442897297,0.07296137339055794,0.36335932530105114,1.0,18/68,23.49%,APOE;MT3;SNX17;ABCG1;LSS;DHCR24;PIP4P1;ACAA2;CLN6;SOAT2;CLN8;CH25H;PLPP6;OSBPL1A;FDPS;NSDHL;PMVK;ACLY
prerank,regulation of T cell activation (GO:0050863),0.5069369870210984,1.3497654038086933,0.08636363636363636,0.36303374644052505,1.0,12/42,20.94%,LAPTM5;GPNMB;LGALS3;DUSP3;SIRPA;HSPD1;THY1;FGL1;CCL2;CCR2;PRELID1;PYCARD
prerank,epithelium development (GO:0060429),0.4717209972532449,1.3495559902536505,0.0408997955010225,0.363087393515715,1.0,22/107,13.45%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;RCN3;SOX18;CD34;TOLLIP;LGALS3;NDRG4;PGK1;PROX1;KDR;MFSD2A;DNPH1;PIH1D1;SOX17;PCNA;SOX8;SOX9;BMP2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5922731138421151,1.3495318497174882,0.11712846347607053,0.36269074052187233,1.0,6/19,12.78%,KLF2;SLCO1C1;TNF;PDGFB;WFS1;KLF4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6306548604228381,1.3494138554460544,0.13988919667590027,0.36250661113723803,1.0,5/13,15.47%,CLU;MANF;NUPR1;WFS1;NR1H2
prerank,cAMP biosynthetic process (GO:0006171),-0.5550238736190177,-1.3490055652273762,0.1377049180327869,0.5062553242741712,1.0,4/10,10.19%,ADCY9;ADCY1;ADCY5;ADCY7
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5427150912756631,1.348842464639507,0.11708482676224612,0.36344226863764595,1.0,3/29,4.50%,LAMP1;TYROBP;SPI1
prerank,positive regulation of B cell activation (GO:0050871),0.5025968411813336,1.3486242096410388,0.0967741935483871,0.3634976316449618,1.0,14/50,20.07%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2;VAV3;SH3KBP1;MMP14;SYK;GPR183;IL6;MEF2C
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.652115223533218,1.3484288778557851,0.12394366197183099,0.36350617649823286,1.0,8/10,32.99%,GABRG3;GABRA2;GABRA3;GABRB2;GABRA4;GABRG2;GABRA1;GABRG1
prerank,positive regulation of angiogenesis (GO:0045766),0.4713149682924517,1.3480634338417399,0.029045643153526972,0.36392414487223235,1.0,32/108,17.05%,S100A1;RAMP2;MDK;HSPB1;GRN;HMOX1;RHOB;CD34;PKM;ECM1;APLNR;ADAM12;EMC10;BTG1;HIPK2;KDR;AQP1;TNFSF12;GATA2;NINJ1;PDCD6;WNT5A;KLF4;TIE1;CTSH;RRAS;DLL1;FLT1;GATA4;CDH5;PIK3CD;TWIST1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.6300876743535384,1.3479596696046865,0.1310344827586207,0.36371570454290525,1.0,4/12,13.46%,RPS27L;RPA2;CCND1;FBXO31
prerank,regulation of axon extension (GO:0030516),0.5232852521028875,1.347372272030367,0.08996539792387544,0.36472919275144244,1.0,8/37,9.08%,APOE;MT3;SEMA7A;RTN4;NRCAM;MAPT;MAP2;NTN1
prerank,autophagy of mitochondrion (GO:0000422),0.5228089505593358,1.3471381057832559,0.09038901601830664,0.3648716368603027,1.0,7/38,5.66%,GABARAP;MAP1LC3B;PINK1;MAP1LC3A;GABARAPL2;GABARAPL1;ATG9A
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5413398494639541,1.3459043958815842,0.1071863580998782,0.3675366677039321,1.0,5/30,8.81%,GPX1;HMOX1;PARK7;TNFAIP3;FAIM2
prerank,mesonephric tubule development (GO:0072164),-0.4868360208111967,-1.34539752976702,0.14022140221402213,0.5115089712951116,1.0,7/15,19.40%,SLIT2;FGFR2;PKD1;SIX1;WNT11;BMP4;PKD2
prerank,negative regulation of inflammatory response (GO:0050728),0.4569037554665407,1.3448903946028303,0.014127144298688193,0.36957523078776183,1.0,45/182,19.87%,APOE;RPS19;RAMP2;MDK;GRN;TREM2;POMC;GPER1;NR1D1;LRFN5;SCTR;SIRPA;TNFAIP3;DRD5;CD163;FEM1A;RXFP1;OTULIN;PRKAR1A;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;KLF4;ADCY4;TNFRSF1A;FNDC4;TYRO3;ADCY8;HTR7;CDH5;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;CXCL17;NLRP3;IL6;GIT1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.39272083034784044,-1.3448662855533304,0.06077348066298342,0.5097260212538214,1.0,10/29,15.71%,TCF7L2;CREBBP;TLE1;PYGO1;BCL9L;ASH2L;TERT;KMT2D;TLE3;CDC73
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5611551603279953,1.344421635842762,0.11223203026481715,0.3697712867458108,1.0,9/23,15.07%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5611551603279953,1.344421635842762,0.11223203026481715,0.3697712867458108,1.0,9/23,15.07%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,calcium ion homeostasis (GO:0055074),0.4723767803017573,1.3442657031659007,0.042355371900826444,0.3697031001843136,1.0,28/95,19.55%,TPT1;CALR;SLC30A1;CXCL12;CCL19;SLC24A4;SLC24A2;TMTC2;GRIN1;DRD5;TMCO1;HTR2C;ATP13A2;CALCB;WFS1;ATP2B1;ATP1B1;SLC8A1;RYR2;CCL3;CAV1;CDH5;CCL8;CCR2;SELENON;EDN3;SNCA;TFAP2B
prerank,rRNA transcription (GO:0009303),0.5876929407743322,1.343122529360856,0.12965340179717585,0.37214809649018,1.0,3/17,4.75%,CAVIN1;ANG;GTF3C6
prerank,regulation of mitochondrial depolarization (GO:0051900),0.661683318921483,1.3427122384865935,0.134180790960452,0.37272127881444084,1.0,4/10,9.63%,RACK1;FZD9;KDR;DCN
prerank,cellular potassium ion homeostasis (GO:0030007),0.621620414132992,1.342211073515289,0.14654002713704206,0.3734904909192845,1.0,7/13,18.33%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3;KCNMA1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6573282380513179,1.3421704112616326,0.125,0.3731164551525445,1.0,1/10,1.05%,CD81
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.589107953450084,1.3421020174592,0.1222366710013004,0.372801603870048,1.0,5/17,4.18%,VTN;MDK;S100A11;PDGFB;IGFBP5
prerank,UV protection (GO:0009650),0.6696685312650107,1.3417947967609154,0.12273361227336123,0.37309138864414115,1.0,5/10,13.89%,GPX1;MFAP4;SDF4;MC1R;CAT
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4897146505640755,1.3413582554565895,0.06472491909385113,0.3737276931179553,1.0,30/65,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;GPR132;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;VPS4A;PSMA6;SKP1;PSMA4;PSMC1;PSMD9;PSMB2;PSMD4;CHMP4C;PSMD10
prerank,ovarian follicle development (GO:0001541),0.6215781711473729,1.3413497047696306,0.13821138211382114,0.37328367226111375,1.0,8/13,25.30%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;INHA
prerank,regulation of programmed cell death (GO:0043067),0.4568492485468746,1.3409539057159903,0.019230769230769232,0.3738158074733459,1.0,38/161,14.37%,TPT1;RPS3;CLU;CTSB;HSP90AA1;CALR;LGALS1;AKT1;NME1;TGM2;PINK1;AGT;IGFBP3;BEX2;MAGED1;TNF;PRDX2;RTN4;VCP;ALPK2;OMA1;NDRG1;BNIP3L;SGK1;CXCL10;TARDBP;GAS1;APEX1;BAX;ZBTB7A;WFS1;PMAIP1;ACTN1;PHLPP1;SOX9;NME2;GLS2;IKZF3
prerank,cellular metal ion homeostasis (GO:0006875),0.46706445737727487,1.3409071274687154,0.0371900826446281,0.3734466659529293,1.0,29/102,18.94%,TPT1;CALR;MT3;SLC30A1;CXCL12;CCL19;SLC24A4;SLC24A2;DRD5;ATP1A3;ATP1B2;TMCO1;HTR2C;ATP13A2;CALCB;ATP1A4;ATP1A1;ATP2B1;ATP1B1;SLC8A1;RYR2;CCL3;CAV1;CDH5;CCL8;ATP1B3;CCR2;KCNMA1;EDN3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.6199969627730102,1.3407150222919801,0.1313969571230982,0.3734374826340753,1.0,6/13,21.18%,BOLA2;GLRX5;LTO1;CIAO1;CIAO2A;CIAO2B
prerank,regulation of cell motility (GO:2000145),0.4616689878888708,1.340399355281224,0.028836251287332648,0.3737267213587299,1.0,24/121,10.78%,TMSB4X;TMSB10;CAVIN1;RHOB;AKT1;CCL19;SPOCK2;SERPINE2;NRG1;ERBB4;RAC1;PIN1;FLNA;FRMD5;ENPP2;SGK1;PKN1;ROBO4;SPOCK3;NTN1;CADM4;PHPT1;CSF1R;DOCK10
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5880978425469677,1.3402529771443474,0.13112582781456952,0.3736117347977243,1.0,10/18,27.18%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,nitric oxide metabolic process (GO:0046209),0.6127442792030291,1.3397840389444362,0.1286472148541114,0.3743348572917555,1.0,5/14,17.55%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4869468450927372,1.33922128149228,0.06852248394004283,0.3753534296910632,1.0,16/63,12.44%,CST3;MT3;TIMP2;AKT1;EIF4G2;TREM2;APOC1;RASIP1;SORL1;NELL1;MFSD2A;NUPR1;TIMP1;MTMR9;ATRAID;TIMP3
prerank,regulation of monooxygenase activity (GO:0032768),0.5584837868542806,1.3390247992919173,0.11553273427471117,0.3753736724889276,1.0,9/23,19.11%,CALM1;HSP90AA1;AKT1;CYGB;SPR;DDAH1;CAV1;DDAH2;SNCA
prerank,negative regulation of catabolic process (GO:0009895),0.5050141460604811,1.338531550203976,0.07936507936507936,0.37613090464586074,1.0,10/47,10.10%,CST3;APOC1;TNF;PIN1;BSCL2;FLNA;PDE3B;FMN2;NUPR1;ADGRB1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5869727715685308,1.3383860272401544,0.12082262210796915,0.3760184978516346,1.0,7/19,19.15%,MDK;MAPK3;CAMK1D;RARRES2;CSF1R;JAM3;CXCL17
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4607496733947671,-1.337182344974964,0.1187214611872146,0.5254739934491964,1.0,7/17,14.17%,CACNA1C;ANK2;ATP1A2;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5443202838219203,1.3371814363122096,0.1111111111111111,0.37862317870577644,1.0,12/27,20.94%,MDK;ITGB2;TNF;SIRPA;HSPD1;THY1;RHOA;CCL2;SKAP1;CCR2;IL6;PYCARD
prerank,regulation of axon regeneration (GO:0048679),0.617498286536512,1.33678447726276,0.13642756680731363,0.37916318746862826,1.0,3/12,7.62%,GRN;CERS2;KLK8
prerank,defense response to symbiont (GO:0140546),0.47256417050936245,1.33656010130636,0.04842105263157895,0.37921253814208133,1.0,30/92,22.14%,IFITM3;IFITM2;IFITM1;SHFL;PTPRC;RNASE1;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;IFIT1;PMAIP1;BST2;LILRB1;PDE12;IRF7;SERINC5;F2RL1;G3BP1;OAS3;IL6;DDIT4;PYCARD;RSAD2;EXOSC4;IFI27;ISG20
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4634487320680912,1.3362588759397538,0.029896907216494847,0.3794800422561034,1.0,60/124,28.47%,CALM1;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;RAC1;PSMD1;PSMC3;CTNNB1;PSMD6;AP2M1;SFRP5;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;GNAO1;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;SFRP4;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;AGO1;ARHGEF19;PPP3CA;PSMA6;SFRP1;PSMA4;FZD2;FZD1;AP2A1;PPP3R1;PSMC1;PARD6A;WNT7A;PSMD9;PDE6G;CELSR3;PSMB2;PSMD4;PSMD10;FZD3;LEF1;PSMC5;VANGL2;FZD5;MAP3K7;CCDC88C
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6214822741750576,1.3359910872047938,0.126514131897712,0.37966088861454717,1.0,2/14,1.61%,RPL7;RPL35
prerank,anterior/posterior pattern specification (GO:0009952),-0.3466596843532772,-1.335855260389667,0.05217391304347826,0.5254912114683249,1.0,19/53,16.73%,WLS;HOXB6;HOXB3;HOXA3;LRP5;SKI;HOXB4;HOXA5;HOXC4;TGFBR1;HOXB5;PCSK5;HOXC6;HOXA6;HOXC5;SMAD2;HEY2;BMPR2;ACVR2B
prerank,C4-dicarboxylate transport (GO:0015740),0.6103976890580254,1.335171117144315,0.13932291666666666,0.38130856310981337,1.0,10/14,30.04%,SLC1A2;SLC25A13;SLC25A11;SLC1A1;SLC25A22;SLC25A18;SLC25A14;SLC25A12;SLC13A5;SLC25A30
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5057624767461409,1.334565328028787,0.0930493273542601,0.38239881843056717,1.0,12/44,13.55%,GPX1;MT3;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;KLF4;GAS6
prerank,synapse organization (GO:0050808),0.46205103265534886,1.3341844499441142,0.03268641470888662,0.38296389747905357,1.0,44/125,19.95%,C1QB;C1QA;CHCHD10;C1QC;NRXN1;SPOCK2;NLGN1;GRM5;ANK3;LRFN5;C5AR1;DSCAM;PIN1;LRP4;ADGRL3;DNM3;LRRC4C;MUSK;GPHN;KIRREL3;NRCAM;PPFIA4;PPFIA2;MAPT;PAK3;DNER;PTPRD;DOK7;NRXN2;DCTN1;CBLN2;LRRC4B;CX3CR1;ELFN1;PPFIA3;ACHE;CDK5;RAB39B;PCDHB14;GPM6A;CTNND2;SNCA;AGRN;POU4F1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5482813564143086,1.3340583248976954,0.13022113022113022,0.382827396431969,1.0,9/24,17.95%,CD151;RHOC;ACVRL1;MRTFA;FLNA;LCP1;RHOA;ADAM17;TMEFF2
prerank,positive regulation of proteolysis (GO:0045862),0.49693727476115956,1.3340520525722879,0.06500541711809317,0.3823626420983615,1.0,18/55,22.30%,APOE;AURKAIP1;NDUFA13;RCN3;PINK1;TNF;ATP5IF1;CLN6;CTSH;BAD;SNX33;TRIM32;CTSC;WDR48;CAPN3;BAK1;STUB1;TNIP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4746863520641323,1.3340448681216388,0.06335797254487856,0.3819062510018522,1.0,22/82,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NPM1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;ATF5;CEP131;DCTN1;NEK10;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.524589611818794,1.334023520289347,0.08833522083805209,0.3815050177347666,1.0,11/36,17.48%,CD74;LAPTM5;HSPA1B;TICAM2;WNT5A;C1QTNF4;HSPA1A;GAS6;CXCR4;CD300LF;ADAM17
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4731464692330523,1.333942850603446,0.05876180482686254,0.38123428598728554,1.0,20/88,13.45%,APOE;SPARC;AKT1;ATP5F1A;PDGFB;ACVRL1;ANG;ECM1;CAV2;ATP5IF1;EMC10;VASH1;PROX1;KDR;TNFSF12;PDCD6;WNT5A;FLT4;TIE1;BMP2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6486780038019456,1.3336491355013689,0.12290502793296089,0.38146006787747794,1.0,3/11,7.08%,HSPA5;ATF4;CEBPB
prerank,glutamate metabolic process (GO:0006536),0.5770359409985527,1.3334507544668956,0.13246753246753246,0.38149509457451175,1.0,8/19,21.67%,OAT;GLUL;GLS2;GLS;GLUD1;GOT1;GAD1;MTHFS
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.45994680143740563,-1.3326426504996784,0.11627906976744186,0.5304632241371479,1.0,6/16,14.10%,CREBBP;NAA40;KAT2B;NAA16;NAA15;NAA35
prerank,cellular response to virus (GO:0098586),0.5345812000593197,1.3320844013287363,0.10820451843043995,0.38443805481273535,1.0,8/30,15.22%,HSP90AA1;CCL19;EIF5A;CXCL10;RRP1B;BAX;ARF1;MAPK11
prerank,artery morphogenesis (GO:0048844),-0.39772882079792743,-1.3318964331294327,0.09248554913294797,0.5291048036971443,1.0,12/30,16.91%,BMPR1A;NRP1;ADAMTS9;TGFBR1;SMAD7;PDGFRB;LRP1;JAG1;BMP4;HEY2;BMPR2;NF1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5766074382150551,1.3313902457805369,0.13071065989847716,0.3856864841314471,1.0,6/20,16.01%,ACADVL;APOC1;GPER1;FBXW7;BMP2;ABCA2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4568334467313012,1.3312493821854985,0.020161290322580645,0.38554934167813265,1.0,41/166,16.45%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;HSP90AA1;HSP90AB1;PARK7;AKT1;KLF2;CCL19;EIF3D;NPM1;RPS27L;TNF;PDGFB;NR1D1;MID1IP1;CTDNEP1;EIF3C;MFSD2A;MLXIPL;STARD4;EGR1;DDB1;PCIF1;PCNA;ZCCHC4;KLF4;PRMT1;DDAH1;TLR6;ABCB10;ARPP19;IGF2;NR1H2;CIRBP;YTHDF1;EIF4A3;DDAH2
prerank,primary miRNA processing (GO:0031053),-0.5245592705040409,-1.3311726932830026,0.15822784810126583,0.5275708903227383,1.0,5/10,15.02%,SMAD3;DROSHA;SMAD1;SMAD2;SRRT
prerank,myeloid dendritic cell activation (GO:0001773),0.6229026187856977,1.3310201048565296,0.15217391304347827,0.38566727171415055,1.0,5/12,20.94%,DOCK2;HMGB1;BATF3;BATF2;PYCARD
prerank,mammary gland epithelium development (GO:0061180),0.6022406111705365,1.330290620370379,0.16098226466575716,0.38701780217106924,1.0,3/14,10.71%,AKT1;ERBB4;CSF1R
prerank,neural crest cell migration (GO:0001755),0.521797489233398,1.3300172965419454,0.09133489461358314,0.3872785171458395,1.0,10/36,13.41%,ERBB4;SEMA3F;SEMA7A;SEMA4C;FN1;CORO1C;SEMA6D;SEMA4A;SOX8;SEMA4G
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.48799065716687007,1.329538680915822,0.08924731182795699,0.38798690213924236,1.0,27/57,25.00%,NLGN1;DLGAP2;GRIA2;DLGAP1;DLG2;SHISA7;NEFL;GRIN1;GRIA4;LYNX1;GRIN2A;CRH;GRIA1;BEGAIN;LRRC7;MAPK8IP2;CACNG8;NPTXR;GRIN2B;CACNG5;MEF2C;GRIA3;CACNG2;APP;NPTX1;SHISA6;PRRT1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.49978937828695674,1.3291254913594719,0.08998875140607424,0.38850758498539095,1.0,17/47,20.94%,TYROBP;SOD1;CYBA;ITGB2;AGT;PDGFB;ROMO1;GRIN1;MAPT;ADGRB1;DCXR;TLR6;F2RL1;SYK;CBR1;TGFB1;GADD45A
prerank,positive regulation of bone resorption (GO:0045780),0.6451237503655847,1.328277398706371,0.1289437585733882,0.39021957164989124,1.0,6/11,25.11%,SPP1;ATP6AP1;DEF8;SYK;TNFRSF11A;PRKCA
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5484438602771781,1.3279353158143308,0.12224938875305623,0.39061337800584134,1.0,12/24,22.49%,CXCL12;NBL1;LGMN;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;CCR2;CXCL17;CCN3;DUSP1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5452209726506294,1.3277546898278252,0.12640801001251564,0.39062383210693274,1.0,9/24,21.42%,PRNP;ITGB2;ANK3;HRAS;MTCL1;MIEF2;MFF;C2CD5;FIS1
prerank,protein localization to cilium (GO:0061512),-0.3825021128678101,-1.327630671865651,0.0880503144654088,0.5332446143909916,1.0,11/32,14.54%,ZNF423;RABEP1;BBS9;INVS;ARL3;WDR35;TULP3;IFT140;IFT122;TULP2;WDR19
prerank,positive regulation of cytokine production (GO:0001819),0.443557381595604,1.3275385138716267,0.0050150451354062184,0.39071088283015465,1.0,86/292,22.12%,RPS3;CD74;GAPDH;MBP;TYROBP;MDK;LAPTM5;POLR2E;HMOX1;PARK7;SOD1;C3;ATF4;PDE4B;CCL19;CYBA;CD34;SLC7A5;AGT;S100A13;NFAM1;POLR2F;TNF;LAMTOR5;PTPRC;FCER1G;SORL1;MIF;HSPA1B;FLOT1;TIRAP;CTNNB1;HYAL2;ISG15;CEBPB;PQBP1;CLEC6A;HSPD1;IL2;LPL;EGR1;LILRA5;HMGB1;CSF1R;WNT5A;PNP;FLT4;C1QTNF4;AIF1;POLR2K;SLC11A1;HSPA1A;LILRB1;RIPK2;TLR6;IRF7;F2RL1;G3BP1;TLR5;MAPK11;TLR1;RASGRP1;HPSE;GATA4;PIK3CD;TWIST1;ADAM17;NOS2;SYK;CCR2;CXCL17;CD14;CD86;NLRP3;IL6;TGFB1;SPHK2;TMEM106A;PYCARD;CRLF2;POLR2H;DDIT3;TMED10;POLR3K;IRF5;POLR3D
prerank,positive regulation of secretion (GO:0051047),0.638223200726546,1.327253099667382,0.14772727272727273,0.39094607127898057,1.0,4/11,18.54%,TRH;AQP1;SCIN;ACSL3
prerank,positive regulation of calcium ion transport (GO:0051928),0.5222443280594693,1.3271377735247913,0.1076923076923077,0.39077616494213907,1.0,12/36,16.88%,CXCL12;PDGFB;LGALS3;GRIN1;P2RX7;LILRA5;WFS1;ATP2B1;CCL2;CCL3;CAV1;ORAI1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5486441497599138,1.326745985197191,0.12745098039215685,0.3913477939972858,1.0,5/25,14.62%,B2M;LAPTM5;SLC7A5;WNT5A;F2RL1
prerank,histone deacetylation (GO:0016575),-0.34392555859948587,-1.3264755305260216,0.04950495049504951,0.532909975954477,1.0,12/43,9.37%,PRDM5;MIDEAS;BAZ2A;HDAC4;PER2;MTA3;HDAC8;TBL1X;SMARCAD1;RCOR1;MIER1;TBL1XR1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.459817955096702,-1.326369982080486,0.12643678160919541,0.529966823026159,1.0,6/15,9.67%,GPC3;WNT5B;RNF213;RSPO3;NPHP3;SPEF1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5882914133981759,1.3263511967620125,0.13446475195822455,0.3918722912009677,1.0,4/16,9.52%,HMOX1;APLNR;JCAD;GATA2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.44778771225787745,1.326126265350173,0.014056224899598393,0.391967856119186,1.0,65/214,20.03%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;PIN1;MIF;NDRG4;DUSP3;TIRAP;ATP6AP1;SIRPA;DDT;FN1;P2RY6;DUSP26;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;CAMK2N1;PTPRR;TIMP3;FBXW7;CNKSR3;SPRY1;NEK10;BMP2;GAS6;YWHAZ;CCL2;RRAS;F2RL1;PDGFA;RASGRP1;EPHB1;ARRB2;ADRA1A;DAB2IP;CCL3;GATA4;ADCYAP1;CCL8;SYK;FAM83D;SPRY3;GPR183;NOTCH1;TGFB1;THPO
prerank,protein localization to organelle (GO:0033365),0.4532687786117124,1.3259251321535332,0.03979591836734694,0.39201637962066876,1.0,28/133,11.98%,RPL11;LAMP1;CALR;COL1A1;HMOX1;SEC61B;PRNP;WDR83OS;TMEM30A;GABARAPL2;TOLLIP;AUP1;SEC61G;SORL1;IFT20;YWHAE;CTDNEP1;RPA2;ISG15;YBX1;VAMP2;ARF6;CD68;DNAJA1;MSX1;ZBTB7A;SERP1;ARL1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.623093964247155,1.3254924153671603,0.1424581005586592,0.3926118176008857,1.0,3/12,13.00%,RBP4;STRAP;SOX9
prerank,histone H4 deacetylation (GO:0070933),-0.5336106504529543,-1.325014280344171,0.14527027027027026,0.5302311725367094,1.0,4/10,7.12%,HDAC4;HDAC8;SMARCAD1;RCOR1
prerank,negative regulation of apoptotic process (GO:0043066),0.4411979669696768,1.3247278359856611,0.0,0.3941654807378907,1.0,125/444,20.87%,APOE;TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;UBB;GPX1;MDK;HSPB1;GRN;MT3;CFL1;PARK7;SOD1;RPL10;MAPK3;HSPA5;LGMN;AKT1;FOXQ1;HIGD2A;CCND2;TMBIM6;UBE2Z;TREM2;CRYAB;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;PINK1;TNF;HSP90B1;FZD9;PRDX2;LAMTOR5;HCLS1;GLO1;NTRK2;NAA38;MIF;BNIP2;HSPA1B;CTNNB1;FLNA;YWHAE;IL2RB;LTK;TMEM14A;BEX3;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;KDR;AQP1;IL2;FAIM2;DHCR24;NUPR1;SET;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;KLF4;SOX9;HSPA1A;RIPK2;GAS6;YWHAZ;NME2;CAT;CTSH;CX3CR1;CCL2;PTPRZ1;MAPK8IP2;ARF4;DLL1;TYRO3;ATAD3A;CAV1;DDAH2;VHL;GATA4;PIM3;SQSTM1;PSEN2;PCID2;PPARGC1A;ASNS;CIAPIN1;AGAP2;ERBB3;MAZ;QARS1;HMGN5;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;TFAP2B;NOTCH1;HGF;IL6;POU4F1;CITED2;MEF2C;SFRP1;CAPN3;MYC;CRLF1;NFKBIA;HSPA9
prerank,nitric oxide biosynthetic process (GO:0006809),0.6201473714198789,1.3243884730032394,0.1432469304229195,0.39456334254979847,1.0,5/13,17.55%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,myelination (GO:0042552),0.49822357742379697,1.3242005912849801,0.10874439461883408,0.39455611127640455,1.0,16/46,15.94%,MBP;PLP1;MPZ;PLLP;PMP22;MAL;KLK6;GAL3ST1;B4GALT6;MYRF;MALL;CXCR4;BCAS1;NFASC;DEGS1;EPB41L3
prerank,regulation of ion transport (GO:0043269),0.4761290263328991,1.3239775423710323,0.07301587301587302,0.3946291630113816,1.0,21/76,16.40%,B2M;NKAIN2;ANK3;CA2;YWHAH;KCNJ10;SYT1;NKAIN3;P2RX7;SYT12;SYT11;VAMP3;VAMP2;SYT6;SYT4;KCNA2;ATP1A1;CHRNA4;SYT10;SPTBN4;SYT2
prerank,regulation of cell development (GO:0060284),0.5062345185433508,1.3226426210546023,0.11059371362048893,0.39746034160022314,1.0,11/36,16.38%,RPS19;GRN;AKT1;CTNNB1;HES1;HES6;BHLHE41;CX3CR1;HEY1;DLL1;HDAC9
prerank,regulation of glycolytic process (GO:0006110),-0.3260559954429408,-1.3224290337892572,0.03773584905660377,0.5338194262396159,1.0,12/68,8.24%,ZBTB20;PRKAG2;ARNT;RANBP2;HDAC4;OGT;PPARA;NUP98;NCOR1;INSR;IGF1;PRKAA2
prerank,positive regulation of cell development (GO:0010720),0.5293763559302384,1.3223176011494757,0.11366384522370013,0.3978419211081021,1.0,10/31,18.97%,TYROBP;SERPINF1;TGM2;GPER1;ATP6AP1;SNW1;CX3CR1;BAD;TRIM32;SOX11
prerank,neural crest cell development (GO:0014032),0.4996134774523547,1.3215009884287015,0.10079275198187995,0.3994836976728439,1.0,11/44,13.41%,NRG1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;SEMA4A;PDCD6;SOX8;SEMA4G
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6353085266829293,1.3214766991681457,0.14042553191489363,0.39908049167148774,1.0,3/11,10.15%,CD74;MIF;TAF9
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4984166413996743,-1.321148798307296,0.137546468401487,0.5336612471440776,1.0,7/13,22.30%,SNX6;CBLB;ERRFI1;SOCS5;GPRC5A;CBL;TSG101
prerank,regulation of cell cycle phase transition (GO:1901987),0.46568065791811686,1.320990990556628,0.06589958158995816,0.39980337093473195,1.0,40/91,28.26%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXW7;NEK10;FBXO5;PSMB10;PSMB1;PSMB5;PSMA6;SKP1;PSMA4;TFAP4;PSMC1;FZR1;PSMD9;CDC20;PSMB2;XPC;PSMD4;PSMD10;ERCC2;CDKN1A;PSMC5;TRIM39;ATP2B4
prerank,entry into host (GO:0044409),0.6139387933224317,1.3203988419494916,0.13387978142076504,0.4008444582483889,1.0,4/13,13.70%,PPIA;CTNNB1;CCR5;CXCR4
prerank,negative regulation of endocytosis (GO:0045806),0.5524378714271838,1.319602160435166,0.11265822784810127,0.40242411104346487,1.0,11/24,19.37%,APOC1;LGALS3;RAC1;SYT11;ARF6;LILRB1;NR1H2;SNX33;CAV1;CD300A;UNC119
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.4010375648525213,-1.3195774849029607,0.13068181818181818,0.5342480694627264,1.0,10/28,16.08%,PARP9;KMT5C;PARP3;KMT5B;SHLD1;MRNIP;CYREN;KDM4D;SMCHD1;SIRT7
prerank,neutrophil activation (GO:0042119),0.6274204122063938,1.3192605021094537,0.16010854816824965,0.4028074565464466,1.0,4/12,17.99%,TYROBP;FCER1G;F2RL1;SYK
prerank,positive regulation of defense response (GO:0031349),0.4676832947073147,1.3191884802614398,0.061246040126715945,0.40250973166856024,1.0,33/89,26.21%,MDK;GRN;CYBA;AGT;TNF;S100A9;S100A8;DDT;HYAL2;FEM1A;CEBPA;IL2;LPL;SLC15A4;LILRA5;NINJ1;PLA2G7;WNT5A;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;MEF2C;NFKBIA;POLR3D;TNIP1;AKIRIN2;APP;PDE2A;IL33;TLR7;CX3CL1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5324030121375357,1.3190663738871704,0.12212817412333736,0.40235065198347564,1.0,11/29,23.49%,SCD5;ELOVL1;ELOVL2;FASN;ELOVL7;SCD;SLC25A1;ACSL3;ELOVL6;ACSL4;ACLY
prerank,androgen metabolic process (GO:0008209),0.5815883623333583,1.3190547416813405,0.14177215189873418,0.40190835641776124,1.0,4/18,12.81%,SPP1;HSD17B6;HSD17B4;HSD3B2
prerank,regulation of cellular response to heat (GO:1900034),0.4725314881930808,1.3187901880178365,0.05919661733615222,0.4021138948077633,1.0,23/77,18.99%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;MAPK3;CRYAB;CD34;HSPA1B;YWHAE;RPA2;BAG5;BAG1;MAPT;HSPB8;HSPA1A;NUP85;NUP88;PTGES3;DNAJB1;IER5;NUP50;AKT1S1;CCAR2
prerank,negative regulation of calcium ion transport (GO:0051926),0.5939516183709069,1.3187293179167174,0.12743823146944083,0.40179548341834764,1.0,5/15,16.27%,SLC30A1;TMBIM6;PLN;LILRB1;CBARP
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5628458035656828,1.318616832231363,0.13520408163265307,0.40158994278936905,1.0,5/20,8.05%,HSP90AB1;C3;TXN;TXNIP;P2RX7
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5632695396340625,1.3180996216766212,0.14010282776349614,0.40243392342885576,1.0,8/20,13.09%,HSP90AA1;HSP90AB1;PINK1;EPAS1;HSPA1B;EGR1;DNAJB2;HSPA1A
prerank,cellular protein catabolic process (GO:0044257),0.48283614619471255,1.317676167282544,0.0911062906724512,0.4030613374200082,1.0,11/59,9.52%,CTSB;CTSL;CTSZ;CTSS;LGMN;CHEK2;UBE2G2;AP2M1;BNIP3L;CLTC;AP2S1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6091882698033424,1.317024274948571,0.1412894375857339,0.4042618688669086,1.0,7/14,27.39%,UQCC2;COA3;TRUB2;RPUSD4;C1QBP;TRMT10C;RCC1L
prerank,negative regulation of locomotion (GO:0040013),0.629977915526557,1.3169201634867478,0.15436241610738255,0.4040748976843445,1.0,4/12,8.70%,PIN1;DUSP3;FRMD5;SPOCK3
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3062246875570594,-1.3165919338381051,0.0,0.5385420555679559,1.0,33/108,13.39%,SULF1;NXN;WWOX;TRABD2B;WLS;DCDC2;LRRK2;VGLL4;MACF1;KREMEN1;GPC3;SKI;PTK7;PRKN;NFATC1;AXIN1;TLE1;GRB10;MDFIC;RSPO3;FGFR2;BTRC;KANK1;ESR1;TERT;PSEN1;LRP1;ITGA3;CSNK2A1;NLK;RNF43;ZRANB1;CBFB
prerank,negative regulation of catalytic activity (GO:0043086),0.5439106135496153,1.3156226055905884,0.14250614250614252,0.4069172342282504,1.0,11/24,19.63%,MT3;NES;ATP5IF1;PLN;IFIT1;TIMP1;PHPT1;HP;TMBIM1;CCAR2;NOTCH1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6036925196304008,1.3155515680819168,0.14419225634178906,0.40663330174912704,1.0,4/14,10.71%,MDK;MAPK3;RARRES2;CSF1R
prerank,regulation of cytokine production (GO:0001817),0.45438066829777973,1.3152909560656931,0.034764826175869123,0.40683342877401374,1.0,32/126,18.30%,GAPDH;GPNMB;SOD1;TREM2;AGT;S100A13;NFAM1;TNF;PLD3;PTPRC;BTN3A3;MIF;FLOT1;SIRPA;ISG15;CLEC6A;SYT11;BCL6B;MOG;ICOSLG;IRF8;SRGN;ATP2B1;SLC11A1;IRF7;TRAF3;TRIL;HDAC9;PIK3CD;TRIM32;NOS2;CCR2
prerank,negative regulation of cellular component organization (GO:0051129),0.4682850075463054,1.314983913075287,0.08456659619450317,0.4071951661846567,1.0,19/74,18.23%,HSPA8;CLU;HSPA5;CRYAB;TNF;LGALS3;SORL1;HSPA1B;SYT11;SVIP;DNAJB2;HSPA1A;LILRB1;SACS;DNAJB1;DNAJA4;SNX33;TMEFF2;NOP53
prerank,metal ion transport (GO:0030001),0.46649789048203666,1.3148735446185387,0.07255520504731862,0.40703643218120844,1.0,24/86,18.52%,TPT1;RAMP2;MT3;SLC30A1;CACNA1A;GRIN3A;CCR5;SELENOK;SLC3A2;NIPAL4;RAMP3;TRPM2;CHRNA4;SLC11A1;TRPC1;SLC8A1;RYR2;CCL3;CAV1;CACNG8;PSEN2;CCL8;MAGT1;NIPA1
prerank,T cell receptor signaling pathway (GO:0050852),0.4507621572710912,1.3146763083328652,0.037525354969574036,0.40705899090444553,1.0,61/138,30.41%,PSMB4;PSME1;PDE4B;PSMB6;PSME2;PSMB8;PSMD2;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;PSMD13;RBCK1;PSMB3;PSMB11;CTLA4;RIPK2;PSMB10;PSMB1;PSMB5;PIK3CD;SKAP1;LCP2;EIF2B5;PSMA6;SKP1;TRAT1;PSMA4;NFKBID;PSMC1;PSMD9;INPP5D;CD28;RELA;CD276;RFTN1;PSMB2;PSMD4;PRKCQ;PSMD10;STOML2;ITK;IKBKG;PSMC5;CD3E;MAP3K7;PSME3;TXK;EIF2B1;ZAP70;PSMC2
prerank,actomyosin structure organization (GO:0031032),-0.3119262489874237,-1.3142146820320715,0.034482758620689655,0.5412199295199653,1.0,12/75,7.11%,ROCK2;SORBS1;PHACTR1;TMOD3;FRMD6;ROCK1;ACTN2;EPB41L5;EPB41L2;MYH9;CDC42BPB;MYH10
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.562592924419211,1.314079174803238,0.14430379746835442,0.40805847559101943,1.0,11/20,28.16%,SCD5;HSD17B4;FASN;SCD;SLC25A1;ACSL3;DGAT1;ACSL4;ACLY;FAR2;HSD17B8
prerank,positive regulation of gene expression (GO:0010628),0.4382364941498653,1.3140783053831109,0.002,0.4075856682223322,1.0,117/442,20.23%,ACTB;RPL26;RPL23;RPS3;ACTG1;RPL11;RPS4X;RPS7;RPL5;CD74;CLU;EEF2;VIM;CLDN5;GSN;GAPDH;RAMP2;TYROBP;ACTA2;MT3;POLR2E;PARK7;SOD1;MAPK3;ATF4;AKT1;EIF3D;TREM2;CD34;NPM1;RPS27L;ANK3;AGT;S100A13;NFAM1;GPER1;POLR2F;TNF;PDGFB;LAMTOR5;NTRK2;AMH;MIF;HSPA1B;FLOT1;POLR1B;FN1;MUSK;TFRC;MSN;RIMS2;EIF3C;RIMS1;CLEC6A;P2RX7;VSIR;EGR1;GATA2;ATP13A2;DEK;LRP3;WNT5A;PCIF1;RAMP3;POU3F1;ELAVL4;WARS1;WBP2;TMEM119;CAMK2N1;ZCCHC4;KLF4;POLR2K;SLC11A1;SOX9;HSPA1A;GJA1;LILRB1;BMP2;GAS6;SFRP4;CTSH;TLR6;PF4;IFNGR1;MAPK11;CIRBP;HEY1;YTHDF1;EIF4A3;DNAJA4;CCL3;DNMT3B;EPB41L4B;CDH5;PIK3CD;TWIST1;PDCD5;PPARGC1A;ERCC6;AGO1;MAP2K2;MAZ;HMGN5;SOX11;TBP;DDRGK1;POLR1H;INHBA;NOTCH1;IL6;ERP29;TGFB1;POU4F1;CITED2;MEF2C;SPHK2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5845296829734148,1.3139685929478033,0.1422976501305483,0.4074114421050294,1.0,7/16,23.49%,SCD5;FASN;SCD;ACAT1;SLC25A1;PPCS;ACLY
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6393692903725033,1.313927744623801,0.16716417910447762,0.4070642883572827,1.0,4/10,15.91%,PTPRC;LILRB1;CX3CR1;ARRB2
prerank,excitatory postsynaptic potential (GO:0060079),0.581920900153774,1.3136941559658981,0.1421188630490956,0.40717549813510806,1.0,10/19,22.37%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.41710483919016295,-1.3128536413358136,0.1411764705882353,0.5414884791123683,1.0,9/23,19.80%,HDAC4;CLK2;PPARA;NCOR1;SIK1;C1QTNF3;CRY1;TIGAR;PFKFB1
prerank,defense response to virus (GO:0051607),0.46047193709726075,1.3122204730816147,0.06047966631908238,0.41064063129966316,1.0,32/100,22.14%,IFITM3;IFITM2;IFITM1;SHFL;PTPRC;RNASE1;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;CXCL10;IFIT1;PMAIP1;BST2;LILRB1;PDE12;IRF7;SERINC5;F2RL1;G3BP1;ATAD3A;OAS3;IL6;DDIT4;PYCARD;RSAD2;EXOSC4;IFI27;ISG20
prerank,negative regulation of cell death (GO:0060548),0.46097873643523346,1.3114335395557302,0.07061266874350987,0.41225604619996564,1.0,25/88,19.95%,CLU;GPNMB;MT3;PARK7;AKT1;CD34;PINK1;NENF;SORL1;HSPA1B;LRPAP1;BNIP3L;CCN2;ATP13A2;CHGA;TMEM109;WFS1;HSPA1A;PDE12;CDK5;GATA4;PPARGC1A;SOX11;SNCA;POU4F1
prerank,cAMP metabolic process (GO:0046058),-0.49733120691929156,-1.310884999835153,0.13011152416356878,0.5431551036611679,1.0,3/13,2.23%,ADCY9;ADCY1;ADCY5
prerank,neuron development (GO:0048666),0.45305731701503854,1.3108153328158942,0.0425531914893617,0.413383749581026,1.0,51/141,20.64%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;NTRK2;CNTN4;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;TENM2;TENM3;MANF;LGI1;ATP8A2;PQBP1;PRDM12;MAPT;MAP2;STMN4;CDK5R1;EPHA5;HMGB1;B4GALT6;BLOC1S1;BLOC1S3;TENM4;BLOC1S5;PRMT1;CLN5;STMN1;GPRIN2;EHD1;UGDH;CDK5;NCDN;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;MYT1L;ATCAY;DCX;IL6;VAPA;POU4F1;MEF2C;SRRM4
prerank,negative regulation of vascular permeability (GO:0043116),0.627555150356535,1.3105546303517432,0.15437158469945356,0.4135610233630609,1.0,3/12,5.39%,CLDN5;RAMP2;SH3GL2
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.471798880820975,-1.3093001932836261,0.13617021276595745,0.5440807274520769,1.0,6/16,15.43%,FTO;RREB1;SIX1;SIRT1;NAPEPLD;SOX13
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5262488395911251,1.3090164795045438,0.12967289719626168,0.4171492846322656,1.0,13/30,18.84%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,negative regulation by host of viral transcription (GO:0043922),0.6173385892245776,1.3088278365817962,0.1620879120879121,0.4171644000522828,1.0,9/12,34.40%,PSMC3;JUN;TARDBP;CCL3;TFAP4;REST;POU2F3;CCL5;HMGA2
prerank,bone morphogenesis (GO:0060349),-0.4722608836482479,-1.3088009540207972,0.16535433070866143,0.5422061187425733,1.0,4/14,8.39%,LRP5;SKI;LRP6;FGFR2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6453396967327666,1.308711589677202,0.15694444444444444,0.4169698249013545,1.0,3/10,3.67%,PARK7;TXN;GPR37L1
prerank,microtubule-based transport (GO:0099111),-0.49436726080194093,-1.3085523165763233,0.1357142857142857,0.5397584253627644,1.0,8/12,30.04%,SPAG17;SPA17;DNAAF2;DYNC1I2;ROPN1L;CCDC40;DNAAF4;ADCY10
prerank,regulation of exit from mitosis (GO:0007096),0.5074124853385565,1.3085154108705426,0.11376564277588168,0.4170374653133491,1.0,3/38,0.82%,RPS27A;UBC;UBB
prerank,establishment of spindle localization (GO:0051293),0.588596083292701,1.3084373594828813,0.16375838926174496,0.4167422314571151,1.0,9/14,32.40%,CFL1;CLASP1;LLGL1;KPNB1;ZBED3;MAP4;ESPL1;CLASP2;DYNC1H1
prerank,positive regulation of sodium ion transport (GO:0010765),0.6106930897311468,1.3083588650398006,0.1825503355704698,0.41647545726506446,1.0,4/12,15.00%,ANK3;SCN4B;CNKSR3;PRSS8
prerank,ventricular septum development (GO:0003281),-0.36532171566300486,-1.3080417256375143,0.0945945945945946,0.537903520987786,1.0,11/37,10.54%,TGFBR3;HECTD1;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;MDM4;SMAD7;SMAD4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.32206568447681444,-1.307985894446796,0.015873015873015872,0.5350566711285656,1.0,19/79,10.54%,SULF1;ADAMTS12;SMAD6;BMPR1A;CRIM1;SMURF2;SLIT2;SKI;NIBAN2;BMPER;SMAD9;CASK;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4790277837639294,1.3078701796550107,0.10668103448275862,0.41731383512327147,1.0,25/60,24.76%,HSP90AA1;HSP90AB1;MAPK3;CCT2;PDGFB;CTNNB1;CCT7;CCT8;PCNA;KLF4;RFC2;HNRNPA1;PTGES3;PARM1;HGF;DKC1;MAPK15;RFC4;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP;CCT3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5260017617240083,1.3078575505473928,0.12778429073856976,0.416865170104619,1.0,18/29,31.71%,APOE;SHISA7;GRIK2;SYNGR1;SYP;PPFIA3;NCDN;NSMF;APP;SHISA6;ZDHHC2;NETO1;ACP4;CAMK2B;MCTP1;DRD2;RAB3A;DBN1
prerank,positive regulation of embryonic development (GO:0040019),0.571166688436106,1.3074851872231088,0.1434108527131783,0.41734234184926533,1.0,4/19,11.04%,RACK1;CFL1;OTX2;TENM4
prerank,L-amino acid transport (GO:0015807),0.5352452761244385,1.307357331003225,0.13581730769230768,0.4171922610026219,1.0,8/28,12.67%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC3A2;SLC1A1;SLC25A22
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.5296276101620909,-1.307197734752616,0.14696485623003194,0.5310943652755222,1.0,6/10,16.99%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),-0.5296276101620909,-1.307197734752616,0.14696485623003194,0.5310943652755222,1.0,6/10,16.99%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,transferrin transport (GO:0033572),0.5285682830108985,1.3071936186687731,0.12018669778296383,0.4171386602149781,1.0,8/33,11.17%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6AP1;ATP6V0E2;TFRC;CLTC;ATP6V0D2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4585686986912307,1.3069734863649307,0.05399792315680166,0.4172739285505794,1.0,52/107,28.08%,NRG3;NLGN1;DLGAP2;GRM5;DLGAP1;GRID2;TNF;GRIK5;GRIK2;LRRC4C;CACNA1A;SYT1;LGI1;RIMS2;GRM8;RIMS1;TPRG1L;GRM7;DGKI;GRID1;GRM1;BEGAIN;SYN1;HCRT;ABR;CX3CR1;MAPK8IP2;LRP8;CDK5;CLSTN2;CLSTN1;TMEM108;NPTXR;GRM4;KCTD13;CACNG5;MEF2C;CLSTN3;GRIK1;STX1B;UNC13A;APP;AGER;NPTX1;CACNA1B;SLC4A8;ITGB1;KCNMB4;PSMC5;CPLX1;CHRNA7;HOMER1
prerank,receptor metabolic process (GO:0043112),0.4872345808076181,1.3066462927047335,0.1111111111111111,0.41767790774231894,1.0,19/53,19.83%,CD81;RAMP2;LGMN;NSG1;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;SNCA;GRK2;RAB31;TGFB1
prerank,negative regulation of transferase activity (GO:0051348),0.5231367218416862,1.3064112475880745,0.12139423076923077,0.41782437206257605,1.0,9/28,13.74%,PARK7;TERF1;BAG5;CDKN1C;MAPT;PHPT1;ZFP36;FBXO5;HNRNPU
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6151956576876002,1.3058960291051522,0.14421768707482993,0.4186668269719189,1.0,8/13,32.37%,ELOVL1;ELOVL2;TECRL;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.45750001874339435,1.3054947111037263,0.05973223480947477,0.4192194926601399,1.0,47/109,27.72%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;PSMB10;MAPK10;VAV3;PSMB1;PSMB5;LCP2;SYK;TAB1;PPP3CA;PSMA6;SOS1;SKP1;PSMA4;MAP2K7;PPP3R1;PSMC1;PSMD9;RELA;PSMB2;PSMD4;PRKCQ;PSMD10;ITK;IKBKG;PSMC5
prerank,neuron projection development (GO:0031175),0.4440285512228454,1.3054371321762968,0.019133937562940583,0.41889726012480194,1.0,55/168,20.32%,APOE;UBB;PLP1;NBL1;NLGN1;BLOC1S4;CNTNAP2;PACSIN1;CNTN4;NEFH;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;PRDM12;KLK8;SGK1;PAK1;GRM7;MAPT;MAP2;STMN4;CDK5R1;HMGB1;PAK3;BLOC1S1;DOCK10;BLOC1S3;NYAP2;BLOC1S5;PRMT1;SHTN1;STMN1;GPRIN2;EHD1;EPHB1;CDK5;NCDN;EPB41L3;DAB2IP;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;ATCAY;CTNND2;IL6;VAPA;POU4F1;CTTN
prerank,positive regulation of biosynthetic process (GO:0009891),0.5126686702956122,1.3053889947120871,0.11073446327683616,0.4185461545917035,1.0,8/40,10.10%,APOE;VIM;AKT1;CYBA;GRIN1;HSD17B13;MLXIPL;ADGRB1
prerank,negative regulation of TOR signaling (GO:0032007),-0.3681924737217956,-1.305141655959682,0.08666666666666667,0.533279871330224,1.0,16/36,23.13%,RNF152;FNIP1;UBR1;UBR2;PRKAA2;SESN1;ATM;DEPTOR;SIRT1;TSC1;ITFG2;SPAAR;CASTOR2;CASTOR1;KPTN;SESN2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.45754351065226984,1.305116821886203,0.07061266874350987,0.4188079874178722,1.0,41/95,29.64%,VIM;PDE4B;NR1D1;TIRAP;SIRPA;CD180;TNFAIP3;CCR5;CXCL10;TICAM2;CD68;HMGB1;ZFP36;CHMP5;WNT5A;RHOA;LILRB1;CX3CR1;CCL2;PF4;DAB2IP;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;PYCARD;SIRT2;SELENOS;NUGGC;RELA;LBP;CASP1;XBP1;TNFRSF1B;FZD5;PPBP;TLR2;NOD2;ACOD1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4782838233314622,1.3041806774101687,0.10175054704595186,0.4207384324865013,1.0,14/59,13.82%,RPS27A;UBC;UBB;AKT1;TNF;PRDX4;UBA52;TICAM2;NKIRAS1;RBCK1;TBKBP1;RIPK2;TNFRSF1A;NKIRAS2
prerank,neutral amino acid transport (GO:0015804),0.52870866264897,1.303592212291368,0.1597560975609756,0.42181339065182627,1.0,7/28,12.43%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC6A17;SLC3A2;SLC1A1
prerank,endoplasmic reticulum organization (GO:0007029),0.4690901552264194,1.3028093168214312,0.09090909090909091,0.4234152540891435,1.0,27/72,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;LMAN2;SEC61G;RTN4;CAV2;REEP5;LMAN1;REEP6;VAMP2;REEP2;SERP1;SEC61A1;SHTN1;SGTA;TRAM1L1;DNM1L;LNPK;RAB18;MAPK15;VAPA;TMEM33;TRAM1;RTN3;CYB5A
prerank,regulation of cation transmembrane transport (GO:1904062),0.518428324597632,1.3027470421183351,0.13695395513577333,0.4231111954322103,1.0,8/29,15.36%,CD63;KCNIP4;DPP10;DPP6;FGF12;KCNN2;KCNE5;KCNIP1
prerank,positive regulation of cell population proliferation (GO:0008284),0.4342841005334211,1.302515346499406,0.004,0.42321508068549923,1.0,121/423,21.14%,RPL23;RPS9;RPS4X;RPS15A;CD74;S100A6;CLDN5;CD81;MDK;GRN;CALR;GNAI2;CAPNS1;HMOX1;LAMC1;RPS6;LGMN;AKT1;TSPAN31;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;COPS9;AGT;S100A13;NES;GPER1;COX17;TNF;EMP2;PDGFB;FZD9;ROMO1;PTPRC;HCLS1;NTRK2;C5AR1;MIF;SSR1;SERTAD1;HES1;FN1;MATK;RHOG;RNF187;NAMPT;PAK1;PROX1;KDR;AQP1;IL2;VIPR1;MLXIPL;TIMP1;LAMC2;HCK;KITLG;CSF1R;WNT5A;IL11;CEP131;FLT4;HRAS;TMEM119;SOX8;AIF1;PRMT1;SOX9;BST2;GJA1;BMP2;FBXO5;GAS6;NME2;HNRNPU;CTSH;SDCBP;TIAM1;BAD;PDF;FOLR2;IGF2;PDGFA;DLL1;ADRA1D;HPSE;FLT1;CCKBR;CIAO1;ADAM17;CNBP;TBRG4;DDR2;ERBB3;MAZ;STX4;HMGN5;EDN3;SOX11;TOX;DDRGK1;CD86;RTKN2;TFAP2B;FLT3;NOTCH1;IL6;MAPK15;TGFB1;THPO;MEF2C;SFRP1;MYC;CRLF1;PTPN6;CRLF2;ID2
prerank,anion transmembrane transport (GO:0098656),0.47602084293622976,1.3020701168937705,0.10206297502714441,0.4239332932960166,1.0,32/67,28.02%,SLC38A5;SLC25A5;LRRC8A;SLC7A5;SLC1A2;SLC25A4;SLC25A13;SLC25A29;SLC6A5;SLC25A11;SLC3A2;SLC1A1;SLC25A21;SLC25A22;SLC19A1;SLC35A3;SLC25A19;SLC25A1;SLC35A1;SLC25A18;SLC35B4;MFSD12;SLC25A14;SFXN1;SLC35B1;SLC6A8;ABCC5;SLC6A9;SLC25A12;SLC35A2;SLC16A7;SLC13A5
prerank,regulation of protein localization to cell surface (GO:2000008),0.5138424907771115,1.3019524042794017,0.13895486935866982,0.4237644015289393,1.0,7/33,7.82%,TYROBP;HSP90AB1;TNF;MAP1A;CTNNB1;GPM6B;LEPROT
prerank,positive regulation of cell motility (GO:2000147),0.4407750839313816,1.3015353138679249,0.019076305220883535,0.4244337281220573,1.0,62/205,19.83%,ACTG1;RACK1;CAVIN1;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;HSPA5;CCL19;SPOCK2;GPER1;RHOC;SEMA3F;PDGFB;SEMA7A;SEMA4C;MYADM;FAM107A;CXCL16;SEMA6D;PAK1;PODXL;KDR;VSIR;NTN1;LGR6;LAMC2;PHPT1;SEMA4A;CSF1R;PECAM1;ELP3;HRAS;AIF1;SEMA4G;BMP2;CTSH;SDCBP;TIAM1;F2RL1;PDGFA;FLT1;CCL3;CAV1;PLAU;CDH5;CASS4;PIK3CD;TRIM32;TWIST1;F10;MMP14;ADAM17;MAZ;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;TGFB1
prerank,cellular response to reactive oxygen species (GO:0034614),0.48362233387270925,1.3014838148839223,0.08705114254624592,0.42407710985891395,1.0,14/59,11.56%,RPS3;PARK7;RHOB;MAPK3;AKT1;PRDX5;ROMO1;SIRPA;TNFAIP3;AQP1;MAPT;NET1;JUN;TRPM2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.46808347730167577,1.3010764115981392,0.08737864077669903,0.4245984085067164,1.0,33/73,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;SPI1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;KITLG;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMC1;PSMD9;METTL3;TCF3;METTL14;PSMB2;PSMD4;PSMD10
prerank,regulation of ERAD pathway (GO:1904292),0.6241230542646345,1.3010616651318627,0.15955983493810177,0.4241612765685067,1.0,5/11,21.24%,UBXN1;RNFT1;HERPUD1;TMEM259;USP13
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.6174502428540938,1.3006411541781253,0.17123287671232876,0.42480017217141824,1.0,4/12,17.00%,MDK;AKT1;FUT9;SKAP1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6150066692948614,1.30062803001795,0.1655359565807327,0.42438321407869306,1.0,3/13,8.53%,CD74;MIF;PTTG1IP
prerank,sphingolipid metabolic process (GO:0006665),0.4503497241575103,1.3004465326526922,0.06101344364012409,0.42439840512772664,1.0,37/108,23.78%,PSAP;GM2A;HEXB;SERINC1;HEXA;CERS2;ORMDL3;B4GALNT1;PPP2R1A;ELOVL1;ENPP2;ELOVL2;GAL3ST1;SMPD1;ELOVL7;CTSA;GLTP;SPTLC1;ST6GALNAC3;DEGS1;ABCA2;NEU1;FA2H;CSNK1G2;CLN8;CERKL;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;ASAH2;SGPL1;ORMDL2;ELOVL6;ALDH3B1;VAPB
prerank,histone methylation (GO:0016571),-0.401348373427474,-1.2999712298760329,0.09183673469387756,0.543378387594223,1.0,12/26,20.60%,NSD1;CREBBP;SMYD3;EHMT1;NSD3;EHMT2;CARM1;EZH2;SIRT7;PRMT6;SETD6;PRMT8
prerank,intracellular protein transmembrane transport (GO:0065002),0.4980343328992078,1.299879503213605,0.13018433179723501,0.42546888902179714,1.0,11/42,15.80%,SEC61B;HSPA5;ROMO1;SEC61G;DNLZ;HSPD1;TOMM40L;SEC61A1;TIMM50;TOMM20L;PEX6
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.44207241656586466,1.2991113032916137,0.029233870967741934,0.4271071077358302,1.0,62/163,27.90%,PSMB4;PSME1;PDE4B;PSMB6;PSME2;PSMB8;PSMD2;NFAM1;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;PSMD13;RBCK1;PSMB3;PSMB11;CTLA4;RIPK2;PSMB10;VAV3;SH2B2;PSMB1;PSMB5;PIK3CD;SKAP1;LCP2;SYK;EIF2B5;PSMA6;MEF2C;SKP1;TRAT1;PSMA4;NFKBID;PSMC1;PSMD9;INPP5D;CD28;RELA;PLEKHA1;CD276;RFTN1;PSMB2;PSMD4;BLNK;PRKCQ;PSMD10;STOML2;ITK;IKBKG;PSMC5;CD3E
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.44155210051305793,1.2984765181784088,0.043522267206477734,0.42832480330367856,1.0,29/148,15.69%,RPL23;RPL11;RPS15;RPL37;RPL5;RPS20;AKT1;CSNK2B;MBD3;CHEK2;PIN1;RPA2;HIPK2;TTC5;BRPF1;SGK1;TAF10;CDK5R1;PIP4P1;TAF9;SSRP1;CCNG1;RFC2;STK11;PRR5;HEXIM1;L3MBTL1;MAPK11;CDK5
prerank,negative regulation of protein kinase activity (GO:0006469),0.4590932480948849,1.297560651057035,0.09004237288135593,0.4302567682836427,1.0,36/88,23.15%,PPIA;HSPB1;PARK7;AKT1;NPM1;CAMK2N2;PTPRC;SORL1;DUSP3;HYAL2;CDKN1C;DBNDD2;CORO1C;PTK6;DUSP26;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;PTPRB;SRCIN1;SLC8A1;DAB2IP;CAV1;PRKRIP1;AKT1S1;QARS1;TAB1;SNCA;PYCARD;GADD45A;PTPRO;PPM1F;PTPN1;TESK1
prerank,response to amyloid-beta (GO:1904645),0.49085217271971615,1.2973206871462073,0.10983981693363844,0.43039726200614836,1.0,14/44,16.62%,LGMN;PRNP;TREM2;GRM5;GRIN1;CACNA1A;ATP1A3;GRIN2A;MMP3;RAMP3;GJA1;TLR6;CDK5;VCAM1
prerank,cellular calcium ion homeostasis (GO:0006874),0.4459678465418043,1.2969590731942728,0.05188199389623601,0.43088228455256716,1.0,40/133,18.94%,TPT1;CALR;SLC30A1;CXCL12;SMDT1;CCL19;GPER1;SLC24A4;SLC24A2;FZD9;CAV2;YWHAE;DRD5;CALB1;TMCO1;KCTD17;PLN;SELENOK;HTR2C;ATP13A2;CALCB;BAX;TRPC7;WFS1;ATP2B1;TRPC1;ATP1B1;SLC8A1;RYR2;ADCY8;CCL3;CAV1;CDH5;HERPUD1;HCRTR1;CCL8;FKBP1B;CCR2;ANXA6;EDN3
prerank,Fc receptor signaling pathway (GO:0038093),0.4542078581244937,1.2966116634956892,0.06914344685242518,0.431369448011278,1.0,47/110,27.72%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;PSMB10;MAPK10;VAV3;PSMB1;PSMB5;LCP2;SYK;TAB1;PPP3CA;PSMA6;SOS1;SKP1;PSMA4;MAP2K7;PPP3R1;PSMC1;PSMD9;RELA;PSMB2;PSMD4;PRKCQ;PSMD10;ITK;IKBKG;PSMC5
prerank,basement membrane organization (GO:0071711),0.5978249901498993,1.296107398990746,0.1827956989247312,0.43219961950499075,1.0,4/14,8.25%,RAMP2;CTSS;LAMB2;COL4A1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4625090970609041,1.2956152493532136,0.07886435331230283,0.4330247642553611,1.0,14/86,9.84%,APOE;RPS3;CLU;GPX1;RAC1;PFN1;NAV3;PAK1;PROX1;CLASP1;MAPT;ARF6;CDK5R1;HCK
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4418807636981936,1.2955493340789683,0.04467005076142132,0.4326987067327852,1.0,41/159,16.80%,BSG;CLDN5;MPZ;NLGN1;ITGB2;UNC5D;CD84;GRID2;LRFN5;DSCAM;CNTN4;PCDHGB4;CDH20;ADGRL3;LRRC4C;TENM2;TENM3;SELL;CLDN11;KIRREL3;CDH18;ROBO4;IL1RAPL1;EMB;PECAM1;TENM4;FGFRL1;CADM3;PTPRD;CDH12;LRRC4B;CDH19;DCHS1;IGSF9;DSCAML1;ROBO2;CDH7;CDH24;VCAM1;CDH10;CDH5
prerank,positive regulation of cell killing (GO:0031343),0.6008760733919906,1.2947483784310663,0.18361955085865259,0.43431602655133245,1.0,5/13,17.99%,CYBA;RAC1;WNT5A;NOS2;SYK
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5619683119090375,1.2938570084526317,0.14430379746835442,0.4361266230657857,1.0,11/21,25.43%,BGN;BCAN;DCN;CHPF2;CHPF;UGDH;VCAN;CSGALNACT2;CHSY3;CHST9;CSPG5
prerank,epithelial tube morphogenesis (GO:0060562),0.5162869650004717,1.2933094002239618,0.15971394517282478,0.4370990181066754,1.0,11/32,11.29%,RHOB;CSNK2B;RASIP1;ACVRL1;CTNNB1;HES1;PAK1;PODXL;COL4A1;CSF1R;SOX17
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5878749666129727,1.293131275682146,0.1778975741239892,0.43707884838877853,1.0,13/16,32.42%,TMEM50A;LEPROT;CHMP5;CHMP6;VPS28;CHMP7;VPS36;CHMP4C;SNF8;LEPROTL1;TMEM50B;CHMP4A;CHMP4B
prerank,cellular response to amyloid-beta (GO:1904646),0.5080560914546801,1.293131274671668,0.1443661971830986,0.43660168807394356,1.0,12/35,16.62%,LGMN;PRNP;TREM2;GRM5;GRIN1;CACNA1A;ATP1A3;GRIN2A;GJA1;TLR6;CDK5;VCAM1
prerank,regulation of cellular response to stress (GO:0080135),0.45068203950922175,1.293086263501152,0.05870236869207003,0.43623784883072547,1.0,23/115,9.16%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;CHCHD2;MAPK3;ATF4;CRYAB;NPM1;PINK1;IER3;HSPA1B;YWHAE;MANF;RPA2;BAG5;BAG1;USP51;CEBPB;VASH1;MAPT;NUPR1;HSPB8
prerank,non-motile cilium assembly (GO:1905515),-0.3880472210868858,-1.2928442146122954,0.10526315789473684,0.5585316290333581,1.0,14/30,22.08%,PCM1;PIBF1;CEP290;IFT88;RPGRIP1L;CEP89;TMEM80;IFT122;C2CD3;IFT57;TBC1D32;RPGRIP1;GORAB;BBS10
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5763704700955476,1.292314448494714,0.1765498652291105,0.43777725696072134,1.0,4/16,6.77%,APOD;TREM2;SIRPA;CUEDC2
prerank,L-serine metabolic process (GO:0006563),0.6281620268533877,1.2920374965245205,0.16666666666666666,0.4380386409505802,1.0,5/10,20.45%,SERINC3;SDS;PHGDH;SERINC5;SHMT2
prerank,central nervous system development (GO:0007417),0.43282160642562734,1.2918478650167389,0.01306532663316583,0.4381051904841045,1.0,82/250,22.42%,C1QA;APOD;GSN;MBP;BCAN;C3;MARCKS;ASIC2;S100B;SLC2A1;NES;CNTNAP2;ADAM23;CNTN4;SCTR;NDRG4;MAL;ECRG4;ABCB6;ADGRL3;SH3GL2;SPOCK1;GRIN1;TAGLN3;HAPLN2;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;NRCAM;KLK6;PROX1;MAST1;COL4A1;GRIN2A;MFSD2A;MOG;SLC6A17;CDK5R1;DNAJC30;MARCKSL1;DNER;AATK;MYRF;HAP1;ATP6AP2;ELP3;SOX8;LSR;CLN5;SOX9;CXCR4;CAPG;CX3CR1;PTPRZ1;IER3IP1;DSCAML1;ROBO2;CDK5;COX7B;DLL1;VCAN;GLIS2;SCIN;GRIN2B;EIF2B5;QARS1;SOX11;RAB18;DCX;NNAT;HSPG2;DDIT4;SOX10;HAPLN4;GRIK1;ROGDI;SNTG2;POU6F2;GRHL2;ACAN
prerank,positive regulation of response to external stimulus (GO:0032103),0.44626968676640155,1.2917308020693459,0.062436028659160696,0.4379585565305068,1.0,48/128,26.54%,MDK;GRN;THBD;CCL19;CYBA;TREM2;AGT;TNF;PDGFB;S100A9;S100A8;LY86;CD180;DDT;RARRES2;HYAL2;FEM1A;CEBPA;IL2;LPL;SLC15A4;P2RY12;LILRA5;NINJ1;PLA2G7;WNT5A;AIF1;TNFRSF1A;F2RL1;GPSM3;CCL3;CCR2;STX4;SNCA;TGFB1;NFKBIA;PPM1F;POLR3D;TNIP1;AKIRIN2;PTN;APP;PDE2A;PRKCA;IL33;TLR7;CX3CL1;STX3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3455405983717449,-1.291497504760009,0.0898876404494382,0.5589807271653495,1.0,13/56,10.54%,BMP6;LDLRAD4;RBPMS;SMAD6;ACVR1;BMPR1A;DAB2;BMPER;TGFBR1;PMEPA1;SMAD7;GDF1;SMAD4
prerank,cell differentiation in hindbrain (GO:0021533),0.6283489152339433,1.2914221830111057,0.1592797783933518,0.43827999665403033,1.0,4/11,8.81%,GRID2;KNDC1;PROX1;FAIM2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6309567647061038,1.2910285657920366,0.17221418234442837,0.4388406790551923,1.0,4/10,13.55%,CXCL12;CCL19;LILRB1;GAS6
prerank,histone H4-K16 acetylation (GO:0043984),-0.434546243127355,-1.290924123824538,0.15151515151515152,0.5572890337623073,1.0,6/19,18.15%,OGT;KMT2A;KAT7;KANSL3;JADE2;KAT8
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6160314020162169,1.2905321209633325,0.16547788873038516,0.43968292716513185,1.0,6/11,22.12%,PARK7;PINK1;P4HB;MMP3;GATA4;REST
prerank,negative regulation of innate immune response (GO:0045824),0.5112227468496595,1.290093646672408,0.12987012987012986,0.4403931433194096,1.0,6/34,9.66%,RPS19;GRN;A2M;TNFAIP3;ISG15;SERPING1
prerank,positive regulation of vascular permeability (GO:0043117),-0.49552436997801236,-1.2899294231535223,0.16853932584269662,0.5568062777490602,1.0,2/12,6.03%,BMP6;ANGPT1
prerank,response to amino acid (GO:0043200),0.5196382868321107,1.2897997902725462,0.14099526066350712,0.44067595031628354,1.0,12/31,18.83%,TMBIM6;LAMTOR2;LAMTOR4;LAMTOR5;GRIN1;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF;GLRA3
prerank,activation of GTPase activity (GO:0090630),-0.32276387115425714,-1.28966036720014,0.0,0.5545722900995539,1.0,23/89,12.34%,ARHGAP29;SIPA1L1;ARHGAP42;BCAS3;TIAM2;SGSM2;USP6NL;NTRK3;TBC1D12;RALGAPB;DOCK7;SIPA1L3;TBC1D2B;RABGAP1;TBC1D9B;BCR;TBC1D4;SYDE2;PIP5K1A;TBC1D8B;TBCK;SIPA1;RALGAPA1
prerank,regulation of NMDA receptor activity (GO:2000310),0.513899259515092,1.2882679819862972,0.12602100350058343,0.44428917383542527,1.0,16/32,21.61%,NLGN1;GRIA2;DLG2;NEFL;GRIN1;GRIA4;GRIN2A;CRH;GRIA1;CCL2;LRRC7;MAPK8IP2;GRIN2B;CCR2;MEF2C;GRIA3
prerank,anion transport (GO:0006820),0.5131553533574712,1.2881645052740545,0.14099526066350712,0.44408569422224536,1.0,10/33,19.96%,TSPO;SLC17A8;LRRC8A;SLC26A4;SLC17A7;SLC17A6;SLC19A1;SLC4A2;VDAC2;SLCO1B1
prerank,regulation of microtubule nucleation (GO:0010968),0.6310288456506052,1.288091566692186,0.1833810888252149,0.44376764037072125,1.0,6/10,19.87%,HSPA1B;PAK1;ARHGEF7;DCTN1;HSPA1A;GIT1
prerank,vesicle organization (GO:0016050),0.4900185168355058,1.2875099805173258,0.11698537682789652,0.4448299785177282,1.0,14/46,17.51%,CD34;CAV2;CHMP2B;SAR1A;CORO1A;SRGN;FNBP1L;SNX11;SORT1;SNX33;CAV1;USP8;SQSTM1;HOOK1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.6301667259667831,1.2869834090644015,0.2026431718061674,0.44581178550185097,1.0,6/10,22.30%,NOP10;NHP2;GAR1;DKC1;RPUSD4;NAF1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4622772920002105,1.286443760804927,0.10481283422459893,0.44678835900161523,1.0,27/75,23.15%,APOE;AKT1;AGT;RASIP1;SORL1;UCHL1;RGS2;HYAL2;CDKN1C;CEBPA;PRKAR1A;SMPD1;PRKAR1B;SPRY1;HEXIM1;SLC8A1;DAB2IP;PRKAR2B;CD300A;SPRY3;TFAP4;PYCARD;GADD45A;MEN1;DUSP1;PTPN1;TESK1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6273102261608232,1.286396944654846,0.17744154057771663,0.446450032470458,1.0,6/10,29.62%,NAMPT;KDR;CCL2;IL33;TLR2;NOD2
prerank,membrane organization (GO:0061024),0.4376772767261308,1.28581532699167,0.031031031031031032,0.4474633502847652,1.0,52/227,16.40%,ACTB;MTCH1;RPS27A;ACTG1;HSPA8;UBC;UBB;ANK3;SGCZ;SYNGR2;SH3GL2;CHMP2B;CTDNEP1;DNM3;AP2M1;MYADM;SYT1;TFRC;UBA52;SYNGR1;SAR1A;CORO1C;AMPH;CD3D;RIMS1;CLTC;VAMP3;VAMP2;EPN1;AP2S1;CHMP5;CHMP6;FNBP1L;FCHO1;WNT5A;ARPC3;VAMP8;SERP1;CHRM2;GLTP;ARPC5;TIMM50;CCDC88A;SYP;ARPC4;CLTA;M6PR;ARRB2;CHMP1B;SH3KBP1;NAPA;SYT2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6032395354286441,1.2857942351034748,0.16016713091922005,0.44703776155581754,1.0,5/12,14.96%,SEC61B;HSPA5;SEC61G;SEC61A1;SGTA
prerank,JNK cascade (GO:0007254),0.490334250753093,1.2857720470450231,0.13203214695752008,0.4466172331923221,1.0,8/40,14.13%,RPS27A;UBC;UBB;UBA52;SH2D3C;RIPK2;UBE2V1;MAPK10
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5416302879862221,1.2857249656130847,0.15298507462686567,0.4462732771135391,1.0,2/23,4.50%,TMSB4X;SPI1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5896864860266117,1.2855968631799595,0.16198125836680052,0.44566100739284026,1.0,5/15,12.70%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5896864860266117,1.2855968631799595,0.16198125836680052,0.44566100739284026,1.0,5/15,12.70%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,peptidyl-arginine modification (GO:0018195),0.5793948673532249,1.2855609653643003,0.17506631299734748,0.44528713304633794,1.0,3/15,12.90%,PARK7;KRTCAP2;PRMT1
prerank,ameboidal-type cell migration (GO:0001667),0.4833764541913519,1.2855455757317644,0.14027149321266968,0.4448459259609452,1.0,16/51,21.70%,AKT1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;PKN1;SEMA4A;SOX8;SEMA4G;AMOT;ANXA6;SOX10;SGPL1;CCN3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5703516496694873,1.2855036944384834,0.16710526315789473,0.4444633992987439,1.0,5/18,7.45%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,negative regulation of protein catabolic process (GO:0042177),0.4885455308783974,1.2853482410995112,0.1397228637413395,0.4444082077672974,1.0,16/40,21.36%,CST3;TIMP2;PIN1;FLNA;NELL1;FMN2;TIMP1;ADGRB1;ATRAID;CTSA;TIMP3;DAB2IP;AGAP2;SNCA;TIMP4;SIRT2
prerank,regulation of regulated secretory pathway (GO:1903305),0.511013339061492,1.2852836459705685,0.14035087719298245,0.44412058990413295,1.0,18/34,25.63%,SYT1;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYT6;RAB3D;SYT4;SYN1;SYT10;DOC2A;SYT2;PREPL;SYT3;SYT5;UNC13D;SYT17
prerank,neuron projection organization (GO:0106027),0.589511385390123,1.2852766615590543,0.15637319316688567,0.4436680947080152,1.0,6/15,14.51%,LGMN;PRNP;MAP1A;ATP1A3;DCTN1;ARF1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.634767603716624,1.2852100226208454,0.1861777150916784,0.4433726262829304,1.0,2/10,8.68%,PRNP;PRKAR1A
prerank,mesoderm development (GO:0007498),0.5594099468158518,1.2850661184378704,0.16925064599483206,0.4432818947490479,1.0,9/18,31.73%,IKZF1;HCK;TIE1;IKZF3;GDF11;MESD;MEST;TCF15;BTK
prerank,cell cycle checkpoint signaling (GO:0000075),-0.4872748915415536,-1.2850483885973485,0.14942528735632185,0.5630220755259474,1.0,5/12,21.09%,WEE1;PRCC;CHFR;PLK2;ZWILCH
prerank,cellular response to cytokine stimulus (GO:0071345),0.4267569724853832,1.2849255756229474,0.002,0.4431462717514611,1.0,120/416,21.24%,RPS3;RPS27A;HSPA8;MT1X;UBC;VIM;IFITM2;UBB;GAPDH;RPL13A;HSP90AA1;F13A1;CXCL12;HMOX1;NDUFA13;MT2A;AKT1;CCL19;AQP4;AKAP6;ITGB2;IL5;POMC;GPER1;TNF;HSP90B1;NR1D1;HCLS1;ZFP36L1;UBE2G2;JUNB;ZFP36L2;SIRPA;IL2RB;CSF3R;S1PR1;HYAL2;CDC34;FN1;UBA52;CCND1;CCR5;IL1RAPL1;CEBPA;CXCL10;IL2;IFIT1;TIMP1;EGR1;HCK;ZFP36;IRF8;CSF1R;WNT5A;IL11;MMP3;LCN2;IL2RG;IL3RA;MAOA;AIF1;SELPLG;COL1A2;SOX9;VAV1;RHOA;GAS6;DOCK8;YWHAZ;CXCR4;HNRNPU;TNFRSF1A;PDE12;RHOU;ERBIN;RO60;NDN;CCL2;PTPRZ1;PF4;IFNGR1;MAPK11;LRP8;CSF2RB;YBX3;SIGIRR;DAB2IP;CCL3;VCAM1;PIK3CD;TWIST1;NOS2;CCL8;SYK;CCR2;SLA;STX4;EPRS1;IL20RA;MUC1;CD86;SOS1;FLT3;HGF;IL6;IFNGR2;TGFB1;CSF2RA;POU4F1;IL10RB;PDE1B;SFRP1;IL1RAP;MYC;CRLF1;PTPN6;PYCARD;CRLF2;ASAH2;CDK9
prerank,B cell receptor signaling pathway (GO:0050853),0.5099533649687734,1.284825371322308,0.1467136150234742,0.44293724032721277,1.0,13/32,26.68%,NFAM1;PTPRC;BAX;CTLA4;VAV3;SH2B2;PIK3CD;SYK;MEF2C;PLEKHA1;RFTN1;BLNK;ITK
prerank,regulation of vasculature development (GO:1901342),0.5288293365411137,1.284767826957576,0.15143929912390489,0.44262333622323763,1.0,7/26,11.61%,GPNMB;HMOX1;EMP2;CTNNB1;VASH1;RNH1;WARS1
prerank,actin nucleation (GO:0045010),0.5491270820224792,1.2844921057637724,0.1710691823899371,0.44282180300783597,1.0,9/21,17.68%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2;SCIN
prerank,autophagosome organization (GO:1905037),0.48717810621921037,1.2836928470706532,0.12331838565022421,0.4444380779508428,1.0,12/50,14.91%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A;ATP13A2;ULK3;UBQLN2;VMP1;ATG101
prerank,nitrogen compound transport (GO:0071705),0.44158636853653693,1.283604649479398,0.058163265306122446,0.44421124137436424,1.0,34/141,18.56%,SLC38A5;RAMP2;RCN3;SLC18A1;LRP1B;SLC7A5;SLC1A4;TXNIP;TMEM30A;HSP90B1;ABCB6;CHMP2B;RD3;ARRDC1;SLC25A29;SCAMP3;SLC6A6;AQP1;SLC6A2;SLC15A4;VAMP2;SLC3A2;SLC48A1;SLC7A14;RAMP3;CMTM6;SLC11A1;SCAMP2;ARRDC3;SLC15A2;CHMP1B;ATP11B;SLC52A1;SLC19A2
prerank,nucleotide-excision repair (GO:0006289),0.45037937457577953,1.2834565525421666,0.07605344295991778,0.44413862353688627,1.0,38/101,26.91%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;PARP1;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2;COPS8;POLD4;CETN2;BRCA2;ERCC6;RAD23A;RFC4;ERCC1;POLR2H;POLD1;PNKP;RPA3;PPIE;XPC;LIG1;GTF2H5;ERCC2;CCNH
prerank,negative chemotaxis (GO:0050919),0.509563354258271,1.2829734221666376,0.1415204678362573,0.44496222347952635,1.0,14/33,16.95%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;NTN1;LGR6;UNC5C;SEMA4A;LRTM2;RHOA;SEMA4G;PDGFA;SLIT3;SLIT1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5239774639779197,1.2828755114449584,0.13238770685579196,0.44472335802269697,1.0,9/30,16.39%,BGN;HEXB;BCAN;HEXA;DCN;CHPF2;CHPF;UGDH;VCAN
prerank,regulation of microtubule polymerization (GO:0031113),0.49219973950209733,1.2826334570585953,0.1145475372279496,0.444923460996689,1.0,15/40,16.80%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;TUBB4A;MAP2;CDK5R1;DCTN1;CLIP3;STMN1;ARL2;MAPRE3;CDH5
prerank,cell junction organization (GO:0034330),0.46427535917611573,1.2825579901386301,0.1059322033898305,0.44465268937759794,1.0,23/71,19.89%,ACTB;ACTG1;C1QA;GRM5;PIN1;LRP4;FLNA;PPFIA4;PPFIA2;MAPT;PAK3;CBLN2;RHOA;VMP1;ELFN1;PPFIA3;RAB39B;CTNND2;FBLIM1;SNCA;TGFB1;MARVELD2;AGRN
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.45058031736564674,-1.2822300236858775,0.14222222222222222,0.5672597310186792,1.0,7/18,15.00%,SARNP;DDX19A;IWS1;PABPN1;DDX19B;MCM3AP;THOC2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5304397873491101,1.282103022045579,0.1610062893081761,0.44541762368125565,1.0,7/25,14.18%,AKT1;AGT;GPER1;RTN4;PTK6;HAP1;CCDC88A
prerank,neuronal action potential (GO:0019228),0.5479121973820754,1.2818877294338027,0.15318627450980393,0.44554150469714315,1.0,10/22,26.89%,ANK3;GPER1;SCN1A;KCNA2;KCNA1;SCN9A;MYH14;SCN8A;SCN2A;KCNMB4
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.632823449436839,1.2818603534115445,0.16946778711484595,0.4451466129318929,1.0,5/10,23.48%,ANK3;KCNE4;KCNE5;CAV1;KCNAB1
prerank,negative regulation of kinase activity (GO:0033673),0.46908467847038754,1.2815771279586163,0.12374581939799331,0.44539673058253737,1.0,20/62,19.11%,PPIA;HSPB1;PARK7;AKT1;CAMK2N2;PTPRC;CDKN1C;DBNDD2;THY1;YWHAG;MAPT;RTRAF;WARS1;CAMK2N1;HNRNPU;PRKRIP1;AKT1S1;QARS1;TAB1;SNCA
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4870695513574451,1.281560392592787,0.12679162072767364,0.4449896968159139,1.0,21/46,24.19%,NRXN1;NLGN1;GRM5;TNF;SYT1;GRM8;TPRG1L;GRM7;DGKI;GRM1;CCL2;MAPK8IP2;CDK5;CACNG8;GRM4;CCR2;CACNG5;MEF2C;GRIK1;UNC13A;CACNG2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4831452179518545,1.281503651877507,0.11495535714285714,0.44466210070213114,1.0,17/50,16.86%,RPS3;PARK7;UBXN1;AKT1;HSPA1B;BAG5;TNFAIP3;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;FBXO5;ARRB2;CAV1;SQSTM1
prerank,secondary alcohol metabolic process (GO:1902652),0.4885105542151871,1.281488049193005,0.13378684807256236,0.44424257995239347,1.0,10/42,23.09%,APOE;ABCG1;PIP4P1;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;IDH3G;NSDHL
prerank,pseudouridine synthesis (GO:0001522),0.5881060619937315,1.280841803584492,0.18930041152263374,0.4455514090572268,1.0,7/13,20.46%,NOP10;NHP2;TRUB2;PUSL1;GAR1;DKC1;PUS7
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5282000368996111,1.2807156023414368,0.14320685434516525,0.4454341844912535,1.0,3/25,4.03%,RPS3;PDE4B;PTPRC
prerank,epithelial structure maintenance (GO:0010669),0.6163241441065235,1.280508340358712,0.1825726141078838,0.44548979402359,1.0,2/11,7.22%,RBP4;STRAP
prerank,peptidyl-asparagine modification (GO:0018196),0.5139845612175213,1.2804414752139415,0.15537383177570094,0.44521148767103114,1.0,13/31,18.84%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5126922424451277,1.2799038233875444,0.16260162601626016,0.44614942114366996,1.0,4/33,4.40%,CD74;TNF;HCLS1;ZFP36L1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.46446224078710446,1.2797247757968147,0.09761388286334056,0.4461411007812748,1.0,22/66,20.94%,TYROBP;HSPB1;CCL19;TNF;SIRPA;TNFAIP3;P2RX7;LPL;EGR1;LILRA5;WNT5A;RIPK2;NLRP2B;CX3CR1;TLR6;F2RL1;CCL3;NLRP3;IL6;GIT1;TMEM106A;PYCARD
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.41495163420231856,-1.2796709497444378,0.14485981308411214,0.570990449143341,1.0,2/19,0.28%,BMP6;AFDN
prerank,positive regulation of dendritic spine development (GO:0060999),0.5455217967890384,1.2795258116238528,0.16835443037974684,0.446200750747086,1.0,2/20,2.44%,APOE;NLGN1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5145495187685734,1.279301432709526,0.1606280193236715,0.4463441340292194,1.0,13/30,23.58%,PTPRC;PPP2R1A;HYAL2;PTK6;THY1;CADM4;SRCIN1;DMTN;CAV1;CD300A;SFRP1;PTPN6;SOCS3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4478184334627451,-1.2792888137677259,0.16260162601626016,0.5691200757328782,1.0,7/15,10.33%,TNRC6B;TNRC6A;TNRC6C;TENT4B;CNOT1;CPEB3;CNOT7
prerank,regulation of neurogenesis (GO:0050767),0.46578483681362604,1.2790028437173147,0.12292358803986711,0.4466846803518075,1.0,18/55,19.67%,B2M;SERPINF1;TGM2;GPER1;TNF;SORL1;CTNNB1;HES1;HES6;BHLHE41;SNW1;CX3CR1;HEY1;DLL1;TRIM32;SOX11;NOTCH1;IL6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5489131528776049,1.2789520449195653,0.14634146341463414,0.44634409819335336,1.0,5/22,12.44%,APOE;TIMP2;TNF;TIMP1;TIMP3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6117138451022928,1.278658569732173,0.1863013698630137,0.44665707587055625,1.0,6/12,19.93%,TRH;MAOA;ODC1;SMS;SRM;OAZ2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.39667048069172617,-1.2778616484737195,0.12755102040816327,0.569769094146646,1.0,8/21,15.34%,SMO;DCDC2;TTC23;DLG5;GAS8;EVC;UCHL5;KIF7
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4507374798224236,-1.2776579130797825,0.15384615384615385,0.5672891889567896,1.0,4/16,4.58%,PRKAG2;APPL2;LONP2;PPARA
prerank,stress-activated MAPK cascade (GO:0051403),0.46220772002455823,1.2776212524283257,0.12526997840172785,0.44892102293848807,1.0,12/61,15.22%,RPS27A;UBC;UBB;MAPK3;ZFP36L1;UBA52;ZFP36;SH2D3C;RIPK2;UBE2V1;MAPK10;MAPK11
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4116604075980078,-1.2773081240622284,0.1440677966101695,0.5652249202053793,1.0,4/20,8.24%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,glycosaminoglycan catabolic process (GO:0006027),0.46941221359369895,1.2769788630967316,0.10949720670391061,0.45008486146442306,1.0,22/55,20.60%,BGN;HEXB;BCAN;FMOD;LUM;HEXA;HYAL2;GUSB;DCN;SDC4;FUCA1;GPC5;SGSH;NAGLU;HPSE;VCAN;SDC3;HPSE2;HSPG2;TGFB1;AGRN;LYVE1
prerank,cholesterol homeostasis (GO:0042632),0.46686959612050766,1.2763050909738587,0.11400651465798045,0.4513157740491349,1.0,16/64,17.90%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;EHD1;NR1H2;ABCA2;HDAC9;CAV1;SOAT2;CNBP
prerank,regulation of phospholipase C activity (GO:1900274),-0.4410357320196038,-1.2762064561855064,0.13821138211382114,0.5651696456764995,1.0,8/15,19.26%,ABL1;NTRK3;PDGFRB;ESR1;ABL2;KIT;PDGFRA;FGF2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.45932046267292126,1.2761982302474637,0.1263498920086393,0.45113970901483674,1.0,30/70,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMC1;PSMD9;METTL3;TCF3;PSMB2;PSMD4;PSMD10
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5981302802232468,1.2761444953661434,0.1825503355704698,0.4508055799090328,1.0,7/13,29.62%,NAMPT;KDR;CCL2;SELENOS;IL33;TLR2;NOD2
prerank,purine nucleotide catabolic process (GO:0006195),0.5948407545579997,1.2758854995868367,0.18995929443690637,0.45104385168275124,1.0,5/13,17.44%,GPX1;HINT1;DNPH1;PNP;NT5C
prerank,regulation of astrocyte differentiation (GO:0048710),0.6075349431838744,1.2756437122477289,0.18194444444444444,0.4512470541443183,1.0,6/12,21.14%,SERPINE2;HES1;BMP2;NOTCH1;IL6;ID2
prerank,sterol homeostasis (GO:0055092),0.4660275564115325,1.2756381679937432,0.10869565217391304,0.45080525086731493,1.0,16/65,17.90%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;EHD1;NR1H2;ABCA2;HDAC9;CAV1;SOAT2;CNBP
prerank,positive regulation of cellular protein localization (GO:1903829),0.46228861813359773,1.2749184632220074,0.12039045553145336,0.4523168681854621,1.0,23/69,23.15%,TYROBP;HSP90AB1;PARK7;AKT1;TNF;MAP1A;LAMTOR5;ORMDL3;RTN4;TFRC;SYT11;MAPT;GPR137B;VPS28;CCDC88A;SNX33;STX4;DDRGK1;TGFB1;GNL3L;TMEM35A;PARD6A;TESK1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6220715070302502,1.2740588099362005,0.18938307030129126,0.4541761230849923,1.0,5/10,19.11%,MT3;DRD5;AOC3;HP;SNCA
prerank,dendritic cell migration (GO:0036336),0.5714478683945982,1.2739695759070013,0.17795484727755645,0.4539373929795904,1.0,7/16,19.49%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,sensory perception (GO:0007600),0.48060429692886,1.2737828574208274,0.1309255079006772,0.4539645908813492,1.0,14/45,22.52%,C5AR1;PCDH15;PENK;PRDM12;P2RX7;PDYN;TMEM150C;KCNA2;CHRNA4;CCL2;CCR2;NTSR2;SCN9A;USH2A
prerank,T cell homeostasis (GO:0043029),0.6346811273238294,1.2735043660468137,0.1729106628242075,0.4542323567672101,1.0,4/10,23.45%,AKT1;PMAIP1;ZC3H8;PPP2R3C
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4969922946361756,1.2734703524347875,0.14614499424626007,0.45384712189810283,1.0,14/36,20.94%,APOE;CSNK2B;TNF;ACVRL1;VASH1;DCN;HMGB1;ADGRB1;DAB2IP;DNAJA4;NOTCH1;TGFB1;MEF2C;GADD45A
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4320823488945242,1.2727278065161551,0.05918367346938776,0.45530927185127434,1.0,38/144,15.14%,CD81;PRNP;TOMM7;OAZ1;ITGB2;PINK1;ANK3;RAN;TMEM30A;YWHAB;HCLS1;UBL5;SORL1;YWHAH;PRR5L;FLNA;YWHAE;HYAL2;SAR1A;TRIM28;LEPROT;YWHAG;VAMP2;CAMK1;CEP131;PMAIP1;HRAS;B3GAT3;YWHAQ;FBXW7;GAS6;YWHAZ;MTCL1;RHOU;MIEF2;BBC3;BAD;MFF
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.606450323272,1.272726799058871,0.1902097902097902,0.45485224905939076,1.0,2/12,2.92%,ACADVL;APOC1
prerank,positive regulation of vasculature development (GO:1904018),0.45189198948483245,1.2718193397021011,0.09005235602094241,0.45669682235366477,1.0,27/94,17.05%,RAMP2;HSPB1;GRN;HMOX1;RHOB;CD34;ECM1;APLNR;ADAM12;EMC10;BTG1;HIPK2;KDR;AQP1;TNFSF12;GATA2;NINJ1;PDCD6;WNT5A;TIE1;CTSH;RRAS;FLT1;GATA4;CDH5;PIK3CD;TWIST1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5598996219573226,1.2717409796547228,0.17010309278350516,0.4564582147257484,1.0,5/18,15.32%,ATF4;MAF1;FLNA;POLR2K;UBTF
prerank,histone H3-K4 methylation (GO:0051568),-0.3944739175494286,-1.271387943591062,0.14285714285714285,0.5746589433467101,1.0,15/26,22.76%,KMT2C;TET2;OGT;TET3;KMT2A;ASH2L;KMT2D;WDR82;SETD4;PRDM9;SETD1B;WDR5B;BEND3;KDM6A;CTR9
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5520638402015815,1.2711673496463292,0.16645326504481434,0.4575409018345454,1.0,4/20,4.81%,PPIA;PPIB;FKBP1A;PIN1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5471958997444988,1.270999215052667,0.17310087173100872,0.45754378342481083,1.0,10/20,19.55%,ATP6AP1;ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3;KCNMA1;TFAP2B
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5501495919826336,1.2709462527864077,0.17183462532299743,0.45676312089408855,1.0,6/19,12.82%,POLR2E;POLR2D;TERF1;POLR2F;POLR2G;POLR2K
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5501495919826336,1.2709462527864077,0.17183462532299743,0.45676312089408855,1.0,6/19,12.82%,POLR2E;POLR2D;TERF1;POLR2F;POLR2G;POLR2K
prerank,epithelial cell migration (GO:0010631),-0.36312613119648635,-1.2709258677468647,0.10483870967741936,0.5731996296592806,1.0,9/37,6.62%,ABL1;KANK2;ROCK1;NRP1;ADGRA2;STARD13;DPP4;PXN;FAP
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5741885844728,1.2708164994729267,0.18068965517241378,0.45661703765839023,1.0,2/14,3.71%,PARK7;TNF
prerank,supramolecular fiber organization (GO:0097435),0.4278398261552572,1.2707707536147144,0.011,0.45626726704738013,1.0,67/333,14.18%,CST3;RPS27A;GFAP;ALDOA;UBC;VIM;B2M;UBB;GSN;HSP90AB1;COL1A1;H3-3A;ITM2B;CD151;PPIB;RHOB;TPPP3;SERPINH1;MARCKS;LUM;TPM2;MFGE8;RHOC;ARHGAP25;EMP2;RAC1;FKBP1A;PLEC;NEFL;PIN1;SORL1;PSENEN;LOX;STMN3;ELMO1;RHOG;TTR;UBA52;MFAP4;CORO1C;P4HB;CORO1A;CALB1;MYO5A;COL6A1;COL4A1;MYO7B;MAPT;COL3A1;STMN4;LAMC2;KRT9;EPPK1;COL9A1;MYO1F;MARCKSL1;MYH11;ACTN1;DCTN1;COL1A2;RHOA;DPT;FLII;CLIP3;DES;STMN1;CCDC88A
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4930095468662583,1.2707053677008886,0.16359447004608296,0.455991942698832,1.0,9/35,13.41%,ARHGDIA;SEMA3F;RAC1;SEMA7A;FLNA;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4431196510562286,1.2705563140483713,0.06864754098360656,0.4559246178663375,1.0,40/121,19.83%,CD74;VTN;CD81;PRNP;TREM2;GRM5;ERBB4;IL5;AGT;TNF;PDGFB;PTPRC;HCLS1;ARL2BP;MIF;HES1;CLEC6A;ENPP2;PTK6;IL2;LILRA5;FCGR1A;CSF1R;PECAM1;IL11;DOK7;SRCIN1;RIPK2;GAS6;TNFRSF1A;IGF2;LRP8;CASS4;ERBB3;UNC119;FLT3;HGF;IL6;EFNA1;TGFB1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6276958740780586,1.2702058368619993,0.2,0.4564113668805389,1.0,1/10,0.06%,CST3
prerank,cellular response to leucine starvation (GO:1990253),-0.5280498341473936,-1.2697649042318873,0.21708185053380782,0.5733531275003723,1.0,6/10,25.90%,EIF2AK4;RRAGB;SESN1;LARS1;SESN2;SESN3
prerank,regulation of actin filament polymerization (GO:0030833),-0.31740512307652174,-1.2697130404054169,0.023255813953488372,0.5706771435022508,1.0,17/69,11.99%,ARHGAP28;FCHSD2;FER;BAIAP2L1;ARFGEF1;SLIT2;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;PLEKHG2;GBA2;KANK1;SNX9;NCK1;ARHGAP18
prerank,ESCRT III complex disassembly (GO:1904903),0.6329842785692978,1.269124611198561,0.1939655172413793,0.45843447598330306,1.0,6/10,24.79%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,ESCRT complex disassembly (GO:1904896),0.6329842785692978,1.269124611198561,0.1939655172413793,0.45843447598330306,1.0,6/10,24.79%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,positive regulation of transferase activity (GO:0051347),0.4325267195727933,1.2690971056208387,0.06578947368421052,0.4580531221290987,1.0,48/142,22.30%,CD74;RPS2;DBI;HSP90AA1;HSP90AB1;MAPK3;SERINC1;TREM2;ERBB4;PINK1;CCT2;NTRK2;PIN1;SORL1;CTNNB1;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;PCNA;KLF4;FBXW7;TIE1;RFC2;SERINC5;PTGES3;ARRDC3;IGF2;EPHB1;PARM1;FLT1;TYRO3;DDR2;ERBB3;EPM2AIP1;FLT3;DKC1;MAPK15;TGFB1;RFC4;MAGEC2;MYC;MAP2K7;CCT4;GRHL2;NAF1
prerank,cellular response to interferon-gamma (GO:0071346),0.4469976173065187,1.2689745998574058,0.10031347962382445,0.45792138708795926,1.0,28/88,23.81%,B2M;GAPDH;RPL13A;MT2A;CCL19;AQP4;SIRPA;HCK;FCGR1A;IRF8;WNT5A;AIF1;PDE12;CCL2;IRF7;IFNGR1;CCL3;VCAM1;NCAM1;CCL8;OAS3;EPRS1;IFNGR2;IRF9;IRF5;TRIM68;IL12RB1;CAMK2G
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6301793682292594,1.2686481081959429,0.19549929676511954,0.45833435995415506,1.0,2/10,8.66%,PRNP;VSIR
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.33328438126879883,-1.2685922027075762,0.0847457627118644,0.5704570636963339,1.0,8/45,5.77%,EGFR;PLCE1;GAREM1;BRAF;GAB1;SLC30A10;PDPK1;EFEMP1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6188220932663542,1.268567013935053,0.19130434782608696,0.45809190058184834,1.0,4/10,14.62%,TIRAP;TICAM2;NINJ1;F2RL1
prerank,cellular response to UV (GO:0034644),0.45130790973728724,1.2681942730408964,0.1130890052356021,0.458610637109998,1.0,16/76,12.07%,RPL26;CRIP1;ATF4;NPM1;COPS9;PARP1;HYAL2;MFAP4;AQP1;TIMP1;DDB1;SMPD1;MC1R;MMP3;PCNA;NSMCE3
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6007968007039715,1.2677676937702278,0.18353576248313092,0.4592916771224927,1.0,3/12,4.23%,APOE;PRNP;FKBP1A
prerank,embryonic organ morphogenesis (GO:0048562),-0.34572705185047525,-1.2676615239431106,0.10569105691056911,0.5701226960390422,1.0,9/42,5.77%,FBN1;HOXB3;ACVR1;HOXA3;NIPBL;HOXB4;HOXC4;RARG;EFEMP1
prerank,intracellular sterol transport (GO:0032366),0.5958806901956776,1.2676427946273727,0.1857335127860027,0.45914689150353183,1.0,4/13,9.19%,NPC2;ABCG1;TSPO2;STARD4
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4290619494063914,1.2664253415221411,0.055780933062880324,0.46191926179142095,1.0,42/161,16.41%,APOE;IGFBP6;PFDN5;PSMB4;MDK;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;PSMD1;LRP4;PSMC3;TLE5;PSMD6;ANKRD6;SFRP5;PSMA7;JADE1;PSMD5;RBX1;PSMB9;PSMD13;WNT5A;SOX17;PSMB3;PSMB11;IGFBP2;SOX9;BMP2;TNN;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5429224854709221,1.266062865941519,0.18963337547408343,0.4624197245401923,1.0,6/20,8.17%,HSP90AB1;AKT1;CCND2;PDGFB;CCND1;PROX1
prerank,regulation of endothelial cell migration (GO:0010594),0.4495263756285335,1.265977507812941,0.09404388714733543,0.46219572691860217,1.0,21/85,11.65%,APOE;SPARC;GRN;CALR;RHOB;AKT1;AGT;EMP2;RAC1;ACVRL1;EMC10;GLUL;VASH1;PROX1;KDR;DCN;ADGRB1;PDCD6;WNT5A;AAMP;FLT4
prerank,axonal transport (GO:0098930),0.4983925347869297,1.2659313531474792,0.14481185860889395,0.4618612702238691,1.0,10/36,12.87%,SOD1;BLOC1S4;NEFL;AP3B2;MAPT;BLOC1S1;BLOC1S3;HAP1;BLOC1S5;DCTN1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5957449762427808,1.2658849498236682,0.20253164556962025,0.46151601012655336,1.0,4/12,17.00%,TNF;FLOT1;THY1;SKAP1
prerank,lipid homeostasis (GO:0055088),0.4716697220612262,1.2658401771930192,0.13646288209606988,0.4611695200271667,1.0,13/57,13.10%,APOE;RCN3;PNPLA2;TREM2;ORMDL3;ABCG1;LIPG;RBP1;CEBPA;MLXIPL;ATP13A2;ABHD8;FBXW7
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3556160407851383,-1.265803879277469,0.08088235294117647,0.572059478126871,1.0,14/39,15.12%,ARID2;PARP9;KMT5C;SPIDR;PARP3;KMT5B;SHLD1;MMS19;MRNIP;FUS;KDM4D;FANCB;MGMT;SMCHD1
prerank,post-translational protein modification (GO:0043687),0.42264200590772427,1.2655064099542765,0.012036108324974924,0.4616005842639406,1.0,85/332,20.58%,APOE;CST3;PSMB4;ELOB;SPARCL1;SPP1;LGALS1;C3;LAMC1;LAMB2;PSME1;PSMB6;PNPLA2;PSME2;PSMB8;CKAP4;PSMD2;COPS7A;IGFBP3;MFGE8;COPS6;IGFBP4;FBXO15;HSP90B1;KLHL9;IGFBP5;PSMD1;SHISA5;EPAS1;PSMC3;PDIA6;PSMD6;PENK;FN1;PSMA7;P4HB;FN3KRP;FEM1A;FEM1C;FBXL14;APLP2;UBE2M;VWA1;PSMD5;RBX1;NEDD8;FBXO27;TIMP1;DDB1;ICMT;PSMB9;PSMD13;PSMB3;FBXW5;WFS1;PSMB11;MXRA8;ASB13;FBXW7;FBXO30;FBXO31;GAS6;PSMB10;KBTBD7;SPSB3;COPS8;PSMB1;RNF7;PSMB5;VCAN;VHL;EVA1A;SCG3;RBBP5;NOTUM;STT3A;PSMA6;FBXL16;IL6;SKP1;PRSS23;QSOX1;PSMA4;KLHL25;BTBD6
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5716949626681619,1.265498390720355,0.2102496714848883,0.46116898495125996,1.0,5/15,15.47%,C3;CTDNEP1;MFSD2A;FBXW7;NR1H2
prerank,fatty acid elongation (GO:0030497),0.5926255740592912,1.2654723851742622,0.2024793388429752,0.4607753338398799,1.0,7/13,32.37%,ELOVL1;ELOVL2;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,ephrin receptor signaling pathway (GO:0048013),0.44762154388792114,1.2652310462411422,0.1246040126715945,0.4609517557831773,1.0,30/82,19.87%,ACTB;ACTG1;ANKS1B;RAC1;PSENEN;GRIN1;AP2M1;PAK1;CDK5R1;AP2S1;EPHA5;ARPC1B;ARHGEF7;PAK3;ARPC3;HRAS;ARPC5;RHOA;VAV3;SDCBP;TIAM1;ARPC4;EPHB1;PSEN2;EFNB1;ARPC2;APH1B;GRIN2B;EFNA1;GIT1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5461496556761062,1.2651342150298854,0.18238993710691823,0.46073189431103106,1.0,10/18,28.03%,MDK;HES1;TENM4;CXCR4;PTPRZ1;NOTCH1;SOX1;PTN;TMEM98;TNFRSF1B
prerank,linoleic acid metabolic process (GO:0043651),0.5589241040780605,1.2646233711989638,0.18410596026490067,0.46157485570260975,1.0,4/17,11.13%,FADS1;ELOVL1;ELOVL2;GSTM2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5788356491965261,1.264417206839771,0.17615176151761516,0.46166185073393834,1.0,7/15,21.40%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1;SELENOS
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6150725346001041,1.2642277155209938,0.1820689655172414,0.46168997975995857,1.0,5/12,17.69%,FXYD1;ANK3;ATP1B2;ATP1B1;ATP1B3
prerank,regulation of protein catabolic process (GO:0042176),0.4414501058029717,1.2638315866101728,0.10187110187110188,0.46234984486294933,1.0,28/99,18.18%,EEF1A1;GFAP;NDUFA13;OAZ1;TNF;CHEK2;PIN1;SORL1;FLNA;EEF1A2;VCP;TNFAIP3;FMN2;TNFSF12;ATP13A2;ADGRB1;DDB1;CHMP6;WNT5A;CTSA;VPS28;ODC1;EGLN2;RAB26;DAB2IP;TRIM32;FAM83D;AGAP2
prerank,protein import (GO:0017038),0.4502717736668499,1.2632509795482012,0.11965811965811966,0.4634317300297513,1.0,18/84,18.27%,APOE;CLU;HSP90AA1;AKT1;RAN;PXMP2;FAM53C;PTTG1IP;GDAP1;IPO4;NUP85;NUP88;SNX33;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2
prerank,cartilage development (GO:0051216),-0.33497539367383733,-1.263023821525593,0.09574468085106383,0.5764594736905286,1.0,20/49,23.95%,SULF1;NFIB;SOX5;ZBTB16;WNT5B;ATP7A;ITGB8;PKD1;CREB3L2;BMP4;RUNX2;TRIP11;GPLD1;FGF2;SULF2;HOXD3;WNT2B;COL11A2;TRPV4;HYAL3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4340385523214251,-1.2629703380877975,0.17842323651452283,0.5737839385348684,1.0,4/17,8.24%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6142167256584294,1.2628340498606911,0.22022160664819945,0.46415847270778965,1.0,3/11,10.24%,AGT;ABCG1;PLA2G7
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4510600562062982,1.2625759827645426,0.10395010395010396,0.4644056829789448,1.0,23/88,16.33%,FTH1;FTL;HSPA8;BLOC1S4;SORL1;SH3GL2;SORCS1;RAB14;SCAMP3;MYO5A;CLVS1;CLTC;VAMP2;CLVS2;BLOC1S1;BLOC1S3;VAMP8;SCAMP2;SORT1;ARF1;CLTA;GOLGA7;NAPA
prerank,regulation of sodium ion transport (GO:0002028),0.5008851109991584,1.2622227576242984,0.15204678362573099,0.4648596812547113,1.0,11/34,15.65%,NKAIN2;ANK3;YWHAH;NKAIN3;P2RX7;SCN4B;FGF12;ATP1A1;CNKSR3;PRSS8;SPTBN4
prerank,negative regulation of protein transport (GO:0051224),0.5277431670584881,1.2620261518632216,0.17087845968712395,0.4649523153565265,1.0,6/25,21.84%,APOE;DPH3;RSC1A1;ERP29;RSAD2;PPM1F
prerank,membrane assembly (GO:0071709),0.5045922252440235,1.2618846545929594,0.16159250585480095,0.4648783367942639,1.0,10/34,12.53%,NRXN1;NLGN1;S100A10;ANK3;EMP2;LRP4;FLOT1;IL1RAPL1;PTPRD;NRXN2
prerank,regulation of hormone secretion (GO:0046883),0.5717139051653227,1.2617851081847227,0.1863270777479893,0.46469459247998657,1.0,7/15,18.97%,SCG5;VAMP3;VAMP2;IL11;NMB;EDN3;SOX11
prerank,regulation of cell death (GO:0010941),0.44256509743135797,1.2612416310831447,0.1032325338894682,0.46567586212459966,1.0,20/94,15.67%,CLU;UBB;CTSZ;MT3;PARK7;DCC;CRYAB;HSPA1B;LRPAP1;BNIP3L;CCN2;DHCR24;RAMP3;TMEM109;HSPA1A;RIPK2;PDE12;HPR;HP;EPHB1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.541598711976787,1.261142279095234,0.18494897959183673,0.46549170271698087,1.0,2/20,1.05%,B2M;CD81
prerank,positive regulation of hormone secretion (GO:0046887),0.5621582649588376,1.2608571688264651,0.17976031957390146,0.4658380560870654,1.0,6/17,18.97%,SPP1;RASL10B;VAMP8;NMB;EDN3;SOX11
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.45774341244165967,1.2603862906953731,0.12567132116004295,0.4666506922488479,1.0,17/72,16.77%,RPS27A;UBC;UBB;RNASE1;RNASE4;PARP1;RPA2;UBA52;PNRC2;RBX1;DDB1;EDC4;PCNA;RFC2;PDE12;POLD4;MUS81
prerank,regulation of DNA repair (GO:0006282),-0.3447549570669089,-1.2596871649228383,0.08333333333333333,0.5796071390774576,1.0,15/44,13.42%,EYA2;EGFR;EYA1;BABAM2;TRIP12;UBR5;KAT7;UIMC1;RNF8;PML;EYA4;PARG;EYA3;ERCC8;SIRT1
prerank,regulation of interleukin-10 production (GO:0032653),0.4770555037011941,1.2595981000449552,0.1568409343715239,0.46824799080327745,1.0,15/44,24.49%,TYROBP;CD34;ISG15;HSPD1;VSIR;LILRA5;HMGB1;LILRB1;F2RL1;DLL1;SYK;IL6;PYCARD;CD28;AGER
prerank,mRNA polyadenylation (GO:0006378),-0.38745691465254234,-1.259486178051926,0.11794871794871795,0.5745610913932104,1.0,12/26,21.82%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,RNA polyadenylation (GO:0043631),-0.38745691465254234,-1.259486178051926,0.11794871794871795,0.5745610913932104,1.0,12/26,21.82%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,alanine transport (GO:0032328),0.61253760314326,1.2594840944102004,0.22206303724928367,0.4680452549997236,1.0,3/10,9.01%,SLC1A4;SLC6A6;SLC6A17
prerank,mucosal immune response (GO:0002385),0.5711075293396566,1.259478152688708,0.20860495436766624,0.46760963992985854,1.0,1/15,0.48%,RPL39
prerank,mitotic recombination (GO:0006312),-0.44156300016023375,-1.259163876997562,0.17857142857142858,0.572626129675926,1.0,3/15,7.07%,NSMCE2;TEP1;MSH3
prerank,membrane raft organization (GO:0031579),0.5702464645368308,1.2590846412157326,0.20933333333333334,0.46822542739138423,1.0,4/15,6.04%,S100A10;EMP2;FLOT1;MYADM
prerank,negative regulation of protein secretion (GO:0050709),0.4861285005172721,1.2580104957517455,0.19014891179839633,0.4705228676003338,1.0,10/38,23.19%,APOE;DPH3;CHGA;ERP29;SFRP1;RSAD2;INHBB;CCN3;REST;PSMD9
prerank,presynapse assembly (GO:0099054),0.5537446722681084,1.2579479883705638,0.18637532133676094,0.4702238293915879,1.0,8/16,23.04%,NLGN1;LRP4;IL1RAPL1;WNT5A;PTPRD;LRRTM3;FZD1;WNT7A
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.42206485028638696,-1.257366473446598,0.18222222222222223,0.5742417069989904,1.0,8/19,14.38%,PARD3B;PARD3;DLG1;PATJ;SYNJ2BP;MARK2;PRKCI;CLIC4
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5635673007518553,1.256931712490816,0.18607764390896922,0.4724508244982781,1.0,4/15,10.15%,CD74;MIF;PTTG1IP;TAF9
prerank,cell projection assembly (GO:0030031),0.532804836944339,1.2554845703477278,0.17543859649122806,0.47587518912660404,1.0,10/22,17.68%,GSN;RAC1;NEFH;RHOG;RHOV;RHOU;CAPG;PDGFA;RAC2;SCIN
prerank,glycerophospholipid catabolic process (GO:0046475),0.5123620633009253,1.2553899735968421,0.16508313539192399,0.47568136760263297,1.0,12/27,26.52%,PRDX6;ENPP2;PLA2G7;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;ABHD16A;GDPD3;ABHD12;PLA2G6
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4190995181194456,1.2546883745105206,0.021,0.4771349154479305,1.0,91/348,20.07%,RPL23;RPS3;ACTG1;RPL11;RPS7;RPL5;CD74;CLU;CD63;CLDN5;GSN;RAMP2;TYROBP;LAPTM5;ACTA2;MT3;PARK7;MAPK3;ATF4;AKT1;KLF2;TREM2;CD34;ANK3;GPER1;TNF;PDGFB;LAMTOR5;NTRK2;AMH;HSPA1B;FN1;MUSK;TFRC;MSN;RIMS2;RIMS1;TRIM28;P2RX7;VSIR;VAMP3;EGR1;GATA2;ATP13A2;LRP3;WNT5A;RAMP3;POU3F1;WARS1;WFS1;TMEM119;CAMK2N1;KLF4;SLC11A1;SOX9;HSPA1A;GJA1;LILRB1;BMP2;GAS6;SFRP4;CTSH;TLR6;PF4;IFNGR1;MAPK11;HEY1;ARRB2;DNAJA4;CCL3;DNMT3B;EPB41L4B;CDH5;PIK3CD;TWIST1;PDCD5;PPARGC1A;AGO1;MAZ;HMGN5;SOX11;SNCA;DDRGK1;INHBA;NOTCH1;IL6;ERP29;TGFB1;POU4F1;CITED2;MEF2C
prerank,renal absorption (GO:0070293),0.6069791126817654,1.2546584014631357,0.21304347826086956,0.4767661822559643,1.0,4/10,15.42%,GSN;HYAL2;SGK1;SLC15A2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5139028975464743,1.2543223482574777,0.17488262910798122,0.4771493141699778,1.0,7/29,9.13%,APOE;AKT1;MID1IP1;CTDNEP1;HSD17B13;MFSD2A;MLXIPL
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5241116378542496,1.254282768148513,0.1775,0.4768016012948446,1.0,7/24,15.84%,TPPP3;PIN1;STMN3;MAPT;STMN4;STMN1;FGF13
prerank,negative regulation of nervous system development (GO:0051961),0.5508302495709697,1.2537624699823884,0.18351063829787234,0.47773888562244493,1.0,9/17,23.04%,B2M;TNF;SORL1;ROBO2;SLIT1;NOTCH1;IL6;REST;WNT7A
prerank,regulation of apoptotic process (GO:0042981),0.4161120609553498,1.253723488723662,0.003,0.4773875835067537,1.0,190/676,20.94%,TPT1;RPS3;MTCH1;RPS27A;CTSD;PTMA;PPIA;ARHGDIA;CD74;CLU;CTSB;UBC;RACK1;UBB;HSP90AA1;HSPB1;CALR;LGALS1;MT3;CFL1;PARK7;SOD1;RPL10;RHOB;HSPA5;ATF4;RPS6;AKT1;NME1;HIGD2A;CCND2;TMBIM6;UBE2Z;CRYAB;TGM2;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;PINK1;AGT;IGFBP3;GPER1;GRID2;BEX2;MAGED1;TNF;HSP90B1;FZD9;PRDX2;GLO1;NAA38;RTN4;MIF;BNIP2;HSPA1B;PSENEN;CTNNB1;FLNA;IL2RB;VCP;ALPK2;LTK;TMEM14A;BAG1;TFRC;OMA1;UBA52;NDRG1;BNIP3L;ARHGEF4;FOXL2;SGK1;HSPD1;FMN2;KDR;CXCL10;AQP1;IL2;CSRNP3;FAIM2;DHCR24;NUPR1;NET1;TRIM2;RRP1B;JUN;HMGB1;HCK;ARHGEF7;TAF9;TARDBP;SMPD1;GAS1;APBB1;APEX1;WNT5A;ATF5;DNAJA1;BAX;ZBTB7A;FLT4;WFS1;PMAIP1;PNMA2;TCTN3;SOX8;ACTN1;PHLPP1;CTLA4;MCF2L;SOX9;HSPA1A;VAV1;LILRB1;BMP2;SPTLC1;RIPK2;GAS6;WNT10B;YWHAZ;NME2;CLIP3;NLRP2B;CAT;SFRP4;GLS2;VAV3;ABR;CTSH;EGLN2;IKZF3;TIAM1;BAD;IER3IP1;ARF4;LRP8;CDK5;DAB2IP;ATAD3A;DDAH2;VHL;PIM3;SQSTM1;PSEN2;DNM1L;PDCD5;PCID2;SCIN;ASNS;APH1B;CIAPIN1;GRM4;NOP53;KCNMA1;AKT1S1;ANP32A;TNFRSF12A;NSMF;HMGN5;ARHGEF19;ANP32E;CCAR2;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;SOS1;TFAP2B;FLT3;HGF;IL6;KLF11;ING5;CITED2;OSGIN1;MEF2C;SFRP1;SPHK2;CAPN3;TFAP4;MYC;NFKBIA;HSPA9;BAK1;PTPN6;PYCARD;GADD45A
prerank,regulation of embryonic development (GO:0045995),-0.36630940091525294,-1.2534503562796562,0.1346153846153846,0.581476795791666,1.0,11/34,9.93%,PHLDB2;TRIP12;NIPBL;DHX36;NIBAN2;EHMT1;WDPCP;INSR;NPHP3;TDG;NR2C2
prerank,mRNA metabolic process (GO:0016071),0.4395408452245456,1.2533654744557312,0.11962224554039874,0.47787925983182494,1.0,36/90,25.42%,SNRPG;AURKAIP1;RNASE4;LSM6;SNRPE;HSPA1B;ZFP36L2;SNRPF;SRSF9;HNRNPA0;ZFP36;RNH1;PRPF8;SUPT4H1;SRSF2;SF3A2;SF3B2;HSPA1A;NONO;SNRPB;SF3A3;NUDT16;PPARGC1A;NANOS2;SLBP;TBRG4;SNRPD3;SF3A1;SRSF1;SRRM4;PCBP2;LSM5;ALKBH5;METTL3;PRKACA;PNPT1
prerank,regulation of biosynthetic process (GO:0009889),0.5984205370970841,1.2529737585128378,0.21598877980364656,0.47843997673969474,1.0,3/11,20.23%,MID1IP1;SNCA;SPHK2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5237279571489124,1.252923151751479,0.18159203980099503,0.4781193628278144,1.0,10/25,20.94%,PINK1;GPER1;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PYCARD
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4908505376032397,1.2529135193601955,0.1764018691588785,0.47769183830393425,1.0,4/37,6.51%,APOE;MT3;PINK1;LRPAP1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.511723551604822,1.2528742819032233,0.1773220747889023,0.47735601210995116,1.0,10/27,21.01%,CALM1;FKBP1A;YWHAE;AHNAK;PLN;JPH4;FKBP1B;SELENON;CALM2;CACNB4
prerank,Golgi ribbon formation (GO:0090161),-0.4670550720003215,-1.2527731422948578,0.1576923076923077,0.5806889717952413,1.0,6/13,15.81%,VTI1A;STX16;GOLGA2;OPTN;MYO18A;TRIP11
prerank,regulation of cell killing (GO:0031341),0.557707409050181,1.25243313954881,0.19714656290531776,0.47804534979551844,1.0,4/16,11.15%,CYBA;RAC1;WNT5A;IL11
prerank,cellular response to chemokine (GO:1990869),0.4714954403368266,1.2519894953999284,0.1555806087936866,0.47882410550807863,1.0,21/46,34.30%,CXCL12;CCL19;CXCL10;RHOA;DOCK8;CCL2;PF4;CCL3;CCL8;CCR2;DUSP1;OXSR1;CX3CL1;PPBP;CCL13;CCL14;GPR35;ACKR3;LRCH1;CCL5;SLC12A2
prerank,phagosome maturation (GO:0090382),0.4962762075278643,1.2519258043844086,0.16783216783216784,0.47855590769918277,1.0,18/35,32.21%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;RAB14;CORO1A;ATP6V0D2;RAB20;RAB31;ATP6V1A;ATP6V0A1;ATP6V0B;TCIRG1;MREG;ATP6V0E1;RAB38;RAB34;RAB39A
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.37409498867773594,-1.2519041909069157,0.11801242236024845,0.580066316136938,1.0,10/29,14.87%,STRN3;KANK2;YAP1;AXIN1;CNOT1;UFL1;ESR1;KMT2D;CBFB;CARM1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.4960474708336723,-1.25183460057095,0.2103448275862069,0.5775903026036084,1.0,5/11,9.89%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4600979380572814,1.2514870760264603,0.15224534501642936,0.47928972872865244,1.0,20/54,27.61%,CD63;KCNIP4;AKAP6;DPP10;FLNA;YWHAE;KCNJ10;DPP6;KCNN2;KCNE5;KCNIP1;CAV1;KCNMA1;GABBR2;KCNJ3;KCNAB1;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,negative regulation of programmed cell death (GO:0043069),0.41835066605225163,1.2514278948902817,0.012,0.47899875339728576,1.0,93/355,20.87%,TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;GPX4;UBB;HSPB1;LAPTM5;MT3;CFL1;PARK7;RPL10;HSPA5;AKT1;HIGD2A;CCND2;TMBIM6;UBE2Z;TREM2;CRYAB;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;HSP90B1;PRDX2;GLO1;NAA38;MIF;BNIP2;HSPA1B;CTNNB1;FLNA;IL2RB;LTK;TMEM14A;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;KDR;AQP1;IL2;FAIM2;DHCR24;NUPR1;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;SOX9;HSPA1A;RIPK2;GAS6;YWHAZ;NME2;CAT;CTSH;ARF4;ATAD3A;DDAH2;VHL;PIM3;SQSTM1;PSEN2;PCID2;ASNS;CIAPIN1;HMGN5;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;TFAP2B;HGF;IL6;POU4F1;CITED2;SFRP1;CAPN3;MYC;NFKBIA;HSPA9
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.49993324097418596,-1.2512281244437888,0.1935483870967742,0.5764194664602958,1.0,3/10,15.71%,DHX36;CPEB3;CDC73
prerank,negative regulation of developmental process (GO:0051093),0.4505955735587602,1.251199754131811,0.13205537806176784,0.47918029700944326,1.0,24/69,20.17%,CST3;DCC;VAT1;PINK1;SPI1;MIF;ALPK2;SFRP5;GRIN3A;TFRC;OMA1;VASH1;THY1;MAPT;SOX9;BMP2;GAS6;HEY1;DLL1;BCL11A;SPRY3;NOTCH1;TGFB1;SFRP1
prerank,negative regulation of cell division (GO:0051782),0.6097175405933225,1.2509469093516963,0.20454545454545456,0.47939706956777767,1.0,6/11,28.98%,TXNIP;VPS4A;MYC;BLM;CHMP4C;AURKB
prerank,Golgi to lysosome transport (GO:0090160),0.6110321562221473,1.2507972070716145,0.2030812324929972,0.47935010080542123,1.0,2/11,1.38%,LAMP1;LAPTM5
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4013162225734709,-1.2507489390278812,0.18396226415094338,0.5749584145028865,1.0,11/22,15.71%,SCAF8;BRD4;KAT7;CCNT1;CDK12;TCERG1;CCNK;CDK13;ELL;THOC5;CDC73
prerank,T cell differentiation in thymus (GO:0033077),0.5814877453147186,1.250724729159909,0.21256684491978609,0.47908200783289356,1.0,3/14,5.16%,PTPRC;ZFP36L1;ZFP36L2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.43736294075891746,1.2506685470188244,0.10754912099276112,0.47877894694935685,1.0,32/101,21.40%,VIM;PDE4B;TNF;NR1D1;SIRPA;CD180;TNFAIP3;CCR5;CXCL10;TICAM2;CD68;HMGB1;HCK;ZFP36;CHMP5;WNT5A;RHOA;LILRB1;CX3CR1;CCL2;PF4;DAB2IP;CCL3;CD14;CD86;NLRP3;IL6;TGFB1;GIT1;MEF2C;PYCARD;SELENOS
prerank,regulation of cellular component organization (GO:0051128),0.4350132739053716,1.2501471576060261,0.08,0.4797003848334844,1.0,30/135,14.19%,APOE;HSPA8;GFAP;HSP90AA1;PARK7;SNX17;NRG3;PINK1;AGT;LAMTOR2;TNF;LTBP4;PACSIN1;SPOCK1;BAG5;TFRC;FAM107A;KLK8;SGK1;WFDC1;CD22;NET1;AP2S1;WNT5A;ATF5;SSRP1;NCLN;HNRNPU;STK11;EGLN2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4649106795229344,1.2500789933225782,0.1511111111111111,0.4794427018025962,1.0,20/54,22.79%,RACK1;LAPTM5;TNF;HSPA1B;TNFAIP3;SPPL2B;OTULIN;RBCK1;HSPA1A;GAS6;TNFRSF1A;CLIP3;NLRP2B;F2RL1;ADAM17;SYK;TRAIP;PYCARD;SPPL2A;PELI3
prerank,lymphocyte chemotaxis (GO:0048247),0.49107848339164806,1.250078119315731,0.16822429906542055,0.4789986706380796,1.0,10/34,19.49%,CCL19;CXCL16;CXCL10;GAS6;CCL2;CCL3;PIK3CD;CCL8;CH25H;GPR183
prerank,regulation of cardiac muscle contraction (GO:0055117),0.48707078131659887,1.2497696036915975,0.17660818713450294,0.479399039999901,1.0,12/34,19.10%,CALM1;PDE4B;CALM3;RGS2;PLN;CHGA;ATP1B1;SLC8A1;RYR2;ADRA1A;SRI;CALM2
prerank,mesonephros development (GO:0001823),-0.49249382940077674,-1.2496009788806648,0.19649122807017544,0.5750809346470368,1.0,3/11,13.72%,ZBTB16;FGF1;BMP4
prerank,regulation of T cell proliferation (GO:0042129),0.45546352736980433,1.2495324034587652,0.1437980241492865,0.4795949822901687,1.0,13/61,19.67%,GPNMB;CCL19;PTPRC;LGALS3;TFRC;CEBPB;SDC4;PNP;AIF1;LILRB1;VCAM1;CD86;IL6
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5098005958353641,-1.2490363390660177,0.1986754966887417,0.5738860531771428,1.0,3/10,9.60%,RARB;RARG;PPARG
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2657250199941139,-1.2488082863337435,0.08333333333333333,0.5718983832260686,1.0,45/138,18.69%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;YAP1;PPARA;RARG;NCOR1;KAT2B;TBL1X;NR1D2;MAML1;TBL1XR1;TEAD2;PPARG;ESR1;NR2C2;MED26;GTF2E2;RBPJ;TAF2;AR;POLR2A;NR2F1;RORA;GTF2H4;POLR2B;CDK7;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF7;TAF4B;NR5A2;GTF2H2;MED23
prerank,negative regulation of protein modification process (GO:0031400),0.44922370265386713,1.248049085258172,0.12978723404255318,0.48327251959729856,1.0,18/79,11.61%,PPIA;DBI;PARK7;FKBP8;PRNP;FXYD1;IGFBP3;PPP1R15B;YWHAB;PRR5L;SIRPA;SH3GL2;MYADM;CORO1C;MAPT;CADM4;TARDBP;WARS1
prerank,regulation of inflammatory response (GO:0050727),0.4219142125359363,1.2479987430078063,0.06350806451612903,0.4829386199394151,1.0,45/190,19.67%,TMSB4X;APOE;MDK;GRN;PARK7;AGT;GPER1;TNF;NR1D1;LRFN5;SEMA7A;S100A9;S100A8;SIRPA;DDT;HYAL2;TNFAIP3;FEM1A;CEBPA;OTULIN;IL2;BCL6B;LPL;VAMP3;VAMP2;LILRA5;HCK;NINJ1;PLA2G7;WNT5A;MMP3;KLF4;TNFRSF1A;AKNA;GPSM3;FNDC4;TYRO3;CCL3;CDH5;CCR2;SNCA;PSMA6;CXCL17;NLRP3;IL6
prerank,aortic valve morphogenesis (GO:0003180),-0.3732777343621331,-1.2479146717230751,0.11931818181818182,0.5715642523210639,1.0,10/30,14.92%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1;ELN;JAG1;BMP4;HEY2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5281567580268075,1.247704613434588,0.19053549190535493,0.48325349682984364,1.0,5/22,9.13%,APOE;AKT1;EEF1A2;HSD17B13;MLXIPL
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.45092479938662483,1.2475066916572715,0.1326963906581741,0.4832972232103509,1.0,24/72,23.70%,CD74;RACK1;HSP90AB1;TNF;PTPRC;TNFAIP3;SPPL2B;OTULIN;CD24;RBCK1;CDC37;GAS6;TNFRSF1A;CLIP3;IFNGR1;SIGIRR;SYK;IFNGR2;PTPN6;PYCARD;SPPL2A;PTPN1;SOCS3;AGPAT2
prerank,regulation of exocytosis (GO:0017157),0.4757444074244151,1.2474139675151485,0.15181518151815182,0.48306694947697043,1.0,13/46,11.11%,ATP6AP1;SYT1;RIMS2;RAB15;IL1RAPL1;CLASP1;RAB3C;VAMP2;CADPS;STXBP5L;RAB3D;CHMP6;HAP1
prerank,neuron projection morphogenesis (GO:0048812),0.43136439035241,1.246583872254945,0.07951070336391437,0.48476896230360844,1.0,38/137,16.84%,ACTB;S100A6;UBB;DCC;NBL1;NLGN1;S100B;CTNNA2;ANK3;MAP1A;CNTNAP2;PACSIN1;CNTN4;LRP4;CTNNB1;NEFH;KLK8;SGK1;PAK1;NRCAM;MAP2;PAK3;ADGRB1;DOCK10;APBB1;NYAP2;TMEM106B;SHTN1;CCK;TNN;MAPK8IP2;DSCAML1;SPTBN4;EPHB1;CDK5;EPB41L3;DAB2IP;BRSK2
prerank,regulation of defense response (GO:0031347),0.44455878301268015,1.2463074337637337,0.14497354497354498,0.48508187760257915,1.0,14/76,15.50%,TMSB4X;APOE;GRN;PARK7;TREM2;SEMA7A;TIRAP;BCL6B;HCK;WNT5A;ELMOD2;AKNA;TRAF3;LRP8
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4798092309449551,-1.2462805633926743,0.19784172661870503,0.5733230201114342,1.0,5/11,22.44%,CAMK2D;SESTD1;NOS1AP;NOS1;CACNB1
prerank,regulation of neutrophil migration (GO:1902622),0.6300518711534541,1.245799935606975,0.20232896652110627,0.4859971401466531,1.0,5/10,25.39%,RAC1;RHOG;JAM3;RAC2;MPP1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.49934546999066826,1.2457164940630951,0.17339667458432304,0.4857679155550946,1.0,8/32,9.13%,TMSB4X;TREM2;PINK1;ENO1;VCP;P2RX7;NUPR1;MLXIPL
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5487644670318226,1.245620526781296,0.1986754966887417,0.4855920307484969,1.0,10/18,27.24%,TREM2;CCT2;TNF;CCT7;CCT8;DKC1;CCT4;CCT3;CHP1;CORO2B
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6106011506855445,1.2453209429264023,0.22786647314949202,0.48592991394866647,1.0,4/10,21.65%,FBXW7;NCF1;ADAM17;TGFA
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.559920542408116,1.2451855976733244,0.22002635046113306,0.48583298482182763,1.0,5/15,19.83%,CST3;CLASP1;DDR2;IL6;TGFB1
prerank,regulation of cell growth (GO:0001558),0.4217146987281117,1.245153480880174,0.061122244488977955,0.48546164979700507,1.0,70/204,21.93%,RACK1;H3-3A;MT3;NDUFA13;AKT1;NRG3;AKAP6;EIF4G2;AGT;LAMTOR2;CCDC85B;ADAM15;LTBP4;ACVRL1;ENO1;RTN4;S100A9;S100A8;HSPA1B;PPP2R1A;SPOCK1;HYAL2;BTG1;LGI1;TFRC;FAM107A;CXCL16;SGK1;DDX49;WFDC1;JADE1;IL2;MFSD2A;NET1;DNPH1;EXOSC2;KIF26A;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;EGLN2;SDCBP;IL17RB;ING1;DACT3;ATAD3A;TRIM32;SLIT3;NDUFS3;MMP14;ADAM17;EXOSC9;SCGB3A1;CCAR2;INHBA;TGFB1;OSGIN1;SFRP1;TMEM97;SPHK2;PAK5;RERG;EXOSC4;CCN3;CDA
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.43146880284789435,-1.2451033083960152,0.15476190476190477,0.5736319038596678,1.0,6/16,13.42%,PDK1;PRKN;FOXK2;FOXK1;RORA;SIRT1
prerank,superoxide metabolic process (GO:0006801),0.502635187134131,1.244198413208759,0.18787878787878787,0.48756892006449,1.0,6/29,9.70%,MT3;SOD1;CYBA;PRDX2;CYBB;PRDX1
prerank,negative regulation of cell adhesion (GO:0007162),0.4436491271535714,1.2435644122061762,0.1514500537056928,0.48888489564812926,1.0,29/72,27.79%,ARHGDIA;MDK;PTPRC;ACVRL1;DSCAM;PDE3B;SPOCK1;ARHGDIB;PODXL;ARHGDIG;RHOA;JAM3;DMTN;ERBB3;LPXN;MUC1;NOTCH1;TGFB1;PTPRO;PLXND1;CD164;DUSP1;PLXNB2;TBCD;PLXNB3;CX3CL1;CORO2B;PLXNA3;ADAM22
prerank,mitochondrion transport along microtubule (GO:0047497),0.5820394728790533,1.2434183351382935,0.21066666666666667,0.48883020645919234,1.0,3/13,8.71%,UBB;NEFL;MAPT
prerank,regulation of protein localization (GO:0032880),0.4570734913013216,1.2433834396293078,0.14823008849557523,0.48846639568205374,1.0,16/58,18.87%,CTSD;RACK1;HSP90AA1;HSP90AB1;FKBP1A;PARP1;RAB14;SLC26A4;MAP2;CAMK1;FBXW7;MMD2;USP8;ADCYAP1;ATCAY;VPS4A
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5031601173758912,1.2423723473563255,0.21301775147928995,0.49074480960482736,1.0,12/29,20.94%,AGT;GPER1;TNF;HYAL2;TNFSF12;PMAIP1;CAV1;LTBR;TNFRSF12A;INHBA;SFRP1;PYCARD
prerank,positive regulation of hydrolase activity (GO:0051345),0.4285153820553885,1.2419994903007585,0.0860655737704918,0.49125428778390107,1.0,39/137,20.99%,RPS3;PSAP;RACK1;CALM1;NDUFA13;CCL19;RCN3;S100A10;CALM3;TGM2;PINK1;RHOC;PIN1;CAV2;THY1;NET1;ARHGEF7;RGS10;MTMR9;DOCK10;HRAS;RHOA;BMP2;DOCK8;MTCL1;CTSH;CCL2;F2RL1;RASGRP1;CCL3;ADCYAP1;CCL8;RASGRF1;RGS7;CALM2;AGRN;SFRP1;DOCK9;RGS6
prerank,chromatin organization (GO:0006325),-0.28602551465695547,-1.2417728099461658,0.0,0.5795185537702372,1.0,37/132,15.01%,BAZ2B;BRWD1;SETD5;BAZ2A;SETD2;HDAC4;HMG20A;EHMT1;NUDT5;KDM5B;HDAC8;ARID1A;KAT2B;JARID2;MYSM1;SMARCAD1;SMARCE1;CHD1;SMARCA5;BAZ1B;TOP1;ZBTB1;CDAN1;INO80;SETDB1;KDM5C;ESR1;MCM3AP;KDM4C;PBRM1;LRWD1;SETD7;SIRT1;KDM4D;RSF1;EZH2;EZH1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4247338864069822,1.2417055466656501,0.09257375381485249,0.4916090914473834,1.0,40/149,20.94%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;NPM1;AGT;TNF;LAMTOR5;S100A9;S100A8;HSPA1B;FLOT1;TIRAP;TFRC;UBA52;RBCK1;WNT5A;ZBTB7A;RHEBL1;HSPA1A;RIPK2;UBE2V1;CX3CR1;TLR6;CAV1;TRIM32;TERF2IP;TAB1;PSMA6;DDRGK1;RTKN2;NLRP3;TRIM13;IL6;IL1RAP;CAPN3;NFKBIA;PYCARD
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5851175421227544,1.2413775626306798,0.2083916083916084,0.4919889947416355,1.0,2/12,2.16%,NBL1;AKT1
prerank,membrane repolarization (GO:0086009),0.5573157367493637,1.2412277735281114,0.20990873533246415,0.4919113680363143,1.0,6/15,17.69%,ATP1B2;KCNE4;ATP1A1;KCNE5;ATP1B1;ATP1B3
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5780312014771756,1.2411884143871883,0.20244565217391305,0.4915626901641117,1.0,9/12,25.37%,TUBB4A;MAP2;ARHGEF7;CLIP3;STMN1;CDH5;SNCA;TBCD;MAPRE1
prerank,regulation of microtubule-based process (GO:0032886),-0.35298514953468585,-1.2406538378695942,0.09848484848484848,0.5796971853165941,1.0,10/36,14.72%,PHLDB2;EPHA3;MEMO1;MACF1;ROCK1;PRKAA2;DIAPH1;GSK3B;MARK2;TAOK1
prerank,glycerolipid catabolic process (GO:0046503),0.5341381370952996,1.2399225017046958,0.2034525277435265,0.49453771618138426,1.0,10/19,28.06%,PRDX6;LYPLA2;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;GDPD3;ABHD12;MGLL
prerank,atrial septum morphogenesis (GO:0060413),-0.492680750093374,-1.239766780804007,0.2,0.579351007745972,1.0,2/10,1.44%,NOTCH2;ACVR1
prerank,DNA double-strand break processing (GO:0000729),-0.41039808007341816,-1.2386391837898052,0.16444444444444445,0.5796627632974365,1.0,5/18,12.01%,SMARCAD1;RBBP8;SLX4;RNF138;ATM
prerank,regulation of acrosome reaction (GO:0060046),0.6087598524156,1.238540638184682,0.20857142857142857,0.49784083126243056,1.0,2/10,11.81%,PRSS37;GLRA1
prerank,vasculature development (GO:0001944),0.5549961603834406,1.2385272340554405,0.20130718954248367,0.4974276093066054,1.0,7/16,16.80%,SOX18;ACVRL1;APLNR;FLT4;FBXW7;STK11;CDH5
prerank,synapse assembly (GO:0007416),0.4453760593186456,1.2384940679949263,0.16268980477223427,0.4970866639572994,1.0,26/67,23.67%,NRXN1;SPOCK2;NLGN1;GRID2;DSCAM;ADGRL3;DNM3;GABRA2;KIRREL3;NRCAM;DNER;WNT5A;GABRB3;NRXN2;ACHE;CDK5;FGF13;GABRB2;PCDHB14;GPM6A;LRRTM3;POU4F1;PLXND1;FZD1;WNT7A;PLXNB2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5405702109907792,1.2383326077258163,0.19678714859437751,0.49704982379124696,1.0,6/18,16.24%,HSP90AA1;MSN;NELL1;PTTG1IP;ATRAID;DAB2IP
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.39843212321158844,-1.2382437298646527,0.1711229946524064,0.5780848414966814,1.0,7/22,10.54%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A;SMAD4
prerank,B cell differentiation (GO:0030183),0.46954949939810103,1.2381102963528134,0.16874292185730463,0.4972016755913658,1.0,20/46,26.79%,SLC25A5;LYL1;NFAM1;PTPRC;IL11;ZBTB7A;SYVN1;IRF2BP2;HDAC5;HDAC9;VCAM1;ADAM17;DNAJB9;FLT3;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5874025033754781,1.2379514957179965,0.2124492557510149,0.49720002301801686,1.0,4/12,14.24%,CYBA;GRIN1;ADGRB1;TLR6
prerank,response to acidic pH (GO:0010447),0.5726396240080175,1.2377690544406919,0.22146739130434784,0.49722652796458633,1.0,2/13,2.14%,CTSS;LGMN
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6062372182577096,1.2376224685189998,0.22608695652173913,0.49714486391431517,1.0,2/10,1.51%,VTN;MT3
prerank,lipid droplet formation (GO:0140042),0.6045500767109185,1.2374279935050498,0.2148997134670487,0.49722406507995465,1.0,3/10,5.09%,CDS1;AUP1;BSCL2
prerank,B cell activation (GO:0042113),0.448356948600812,1.2367413546979145,0.14715359828141783,0.4985692756846765,1.0,27/68,26.79%,SLC25A5;LYL1;NFAM1;PTPRC;HSPD1;CD22;IL11;ZBTB7A;CHRNA4;HDAC5;RASGRP1;HDAC9;VCAM1;PIK3CD;ADAM17;DNAJB9;CD86;GPR183;FLT3;MEF2C;BANK1;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,copper ion transport (GO:0006825),0.6105565343001393,1.236623984518176,0.2140845070422535,0.49843752833111576,1.0,4/11,15.43%,ATOX1;COX17;STEAP4;SLC31A1
prerank,response to estradiol (GO:0032355),-0.34899016160700125,-1.2363389550023351,0.1610738255033557,0.5803420781803478,1.0,7/31,9.87%,STRN3;EGFR;NRIP1;STAT5B;LCOR;STAT3;ESR1
prerank,chondrocyte differentiation (GO:0002062),-0.35037190273587987,-1.2363207361213517,0.14,0.57787384694758,1.0,12/32,21.54%,SULF1;NFIB;SOX5;WNT5B;EIF2AK3;CREB3L2;BMP4;RUNX2;BMPR2;GPLD1;SULF2;WNT2B
prerank,positive regulation of dendrite extension (GO:1903861),0.5412593605806916,1.2360874422899686,0.20848938826466917,0.4994253704330375,1.0,11/17,25.63%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;CPNE6;SYT2;SYT3;UNC13A;RNF157;SYT17
prerank,regulation of dendrite extension (GO:1903859),0.5359576149374539,1.2360644220095685,0.21331689272503082,0.499022691614785,1.0,11/18,25.63%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;CPNE6;SYT2;SYT3;UNC13A;RNF157;SYT17
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4767199779403959,-1.2357570189710014,0.23693379790940766,0.5768896325660989,1.0,5/12,9.89%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,hippo signaling (GO:0035329),-0.367483191354102,-1.2355107388099684,0.15168539325842698,0.5750060055956868,1.0,7/26,13.23%,TEAD1;STK3;YAP1;TEAD2;LATS2;SAV1;CASP3
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5259274705549155,1.2351543021683433,0.19590268886043533,0.5010696112776871,1.0,6/22,9.52%,MDK;NES;TAFA1;FZD9;PROX1;GATA2
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3115977737433796,-1.2344917537853641,0.08235294117647059,0.5752026485977153,1.0,25/61,19.39%,EYA2;EGFR;EYA1;BABAM2;DHX36;OTUD4;UIMC1;PARP3;RNF8;PML;EYA4;PDGFRB;EYA3;SMOC2;ERCC8;SIRT1;SMCHD1;MECP2;RTEL1;TIGAR;USP9X;ZCWPW1;FGF2;WRN;PRKD2
prerank,engulfment of apoptotic cell (GO:0043652),0.5641859846581534,1.234299266591589,0.23086900129701687,0.502900589115856,1.0,6/15,20.23%,RAC1;RHOG;XKR4;ADGRB1;RAC2;XKR6
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.42119158581942306,-1.2337734421226312,0.16908212560386474,0.5745745005750081,1.0,5/17,7.71%,BMP6;SASH1;CARD16;TRIM5;LY96
prerank,positive regulation of lipid storage (GO:0010884),0.531382964680255,1.2337109765755447,0.2018111254851229,0.5040711228276622,1.0,5/21,14.66%,C3;LPL;PLIN3;MSR1;EHD1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4737476772429276,1.2334432478518396,0.18327605956471935,0.5043214116832807,1.0,16/42,24.51%,LARS2;GARS1;SARS1;SARS2;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;PPA1;QARS1;EPRS1;AIMP2;YARS2;MARS2
prerank,maintenance of protein location in nucleus (GO:0051457),0.5327623461941873,1.2332051405018822,0.20234986945169714,0.5044728117516224,1.0,10/20,24.59%,CHCHD10;PARK7;ARL2BP;HNRNPU;ARL2;RANGAP1;SYNE1;SKP1;SUN2;BARD1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5661868765733087,1.2330497459525205,0.2182061579651941,0.5044298483370901,1.0,5/14,14.67%,AK4;AK3;SMPDL3A;NME2;CMPK2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5847068421676442,1.23290941161247,0.21823204419889503,0.5043452215667517,1.0,3/12,10.47%,HSPA5;KDELR1;RER1
prerank,response to ATP (GO:0033198),0.5374286259854871,1.2328461860651743,0.21141374837872892,0.5040470185802315,1.0,4/18,9.31%,HSP90B1;P2RX7;P2RY1;P2RY12
prerank,neuropeptide signaling pathway (GO:0007218),0.4522246829998867,1.2327488608187678,0.16198704103671707,0.5038569849134077,1.0,16/58,19.64%,SORL1;CPE;SORCS1;PENK;SSTR4;PDYN;GLRA2;PPY;SORCS3;GLRA1;NTS;SORT1;HCRTR1;ADCYAP1;GLRA3;GPR149
prerank,positive regulation of protein localization to membrane (GO:1905477),0.4270041805856996,1.2325339421509809,0.12058212058212059,0.5039552208979958,1.0,30/98,17.19%,CD81;AKT1;PRNP;ITGB2;TREM2;ANK3;GPER1;TNF;YWHAB;LGALS3;DPP10;YWHAH;YWHAE;RHOG;YWHAG;ARF6;ZDHHC5;RAMP3;PMAIP1;HRAS;YWHAQ;YWHAZ;CLIP3;MTCL1;MIEF2;BBC3;BAD;MFF;SQSTM1;PDCD5
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.51788501453847,1.2315169495054872,0.21025641025641026,0.5063139443954279,1.0,5/23,15.91%,LAMP1;LILRB1;NCR1;RASGRP1;ARRB2
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.29268304819735014,-1.2312973728197885,0.03773584905660377,0.5780737900277527,1.0,18/76,13.04%,FCHSD2;FER;ABL1;BAIAP2L1;BCAS3;PRKCE;NRP1;BAIAP2;SORBS3;NTRK3;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1;KATNBL1;SYNPO2;NUMA1
prerank,axonogenesis (GO:0007409),0.417331610559044,1.2310239714988715,0.045090180360721446,0.5071647181095387,1.0,64/237,17.53%,ACTB;BSG;S100A6;HSP90AA1;HSP90AB1;CXCL12;MAPK3;DCC;NRXN1;S100B;CTNNA2;ANK3;UNC5D;LYPLA2;MAP1A;SEMA3F;DSCAM;CNTN4;SEMA7A;NEFH;SEMA4C;SHC3;LGI1;NRXN3;DAB1;OTX2;TNR;SEMA6D;ROBO4;NRCAM;LGR6;EMB;UNC5C;CDK5R1;EPHA5;KIF5A;PAK3;B4GALT6;ADGRB1;SEMA4A;LRTM2;APBB1;WNT5A;GFRA1;DOK5;SEMA4G;SHTN1;CCK;CXCR4;IGSF9;DSCAML1;ROBO2;SPTBN4;EPHB1;CDK5;SH3KBP1;GFRA2;SPTBN2;BRSK2;PIK3CD;SLIT3;SLIT1;EFNB1;NCAM1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.44211933624459643,1.2306215585150466,0.14775160599571735,0.5078167696064315,1.0,31/78,27.26%,ACTB;AKT1;CCNI;CCND2;PDGFB;SERTAD1;CDKN1C;CCND1;CEBPA;PROX1;CDK5R1;CDC37;CCNG1;CDK5R2;HEXIM1;MAPRE3;ADAM17;CCNJL;CDC25A;TFAP4;GADD45A;MEN1;BLM;CCNA2;CDKN2B;CCNG2;HHEX;PSMD10;CCNH;CDKN1A;CNPPD1
prerank,telomere maintenance via telomerase (GO:0007004),0.5033806611251855,1.230611586110761,0.19706242350061198,0.5073839871471105,1.0,9/28,19.74%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4870905717155713,1.23012010236822,0.20048309178743962,0.508170239193986,1.0,9/33,17.48%,AKT1;AGT;GPER1;PTK6;HAP1;FBXW7;CCDC88A;NCF1;ADAM17
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3373080946995679,-1.2296165871067941,0.14,0.57975847313926,1.0,16/44,14.11%,ROCK2;ABL1;LPAR1;PPM1E;NRP1;SORBS3;ARHGEF10L;CARMIL1;TGFBR1;PXN;TPM1;RAPGEF3;FERMT2;NF2;WNT11;TGFB3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.41212595771537136,1.2284939568216484,0.04504504504504504,0.5121097643460003,1.0,68/291,16.24%,ACTB;RPS3;VIM;MT3;NDUFA13;MAPK3;AKT1;PDE4B;AKAP6;TGM2;PRDX5;LAMTOR2;GPER1;LAMTOR4;HSP90B1;PDGFB;LAMTOR5;ROMO1;NR1D1;IGFBP5;ZFP36L1;TIRAP;SIRPA;CD180;VCP;LTK;TNFAIP3;DRD5;BRINP3;CCR5;PTK6;P2RY6;P2RX7;CXCL10;AQP1;MAPT;LPL;P2RY1;EGR1;P2RY12;TICAM2;JUN;CD68;HMGB1;ZFP36;CHMP5;BRINP1;WNT5A;MMP3;GLRA2;RAMP3;GLRA1;BRINP2;SNW1;SOX9;RHOA;LILRB1;LAMTOR3;WNT10B;CX3CR1;CCL2;PF4;RRAGC;HCN1;NCF1;RRAGD;DMTN;DAB2IP
prerank,camera-type eye morphogenesis (GO:0048593),-0.4978769736366917,-1.2283758565875424,0.23214285714285715,0.5804974352775828,1.0,5/10,16.91%,SHROOM2;SKI;LRP6;IFT122;NF1
prerank,positive regulation of cell cycle (GO:0045787),0.44824839475667183,1.227865119908957,0.16901408450704225,0.5133420494381409,1.0,19/62,20.01%,RPS15A;CALR;LGMN;AKT1;CCND2;PDGFB;DUSP3;CCND1;PTK6;PROX1;NUPR1;MAPRE3;NUDT16;TRIM32;ADAM17;ASNS;USP22;RAD23A;CITED2
prerank,regulation of stem cell differentiation (GO:2000736),0.4307461255684644,1.22734400074846,0.1549738219895288,0.514296594691083,1.0,35/89,25.42%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;ZFP36L2;PSMD6;HES1;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;HNRNPU;PSMB1;PSMB5;LMO1;PSMA6;ESRRB;NOTCH1;PSMA4;PUS7;PSMC1;PTN;PSMD9;METTL3;TCF3;PSMB2;PSMD4
prerank,mitochondrion organization (GO:0007005),0.41654837099094816,1.2273250556750854,0.10595358224016145,0.5138935429687989,1.0,38/165,18.30%,CHCHD10;TSPO;ATP5F1B;ATP5F1D;CHCHD2;TIMM8B;TIMM13;PARK7;TOMM5;TOMM7;HIGD2A;PINK1;COX7A2L;SLC25A4;COX7A2;CAV2;PARP1;AIP;TIMM10B;DNM3;OMA1;BNIP3L;HSPD1;HIGD1B;HAP1;BAX;GDAP1;TMEM70;TIMM50;MIEF2;SPG7;MFF;ATAD3A;BCAP31;DNM1L;PPARGC1A;FMC1;ATCAY
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4360994122772676,1.2268581597492423,0.14360587002096437,0.5147126750248424,1.0,20/76,16.46%,GRM5;TGM2;AGT;C5AR1;GNA11;DRD5;P2RY6;TACR1;HTR2C;P2RY1;P2RY12;GRM1;GPR18;CHRM2;GRPR;CX3CR1;F2RL1;ADRA1D;ADRA1A;CCKBR
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3640513284832111,-1.2266954053374537,0.13690476190476192,0.5822194087289726,1.0,13/30,23.30%,TRIP12;UBR5;SHLD1;RNF169;FBH1;CYREN;FANCB;CGAS;SMCHD1;RMI2;SHLD2;SHLD3;POLQ
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5740755257312113,1.2266221360348724,0.2175732217573222,0.5149068515724944,1.0,3/12,5.31%,APOD;NDRG4;IFT20
prerank,protein localization to nucleus (GO:0034504),0.4289151922895926,1.2262982397235818,0.13111342351716962,0.5153272145785038,1.0,24/102,18.25%,RPL11;CHCHD10;CALR;COL1A1;AKT1;RAN;ARL2BP;FAM53C;YWHAE;CTDNEP1;PTTG1IP;MSX1;ZBTB7A;IPO4;HNRNPU;NUP85;ARL2;NUP88;LMNA;SPRN;EIF4ENIF1;SYK;NOP53;NUP50
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5546516826260834,1.2262328614870448,0.2318840579710145,0.5150301251850965,1.0,4/16,15.47%,PNPLA2;CTDNEP1;MFSD2A;NR1H2
prerank,eosinophil migration (GO:0072677),0.5695945495133041,1.2257778694184351,0.23097463284379172,0.5153677697444281,1.0,7/14,29.89%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13
prerank,eosinophil chemotaxis (GO:0048245),0.5695945495133041,1.2257778694184351,0.23097463284379172,0.5153677697444281,1.0,7/14,29.89%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13
prerank,mesenchymal cell differentiation (GO:0048762),-0.3182113138061704,-1.2252217703620438,0.09482758620689655,0.5837809210285726,1.0,11/51,8.39%,ROCK2;RANBP3L;TGFBR3;FBXL17;ROCK1;LRP6;LIMS1;TGFBR1;DLG5;LOXL3;FGFR2
prerank,positive regulation of immune effector process (GO:0002699),0.49588366355096486,1.224877644604185,0.20326223337515684,0.5173176325056035,1.0,4/27,8.64%,RPS19;CD81;PTPRC;IL2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4915638712254268,1.224366295490249,0.20334928229665072,0.5182551453852798,1.0,7/32,9.13%,APOE;C3;AKT1;GPER1;MID1IP1;HSD17B13;MLXIPL
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5524111620625038,1.2243275914801053,0.24254215304798962,0.5178893585887123,1.0,4/16,15.99%,TYROBP;VSIR;LILRB1;DLL1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4420449582140939,1.2238564163361054,0.1583949313621964,0.5186874236481871,1.0,21/73,21.58%,ACTB;GPX1;H3-3A;POLR2E;POLR2F;SPI1;POLR1B;CREBZF;DEK;WBP2;POLR2K;HDAC5;IGF2;KDM1B;DNMT3B;ERCC6;TBP;POLR1H;SPHK2;POLR2H;PHF1
prerank,nucleotide catabolic process (GO:0009166),0.5511346299961735,1.2230436718923297,0.2438391699092088,0.5204298583987825,1.0,5/16,11.48%,GPX1;VCP;DNPH1;NUDT3;PNP
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4881602602660744,1.2230330396885116,0.1955241460541814,0.5200035365161343,1.0,11/33,16.75%,APOE;ACVRL1;CORO1C;VASH1;DCN;EPPK1;ADGRB1;PTPRR;DAB2IP;DNAJA4;PFN2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.42700201140643623,-1.2229999615570328,0.2125,0.5868502377190293,1.0,3/16,3.19%,SOX5;DHX36;HOXB4
prerank,arachidonic acid metabolic process (GO:0019369),0.4783590016985506,1.2224026223224382,0.20521945432977462,0.5212458950464101,1.0,3/35,1.19%,GPX4;PTGDS;GPX1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5038305731483169,1.2223783945296602,0.22592592592592592,0.520861245809023,1.0,11/25,26.21%,AKAP6;GPER1;APLNR;THY1;CXCL10;RAMP3;TRPC1;SNCA;CAPN3;F2RL3;CX3CL1
prerank,regulation of potassium ion transport (GO:0043266),0.48794940883824583,1.2220630288677943,0.21856639247943596,0.5212762398512633,1.0,8/31,15.36%,CD63;KCNIP4;ANK3;DPP10;DPP6;KCNN2;KCNE5;KCNIP1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6058282770833917,1.2218924889834506,0.24585635359116023,0.5212731335314532,1.0,7/10,27.39%,JUN;HSPA1A;DNAJB1;VHL;CITED2;SIRT2;HIF1AN
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5225127546831151,1.2216245953081952,0.21375,0.5215429546491418,1.0,10/21,21.84%,RACK1;MLXIPL;CNKSR3;INPP5J;NLRP2B;DMTN;CAV1;DDIT4;GADD45A;PPM1F
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4409890431796156,1.2216050413349682,0.15817409766454352,0.5211424509342658,1.0,19/76,21.15%,TMSB4X;SPI1;TNFAIP3;ADORA3;OTULIN;RBCK1;KLF4;NLRP2B;ERBIN;TRAF3;G3BP2;ARRB2;DAB2IP;TCEAL7;COMMD7;NLRP3;NFKBIA;PYCARD;DDIT3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5850039914994304,1.2215602830529166,0.2443820224719101,0.5208018724702818,1.0,4/11,18.23%,NCL;PIH1D1;DDX11;NOP53
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5824352300258221,1.2214577631936743,0.2298050139275766,0.5206174350757287,1.0,5/12,21.09%,PODXL;BASP1;CD24;PROM1;PTPRO
prerank,neuron projection fasciculation (GO:0106030),0.6048215727704314,1.2212039967284125,0.24963924963924963,0.5208488792474819,1.0,4/10,9.33%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,protein import into mitochondrial matrix (GO:0030150),0.5352909026438837,1.2209641856991904,0.23096774193548386,0.5210402578654065,1.0,5/18,14.02%,ROMO1;DNLZ;TOMM40L;TIMM50;TOMM20L
prerank,negative regulation of response to wounding (GO:1903035),0.5199583694023321,1.2207468216214776,0.21231979030144169,0.5211680665236201,1.0,4/19,9.80%,MDK;CERS2;KLK8;EPPK1
prerank,protein insertion into membrane (GO:0051205),0.4881519812255069,1.2204607750949932,0.19207683073229292,0.5214582440412386,1.0,12/32,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;SEC61G;VAMP2;SERP1;SGTA;TRAM1L1;VAPA;TRAM1;CYB5A
prerank,regulation of cellular respiration (GO:0043457),0.5478671424598623,1.2201984139242485,0.22715404699738903,0.5216940493329285,1.0,10/17,30.36%,VCP;NOS2;NOP53;PRELID1;IL10RB;SHMT2;PNPT1;IDE;IFNAR1;IFNLR1
prerank,phagosome acidification (GO:0090383),0.5053342882162842,1.22005372460247,0.21628189550425272,0.521640990386094,1.0,9/26,23.58%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5393173751037655,1.2199156291441426,0.2388818297331639,0.5215586144216093,1.0,3/17,8.53%,CD74;MIF;PTTG1IP
prerank,negative regulation of cell communication (GO:0010648),0.5210228482258634,1.219690225376042,0.23220973782771537,0.5216963365673947,1.0,9/21,23.07%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;ERBB3;SRMS;BRAP;PTPN1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.43205438691971587,1.2195090758534428,0.1650893796004206,0.5217306483712908,1.0,36/88,26.27%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;FBXL14;PSMD5;RBX1;FBXO27;PSMB9;PSMD13;PSMB3;FBXW5;PSMB11;FBXW7;FBXO31;PSMB10;PSMB1;PSMB5;PSMA6;FBXL16;SKP1;PSMA4;PSMC1;PSMD9;FBXO2;FBXL3;PSMB2;PSMD4;PSMD10;CUL2
prerank,regulation of mitotic cell cycle (GO:0007346),0.4119888124938313,1.21948513161068,0.10976837865055387,0.5213349675054292,1.0,66/171,26.73%,PSMB4;PSME1;LGMN;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PIN1;CAV2;PSMC3;DUSP3;PSMD6;CDKN1C;BTG1;BRINP3;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;GAS1;BRINP1;BUB3;PSMB3;PSMB11;BRINP2;FBXO5;PSMB10;RNF40;HNRNPU;SDCBP;L3MBTL1;PSMB1;PSMB5;PIM3;ASNS;USP22;BTG4;PSMA6;TGFB1;DYNLT3;SKP1;PSMA4;TFAP4;ASAH2;CDK9;FOXA1;CCDC8;PSMC1;FZR1;PSMD9;MEIS2;CDK10;INTS13;APP;RCC1;CDC20;PSMB2;PRKCA;XPC;KIF20B;PSMD4;PSMD10;CDK11B;ERCC2
prerank,zinc ion transport (GO:0006829),0.5191706357748949,1.2194719840408872,0.2206266318537859,0.5209265711769039,1.0,5/21,11.56%,MT3;SLC30A1;SLC39A1;SLC39A7;TRPM2
prerank,collagen fibril organization (GO:0030199),-0.2842103031030407,-1.219369446329971,0.05,0.5934980869115264,1.0,24/88,9.97%,COL5A2;COL22A1;COL4A3;COL5A1;COL8A1;COL4A5;PLOD2;ADAMTS2;COL4A6;COL25A1;COL13A1;LOXL1;COL26A1;TLL1;COL12A1;COL27A1;TGFBR1;PXDN;ATP7A;COL4A4;LOXL3;COL11A1;COL8A2;ITGB4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4600971779664616,-1.2193597219424568,0.2007168458781362,0.5910789833609325,1.0,8/12,30.84%,MAD1L1;CENPC;CENPE;NDC80;MIS12;NUF2;RMDN1;KIF2C
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5193223313584273,1.2192158806383833,0.22950819672131148,0.521146353277464,1.0,10/21,19.10%,CALM1;AKAP6;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;SRI;FKBP1B;CALM2
prerank,negative regulation of signaling (GO:0023057),0.5032501421054018,1.2189343985013565,0.2210144927536232,0.5214159118882477,1.0,11/25,23.07%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;ERBB3;SRMS;TRAT1;BRAP;AP1AR;PTPN1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5369065025198,1.2189275816734921,0.23536895674300254,0.5209859491826943,1.0,9/17,20.17%,NELL1;ATRAID;TMEM119;SOX8;RHOA;BMP2;TNN;HPSE;SFRP1
prerank,positive regulation of apoptotic process (GO:0043065),0.40955286808057084,1.2184402560833922,0.04904904904904905,0.5218192888460419,1.0,89/293,21.46%,RPS3;MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;GRN;SOD1;RHOB;ATF4;RPS6;PRNP;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;TLE5;CTNNB1;BTG1;OMA1;UBA52;BNIP3L;ARHGEF4;FOXL2;HSPD1;CSRNP3;NUPR1;NET1;CDK5R1;RRP1B;JUN;HMGB1;ARHGEF7;SMPD1;APBB1;DNAJA1;BAX;PMAIP1;PNMA2;TCTN3;CTLA4;MCF2L;VAV1;LILRB1;BMP2;WNT10B;CLIP3;NLRP2B;SFRP4;VAV3;ABR;TIAM1;BAD;DLC1;CDK5;DAB2IP;CCL3;BACE1;SQSTM1;PSEN2;DNM1L;PDCD5;SCIN;APH1B;KCNMA1;TNFRSF12A;ARHGEF19;CCAR2;SNCA;SOS1;TFAP2B;IL6;KLF11;ING5;SFRP1;SPHK2;TFAP4;BAK1;PYCARD;GADD45A;DDIT3;FOXA1;SIRT2;SUDS3
prerank,regulation of cellular protein localization (GO:1903827),0.45910896221054615,1.218095613085232,0.20344827586206896,0.522337703880863,1.0,13/45,11.05%,HSP90AA1;HSP90AB1;MAP1A;PIN1;PARP1;CTNNB1;VCP;MAPT;MAP2;LCP1;ATP13A2;SUMO3;GPC5
prerank,ureteric bud development (GO:0001657),-0.41537877838849724,-1.217958111630541,0.244,0.5923004271636598,1.0,6/17,13.72%,GPC3;SLIT2;FGFR2;SIX1;WNT11;BMP4
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4798458452596277,1.2178180975773598,0.21785714285714286,0.5226453022088149,1.0,8/34,16.26%,MT1G;RAMP2;HSPB1;KDR;GAS1;FLT4;DAB2IP;FLT1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4790155353977056,-1.2177568735758388,0.19,0.5903399654100159,1.0,5/11,14.92%,BMPR1A;ZFPM2;JAG1;BMP4;HEY2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.35001761269001824,-1.2175478313034822,0.1411042944785276,0.5885012035524958,1.0,9/30,11.01%,GOLGA4;VAMP5;MACF1;SPTBN1;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4504009016182324,1.2175446254779867,0.18584070796460178,0.5229332297457325,1.0,19/57,21.42%,CHCHD10;PARK7;TREM2;PINK1;GPER1;KDR;DCN;BAX;PMAIP1;MIEF2;BBC3;BAD;MFF;DNM1L;PDCD5;PPARGC1A;BAK1;PYCARD;FIS1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.43599354217578523,1.2171218711473255,0.16631578947368422,0.523585745056938,1.0,22/75,17.48%,MDK;HMOX1;AKT1;PDGFB;ANG;ECM1;APLNR;EMC10;PROX1;KDR;TNFSF12;JCAD;GATA2;HMGB1;PDCD6;WNT5A;FLT4;BMP2;IGF2;EGFL7;PIK3CD;ADAM17
prerank,positive regulation of protein polymerization (GO:0032273),0.44357861066615467,1.2168981923143851,0.17433155080213902,0.5237253048336241,1.0,13/65,9.84%,RPS3;HSP90AA1;TPPP3;PINK1;RAC1;PFN1;NAV3;PAK1;CLASP1;MAPT;ARF6;CDK5R1;HCK
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5556995813802552,1.2166932647289428,0.23283983849259757,0.5238164745878048,1.0,10/15,31.70%,SRP14;SEC61G;SPCS1;SEC61A1;SPCS2;RYR2;ZFAND2B;SRPRB;SRPRA;SPCS3
prerank,Notch signaling involved in heart development (GO:0061314),-0.4751631577019124,-1.2165089987619375,0.19732441471571907,0.5886420198851465,1.0,5/11,14.92%,NOTCH2;GALNT11;RBPJ;JAG1;HEY2
prerank,regulation of protein phosphorylation (GO:0001932),0.40946593068385456,1.2159209158402489,0.06312625250501001,0.5254876644135567,1.0,62/256,15.65%,PPIA;CD74;RACK1;HSP90AA1;HSPB1;GPNMB;MT3;PARK7;SOD1;C3;MAPK3;ATF4;AKT1;FKBP8;PRNP;ITGB2;CCND2;TREM2;GRM5;ERBB4;NPM1;PINK1;IGFBP3;PPP1R15B;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;PRR5L;KNDC1;SIRPA;SH3GL2;RARRES2;MYADM;FN1;MUSK;TFRC;CCND1;CEBPB;CORO1C;PAK1;KDR;P2RY1;CADM4;TARDBP;CSF1R;PECAM1;WARS1;FLT4;HRAS;TMEM119;SOX9;BMP2;GAS6;CLIP3;CCDC88A;IGF2;PDGFA;RASGRP1;SPTBN4
prerank,stem cell development (GO:0048864),0.5355250788775824,1.2158705950639352,0.25066666666666665,0.5251677571303189,1.0,10/16,32.28%,NRG1;PTPRC;PDCD6;SOX8;SOX11;WNT7A;NOLC1;KBTBD8;CDH2;SHH
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5129826209494264,1.215789672959797,0.23514538558786346,0.5249419676941988,1.0,4/22,12.65%,MDK;IL2;VSIR;CTLA4
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3033795811497284,-1.2157211522294642,0.125,0.588234353106997,1.0,25/85,12.69%,AKAP13;NOTCH2;PLCE1;DENND4A;ARHGAP17;KANK2;DENND4C;MAPKAP1;OGT;EPS8;ARHGEF18;RAF1;SHOC2;STARD13;DENND1A;RAPGEF1;BCR;IGF1;KANK1;NGF;EPHB2;OPHN1;MYO9B;DENND3;ARHGEF2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4838707698102321,1.215461565212201,0.23501762632197415,0.5249172741662657,1.0,10/29,23.49%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4838707698102321,1.215461565212201,0.23501762632197415,0.5249172741662657,1.0,10/29,23.49%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,acute-phase response (GO:0006953),0.5758976678766151,1.215394279967071,0.24369747899159663,0.5246584092829235,1.0,5/12,24.75%,MBL2;CEBPB;SIGIRR;IL6;LBP
prerank,negative regulation of hydrolase activity (GO:0051346),0.45046712258663013,1.2151566951048172,0.20044296788482835,0.524795283865395,1.0,12/49,16.24%,CST3;ECM1;ATP5IF1;CSTB;TMED2;MAP2;RRP1B;NEIL1;HRAS;PPP1R35;ARL2;DAB2IP
prerank,vacuolar acidification (GO:0007035),0.5239497692916562,1.2150938635910586,0.23625,0.5245212954066641,1.0,7/21,12.96%,GRN;ATP6V0E2;ATP6V0D2;ATP6AP2;SLC11A1;CLN5;CLN6
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.35831690796551885,-1.2141150717324483,0.16981132075471697,0.5896880113342472,1.0,9/32,15.37%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;ATM;TAOK1;CLSPN
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42145497598652276,1.2138513583110646,0.13963039014373715,0.5274707127503009,1.0,23/100,14.29%,RPL11;CLU;RACK1;GABARAP;ELOB;HSP90AB1;PARK7;UBXN1;MAP1A;HSPA1B;VCP;BAG5;FOXF2;USP5;CEBPA;RBX1;XPO1;TAF9;SUMO2;DNAJB2;HSPA1A;HSPBP1;SDCBP
prerank,regulation of endocytosis (GO:0030100),0.4478099969580701,1.2138044948173712,0.18695652173913044,0.5271455316466138,1.0,17/61,17.07%,APOE;CD151;CCL19;SNX17;LGALS3;PACSIN1;FLOT1;LRPAP1;SYT11;CD22;AP2S1;SMPD1;LILRB1;CLIP3;DLL1;SNX33;RAB5C
prerank,positive regulation of protein metabolic process (GO:0051247),0.4232437803923881,1.213773851150277,0.14891416752843847,0.5267781330512563,1.0,32/110,20.79%,APOE;CLU;NDUFA13;AKT1;KLF2;OAZ1;AGT;TNF;SORL1;VCP;TNFAIP3;TNFSF12;DDB1;WNT5A;WFS1;VPS28;KLF4;PRMT1;EGLN2;ABCB10;NR1H2;RASGRP1;ABCA2;DAB2IP;TRIM32;CD86;INHBA;HECW1;TGFB1;OAZ2;SLC25A37;NFKBIA
prerank,regulation of cell size (GO:0008361),0.5047945550943665,1.2136382454870893,0.23485784919653893,0.5266759657824005,1.0,8/23,18.36%,LAMTOR4;LAMTOR5;RAC1;MSN;VAV1;RHOA;VAV3;AKT1S1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4741704604140603,1.213035337967288,0.2047244094488189,0.5277669925096955,1.0,11/39,16.80%,RAMP2;GPER1;TNF;TNFAIP3;KDR;GATA2;ECSCR;IL11;GAS6;CCL2;CDH5
prerank,regulation of organelle assembly (GO:1902115),-0.2930492506649834,-1.2127733058263948,0.16393442622950818,0.5906323189733645,1.0,15/72,8.13%,ALMS1;DCDC2;CEP295;PDCD6IP;MTMR3;SENP6;ATXN2;TBC1D19;USP6NL;TBC1D12;STX18;TBC1D2B;RABGAP1;TBC1D9B;IFT88
prerank,regulation of angiogenesis (GO:0045765),0.41284704978870745,1.212572523100043,0.0763819095477387,0.5285665817793211,1.0,53/192,18.30%,SPARC;CLDN5;RAMP2;HSPB1;GRN;GPNMB;HMOX1;RHOB;SERPINF1;CD34;EMP2;ECM1;CTNNB1;APLNR;PDE3B;ADAM12;TNFAIP3;EMC10;BTG1;PGK1;HIPK2;GLUL;VASH1;KDR;CXCL10;AQP1;TNFSF12;SARS1;GATA2;DCN;ADGRB1;ECSCR;NINJ1;STAB1;RNH1;PDCD6;WNT5A;WARS1;KLF4;TIE1;CTSH;RRAS;PF4;DAB2IP;FLT1;GATA4;AMOT;CDH5;PIK3CD;TWIST1;AGO1;ADAMTS1;CCR2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.42463738672537615,1.212488581021807,0.12321792260692464,0.5283443090557252,1.0,37/107,21.40%,HSPA5;ATF4;RCN3;PPP1R15B;HSP90B1;FLOT1;VCP;CEBPB;P4HB;PDIA3;TMCO1;UFC1;SELENOK;JUN;BAX;WFS1;SYVN1;BBC3;UBXN6;ERO1A;DAB2IP;HERPUD1;BCAP31;BRSK2;RASGRF1;PPP1R15A;DNAJB9;EIF2B5;DNAJC10;PDIA4;DDRGK1;TMEM259;TMEM33;BAK1;DDIT3;HYOU1;SELENOS
prerank,purine ribonucleotide transport (GO:0015868),0.5361163983682823,1.212032443694416,0.23285899094437257,0.5290945613086024,1.0,3/16,13.31%,LRRC8A;SLC25A4;SLC19A1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.46226987196275443,1.2118394487883726,0.19932049830124576,0.5291594442716461,1.0,16/42,31.16%,CXCL12;CCL19;CXCL10;CCL2;PF4;CCL3;CCL8;CCR2;THPO;OXSR1;CX3CL1;PPBP;CCL13;CCL14;GPR35;ACKR3
prerank,protein ADP-ribosylation (GO:0006471),-0.3681440544689811,-1.2118336358481459,0.17365269461077845,0.5905956523609202,1.0,9/28,15.22%,PARP4;PARP9;PARP12;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,protein polymerization (GO:0051258),0.4558393382629853,1.2116584315550112,0.1796276013143483,0.5292095008654553,1.0,11/55,13.12%,GPX4;GSN;TPPP3;RAC1;MID1IP1;ANG;PIN1;FAM107A;MAPT;AIF1;MSRB1
prerank,regulation of transposition (GO:0010528),-0.44815069682083064,-1.211342993185343,0.21839080459770116,0.5893832036432487,1.0,4/13,16.08%,UBR2;MYBL1;TEX15;SIRT7
prerank,positive regulation of viral transcription (GO:0050434),0.4976396098196346,1.2111637670527289,0.2273838630806846,0.5300625165918024,1.0,10/25,21.24%,POLR2E;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;POLR2K;NELFE;POLR2H;CDK9
prerank,regulation of catecholamine secretion (GO:0050433),0.49169748361001947,1.2105812320501634,0.20186697782963828,0.531143463429138,1.0,15/29,25.63%,SYT1;SYT12;SYT11;SYT6;SYT4;CHGA;KCNA2;CHRNA4;SYT10;SYT2;SNCA;GRK2;SYT3;SYT5;SYT17
prerank,inflammatory response (GO:0006954),0.4087756344953367,1.2105018063295938,0.0914572864321608,0.5309217779574265,1.0,54/195,20.09%,CCL19;CYBA;ITGB2;PRDX5;NFAM1;TAC1;TNF;RAC1;C5AR1;S100A9;S100A8;CYBB;ADORA3;CEBPB;CCR5;HNRNPA0;CXCL10;TACR1;CRH;SIGLEC1;HMGB1;TUSC2;AOC3;CSF1R;AIF1;SLC11A1;BMP2;RIPK2;CXCR4;TNFRSF1A;HDAC5;KLRG1;TLR6;CCL2;PF4;TLR5;FOLR2;HPR;HP;TLR1;ADCY8;CCL3;HDAC9;PIK3CD;PTGIR;NOS2;CCL8;CCR2;CD14;NLRP3;IL6;HSPG2;TGFB1;IL10RB
prerank,positive regulation of cell migration (GO:0030335),0.4068194704500314,1.2103900378292498,0.06018054162487462,0.5307762478280126,1.0,73/253,19.83%,ACTG1;RACK1;VTN;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;S100A11;HSPA5;GPER1;RHOC;SEMA3F;PDGFB;PTPRC;SEMA7A;RTN4;SEMA4C;MYADM;PFN1;FN1;FAM107A;CXCL16;SEMA6D;ENPP2;PAK1;PODXL;CLASP1;KDR;VSIR;LGR6;LAMC2;ARHGEF7;SEMA4A;CSF1R;PECAM1;ELP3;HRAS;AIF1;SOX9;SEMA4G;SHTN1;BMP2;FBXO5;CTSH;SDCBP;TIAM1;F2RL1;PDGFA;DMTN;DAB2IP;FLT1;CCL3;CAV1;PLAU;CDH5;CASS4;PIK3CD;TRIM32;F10;MMP14;ADAM17;DDR2;CCR2;MAZ;NSMF;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;TGFB1
prerank,cellular response to acid chemical (GO:0071229),0.501614817014193,1.2102682670062765,0.22399020807833536,0.5306627151631096,1.0,10/27,18.74%,KLF2;LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,regulation of myoblast fusion (GO:1901739),0.5752455231079007,1.2097994628566942,0.26068965517241377,0.5314173880290426,1.0,6/11,18.67%,FLOT1;CD53;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.49450613455439163,-1.2096460208378725,0.22180451127819548,0.5911536118624353,1.0,4/10,16.18%,CAMK2D;PRKCE;HECW2;STK39
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4594069627308269,1.2091971926319005,0.18853362734288864,0.5325666457694316,1.0,11/48,12.82%,ACTB;POLR2E;ELOF1;POLR2F;SERTAD1;POLR1B;H1-0;DEK;WBP2;ZMIZ2;POLR2K
prerank,import into nucleus (GO:0051170),0.4339775644456396,1.2084653885540948,0.17363344051446947,0.5340835098295383,1.0,19/73,18.55%,SNRPG;AKT1;GEMIN7;RAN;SNRPD2;SNRPE;FAM53C;SNRPF;PTTG1IP;IPO4;NUP85;HNRNPA1;SNRPB;NUP88;SPRN;EIF4ENIF1;SYK;NUP50;SNRPD3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44420317879820803,1.2076107935550187,0.18151447661469933,0.5359402803372214,1.0,15/52,15.07%,TOMM7;PINK1;YWHAB;UBL5;YWHAH;YWHAE;LEPROT;YWHAG;PMAIP1;YWHAQ;FBXW7;YWHAZ;RHOU;BBC3;BAD
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.47532212780438127,1.2075032856396728,0.2088167053364269,0.5357912900061352,1.0,14/38,24.36%,RACK1;AKT1;GPER1;HYAL2;SFRP5;PDCD6;PHLPP1;ARRB2;NOP53;THEM4;DDIT3;BANK1;PHLDA3;PLEKHA1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5457187197774268,1.2069947135027375,0.24563758389261744,0.5367483588929411,1.0,7/15,17.69%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3
prerank,negative regulation of defense response (GO:0031348),0.4326436170951964,1.206862416236031,0.17391304347826086,0.5366353683984527,1.0,21/77,23.80%,APOE;GPER1;NR1D1;LRFN5;SIRPA;TNFAIP3;FEM1A;OTULIN;KLF4;TNFRSF1A;FNDC4;TYRO3;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;C1QBP;PCBP2;TEK
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.46976749790450734,-1.2061562366761598,0.2125984251968504,0.5978979814431103,1.0,4/11,15.02%,CLK2;SIK1;C1QTNF3;CRY1
prerank,secretory granule organization (GO:0033363),0.5947341279959175,1.2059904996764736,0.24551724137931036,0.5385202246357036,1.0,6/10,24.34%,BLOC1S1;SRGN;BLOC1S3;BLOC1S2;LYST;F2RL3
prerank,proteasome assembly (GO:0043248),0.5828484443596428,1.2057041459494877,0.26825842696629215,0.5388099959473053,1.0,7/11,26.19%,POMP;PSMD5;PSMD13;OTUD6B;PSMD9;PSMD4;PSMD10
prerank,plasma membrane invagination (GO:0099024),0.4846139613457228,1.2054134969735295,0.2243667068757539,0.5390807147575734,1.0,9/29,16.40%,GSN;ITGB2;ARHGAP25;ELMO1;FCGR1A;MSR1;AIF1;RHOA;SNX33
prerank,glucose import (GO:0046323),0.5692657476884744,1.204975742916011,0.2639455782312925,0.539796311772097,1.0,3/13,18.03%,SLC2A1;SORT1;SLC2A3
prerank,negative regulation of cellular senescence (GO:2000773),-0.4550530655993481,-1.2047049633392697,0.23018867924528302,0.5992041270440934,1.0,7/13,13.42%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,somite development (GO:0061053),-0.4829148050924199,-1.204649223374817,0.23174603174603176,0.5970402335514904,1.0,6/11,25.52%,SMO;MEOX2;LOXL3;PPP2R3A;PTCH1;MTHFD1
prerank,apical protein localization (GO:0045176),0.6018064773766071,1.2044890186899144,0.24339360222531292,0.5406542040155924,1.0,2/10,5.26%,ACTB;MAL
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.52058961292782,1.203888117826802,0.2402088772845953,0.5418384776804076,1.0,6/19,16.24%,CD63;CADM4;JCAD;DCN;DLL1;DAB2IP
prerank,protein localization to mitochondrion (GO:0070585),0.5831598604474506,1.2038839347344057,0.2678062678062678,0.5414072687389405,1.0,4/11,11.32%,AKT1;PINK1;ISG15;DNAJA1
prerank,embryonic digestive tract development (GO:0048566),-0.4095351347823292,-1.2035488174343252,0.22362869198312235,0.5975120706306147,1.0,6/18,8.39%,RARB;GLI3;GLI2;NIPBL;PCSK5;FGFR2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.42649015906209764,1.2034418052659874,0.16736401673640167,0.5421378682415378,1.0,31/93,19.98%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;MLXIPL;CAMK1;IL11;RAMP3;SH2D3C;CNKSR3;RIPK2;INPP5J;GAS6;NLRP2B;SPTBN4;DMTN;CAV1;PFN2;TERF2IP;SNCA;IL6;TGFB1;DDIT4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.510499225835014,1.2033496917557054,0.24436090225563908,0.5419425261773799,1.0,5/22,15.32%,ATF4;NCL;PIH1D1;DDX11;UBTF
prerank,regulation of cellular component size (GO:0032535),0.4858974285757419,1.2032458025424608,0.2215568862275449,0.5417804198663903,1.0,9/30,14.14%,PPP1CA;LAMTOR4;LAMTOR5;RAC1;AP2M1;MSN;ATP13A2;VAV1;VAV3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4322142930945108,1.203172603085271,0.17967914438502675,0.5415351639046011,1.0,12/73,8.71%,MTCH1;RACK1;LAPTM5;RPS27L;HSPE1;TNF;S100A9;S100A8;VCP;BEX3;HSPD1;MAPT
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5977803103516877,1.2030820075877908,0.25761772853185594,0.5413448097829237,1.0,6/10,24.96%,HSPA5;ATF4;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.46246440099749025,1.2020730953631458,0.2198830409356725,0.543633946141722,1.0,6/37,6.77%,APOD;TREM2;TNF;PLD3;SIRPA;CUEDC2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5193349980687714,1.2020315149227667,0.24469413233458176,0.5433053583290441,1.0,7/20,19.95%,PARK7;LAMTOR5;H1-0;TWIST1;DDRGK1;TGFB1;POU4F1
prerank,carboxylic acid transport (GO:0046942),0.44718622660516877,1.2015688148782235,0.19716775599128541,0.5441429087832725,1.0,10/55,12.43%,PSAP;SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC15A4;SLC3A2;SLC1A1
prerank,endothelial cell proliferation (GO:0001935),0.5215237535674504,1.2015260258441105,0.24484181568088034,0.5438056561435544,1.0,3/17,4.15%,HMOX1;CD34;ACVRL1
prerank,smooth muscle cell differentiation (GO:0051145),0.5613966263246017,1.2014961346352249,0.25603217158176944,0.5434394267188566,1.0,5/12,20.07%,MRTFA;APLNR;HEY1;TMEM204;MEF2C
prerank,secondary palate development (GO:0062009),-0.437779797273393,-1.2008189066359936,0.1970260223048327,0.6020183168114175,1.0,5/14,14.11%,TGFBR3;SMAD4;WNT11;SMAD2;TGFB3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4331372106669738,1.2005124506560565,0.20042872454448016,0.5456496604121421,1.0,23/73,19.83%,HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;CAMK1;IL11;RAMP3;SH2D3C;RIPK2;GAS6;CAV1;PFN2;TERF2IP;SNCA;IL6;TGFB1
prerank,ear morphogenesis (GO:0042471),-0.3933851304022884,-1.2002641045689402,0.19004524886877827,0.6011788748158935,1.0,5/20,13.03%,NIPBL;FGFR2;EPHB2;ZIC1;SIX1
prerank,regulation of multicellular organismal development (GO:2000026),-0.3619395531337274,-1.2001677223853104,0.16393442622950818,0.5991494445801547,1.0,7/25,8.98%,TRIP12;NIPBL;DHX36;EHMT1;MYSM1;INSR;TDG
prerank,regulation of cell differentiation (GO:0045595),0.4128087856559141,1.2000909149863144,0.1458966565349544,0.5463319392572606,1.0,28/148,9.68%,MDK;HSP90AB1;UQCC2;ATF4;SPOCK2;NLGN1;TNF;EMP2;LTBP4;NR1D1;LGALS3;ZFP36L1;YWHAH;MCRIP1;PPP2R1A;PLEKHB1;LTK;FADS1;CEBPB;SLC6A6;KLK6;CLASP1;CCN2;YWHAG;BCL6B;CD24;CDK5R1;CAMK1
prerank,positive regulation of chromatin organization (GO:1905269),0.565331093343562,1.2000487174821073,0.2793522267206478,0.5460059406727518,1.0,2/12,2.97%,H3-3A;TERF1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5936947475200762,1.1996629706358652,0.25857142857142856,0.5460756963798616,1.0,2/10,15.93%,REEP6;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5936947475200762,1.1996629706358652,0.25857142857142856,0.5460756963798616,1.0,2/10,15.93%,REEP6;CNGB1
prerank,positive regulation of T cell activation (GO:0050870),0.43790814807846357,1.1993860859157062,0.20152505446623092,0.5463598737820371,1.0,17/62,20.94%,CD81;MDK;CCL19;PTPRC;SIRPA;TFRC;HSPD1;THY1;PNP;AIF1;DOCK8;CCL2;VCAM1;CCR2;CD86;IL6;PYCARD
prerank,peptidyl-threonine modification (GO:0018210),-0.304364944593759,-1.1986935139505484,0.12307692307692308,0.6005464561701681,1.0,19/66,14.02%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;GALNT11;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;GALNT1;TBK1;CSNK2A1;CSNK2A2;NLK;PRKD1;GSK3B;MARK2
prerank,positive regulation of protein kinase activity (GO:0045860),0.4130826048579626,1.1985029764349309,0.1346153846153846,0.5482489813838636,1.0,44/148,19.75%,CLU;CALM1;HSP90AA1;HSP90AB1;CCL19;PRNP;CALM3;GRM5;AGT;TNF;EMP2;PDGFB;PTPRC;PAK1;EGR1;LILRA5;CAMK1;PAK3;PIH1D1;FCGR1A;CSF1R;DOK7;SLC11A1;RHOA;SRCIN1;GAS6;CCDC88A;STK11;MMD2;LRP8;MAPRE3;DAB2IP;CASS4;LCP2;ADCYAP1;CAMKK1;AGAP2;DDR2;ERBB3;MAP2K2;CALM2;SNCA;UNC119;EFNA1
prerank,protein-DNA complex disassembly (GO:0032986),0.5332354284083723,1.1978473910785838,0.2585301837270341,0.5496100894449586,1.0,1/16,0.13%,RPL23
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5300081162950906,1.1973937182261403,0.2394736842105263,0.5503739773504379,1.0,6/17,16.80%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5889405355281777,1.1970923554683572,0.26912181303116145,0.5507376381360392,1.0,4/10,15.85%,PTPRC;TLE5;KLF4;SIGIRR
prerank,positive regulation of protein modification process (GO:0031401),0.40520660213396603,1.1968444602175974,0.09829488465396188,0.5509488372745477,1.0,56/203,20.03%,PPIA;CD74;RACK1;CALM1;HSP90AA1;GPNMB;MT3;C3;MAPK3;AKT1;TXN;CALM3;CCND2;TREM2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;KNDC1;RARRES2;MUSK;TFRC;CCND1;PAK1;KDR;P2RY1;CAMK1;SMPD1;CSF1R;PECAM1;SVIP;FLT4;HRAS;TMEM119;SOX9;BMP2;GAS6;CLIP3;IGF2;DLC1;RASGRP1;ASPSCR1;CDH5;ADAM17;TERF2IP;NSMF;CALM2;HGF;EFNA1;ERP29;TGFB1;THPO
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4706093000921883,1.1966150395745196,0.23634204275534443,0.551094884620796,1.0,11/33,21.67%,OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;GLUD1;GOT1;ALDH4A1;MTHFS
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5660377159503817,1.196277189020995,0.26258503401360545,0.5515415702385656,1.0,7/12,31.39%,FLOT1;PQBP1;IFIT1;CAV1;RALB;DHX9;MAVS
prerank,response to calcium ion (GO:0051592),0.4207225017597012,1.1951052060902196,0.15544041450777202,0.5543791667811938,1.0,31/102,20.40%,CALM1;LGMN;NLGN1;CALM3;SLC25A13;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;PDCD6;WNT5A;TRPM2;TRPC1;ALOX5AP;CPNE5;SYT10;CPNE6;RYR2;DMTN;ADCY8;SYT2;CAV1;KCNMA1;PPP3CA;CALM2;CPNE4;D2HGDH;MEF2C;CAPN3
prerank,chromatin disassembly (GO:0031498),-0.43532240367661645,-1.194327340168765,0.23735408560311283,0.6067580769124056,1.0,3/14,6.65%,ARID2;ARID1A;SMARCE1
prerank,nucleosome disassembly (GO:0006337),-0.43532240367661645,-1.194327340168765,0.23735408560311283,0.6067580769124056,1.0,3/14,6.65%,ARID2;ARID1A;SMARCE1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.510343647096759,1.1939261463804356,0.24743589743589745,0.5571711590925269,1.0,7/21,18.08%,YWHAB;FKBP1A;PPP1R1B;YWHAE;ARPP19;FKBP1B;PPP1R15A
prerank,extracellular matrix assembly (GO:0085029),0.5066006513286943,1.1937277692285126,0.24171779141104294,0.5573006572519774,1.0,8/23,20.16%,RAMP2;LAMB2;GPM6B;MFAP4;MYH11;GAS6;TGFB1;QSOX1
prerank,regulation of cellular localization (GO:0060341),0.44550860918802687,1.19267484471178,0.22605790645879734,0.5596205570304579,1.0,10/46,9.65%,GSN;HSP90AA1;HSP90AB1;PINK1;NR1D1;PARP1;REEP5;REEP6;MAP2;EPHA5
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.42774845179840115,1.19239774523447,0.18723849372384938,0.5598626915897789,1.0,26/77,19.66%,CLU;GPX1;NDUFA13;PARK7;AKT1;SLC25A5;TMBIM6;PINK1;TNF;FZD9;LGALS3;GHITM;TMEM14A;PIH1D1;ACAA2;HSPA1A;CX3CR1;MAPK8IP2;GATA4;HERPUD1;NDUFS3;MAZ;QARS1;PRELID1;RTKN2;HGF
prerank,glial cell development (GO:0021782),0.4925176590264795,1.1918348324283081,0.2596754057428215,0.5609107335052199,1.0,15/25,32.53%,MDK;MT3;S100A9;MYRF;MXRA8;DLL1;EIF2B5;SOX11;SOX10;APP;CSPG5;TLR2;EIF2B1;SOX4;PRDM8
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5284063411759035,1.191445201897451,0.26208651399491095,0.5615212775444854,1.0,6/18,18.87%,ACTB;VAMP8;CDK5;ABCA2;MMP14;VPS4A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.3856075860042505,-1.1913977422616535,0.20535714285714285,0.6120695396757494,1.0,7/19,11.61%,TGFBR3;BMPR1A;VGLL4;TGFBR1;ZFPM2;FGFR2;RBPJ
prerank,cellular response to oxygen levels (GO:0071453),0.5879315301728316,1.1908378971863334,0.27348066298342544,0.5627169292428614,1.0,3/10,8.91%,ATP6V1G1;ATP6AP1;NDUFS2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49807025582297715,1.1900003000804422,0.2456575682382134,0.5645056794404112,1.0,5/23,16.24%,RPS3;TNF;PAK1;TLR6;DAB2IP
prerank,regulation of protein transport (GO:0051223),0.48508213228371433,1.1898554447479837,0.26506024096385544,0.5644420987115675,1.0,6/27,11.32%,HSPA8;TNF;LCP1;ATP13A2;STXBP5L;DNAJA1
prerank,sulfur amino acid catabolic process (GO:0000098),0.5819393891424124,1.1895123683548656,0.26495726495726496,0.5649343377078766,1.0,4/10,24.30%,MPST;TXN2;TST;ADO
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4651430531972431,1.1894069593911538,0.22388059701492538,0.564743818860411,1.0,11/35,12.02%,ARHGDIA;MDK;HCLS1;ARHGDIB;IQGAP2;ESAM;HCK;PHPT1;CSF1R;TRPM2;HRAS
prerank,polyamine metabolic process (GO:0006595),0.557273806918368,1.1893797239673236,0.2786885245901639,0.5643566834301259,1.0,5/13,19.93%,ODC1;SMS;SMOX;SRM;OAZ2
prerank,tRNA aminoacylation (GO:0043039),0.46307596008081925,1.1889985330417514,0.23058823529411765,0.5649461864323534,1.0,14/37,24.51%,LARS2;GARS1;SARS1;SARS2;KARS1;WARS1;NARS1;CARS1;PPA1;QARS1;EPRS1;AIMP2;YARS2;MARS2
prerank,response to muscle stretch (GO:0035994),0.53409100984224,1.1885902518233817,0.25298013245033113,0.5656447486203928,1.0,4/15,15.89%,GSN;CTNNB1;SLC8A1;RYR2
prerank,steroid metabolic process (GO:0008202),0.4266420221189036,1.1883307092493538,0.20260021668472372,0.5659142113489888,1.0,10/72,12.81%,TSPO;LGMN;SCP2;RDH5;LSS;HSD17B4;DHCR24;FDX2;GC;HSD3B2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5763488626553248,1.1881266262146777,0.25426136363636365,0.56601810781492,1.0,2/10,13.39%,CD24;LILRB1
prerank,regulation of actin nucleation (GO:0051125),0.5652967262064007,1.187894920960468,0.28083989501312334,0.5661934423201079,1.0,4/12,17.68%,GSN;CORO1A;ARF1;SCIN
prerank,regulation of kinase activity (GO:0043549),0.41431295516833183,1.187824707608074,0.20146137787056367,0.565938435115363,1.0,22/89,18.23%,EEF1A1;CD74;SOD1;TREM2;ERBB4;EMP2;NTRK2;LTK;CDKN1C;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;HNRNPU;EPHB1;FLT1;TYRO3;DDR2;ERBB3
prerank,regulation of dopamine secretion (GO:0014059),0.499661862655788,1.1877938524898692,0.2433734939759036,0.5655525119504835,1.0,13/25,25.63%,SYT1;SYT12;SYT11;SYT6;SYT4;KCNA2;CHRNA4;SYT10;SYT2;SNCA;SYT3;SYT5;SYT17
prerank,response to muramyl dipeptide (GO:0032495),0.5691376658054792,1.1877278585272373,0.2673130193905817,0.5652805665589266,1.0,4/12,14.04%,VIM;CHMP5;RIPK2;ERBIN
prerank,positive regulation of protein transport (GO:0051222),0.4302843568576126,1.1876821855753603,0.22470713525026625,0.5649516446382828,1.0,21/67,19.93%,PPIA;RACK1;OAZ1;TREM2;TNF;ANG;PRR5L;ABCG1;VAMP2;ARF6;ATP13A2;APBB1;CEP131;VPS28;B3GAT3;IER3IP1;ACHE;DNM1L;ACSL3;TGFB1;OAZ2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.43233012251355063,1.1876715908582227,0.18696581196581197,0.5645309984054532,1.0,21/69,21.86%,SEC61B;HSPA5;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;WFS1;SYVN1;DNAJB2;MAN1B1;UBQLN2;SGTA;HERPUD1;DNAJB9;DNAJC10;TRIM13;SELENOS;STUB1;AMFR
prerank,regulation of telomerase activity (GO:0051972),0.4480989892812155,1.1870614895066118,0.23261117445838084,0.5657647646930332,1.0,20/45,25.94%,HSP90AA1;HSP90AB1;MAPK3;TERF1;CCT2;CTNNB1;KLF4;PTGES3;PARM1;DKC1;MAPK15;MYC;MEN1;MAP2K7;CCT4;GRHL2;NAF1;PNKP;PIF1;PRKCQ
prerank,diterpenoid metabolic process (GO:0016101),0.4376503166033487,1.1870025146079675,0.23444444444444446,0.5654695238936133,1.0,16/55,19.89%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;LRP8;LRAT;BCO2;SDC3;HSPG2;AGRN
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5613689635506321,1.18631864711513,0.272984441301273,0.5669039701451594,1.0,5/12,19.67%,TREM2;TNF;NUPR1;CCL3;IL6
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.47921975474438183,1.18611312275315,0.24439197166469895,0.5670518441882378,1.0,15/32,27.25%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.47191404983579854,1.1858260164844376,0.25415676959619954,0.567395602463714,1.0,10/33,19.74%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;CTC1;TERF2IP;DKC1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5747076227013439,1.1857635135083695,0.2812920592193809,0.5671108054780715,1.0,1/10,1.89%,MAPK3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.48036081466024394,1.1857174960796826,0.26277372262773724,0.5667886865619174,1.0,7/27,19.38%,CD74;MIF;PTTG1IP;MSX1;PMAIP1;TWIST1;HIC1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39179775318202165,1.1853074729809572,0.026,0.5674776942979448,1.0,139/509,20.91%,RPL23;RPS3;RPS15;RPL37;CD74;RPS20;RACK1;GAPDH;HSP90AA1;HSP90AB1;LAPTM5;LGALS1;HMOX1;PARK7;CCL19;TXN;NLGN1;S100B;NRG1;TREM2;TGM2;ERBB4;PINK1;AGT;S100A13;LAMTOR2;GPER1;LAMTOR4;GPR37L1;TNF;EEF1D;RHOC;PDGFB;LAMTOR5;PTPRC;HCLS1;RAC1;FKBP1A;NTRK2;SHISA5;ECM1;SCTR;RTN4;S100A9;S100A8;MIF;CAV2;TIRAP;FLNA;FN1;TFRC;RHOG;EPOR;TMEM101;CLEC6A;KDR;NUPR1;P2RY12;TICAM2;JCAD;LILRA5;TMEM9B;DCN;HMGB1;KITLG;MC1R;RBCK1;WNT5A;IL11;BAX;RAMP3;FLT4;PMAIP1;C1QTNF4;HRAS;SOX9;BST2;VAV1;RUNDC3A;RHOA;GJA1;BMP2;LAMTOR3;RIPK2;GAS6;TNFRSF1A;UBE2V1;CX3CR1;TLR6;HEXIM1;BBC3;F2RL1;BAD;GDF15;RRAGC;IGF2;PDGFA;NCF1;ADRA1D;ADRA1A;RRAGD;DAB2IP;HPSE;FLT1;CCL3;CAV1;CASS4;BCAP31;PIK3CD;TRIM32;DNM1L;F10;RAC2;S100A4;GRM4;ERBB3;TERF2IP;LTBR;KLB;MAZ;SOX11;CD14;CD86;RTKN2;FLT3;TRIM13;HGF;IL6;TGFB1;VAPA;THPO;CANT1;TRAT1;SPHK2;GOLT1B;ADRA2B;TMEM106A;PTPN6;THEM4
prerank,negative regulation of B cell proliferation (GO:0030889),0.5728568947721504,1.1852786786642553,0.27972027972027974,0.5671065358852186,1.0,4/11,24.10%,TYROBP;CTLA4;CD300A;TNFRSF13B
prerank,female gonad development (GO:0008585),0.5142792883003433,1.1846983706944874,0.2503209242618742,0.5682087278063462,1.0,9/19,25.30%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;COL9A3;INHA
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5848189600418897,1.184549579252817,0.2718168812589413,0.5681872267964526,1.0,5/10,31.52%,CTNNB1;CX3CR1;CX3CL1;FZD3;DRD2
prerank,ERAD pathway (GO:0036503),0.4213504084173506,1.1841758109579694,0.20395421436004163,0.5687547012767599,1.0,25/83,21.86%,SEC61B;HSPA5;RCN3;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;WFS1;SYVN1;DNAJB2;MAN1B1;UBQLN2;SGTA;UBXN6;HERPUD1;BRSK2;DNAJB9;DNAJC10;TRIM13;USP13;SELENOS;STUB1;AMFR
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.41209709200882594,1.1840862156787988,0.15843621399176955,0.5685571040542996,1.0,28/117,19.67%,CD81;RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;KARS1;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,cellular response to ionizing radiation (GO:0071479),0.4485111358153952,1.1838174625691475,0.24242424242424243,0.5688458676403633,1.0,8/47,12.02%,RPL26;RHOB;CRYAB;EEF1D;NUCKS1;NET1;TMEM109;HRAS
prerank,metal ion homeostasis (GO:0055065),0.45794486927100175,1.1836210058484715,0.24211711711711711,0.5689396031194753,1.0,12/40,19.55%,MT3;ANK3;TMTC2;GRIN1;SLC12A5;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,muscle contraction (GO:0006936),0.40754618767921674,1.1835443232287093,0.16853932584269662,0.5686833891839899,1.0,23/126,16.42%,MYL6;ALDOA;VIM;CALM1;MYL9;ACTA2;MYL12A;FXYD1;TPM2;CRYAB;MYL1;MYL12B;P2RX6;GNAO1;MYL6B;GLRA1;MYH11;TNNI1;DES;SLC8A1;TMOD1;ADRA1A;DTNA
prerank,negative regulation of translation (GO:0017148),0.4170306325178978,1.1832783303106813,0.20399579390115669,0.5689721360419145,1.0,9/87,4.59%,MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;IGFBP5;NCL;MEX3D
prerank,carnitine shuttle (GO:0006853),-0.4609893833044997,-1.1829774018492496,0.24305555555555555,0.6313078470307146,1.0,3/11,11.96%,PRKAG2;PRKAA2;CPT2
prerank,inhibitory synapse assembly (GO:1904862),0.5654533073356015,1.182858838227807,0.2727272727272727,0.5696211431749929,1.0,5/11,16.30%,GABRA2;WNT5A;GABRB3;FGF13;GABRB2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.49820590367272566,1.1828047145804867,0.25814234016887816,0.5693451434626331,1.0,10/24,24.03%,RAMP2;TNFAIP3;KDR;GATA2;IL11;GAS6;CDH5;SCG2;TEK;PAK4
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3097780416188056,-1.1824585586911953,0.18181818181818182,0.6305079618338849,1.0,17/59,14.02%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;TBK1;CSNK2A1;CSNK2A2;NLK;PRKD1;GSK3B;MARK2
prerank,embryonic heart tube development (GO:0035050),0.5420134708738104,1.182226199051729,0.2668463611859838,0.5703919001404628,1.0,6/14,20.01%,SOX18;NDRG4;HES1;SOX17;RYR2;CITED2
prerank,nucleocytoplasmic transport (GO:0006913),0.45595563399692923,1.1819947978615344,0.24133949191685913,0.57058157120984,1.0,12/40,18.55%,SNRPG;GEMIN7;NPM1;SNRPD2;SNRPE;SNRPF;RBM15B;XPO1;HNRNPA1;SNRPB;ANP32A;SNRPD3
prerank,lymphocyte migration (GO:0072676),0.47349747790161045,1.181727662295113,0.2615933412604043,0.570847127591371,1.0,13/32,34.09%,CCL19;S1PR1;MSN;CCL2;CCL3;CCL8;MYO1G;CX3CL1;CCL13;ZAP70;CCL14;ADAM8;CCL5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5440677731993843,1.1815919114875486,0.25961538461538464,0.5707621013378055,1.0,6/13,19.67%,MDK;ITGB2;TNF;RHOA;FUT9;IL6
prerank,negative regulation of cell growth (GO:0030308),0.4082022178979409,1.181338678119461,0.18507157464212678,0.5710240579014065,1.0,40/121,21.93%,RACK1;MT3;NDUFA13;DCC;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;MAP2;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;FGF13;ING1;DACT3;SLIT3;NDUFS3;SCGB3A1;CCAR2;INHBA;TGFB1;OSGIN1;SFRP1;SPHK2;RERG;CCN3;MAG;CDA
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4282913883575646,1.1811568984507592,0.2093784078516903,0.5710484720296809,1.0,13/66,9.89%,PARK7;AKT1;RAN;CCT2;LAMTOR5;HCLS1;ORMDL3;FLNA;HYAL2;TFRC;CCT7;TRIM28;CCT8
prerank,positive regulation of MAPK cascade (GO:0043410),0.39598702181465295,1.1809063981043595,0.09839357429718876,0.5712862522449546,1.0,68/245,20.94%,APOE;CD74;LAPTM5;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;GPR37L1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;MIF;CAV2;NDRG4;TIRAP;ATP6AP1;DDT;SEMA4C;P2RY6;KDR;CCN2;HTR2C;P2RY1;CD24;JCAD;LILRA5;HMGB1;CSF1R;IL11;RAMP3;FLT4;HRAS;FBXW7;NEK10;BMP2;GAS6;CCL2;F2RL1;GDF15;IGF2;PDGFA;RASGRP1;ARRB2;ADRA1D;ADRA1A;DAB2IP;FLT1;CCL3;GATA4;ADCYAP1;CCL8;GRM4;EDN3;GPR183;FLT3;NOTCH1;IL6;TGFB1;THPO;ADRA2B;TMEM106A;PYCARD
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4040673114948937,1.1800256118016377,0.1461693548387097,0.5732583976567527,1.0,51/173,21.85%,CTSZ;DYNLL2;DYNLL1;USE1;ANK3;LMAN2;DCTN3;ERGIC3;KDELR1;TMED7;F9;TRAPPC2L;LMAN1;SAR1A;TRAPPC5;TRAPPC1;TMED2;CAPZA2;YKT6;ARFGAP2;TICAM2;TEX261;TMED3;TMED9;PDCD6;GRIA1;BET1L;TMED1;DCTN1;YIF1B;GAS6;MCFD2;DCTN2;IER3IP1;ARF4;SPTBN4;NAPA;SPTBN2;BCAP31;F10;TRAPPC3;CTSC;VAPA;YIF1A;GOLT1A;COL7A1;TMED10;HYOU1;COPB2;TGFA;COPG1
prerank,regulation of cellular component movement (GO:0051270),-0.3125501690300197,-1.1799284191044428,0.1717171717171717,0.6349124344975741,1.0,14/49,11.99%,ROCK2;TGFBR3;EGFR;ABL1;MEMO1;ROCK1;RAF1;TGFBR1;CDK6;SP100;DIAPH1;ABL2;ZSWIM4;ARHGAP18
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5106650651329461,1.1794793134844914,0.255050505050505,0.5743107275706558,1.0,4/20,17.42%,TSPO;FDX2;HSD3B2;STARD3NL
prerank,nervous system development (GO:0007399),0.3916035602553115,1.1793267996334038,0.055,0.5742870417026248,1.0,131/429,22.59%,GSN;SCD5;MBP;MDK;ITM2B;BCAN;LSAMP;MPZ;NBL1;MARCKS;ASIC2;NRXN1;SPOCK2;NLGN1;S100B;SLC2A1;NRG1;ERBB4;NES;KCNQ2;FZD9;MOBP;ADAM23;PMP22;DSCAM;CNTN4;MAL;ECRG4;RBFOX3;ADGRL3;SH3GL2;GPM6B;SPOCK1;TAGLN3;HES1;DNM3;STMN3;HAPLN2;FN1;NINJ2;LGI1;LY6H;CRMP1;LRCH4;APLP1;NELL1;PRDM12;NAV3;KIRREL3;NRCAM;KLK6;PROX1;MOG;NDUFS2;ADGRB1;FGF11;NINJ1;MARCKSL1;SMPD1;DNER;ADGRB2;FGF12;HAP1;CHRM3;POU3F1;ELP3;IRF2BPL;GFRA1;SOX8;CHRM2;NRXN2;NRSN2;DCTN1;CLN5;ST8SIA4;CXCR4;CAPG;PTPRZ1;DCHS1;NAGLU;SPG7;NFASC;PRPS1;DSCAML1;ROBO2;RBFOX1;ACHE;EPHB1;CDK5;CPNE6;COX7B;FGF13;DOC2A;GFRA2;GMFB;TYRO3;VCAN;PRX;GLIS2;PPP2R5D;CLN8;PCDHB14;SCIN;ERCC6;GPM6A;APBA2;MYT1L;ERBB3;FABP7;UNC119;INHBA;DCX;TGFB1;POU4F1;MEF2C;GDF11;BTBD6;SRRM4;SOX10;IGF2BP3;PLXND1;HAPLN4;GRIK1;ROGDI;SDHA;SNTG2;POU6F2;GRHL2;CHRNA3;ACAN;DPYSL2
prerank,regulation of lymphocyte migration (GO:2000401),0.5803925309796698,1.1787279344295536,0.2956152758132956,0.5754383779067906,1.0,2/10,6.44%,AKT1;MSN
prerank,regulation of vasculogenesis (GO:2001212),0.542800560551897,1.1786586076596186,0.2585301837270341,0.575187660658033,1.0,5/14,15.74%,CD34;EMP2;KDR;RRAS;HEY1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5332684603049624,1.177912401633877,0.2696774193548387,0.5766743912071707,1.0,1/16,0.71%,VIM
prerank,positive regulation of secretion by cell (GO:1903532),0.4247972255444845,1.1766950299553451,0.21528525296017223,0.5795274348085203,1.0,24/70,22.13%,PPIA;TREM2;GPER1;ANG;ATP6AP1;ABCG1;CLASP1;ARF6;CADPS;ATP13A2;APBB1;BMP2;IER3IP1;ACHE;DNM1L;NMB;EDN3;SOX11;SNCA;GRK2;TGFB1;TMED10;STX1B;RAB27B
prerank,positive regulation of growth (GO:0045927),0.4279947959142495,1.176519413804789,0.24064171122994651,0.5795345049273303,1.0,22/64,21.84%,H3-3A;AKT1;AKAP6;EIF4G2;S100A9;S100A8;LGI1;CXCL16;DDX49;IL2;MFSD2A;DNPH1;EXOSC2;WFS1;SDCBP;TRIM32;MMP14;ADAM17;EXOSC9;SFRP1;EXOSC4;PPM1F
prerank,Notch signaling pathway (GO:0007219),-0.3032173762008224,-1.1758885553720972,0.15306122448979592,0.6428126592772002,1.0,17/59,15.36%,PBX1;GMDS;NOTCH2;ZNF423;CREBBP;MAML2;MIB1;GALNT11;KAT2B;MAML1;ITCH;PSEN1;RBPJ;JAG1;DTX1;HEY2;NLE1
prerank,blood vessel morphogenesis (GO:0048514),0.43345225286932637,1.1758733598955122,0.2374727668845316,0.5808326501943316,1.0,17/54,17.99%,RAMP2;SOX18;ID1;RASIP1;APLNR;LOX;HES1;PROX1;COL4A1;KDR;SOX17;FLT4;SLC1A1;EGFL7;FLT1;CAV1;SYK
prerank,cation transmembrane transport (GO:0098655),0.4477664221248612,1.175714334346182,0.2562358276643991,0.5808243792367265,1.0,11/44,15.77%,SLC38A5;ASIC2;SLC7A5;SLC25A29;SLC6A5;ATP13A2;SLC3A2;TRPM2;ABCC8;ATP1B1;SLC25A19
prerank,regulation of ruffle assembly (GO:1900027),0.5015369874080712,1.1752998526420004,0.26869455006337134,0.5815013236974486,1.0,7/23,16.75%,NLGN1;PFN1;P2RY12;DEF8;HRAS;CAV1;PFN2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.47429505823137363,1.1751060143767749,0.2613768961493582,0.581588100706252,1.0,9/29,14.97%,RPS2;PARK7;PINK1;PIN1;BAG5;FEM1A;FBXW7;FBXO5;ARRDC3
prerank,positive regulation of interferon-gamma production (GO:0032729),0.43919663834420686,1.1750018480880102,0.23423423423423423,0.5813988312084282,1.0,19/48,29.43%,PDE4B;SLC7A5;ISG15;HSPD1;SLC11A1;LILRB1;F2RL1;RASGRP1;CCR2;CD14;PYCARD;IL12RB1;CD276;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5;TXK
prerank,negative regulation of transmembrane transport (GO:0034763),0.5718868324112826,1.174582231692101,0.300561797752809,0.5820700046396757,1.0,2/10,12.48%,AKT1;RSC1A1
prerank,regulation of centrosome cycle (GO:0046605),0.5080958662991757,1.1743800018764246,0.2703045685279188,0.5822086859518991,1.0,7/21,15.97%,NPM1;CHMP2B;CHMP5;ATF5;CEP131;FBXW5;CHMP1B
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.45717437637442165,1.1734145690866247,0.2603211009174312,0.5843393195230852,1.0,9/39,10.98%,FXYD5;FXYD1;ANK3;YWHAH;FGF14;SCN4B;FGF11;FXYD7;FGF12
prerank,chromatin assembly or disassembly (GO:0006333),-0.4516248982757991,-1.172918692622211,0.25874125874125875,0.6481226472045141,1.0,4/11,16.26%,HDAC8;NOC2L;CDAN1;TP53
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5570340114295906,1.172726111120747,0.29435483870967744,0.5857239265216412,1.0,4/12,12.96%,GRN;ATP6AP2;CLN5;CLN6
prerank,negative regulation of response to external stimulus (GO:0032102),0.41176466018873864,1.1725933730114622,0.18814968814968816,0.5856460316241864,1.0,28/105,23.80%,APOE;CTNNA2;CERS2;GPER1;GRID2;NR1D1;LRFN5;DUSP3;SIRPA;TNFAIP3;KLK8;FEM1A;OTULIN;EPPK1;KLF4;TNFRSF1A;SIGIRR;FNDC4;TYRO3;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;C1QBP;PCBP2;TEK
prerank,cardiac muscle contraction (GO:0060048),0.46185227802115814,1.1725848857579289,0.26019184652278177,0.5852255220291024,1.0,9/34,19.17%,GSN;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;GRK2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.46891896312272574,1.172539140078753,0.25,0.5849006245013098,1.0,14/31,25.63%,SYT1;SYT12;SYT11;SYT6;SYT4;SYT10;DOC2A;CBARP;SYT2;DOC2B;REST;SYT3;SYT5;SYT17
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5436515362910643,1.1724446205995118,0.28243243243243243,0.5847181905995262,1.0,8/14,23.07%,HSPA5;BAX;DAB2IP;DNAJB9;DDRGK1;TMEM33;BAK1;PTPN1
prerank,DNA duplex unwinding (GO:0032508),0.440428471186341,1.1722872955645807,0.247546346782988,0.5846801316247324,1.0,8/50,12.09%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1;DDX11
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5798392238075972,1.1722843313405467,0.28312412831241285,0.5842362907540986,1.0,3/11,5.66%,NBL1;MIF;DDT
prerank,regulation of cell projection organization (GO:0031344),0.5425908479460457,1.1720888984291586,0.27600554785020803,0.5843432787947742,1.0,3/13,8.69%,CCL19;TREM2;MFSD2A
prerank,regulation of inclusion body assembly (GO:0090083),0.5632468702555326,1.1718755994341024,0.292817679558011,0.5844650004604081,1.0,8/11,20.71%,HSPA1B;BAG5;DNAJB2;HSPA1A;SACS;DNAJB1;DNAJA4;HSPA2
prerank,polyol biosynthetic process (GO:0046173),-0.4100472410434679,-1.171739096477868,0.25390625,0.6487596336852245,1.0,6/16,19.26%,ITPKB;ACER3;IP6K2;PPIP5K1;CYP27A1;FGF2
prerank,positive regulation of programmed cell death (GO:0043068),0.39513509691039295,1.171444629274708,0.0980980980980981,0.5852474873513798,1.0,78/272,21.46%,MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;LAPTM5;SOD1;RHOB;ATF4;RPS6;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;CTNNB1;OMA1;UBA52;BNIP3L;ARHGEF4;FOXL2;HSPD1;CSRNP3;NET1;RRP1B;JUN;HMGB1;ARHGEF7;SMPD1;APBB1;DNAJA1;BAX;PMAIP1;PNMA2;TCTN3;CTLA4;MCF2L;VAV1;LILRB1;BMP2;WNT10B;CLIP3;NLRP2B;SFRP4;VAV3;ABR;TIAM1;BAD;DAB2IP;SQSTM1;PSEN2;DNM1L;PDCD5;NOS2;SCIN;APH1B;SYK;KCNMA1;TNFRSF12A;ARHGEF19;CCAR2;SNCA;SOS1;IL6;KLF11;ING5;SFRP1;SPHK2;TFAP4;BAK1;PYCARD;GADD45A;FOXA1;SUDS3
prerank,regulation of dendrite development (GO:0050773),0.45379417302222835,1.171085417793264,0.2644341801385681,0.5858301959948845,1.0,18/37,28.27%,DCC;ADGRB3;PACSIN1;CSMD3;CAMK1D;KNDC1;MFSD2A;LRP8;DAB2IP;BCL11A;NSMF;HECW1;CHRNA3;PTN;VLDLR;ALK;LZTS1;RAP2A
prerank,sodium ion homeostasis (GO:0055078),0.49629315832166515,1.1710552742573956,0.2715736040609137,0.5854614907440806,1.0,8/21,19.55%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3;TFAP2B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5429827801642277,1.1706655222186382,0.29347826086956524,0.5860453726083609,1.0,6/13,20.23%,LAMP1;ITGB2;F2RL1;SYK;STX4;SPHK2
prerank,endoderm development (GO:0007492),0.5467831384803731,1.1705234580669002,0.2836411609498681,0.5860020800987171,1.0,5/13,22.49%,LAMC1;SOX17;GATA4;DUSP2;DUSP1
prerank,RNA destabilization (GO:0050779),-0.3989294206277401,-1.1704555562430166,0.23076923076923078,0.6497968081914427,1.0,4/18,5.58%,ROCK2;FTO;ROCK1;YTHDF3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.4078731362669481,-1.170451658766546,0.25333333333333335,0.6474203256409975,1.0,6/16,8.33%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.42023879465311914,1.1704409007728351,0.20859538784067086,0.5857883146274011,1.0,29/86,21.39%,CD74;VTN;CD81;PRNP;ITGB2;TREM2;IL5;AGT;PDGFB;PTPRC;HCLS1;MIF;CLEC6A;ENPP2;CADM4;PECAM1;IL11;RIPK2;IGF2;PDGFA;LRP8;DMTN;HGF;IL6;EFNA1;TGFB1;SFRP1;PTPN6;BANK1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5510847845602088,1.1704316631279426,0.2835408022130014,0.5853622345035341,1.0,6/13,16.12%,NELFCD;SUPT4H1;HNRNPU;HEXIM1;RECQL5;NELFE
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3044974132085002,-1.1701964911350344,0.15217391304347827,0.6458195199689075,1.0,15/56,10.73%,EGFR;FER;ABL1;EPHA3;EPHA4;EFEMP1;INSR;DYRK1A;FGFR2;PDGFRB;ABI1;ABL2;TPST1;PTK2;EPHB2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.42496847501860235,1.170183745890814,0.2217438105489774,0.58557794167945,1.0,11/66,9.80%,APOE;SPARC;B2M;ATP5F1A;MAGED1;CAV2;ATP5IF1;CDKN1C;VASH1;NUPR1;EPPK1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.42468587294618965,1.1697934723159598,0.22835497835497837,0.5861691285282776,1.0,17/64,23.48%,GPX4;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;ACOT1;ACOT4;FAAH;LTC4S;ACSL3;ASAH2;CYP2E1;ELOVL6;ACSL4
prerank,cellular response to organic cyclic compound (GO:0071407),0.40205948396581775,1.1692797125594763,0.17766497461928935,0.5871763339430587,1.0,40/141,20.17%,ACTB;SPP1;GABRB1;AKAP6;TGM2;GPER1;TNF;HSP90B1;PDGFB;IGFBP5;ZFP36L1;CTNNB1;MSN;DRD5;ATP1A3;P2RY6;P2RX7;AQP1;P2RY1;EGR1;P2RY12;GNAI1;RAMP3;TRPM2;ATP1A1;GABRB3;SLC1A1;PDE12;CCL2;HCN1;DMTN;GABRB2;ADCY8;CCL3;HCN3;NCOA4;TGFB1;POU4F1;MEF2C;SFRP1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5508903371358919,1.1690400034333597,0.2845528455284553,0.5874012492910682,1.0,6/12,22.05%,CLTC;PF4;TMEFF2;TGFB1;SELENOS;AP2A1
prerank,stress granule assembly (GO:0034063),0.5051824229234796,1.1689580886077493,0.27331606217616583,0.5871837047679882,1.0,7/20,15.81%,RPS23;MAPT;ATXN2L;CSDE1;G3BP1;CIRBP;YTHDF1
prerank,anterior/posterior axis specification (GO:0009948),-0.42061163030847454,-1.1687816949585268,0.26492537313432835,0.6471533145389418,1.0,3/15,8.57%,WLS;SKI;TASOR
prerank,response to fatty acid (GO:0070542),-0.4058024208174115,-1.16874028848675,0.2283464566929134,0.6448946379440335,1.0,3/17,5.03%,PID1;IRS1;FOXO3
prerank,peripheral nervous system development (GO:0007422),0.5007631399426415,1.1683346101234509,0.27764127764127766,0.5883383022574776,1.0,10/23,26.06%,ASIC2;PMP22;ADGRB1;ADGRB2;SOX8;NFASC;ERBB3;SOX10;SCN8A;GPC1
prerank,vasculogenesis (GO:0001570),0.46247967733985196,1.1680267782974567,0.2814726840855107,0.5887320649359901,1.0,10/32,19.83%,RAMP2;SOX18;RASIP1;APLNR;KDR;SOX17;EGFL7;CAV1;NOTCH1;TGFB1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5232422959557107,1.1677208175537523,0.299738219895288,0.589158369219092,1.0,6/15,27.61%,YWHAE;KCNN2;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4192548768333042,-1.1674415626406678,0.2550607287449393,0.646287694289647,1.0,7/14,22.49%,KMT5C;KMT5B;SHLD1;HMCES;SHLD2;NECTIN2;SHLD3
prerank,regulation of wound healing (GO:0061041),0.44816303112183165,1.167173195623945,0.2677966101694915,0.5901808075591466,1.0,12/42,20.13%,ACTG1;VTN;TNFAIP3;CADM4;EPPK1;HRAS;F2RL1;DMTN;CAV1;PLAU;TNFRSF12A;FOXA2
prerank,regulation of neuron projection development (GO:0010975),0.39750990503216477,1.166090117765333,0.17220543806646527,0.5926767094971754,1.0,29/163,10.03%,APOE;ITM2C;MDK;MT3;CFL1;DCC;AKT1;CTNNA2;NTRK2;CSMD3;S100A9;CAMK1D;NDRG4;KNDC1;SPOCK1;LRRC4C;TENM3;LTK;BAG5;CRMP1;ATP1B2;PTK6;PAK1;IL1RAPL1;PPFIA2;MFSD2A;CDK5R1;CAMK1;PAK3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.43707835427915065,1.165657114912408,0.25083986562150057,0.593432636159477,1.0,15/46,23.07%,GPER1;PTPRC;PIN1;DUSP3;SIRPA;DUSP26;CAMK2N1;PTPRR;TIMP3;CNKSR3;SPRY1;DAB2IP;SPRY3;TNIP1;PTPN1
prerank,regulation of cholesterol storage (GO:0010885),0.5300157586025103,1.1653597253588832,0.3058823529411765,0.5937615908481528,1.0,6/15,15.47%,TREM2;ABCG1;LPL;MSR1;EHD1;NR1H2
prerank,ERBB2 signaling pathway (GO:0038128),0.46496742398650076,1.1649187482557022,0.2598331346841478,0.5945140889628876,1.0,14/31,27.01%,HSP90AA1;NRG1;ERBB4;MATK;PTK6;CDC37;PTPRR;ERBIN;ERBB3;SOS1;STUB1;PRKCA;CPNE3;MYOC
prerank,positive regulation of protein ubiquitination (GO:0031398),0.41395402090257805,1.1648379757935363,0.23844537815126052,0.594293386999949,1.0,18/80,16.41%,UBB;RPS2;LAPTM5;PINK1;FKBP1A;PIN1;FAM107A;CENPX;PTTG1IP;RBX1;PDCD6;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1;ARRDC3;CAV1
prerank,lymphocyte proliferation (GO:0046651),0.4769461697587467,1.1643991763505777,0.29120198265179675,0.5950209081997332,1.0,6/22,20.07%,PTPRC;MSN;HSPD1;RASGRP1;FLT3;MEF2C
prerank,autophagosome assembly (GO:0000045),0.43815978789664606,1.1635773265182676,0.24944567627494457,0.5968511515802509,1.0,7/52,5.66%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.41741776360262933,-1.1633489818625917,0.25833333333333336,0.6549805149719832,1.0,11/15,30.75%,ANAPC1;ANAPC7;NEK6;HECW2;CDC27;CENPE;TPR;PLK1;RIOK2;UBE2C;CDC16
prerank,regulation of neuroinflammatory response (GO:0150077),0.49215481693707447,1.1629326325018652,0.28517110266159695,0.5982010186591187,1.0,5/19,11.31%,TREM2;TNF;NR1D1;NUPR1;MMP3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4277643550517568,-1.1618935169050342,0.2641509433962264,0.6565469957447433,1.0,6/13,10.33%,TNRC6B;TNRC6A;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.45686969632248925,1.161555817719914,0.27667057444314186,0.601514904596503,1.0,4/33,7.85%,CALR;H3-3A;PARK7;PKN1
prerank,cellular lipid catabolic process (GO:0044242),0.47418229899670733,1.160864636648928,0.2857142857142857,0.6029476044438965,1.0,12/27,32.50%,MT3;NUDT19;LIPG;ENPP2;PLBD2;FAAH;SIRT2;ABHD12;AOAH;PLBD1;CEL;ACOX1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.4081616820910663,1.1604056874488395,0.2125,0.6037140557958566,1.0,40/104,27.26%,ACTB;CALM1;AKT1;CCNI;CALM3;CCND2;SERTAD1;CCND1;THY1;CDK5R1;CAMK1;PIH1D1;CSF1R;CDC37;CCNG1;RHOA;CDK5R2;SLC8A1;DAB2IP;CCNJL;CDC25A;MAP2K2;CALM2;SNCA;PYCARD;GADD45A;RALB;BLM;INCENP;TESK1;CCNA2;CDKN2B;CCNG2;HGS;TRIB1;TRIB3;SNF8;CCNH;CDKN1A;CNPPD1
prerank,ventricular septum morphogenesis (GO:0060412),-0.3611693557201159,-1.1600572205809232,0.24607329842931938,0.6591077448854905,1.0,12/27,16.29%,TGFBR3;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;SMAD7;SMAD4;BMP4;HEY2;BMPR2
prerank,membrane depolarization (GO:0051899),0.4581010607832821,1.1596224746847177,0.3002336448598131,0.6053938077192029,1.0,14/32,26.73%,SCN1A;YWHAH;ATP5IF1;CACNA1A;P2RX7;CHRNA4;CAV1;SCN9A;CACNB4;CACNA1E;CACNG2;CACNA1B;SCN8A;SCN2A
prerank,microtubule anchoring at centrosome (GO:0034454),-0.4789826151447536,-1.1595498130658288,0.2647058823529412,0.6582404887074248,1.0,5/10,17.82%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,I-kappaB phosphorylation (GO:0007252),0.5671935879798968,1.1592563925524764,0.3047752808988764,0.6059248249051772,1.0,5/10,29.15%,PRDX4;DAB2IP;TLR7;MAP3K7;TLR2
prerank,negative regulation of angiogenesis (GO:0016525),0.41493391205334257,1.1590974114563377,0.22350472193074503,0.6058812761379021,1.0,23/84,18.30%,SPARC;CLDN5;KLF2;SERPINF1;TNF;CTNNB1;PDE3B;PGK1;VASH1;CXCL10;EPN1;SARS1;DCN;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;AGO1;ADAMTS1;CCR2
prerank,positive regulation of protein catabolic process (GO:0045732),0.40958651213928254,1.158454032374349,0.21812434141201265,0.6071852872131975,1.0,18/84,16.94%,APOE;HSP90AA1;NDUFA13;OAZ1;TNF;SORL1;VCP;TNFAIP3;MSN;PTTG1IP;TNFSF12;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;SNX33;TRIM32
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.45151212362637166,1.1581561391739144,0.2826855123674912,0.6075465508843049,1.0,9/38,20.17%,GPX1;HMOX1;LGALS3;TNFAIP3;FAIM2;PMAIP1;TMBIM1;STX4;SFRP1
prerank,extracellular matrix organization (GO:0030198),0.3883188486537601,1.1581055128677344,0.123,0.6072192781846801,1.0,45/276,9.85%,BSG;SPARC;GSN;VTN;CTSL;BGN;SPP1;COL1A1;CAPNS1;CD151;PPIB;CTSS;BCAN;LAMC1;LAMB2;TMPRSS6;TIMP2;SERPINH1;A2M;SPOCK2;LUM;ITGB2;ADAM15;PDGFB;PLEC;FLOT1;ADAMTS4;GPM6B;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;P4HB;COL6A1;COL4A1;KDR;COL3A1;LCP1;TIMP1;LAMC2;DCN;COL9A1
prerank,negative regulation of transport (GO:0051051),0.4337048821576577,1.157977741938062,0.265993265993266,0.6071052002329956,1.0,15/51,21.84%,RACK1;NRG1;CRYAB;LGALS3;SIRPA;SYT11;RSC1A1;BST2;LILRB1;NR1H2;SNX33;ERBB3;SNCA;TRAT1;PPM1F
prerank,regulation of establishment of protein localization (GO:0070201),0.5367281906114242,1.1578774692561447,0.3083219645293315,0.606951394829914,1.0,2/13,2.84%,CTSD;TREM2
prerank,response to gamma radiation (GO:0010332),0.4847503261906092,1.1572150003330148,0.27341772151898736,0.6083244036175381,1.0,4/24,12.02%,RPL26;CRYAB;TMEM109;HRAS
prerank,positive regulation of innate immune response (GO:0045089),0.4601205457086657,1.1571472883939553,0.27606635071090047,0.6080583710780761,1.0,4/30,11.11%,RPS19;SPI1;SLC15A4;WNT5A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.2635681621284287,-1.1569151151414832,0.0,0.6631037639574462,1.0,38/140,13.40%,ARHGAP29;AKAP13;ARHGAP28;ARHGAP6;ARHGAP20;PLCE1;ARHGAP10;RHOJ;CGNL1;SOS2;ARHGEF11;ARHGAP17;TIAM2;ARHGAP21;SLIT2;ITSN1;ARHGAP23;ARHGEF18;FGD4;RHOT1;STARD13;ARHGAP12;ARHGAP32;ARHGEF12;FAM13B;PLEKHG2;BCR;VAV2;ARHGEF6;SYDE2;ARHGAP31;OPHN1;TRIO;MYO9B;ARHGAP18;ARHGEF2;ARHGEF17;ARHGAP5
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5750089599591036,1.1568900134723026,0.3076923076923077,0.6083066285405041,1.0,5/10,17.75%,FKBP1A;YWHAE;PLN;CBARP;FKBP1B
prerank,DNA biosynthetic process (GO:0071897),0.516964751274101,1.1568623724650506,0.2979002624671916,0.607940473000386,1.0,1/16,0.39%,PPIA
prerank,Golgi organization (GO:0007030),-0.2788518593696042,-1.156596738188825,0.12121212121212122,0.6615666247914942,1.0,38/112,16.73%,LRRK2;BCAS3;ARFGEF1;ARHGAP21;CSNK1A1;USP6NL;VTI1A;RAB30;GORASP2;RAB2A;BLZF1;STX16;GOLGB1;HUWE1;UBXN2B;GOLGA2;GBF1;DYNC2H1;OPTN;BET1;UBXN2A;GOLGA5;GOLGA8B;PLEKHM2;MYO18A;OBSL1;ATP8B1;RAB43;PRKD1;TRAPPC11;SEC16A;SEC16B;NPLOC4;TRIP11;FBXW8;ATL2;LMAN2L;GOLPH3L
prerank,positive regulation of protein processing (GO:0010954),0.5022842904536104,1.1561657189258059,0.2997448979591837,0.609443807540972,1.0,3/19,8.76%,GSN;ENO1;CLEC3B
prerank,chromosome organization (GO:0051276),0.4092330618591548,1.1561288557562135,0.20267489711934156,0.6090903502111172,1.0,19/99,14.77%,RPS27A;UBC;UBB;H3-3A;HDAC11;COPS7A;COPS6;PARP1;NUCKS1;HMGN1;UBA52;RBX1;DDB1;SUPT4H1;ZBTB7A;FAM50A;HDAC5;COPS8;L3MBTL1
prerank,snRNA metabolic process (GO:0016073),-0.40795007988064447,-1.1559284109627992,0.2675438596491228,0.6608837410180455,1.0,7/17,18.66%,INTS8;INTS6;ZCCHC8;TUT1;MTREX;INTS3;INTS11
prerank,pore complex assembly (GO:0046931),-0.3868224311139889,-1.155871261135198,0.22869955156950672,0.6587359226238092,1.0,6/19,11.24%,AFDN;ANO6;NUP98;PLEKHA7;AHCTF1;PDZD11
prerank,placenta development (GO:0001890),0.5502019480330413,1.1557809485441166,0.30563002680965146,0.6095889565315226,1.0,2/12,4.35%,SOD1;ANG
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.31013485666642904,-1.1557395578750267,0.18604651162790697,0.6567222487260354,1.0,17/51,14.11%,ROCK2;ABL1;LPAR1;PPM1E;NRP1;SORBS3;ARHGEF10L;CARMIL1;TGFBR1;PXN;TPM1;RAPGEF3;FERMT2;NF2;SYNPO2;WNT11;TGFB3
prerank,regulation of cell junction assembly (GO:1901888),-0.3454089500636585,-1.1550963279886781,0.23699421965317918,0.656178167005963,1.0,5/27,2.53%,ROCK2;PDLIM5;SETD5;ROCK1;RAPGEF2
prerank,regulation of chromatin organization (GO:1902275),-0.413777314394747,-1.1547989887984036,0.2574626865671642,0.6547077039099588,1.0,5/14,11.57%,MLLT3;SETD5;TLK2;TLK1;PARG
prerank,regulation of lamellipodium assembly (GO:0010591),-0.35064634361120933,-1.1545461671153088,0.2152777777777778,0.653066777009488,1.0,5/34,6.44%,AUTS2;PLCE1;FER;SLIT2;NCKAP1
prerank,histone deubiquitination (GO:0016578),-0.38382475269592387,-1.1544862585699003,0.2543859649122807,0.6509440250780382,1.0,5/18,8.94%,USP3;UIMC1;USP49;USP16;USP36
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5408629892634521,1.1544360896539274,0.30952380952380953,0.6127852049868233,1.0,5/14,14.67%,AK4;AK3;PNP;NME2;CMPK2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.48477890172601734,1.1542663682015526,0.2950423216444982,0.6127824152441739,1.0,9/26,21.11%,AKT1;CYB5R3;SPR;SPTLC1;ABCA2;DDAH2;NOS2;SPHK2;ASAH2
prerank,regulation of gastrulation (GO:0010470),0.5292542704379062,1.154092782675621,0.31466666666666665,0.6128019508129975,1.0,4/14,11.04%,RACK1;OTX2;CLASP1;TENM4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2973884540675096,-1.1538635491303864,0.20454545454545456,0.6504000683812907,1.0,13/52,11.64%,CELF2;RBFOX2;RBM5;RBM25;MBNL2;THRAP3;YTHDC1;TRA2B;RBM4;WTAP;FXR2;HNRNPL;DDX17
prerank,negative regulation of ossification (GO:0030279),0.4867559873309619,1.1537625406806558,0.29913473423980225,0.6132035143597678,1.0,9/23,20.17%,MDK;ECM1;LRP4;SRGN;SOX9;CCL3;NOTCH1;MEF2C;SFRP1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.48335207133686264,1.153734235729323,0.275990099009901,0.6128143332267267,1.0,6/23,7.25%,MAPK3;ATF4;PDE4B;TGM2;DRD5;APLP1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.27814230905819864,-1.1534087281201673,0.1590909090909091,0.6494439162800245,1.0,28/82,16.73%,BMP6;RANBP3L;SMAD6;ACVR1;BMPR1A;SMOC1;CRIM1;SUFU;LRP5;SKI;YAP1;CDK6;IGF1;FGFR2;PPARG;IL6R;TRPM4;PTK2;FERMT2;ZHX3;PRKD1;BMP4;RUNX2;ACVR2A;LIMD1;WNT4;BMPR2;ACVR2B
prerank,regulation of cholesterol transport (GO:0032374),0.49991451871646353,1.1532737037617575,0.2918238993710692,0.6135881640501557,1.0,6/20,16.01%,TSPO;APOC1;LIPG;OSBPL6;NR1H2;ABCA2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.38590851189744,1.1531511358516455,0.094,0.6134727973156656,1.0,92/348,20.03%,PPIA;CD74;RACK1;CALM1;VTN;CD81;HSP90AA1;HSP90AB1;GPNMB;MT3;PARK7;C3;MAPK3;AKT1;CCL19;TXN;PRNP;CALM3;CCND2;TREM2;ERBB4;IL5;PINK1;AGT;CSNK2B;GPER1;TNF;PDGFB;PTPRC;HCLS1;RAC1;ACVRL1;NTRK2;PIN1;MIF;FLOT1;KNDC1;APLNR;RARRES2;MUSK;TFRC;LEFTY2;CCND1;CLEC6A;ENPP2;PAK1;KDR;P2RY1;CAMK1;CSF1R;PECAM1;IL11;RAMP3;FLT4;HRAS;TMEM119;SH2D3C;SOX9;NEK10;BMP2;RIPK2;GAS6;LEFTY1;CLIP3;CX3CR1;SDCBP;MMD2;GDF15;IGF2;PDGFA;LRP8;RASGRP1;MAPRE3;CAV1;PFN2;LCP2;ADCYAP1;ADAM17;CAMKK1;AGAP2;DDR2;TERF2IP;CALM2;SNCA;DDRGK1;INHBA;HGF;IL6;EFNA1;ERP29;TGFB1;THPO
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5143154000292094,1.1526810347431333,0.3107569721115538,0.6142988022237439,1.0,1/16,1.00%,LAMP1
prerank,positive regulation of DNA recombination (GO:0045911),-0.34416269421982315,-1.1524135481662674,0.22110552763819097,0.6497765808936976,1.0,12/27,19.20%,ARID2;KMT5C;KMT5B;SHLD1;MMS19;MRNIP;FUS;FANCB;PRDM9;HMCES;ZCWPW1;SHLD2
prerank,regulation of interleukin-12 production (GO:0032655),0.4326628469075881,1.152340327928159,0.2765237020316027,0.6147708979537564,1.0,10/47,15.22%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;LILRA5;HMGB1;LILRB1;RIPK2;MAPK11
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.44617563360642326,1.1518795329611096,0.2766934557979334,0.6155474500842216,1.0,9/41,13.55%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6
prerank,receptor recycling (GO:0001881),0.5711716475171383,1.1517224057895492,0.31966053748231965,0.6155218852930808,1.0,2/10,4.82%,NSG1;SORL1
prerank,regulation of coagulation (GO:0050818),0.5585833026077126,1.1516964388271869,0.30631868131868134,0.6151351488510944,1.0,5/11,20.13%,HS3ST5;PROCR;F2RL1;CAV1;FOXA2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.47832042902582145,1.1516894326366411,0.31835205992509363,0.6147046677008667,1.0,8/24,22.29%,RPS3;ACVRL1;H1-0;SUB1;TERF2IP;ERCC1;DACH1;BLM
prerank,cell projection organization (GO:0030030),0.46692977026313776,1.151685358679131,0.2891566265060241,0.614264820614008,1.0,12/30,17.68%,GSN;RAC1;NEFH;RHOG;ATP1B2;P2RY12;RHOV;RHOU;CAPG;PDGFA;RAC2;SCIN
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4668434271968395,1.1513390249560385,0.2822677925211098,0.6147848183189095,1.0,7/28,16.24%,GABARAP;TNF;SPI1;BAX;TNFRSF1A;SORT1;DAB2IP
prerank,positive regulation of GTPase activity (GO:0043547),-0.2435658985796136,-1.1511164360542498,0.2,0.6512188560873171,1.0,51/188,15.32%,ARHGAP29;AFDN;SIPA1L1;DOCK11;ASAP3;RSU1;ARHGAP42;BCAS3;RAPGEF2;TIAM2;SGSM2;USP6NL;NTRK3;TBC1D12;RALGAPB;LIMS1;DOCK7;SIPA1L3;TBC1D2B;RAPGEF6;RABGAP1;CCL25;RAPGEF1;TBC1D9B;BCR;TBC1D4;MAP4K4;SYDE2;PICALM;PIP5K1A;BCAR3;ALS2;SNX9;PKP4;TBC1D8B;TBCK;RAPGEF3;FERMT2;SIPA1;RIC1;RALGAPA1;DVL3;WNT11;RGS16;GSK3B;RAP1GDS1;TSC1;EZH2;NGEF;NDEL1;LARS1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5564729750024751,1.1507978735634938,0.31683168316831684,0.6158111129791696,1.0,5/11,23.75%,PCBP1;PCBP4;IGF2BP3;ZNF445;PCBP2
prerank,regulation of dephosphorylation (GO:0035303),-0.4064510027222884,-1.1504523048022899,0.27238805970149255,0.6506813653626025,1.0,4/15,11.65%,SMG6;MTMR3;SMG7;PPP1R16A
prerank,striated muscle tissue development (GO:0014706),0.46124485138705773,1.1502187286957277,0.25696969696969696,0.6168964762810618,1.0,3/29,3.40%,MYL6;RBP4;SGCZ
prerank,hyaluronan catabolic process (GO:0030214),0.502868823604508,1.1499745828212669,0.3078982597054886,0.6170801289510565,1.0,4/18,8.34%,HEXB;HEXA;HYAL2;GUSB
prerank,actin crosslink formation (GO:0051764),-0.43730145209024807,-1.1499185173689854,0.30943396226415093,0.6498752673802098,1.0,4/12,4.65%,DPYSL3;BAIAP2L1;BAIAP2;EPS8
prerank,negative regulation of chemotaxis (GO:0050922),0.4613068510236882,1.1499183610524535,0.29799764428739695,0.616781760745738,1.0,9/31,15.46%,SEMA3F;SEMA7A;DUSP3;SEMA4C;SEMA6D;SEMA4A;AIF1;SEMA4G;ROBO2
prerank,regulation of protein modification process (GO:0031399),0.4345331539054514,1.1498941600366812,0.27048260381593714,0.6163906783058541,1.0,16/50,18.99%,HSPB1;MT3;PPIB;GRM5;PIN1;FN1;CORO1C;CADM4;WARS1;CCDC88A;IGF2;ABCA2;ASPSCR1;CDH5;NOP53;CCAR2
prerank,regulation of cell migration (GO:0030334),0.3837830851794087,1.1496104394107574,0.105,0.6167064615055606,1.0,99/382,20.17%,TMSB4X;ACTG1;CD74;TMSB10;RACK1;CLDN5;IFITM1;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;RHOB;HSPA5;AKT1;SERPINE2;ERBB4;CTNNA2;ADAM15;GPER1;RHOC;SEMA3F;PDGFB;RAC1;ACVRL1;IGFBP5;DNAI3;SEMA7A;SORL1;MIF;DUSP3;PRR5L;FLNA;SEMA4C;MYADM;FRMD5;FAM107A;ADORA3;CORO1C;CXCL16;SEMA6D;NAV3;ENPP2;SGK1;PAK1;PODXL;ROBO4;THY1;KDR;VSIR;LGR6;LAMC2;EPPK1;SEMA4A;CSF1R;DOCK10;PECAM1;ELP3;HRAS;AIF1;BST2;RHOA;SRCIN1;SEMA4G;BMP2;CTSH;SDCBP;TIAM1;F2RL1;IGSF10;SLURP1;PDGFA;DLC1;FLT1;CCL3;CAV1;AMOT;PLAU;CDH5;CASS4;PIK3CD;TRIM32;LMNA;F10;MMP14;ADAM17;TMEFF2;MAZ;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;MAPK15;TGFB1;CITED2;OSGIN1;SFRP1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.41321267987553806,1.149572280374154,0.2658772874058127,0.6163444073625878,1.0,20/70,27.03%,DBI;CHKB;CSNK2B;PLAAT3;ENPP2;MFSD2A;PLA2G7;PLA2G4F;CHAT;NR1H2;ACHE;SLC44A5;STARD10;LPCAT2;SLC44A2;PLA2G3;ABCA3;SLC44A1;PLA2G6;MBOAT7
prerank,regulation of translational initiation (GO:0006446),0.4199812836300237,1.149568118083605,0.25854700854700857,0.6158991589408908,1.0,12/63,10.28%,HSPB1;EIF1;ATF4;EIF4G2;POLR2D;NPM1;EIF1B;PPP1R15B;UHMK1;CEBPB;MIF4GD;POLR2G
prerank,regulation of Notch signaling pathway (GO:0008593),-0.27244478535776934,-1.1493757598135217,0.12727272727272726,0.649070794435457,1.0,19/76,14.26%,TSPAN5;EGFR;ZMIZ1;CREBBP;MAML2;NIBAN2;GALNT11;YAP1;KAT2B;STAT3;MAML1;AAK1;SYNJ2BP;RBPJ;CD46;JAG1;DTX1;WWP2;PRKCI
prerank,glycolipid biosynthetic process (GO:0009247),-0.31836218527068594,-1.1488470528635963,0.2,0.6482869736293684,1.0,17/38,19.97%,LARGE1;ST3GAL4;A4GALT;PGAP2;PIGM;ST3GAL5;PIGN;ST3GAL2;GBGT1;PGAP3;DPM1;PIGO;PIGF;PIGW;PIGL;PIGU;ST6GALNAC5
prerank,regulation of stem cell proliferation (GO:0072091),0.5058713132381789,1.1487921119557005,0.2977303070761015,0.6175964520557385,1.0,5/17,18.97%,PTPRC;ZFP36L1;GJA1;HNRNPU;SOX11
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.559164205031165,1.1482722092852726,0.3162393162393162,0.6185664903536213,1.0,7/11,25.53%,LEPROT;CAV1;VHL;ADIPOR1;SOCS3;PTPRT;HGS
prerank,transcription by RNA polymerase II (GO:0006366),-0.23393086452035158,-1.148267499401075,0.0,0.6476336787990709,1.0,96/305,18.69%,TEAD1;NOTCH2;MLLT3;GLIS3;NR3C2;RARB;PRRX1;SCAF8;SOX5;CREBBP;MAML2;INTS8;NR6A1;SETD2;MNAT1;THRB;TAF15;AFF4;YAP1;PPARA;NFIX;RARG;ELP4;INTS6;NCOR1;KAT2B;CCNT1;TFCP2;TBL1X;SP1;WDR33;NFKB1;NR1D2;CDK12;MAML1;ZBTB1;RNGTT;TAF1A;CSTF3;TFDP1;NFX1;TBL1XR1;IWS1;PABPN1;TEAD2;PPARG;ESR1;TRIM24;NR2C2;CCNK;MED26;CDK13;PIR;SETX;GTF2E2;PMF1;RBPJ;TAF2;ELL;AR;POLR2A;PHAX;RREB1;RPAP2;NR2F1;RORA;CBFB;FIP1L1;NFIC;DTX1;GTF2H4;POLR2B;CDK7;GMEB2;SRRT;POLR2J;CDC73;TRIP11;GTF2A2;ESRRA;ADRM1;NR3C1;RTF1;ICE2;SNAPC3;TAF8;RPRD2;CPSF1;ERCC3;TAF7;TAF4B;INTS3;NR5A2;INTS11;GTF2H2;MED23
prerank,cyclooxygenase pathway (GO:0019371),0.5494324592976253,1.1481375466339216,0.3237822349570201,0.6184901548497652,1.0,5/10,23.33%,PTGDS;HPGDS;PTGES3;CBR1;TBXAS1
prerank,T cell activation (GO:0042110),0.4147525752953683,1.1479476725080873,0.2628755364806867,0.6185837189433829,1.0,15/69,16.91%,CD74;MDK;CCL19;PTPRC;FKBP1A;MSN;DDOST;HSPD1;IL2;LCP1;ICOSLG;F2RL1;RASGRP1;JAG2;PIK3CD
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5059378254335046,1.1478975637746929,0.31496062992125984,0.6182635888217706,1.0,1/17,1.00%,LAMP1
prerank,sensory perception of sound (GO:0007605),0.4074262033927578,1.1476949391773392,0.2505330490405117,0.6183684843599426,1.0,19/88,13.55%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;GRM7;SLC26A4;MYO7B;NDUFB9;GRAP;WFS1;TPRN;PAX3;CRYM;PJVK
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.321418091847125,-1.1473829116961614,0.22131147540983606,0.6475522378589978,1.0,12/44,10.33%,ROCK2;FTO;TNRC6B;ROCK1;TNRC6A;DHX36;TNRC6C;CNOT1;YTHDF3;CPEB3;MOV10;CNOT7
prerank,positive regulation of catalytic activity (GO:0043085),0.4470827913585467,1.1471682403641486,0.29296424452133796,0.6193457312876421,1.0,11/37,18.77%,MT3;SOD1;MAPK3;YWHAB;MID1IP1;PSENEN;B3GAT3;IGF2;CAV1;PSEN2;STX4
prerank,rRNA modification (GO:0000154),0.4923318029346885,1.1471591910760774,0.29214929214929214,0.6189213465310415,1.0,9/21,24.45%,TRMT112;NOP10;FBL;NHP2;ZCCHC4;GAR1;DKC1;FTSJ3;THUMPD1
prerank,lipid translocation (GO:0034204),0.48905679950395403,1.147053713209055,0.31069182389937106,0.6187407629476835,1.0,6/21,18.29%,TMEM30A;ATP8B4;ATP8A2;ATP8A1;ATP11B;RFT1
prerank,cGMP biosynthetic process (GO:0006182),0.5609788713553416,1.1469190289278335,0.32262773722627736,0.6186604623162169,1.0,1/10,2.33%,NPPC
prerank,dendritic spine organization (GO:0097061),0.4717846928125131,1.1465859905354152,0.31467661691542287,0.6190793170380609,1.0,8/26,18.74%,LGMN;PRNP;TREM2;PAK3;DOCK10;ARF1;EPHB1;CTNND2
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3344393583749792,-1.1465668053270253,0.24806201550387597,0.6475090460193067,1.0,9/34,14.03%,NSMCE2;LRP5;ANAPC5;INSR;ANAPC7;IGF1;PDGFRB;PHIP;CDC27
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5230935071493943,1.1464048708937846,0.29747675962815406,0.6191346347696518,1.0,8/13,27.40%,CADM4;PDCD6;DAB2IP;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,negative regulation of reproductive process (GO:2000242),0.5096734454790759,1.1462725816983144,0.32189973614775724,0.6190514120726764,1.0,5/17,13.23%,CALR;NPPC;ARHGDIB;TIMP1;GJA1
prerank,regulation of chromosome organization (GO:0033044),-0.36514140899430547,-1.1459757131634063,0.2639593908629442,0.646891153534076,1.0,6/22,11.43%,SMG6;SMG1;HDAC8;WAPL;YLPM1;TERF2
prerank,organophosphate catabolic process (GO:0046434),0.5487169481132371,1.1459505990539147,0.33,0.6194395774074788,1.0,3/11,14.12%,LIPG;ENPP2;PLBD2
prerank,mitotic cytokinesis (GO:0000281),-0.2986484876992049,-1.1454047777077752,0.1782178217821782,0.6462061857949547,1.0,9/47,7.45%,ROCK2;SON;ROCK1;SPTBN1;PDCD6IP;TTC19;ARL3;MYH10;KLHDC8B
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.47696480494281723,1.1453572970068886,0.2954264524103832,0.620628670375352,1.0,6/22,19.38%,LGMN;VKORC1;RBP1;GC;LRAT;CBR1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4068347007519121,-1.1451146519308015,0.24497991967871485,0.6448985477097599,1.0,4/15,11.61%,EGFR;FER;PTPN12;RBPJ
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5029471570273002,1.144392268140508,0.3080872913992298,0.6227074266698879,1.0,4/18,3.71%,PARK7;RFK;AGT;TNF
prerank,negative regulation of cell migration (GO:0030336),0.3933465667931298,1.1443163295773202,0.20591233435270132,0.6224585762244447,1.0,27/137,9.80%,CD74;CLDN5;IFITM1;CALR;HMOX1;RHOB;IGFBP3;ADAM15;RAC1;ACVRL1;IGFBP5;DNAI3;MIF;NDRG4;DUSP3;HYAL2;ARHGDIB;ADORA3;ADGRG1;CORO1C;ATP1B2;NAV3;CLASP1;THY1;COL3A1;TIMP1;EPPK1
prerank,carnitine metabolic process (GO:0009437),-0.42643439431184665,-1.1441979289996609,0.25435540069686413,0.6450767505820565,1.0,8/12,28.55%,TMLHE;CPT1C;CPT2;ACADM;SHMT1;BBOX1;ALDH9A1;CPT1A
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5340367029257956,1.1439611007581376,0.3169107856191744,0.6229300041672327,1.0,9/15,27.38%,ARL6IP1;RTN4;REEP2;LNPK;RAB18;TMEM33;RTN3;ZFYVE27;REEP1
prerank,regulation of developmental growth (GO:0048638),0.4617632702380497,1.1438165562579,0.3191489361702128,0.6228828961533326,1.0,6/29,9.80%,APOE;SOD1;MUSK;NRCAM;MFSD2A;EPPK1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.482420223527839,1.143744080688818,0.31125,0.6226288624340535,1.0,5/20,14.26%,GSN;GPER1;ECSCR;SFRP4;CCL2
prerank,negative regulation of cell population proliferation (GO:0008285),0.38065370963799755,1.143502220121664,0.117,0.622817534244445,1.0,99/351,22.42%,FTH1;IGFBP6;B2M;APOD;IFITM1;GPNMB;HMOX1;S100A11;NME1;TREM2;RBP4;ERBB4;NPM1;IGFBP3;CSNK2B;GPER1;MAGED1;ACVRL1;IGFBP5;ANG;HSPA1B;NDRG4;CTNNB1;ST18;HES1;SFRP5;TNFAIP3;CDKN1C;BTG1;ADORA3;SSTR4;ADGRG1;ATP8A2;NELL1;PAK1;CEBPA;PROX1;NUPR1;GATA2;CGREF1;EPPK1;ADGRB1;ZBTB49;THAP12;CTBP1;WNT5A;ATF5;ATRAID;WARS1;HRAS;DNAJB2;CAMK2N1;AIF1;KLF4;SOX9;HSPA1A;DDAH1;BMP2;TNN;SFRP4;STK11;COPS8;SLURP1;DLC1;DLL1;ADRA1A;DAB2IP;VHL;TRIM32;LMNA;PTGIR;PDCD5;SCIN;CD300A;ADAMTS1;FABP7;BTG4;SOX11;INHBA;TFAP2B;NOTCH1;IL6;KLF11;TGFB1;ING5;SFRP1;TFAP4;MYC;PTPN6;SST;PTPRU;SIRT2;RERG;CCN3;MEN1;SSTR2;REST;TMEM127;CD164
prerank,protein destabilization (GO:0031648),0.45421666086532464,1.143377817808008,0.3009367681498829,0.6227231244876784,1.0,4/32,4.06%,SERF2;GSN;PRNP;NR1D1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4518485494810253,1.1432585531364554,0.2862190812720848,0.6226051253346243,1.0,14/33,26.93%,AKT1;ZFP36L1;LTK;PIK3C2G;NYAP2;TYRO3;PIK3CD;ERBB3;SIRT2;C1QBP;NYAP1;PLEKHA1;PIK3R5;HTR2B
prerank,sensory perception of mechanical stimulus (GO:0050954),0.40684308486792675,1.1432379731446187,0.25961538461538464,0.6222160480627128,1.0,19/85,13.55%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;GRM7;SLC26A4;MYO7B;NDUFB9;GRAP;WFS1;TPRN;PAX3;CRYM;PJVK
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4335882825898641,1.1431663592684949,0.2779623477297896,0.6219661910588516,1.0,15/45,23.81%,B2M;MT2A;HCK;FCGR1A;IRF8;IRF7;IFNGR1;VCAM1;NCAM1;OAS3;IFNGR2;IRF9;IRF5;TRIM68;CAMK2G
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5029013263740946,1.1431295329812736,0.30115830115830117,0.621608766589434,1.0,6/18,20.52%,FTH1;DAB2IP;TRIM32;CD300A;SFRP1;MYC
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.29141625117929454,-1.1429225462748471,0.18627450980392157,0.6461624415723826,1.0,15/53,13.69%,EYA2;EGFR;EYA1;BABAM2;PLA2R1;UIMC1;RNF8;EYA4;FBH1;FXR2;EYA3;ATM;ERCC8;SIRT1;BCLAF1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3500977527824768,-1.1428914841278748,0.23255813953488372,0.644158003396917,1.0,7/26,6.67%,LGR4;APPL2;OTUD4;BIRC2;FLOT2;IRAK3;BIRC3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.43957721197676314,1.1425385840132418,0.2832764505119454,0.6228340941881428,1.0,9/43,13.55%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6
prerank,protein transport (GO:0015031),0.3846138667345772,1.142518934916293,0.14614614614614616,0.6224341469882865,1.0,94/332,22.86%,APOE;CD74;CLU;RAMP2;ATP6V0C;LAPTM5;SNX17;RCN3;ATP6V1F;NPM1;ANK3;LRP1B;TXNIP;CANX;OLFM2;ARF5;HSP90B1;YWHAH;ATP6V1G1;ATP6AP1;ATP6V0E2;ABCG1;CHMP2B;TFRC;TMED7;RD3;ARRDC1;SAR1A;RAB14;RAB15;SCAMP3;TMED2;ARL11;CLTC;RAB3C;SCG5;VAMP2;ARF6;TICAM2;TMED3;RAB3D;ARL4C;TMED9;PDCD6;ATP6V0D2;RAMP3;PPY;CTSA;CMTM6;SGSM1;ARL4D;ARL1;TMED1;SYNDIG1;VMP1;SCAMP2;ARF1;EHD1;TBC1D22B;TVP23A;ARRDC3;UNC93B1;RAB26;GOLGA7;ARF4;CHMP1B;RAB20;NAPA;SNX33;TBC1D9;RAB5C;LAMP2;PREPL;STX4;SYS1;RAB18;PDIA4;RAB31;UNC119;TBC1D10C;ERP29;CTTN;RAB6B;IFT27;TMED10;COPB2;SCG2;COPG1;AP2A1;ATP6V1A;STX1B;RAB28;ATP6V0A1;EVI5L
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5631096165925609,1.1423937003880127,0.3213793103448276,0.6223328413895233,1.0,6/10,32.37%,MID1IP1;MLXIPL;NR1H2;ABCD2;NR1H3;ELOVL5
prerank,vasoconstriction (GO:0042310),0.5435523075600346,1.1421793716107205,0.32734806629834257,0.6224656610296464,1.0,3/11,18.94%,ACTA2;SLC8A1;EDN3
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5366345665932037,1.142112039090976,0.3047752808988764,0.6222194717784006,1.0,2/12,2.21%,CALR;KLF2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5137871508485137,1.1417826538355362,0.312987012987013,0.622655160400301,1.0,2/17,8.66%,VIM;VSIR
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.39825446944444964,1.1415685744665849,0.23935091277890466,0.6227971653886321,1.0,25/122,16.13%,RPL26;RPS4X;RPL5;EEF2;VIM;AKT1;CCL19;EIF3D;NPM1;RPS27L;PDGFB;EIF3C;NAMPT;KDR;PCIF1;PCNA;ZCCHC4;KLF4;PRMT1;CCL2;ABCB10;IGF2;CIRBP;YTHDF1;EIF4A3
prerank,protein secretion (GO:0009306),0.42153771785626926,1.141303259508662,0.27939590075512405,0.6230504321769564,1.0,20/56,24.00%,PARK7;RCN3;PTPRN;CANX;OLFM2;RIMS2;RAB15;RAB3C;RAB3D;PPY;ARL4D;MAFA;TVP23A;ADCYAP1;PDIA4;PORCN;SCG2;COPG1;CAMK2G;MTTP
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.37235008477788656,-1.141251618582913,0.2523809523809524,0.6464371225071894,1.0,9/20,19.22%,DICER1;DROSHA;ZC3H7A;ZC3H7B;TERT;PUM2;TARBP2;AGO2;AGO4
prerank,proteasomal protein catabolic process (GO:0010498),0.38588787319824785,1.1409291608266845,0.1827309236947791,0.623628498899438,1.0,60/201,21.78%,PSMB4;UBXN1;PSME1;PSMB6;RCN3;PSME2;PSMB8;PSMD2;KCTD10;NR1D1;PSMD1;PSMC3;UCHL1;CTNNB1;PSMD6;VCP;CDC34;RNF187;PSMA7;KCTD2;FEM1C;NHLRC1;PRPF19;KCTD17;PSMD5;TRIM9;RBX1;TRIM2;TNFAIP1;DDB1;PSMB9;PSMD13;RBCK1;PSMB3;FBXW5;PMAIP1;SYVN1;PSMB11;ZSWIM8;FBXW7;PSMB10;KBTBD7;SPSB3;UBXN6;PSMB1;ARRB2;ENC1;PSMB5;BRSK2;KCTD13;PSMA6;HECW1;TRIM13;RAD23A;PSMA4;DDIT3;SIRT2;UBXN11;STUB1;IFI27
prerank,integrated stress response signaling (GO:0140467),0.5343973176502852,1.1408644909017216,0.3293963254593176,0.6233484825179222,1.0,7/14,24.96%,HSPA5;ATF4;OMA1;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,peptide catabolic process (GO:0043171),-0.35676541910996773,-1.1408384881778515,0.2617801047120419,0.6453666505203611,1.0,3/23,5.90%,CPQ;NPEPPS;ANPEP
prerank,import into cell (GO:0098657),0.43853963489575143,1.1406758520183329,0.28308400460299193,0.6234011619518838,1.0,10/41,14.83%,SNAP25;TREM2;LRRC8A;SLC7A5;GLUL;TSPO2;SLC6A6;SLC29A1;SLC19A1;SLC29A2
prerank,mRNA stabilization (GO:0048255),0.4336552721057339,1.1401110837999657,0.29667812142038946,0.6244499504779046,1.0,12/40,17.31%,TIRAP;HNRNPA0;YBX1;ZFP36;TARDBP;ELAVL4;PABPC1;SLC11A1;HNRNPU;CIRBP;YBX3;EIF4ENIF1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3486672049979255,-1.139780458448153,0.28415300546448086,0.6460712698399951,1.0,14/26,32.32%,NSMCE2;ANAPC5;ANAPC7;NEK6;HECW2;CDC27;CENPE;ANAPC4;PLK1;RIOK2;UBE2C;CDC16;CCNB1;RB1
prerank,regulation of small molecule metabolic process (GO:0062012),0.4647828748276769,1.1397766807590928,0.29236276849642007,0.6248480854595573,1.0,2/28,1.95%,APOE;ACADVL
prerank,sodium ion export across plasma membrane (GO:0036376),0.5325425416901484,1.139676625510841,0.31842818428184283,0.6246817455286718,1.0,6/13,17.69%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.38306639276391874,1.1395640953850232,0.17971887550200802,0.6245700636409199,1.0,75/241,23.82%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;PDCD7;EIF4A3;PRPF31;SF3B6;TXNL4A;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200;DHX38;HNRNPH2;SNRPB2;PPWD1;ELAVL1;PCBP2;LSM5
prerank,telomere maintenance via recombination (GO:0000722),-0.44108209482145,-1.1395306770547784,0.25862068965517243,0.6445673573144707,1.0,2/11,3.01%,NSMCE2;TEP1
prerank,positive regulation of vacuole organization (GO:0044090),0.5507406500390347,1.1387916545347114,0.34334763948497854,0.6261926174257559,1.0,1/10,1.29%,GRN
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4662529778822987,1.1385728929189989,0.30335731414868106,0.6263813289772171,1.0,6/26,13.00%,EEF1A1;ZFP36L1;ZFP36L2;DUSP3;ZFP36;SOX9
prerank,response to purine-containing compound (GO:0014074),0.49577987063867013,1.1377357920159488,0.3220779220779221,0.6282704622168118,1.0,5/17,15.89%,P2RY6;P2RX7;P2RY1;TRPM2;RYR2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5452490579430134,1.137670650813295,0.3235294117647059,0.6279978754598247,1.0,2/11,5.80%,AUP1;VCP
prerank,negative regulation of gene expression (GO:0010629),0.3819728429952531,1.1375999471394005,0.14514514514514515,0.6277318520624672,1.0,55/302,13.45%,APOE;MRPL13;RPS3;RPS13;RACK1;CLDN5;GAPDH;RPL13A;RPS26;CALR;H3-3A;GPNMB;PARK7;LGMN;CNPY2;TMBIM6;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;IGFBP5;NCL;SPI1;LSM6;MIF;HSPA1B;ZFP36L2;TLE5;SH3GL2;APLNR;MYADM;CREBZF;KDR;SYT11;MAPT;YBX1;GATA2;ZFP36;TARDBP;LRP3;RNH1;SRGN;PCIF1;HRAS;ATP2B1;MSR1;NCOR2;KLF4;SLC11A1;HSPA1A;FBXW7;BMP2
prerank,long-chain fatty acid transport (GO:0015909),0.4554024713375103,1.137058269644035,0.3023529411764706,0.6287503371129336,1.0,4/30,8.69%,APOE;MID1IP1;FABP5;MFSD2A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4293662825487,1.1369985108891407,0.28815489749430523,0.6284731904175666,1.0,15/42,21.84%,EMP2;PDGFB;RAC1;SPOCK1;MYADM;CORO1C;THY1;RHOA;ARL2;DMTN;FBLN2;RAC2;NOTCH1;PTPRO;PPM1F
prerank,blood circulation (GO:0008015),0.4270648824967494,1.1368856542797818,0.2868131868131868,0.6283519298045314,1.0,9/49,9.66%,GPX1;CXCL12;SOD1;SGCZ;CYB5R3;ACVRL1;CXCL10;PLN;SERPING1
prerank,response to interleukin-6 (GO:0070741),-0.45392187537662243,-1.1359363165504994,0.2847457627118644,0.6517661443165362,1.0,3/10,6.32%,PID1;PTGIS;NFKB1
prerank,retinoid metabolic process (GO:0001523),0.4057992403103265,1.1352183905877842,0.27896995708154504,0.6324378882030619,1.0,17/71,19.89%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;DHRS13;LRP8;LRAT;BCO2;SDC3;HSPG2;AGRN
prerank,sensory perception of pain (GO:0019233),0.48885240391713863,1.134814216570082,0.32540675844806005,0.6331430579976848,1.0,7/21,20.76%,PRDM12;P2RX7;KCNA2;CHRNA4;CCL2;CCR2;SCN9A
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.39878055207443625,1.1346273888980984,0.2544132917964694,0.6332128965832716,1.0,28/85,21.57%,CLU;RACK1;GABARAP;ELOB;TREM2;HSPA1B;PSMC3;VCP;USP5;CEBPA;RBX1;NUPR1;ECSCR;SUMO2;DNAJB2;HSPA1A;FBXW7;RNFT1;HSPBP1;DAB2IP;NOP53;DDRGK1;RNF144B;RAD23A;TMEM259;USP13;SIRT2;STUB1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5147958582620252,1.1341897126100853,0.3254189944134078,0.6339151634170843,1.0,2/13,1.76%,APOD;PARK7
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5432861450208919,1.1340807799180428,0.339568345323741,0.6337597878555284,1.0,3/11,20.21%,TREM2;CCL3;TRAT1
prerank,cellular component maintenance (GO:0043954),0.5256821186167406,1.1338491442985987,0.33243606998654107,0.6339375024294928,1.0,2/12,2.84%,PRNP;TREM2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5157024709078654,1.133834102355543,0.3261455525606469,0.6335226259861453,1.0,6/14,16.80%,PARK7;TMBIM6;CREB3;SYVN1;HSPA1A;HERPUD1
prerank,negative regulation of complement activation (GO:0045916),0.5633136401864081,1.133110828433911,0.34081346423562414,0.635014892351711,1.0,2/10,9.66%,A2M;SERPING1
prerank,oxoacid metabolic process (GO:0043436),0.46381222710233105,1.1328841696302248,0.31695331695331697,0.6351845469679097,1.0,5/27,8.82%,AGXT;MIF;SULT4A1;BPNT2;GRHPR
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.45326009879861595,1.1328554425471353,0.3162291169451074,0.6348172831053649,1.0,7/31,15.80%,ROMO1;DNLZ;HSPD1;TOMM40L;TIMM50;TOMM20L;PEX6
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5131103041178698,1.1327826236941032,0.32647462277091904,0.6341141834598795,1.0,3/14,19.96%,HMOX1;BLVRA;SLCO1B1
prerank,heme catabolic process (GO:0042167),0.5131103041178698,1.1327826236941032,0.32647462277091904,0.6341141834598795,1.0,3/14,19.96%,HMOX1;BLVRA;SLCO1B1
prerank,positive regulation of cell adhesion (GO:0045785),0.40394372084864144,1.1325255324956456,0.2822410147991543,0.6343830948465352,1.0,20/74,20.01%,MDK;CXCL12;TGM2;TNF;PDGFB;RAC1;FRMD5;ADGRG1;P4HB;DUSP26;P2RY12;MAGI1;ARL2;EPB41L4B;TMEM102;FBLN2;SYK;STX4;PPP3CA;CITED2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5338054861496856,1.1319283602265877,0.324,0.6355876900083914,1.0,3/12,17.42%,TSPO;FDX2;STARD3NL
prerank,motor neuron axon guidance (GO:0008045),0.5112685666296871,1.1313892017838336,0.3171355498721228,0.6365777651619805,1.0,6/15,17.41%,RAC1;RHOG;NTN1;LAMC2;SLIT1;RAC2
prerank,cellular response to amino acid starvation (GO:0034198),0.41088258893546264,1.1313120763791424,0.2748414376321353,0.6363363776090454,1.0,10/71,7.08%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.38145208241336204,1.1307712242393897,0.21471774193548387,0.6373590723102377,1.0,43/186,16.41%,APOE;IGFBP6;PFDN5;RACK1;PSMB4;MDK;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;PSMD1;LRP4;PSMC3;TLE5;PSMD6;ANKRD6;ALPK2;SFRP5;PSMA7;JADE1;PSMD5;RBX1;PSMB9;PSMD13;WNT5A;SOX17;PSMB3;PSMB11;IGFBP2;SOX9;BMP2;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5015809813742705,1.130668262868059,0.32127955493741306,0.6372047343300614,1.0,5/16,19.96%,LGALS3;CD22;IKZF3;SOX11;LST1
prerank,regulation of protein kinase A signaling (GO:0010738),0.48388281749274786,1.130635312797943,0.3110831234256927,0.6368403926532191,1.0,6/20,11.35%,AKAP6;MIF;PRKAR1A;MC1R;PRKAR1B;RAMP3
prerank,intracellular cholesterol transport (GO:0032367),0.5209225378789016,1.1305817854296372,0.34404283801874164,0.6365420786572076,1.0,4/15,9.19%,NPC2;ABCG1;TSPO2;STARD4
prerank,myeloid leukocyte differentiation (GO:0002573),0.40569098188215397,1.1305456551172766,0.29621621621621624,0.636208404047555,1.0,18/65,20.15%,MT1G;TYROBP;CCL19;TREM2;GLO1;SPI1;PARP1;CEBPA;DEK;CSF1R;F2RL1;OSTM1;BATF3;OSCAR;PIK3CD;GPR183;BATF2;PDE1B
prerank,regulation of catabolic process (GO:0009894),0.49496789434859423,1.130215030630308,0.3342245989304813,0.6366610267577216,1.0,9/18,26.88%,CHEK2;RARRES2;CHMP6;ODC1;FAM83D;HGS;ZDHHC2;ITGB1;SNF8
prerank,peptide metabolic process (GO:0006518),0.40643936455330176,1.1299477985755852,0.28858350951374206,0.6369296749234145,1.0,19/75,18.38%,GPX1;SOD1;GSTM1;CPXM1;CPD;CPE;SPCS1;GSTM5;AEBP1;CPXM2;GSTM2;CLN5;HPGDS;SPCS2;DNPEP;GLRX2;BACE1;PSEN2;SEC11C
prerank,protein N-linked glycosylation (GO:0006487),0.41147205703036144,1.1294135127627067,0.2742796157950907,0.637913987248297,1.0,20/66,18.84%,OST4;KRTCAP2;TMEM258;RPN1;RPN2;DAD1;DDOST;LMAN1;PMM1;GAL3ST1;MGAT2;DPM3;MPDU1;MOGS;MCFD2;ASGR2;ALG3;DPM2;MAGT1;STT3A
prerank,ncRNA transcription (GO:0098781),0.5288216062810922,1.1292392573082437,0.34594594594594597,0.6379357011610001,1.0,2/13,4.35%,CAVIN1;ANG
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.40079306316505536,1.1287890130780842,0.28197064989517817,0.6386845380285383,1.0,21/94,17.72%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;TCTN3;DCTN1;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B;TCTN1
prerank,organic hydroxy compound transport (GO:0015850),0.44134158587477074,1.1286218288411771,0.3176605504587156,0.6386821615821391,1.0,11/36,28.11%,NPC2;RBP4;SLCO1C1;SLC10A3;SLC16A1;ABCC3;SLCO1B1;SLC10A6;ABCG5;RALBP1;STRA6
prerank,ether lipid biosynthetic process (GO:0008611),-0.46007353577463916,-1.1279647149532905,0.328719723183391,0.670274140591102,1.0,4/10,16.43%,PLA2G4A;FAR1;PEX7;PLA2G4C
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3992210666098941,1.1274423051255509,0.2797055730809674,0.6414856322810194,1.0,22/92,14.50%,SPARC;GRN;CALR;RHOB;AKT1;AGT;RAC1;RTN4;EMC10;PFN1;ENPP2;PROX1;CLASP1;KDR;ARF6;PDCD6;WNT5A;AAMP;FLT4;SOX9;CTSH;RRAS
prerank,synaptic vesicle exocytosis (GO:0016079),0.4359064938341917,1.1272570415992884,0.3150684931506849,0.6415518069262109,1.0,22/40,31.68%,SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;VAMP2;SYT10;CDK5;SYT2;DOC2B;STX4;SNCA;STX1B;SYT5;UNC13A;STX3;PIP5K1C;CPLX1;PCLO;SNPH;SYT7;RAB3A
prerank,cellular response to inorganic substance (GO:0071241),0.4757515370968781,1.1272187587131772,0.3291139240506329,0.6412160756950573,1.0,5/21,12.09%,MT3;AQP1;MMP3;NSMCE3;DDX11
prerank,transcription by RNA polymerase I (GO:0006360),0.450884470954899,1.1270156602750951,0.3259860788863109,0.6413507203090087,1.0,15/34,27.25%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4379999900173994,1.1269456285207093,0.31085714285714283,0.641089278026633,1.0,11/39,21.84%,MBP;FXYD5;AKT1;MYADM;PODXL;KLF4;BMP2;AKNA;NOTCH1;TGFB1;PPM1F
prerank,negative regulation of heart contraction (GO:0045822),0.539369664293662,1.1263908450779154,0.32724719101123595,0.642100097682318,1.0,5/11,19.17%,PLN;SPTBN4;SRI;FKBP1B;GRK2
prerank,positive regulation of developmental process (GO:0051094),0.38311729269675787,1.1260431584965023,0.23255813953488372,0.6425944251714398,1.0,39/164,17.16%,APOE;MDK;HSP90AB1;CFL1;NRXN1;NLGN1;PINK1;TNF;PDGFB;PACSIN1;RTN4;SORL1;TFRC;OTX2;CEBPB;CORO1C;ENPP2;SLC6A6;BASP1;CLASP1;KDR;CCN2;DCN;CAMK1;ARHGEF7;WNT5A;TMEM119;SOX8;SOX9;GJA1;BMP2;FBXO5;MIEF2;MFF;LRP8;DAB2IP;VHL;LMNA;DNM1L
prerank,apoptotic nuclear changes (GO:0030262),0.4653422318151835,1.126038631177961,0.33252720677146314,0.6421642046177943,1.0,5/24,10.22%,GPER1;ENDOG;FOXL2;HMGB1;H1-0
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5275112903739986,1.1257299654867785,0.35524475524475524,0.6425529256745398,1.0,6/12,22.12%,ZFP36L2;HES1;HNRNPU;ESRRB;NOTCH1;REST
prerank,positive regulation of cell growth (GO:0030307),0.3998935239431352,1.1254668838121424,0.26326742976066597,0.6428316290330485,1.0,40/96,26.70%,H3-3A;AKT1;AKAP6;EIF4G2;SEMA7A;S100A9;S100A8;SYT1;LGI1;RIMS2;CXCL16;RIMS1;DDX49;IL2;MFSD2A;MAPT;NTN1;DNPH1;SYT4;EXOSC2;SHTN1;SDCBP;CPNE5;CPNE6;SYT2;TRIM32;MMP14;ADAM17;EXOSC9;SFRP1;EXOSC4;SYT3;TWF2;UNC13A;RNF157;SYT17;ZFYVE27;TAF9B;PSMD10;TGFB2
prerank,regulation of autophagy (GO:0010506),0.3810102080134766,1.1251476574796426,0.18455366098294884,0.6432266960898875,1.0,44/216,16.48%,EEF1A1;PSAP;GFAP;GAPDH;ATP6V0C;HSPB1;MT3;CAPNS1;AKT1;EIF4G2;TREM2;PINK1;LAMTOR2;LAMTOR4;RASIP1;LAMTOR5;TMEM59;ORMDL3;ATP6V1G1;UCHL1;ATP6V0E2;EEF1A2;DEPP1;MAPT;NUPR1;GPR137B;CDK5R1;ATP13A2;DCN;HMGB1;MTMR9;ATP6V0D2;SVIP;CTSA;FBXW7;UBQLN2;LAMTOR3;STK11;ATG101;BAD;RRAGC;CDK5;RRAGD;RAB39B
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4129659452716791,-1.1251398362124851,0.30935251798561153,0.6755558641909786,1.0,7/13,19.68%,NR3C2;ESR1;AR;PLPP1;BMP4;NR3C1;MED1
prerank,protein localization to cell junction (GO:1902414),-0.35559411002501623,-1.1249321942429427,0.26605504587155965,0.673951992308725,1.0,11/22,21.95%,CGNL1;ARHGEF18;HEG1;DLG4;FERMT2;JAK1;NECTIN1;NLGN2;BSN;PAK2;MPP4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4367284578870247,1.124641067081932,0.3159722222222222,0.6441038864270713,1.0,9/35,15.00%,APOE;AKAP6;RIMS2;AQP1;HTR2C;EPHA5;SOX9;NUDT4;CAP1
prerank,regulation of MAPK cascade (GO:0043408),0.3837968479775283,1.1243944584541266,0.25329280648429586,0.6443916118895535,1.0,52/157,20.90%,CD74;LAPTM5;MAPK3;PEBP1;GPER1;GPR37L1;PDGFB;PTPRC;NTRK2;CAV2;DUSP3;FN1;PAK1;P2RX7;KDR;CD24;JCAD;LILRA5;HMGB1;PAK3;IL11;ATP6AP2;FLT4;HRAS;PHLPP1;NEK10;BMP2;YWHAZ;RRAS;GDF15;IGF2;PDGFA;RASGRP1;EPHB1;ADRA1D;ADRA1A;DAB2IP;FLT1;CAV1;SYK;GRM4;FAM83D;MAP2K2;LBH;SPRY3;FLT3;IL6;THPO;PAK5;ADRA2B;TMEM106A;PTPN6
prerank,mitochondrial membrane organization (GO:0007006),0.4516806222906567,1.1243287186688862,0.32786885245901637,0.6441390186305359,1.0,11/32,20.89%,SLC25A5;MICOS13;SLC25A4;GHITM;PMAIP1;TIMM50;SPG7;BAD;APOO;HSPA9;BAK1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.48261633067893955,1.1240291780421194,0.3440993788819876,0.6445261201817672,1.0,11/20,22.55%,TGM2;TMCO1;KCTD17;SELENOK;BAX;WFS1;HERPUD1;BCAP31;BAK1;FIS1;ATP2A2
prerank,regulation of centriole replication (GO:0046599),-0.39063816160409404,-1.123984428688673,0.2786885245901639,0.6743585257928918,1.0,3/17,5.53%,ALMS1;CEP295;KAT2B
prerank,regulation of AMPA receptor activity (GO:2000311),0.46408694292602437,1.1236502405745135,0.3215158924205379,0.6450895392437148,1.0,9/25,25.00%,NLGN1;SHISA7;MAPK8IP2;CACNG8;CACNG5;MEF2C;CACNG2;SHISA6;PRRT1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5331191119871026,1.1233025173786273,0.3333333333333333,0.6455724613314587,1.0,6/13,27.80%,UBE2G2;SVIP;BCAP31;BRSK2;OS9;UBE2J1
prerank,chloride transmembrane transport (GO:1902476),0.42563356701457733,1.1231891058321934,0.3204983012457531,0.6454047347238198,1.0,13/48,18.83%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;GABRB2;ANO4;GLRA3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5405769812981159,1.122291744221973,0.33791208791208793,0.6473670002261825,1.0,5/11,27.61%,YWHAE;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,zinc ion transmembrane transport (GO:0071577),0.46988276805557566,1.12228217763233,0.31852791878172587,0.6469529585252477,1.0,5/22,11.56%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TRPM2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3904367434083774,1.1220305864947442,0.24745417515274948,0.6471894652164509,1.0,36/136,21.72%,TMSB4X;ID3;PRNP;ID1;SPI1;FLNA;HES1;SFRP5;TNFAIP3;ADORA3;HES6;PROX1;OTULIN;NUPR1;RBCK1;WFS1;KLF4;GAS6;FOXS1;NLRP2B;SFRP4;ERBIN;TRAF3;SIGIRR;ARRB2;DAB2IP;TCEAL7;GLIS2;COMMD7;NLRP3;FOXA2;NFKBIA;PYCARD;ID2;DDIT3;MEN1
prerank,positive regulation of DNA binding (GO:0043388),0.44967042437506255,1.1218668979779465,0.3281807372175981,0.6471846375160569,1.0,11/31,21.36%,PARK7;TXN;NME1;HES1;EDF1;HMGB1;H1-0;TWIST1;TGFB1;POU4F1;SIRT2
prerank,regulation of protein kinase activity (GO:0045859),0.38990468629154373,1.1217311130723666,0.2910602910602911,0.6471368078610057,1.0,29/106,19.11%,PPIA;HSPB1;PARK7;SOD1;AKT1;CCL19;CAMK2N2;TNF;PTPRC;C5AR1;DBNDD2;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;GAS6;MMD2;MAPRE3;LCP2;ADCYAP1;CAMKK1;PRKRIP1;AGAP2;DDR2;AKT1S1;QARS1;TAB1;SNCA
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3866194149018348,1.1216055703071606,0.2365482233502538,0.6470394518771314,1.0,49/150,21.84%,PPIA;RACK1;CALM1;HSPB1;PARK7;AKT1;FKBP8;PRNP;CALM3;IGFBP3;PPP1R15B;CAMK2N2;PTPRC;PRR5L;SIRPA;SH3GL2;MYADM;DBNDD2;CORO1C;THY1;YWHAG;MLXIPL;CADM4;RTRAF;TARDBP;WARS1;CAMK2N1;CNKSR3;INPP5J;NLRP2B;DMTN;DAB2IP;CAV1;TWIST1;PRKRIP1;AKT1S1;TERF2IP;QARS1;DNAJC10;TAB1;CALM2;SNCA;TGFB1;DDIT4;SFRP1;PTPN6;SIRT2;MEN1;PPM1F
prerank,cellular response to retinoic acid (GO:0071300),0.4258117433786318,1.121558193513165,0.3291284403669725,0.6467347467302942,1.0,11/42,13.56%,NDUFA13;LTK;BRINP3;PTK6;AQP1;BRINP1;WNT5A;BRINP2;SNW1;SOX9;WNT10B
prerank,positive regulation of exocytosis (GO:0045921),0.4430410987961736,1.1213940528946051,0.3192982456140351,0.6467381651231047,1.0,14/35,26.88%,ATP6AP1;RAB15;CLASP1;CADPS;ATP13A2;RAB3D;SDC4;SDCBP;VPS4A;SNCA;RAB27B;UNC13D;HGS;SNF8
prerank,spinal cord development (GO:0021510),-0.4265018498688573,-1.1211597116661773,0.3210702341137124,0.6799100931667519,1.0,6/12,19.40%,GLI2;VIT;LOXL3;PKD1;NF1;PKD2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3756434718603929,1.1208285402036158,0.19019019019019018,0.6478950346135858,1.0,65/308,17.36%,APOE;RPS19;GAPDH;MDK;COL1A1;PPIB;CFL1;SOD1;GATM;NLGN1;TREM2;AGT;S100A13;NFAM1;UCP2;TNF;PDGFB;EPAS1;FABP5;ENO1;RTN4;SORL1;MIF;FLOT1;BSCL2;CTNNB1;TFRC;LRPAP1;OMA1;OTX2;CEBPB;CLEC6A;IL2;CRH;HAP1;WNT5A;SCD;KDM6B;LCN2;MFAP2;VAMP8;TMEM119;SOX8;THRA;SLC11A1;HCRT;SOX9;GJA1;BMP2;FBXO5;GAS6;NME2;CXCR4;SDCBP;TIAM1;F2RL1;BAD;ACHE;ADRA1D;ADRA1A;CAV1;PIK3CD;TWIST1;ADCYAP1;PPARGC1A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4078452983751924,1.1205033282406982,0.31057268722466963,0.6483374962876457,1.0,13/59,15.46%,BSG;CD84;DSCAM;CNTN4;TENM3;KIRREL3;ROBO4;EMB;PECAM1;CADM3;IGSF9;DSCAML1;ROBO2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.32799314613113917,-1.1199016103292003,0.2619047619047619,0.6812052101277378,1.0,9/31,11.61%,TGFBR3;BMPR1A;TGFBR1;ZFPM2;FGFR2;SMAD7;SMAD4;TPM1;RBPJ
prerank,positive regulation of TOR signaling (GO:0032008),0.43060720550284404,1.11971812135203,0.31995412844036697,0.6500083485138876,1.0,12/40,16.15%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;LAMTOR3;GAS6;RRAGC;RRAGD
prerank,rRNA 3'-end processing (GO:0031125),0.5518727311685905,1.1196841983241081,0.3463687150837989,0.6496414202023194,1.0,2/10,10.38%,RPS21;EXOSC2
prerank,regulation of protein localization to nucleus (GO:1900180),0.43102915410524373,1.1196266241766597,0.32,0.6493651465143001,1.0,9/43,10.86%,PARK7;AKT1;LAMTOR5;ORMDL3;PIN1;TFRC;GLUL;ATP13A2;SUMO3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.38766993289117296,-1.1192871105501774,0.29583333333333334,0.6807242607642795,1.0,6/15,19.25%,NIPBL;TGFBR1;FGFR2;SIX1;PDGFRA;MTHFD1L
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5001837601125079,1.1190427084899408,0.3395225464190981,0.6504814663230851,1.0,8/17,25.28%,NLGN1;RAB15;RAB3D;SYT4;SYT10;DOC2B;UNC13D;SLC4A8
prerank,negative regulation of phosphorylation (GO:0042326),0.40045306519884477,1.1189511429057288,0.26750261233019856,0.6502871472326123,1.0,26/85,19.87%,PPIA;PARK7;DYNLL1;FKBP8;PRNP;IGFBP3;PPP1R15B;PRR5L;SIRPA;SH3GL2;MYADM;CDKN1C;CORO1C;MAPT;NUPR1;CADM4;TARDBP;WARS1;HNRNPU;DAB2IP;PRKRIP1;TERF2IP;DNAJC10;INHBA;TGFB1;GIT1
prerank,midbody abscission (GO:0061952),0.497380447259292,1.118876101074582,0.3443456162642948,0.6500497455067047,1.0,10/17,32.42%,CHMP2B;CHMP5;CHMP6;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C;CHMP4A;CHMP4B
prerank,negative regulation of cell cycle (GO:0045786),0.4024464969336078,1.118389083930468,0.2990353697749196,0.6509060684440388,1.0,26/73,25.82%,RHOB;NPPC;GPER1;CDKN1C;BTG1;BRINP3;GMNN;CEBPA;NUPR1;GAS1;BRINP1;CAMK2N1;BRINP2;LILRB1;BMP2;NLRP2B;HEXIM1;BTG4;INHBA;TGFB1;TFAP4;MEN1;DUSP1;CHMP1A;INHA;HHEX
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4377780638053194,1.1178520214688594,0.32407407407407407,0.6519127390181635,1.0,5/36,5.31%,PPIA;TREM2;PINK1;DUSP3;SIRPA
prerank,positive regulation of lipid localization (GO:1905954),0.5431797216690599,1.1178008543322466,0.34497816593886466,0.651604591125048,1.0,2/11,8.93%,C3;LPL
prerank,negative regulation of glycolytic process (GO:0045820),-0.4471623380391759,-1.1177622600608597,0.31203007518796994,0.680644513123523,1.0,3/10,5.49%,HDAC4;PPARA;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4471623380391759,-1.1177622600608597,0.31203007518796994,0.680644513123523,1.0,3/10,5.49%,HDAC4;PPARA;NCOR1
prerank,sterol transport (GO:0015918),0.492807677285061,1.1177270054688075,0.3178893178893179,0.6513577716829517,1.0,5/19,25.65%,NPC2;MSR1;CAV1;NPC1;ABCG5
prerank,regulation of protein kinase B signaling (GO:0051896),0.37850054917636194,1.1176720838286605,0.24545454545454545,0.6510785580907995,1.0,68/193,26.27%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;CCL19;RCN3;TXN;NRG1;ERBB4;PINK1;GPER1;TNF;PDGFB;HCLS1;RAC1;NTRK2;RTN4;HYAL2;SFRP5;RHOG;P2RY12;KITLG;MC1R;PDCD6;RAMP3;PHLPP1;VAV1;GAS6;CX3CR1;RRAS;GDF15;IGF2;PDGFA;ARRB2;HPSE;CCL3;GATA4;CASS4;PIK3CD;F10;RAC2;ERBB3;NOP53;KLB;MAZ;CD86;FLT3;HGF;TGFB1;THPO;TRAT1;THEM4;DDIT3;BANK1;TGFA;MYDGF;PHLDA3;C1QBP;TEK;CD28;PLEKHA1;PIK3R5;FGF22;MFHAS1;FGFR3;CX3CL1;ITGB1
prerank,cellular response to interleukin-6 (GO:0071354),-0.3433265341629749,-1.1176425462323984,0.2784090909090909,0.6788483277360876,1.0,15/26,22.76%,PID1;FER;PTGIS;YAP1;NFKB1;STAT3;IL6R;SMAD4;JAK1;SBNO2;ST3GAL6;CBL;PTPN11;SRC;CTR9
prerank,presynaptic endocytosis (GO:0140238),0.46762086344286075,1.117007702374374,0.33969465648854963,0.6524408450278841,1.0,9/24,19.11%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA
prerank,negative regulation of DNA replication (GO:0008156),0.5293040319261545,1.1166972844777763,0.3516778523489933,0.6528371575220935,1.0,3/13,7.11%,S100A11;TERF1;GMNN
prerank,pentose-phosphate shunt (GO:0006098),0.5369310803242887,1.1166074078362962,0.36083916083916084,0.652642430348645,1.0,5/11,18.21%,TALDO1;PGLS;RPIA;PGD;TKT
prerank,telomere organization (GO:0032200),0.4213576938466386,1.116514906336151,0.33371428571428574,0.6524342566027292,1.0,15/43,25.10%,H3-3A;TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;DOT1L
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4369570692223431,-1.1163093000092885,0.303886925795053,0.680351463359577,1.0,5/12,17.82%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,protein acetylation (GO:0006473),-0.3288858856834355,-1.115573926007513,0.2532467532467532,0.680251826952374,1.0,11/30,16.20%,CREBBP;NAA40;KAT2B;NAA16;NAA15;ESCO1;KAT6A;SIRT1;NAA35;SPHK1;FOXO1
prerank,RNA transport (GO:0050658),0.4039484390856451,1.1154247889966349,0.29637526652452023,0.6548304954180448,1.0,22/71,22.07%,MAGOHB;MAGOH;DDX39B;ZFP36L1;FLOT1;SRSF9;YBX1;ZFP36;RTRAF;SRSF2;HNRNPA1;RBFOX1;THOC3;TST;EIF4A3;SLBP;U2AF1L4;KIF5C;ALYREF;RAE1;SRSF1;DHX38
prerank,L-glutamate transmembrane transport (GO:0015813),0.5554112546754638,1.1148670542223171,0.35251798561151076,0.6558460528907906,1.0,5/10,19.06%,SLC1A2;SLC25A13;SLC1A1;SLC25A22;SLC25A18
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.44725442139980487,1.114757490501511,0.33171912832929784,0.6557045529675355,1.0,5/31,12.81%,SCP2;PYCR2;GPHN;LSS;HSD3B2
prerank,detection of visible light (GO:0009584),0.5028737259291776,1.114714366126835,0.35309278350515466,0.6553790022963012,1.0,3/16,15.93%,GNA11;REEP6;CNGB1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.48905317682489235,1.1145873176518475,0.33418367346938777,0.6552672813095843,1.0,7/18,23.14%,MDK;CAMK1D;F2RL1;ADAM17;EDN3;IL6;PTN
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.36064656369453996,-1.1139388696864496,0.2692307692307692,0.6828969761749264,1.0,5/20,6.44%,ROCK2;FMNL2;ROCK1;DLG1;NCKAP1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5450326432025886,1.1136805014673647,0.351506456241033,0.6572414062234688,1.0,4/10,19.11%,APOD;NDRG4;PTGIR;SNCA
prerank,regulation of cell population proliferation (GO:0042127),0.36852251416450854,1.1134267377465101,0.1,0.6574547482976371,1.0,167/691,21.14%,FTH1;RPL23;RPS9;RPS4X;RPS15A;CLU;IGFBP6;CLDN5;IFITM1;TSPO;CD81;CALR;GPNMB;GNAI2;CAPNS1;JUND;S100A11;RPS6;LGMN;AKT1;TSPAN31;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;COPS9;AGT;IGFBP3;S100A13;CSNK2B;GPER1;COX17;EMP2;PDGFB;ROMO1;HCLS1;ACVRL1;NTRK2;ZFP36L1;JUNB;HSPA1B;SSR1;ECRG4;CTNNB1;ST18;SERTAD1;HES1;LTK;SFRP5;EID2;FN1;BTG1;MATK;TFRC;RHOG;RNF187;ADORA3;SSTR4;ADGRG1;ATP8A2;NAMPT;SGK1;PAK1;CEBPA;PROX1;KDR;CXCL10;IL2;BCL6B;VIPR1;NUPR1;MLXIPL;TIMP1;CADM4;LAMC2;JUN;CGREF1;HCK;ADGRB1;ZBTB49;KITLG;CSF1R;THAP12;CTBP1;IL11;ATF5;CEP131;WARS1;FLT4;HRAS;DNAJB2;CAMK2N1;AIF1;KLF4;PRMT1;SOX9;HSPA1A;RHOA;DDAH1;BMP2;FBXO5;SFRP4;CTSH;CCDC88A;STK11;SDCBP;TIAM1;PF4;COPS8;SLURP1;PDF;FOLR2;IGF2;PDGFA;DLC1;DLL1;IER5;ADRA1D;ADRA1A;JAG2;DAB2IP;FLT1;CCKBR;VHL;CIAO1;LMNA;PDCD5;ADAM17;SCIN;CNBP;ADAMTS1;TBRG4;ERBB3;FABP7;BTG4;MAZ;SCGB3A1;STX4;HMGN5;EDN3;SOX11;DDRGK1;CD86;INHBA;RTKN2;TFAP2B;FLT3;NOTCH1;IL6;KLF11;MAPK15;TGFB1;ING5;OSGIN1;THPO;SFRP1;TFAP4;MYC;CRLF1;PTPN6;CRLF2;SST;PTPRU;ID2
prerank,epithelial cell morphogenesis (GO:0003382),-0.38326354241757277,-1.1133471835290145,0.2803347280334728,0.6823098020888431,1.0,3/17,7.96%,COL22A1;SIPA1L3;MET
prerank,pancreas development (GO:0031016),-0.4288501044000995,-1.1130058744842375,0.3104693140794224,0.6811918669149126,1.0,3/12,8.84%,TCF7L2;MET;NPHP3
prerank,regulation of cellular amide metabolic process (GO:0034248),0.43683642788137284,1.1128730994402258,0.32555425904317387,0.658522264911261,1.0,7/32,13.19%,PGAM1;RPL10;GRM5;METAP1;PCIF1;RBM4B;METTL18
prerank,negative regulation of cellular process (GO:0048523),0.3686677496620646,1.1126362440959814,0.14,0.6587370617494701,1.0,141/521,22.49%,FTH1;ARHGDIA;CLU;IGFBP6;RACK1;IFITM1;MDK;GPNMB;MT3;NDUFA13;PARK7;RHOB;S100A11;NME1;TMBIM6;TREM2;CRYAB;ERBB4;CD34;NPM1;IGFBP3;TXNIP;CCDC85B;CSNK2B;ADAM15;GPER1;ACVRL1;DSCAM;ENO1;RTN4;MIF;HSPA1B;PPP2R1A;SIRPA;CTNNB1;ST18;PDE3B;HYAL2;SFRP5;ARHGDIB;BTG1;LRPAP1;ADORA3;SSTR4;ADGRG1;ATP8A2;GMNN;BNIP3L;KLK8;PODXL;CEBPA;WFDC1;PROX1;CCN2;SYT11;JADE1;NUPR1;VAMP3;CGREF1;ADGRB1;ZBTB49;ARHGDIG;APBB1;THAP12;BRINP1;CTBP1;SOX17;ATF5;MSX1;TMEM109;WARS1;WFS1;VAMP8;HRAS;DNAJB2;CAMK2N1;ACTN1;KLF4;BST2;HSPA1A;GJA1;DDAH1;LILRB1;BMP2;FBXO5;NLRP2B;PDE12;SFRP4;STK11;COPS8;SLURP1;NR1H2;DLC1;DLL1;ING1;ADRA1A;DACT3;DAB2IP;VHL;SLIT3;LMNA;NDUFS3;PDCD5;SCIN;ADAMTS1;ERBB3;FABP7;BTG4;ANXA6;SCGB3A1;SOX11;CCAR2;LPXN;INHBA;TFAP2B;NOTCH1;IL6;KLF11;TGFB1;ING5;OSGIN1;SFRP1;SPHK2;TFAP4;MYC;PTPN6;SST;PTPRU;SIRT2;PLXND1;RERG;CCN3;MEN1;TDRD9;CDA;SSTR2;REST;TMEM127;BLM;CD164;DUSP1
prerank,intracellular pH reduction (GO:0051452),0.4454534508461133,1.1126001715268554,0.3364595545134818,0.6583803149708474,1.0,10/33,23.58%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;SLC11A1;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,regulation of neuron differentiation (GO:0045664),0.4011607169989266,1.112012164017923,0.317937701396348,0.6595079323217407,1.0,27/76,22.12%,CALR;NBL1;NLGN1;CNTN4;YWHAH;HES1;LTK;BRINP3;NRCAM;YWHAG;CDK5R1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;TIAM1;HEY1;BEND6;DLL1;TRIM32;SOX11;MEF2C;ADRA2B;ID2;REST
prerank,autonomic nervous system development (GO:0048483),0.5063831169714627,1.1117422384396713,0.3482849604221636,0.6597851027565544,1.0,7/17,21.29%,FN1;KIF26A;PHOX2A;SOX8;SOX11;TFAP2B;SOX10
prerank,positive regulation of viral process (GO:0048524),0.4098437379515515,1.1115860834264624,0.31917211328976036,0.6597609918281127,1.0,18/60,21.24%,PPIA;POLR2E;POLR2D;POLR2F;IFIT1;NELFCD;DDB1;POLR2G;SUPT4H1;PABPC1;POLR2K;PDE12;NELFE;TYRO3;VPS4A;RAD23A;POLR2H;CDK9
prerank,potassium ion homeostasis (GO:0055075),0.46935493135724576,1.1115557896244923,0.3450439146800502,0.6594116270066809,1.0,9/23,19.55%,ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;ATP1B1;ATP1B3;KCNMA1;TFAP2B
prerank,covalent chromatin modification (GO:0016569),0.5142775637273784,1.111545560276161,0.33655172413793105,0.6589961621327234,1.0,2/14,1.76%,MT3;PARK7
prerank,iron-sulfur cluster assembly (GO:0016226),0.46447320513629986,1.1111550182172012,0.3669950738916256,0.6596223307333143,1.0,8/24,21.18%,BOLA2;GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B
prerank,ketone body metabolic process (GO:1902224),-0.4541456248592881,-1.1110575337268886,0.3333333333333333,0.6842561211973857,1.0,8/10,29.14%,ACSS3;BDH2;HMGCS2;BDH1;AACS;HMGCLL1;OXCT1;HMGCL
prerank,histone H4-K8 acetylation (GO:0043982),-0.40555705922979235,-1.1107942005487104,0.28888888888888886,0.6807841598669717,1.0,5/15,18.15%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),-0.40555705922979235,-1.1107942005487104,0.28888888888888886,0.6807841598669717,1.0,5/15,18.15%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.43146998713390905,1.1105959382066364,0.3333333333333333,0.6606917043139231,1.0,10/37,16.62%,NLGN1;GRID2;TENM2;TENM3;IL1RAPL1;TENM4;CADM3;PTPRD;DCHS1;VCAM1
prerank,response to ionizing radiation (GO:0010212),-0.2712088854367784,-1.110297964958981,0.24074074074074073,0.6800991663492664,1.0,22/70,18.08%,EYA1;BABAM2;DCUN1D3;COP1;CLK2;BRAT1;SPIDR;UIMC1;RNF8;NHEJ1;INO80;MRNIP;EYA3;ATM;TNKS1BP1;USP28;SIRT1;KDM4D;TP53;INIP;MAPK14;INTS3
prerank,regulation of secretion by cell (GO:1903530),0.415242479173544,1.1098553040823222,0.3322475570032573,0.6622337137836948,1.0,23/54,27.74%,SYT1;RIMS2;RIMS1;RAB15;RAB3C;SCG5;VAMP3;VAMP2;STXBP5L;RAB3D;HAP1;VAMP8;SYN1;HCRT;RAB26;STX4;MEF2C;LLGL1;ARFIP1;KCNMB4;RAB8A;LGI3;CPLX1
prerank,synaptic vesicle localization (GO:0097479),0.5130263141097372,1.1098105763730937,0.3557692307692308,0.6619193173202429,1.0,5/13,18.47%,NLGN1;KIF5A;SYNDIG1;CDK5;KIF5C
prerank,regulation of protein polymerization (GO:0032271),0.43589205082849797,1.1097849764313428,0.3446261682242991,0.6615435024233675,1.0,12/35,16.75%,HSP90AA1;TPPP3;HCLS1;PFN1;ESAM;MAPT;MAP2;COTL1;PAK3;ARL2;MAPRE3;PFN2
prerank,icosanoid biosynthetic process (GO:0046456),0.5537243468898064,1.1093903215519239,0.3620933521923621,0.6621453100033245,1.0,4/10,17.02%,FADS1;MGST3;ALOX5AP;LTC4S
prerank,negative regulation of lyase activity (GO:0051350),0.4951239154052586,1.1091575455507878,0.36015831134564646,0.6623288410717685,1.0,5/16,20.06%,GNAI2;RD3;PHPT1;CCR2;GABBR2
prerank,protein depolymerization (GO:0051261),0.45146172759762876,1.108699313717891,0.3463356973995272,0.6631363267966135,1.0,7/27,13.97%,GSN;CFL1;STMN3;STMN4;MICAL1;DSTN;STMN1
prerank,response to amino acid starvation (GO:1990928),0.4019853917150144,1.108388435922141,0.3150684931506849,0.6635026902925413,1.0,10/72,7.08%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,negative regulation of response to stimulus (GO:0048585),0.40936861275244535,1.108379921808715,0.3304157549234136,0.6630879094348463,1.0,20/60,20.67%,CLU;CD34;IGFBP3;TLE5;PTK6;THY1;COL3A1;YBX1;KIF26A;WFS1;KLF4;DDAH1;FBXO5;NR1H2;PIM3;TWIST1;ERBB3;SRMS;FOXA2;BRAP
prerank,negative regulation of T cell differentiation (GO:0045581),0.5483217491531429,1.1082922380850624,0.36023054755043227,0.6628834686354115,1.0,3/10,13.99%,MDK;CTLA4;ZC3H8
prerank,Rac protein signal transduction (GO:0016601),0.4880275752540298,1.1078482744558051,0.35657894736842105,0.6636313945959443,1.0,6/18,17.41%,RAC1;ELMO1;RHOG;AIF1;TIAM1;RAC2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5428359442926773,1.1078404365509156,0.365034965034965,0.6632167089276413,1.0,5/11,21.36%,RAC1;PAK1;STMN1;HGF;SIRT2
prerank,cellular component assembly (GO:0022607),0.3731421269025914,1.1078071249751638,0.21965897693079237,0.6628781250702782,1.0,63/253,20.50%,ACTB;ACTG1;CD74;GSN;CHCHD10;ELOB;LAMC1;NLGN1;SLC2A1;ARL6IP1;ANK3;RAC1;SYCP2;TAPBP;RTN4;PPP2R1A;NEFH;FLNA;GPM6B;IL2RB;HES1;ADD2;RHOG;FAM107A;OTX2;RIMS1;CAPZA2;MYO7B;LCP1;VAMP3;VAMP2;RHOV;MICAL1;EPPK1;WNT5A;AIF1;SOX9;RHOA;MAGI1;GAS6;YWHAZ;VMP1;RHOU;TSPAN4;CAPG;SPG7;PDGFA;YTHDF1;DMTN;DNM1L;PPARGC1A;RAC2;SCIN;EPRS1;FBLIM1;LPXN;LRRTM3;DCX;TGFB1;QSOX1;IL1RAP;CAPN3;TFAP4
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3525029910594658,-1.1076132139402877,0.2848101265822785,0.685320294212594,1.0,6/26,4.13%,ROCK2;ASAP3;ALMS1;SLC9A1;ROCK1;PRKN
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3529155625240576,-1.1075841838791214,0.3165829145728643,0.6833514775886296,1.0,10/22,19.26%,NTRK3;PDPK1;AGTR1;FGFR2;PDGFRB;ESR1;ABL2;KIT;PDGFRA;FGF2
prerank,protein localization to cell periphery (GO:1990778),0.3793644620865202,1.10739178902836,0.28134556574923547,0.6635477913651469,1.0,34/133,18.17%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;DPP6;TMED2;MYO5A;RAB3C;P2RY1;RAB3D;RAMP3;GAS6;TNFRSF1A;MAP7;EHD1;LIN7C;ATP1B1;SPTBN4;FGF13;EPB41L3;CAV1;CRB3;ATP1B3;EHD2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.42164510093915625,1.1072718012562899,0.34275618374558303,0.663433244366407,1.0,4/42,6.08%,ACTB;VPS72;MBD3;ZNHIT1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4445891830977957,1.106767748051967,0.33821733821733824,0.6643611119741453,1.0,13/26,24.86%,MBP;PSME1;PSME2;PSENEN;GRIN1;VSIR;APH1B;GRIN2B;PRELID1;EFNA1;PYCARD;AGER;APH1A
prerank,kidney development (GO:0001822),-0.2855500689371733,-1.1065292227904864,0.22077922077922077,0.6842954822033092,1.0,17/65,13.72%,SULF1;KANK2;ZBTB16;GLI2;NIPBL;AGTR1;TGFBR1;PYGO1;ARL3;PCSK5;CEP290;IFT88;NPHP3;PKD1;GREB1L;SIX1;BMP4
prerank,ion transport (GO:0006811),0.38595014405859585,1.1059547699984766,0.2949640287769784,0.6661358382497169,1.0,32/111,19.69%,TSPO;SLC17A8;GABRB1;SLC39A1;LRRC8A;SLC24A4;SLC24A2;SLC1A2;GRIN1;SLC12A5;CNGA3;SLC26A4;TMEM63C;SLC15A4;SLC17A7;LASP1;SLC17A6;KCNN2;GLRA1;ATP1A4;SLC1A1;CHRNA4;SLC25A22;SLC8A1;SLC15A2;CNGB1;ATP11B;SLC9A9;SLC4A2;VDAC2;SLC25A18;PKD2L1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4410654665779591,1.10578892584302,0.3409350057012543,0.6661155456969785,1.0,9/33,13.55%,RAMP2;MDK;TNFAIP3;KDR;NUPR1;GATA2;IL11;WFS1;GAS6
prerank,purine nucleotide metabolic process (GO:0006163),0.460068472005839,1.1053046147103895,0.35964912280701755,0.6669715824857093,1.0,11/24,25.99%,GPX1;GART;DNPH1;PNP;PRPS1L1;PRPS1;NT5C;GUK1;GDA;PRPSAP1;ADSL
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5364350519011037,1.1049814451260334,0.38514442916093533,0.6673860825952019,1.0,3/12,13.02%,MAPK3;CSF1R;BST2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4283704982592602,1.104928106933079,0.33373063170441003,0.6670873049613649,1.0,14/35,25.53%,ERBB4;TNF;PTPRC;HES1;LEPROT;CAV1;VHL;NOTCH1;IL6;IL10RB;ADIPOR1;SOCS3;DOT1L;HGS
prerank,hemopoiesis (GO:0030097),0.39026471483180375,1.1049125366500427,0.3217665615141956,0.6666832564128123,1.0,30/87,20.17%,ATF4;CD34;LYL1;GLRX5;PDGFB;PTPRC;ZFP36L2;TIRAP;SBDS;KIRREL3;CEBPA;KDR;KITLG;CSF1R;WNT5A;FLT4;ARMC6;SELPLG;WNT10B;RRAS;L3MBTL1;DLL1;FLT1;TOX;INHBA;RTKN2;FLT3;TGFB1;TPO;SFRP1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.42697008438138234,1.1046719289264018,0.3302325581395349,0.6668732223117418,1.0,13/39,23.48%,RBP4;TRH;LRRC8A;GPER1;CRH;RASL10B;BAD;ADCYAP1;DOC2B;GLUD1;NNAT;PSMD9;ACSL4
prerank,aortic valve development (GO:0003176),-0.32253939916249863,-1.103732084536067,0.26875,0.6896468096195374,1.0,6/34,4.95%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4755694875072727,1.1036475879408227,0.3541666666666667,0.6691956725568591,1.0,5/19,17.16%,PARK7;PINK1;ATP13A2;FBXW7;DNM1L
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3222736999154531,-1.1034962365347378,0.23170731707317074,0.6882601199784796,1.0,8/29,10.54%,PLEKHH2;LIMA1;ARFGEF1;SLIT2;PRKN;ARPIN;KANK1;SMAD4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.3955569926358937,-1.1025173345662596,0.3140495867768595,0.688793925453487,1.0,6/14,22.93%,SEC24D;SCAP;SEC24A;SEC24C;SEC31B;RAB1A
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.38656001447886307,-1.1024591817540808,0.32075471698113206,0.6869245714041267,1.0,6/16,19.40%,FOXD1;FGF1;SIX1;BMP4;FGF2;PKD2
prerank,regulation of trophoblast cell migration (GO:1901163),0.5136372026224457,1.1022494063222894,0.3781163434903047,0.6724349590391654,1.0,4/14,13.23%,CALR;ARHGDIB;TIMP1;GJA1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5210169402002646,1.102067655822743,0.36126373626373626,0.6724957263517296,1.0,6/13,25.50%,PTPRC;HES1;IL6;CRLF2;DOT1L;PTPRT
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4416199614326185,1.1018616254775093,0.33489461358313816,0.6726014596846207,1.0,10/30,23.89%,CD34;ISG15;HSPD1;LILRA5;HMGB1;F2RL1;SYK;IL6;PYCARD;CD28
prerank,cellular amide metabolic process (GO:0043603),0.38718662954276195,1.101707751585473,0.30833333333333335,0.6725694708722715,1.0,32/102,24.24%,DBI;ATF4;CPXM1;CPD;ORMDL3;PPP2R1A;CPE;PLAAT3;SMPD1;AEBP1;OXSM;CPXM2;ACOT1;ACOT7;SLC19A1;GLYAT;DNPEP;NAAA;FOLR2;ABCA2;NIT1;ACOT4;CLN8;SHMT2;THEM4;ASAH2;MTHFS;SGPL1;ACSM5;ORMDL2;CPZ;THOP1
prerank,second-messenger-mediated signaling (GO:0019932),0.3888014284252248,1.1010664318948769,0.3086548488008342,0.6738053865683843,1.0,18/82,18.94%,APOE;RCAN3;AGT;PPP2R1A;CCR5;P2RY12;CHRM3;DDAH1;CXCR4;MAFA;CX3CR1;NUDT4;RYR2;CCL3;DDAH2;NOS2;CCR2;EDN3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4482603121504592,1.101050881465278,0.3654066437571592,0.6734053977449261,1.0,12/28,21.15%,ATF4;CEBPB;SELENOK;BAX;BBC3;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;BAK1;DDIT3
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4561319374116025,1.1007978659734878,0.34681372549019607,0.6736589683519814,1.0,9/25,19.37%,APOC1;RAC1;LRPAP1;ARF6;UBQLN2;SDCBP;ANKRD13D;ABCA2;UNC119
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4478343920130506,1.1005842434078288,0.34296028880866425,0.6737844686245404,1.0,6/27,10.98%,FXYD5;FXYD1;YWHAH;SCN4B;FXYD7;FGF12
prerank,clathrin coat assembly (GO:0048268),0.4967841017203153,1.1003392195301276,0.3687002652519894,0.6739761619812547,1.0,6/15,14.97%,NSG1;CLTC;AP2S1;FCHO1;NSG2;CLTA
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4873001930323312,1.0999304699763781,0.35733333333333334,0.6746437983167743,1.0,5/17,16.41%,CEBPB;CD24;SOX9;DLL1;CAV1
prerank,hyaluronan metabolic process (GO:0030212),0.4606926041656612,1.099744433006601,0.3618925831202046,0.6746844718356544,1.0,4/23,8.34%,HEXB;HEXA;HYAL2;GUSB
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.46884689481640274,1.099633049144972,0.3787878787878788,0.6745503790714428,1.0,9/22,30.38%,RPS21;EXOSC2;EXOSC9;FTSJ3;ERI1;NOP14;NOL9;URB1;PES1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4478919223491246,1.0994802589879973,0.34404761904761905,0.6745343311552717,1.0,14/30,27.25%,CAVIN1;POLR2E;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,regulation of heart contraction (GO:0008016),0.39015602789566817,1.099116498480027,0.29758149316508936,0.6750644416074868,1.0,23/90,17.75%,CALM1;S100A1;NPPC;FXYD1;CALM3;AGT;ADORA3;ATP1A3;ATP1B2;PLN;FXYD7;ATP1A4;ATP1A1;ATP2B1;DES;TRPC1;KCNE5;ATP1B1;SLC8A1;RYR2;SRI;ATP1B3;FKBP1B
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.42819533718873964,1.0989484253164468,0.35555555555555557,0.6750688551049845,1.0,8/34,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;ARHGEF7
prerank,positive regulation of cell cycle process (GO:0090068),-0.24820110130698286,-1.098525588379697,0.1875,0.6957255202268535,1.0,26/91,21.61%,SVIL;CEP295;LRP5;PRKCE;INSR;CDC14A;UBXN2B;IGF1;PDGFRB;CSPP1;CDC25B;INO80;PKP4;GIPC1;NUMA1;PHIP;DYNC1LI1;MAD2L1;CDC14B;RACGAP1;NUP62;PKN2;NDC80;KIF23;XRCC3;TPR
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3967223149402919,1.098407053752627,0.33874458874458874,0.6760515141422176,1.0,10/63,13.46%,RPL26;RPS27L;CHEK2;PCBP4;RPA2;CCND1;BAX;PCNA;PRMT1;FBXO31
prerank,microtubule nucleation (GO:0007020),-0.38006995525122744,-1.098364615136392,0.3183856502242152,0.6941237043889125,1.0,10/19,27.27%,AKAP9;GOLGA2;CCDC57;TUBGCP6;NDEL1;TUBGCP5;TPX2;TUBG1;SLAIN2;TUBG2
prerank,bone development (GO:0060348),0.42260452785065244,1.098295932626801,0.35,0.6759188565980503,1.0,6/39,6.69%,RPL13;PPIB;VKORC1;TGM2;PTPRC;SBDS
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4313560475182473,1.097510283564835,0.3492990654205608,0.6775317509643187,1.0,13/35,25.41%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;RFC4;POLG;POLD1;PNKP;RPA3;LIG1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4014410271853691,-1.0970783001640039,0.3166023166023166,0.69544244841035,1.0,2/13,2.98%,KCNK5;KCNT2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4156269429667183,1.0970468659219605,0.3577981651376147,0.6783300827587857,1.0,15/41,28.86%,CTSS;AKAP6;ANK3;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1;STAC
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.38166255899953694,1.096974361685535,0.3045267489711934,0.6780864022511365,1.0,25/110,17.29%,RAMP2;GPER1;ADGRB3;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;ADGRG1;RXFP1;CXCL10;ADGRB1;MC1R;ADGRB2;CALCB;RAMP3;ADCY4;PF4;ADGRL4;ADRA1D;ADRA1A;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4340879811744754,1.0969015635436248,0.3739545997610514,0.677845544652216,1.0,9/31,19.67%,RBP4;PTPRC;TFRC;IL2;VAMP3;DNAJB9;STX4;CD86;IL6
prerank,dopaminergic neuron differentiation (GO:0071542),0.48142497710603327,1.096859897841233,0.3546284224250326,0.6774997180737933,1.0,6/19,21.30%,CTNNB1;MANF;OTX2;PHOX2A;FOXA2;FOXA1
prerank,negative regulation of hormone secretion (GO:0046888),0.538250345431015,1.0964858605919863,0.37186629526462395,0.6780461334119897,1.0,2/10,13.23%,IL11;GJA1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.4507526542659513,1.0963925682067333,0.3737980769230769,0.6778451963698805,1.0,5/25,7.46%,CTSS;NDUFA4;ANK3;COX17;ATP1B2
prerank,oogenesis (GO:0048477),0.4802558222594028,1.0960721536580016,0.3731931668856767,0.6782593400720464,1.0,6/15,24.56%,MDK;FMN2;NANOS2;IHO1;PTN;METTL3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.27095024702564885,-1.0955504085198493,0.2054794520547945,0.6976922417484784,1.0,17/67,10.73%,EGFR;FER;ABL1;GHR;EPHA3;IL15;EPHA4;EFEMP1;INSR;DYRK1A;PIBF1;FGFR2;PDGFRB;ABI1;ABL2;PTK2;EPHB2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3681102513262089,1.0954621553570445,0.2600401606425703,0.6794405148980547,1.0,60/234,21.50%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;PARK7;AKT1;NPM1;AGT;NFAM1;BEX1;TNF;LAMTOR5;HCLS1;S100A9;S100A8;CAMK1D;HSPA1B;FLOT1;TIRAP;CTNNB1;TFRC;HIPK2;UBA52;EPHA5;RBCK1;WNT5A;ZBTB7A;RHEBL1;HSPA1A;RIPK2;HDAC5;UBE2V1;CX3CR1;TLR6;TSSK4;LRP8;ADCY8;CAV1;TRIM32;PPARGC1A;DDR2;TERF2IP;TAB1;PSMA6;DDRGK1;RTKN2;NLRP3;TRIM13;IL6;IL1RAP;CAPN3;BUD31;NFKBIA;PYCARD;FZD2;DDIT3;FOXA1;FZD1
prerank,response to chemokine (GO:1990868),0.5101350145956111,1.095091777702421,0.39655172413793105,0.679986150516172,1.0,5/13,26.20%,CXCL12;RHOA;DOCK8;DUSP1;OXSR1
prerank,regulation of viral life cycle (GO:1903900),0.46859066936008487,1.0949384733693692,0.37333333333333335,0.6799374241830245,1.0,5/21,22.66%,PPIA;HS3ST5;TYRO3;VPS4A;TRIM68
prerank,response to exogenous dsRNA (GO:0043330),0.4798873029818852,1.0943896499904529,0.36768447837150126,0.6809168617484564,1.0,9/18,31.39%,FLOT1;PQBP1;IFIT1;SLC3A2;CAV1;RALB;RFTN1;DHX9;MAVS
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.510345519875602,1.0943185638815591,0.3673469387755102,0.6806868008245148,1.0,5/13,15.30%,SHISA7;GRIK2;SYNGR1;SYP;PPFIA3
prerank,ion homeostasis (GO:0050801),-0.31340021554620545,-1.0942888386418952,0.3163841807909605,0.6991119115834876,1.0,20/30,34.50%,SLC4A10;CAMK2D;FHL1;WNK4;KLHL3;SLC4A3;HCN4;RANGRF;NEDD4L;SLC4A9;SLC4A5;SLC4A4;SLC4A11;AP3D1;SLC4A7;SLC30A2;SLC30A3;SLC30A8;WNK1;RHAG
prerank,regulation of protein processing (GO:0070613),0.4672906649024927,1.0942131753900113,0.3680297397769517,0.680528685509459,1.0,5/21,10.76%,PRNP;SERPINE2;TMEM59;PRSS37;GAS1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.31927710075575455,-1.0941595825128385,0.2857142857142857,0.6973441134608603,1.0,10/31,14.40%,PARD3B;PARD3;PDCD6IP;DLG1;SYNJ2BP;OPHN1;PDZD11;MARK2;PRKCI;MYO9A
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3642386140166174,-1.0935056109891645,0.34946236559139787,0.6971485490224797,1.0,6/20,16.08%,CLK2;NCOR1;SIK1;C1QTNF3;CRY1;WNT4
prerank,phospholipid metabolic process (GO:0006644),0.3913408813725164,1.0931488700645808,0.33763440860215055,0.682896233899851,1.0,21/71,25.29%,GPX4;PLAAT3;FADS1;LIPG;ENPP2;LPL;PIP4P1;PCYT2;SMPD1;PLA2G4F;GDE1;PLBD2;ABCA2;CLN8;AGPAT5;PLPPR2;PGP;AGPAT2;PLA2G3;PLPPR4;ABHD12
prerank,neuromuscular process controlling balance (GO:0050885),0.5194706834748866,1.0931476121509323,0.38645980253878703,0.6824637383299027,1.0,2/12,5.93%,NRXN1;PCDH15
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.39257248453125254,1.0927057849385,0.3333333333333333,0.6832276158682661,1.0,6/76,4.50%,TMSB4X;RPS3;LAPTM5;CCL19;TNF;SPI1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4289765235210751,1.0920735739707403,0.3394919168591224,0.6844926500382432,1.0,12/34,19.31%,TREM2;NR1D1;TNFAIP3;TICAM2;NLRP2B;TLR6;F2RL1;CD300LF;DAB2IP;TYRO3;CD300A;CD14
prerank,synaptic vesicle recycling (GO:0036465),0.4328223672460065,1.0920184833879274,0.36483253588516745,0.6842158483235125,1.0,18/31,32.94%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA;WNT7A;SYT5;TBC1D24;PIP5K1C;SYT7;RAB3A;CEL;SNCG;SNCB
prerank,blood vessel endothelial cell migration (GO:0043534),0.4636102938413653,1.092015989064666,0.3541147132169576,0.6837842356283294,1.0,5/22,8.38%,AKT1;SOX18;ID1;EMP2;KDR
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48156356987041604,1.0918735378374411,0.3793548387096774,0.6837247114293455,1.0,7/17,17.48%,AKT1;CCND2;PDGFB;CCND1;PROX1;MAPRE3;ADAM17
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5165764586531838,1.0918268621157465,0.3656509695290859,0.6834191761144159,1.0,5/13,19.83%,SOX8;SOX9;DLL1;NOTCH1;TGFB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.40489767903168805,-1.0914993147766876,0.358974358974359,0.6987714434204231,1.0,6/13,16.38%,STAT5B;IL15;IL15RA;STAT3;STAT5A;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),-0.40489767903168805,-1.0914993147766876,0.358974358974359,0.6987714434204231,1.0,6/13,16.38%,STAT5B;IL15;IL15RA;STAT3;STAT5A;JAK1
prerank,neuron projection regeneration (GO:0031102),0.5331895679335215,1.0912998511342278,0.38677918424753865,0.6843845663492597,1.0,7/10,40.34%,GAP43;PTN;DHFR;NREP;MTR;OMG;RTN4RL1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3946589461944903,1.0911780116907228,0.34190782422293675,0.6842907241315073,1.0,22/72,20.90%,TREM2;AGT;GPER1;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;KDR;DCN;SOX9;F2RL1;PDGFA;NCF1;FLT1;PIK3CD;ERBB3;MAZ;FLT3;HGF;PTPN6
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5067179596478679,1.0911425062893112,0.376984126984127,0.683956952740323,1.0,3/13,8.38%,CTNNB1;COL4A1;KDR
prerank,sulfation (GO:0051923),-0.4289406709230483,-1.0911282228487156,0.3391003460207612,0.6976606847825941,1.0,1/11,0.07%,UST
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5143605808388009,1.091016457670749,0.37786774628879893,0.6838393889332273,1.0,4/13,17.48%,MDK;HMGB1;IGF2;ADAM17
prerank,nucleic acid-templated transcription (GO:0097659),0.41832123954085937,1.090676382079863,0.36022727272727273,0.6842731371583307,1.0,8/42,15.37%,PTMA;POLR2E;POLR2D;POLR2F;XAB2;POLR2G;POLR2K;RRAGC
prerank,positive regulation of neuron differentiation (GO:0045666),0.4207900488565781,1.0906135698455215,0.36009174311926606,0.6839869436874575,1.0,18/40,24.63%,NBL1;BRINP3;NRCAM;PROX1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;BEND6;TRIM32;SOX11;MEF2C;ADRA2B;REST;ECT2;TCF3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3091405200467804,-1.0903479872685724,0.28378378378378377,0.6975997302987909,1.0,11/39,15.56%,AFDN;EPHA7;FLOT2;DPP4;SMAD7;PTK2;CDH1;NF2;JAG1;MDGA1;SPINT2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4837620304084007,1.0899773366224261,0.3648468708388815,0.6852599337459664,1.0,3/16,3.71%,MDK;ITGB2;TNF
prerank,regulation of epithelial cell proliferation (GO:0050678),0.38499799165908855,1.0898127232185222,0.33403361344537813,0.6852503836257658,1.0,21/85,16.56%,B2M;GPX1;GRN;LAMC1;NME1;MAGED1;NR1D1;ACVRL1;ZFP36L1;C5AR1;CDKN1C;NUPR1;EPPK1;ZFP36;HRAS;SOX9;TIE1;NME2;BAD;DAB2IP;EPB41L4B
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.44322423824878343,1.0894383545307393,0.357487922705314,0.6857468499874798,1.0,12/27,34.98%,CHKB;PLAAT3;PCYT2;NAAA;ETNPPL;PLA2G3;PLA2G6;CEPT1;PNPLA8;PISD;PLAAT1;PLA2G15
prerank,hepaticobiliary system development (GO:0061008),-0.3591641552775251,-1.0889851702361881,0.3412322274881517,0.6991175979295562,1.0,5/20,7.96%,TGFBR3;NIPBL;COBL;ARID5B;MET
prerank,muscle cell differentiation (GO:0042692),0.434392502486259,1.08866485682009,0.3520286396181384,0.6873218066754074,1.0,8/32,20.07%,SGCZ;MRTFA;SEMA4C;MTLN;NINJ1;SYNE1;TMEM204;MEF2C
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.49404913026024677,1.0886173093004738,0.3615894039735099,0.6870068884871874,1.0,4/15,14.67%,ENTPD3;AK4;NME2;CMPK2
prerank,cholesterol biosynthetic process (GO:0006695),0.43356224141551625,1.0878389558439205,0.3598130841121495,0.6887026986327117,1.0,12/31,28.43%,LSS;DHCR24;ACAA2;SC5D;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.42028853156530904,1.0873897482462296,0.37003405221339386,0.6894963439517392,1.0,9/39,14.60%,FXYD5;FXYD1;YWHAH;YWHAE;SCN4B;FXYD7;FGF12;CHRM3;KCNE5
prerank,regulation of organelle organization (GO:0033043),0.3882403724261603,1.0872592902627969,0.3524504692387904,0.6893846213103477,1.0,21/80,17.16%,MAPK3;ARL6IP1;PINK1;S100A9;S100A8;STMN3;MSN;LMAN1;SAR1A;SURF4;MYO5A;SYT11;MAPT;ATP13A2;TMED9;PJVK;MIEF2;MFF;PDE4DIP;SQSTM1;DNM1L
prerank,regulation of JUN kinase activity (GO:0043506),0.4286596325053602,1.0870606492079697,0.3675115207373272,0.6894425009717724,1.0,7/33,16.24%,RPS3;TNF;PAK1;DNAJA1;MAPK8IP1;TLR6;DAB2IP
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4561910574680925,1.0867665430040403,0.36363636363636365,0.6897948362196304,1.0,3/21,3.08%,MT3;PARK7;PINK1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.39330782418997884,1.0864317560709051,0.3723404255319149,0.6902454540715738,1.0,20/75,18.30%,SPARC;CLDN5;SERPINF1;CTNNB1;PDE3B;PGK1;VASH1;CXCL10;SARS1;DCN;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;AGO1;ADAMTS1;CCR2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3844894645270084,1.0864142380125106,0.36037934668071653,0.6898626711220118,1.0,25/78,19.83%,ACTB;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;TMEM59;AP2M1;RHOG;CLTC;ARF6;ZDHHC5;RAMP3;VAMP8;RSC1A1;CLIP3;CDK5;SQSTM1;MMP14;TMBIM1;STX4;VPS4A;STAC3;TGFB1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.41726294586550305,-1.0861447741768755,0.34765625,0.7049834695795787,1.0,4/12,15.55%,GMDS;FUT8;PARG;GFPT2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.42084660058935475,-1.08571696805883,0.358974358974359,0.7040997089921205,1.0,4/11,8.19%,GHR;IRS1;EIF2AK3;IGF1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.4596478546586391,1.085586401227005,0.3669950738916256,0.691602478339739,1.0,6/23,16.91%,MDK;AGT;SOX8;SOX9;GJA1;PIK3CD
prerank,establishment of protein localization to membrane (GO:0090150),-0.2755136970120501,-1.0851613100894162,0.28169014084507044,0.7037158631318926,1.0,9/66,6.60%,AFDN;EGFR;PARD3;SYNE3;BRAF;SEC63;ZDHHC1;GORASP2;RAB10
prerank,histone H4 acetylation (GO:0043967),-0.2939042739214587,-1.084939096155477,0.308411214953271,0.702372845160298,1.0,11/47,13.78%,OGT;ZZZ3;KMT2A;NAA40;EPC1;KAT7;ATF2;EP400;KANSL3;BRD8;JADE2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38471109758782485,1.0844343348384557,0.35714285714285715,0.6941694273946695,1.0,24/87,16.20%,ARHGDIA;MDK;RHOB;RHOC;RAC1;GPM6B;ARHGDIB;IQGAP2;RHOG;FAM107A;ESAM;CORO1A;PAK1;EPHA5;PHPT1;PAK3;CSF1R;TRPM2;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN
prerank,cardiac muscle cell contraction (GO:0086003),0.4757313787328055,1.0840184753364004,0.36981132075471695,0.6948632698829869,1.0,5/19,11.97%,GSN;SCN1A;SCN4B;FGF12;ATP1A1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.45819818518353805,1.08387146090691,0.3802992518703242,0.6948428699933307,1.0,6/21,18.07%,PDGFB;IGFBP5;P2RY6;JUN;GJA1;ADAMTS1
prerank,thyroid hormone generation (GO:0006590),-0.44423047804894567,-1.083355230343957,0.37362637362637363,0.704670627132766,1.0,1/10,0.40%,CPQ
prerank,steroid hormone biosynthetic process (GO:0120178),0.43689892673383834,1.0832712076543307,0.38875878220140514,0.6960082528486722,1.0,6/29,20.74%,TSPO;HSD17B6;FDX2;HSD3B2;STARD3NL;HSD17B11
prerank,regulation of muscle contraction (GO:0006937),0.43963978681207755,1.082509683203259,0.3714637146371464,0.6976025846015559,1.0,8/26,18.66%,MYL9;ENO1;CHRM2;TNNI1;KCNA1;CAV1;SRI;ANXA6
prerank,lipid transport (GO:0006869),0.38023505581776906,1.0823198944815646,0.33719704952581664,0.6976647007821489,1.0,13/97,12.54%,APOE;PLTP;GM2A;NPC2;SLCO1C1;SCP2;FABP5;ABCG1;MFSD2A;ATP8A1;SLC10A3;NME4;GLTP
prerank,base conversion or substitution editing (GO:0016553),0.5203698944879259,1.0818360133148979,0.40084985835694054,0.6985090477441721,1.0,4/11,24.56%,APOBEC2;NUDT16;APOBEC1;METTL3
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.40787972978042747,-1.08177489660526,0.34701492537313433,0.7069618367269296,1.0,5/12,14.89%,PARP12;PARP16;PARP3;TNKS2;PARP10
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5319484249909474,1.08176203551143,0.4014184397163121,0.6982505995897829,1.0,1/10,2.61%,SERPINE2
prerank,response to peptide hormone (GO:0043434),-0.29642530614182494,-1.081657289928992,0.2905982905982906,0.7053032698732433,1.0,14/43,15.19%,ROCK2;TGFBR3;STAT5B;ROCK1;OGT;IRS1;EIF2B3;STAT3;STAT2;SIRT1;EIF2B2;TSC1;CRY1;STAT5A
prerank,negative regulation of cell development (GO:0010721),0.4422334993029804,1.08145310323464,0.38271604938271603,0.6986032875113253,1.0,10/25,23.04%,B2M;TNF;SORL1;RFLNB;FBXW7;LILRB1;NOTCH1;IL6;REST;WNT7A
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4885447881993763,1.0813667320691425,0.38451268357810414,0.6983986612854198,1.0,8/16,19.10%,CALM1;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;FKBP1B;CALM2
prerank,nucleoside salvage (GO:0043174),0.5276422781344863,1.0809485977814606,0.38526912181303113,0.6990999344563895,1.0,7/10,31.95%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;DCK
prerank,cellular response to hormone stimulus (GO:0032870),0.39610456935523336,1.0806143703162019,0.3576799140708915,0.6995486834452563,1.0,18/69,20.17%,CTSB;CTSL;RAMP2;CTSS;GPER1;ZFP36L1;ATP1A3;RAMP3;WBP2;ATP1A1;CTSH;ROBO2;CAV1;SLIT3;NCOA4;NSMF;MEF2C;SFRP1
prerank,regulation of protein kinase C signaling (GO:0090036),0.4980138705135775,1.0805641723958426,0.39944521497919555,0.6992484784150871,1.0,6/14,20.23%,MYADM;MC1R;WNT5A;FLT4;ADRA1A;SPHK2
prerank,response to tumor necrosis factor (GO:0034612),0.3812616975182371,1.0802018336757664,0.3587866108786611,0.6997554605787941,1.0,18/91,17.61%,RPS3;AKT1;CCL19;GPER1;NR1D1;ZFP36L1;ZFP36L2;HYAL2;CXCL16;ZFP36;SMPD1;ERBIN;CCL2;YBX3;DAB2IP;CCL3;TRIM32;CCL8
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3842267119555451,1.080168446155198,0.35602094240837695,0.6993972579486232,1.0,15/80,10.72%,USE1;ARF5;LMAN2;TAPBP;ERGIC3;KDELR1;TMED7;SURF4;TMED2;ARFGAP2;KIF5A;TMED3;RER1;KIF26A;TMED9
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.22847564404522436,-1.0798434937996442,0.25,0.7083688491007643,1.0,52/166,18.69%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;YAP1;PPARA;RARG;NCOR1;KAT2B;TBL1X;NR1D2;TAF1D;SMARCA5;MAML1;TAF1A;GTF3C1;TBL1XR1;TEAD2;PPARG;ESR1;NR2C2;MED26;GTF2E2;RBPJ;TAF2;AR;POLR2A;NR2F1;RORA;GTF2H4;CRCP;POLR2B;CDK7;RSF1;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF7;TAF4B;RRN3;NR5A2;GTF2H2;MED23
prerank,regulation of neuron projection arborization (GO:0150011),-0.37984646551856116,-1.0796025171933676,0.3489208633093525,0.7070821469421982,1.0,6/15,14.40%,MACF1;MAP3K13;MOV10;DLG4;DVL3;MYO9A
prerank,macroautophagy (GO:0016236),0.3755323068320221,1.079581211473294,0.3312883435582822,0.7005237838226727,1.0,19/118,12.05%,GABARAP;DYNLL2;DYNLL1;TOMM6;TOMM5;TOMM7;MAP1LC3B;PINK1;MAP1LC3A;CSNK2B;GABARAPL2;GABARAPL1;CHMP2B;VCP;ATP13A2;CHMP6;ULK3;VAMP8;VPS28
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3821181159614607,1.0791153810778267,0.34810126582278483,0.7013156339730852,1.0,20/87,13.63%,RPS27A;UBC;CLDN5;UBB;FMOD;ID1;ACVRL1;FKBP1A;EID2;LEFTY2;WFIKKN2;UBA52;ZYX;COL3A1;JUN;AMHR2;ZMIZ2;COL1A2;RHOA;LEFTY1
prerank,protein localization to membrane (GO:0072657),0.36340188648561794,1.0790120751766252,0.32864321608040203,0.7011490936929602,1.0,41/187,16.41%,BSG;CD81;RAMP2;KCNIP4;NRXN1;NLGN1;S100A10;ITGB2;ANK3;TNF;EMP2;DPP10;DLG2;PACSIN1;FLOT1;FLNA;CPE;MYADM;RAB15;DPP6;TMED2;MYO5A;THY1;RAB3C;P2RY1;ABHD17A;RAB3D;RAMP3;NRXN2;GAS6;TNFRSF1A;MAP7;LRRC7;EHD1;LIN7C;FRMPD1;ATP1B1;SPTBN4;FGF13;EPB41L3;CAV1
prerank,brain development (GO:0007420),0.3679749383569459,1.0785465247184063,0.34183673469387754,0.701923832553587,1.0,37/136,19.98%,APOD;CTNNA2;NES;CNTNAP2;CNTN4;SCTR;NDRG4;ABCB6;ADGRL3;GRIN1;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;PROX1;MAST1;COL4A1;GRIN2A;MFSD2A;SLC6A17;CDK5R1;DNAJC30;AATK;HAP1;CLN5;CXCR4;CX3CR1;IER3IP1;DSCAML1;ROBO2;GRIN2B;QARS1;RAB18;NNAT;HSPG2;DDIT4
prerank,vitamin D metabolic process (GO:0042359),0.5059824240078202,1.0782343853004681,0.40581717451523547,0.702309920887604,1.0,2/13,12.74%,LGMN;GC
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5276538215026658,1.0779069225945708,0.40333796940194716,0.702716684027862,1.0,3/10,16.24%,CADM4;DCN;DAB2IP
prerank,positive chemotaxis (GO:0050918),0.4707378073738448,1.0772500084683416,0.37242268041237114,0.7040308459207292,1.0,3/17,7.45%,GPNMB;LGALS3;CORO1A
prerank,cellular response to light stimulus (GO:0071482),0.3885928071907617,1.077064106522242,0.3601694915254237,0.7040514857578656,1.0,9/66,12.07%,RPL26;ATF4;NPM1;COPS9;PARP1;AQP1;SMPD1;PCNA;NSMCE3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3221302686686591,-1.077046809509931,0.29842931937172773,0.7120257050360485,1.0,11/26,16.95%,SORBS1;OSBPL8;BRAF;IRS1;INSR;IGF1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36630309010369855,1.0768999141648719,0.3265720081135903,0.7040202151858777,1.0,31/158,14.62%,CD74;GAPDH;LGALS1;HMOX1;CCL19;S100B;PINK1;S100A13;TNF;EEF1D;RHOC;LAMTOR5;FKBP1A;SHISA5;ECM1;TIRAP;FLNA;TFRC;TMEM101;CLEC6A;TICAM2;TMEM9B;RBCK1;BST2;RHOA;GJA1;RIPK2;TNFRSF1A;UBE2V1;TLR6;F2RL1
prerank,response to retinoic acid (GO:0032526),0.39435387678225664,1.0768800569239112,0.35236004390779363,0.7036362654193554,1.0,13/59,14.17%,NDUFA13;RBP4;LTK;BRINP3;PTK6;AQP1;BRINP1;WNT5A;BRINP2;SNW1;SOX9;WNT10B;CTSH
prerank,regulation of collagen biosynthetic process (GO:0032965),0.46936663804714507,1.076548315213814,0.41405269761606023,0.7040608286636838,1.0,1/19,0.71%,VIM
prerank,positive regulation of phosphorylation (GO:0042327),0.3636531954648163,1.0764756194333878,0.3003003003003003,0.7038194464345289,1.0,51/240,16.31%,PPIA;CD74;RACK1;HSP90AA1;GPNMB;MT3;C3;MAPK3;AKT1;CCND2;TREM2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;ANG;DSCAM;PIN1;MIF;FLOT1;KNDC1;RARRES2;LTK;MUSK;TFRC;CCND1;PAK1;P2RX7;KDR;MLXIPL;P2RY1;EPHA5;CSF1R;PECAM1;FLT4;HRAS;TMEM119;SOX9;TIE1;BMP2;GAS6;CLIP3;SDCBP;PTGES3;IGF2;RASGRP1;EPHB1;FLT1;TYRO3
prerank,macrophage differentiation (GO:0030225),-0.3958235117017161,-1.0764649761549567,0.35231316725978645,0.7115623866467808,1.0,5/13,13.72%,IL31RA;IL15;SIRT1;CASP8;BMP4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.5164875800738224,1.0762265892950764,0.3853868194842407,0.7040122727088314,1.0,5/10,19.27%,C3;TREM2;F2RL1;CD300A;RAB31
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5059996037655919,1.0760790460352005,0.39944521497919555,0.7039534568321666,1.0,3/12,14.54%,SERINC3;PHGDH;SERINC5
prerank,regulation of macroautophagy (GO:0016241),0.3762812637665286,1.0758407868813897,0.3581932773109244,0.7040996790460731,1.0,24/105,16.15%,GAPDH;ATP6V0C;CAPNS1;AKT1;PINK1;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;UCHL1;ATP6V0E2;BNIP3L;SCOC;KDR;CDK5R1;ATP13A2;DCN;ATP6V0D2;UBQLN2;LAMTOR3;ATG101;RRAGC;CDK5;RRAGD
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.36089950828773737,1.0758283300356726,0.29187562688064195,0.7036960803274431,1.0,69/264,21.41%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;STRAP;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;PDCD7;EIF4A3;PRPF31;SF3B6;TXNL4A;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200
prerank,odontogenesis (GO:0042476),-0.30654446170487276,-1.075817312770101,0.2808219178082192,0.7112144402531431,1.0,6/35,8.39%,EDA;ANKRD11;GLI2;LRP6;BCOR;FGFR2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36201439391827867,1.0757435630866408,0.3075376884422111,0.7034514671597362,1.0,53/208,20.94%,CD74;GAPDH;HSPB1;LGALS1;HMOX1;CCL19;S100B;TREM2;PINK1;S100A13;TNF;EEF1D;RHOC;LAMTOR5;NR1D1;FKBP1A;SHISA5;ECM1;TIRAP;FLNA;TNFAIP3;TFRC;TMEM101;CLEC6A;OTUD7A;TICAM2;TMEM9B;TRIM59;RBCK1;WNT5A;BST2;RHOA;GJA1;RIPK2;TNFRSF1A;UBE2V1;TLR6;F2RL1;TRAF3;DAB2IP;SQSTM1;TRIM32;S100A4;TERF2IP;LTBR;TRIM13;VAPA;CANT1;SPHK2;GOLT1B;CAPN3;TMEM106A;PYCARD
prerank,regulation of mast cell activation (GO:0033003),0.5305887358458448,1.075699187503402,0.42877094972067037,0.7031387610180214,1.0,5/10,33.35%,CD84;CD300LF;CRLF2;PLSCR1;MILR1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4076558237756607,1.0755649583844091,0.38198403648802737,0.7030614790884128,1.0,10/45,12.33%,AURKAIP1;ZFP36L1;ZFP36L2;CTNNB1;CDKN1C;BTG1;BRINP3;GAS1;BRINP1;BRINP2
prerank,lysosome organization (GO:0007040),0.4221388279294761,1.0752937910239293,0.37485448195576254,0.7033647954592147,1.0,8/36,13.30%,GRN;CORO1A;CLVS1;CLVS2;GAA;CLN5;CLN6;TMEM106B
prerank,cellular response to calcium ion (GO:0071277),0.3898304526005325,1.0751725062229867,0.3638297872340426,0.7032760913579308,1.0,25/67,25.93%,LGMN;NLGN1;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;WNT5A;TRPM2;ALOX5AP;CPNE5;SYT10;CPNE6;DMTN;ADCY8;SYT2;CPNE4;MEF2C;CAPN3;SYT3;SYT5;ECT2;SYT17;CPNE3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3677583842699051,1.0746904708760863,0.3373737373737374,0.704113343325247,1.0,58/151,31.63%,APOE;CHKB;GSTM1;CERS2;CSNK2B;GPHN;MGST1;GSTO1;ELOVL1;ELOVL2;MFSD2A;GSTM5;MGST3;GSTM2;ELOVL7;CHAT;GCNT1;HPGDS;SPTLC1;DEGS1;ACHE;FA2H;CSNK1G2;SPTSSA;AKR1A1;INHBA;VAPA;ESD;SGPP1;SPHK2;SGPP2;SLC44A5;SGPL1;TNIP1;STARD10;LPCAT2;MOCS2;ELOVL6;ALDH3B1;VAPB;SLC44A2;INHA;LCMT2;ASL;HACD4;SLC44A1;SAMD8;CERT1;GSTM4;ALAS2;ASS1;ARG2;CEPT1;SPNS2;ALDH3A2;PCSK1;ELOVL4;ALAS1
prerank,cellular response to starvation (GO:0009267),0.3706762199384767,1.074400316914898,0.34213197969543147,0.7044423666470718,1.0,18/147,7.08%,HSPA8;GABARAP;ATP6V0C;MAPK3;HSPA5;ATF4;ATP6V1F;MAP1LC3B;MAP1LC3A;LAMTOR2;LAMTOR4;GABARAPL2;LAMTOR5;ATP6V1G1;GABARAPL1;ATP6V0E2;FADS1;CEBPB
prerank,response to histamine (GO:0034776),0.5363840622365222,1.0742384395174347,0.3997113997113997,0.7044404335545341,1.0,3/10,16.30%,GABRB1;GABRB3;GABRB2
prerank,apoptotic DNA fragmentation (GO:0006309),0.47847784499141977,1.0738446009493525,0.39575033200531207,0.7050352800969176,1.0,4/16,10.22%,ENDOG;FOXL2;HMGB1;H1-0
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.492732915186315,1.0738258358615025,0.42013422818791946,0.7046443330973166,1.0,2/14,10.09%,CHKB;PCYT2
prerank,sensory perception of chemical stimulus (GO:0007606),0.49051220129003203,1.0736728112208218,0.38992042440318303,0.7046190105194747,1.0,3/15,15.44%,SLC24A4;C5AR1;SYT10
prerank,protein-containing complex subunit organization (GO:0043933),0.37062219696281395,1.0730810835519455,0.3474663908996898,0.7057206778257358,1.0,28/109,20.50%,CD74;CHCHD10;ELOB;LAMC1;SLC2A1;TAPBP;PPP2R1A;IL2RB;HES1;ADD2;OTX2;RIMS1;CAPZA2;VAMP3;VAMP2;SOX9;MAGI1;TSPAN4;CAPG;SPG7;DMTN;DNM1L;PPARGC1A;EPRS1;LPXN;IL1RAP;CAPN3;TFAP4
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.45805275589635597,1.0729473417466282,0.376720901126408,0.7056434778377169,1.0,2/22,7.89%,B2M;HSPD1
prerank,axonal fasciculation (GO:0007413),0.509235134434953,1.0725108759196365,0.389196675900277,0.706351298608406,1.0,4/12,9.33%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,chloride transport (GO:0006821),0.388974569332845,1.0723747842612588,0.38812301166489926,0.7063083271657128,1.0,14/74,12.51%,GABRB1;FXYD1;LRRC8A;GABRG3;GABRA2;SLC12A5;TTYH1;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;CLIC1;TTYH3
prerank,erythrocyte development (GO:0048821),0.5140972712247655,1.0722981336325106,0.4105865522174535,0.7060780419631977,1.0,5/10,31.63%,ZBTB7A;ABCB10;DMTN;ALAS2;ALAS1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.27665419158002447,-1.0710692224215377,0.28888888888888886,0.722227136749018,1.0,14/56,14.03%,EGFR;UBE2E2;NSMCE2;BRD4;ANAPC5;ANAPC7;TFDP1;CDC25B;RAD51B;EIF4G1;ANKRD17;KLHL18;CCND3;CDC27
prerank,myelin assembly (GO:0032288),0.5299304610285477,1.0710242673600663,0.4103967168262654,0.7089671173001737,1.0,7/10,31.35%,PMP22;TENM4;EPB41L3;ABCA2;GPC1;CD9;CNTNAP1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5038448176481745,1.070958565122494,0.40308988764044945,0.7087010306135559,1.0,2/13,6.02%,SULT4A1;BPNT2
prerank,embryonic axis specification (GO:0000578),-0.3802802593387396,-1.070702940050816,0.3474903474903475,0.721222253188299,1.0,4/15,13.79%,SMAD6;COBL;TASOR;SMAD2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.47043794657703064,1.0706107636071904,0.40657894736842104,0.7091465496070656,1.0,8/19,23.97%,RPS27L;HIPK2;TMEM109;SNW1;DDIT4;PYCARD;PHLDA3;DYRK2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.42871376830592545,-1.0698692404019705,0.3860759493670886,0.7215529654285558,1.0,6/10,20.46%,SETD2;EHMT1;SETD7;SETD4;SETD3;SETD6
prerank,cellular response to glucose starvation (GO:0042149),-0.2976507867328435,-1.0698058416223146,0.3253968253968254,0.7197527587696729,1.0,12/41,16.26%,PRKAG2;SIK2;MTMR3;FOXO3;EIF2AK3;SIK1;PRKAA2;SESN1;NUAK1;PRKAG1;ITFG2;TP53
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3591608428279774,1.069790709649408,0.287,0.710813253574698,1.0,59/314,13.85%,RPS27A;UBC;UBB;PSMB4;SEC61B;UBXN1;HSPA5;PSME1;PSMB6;PSME2;PSMB8;PSMD2;KCTD10;HSP90B1;PSMD1;AUP1;UBE2G2;PSMC3;UCHL1;ECRG4;CTNNB1;PSMD6;VCP;CDC34;RNF187;UBA52;PSMA7;KCTD2;FEM1A;FEM1C;FBXL14;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;FBXO27;TRIM2;TNFAIP1;DDB1;PSMB9;SEL1L2;PSMD13;RBCK1;BUB3;PSMB3;FBXW5;WFS1;SYVN1;DNAJB2;MAN1B1;PSMB11;ZSWIM8;FBXW7;UBQLN2;FBXO5;FBXO31;PSMB10;KBTBD7
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3177884821931993,-1.0697823764158734,0.30718954248366015,0.7178511252246527,1.0,6/31,8.39%,HOXB3;HOXA3;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,regulation of synapse maturation (GO:0090128),0.5277220769996207,1.0696819013765642,0.4102941176470588,0.7106680918024952,1.0,6/10,32.76%,NRXN1;YWHAZ;DAB2IP;CDC20;CAMK2B;RELN
prerank,thymus development (GO:0048538),0.4989491281738366,1.069172365817617,0.40829986613119146,0.7115928159678933,1.0,2/13,5.71%,SOD1;HES1
prerank,regulation of T cell chemotaxis (GO:0010819),0.5230383844008222,1.0690894071798889,0.4025423728813559,0.7113691755671376,1.0,5/11,26.20%,CXCL10;WNT5A;ADAM17;CCR2;OXSR1
prerank,regulation of platelet aggregation (GO:0090330),0.47214613431750163,1.0685824271918665,0.4020356234096692,0.7122603821126281,1.0,6/17,26.81%,SERPINE2;DMTN;SYK;PRKCA;PRKCQ;CD9
prerank,negative regulation of interleukin-6 production (GO:0032715),0.43576944332931117,1.068264079780297,0.4,0.7127145280785606,1.0,7/27,21.40%,TNF;SIRPA;TNFAIP3;SYT11;GAS6;PTPN6;SELENOS
prerank,protein homotetramerization (GO:0051289),0.39604678090198997,1.0680745353798118,0.37682789651293586,0.7127702478991557,1.0,3/49,2.27%,ALDOA;B2M;AQP4
prerank,granulocyte differentiation (GO:0030851),0.47003609509556216,1.067817632237758,0.39948119325551235,0.7130096493185513,1.0,3/18,10.36%,SPI1;CEBPA;DEK
prerank,protein localization to plasma membrane (GO:0072659),0.3670836203955492,1.0673102522009523,0.36493374108053006,0.7138941486987886,1.0,33/129,18.17%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;DPP6;TMED2;MYO5A;RAB3C;P2RY1;RAB3D;RAMP3;GAS6;TNFRSF1A;MAP7;CCDC88A;EHD1;ATP1B1;SPTBN4;FGF13;EPB41L3;CRB3;ATP1B3;EHD2
prerank,negative regulation of cell differentiation (GO:0045596),-0.23197773887153766,-1.0671880399658547,0.0,0.7231908073823246,1.0,45/181,16.53%,LDLRAD4;RANBP3L;SMAD3;COL5A2;EGFR;ADAMTS12;SMAD6;COL5A1;CRIM1;ZBTB16;SUFU;LRP5;SKI;YAP1;EIF2AK4;PPARA;ADGRV1;TGFBR1;EFEMP1;ASXL1;ZFPM2;CDK6;RUNX1T1;TRIB2;NPHP3;SMAD7;ENPP1;PPARG;PTEN;TRPM4;PDCD4;FERMT2;TRIO;JAG1;RORA;SIRT1;BMP4;DTX1;CHADL;IL17RD;CDC73;LIMD1;FOXO1;ANKRD26;WNT9A
prerank,calcium ion import across plasma membrane (GO:0098703),0.4899776514622201,1.0671688768025274,0.4106412005457026,0.7138162741760451,1.0,5/14,28.26%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,oligodendrocyte development (GO:0014003),0.4830626247212936,1.0667565890677548,0.3967391304347826,0.7144591782908202,1.0,9/15,33.08%,PLP1;B4GALT6;MYRF;EIF2B5;SOX10;EIF2B1;CNTNAP1;PRDM8;B4GALT5
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.2831544935327982,-1.0665377348527507,0.410958904109589,0.7229869435139838,1.0,11/61,10.41%,AUTS2;AKAP13;NOTCH2;ROBO1;LPAR1;SHOC2;RAPGEF1;IGF1;MAP4K4;ALS2;NGF
prerank,mRNA splice site selection (GO:0006376),-0.31508336833054357,-1.0654281789560394,0.35,0.7239920079604761,1.0,7/30,10.92%,CELF2;LUC7L2;SFSWAP;YTHDC1;KHDC4;PRPF39;SETX
prerank,protein localization to synapse (GO:0035418),0.5060228092051569,1.0651834044527138,0.41609822646657574,0.718066573433631,1.0,3/12,12.53%,NRXN1;NLGN1;NRXN2
prerank,response to lipopolysaccharide (GO:0032496),0.3645133129376431,1.064923969009963,0.36133603238866396,0.7183314892404953,1.0,52/138,29.83%,VIM;PDE4B;NR1D1;S100A9;S100A8;TIRAP;SIRPA;CD180;TNFAIP3;CCR5;HNRNPA0;CXCL10;TICAM2;CD68;HMGB1;ZFP36;CHMP5;WNT5A;SLC11A1;RHOA;LILRB1;ERBIN;CX3CR1;CCL2;PF4;DAB2IP;ADAM17;NOS2;SNCA;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;PYCARD;SELENOS;NUGGC;RELA;TNFRSF11A;LBP;CASP1;TRIB1;SCARB1;XBP1;TNFRSF1B;GGT5;PPBP;GGT7;NOD2;ACOD1;IFNAR1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3589781604745023,1.0642688092847685,0.3350050150451354,0.7195838982839344,1.0,61/268,19.69%,ATP5MF;ATP6V0C;ATP5F1B;SLC30A1;ASIC2;ATP6V1F;SLC39A1;UCP2;SLC24A4;SLC24A2;KCNQ3;SCN1A;KCNQ2;KCNC3;FKBP1A;KCND2;ATP6V0E2;KCNJ10;CACNA1A;ATP1A3;SLC39A7;TMCO1;SLC6A6;P2RX7;HVCN1;SLC6A17;SLC6A5;SLC6A2;SCN4B;SLC6A16;KCNC1;KCNA2;TRPM2;TRPC7;KCNN2;SLC40A1;ATP1A4;ATP1A1;KCNK9;SLC11A1;SLC25A27;ABCC8;GAS6;TRPC1;KCNF1;ATP1B1;SLC8A1;HCN1;KCNK3;KCNA1;ORAI1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.32057812766746274,-1.0641600426213549,0.3651685393258427,0.7255480602690594,1.0,11/28,18.00%,FOXP1;APPL2;BIRC2;RNF135;BIRC3;TRIM5;CASP8;PTPN22;APPL1;CD55;DHX58
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4190255866682459,1.0635690725726141,0.3990554899645809,0.7210083472253511,1.0,13/32,25.94%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4868930208464604,1.0635141823463996,0.39808481532147744,0.7207083111962275,1.0,5/14,17.36%,AKT1;DDB1;PMAIP1;ARPP19;PPARGC1A
prerank,amino acid import across plasma membrane (GO:0089718),0.4467766998056605,1.0632853066584254,0.4049689440993789,0.7208352482390559,1.0,8/24,12.43%,SLC7A5;SLC1A4;SLC1A2;TSPO2;SLC6A6;SLC6A5;SLC3A2;SLC1A1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2396982417871432,-1.0630098087213324,0.14285714285714285,0.7267572834131699,1.0,41/153,14.26%,ROCK2;LRRK2;ROCK1;CAMK2D;PRKCE;CSNK1A1;MAP3K13;MARK1;SMG1;PDPK1;RICTOR;TLK2;TGFBR1;EIF2AK3;TLK1;MAST2;DYRK1A;MARK3;MAPKAPK3;TOP1;NEK6;MAPK9;HIPK3;RIPK1;DMPK;PKD1;MORC3;TBK1;DGKQ;LATS2;STK38;ATM;CSNK2A1;CSNK2A2;NLK;ULK2;PRKD1;SRPK2;GSK3B;MARK2;PRKCI
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4836034497624537,1.0628912810327082,0.4051948051948052,0.7213948437972759,1.0,4/15,11.24%,PNPLA2;TREM2;LPL;PLIN3
prerank,mitotic cytokinetic process (GO:1902410),0.4632275146671,1.0615060626315593,0.4045226130653266,0.7245543482017239,1.0,9/20,25.87%,CHMP2B;CHMP5;CHMP6;RHOA;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C
prerank,cellular defense response (GO:0006968),0.4110882975362334,1.0613393393527435,0.3870220162224797,0.7245637684850124,1.0,15/40,26.68%,TYROBP;CD5L;LGALS3BP;C5AR1;CCR5;KLRG1;CX3CR1;NCR1;NCF1;TRAT1;NCF2;RELA;LBP;ITGB1;ITK
prerank,RNA splicing (GO:0008380),0.37451699458143717,1.0611552811465168,0.384297520661157,0.7245608672265115,1.0,25/95,19.03%,SNRPG;MAGOHB;MAGOH;DDX39B;SNRPD2;LSM4;LSM6;PPP2R1A;SNRPF;TARDBP;PRPF8;SRSF2;SF3B2;IVNS1ABP;NONO;SNRPB;SF3A3;RRAGC;PDCD7;CELF3;PPARGC1A;TXNL4A;SNRPD3;CCAR2;USB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4615511438068235,1.0609657600842661,0.41,0.7246593206674679,1.0,6/18,18.76%,NRXN1;NLGN1;CCL2;CACNG8;CCR2;CACNG5
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.37136247651764254,-1.0609228473846855,0.34763948497854075,0.7303804976141962,1.0,7/14,21.56%,ADAMTS12;TGFBR1;EFEMP1;CHADL;WNT9A;ADAMTS7;PTPN11
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4594995973165318,1.0608795895690015,0.4065359477124183,0.7244508576345314,1.0,3/18,14.43%,FCER1G;C5AR1;SH2B2
prerank,positive regulation of chromosome organization (GO:2001252),-0.3752561530336096,-1.0603851378063867,0.37130801687763715,0.7300266538447251,1.0,4/15,20.89%,DHX36;PML;RTEL1;SIRT6
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.4028931743380515,-1.0603809474990096,0.35365853658536583,0.7280928582701153,1.0,5/13,11.61%,TGFBR3;BMPR1A;ZFPM2;FGFR2;RBPJ
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.42518127844296516,-1.0601685202474225,0.3514376996805112,0.726688213044256,1.0,3/10,15.22%,SMAD7;RC3H2;NFKBIZ
prerank,regulation of nuclear division (GO:0051783),0.4440165779216505,1.0601417408472213,0.40283140283140284,0.7259588591756732,1.0,8/20,28.87%,PIN1;CAV2;FBXO5;L3MBTL1;CCDC8;RCC1;KIF20B;MKI67
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.48914857362323577,1.0601102829489928,0.3852573018080668,0.7256042528139418,1.0,8/12,31.95%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;CAD;DCK
prerank,regulation of neuron migration (GO:2001222),0.43674758338693065,1.0600215032874984,0.40803897685749085,0.725389753165746,1.0,12/26,26.21%,MDK;CTNNA2;ADGRG1;COL3A1;SHTN1;TNN;IGSF10;DAB2IP;NSMF;PLXNB2;KIF20B;CX3CL1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4411774093136084,1.0600177805375588,0.40302267002518893,0.7249652413616939,1.0,7/22,19.24%,APOD;PARK7;LMAN1;GDI1;DMTN;RANGAP1;CABP1
prerank,negative regulation of immune response (GO:0050777),0.3621872980962368,1.059924884350168,0.3698074974670719,0.7247624744674788,1.0,33/154,18.70%,RAMP2;TREM2;POMC;LGALS3;SPI1;SCTR;TNFAIP3;DRD5;CD163;RXFP1;PRKAR1A;COL3A1;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;LILRB1;ADCY4;TYRO3;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;CD300A;SYK;CCR2;GPR83
prerank,regulation of protein localization to membrane (GO:1905475),0.42659519598731266,1.059900158960958,0.3966547192353644,0.724390186953892,1.0,2/28,0.88%,ACTB;GSN
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.36871402810254644,1.0592194808416113,0.37899073120494337,0.7257196334587094,1.0,26/116,19.67%,RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,regulation of biomineral tissue development (GO:0070167),0.43352291759652223,1.059186243555544,0.4035928143712575,0.7253582893811825,1.0,12/26,19.83%,ECM1;S1PR1;CEBPB;SOX9;FBXO5;GAS6;HEY1;TWIST1;DDR2;NOTUM;NOTCH1;TGFB1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.42622022578909885,1.0584311111922289,0.4177671068427371,0.726893454246668,1.0,10/28,17.33%,AKT1;ARRDC1;GATA2;ZBTB7A;FBXW7;HEY1;BEND6;DLL1;EGFL7;MMP14
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5115455621659252,1.058219847503107,0.43912448700410395,0.7270445676956266,1.0,3/11,15.47%,CTDNEP1;MFSD2A;NR1H2
prerank,carbohydrate transport (GO:0008643),0.5041051269024223,1.0575713783605178,0.4199438202247191,0.7282959543849764,1.0,3/11,16.51%,AQP1;SLC50A1;SLC2A2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.41989200702130774,1.057518274757046,0.397196261682243,0.7279943873841244,1.0,11/32,22.37%,SLC30A1;GPER1;RIMS2;RIMS1;SYT11;SYN1;HCRT;PREPL;MEF2C;STX1B;CHRNA3
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.35008212858831783,-1.0573968481280493,0.35454545454545455,0.7321623854439183,1.0,7/19,16.29%,SMAD6;ACVR1;BMPR1A;MDM4;SMAD4;HEY2;BMPR2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3620802503259648,1.0572887013322128,0.38109756097560976,0.7281288858722157,1.0,37/142,18.30%,CD52;CHRNA9;GPER1;TAC1;FZD9;C5AR1;CAV2;YWHAE;CACNA1A;CCR5;CALB1;PLN;TACR1;P2RY1;CD24;HMGB1;CALCB;WNT5A;TRPC7;ATP2B1;CXCR4;TRPC1;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1D;ADRA1A;ADCY8;CAV1;CCKBR;BCAP31;HCRTR1;PTGIR;ADCYAP1;FKBP1B;CCR2
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2843351347420039,-1.0570757681360183,0.29914529914529914,0.7311024542838345,1.0,10/44,10.84%,FCHSD2;FER;BAIAP2L1;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1
prerank,histone H2A ubiquitination (GO:0033522),-0.35925134916709855,-1.0570113698212866,0.3644067796610169,0.7293568516108003,1.0,5/17,11.00%,BCOR;RNF8;UBR2;DDB2;CUL4B
prerank,neuron differentiation (GO:0030182),0.35935912816561943,1.0569880168315289,0.37298387096774194,0.7284408848596113,1.0,57/165,29.19%,ITM2C;NTRK2;PIN1;CTNNB1;SPOCK1;TENM2;TENM3;MANF;OTX2;ATP8A2;IL1RAPL1;CDK5R1;EPHA5;PHOX2A;TENM4;WNT5A;PTPRD;IRX3;WNT10B;UGDH;CDK5;OLIG1;MYEF2;FUT9;BRSK2;ERCC6;MYT1L;BTG4;ACSL3;SOX11;INHBA;DDIT4;MEF2C;FOXA2;FZD2;ID2;FOXA1;HS6ST1;FZD1;USH2A;IER2;WNT7A;ACSL4;OLIG2;SRF;RORB;FZD3;ALK;TGFB2;ERCC2;XBP1;TENM1;ATP2B2;FZD5;MTPN;SNPH;IRX5
prerank,glucan biosynthetic process (GO:0009250),0.4998400217360015,1.0567476974360592,0.40953716690042075,0.7281823184499407,1.0,3/12,8.42%,NR1D1;GYS2;NHLRC1
prerank,glycogen biosynthetic process (GO:0005978),0.4998400217360015,1.0567476974360592,0.40953716690042075,0.7281823184499407,1.0,3/12,8.42%,NR1D1;GYS2;NHLRC1
prerank,regulation of protein autophosphorylation (GO:0031952),0.41461239146460366,1.0566949883251273,0.41540256709451573,0.727878821147885,1.0,4/36,3.89%,CALM1;GPNMB;CALM3;PDGFB
prerank,establishment of protein localization to organelle (GO:0072594),0.3782771149168351,1.0566231764017378,0.40514469453376206,0.7276301313132301,1.0,16/72,18.27%,LAMP1;AKT1;PINK1;RAN;FAM53C;PTTG1IP;CD68;IPO4;NUP85;NUP88;RYR2;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.35956599205884415,1.056425557214694,0.3789260385005066,0.727727897621707,1.0,32/170,15.64%,APOE;CRIP1;PCBP1;HNRNPAB;TREM2;HNRNPK;PTPRC;TAPBP;ZFP36L1;PIN1;FLOT1;SIRPA;APLNR;PCBP4;ALPK2;RNF187;NELL1;PRDM12;PROX1;YBX1;TARDBP;MTMR9;KDM6B;ATRAID;AIF1;RO60;SORT1;ARF1;ATP1B1;DHH;SLC8A1;YBX3
prerank,regulation of protein secretion (GO:0050708),0.36846000567438875,1.0561592692742916,0.39325842696629215,0.7279736479933931,1.0,29/119,21.29%,APOE;PPIA;UQCC2;MTNR1B;SLC2A1;SNAP25;TREM2;TNF;ANG;ABCG1;CACNA1A;ARF6;ATP13A2;DPH3;STXBP5L;APBB1;ABCC8;IER3IP1;ACHE;SLC2A2;DNM1L;NOS2;TFAP2B;IL6;ERP29;TGFB1;KCNC2;RSAD2;TMED10
prerank,regulation of receptor internalization (GO:0002090),0.41353564181267305,1.0560868864488258,0.39351851851851855,0.7277345965760476,1.0,8/35,15.91%,CD63;FLOT1;LRPAP1;SFRP4;SDCBP;ARF1;ANKRD13D;ARRB2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39231294585263377,1.055936857050223,0.39888268156424583,0.7276946028736924,1.0,14/48,24.88%,CRIP1;RPS27L;CHEK2;HIPK2;BAX;TMEM109;SNW1;HIC1;DDIT4;BAK1;PYCARD;PHLDA3;DYRK2;BOK
prerank,neural tube closure (GO:0001843),-0.30660808606516005,-1.0555606787601093,0.32075471698113206,0.7312438335842205,1.0,8/34,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;DVL3;IFT122;CELSR1
prerank,icosanoid metabolic process (GO:0006690),0.40660225154466084,1.055269054486114,0.4068965517241379,0.7290544823569927,1.0,7/40,17.02%,GPX4;GPX1;FADS1;DPEP2;ALOX5AP;FAAH;LTC4S
prerank,transport across blood-brain barrier (GO:0150104),0.377341247139018,1.0550064087899016,0.40021119324181625,0.7293092489939801,1.0,22/83,16.01%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;FABP5;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;LRP3;ATP8A1;SLC29A1;ATP1A4;SLC1A1;SLC19A1;SLC29A2;SLC16A1;SLC15A2;ABCA2
prerank,acidic amino acid transport (GO:0015800),0.47009157758459647,1.0550044169174784,0.4287581699346405,0.7288807818919711,1.0,6/17,13.23%,SLC1A2;SLC25A13;SLC6A6;SLC1A1;SLC25A22;GJA1
prerank,lipid biosynthetic process (GO:0008610),0.3769461551369721,1.0549545890837444,0.40827147401908803,0.7285859850749267,1.0,17/77,23.49%,SCD5;SCP2;FADS1;LIPG;LSS;LPL;PCYT2;OXSM;SCD;HSD3B2;CLN8;AGPAT5;PDSS1;ACSM5;NDUFAB1;PRLR;ACLY
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4106769613640666,-1.0545562356732807,0.35374149659863946,0.732180214588812,1.0,2/12,1.09%,NOTCH2;DOCK11
prerank,cortical cytoskeleton organization (GO:0030865),0.4043173868609301,1.0542975453223775,0.3951332560834299,0.7298286147735591,1.0,14/41,17.41%,RHOB;NLGN1;TNF;RHOC;RAC1;RHOG;LCP1;ARF6;FMNL1;RHOA;EPB41L3;FMNL3;FHOD3;RAC2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4368233978982438,1.0542749663374078,0.4155528554070474,0.7294570276290833,1.0,12/24,34.38%,ITGB2;MSN;PECAM1;VCAM1;SYK;CERCAM;TNIP1;ITGB1;SEMA4D;ITGAL;CCL5;FERMT3
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.477981766195659,1.0540939658360804,0.4217335058214748,0.729480627892258,1.0,5/17,16.38%,APOC1;LPL;SORT1;NR1H2;HDAC9
prerank,mRNA processing (GO:0006397),0.3523335449899569,1.0536902032867204,0.34634634634634637,0.7301166736709206,1.0,98/287,26.91%,HSPA8;PCBP1;SNRPG;AURKAIP1;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SUPT4H1;SRSF2;SF3A2;PABPC1;CMTR1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;THOC3;PDCD7;EIF4A3;PRPF31;SF3B6;PPARGC1A;TXNL4A;TBRG4;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;SRRM4;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200;DHX38;RAMAC;HNRNPH2;SNRPB2;PPWD1;ELAVL1;PCBP2;LSM5;ALKBH5;METTL3;METTL14;PRPF40B;PRKACA;PPIE;DNAJC8;GTF2H5;RPRD1A;SART1;HNRNPC;SYMPK;ERCC2;USP39;CCNH
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.387353745730082,1.0536645728001583,0.419672131147541,0.7297513232211487,1.0,16/55,22.67%,MT3;PINK1;AGT;PDGFB;ROMO1;RAC1;DCXR;ARF4;RAC2;BCO2;SNCA;CBR1;SPHK2;GADD45A;SIRT2;MPV17
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4366394663895532,1.053345884044476,0.41646191646191644,0.7301446290816541,1.0,5/26,7.45%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,aorta development (GO:0035904),-0.38816295540199164,-1.05327558355485,0.375,0.7337529818397408,1.0,6/14,12.82%,HECTD1;ROBO1;ADAMTS9;PDGFRB;LRP1;JAG1
prerank,protein autophosphorylation (GO:0046777),-0.23293862395547962,-1.0530850597034254,0.25,0.7323681427591217,1.0,33/157,11.16%,GRK5;EGFR;FER;ABL1;DAPK1;LRRK2;CAMK2D;SIK2;MAP3K3;MAP3K13;CLK2;SMG1;EIF2AK4;PDPK1;EPHA4;STK24;CDK12;EIF2AK3;INSR;DYRK1A;MARK3;MAPKAPK3;SIK1;TAOK3;FGFR2;NEK6;AAK1;STK10;PDGFRB;RIPK1;PTK2;SLK;DAPK2
prerank,TOR signaling (GO:0031929),0.43536756594381093,1.0530046185153452,0.4233055885850178,0.7305948773200638,1.0,7/26,14.27%,RPS6;AKT1;PINK1;PRR5L;RHEBL1;CCDC88A;PRR5
prerank,positive regulation of neurogenesis (GO:0050769),0.37866746590604816,1.052960160770945,0.412972972972973,0.7302654633021194,1.0,24/68,26.32%,ARHGDIA;SERPINF1;TGM2;GPER1;NTRK2;CTNNB1;IL1RAPL1;SS18L2;PTPRD;SOX8;SNW1;RHOA;CX3CR1;TIAM1;ROBO2;TRIM32;SOX11;PLXND1;SS18L1;PLXNB2;NAP1L1;PLXNB3;CX3CL1;FZD3
prerank,regulation of protein import into nucleus (GO:0042306),0.40659893394596247,1.052712427338081,0.4098939929328622,0.7304731359345277,1.0,6/36,7.50%,APOD;RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4837885948370171,1.052684880086931,0.4251655629139073,0.7301138104230138,1.0,2/14,3.41%,PPP1CA;PPP1R15B
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39325249382300304,1.0522351088449031,0.40732519422863483,0.7308648377548582,1.0,9/47,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;CORO1C;P4HB;ARHGEF7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5057226323882984,1.0521974658628364,0.4164265129682997,0.7305331792112096,1.0,5/12,16.12%,NELFCD;HNRNPU;HEXIM1;RECQL5;NELFE
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2638211554205763,-1.0516762055633415,0.2692307692307692,0.7343279734661059,1.0,18/63,13.92%,WWOX;TCF7L2;ACVR1;BIRC6;CFLAR;ZMYND11;SH3RF1;TGFBR1;PML;IGF1;SP100;RIPK1;BCL2L12;AR;DEPTOR;CASP8;BMP4;PHIP
prerank,ganglion development (GO:0061548),0.5091195974601335,1.0516206784750703,0.4383378016085791,0.7315485034987513,1.0,3/11,9.29%,SEMA3F;CTNNB1;UNC5C
prerank,histone H2B ubiquitination (GO:0033523),-0.41854715576413287,-1.0512298979453527,0.39,0.7336587860234679,1.0,6/10,22.76%,RNF8;CDC73;UBE2E1;WAC;RNF20;CTR9
prerank,T cell mediated immunity (GO:0002456),0.49098846204717683,1.0509962317760875,0.42819148936170215,0.7327352882684188,1.0,5/13,26.74%,EMP2;BTN3A3;CTSH;MYO1G;GNL1
prerank,Rho protein signal transduction (GO:0007266),0.3879579871981758,1.0500734649514032,0.4015748031496063,0.7346880284302754,1.0,13/53,13.96%,ARHGDIA;CFL1;RHOB;ARHGDIB;RHOG;ADGRG1;NTN1;RHOV;ARHGDIG;COL1A2;RHOA;SHTN1;RHOU
prerank,nucleic acid metabolic process (GO:0090304),0.38031942084692666,1.0494711244524608,0.426264800861141,0.7357796354163816,1.0,23/69,25.03%,PCBP1;POLR2E;POLR2D;HNRNPK;POLR2F;RAN;LSM8;HNRNPA0;POLR2G;POLR2K;HNRNPU;PDE12;HNRNPA1;RECQL5;WDR74;HNRNPA3;POLR2H;HNRNPF;POLG;HNRNPH2;PCBP2;METTL3;METTL14
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.24696890824448436,-1.0491382159701543,0.3,0.737544257454593,1.0,9/86,1.92%,BMP6;SULF1;RBPMS;ZNF423;ACVR1;BMPR1A;CREBBP;FOXD1;DAB2
prerank,protein modification by small protein removal (GO:0070646),0.35278638077972646,1.048427781860192,0.36472945891783565,0.7380330459703346,1.0,63/252,21.46%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSME2;PSMB8;PSMD2;COPS7A;RCE1;COPS6;PSMD1;PSMC3;UCHL1;PSMD6;VCP;TNFAIP3;USP51;UBA52;PSMA7;USP5;ABRAXAS2;TAF10;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;COPS8;USP26;BABAM1;TRAF3;OTUB1;KDM1B;PSMB1;ARRB2;PSMB5;USP8;USP22;CDC25A;TAB1;PSMA6;DESI2;DESI1;WDR48;NLRP3;RAD23A;PSMA4;MYC;NFKBIA;ACTR5;USP13;SUDS3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4144265902458574,1.0476584939971147,0.4117647058823529,0.7395468988797489,1.0,9/32,26.26%,CHKB;CSNK2B;MFSD2A;CHAT;ACHE;SLC44A5;STARD10;SLC44A2;SLC44A1
prerank,protein tetramerization (GO:0051262),0.37549909222127076,1.0467520428969663,0.41278439869989164,0.7413770517167648,1.0,13/67,20.45%,ALDOA;B2M;AQP4;KCNC3;GRIN1;KCNC1;TRPM2;GLS;HCN1;GRIN2B;SNCA;PKD2L1;SHMT2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3936517451380052,-1.0466953677828559,0.39015151515151514,0.7421070631994933,1.0,6/13,13.72%,NFIB;PPARA;NFATC4;PPARG;NFATC3;BMP4
prerank,positive regulation of type I interferon production (GO:0032481),0.3759984354239459,1.0464347154508253,0.40865892291446676,0.741762588260005,1.0,19/73,22.12%,GAPDH;HSP90AA1;POLR2E;POLR2F;FLOT1;CTNNB1;ISG15;PQBP1;HSPD1;POLR2K;RIPK2;IRF7;G3BP1;OAS3;CD14;POLR2H;POLR3K;IRF5;POLR3D
prerank,sensory perception of taste (GO:0050909),0.5165918110136,1.0463118857496239,0.44366197183098594,0.7416398021419972,1.0,5/10,33.39%,ASIC2;PKD2L1;TAS1R1;PKD1L3;CD36
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3780834410393101,1.0462275415872713,0.4084967320261438,0.7414374959367296,1.0,15/68,16.68%,DBI;HINT1;RAN;SULT4A1;BPNT2;ADSS1;AK4;AK3;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;BAD;ACOT4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.41733912181018024,1.0455286421828962,0.42248520710059173,0.7427930823754626,1.0,11/29,31.74%,DBI;PLAAT3;PLA2G4F;NR1H2;LPCAT2;PLA2G3;PLA2G6;MBOAT7;PLBD1;PNPLA8;NR1H3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3563412232949209,1.0450122272978153,0.403420523138833,0.7436940976611809,1.0,50/182,20.21%,APOE;RACK1;CLDN5;HSP90AB1;PARK7;LGMN;CNPY2;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;SPI1;MIF;TLE5;SH3GL2;APLNR;MYADM;LRPAP1;KDR;MAPT;GATA2;TARDBP;LRP3;HRAS;MSR1;KLF4;FBXW7;BMP2;SDCBP;ANKRD13D;SUB1;CCL3;VHL;NOS2;AGO1;MAP2K2;APOBEC1;SOX11;DDRGK1;NOTCH1;ERP29;TGFB1;POU4F1;CITED2;MEF2C;SFRP1;TRAT1
prerank,cell-substrate junction assembly (GO:0007044),0.4147984890030899,1.0445802142541003,0.43157894736842106,0.7443407177866229,1.0,12/33,22.31%,CD151;LAMC1;PLEC;FN1;THY1;LAMC2;ARHGEF7;ACTN1;DLC1;CTTN;THSD1;RCC2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.46894298206029567,1.0445703398047443,0.41509433962264153,0.7439357732122422,1.0,4/16,10.25%,ZFP36L1;ZFP36L2;ZFP36;TARDBP
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3779013335291176,1.0444915743551115,0.44089456869009586,0.7437060505325837,1.0,11/72,10.83%,APOE;ARHGDIA;KCTD10;RASIP1;RAC1;ARHGDIB;ADGRG1;COL3A1;NET1;TNFAIP1;GPR18
prerank,cellular response to lipid (GO:0071396),0.3537536780446411,1.0442248627607535,0.4026236125126135,0.7439353274716058,1.0,51/191,20.23%,VIM;SPP1;NDUFA13;PDE4B;ADAM15;GPER1;NR1D1;SIRPA;CD180;LTK;TNFAIP3;MSN;BRINP3;MGST1;ATP1A3;CCR5;PTK6;CXCL10;AQP1;LPL;TICAM2;CD68;HMGB1;ZFP36;CHMP5;GNAI1;BRINP1;WNT5A;RAMP3;ATP1A1;BRINP2;SNW1;SOX9;RHOA;LILRB1;WNT10B;CX3CR1;CCL2;PF4;DAB2IP;ADCY8;NCOA4;CD14;CD86;NLRP3;IL6;GIT1;POU4F1;MEF2C;SFRP1;SPHK2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.42085088196800924,1.0442138775822443,0.41442542787286063,0.7435375619326412,1.0,5/29,9.31%,CD81;CCL19;PDGFB;EEF1A2;P2RY12
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4179095770318825,1.044212552643071,0.4385342789598109,0.74310854332464,1.0,13/32,24.88%,HINT1;RPS27L;HIPK2;TMEM109;PMAIP1;SNW1;STK11;POU4F1;DDIT4;PYCARD;PHLDA3;DYRK2;BOK
prerank,regulation of secretion (GO:0051046),0.48488471964175206,1.0440134810621438,0.43443708609271525,0.7431747470147125,1.0,5/13,18.54%,NRG1;SGK1;SCIN;ERBB3;ACSL3
prerank,NAD biosynthetic process (GO:0009435),-0.33632530953603806,-1.0436270727693504,0.34418604651162793,0.7486163623798224,1.0,8/20,21.13%,PTGIS;PARP9;PARP16;PARP10;NADSYN1;NUDT12;NMNAT2;NMNAT3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.44889087403161454,1.0435987056793763,0.44110275689223055,0.7438343077055911,1.0,5/19,15.15%,GMPPB;PMM1;AMDHD2;NANS;UGDH
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.347207008801243,-1.0435707313840394,0.38222222222222224,0.7468560334039974,1.0,4/18,2.52%,ROCK2;BCAS3;ARFGEF1;ROCK1
prerank,axon guidance (GO:0007411),0.35407123665793333,1.0435587095450234,0.3949748743718593,0.7435087655699979,1.0,52/201,17.53%,BSG;CXCL12;MAPK3;DCC;NRXN1;UNC5D;LYPLA2;SEMA3F;RAC1;DSCAM;CNTN4;SEMA7A;SEMA4C;SHC3;LGI1;NRXN3;RHOG;DAB1;OTX2;TNR;SEMA6D;ROBO4;NTN1;LGR6;EMB;UNC5C;CDK5R1;LAMC2;EPHA5;KIF5A;SEMA4A;LRTM2;WNT5A;GFRA1;DOK5;SEMA4G;CXCR4;IGSF9;DSCAML1;ROBO2;SPTBN4;EPHB1;GAP43;SH3KBP1;GFRA2;SPTBN2;PIK3CD;SLIT3;SLIT1;EFNB1;RAC2;NCAM1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.46632016460647097,1.0434228391414908,0.40450928381962864,0.743433921970948,1.0,2/16,2.92%,ACADVL;APOC1
prerank,focal adhesion assembly (GO:0048041),-0.33250440893765637,-1.0432595542488499,0.39086294416243655,0.7458579088683356,1.0,6/21,11.07%,SORBS1;ACTN2;BCR;PIP5K1A;TESK2;FERMT2
prerank,regulation of mitotic spindle organization (GO:0060236),0.4132654732189698,1.0430787866005748,0.41367323290845887,0.7438894444406855,1.0,10/35,15.97%,HSPA1B;CHMP2B;CLTC;TACC3;CHMP5;GNAI1;DCTN1;HSPA1A;HNRNPU;CHMP1B
prerank,positive regulation of behavior (GO:0048520),0.5057326711725625,1.0425995967513229,0.4388888888888889,0.7446576791382314,1.0,3/10,9.16%,NLGN1;INSL5;CRH
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.4104704280355847,-1.0423574980437262,0.3971119133574007,0.746289035608012,1.0,4/11,16.26%,EGFR;RIPK1;BMP4;TP53
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.43853884833761736,1.0422975345354086,0.4269377382465057,0.7449760206500238,1.0,9/21,21.40%,PARK7;TMBIM6;CREB3;PMAIP1;SYVN1;HSPA1A;HERPUD1;DDIT3;SELENOS
prerank,protein deubiquitination (GO:0016579),0.3518801269727693,1.0420842952702827,0.3856998992950655,0.7450842798221032,1.0,61/242,21.46%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RCE1;PSMD1;PSMC3;UCHL1;PSMD6;VCP;TNFAIP3;USP51;UBA52;PSMA7;USP5;ABRAXAS2;TAF10;OTULIN;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;USP26;BABAM1;TRAF3;OTUB1;KDM1B;PSMB1;ARRB2;PSMB5;USP8;USP22;CDC25A;TAB1;PSMA6;DESI2;WDR48;NLRP3;RAD23A;PSMA4;SHMT2;MYC;NFKBIA;ACTR5;USP13;SUDS3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.423259768398105,1.0417895522478215,0.4147239263803681,0.7454059484999929,1.0,7/27,18.28%,AKT1;TREM2;CTNNA2;IL1RAPL1;CCDC88A;BRSK2;NCS1
prerank,response to organonitrogen compound (GO:0010243),0.4035170999596909,1.0411700798848706,0.4205607476635514,0.7465848310944898,1.0,12/38,21.91%,RCN3;VCP;GLRA2;TRPM2;SYVN1;GLRA1;RRAGC;UBXN6;BRSK2;GLRA3;IL6;IRF5
prerank,positive regulation of protein acetylation (GO:1901985),-0.4074775454163695,-1.0409334669796733,0.3840304182509506,0.7481558058355962,1.0,5/12,14.72%,CEP295;FAM161A;PRKAA2;RAPGEF3;TAOK1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.39700925325308944,1.0406284488434767,0.4364454443194601,0.7475670684545098,1.0,11/41,18.26%,CCL19;SLC24A2;PTPRC;GRIN1;GRIN2A;HTR2C;TRPM2;SLC8A1;RYR2;ERO1A;GRIN2B
prerank,glycine metabolic process (GO:0006544),0.4884364907042239,1.040599840751547,0.44414535666218036,0.7472067526757428,1.0,7/12,34.77%,SDS;GLYAT;SHMT2;DLD;RIDA;GCAT;GCSH
prerank,keratan sulfate metabolic process (GO:0042339),0.41389176367331426,1.0405594679759174,0.4224343675417661,0.7468732732370632,1.0,6/31,10.09%,HEXB;FMOD;LUM;HEXA;CHST1;B4GALT6
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3724850582577899,-1.0404276617699604,0.3953488372093023,0.7476121696510376,1.0,3/14,4.69%,ACTN2;ANK2;AKAP9
prerank,ceramide biosynthetic process (GO:0046513),0.3970056535983934,1.0399457404240167,0.42476851851851855,0.7480025132580924,1.0,12/40,21.11%,CERS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA4;SPTLC1;ST6GALNAC3;DEGS1;FA2H;CLN8;SPTSSA;ASAH2
prerank,skeletal muscle tissue development (GO:0007519),0.4155668212012543,1.0398674449962868,0.44138755980861244,0.7477761988183738,1.0,8/32,21.04%,MYL6;CAV2;FOXL2;MYL6B;CAV1;SELENON;MEF2C;MYH14
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.44726178397710814,1.0396257767276578,0.4339378238341969,0.7479541657523409,1.0,9/18,27.81%,BAX;PMAIP1;RNFT1;TMEM259;BAK1;DDIT3;USP13;BOK;XBP1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4007328514518512,-1.0395925126537684,0.37966101694915255,0.7480643249078456,1.0,5/11,21.36%,VCL;PLEKHA7;KIT;ITGB5;THBS4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3496205391737012,-1.039504809169686,0.375,0.7464183349067167,1.0,4/17,5.66%,ROBO1;SLIT2;NRP1;EFNB2
prerank,neurotransmitter uptake (GO:0001504),0.4946254478677752,1.0385018265643495,0.4309623430962343,0.7503712604885396,1.0,4/12,14.83%,SNAP25;GLUL;SLC29A1;SLC29A2
prerank,cellular response to sterol (GO:0036315),-0.3975573104178775,-1.038360501986328,0.408,0.7476730756693343,1.0,7/13,23.75%,SMO;LRP6;GRAMD1C;RORA;GPLD1;PTCH1;RORC
prerank,regulation of histone acetylation (GO:0035065),0.41105107530593527,1.0382982233452476,0.4544392523364486,0.7504309424398072,1.0,9/33,19.11%,PARK7;MAPK3;SPI1;SET;CAMK1;CTBP1;HDAC5;PPARGC1A;SNCA
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3559436942443737,-1.0382074810687973,0.3807531380753138,0.7462020653373983,1.0,4/16,9.11%,FER;ABL1;NRP1;PDGFRB
prerank,modulation by host of symbiont process (GO:0051851),0.4080580173058189,1.0381270838540442,0.42321644498186217,0.750432298091396,1.0,11/31,22.12%,NUCKS1;AQP1;RRP1B;JUN;TARDBP;SNW1;CX3CR1;CCL3;TFAP4;SAP30BP;REST
prerank,axonal transport of mitochondrion (GO:0019896),0.498930690719131,1.0380330295322968,0.4516574585635359,0.7502483434707085,1.0,3/11,11.11%,NEFL;MAPT;HAP1
prerank,ganglioside biosynthetic process (GO:0001574),0.46405838019387957,1.0377620905801268,0.4401595744680851,0.7505172545243769,1.0,4/15,15.57%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3
prerank,regulation of water loss via skin (GO:0033561),0.46973972687862725,1.0376336152637,0.43766937669376693,0.7499939554231816,1.0,4/15,16.89%,HRNR;LSR;STMN1;FA2H
prerank,establishment of skin barrier (GO:0061436),0.46973972687862725,1.0376336152637,0.43766937669376693,0.7499939554231816,1.0,4/15,16.89%,HRNR;LSR;STMN1;FA2H
prerank,lipid oxidation (GO:0034440),0.4922910892757118,1.037320016343893,0.45734265734265733,0.7503256658299202,1.0,5/12,34.12%,PLA2G7;PPARGC1A;ADIPOR1;ACOX1;ADIPOR2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.38699941018234424,-1.0370585109487513,0.45,0.7472715218283966,1.0,4/13,8.19%,SORBS1;IRS1;INSR;IGF1
prerank,mRNA destabilization (GO:0061157),-0.2958938350973263,-1.0370386561327292,0.3821656050955414,0.7454593251678712,1.0,10/38,10.06%,ROCK2;FTO;ROCK1;DHX36;CNOT1;YTHDF3;TUT7;CPEB3;MOV10;RC3H2
prerank,negative regulation of synaptic transmission (GO:0050805),0.4367551183867412,1.0367278399774564,0.4424778761061947,0.7513430673655055,1.0,5/23,15.62%,SLC30A1;SLC24A2;SYT11;ARF1;ACHE
prerank,negative regulation of cyclase activity (GO:0031280),0.4782484150323124,1.0352829150017546,0.4614343707713126,0.7544447888555241,1.0,4/14,20.06%,GNAI2;RD3;CCR2;GABBR2
prerank,phospholipid translocation (GO:0045332),0.4186849221444405,1.0351595284041724,0.44188861985472155,0.7543250663056975,1.0,6/28,10.95%,TMEM30A;ATP8B4;ATP8A2;P2RX7;MFSD2A;ATP8A1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.42604825868470314,1.035130584106286,0.43757725587144625,0.7539686390546528,1.0,11/24,27.40%,VTN;MT3;CADM4;PDCD6;DAB2IP;TMEM204;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,regulation of MAP kinase activity (GO:0043405),0.3633520919342915,1.0349325012015502,0.4408376963350785,0.7540292235901394,1.0,22/92,19.83%,APOE;AGT;TNF;PDGFB;SORL1;UCHL1;RGS2;HYAL2;CD24;SMPD1;HRAS;SPRY1;NEK10;PDGFA;RASGRP1;DAB2IP;FLT1;CD300A;EDN3;SPRY3;FLT3;TGFB1
prerank,metal ion export (GO:0070839),0.41194708937479285,1.0348259869312417,0.4186320754716981,0.7538654140722939,1.0,10/31,17.69%,ATP1A3;ATP1B2;KCNE4;SLC40A1;ATP1A4;ATP1A1;SLC11A1;KCNE5;ATP1B1;ATP1B3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5013579225874202,1.0344849510554832,0.45491803278688525,0.754278137596735,1.0,2/11,9.41%,KLF2;EPN1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.49217032985702214,1.0338073958167016,0.4507628294036061,0.7555555238712899,1.0,5/12,25.94%,CLEC6A;SLC11A1;CCR2;IL12RB1;PRKCQ
prerank,protein palmitoylation (GO:0018345),0.4139267552033121,1.0337298583134165,0.4468599033816425,0.7553338871335838,1.0,12/30,29.54%,GLUL;SELENOK;ZDHHC5;GOLGA7B;CLIP3;GOLGA7;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,tight junction assembly (GO:0120192),0.3865373572493596,1.0336707085609802,0.43666666666666665,0.7550464155568068,1.0,15/49,24.27%,ACTG1;CLDN5;RAMP2;CLDN11;ESAM;PECAM1;LSR;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,regulation of cell morphogenesis (GO:0022604),0.4143946368078414,1.0336434001174535,0.4243498817966903,0.754682121073239,1.0,2/30,1.57%,SPARC;CFL1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.33015286323676063,-1.0336130493603002,0.4039408866995074,0.7528644535696631,1.0,3/24,6.44%,AUTS2;PLCE1;NCKAP1
prerank,regulation of intracellular protein transport (GO:0033157),0.4094747589554769,1.0329836213033579,0.4297820823244552,0.7559092065617063,1.0,16/32,28.06%,OAZ1;PRR5L;UHMK1;LCP1;VAMP2;ATP13A2;CEP131;B3GAT3;TGFB1;OAZ2;IFI27;PTPN1;KIF20B;ICE1;PCNT;TENM1
prerank,regulation of T cell cytokine production (GO:0002724),0.4717832009227223,1.0324343091390933,0.45152722443559096,0.7568704363822685,1.0,1/15,0.77%,B2M
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4987570552727246,1.0324248282523598,0.44536652835408025,0.756461397101506,1.0,3/11,10.02%,CORO1C;ENPP2;ARHGEF7
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3587643089690137,-1.0316183761818467,0.39759036144578314,0.7563356246126841,1.0,9/16,17.18%,SMG6;DHX36;SLX4;TNKS2;TERF2;ATM;TINF2;PINX1;RTEL1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3079827654573073,-1.0315990351408213,0.38285714285714284,0.7545059190562157,1.0,9/30,13.79%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,positive regulation of metabolic process (GO:0009893),0.36044732512269284,1.0307828205496428,0.43078512396694213,0.760094314959341,1.0,31/103,23.49%,GATM;UCP2;TNF;EPAS1;FABP5;CAMK1D;BSCL2;OMA1;CEBPB;FASN;SCD;KDM6B;LCN2;MFAP2;THRA;HCRT;GJA1;CXCR4;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ADIPOR1;TSHR;PRLR;ELOVL6;ACLY
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3356928725139191,-1.030635077502512,0.3721973094170404,0.7551896809225767,1.0,3/21,2.23%,ADCY9;ADCY1;ADCY5
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.3592317533659341,-1.0303923846154852,0.3738738738738739,0.75393328136981,1.0,6/15,19.29%,LARGE1;OGA;MGAT3;RENBP;CHST3;NAGK
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4247324283048731,1.0301592269456636,0.4510532837670384,0.7612247515334716,1.0,8/27,16.28%,RNASE1;RNASE4;NHP2;POP7;RNASEH1;TOE1;PDE12;NUDT16
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.3081762332101195,-1.0299760371978568,0.4342857142857143,0.7532738936904392,1.0,9/27,16.26%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,sodium ion import across plasma membrane (GO:0098719),-0.34670400936540335,-1.029970875604634,0.365296803652968,0.751422337297303,1.0,3/17,10.62%,SLC9A1;SLC9A2;TRPM4
prerank,organic anion transport (GO:0015711),0.368286614023671,1.0296957640470106,0.43756558237145854,0.7619191248057183,1.0,20/76,20.84%,LRRC8A;SLCO1C1;CA2;SLC25A4;MGST1;AQP1;SLCO4C1;CA4;SLC19A1;SLC35A3;SLC25A19;SLC2A2;MFSD10;SLC52A1;SLC4A2;SLC35A1;SLC35B4;SLCO1B1;CYB5R1;CA3
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5053706879538953,1.029657355287755,0.45803698435277385,0.7615811175002986,1.0,3/10,11.32%,TERF1;MAPT;DNAJA1
prerank,positive regulation of reproductive process (GO:2000243),0.4144509714643394,1.0294965639256017,0.44945188794153473,0.7615280428214746,1.0,8/31,23.52%,PGAM4;PRSS37;TACR1;GLRA1;INHBA;SIRT2;INHBB;C1QBP
prerank,positive regulation of protein secretion (GO:0050714),0.37422452665914857,1.0294330085573673,0.43211206896551724,0.7612591157658344,1.0,20/69,19.83%,PPIA;TREM2;RBP4;TRH;LRRC8A;GPER1;ANG;ABCG1;ARF6;ATP13A2;APBB1;F2RL1;BAD;IER3IP1;ACHE;DNM1L;DOC2B;GLUD1;NNAT;TGFB1
prerank,negative regulation of histone acetylation (GO:0035067),0.49153869742846523,1.0288103452353419,0.46005509641873277,0.7623911979807811,1.0,4/11,19.11%,SPI1;SET;CTBP1;SNCA
prerank,apoptotic process (GO:0006915),0.34867475879197324,1.028745680983948,0.42527582748244735,0.7621309114687943,1.0,51/203,20.94%,PPIA;GAPDH;RHOB;DCC;AKT1;NSG1;ITGB2;RFK;ADAM15;IER3;RTN4;BNIP2;PPP2R1A;PARP1;MAL;ELMO1;SFRP5;MAGEH1;HSPD1;TNFSF12;JADE1;DHCR24;TNFAIP1;BAX;PMAIP1;PAX3;CXCR4;STK11;BBC3;BAD;RRAGC;DLC1;CDK5;GLRX2;ADRA1A;PRUNE2;PPP1R15A;ERBB3;ATCAY;TRAIP;CD14;NLRP3;DDIT4;PDE1B;CAPN3;MYC;NFKBIA;PAK5;BAK1;PYCARD;GADD45A
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.49347038786689323,1.0286376240777406,0.43768115942028984,0.7619591230029138,1.0,5/11,24.55%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4368007698934238,1.0283311624641442,0.442643391521197,0.7622701647500302,1.0,3/23,8.79%,CALM1;METAP1;METAP2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36497864163276617,1.0281924604390191,0.44561774023231254,0.762196506255006,1.0,24/78,21.57%,CLU;RACK1;GABARAP;ELOB;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;UBQLN2;HSPBP1;SGTA;CAV1;HERPUD1;BCAP31;NOP53;DDRGK1;RNF144B;RAD23A;SIRT2;STUB1
prerank,calcium ion import into cytosol (GO:1902656),0.4640648431926169,1.0278393034309028,0.45121951219512196,0.7626391400755371,1.0,5/15,28.26%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,cellular response to growth factor stimulus (GO:0071363),0.3550551246621199,1.0276606579308432,0.4508611955420466,0.7626495087650096,1.0,28/151,14.66%,EEF1A1;MT1G;RACK1;RAMP2;HSPB1;LGMN;AKT1;PDGFB;ACVRL1;NTRK2;ZFP36L1;ZFP36L2;DUSP3;CTNNB1;HYAL2;KDR;MAPT;CLEC3B;ZFP36;GAS1;WNT5A;FLT4;AMHR2;KLF4;SOX9;BMP2;CCL2;EHD1
prerank,acute inflammatory response (GO:0002526),0.42833029914796217,1.0274361914849022,0.44025157232704404,0.7627923449531214,1.0,6/23,19.67%,MBL2;CEBPB;HPR;HP;SIGIRR;IL6
prerank,positive regulation of signaling receptor activity (GO:2000273),0.39733186948381394,1.0273861200775074,0.46412037037037035,0.7624795707357788,1.0,9/36,21.65%,PARK7;FBXW7;CCL2;NCF1;ADAM17;CCR2;BUD31;ADRA2B;TGFA
prerank,protein dephosphorylation (GO:0006470),-0.2332036642161285,-1.0272115501779295,0.3888888888888889,0.7569409617325495,1.0,47/135,19.88%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PPP1R12A;PTPN14;TNS2;PPM1E;MTMR3;PPM1D;PTPN3;DUSP16;PPP4R1;DUSP10;EYA4;PPEF2;PPP2R5E;PTPN12;DAPP1;PPP4R2;BTRC;PTEN;FBXW11;NCK1;DUSP7;EYA3;PTPN2;PPP2CB;LHPP;RPAP2;PPP6C;PPP2R2A;PTPN22;DUSP11;SSH1;PPP3CB;PPP3CC;PPP2R1B;SDHAF2;PPTC7;CTTNBP2NL;PTPRM;PPP2R3A;CDC14B;PTPRK;PPM1H
prerank,actin filament polymerization (GO:0030041),0.4195297739387702,1.0268052686345372,0.4326923076923077,0.7635310769754081,1.0,6/29,13.12%,GSN;RAC1;ANG;FAM107A;AIF1;MSRB1
prerank,synaptonemal complex organization (GO:0070193),0.4625930903968652,1.0264841905367614,0.4664082687338501,0.7634180200577293,1.0,1/15,4.14%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.4625930903968652,1.0264841905367614,0.4664082687338501,0.7634180200577293,1.0,1/15,4.14%,SYCP2
prerank,regulation of synapse assembly (GO:0051963),0.3921974159943007,1.0260728395906316,0.44130925507900676,0.7640045734419529,1.0,22/46,24.37%,NRXN1;NLGN1;GRID2;LRFN5;LHFPL4;MUSK;IL1RAPL1;PTPRD;SYNDIG1;LRRC4B;ROBO2;EPHB1;CLSTN2;CLSTN1;SLIT1;SNCA;MEF2C;IL1RAP;CLSTN3;SLITRK3;WNT7A;APP
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5066395117142798,1.0260631548155505,0.45714285714285713,0.763597768025832,1.0,4/10,27.80%,UBE2G2;SVIP;OS9;UBE2J1
prerank,histone ubiquitination (GO:0016574),-0.33006097632082493,-1.0258885624046028,0.40186915887850466,0.7586081179468418,1.0,9/21,25.10%,HUWE1;RNF8;UBR2;CDC73;UBE2E1;WAC;RNF20;CTR9;PHC1
prerank,regulation of membrane repolarization (GO:0060306),0.4756493152060475,1.0257850658762309,0.4552736982643525,0.7638386103164335,1.0,4/13,16.41%,AKAP6;YWHAE;KCNE5;CAV1
prerank,positive regulation of heart contraction (GO:0045823),0.4484367294317114,1.0255883473968037,0.4494818652849741,0.7638925762086175,1.0,8/19,27.61%,RGS2;CHGA;RYR2;ADRA1A;EDN3;ATP2A2;TGFB2;KCNQ1
prerank,striated muscle contraction (GO:0006941),0.3800475888913245,1.0254033260296103,0.4551569506726457,0.7639071030384809,1.0,12/53,21.04%,ALDOA;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;DTNA;GRK2;STAC3;MYH14
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3465602434167546,1.0251958612459313,0.4409687184661958,0.7639708086809281,1.0,54/190,25.01%,TMSB4X;RACK1;NDUFA13;AKT1;TREM2;PINK1;PEBP1;GPER1;ARHGAP25;NR1D1;SPI1;DUSP3;APLNR;PDE3B;HYAL2;SFRP5;MYADM;TNFAIP3;CDC34;P2RX7;CD22;OTUD7A;TRIM59;PIK3IP1;PDCD6;PHLPP1;ARRB2;DAB2IP;CAV1;HERPUD1;NDUFS3;TWIST1;NOP53;AKT1S1;SPRY3;RTKN2;NLRP3;DDIT4;PDE11A;THEM4;PYCARD;DDIT3;BANK1;CCN3;TMEM127;TNIP1;ADIPOR1;DUSP1;PHLDA3;RELA;PLEKHA1;EPM2A;PDE2A;RNF157
prerank,amino acid transport (GO:0006865),0.3843941552456681,1.0251885142958528,0.4450610432852386,0.763556971670078,1.0,8/49,11.28%,SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC3A2;SLC7A14
prerank,calcium ion transport into cytosol (GO:0060402),0.4350083465015149,1.0251018481483514,0.44362745098039214,0.7633428893215457,1.0,10/21,24.69%,GRIN1;GRIN2A;TRPM2;JPH4;SLC8A1;RYR2;ADRA1A;GRIN2B;CACNA2D1;ITPR3
prerank,heterochromatin organization (GO:0070828),-0.37337429137120465,-1.0249642611077265,0.4074074074074074,0.7592939501771705,1.0,5/14,15.12%,SETDB1;SETD7;SIRT1;EZH1;SMCHD1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3977455804297335,-1.0245895579888638,0.41935483870967744,0.7584663384513605,1.0,3/12,6.72%,DPYSL3;DPYD;CTPS2
prerank,positive regulation of wound healing (GO:0090303),0.39631437858077273,1.0240924757687362,0.47058823529411764,0.7654378689202331,1.0,2/36,0.90%,ACTG1;VTN
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.38180319442112254,1.0239831627629161,0.45475113122171945,0.7652927802015826,1.0,11/48,11.85%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;IL1RAPL1;ARHGEF7;SS18L2;PTPRD
prerank,regulation of interferon-beta production (GO:0032648),0.3854212326384507,1.0239596080584834,0.4449489216799092,0.7649276423203579,1.0,20/46,32.13%,HSP90AA1;FLOT1;TIRAP;SIRPA;ISG15;LILRB1;RIPK2;IRF7;TRAF3;OAS3;PYCARD;IRF5;POLR3D;TLR7;DHX9;TLR2;TRIM56;POLR3C;MAVS;DDX3X
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5100701991067899,1.023264576378241,0.45760233918128657,0.7662168463635615,1.0,3/10,19.35%,PDE3B;JAM3;MUC1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.5018951688486168,1.0231291279618013,0.463519313304721,0.766110766687293,1.0,2/10,5.95%,DDX39B;RPA2
prerank,response to UV-A (GO:0070141),0.4645418433621873,1.0223342473640573,0.4438430311231394,0.7676449134813418,1.0,4/14,11.31%,AKT1;CCND1;TIMP1;MMP3
prerank,lytic vacuole organization (GO:0080171),0.40353175489198956,1.0222399398816169,0.44028103044496486,0.7674429777808566,1.0,7/32,13.30%,GRN;CLVS1;CLVS2;GAA;CLN5;CLN6;TMEM106B
prerank,vascular transport (GO:0010232),0.3661353578480208,1.0221859054794578,0.4491525423728814,0.7671390799174992,1.0,21/81,16.01%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;LRP3;ATP8A1;SLC29A1;ATP1A4;SLC1A1;SLC19A1;SLC29A2;SLC16A1;SLC15A2;ABCA2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.295546159930702,-1.0221449461089056,0.42063492063492064,0.7631607386044239,1.0,7/39,12.93%,PI4KA;TTC7B;SMG1;ITPKB;IP6K2;PIP4K2C;SOCS5
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.47784192733872594,1.0218856212965353,0.4519230769230769,0.7674358133281726,1.0,6/13,23.63%,BNIP3L;BAX;PMAIP1;BAD;VDAC2;BLOC1S2
prerank,carboxylic acid metabolic process (GO:0019752),0.4064707019784044,1.0218085055472828,0.4357142857142857,0.7671995845665183,1.0,10/33,18.03%,SLC2A1;AGXT;CYB5R3;MIF;GSTO1;GRHPR;GLYAT;ACOT4;GLUD1;SLC2A3
prerank,defense response to tumor cell (GO:0002357),0.4956269789374832,1.0216834796282146,0.44857142857142857,0.7670667219368635,1.0,3/10,4.50%,LAPTM5;PRDX2;SPI1
prerank,regulation of fibroblast migration (GO:0010762),0.4382948493466475,1.0215839429995672,0.4573248407643312,0.7668754349414433,1.0,8/20,19.83%,RAC1;PRR5L;HYAL2;CORO1C;ARHGEF7;DMTN;DDR2;TGFB1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3558469930572432,1.0212684064672761,0.477319587628866,0.7671814097985772,1.0,27/100,19.66%,MAPK3;TREM2;AGT;GPER1;IER3;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;KDR;DCN;PIK3IP1;SOX9;F2RL1;PDGFA;NCF1;DAB2IP;FLT1;PIK3CD;TWIST1;ERBB3;NOP53;MAZ;FLT3;HGF
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3483488066183057,1.0210766237041264,0.4566768603465851,0.7672210513902197,1.0,53/150,27.01%,HSP90AA1;HSP90AB1;PARK7;CCL19;TXN;NRG1;ERBB4;PINK1;TNF;PDGFB;HCLS1;RAC1;RTN4;RHOG;P2RY12;KITLG;MC1R;RAMP3;VAV1;GAS6;CX3CR1;GDF15;IGF2;PDGFA;HPSE;CCL3;CASS4;PIK3CD;F10;RAC2;ERBB3;KLB;MAZ;CD86;FLT3;HGF;TGFB1;THPO;TRAT1;THEM4;TGFA;MYDGF;C1QBP;TEK;CD28;PIK3R5;FGF22;MFHAS1;FGFR3;CX3CL1;ITGB1;TRIB3;MYOC
prerank,calcium ion import (GO:0070509),-0.3033738316713644,-1.0210563371575383,0.4146341463414634,0.7642956222162934,1.0,8/28,14.17%,MCU;CACNA1C;MICU1;MICU2;TRPC4;CACNA1G;AFG3L2;CACNA1D
prerank,heterocycle biosynthetic process (GO:0018130),0.4730033783044303,1.0209960971711516,0.44808743169398907,0.766991556490556,1.0,2/14,6.40%,PYCR2;GPHN
prerank,mitochondrial genome maintenance (GO:0000002),0.4937636985574376,1.020958783937871,0.45938375350140054,0.7666443506152962,1.0,6/11,30.85%,SLC25A4;PARP1;MPV17;LONP1;SLC25A36;MGME1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.42735361012393225,1.0204985153846047,0.4654320987654321,0.7673310580150794,1.0,8/24,22.84%,MT3;ACADVL;SLC25A13;MTLN;PPARGC1A;MYC;CYCS;COQ10A
prerank,protein O-linked mannosylation (GO:0035269),-0.3467522810952111,-1.0203708629850117,0.4265402843601896,0.7641812424974749,1.0,3/18,1.53%,TMTC1;LARGE1;TMTC4
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.503455376460418,1.0203389135713687,0.46089385474860334,0.7672883676370011,1.0,5/10,18.76%,DLGAP2;DLGAP1;BEGAIN;NPTXR;CACNG5
prerank,phospholipid dephosphorylation (GO:0046839),-0.2824707751451266,-1.0200580678398103,0.38571428571428573,0.7632101264825302,1.0,18/37,24.14%,PLPP3;MTMR3;MTMR11;PTEN;SACM1L;PLPP5;EPHX2;MTMR10;PLPP1;PIP4P2;PLPP2;INPP5B;PLPPR1;TPTE;PLPPR3;MTMR1;SYNJ2;MTMR7
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.45189128087991537,1.0200217762913486,0.4634146341463415,0.7676282066448579,1.0,8/17,17.75%,ATP1A3;ATP1B2;ATP1A1;GJA1;ATP1B1;SLC8A1;RYR2;FKBP1B
prerank,electron transport chain (GO:0022900),0.4638873316421812,1.0195309259012721,0.44906166219839144,0.7683947511906247,1.0,6/15,22.11%,ETFB;NDUFA5;SDHB;UQCRFS1;PPARGC1A;SDHA
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4779397212286215,1.0194335245772659,0.46621621621621623,0.7682166339181696,1.0,4/13,17.58%,SYT1;SYT4;SYT10;DOC2B
prerank,negative regulation of signaling receptor activity (GO:2000272),0.42028971785395997,1.0191608287180787,0.47160493827160493,0.7684620875443005,1.0,4/25,11.35%,CNRIP1;TNF;CHMP6;RAMP3
prerank,purine-containing compound catabolic process (GO:0072523),0.47485510163645,1.0190467183054062,0.4796747967479675,0.7683294090703494,1.0,4/13,17.44%,GPX1;DNPH1;PNP;NT5C
prerank,"DNA-templated transcription, termination (GO:0006353)",0.37155080693859066,1.01903455679694,0.47737068965517243,0.7679248188523704,1.0,25/68,27.25%,CAVIN1;SNRPG;POLR2E;POLR2F;SNRPE;POLR1B;SNRPF;POLR2K;CPSF2;SNRPB;UBTF;SLBP;SNRPD3;MAZ;TBP;POLR1H;CPSF4;POLR2H;POLR3K;POLR1G;GTF2H5;SYMPK;ERCC2;CCNH;POLR1F
prerank,aminoglycan biosynthetic process (GO:0006023),-0.271476097926364,-1.0188774550506001,0.4049586776859504,0.7645006068352037,1.0,10/49,8.46%,GPC6;EXT1;GPC4;GPC3;HS3ST3A1;B3GNT2;HS2ST1;B3GALT1;NDST1;SLC35D2
prerank,protein maturation (GO:0051604),0.358676440448474,1.0188534847898556,0.46659707724425886,0.7679288085640796,1.0,35/95,25.56%,BOLA2;CTSS;CPXM1;CPD;SORL1;PSENEN;CPE;PRSS37;HSPD1;METAP2;PCSK2;SRGN;NAA10;AEBP1;CPXM2;BACE1;DNAJB11;CIAO1;PSEN2;MMP14;ADAM17;APH1B;NNAT;LMF2;CIAO2A;CIAO2B;STUB1;TSPAN32;ECE2;NDUFAB1;AANAT;CPZ;APH1A;PCSK6;LIPT1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2514095738348982,-1.018784257787951,0.4657534246575342,0.7629446400873153,1.0,13/62,8.78%,KMT2C;CNOT4;TNRC6B;CREBBP;ZBTB16;TNRC6A;HOXA5;KMT2A;TNRC6C;KAT2B;CDK6;ASH2L;MOV10
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.42276582934912565,1.018647163266714,0.4646840148698885,0.7679478615959076,1.0,6/22,21.01%,PDE4B;AHNAK;CBARP;SRI;STAC3;CACNB4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.35587603073423557,1.0180342713595045,0.47433264887063653,0.769017824352913,1.0,28/101,19.83%,CALM1;AKT1;CALM3;CCND2;TNF;PDGFB;CCND1;PROX1;CD24;CAMK1;PIH1D1;CSF1R;WNT5A;HRAS;RHOA;NEK10;PDGFA;RASGRP1;MAPRE3;DAB2IP;FLT1;ADAM17;MAP2K2;EDN3;CALM2;SNCA;FLT3;TGFB1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.488312304896539,1.0179612499327833,0.4592391304347826,0.7687540461858975,1.0,6/11,34.09%,ANK3;SYK;PRKCA;PRKCQ;PLAUR;CCL5
prerank,regulation of DNA binding (GO:0051101),0.3852947728247787,1.0178816834865974,0.4664391353811149,0.7685281666565636,1.0,9/44,11.55%,TXN;NME1;CSNK2B;HES1;EDF1;JUN;HMGB1;SUMO3;ZBTB7A
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.3957745631249707,-1.0178087838537715,0.4318181818181818,0.7638271136414799,1.0,4/12,8.19%,SORBS1;IRS1;INSR;IGF1
prerank,myotube differentiation (GO:0014902),0.4505655183051603,1.0177923347494073,0.4582278481012658,0.7683385120836692,1.0,6/17,20.07%,PLD3;ADGRB3;ADAM12;SORT1;MYEF2;MEF2C
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.49095231463608835,1.0177882519982628,0.4588068181818182,0.7679236753149623,1.0,2/11,13.39%,PTPRC;LILRB1
prerank,regulation of focal adhesion assembly (GO:0051893),0.3736391835803218,1.0171112257177897,0.4613686534216336,0.7691730566053495,1.0,12/54,8.38%,ACTG1;APOD;S100A10;RAC1;ACVRL1;DUSP3;GPM6B;FAM107A;CORO1C;CLASP1;THY1;KDR
prerank,cell differentiation in spinal cord (GO:0021515),0.5004601051081975,1.0170001849246566,0.4607703281027104,0.7690573356818237,1.0,1/10,3.02%,MDGA2
prerank,positive regulation of JNK cascade (GO:0046330),0.36412671541094294,1.016866718373328,0.4681081081081081,0.7689722806807877,1.0,25/70,25.38%,CCL19;TIRAP;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;MAPK8IP1;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1
prerank,regulation of interleukin-17 production (GO:0032660),0.40283274437794625,1.0166034781010833,0.45195729537366547,0.7691866436640987,1.0,9/31,25.94%,PRNP;SLC7A5;IL2;VSIR;IL6;TGFB1;DDIT3;RFTN1;PRKCQ
prerank,cell-matrix adhesion (GO:0007160),0.3578905062983207,1.0165446910625116,0.463768115942029,0.7689009228891035,1.0,22/95,16.62%,CD63;VTN;ITGB2;CD34;ADAM15;EMP2;RAC1;TIMM10B;FN1;BCAM;PPFIA2;ZYX;THY1;COL3A1;SIGLEC1;ARHGEF7;ACTN1;TNN;TIAM1;DLC1;HPSE;VCAM1
prerank,regulation of cell cycle (GO:0051726),0.3403091952626345,1.0164109281570424,0.4593781344032096,0.7688134201579127,1.0,85/271,25.60%,RPL23;RPS15A;RACK1;HSP90AB1;CALR;JUND;RHOB;EIF4G2;GPER1;BEX2;FZD9;PTPRC;JUNB;MIF;UHMK1;HIPK2;USP51;SPATA22;CCND1;GMNN;PTK6;PROX1;DHCR24;NUPR1;MLXIPL;JUN;ZBTB49;TARDBP;APBB1;BRINP1;CTBP1;HRAS;CAMK2N1;SOX9;LILRB1;BMP2;FBXO5;RNF40;HNRNPU;NLRP2B;SND1;STK11;SDCBP;L3MBTL1;CDK5;DAB2IP;PIM3;TRIM32;PPP1R15A;TBRG4;NOP53;CDC25A;BTG4;INHBA;NOTCH1;RAD23A;MLF1;TGFB1;POU4F1;CITED2;DYNLT3;SFRP1;TFAP4;MYC;GADD45A;ASAH2;ID2;CDK9;SIRT2;MEN1;DUSP1;CDK10;INTS13;FOXM1;METTL3;BARD1;CHMP1A;BAP1;CDKN2B;FBXL3;PRKACA;INHA;KIF20B;PNPT1;WDR6
prerank,pre-miRNA processing (GO:0031054),-0.36415524206691996,-1.0162404146923085,0.4085106382978723,0.7662759926288948,1.0,8/14,19.58%,DICER1;DROSHA;TUT7;TARBP2;TUT4;AGO2;AGO4;ADAR
prerank,response to UV (GO:0009411),0.35798032334426483,1.016175526319685,0.47253886010362695,0.7689788698978557,1.0,25/95,21.83%,RPL26;GPX1;ATF4;AKT1;NPM1;COPS9;PARP1;MFAP4;CCND1;AQP1;SDF4;SMPD1;MC1R;PCNA;NSMCE3;CAT;CIRBP;TRIM32;ERCC6;CDC25A;CCAR2;MYC;BAK1;MEN1;MAP2K7
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.500904186155201,1.0161211107062762,0.46956521739130436,0.7686883920406701,1.0,6/10,35.56%,PIH1D1;TAF9;NAF1;RUVBL2;ZNHIT3;NUFIP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.36714785799546795,1.0160851410996308,0.46153846153846156,0.7683491063164094,1.0,16/59,23.49%,PARK7;GATM;SCP2;LIPG;SDS;LPL;HSD17B4;OXSM;OSBPL6;OSBPL3;CH25H;GAMT;ACSM5;OSBPL1A;NDUFAB1;ACLY
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.45916610637915145,1.0160567351154755,0.4688741721854305,0.7679840422102983,1.0,8/15,25.43%,BGN;BCAN;DCN;B3GAT3;VCAN;CSGALNACT2;CHST14;CSPG5
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.44489343305914086,1.0160486887248277,0.47162673392181587,0.7675836408944517,1.0,7/17,21.36%,CALM1;CALM3;CADM4;DMTN;CALM2;DDIT4;SIRT2
prerank,regulation of cell communication (GO:0010646),0.4024376828675943,1.0158315467409271,0.4717416378316032,0.7676832056002546,1.0,11/35,19.68%,MTCH1;KAZALD1;YWHAG;SCG5;NCLN;SLC8A1;GLRX2;RYR2;SRI;GRK2;IGFBPL1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.28507144463279827,-1.0157912050683215,0.4224137931034483,0.765755295611529,1.0,18/42,23.30%,ARID2;SETD2;SPIDR;SHLD1;MMS19;PPP4R2;FBH1;MRNIP;FUS;FANCB;CGAS;SMCHD1;RTEL1;RMI2;SHLD2;SIRT6;SHLD3;POLQ
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.33197901870155333,-1.0154763522109989,0.43859649122807015,0.764791629377377,1.0,5/25,6.88%,EXT1;B3GNT2;HS2ST1;B3GALT1;NDST1
prerank,regulation of striated muscle contraction (GO:0006942),0.4140464207732853,1.0154472417318994,0.4522058823529412,0.7682126469433181,1.0,7/27,19.17%,CALM1;CALM3;TNNI1;RYR2;SRI;CALM2;GRK2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4157667962676399,1.0153135063342063,0.4717887154861945,0.7681248402842177,1.0,4/26,3.99%,PRNP;AKAP6;TNF;HOMER2
prerank,positive regulation of vasculogenesis (GO:2001214),0.5019382914727998,1.0153067180660764,0.4868965517241379,0.7677268361194087,1.0,3/10,14.50%,CD34;KDR;RRAS
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3603813406509737,1.0146779213339616,0.4777542372881356,0.7688421188126303,1.0,15/76,14.26%,CLU;RACK1;GABARAP;ELOB;LAPTM5;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;FBXW7;HSPBP1
prerank,calcium ion transport (GO:0006816),0.35415863536905245,1.0146227781007868,0.4658511722731906,0.7685558049989896,1.0,26/113,17.61%,TPT1;RAMP2;SLC24A4;SLC24A2;FKBP1A;CACNA1A;GRIN3A;CCR5;TMCO1;P2RX7;SELENOK;SLC3A2;RAMP3;TRPM2;TRPC7;CHRNA4;GAS6;TRPC1;SLC8A1;RYR2;CCL3;CAV1;CACNG8;ORAI1;PSEN2;CCL8
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4073833085463713,1.014530723677394,0.466903073286052,0.7683516343062106,1.0,11/30,28.43%,LSS;DHCR24;ACAA2;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,regulation of signal transduction (GO:0009966),0.343557263542824,1.0141956381270112,0.46579476861167,0.7687037195220411,1.0,56/190,24.62%,MTCH1;PPIA;CLU;IGFBP6;CD63;RGS5;PRNP;TREM2;IGFBP3;IGFBP4;IGFBP5;PPP2R1A;RGS2;NUCKS1;OTX2;PTK6;KAZALD1;YWHAG;TIMP1;CD24;KIF26A;RGS12;GAS1;DOK5;SNW1;IGFBP2;NCLN;FRMPD1;MAPK8IP2;UBTF;GLRX2;DLL1;ADCYAP1;NCAM1;TMEM108;ERBB3;SRMS;TMEM204;RFNG;GRK2;IGFBPL1;TGFB1;GIT1;BRAP;RGS6;AMFR;FRRS1L;LLGL1;LFNG;PTPN1;ZFAND2B;KCTD8;ANKRD54;APP;RGS4;TCF7L1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.42639320430255856,1.013739593834216,0.4806763285024155,0.769355842585539,1.0,6/24,9.68%,NRG1;CTNNA2;OLFM2;BNIP2;CTNNB1;CAMK1
prerank,regulation of cardiac conduction (GO:1903779),0.3726237175662614,1.0134303231720132,0.46740331491712706,0.7696995678806542,1.0,15/54,17.75%,NPPC;FXYD1;AGT;ATP1A3;ATP1B2;FXYD7;ATP1A4;ATP1A1;ATP2B1;TRPC1;ATP1B1;SLC8A1;RYR2;ATP1B3;FKBP1B
prerank,protein prenylation (GO:0018342),0.49616426392540486,1.0133953329189445,0.4683357879234168,0.7693520639504434,1.0,1/10,3.04%,RCE1
prerank,positive regulation of interferon-beta production (GO:0032728),0.40233263670358504,1.0125590338513373,0.46674445740956827,0.7709163366000328,1.0,15/33,32.13%,HSP90AA1;FLOT1;ISG15;RIPK2;IRF7;OAS3;IRF5;POLR3D;TLR7;DHX9;TLR2;TRIM56;POLR3C;MAVS;DDX3X
prerank,establishment of protein localization to extracellular region (GO:0035592),0.39500876564956544,1.0124035072403348,0.4874429223744292,0.770851367606551,1.0,13/39,24.00%,RCN3;CANX;OLFM2;RAB15;RAB3C;RAB3D;PPY;ARL4D;TVP23A;PDIA4;SCG2;COPG1;MTTP
prerank,response to iron ion (GO:0010039),0.4843774312521043,1.012036458574147,0.49022346368715086,0.7713015131352757,1.0,1/12,0.77%,B2M
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4768917334115097,1.0116434889418053,0.48904109589041095,0.7718262930498577,1.0,5/13,20.89%,LGMN;GRIN2A;RIPK2;BAD;BAK1
prerank,primary neural tube formation (GO:0014020),-0.3013383202997236,-1.0110604046790272,0.4472049689440994,0.7750285884849437,1.0,7/30,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,regulation of monocyte differentiation (GO:0045655),0.47212254628196004,1.0108740825888358,0.46816976127320953,0.7732668417861366,1.0,2/14,4.40%,CD74;ZFP36L1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.49569116097154786,1.010844304610663,0.447870778267254,0.772917474464943,1.0,5/10,24.55%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3914439581460869,1.010773633862243,0.4735023041474654,0.7726714830595487,1.0,12/41,21.30%,MDK;ANK3;TNF;FLOT1;PODXL;THY1;MAGI1;SKAP1;CITED2;FOXA2;PTPRU;FOXA1
prerank,regulation of lipid storage (GO:0010883),0.4219611136608253,1.0106998863255756,0.46540880503144655,0.7724357890860492,1.0,7/22,20.79%,C3;TNF;LPL;ALKBH7;FBXW7;IL6;NFKBIA
prerank,SNARE complex assembly (GO:0035493),0.48539927254386467,1.0106462906693394,0.46853146853146854,0.7721386207199583,1.0,4/10,19.11%,VAMP3;VAMP2;VAMP8;SNCA
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4220517505740475,1.010421778386308,0.46446700507614214,0.7722283036408762,1.0,7/23,16.41%,PTPRC;HYAL2;PTK6;THY1;CHMP6;SRCIN1;CAV1
prerank,diacylglycerol metabolic process (GO:0046339),0.41891179163049286,1.010168537200712,0.45717884130982367,0.7723900934537602,1.0,10/23,22.74%,PNPLA2;ANG;DGKH;LIPE;DGKI;MOGAT2;DGAT1;DGKK;DGKB;MOGAT1
prerank,positive regulation of developmental growth (GO:0048639),0.37942199537783783,1.010107338236228,0.4871508379888268,0.7721129231643127,1.0,20/49,25.84%,PPIB;SEMA7A;SYT1;RIMS2;RIMS1;MAPT;NTN1;SYT4;SHTN1;CPNE5;CPNE6;DLL1;SYT2;AGRN;SYT3;TWF2;UNC13A;RNF157;SYT17;ZFYVE27
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.38808533044420174,1.00970116799959,0.49263873159682897,0.7726699766604014,1.0,9/43,13.23%,HMOX1;AKT1;TNF;PDGFB;IGFBP5;P2RY6;JUN;AIF1;GJA1
prerank,protein sumoylation (GO:0016925),-0.2692169244733037,-1.0092795000945058,0.39805825242718446,0.7781799253340472,1.0,13/49,16.30%,EYA1;RANBP2;NSMCE2;PIAS1;PIAS2;NUP98;SAE1;TOPORS;TRPM4;STX1A;AAAS;NUP214;NUP35
prerank,regulation of gluconeogenesis (GO:0006111),-0.3078184629554396,-1.0092393756682627,0.48125,0.7764243546559422,1.0,9/27,16.08%,OGT;CLK2;SIK1;C1QTNF3;DGKQ;PTPN2;SIRT1;CRY1;SIRT7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.439108450474357,1.0083796782578827,0.4839948783610755,0.775387454279781,1.0,6/18,23.48%,ELOVL1;ELOVL2;ELOVL7;ACSL3;ELOVL6;ACSL4
prerank,centromere complex assembly (GO:0034508),-0.29332183368102827,-1.0082224524445165,0.39855072463768115,0.7773566287401213,1.0,18/36,26.05%,SMARCA5;POGZ;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPE;CENPU;CENPI;CENPH;MIS18BP1;MIS12;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,positive regulation of organelle organization (GO:0010638),0.3986934471086546,1.0080808003888673,0.47591069330199764,0.7756886494905111,1.0,9/32,20.86%,TREM2;LMAN1;SURF4;P2RX7;TMED9;LNPK;PPARGC1A;DOC2B;C2CD5
prerank,aminoglycan catabolic process (GO:0006026),0.4028321537374379,1.007920259711394,0.47073474470734744,0.7756773051480367,1.0,13/28,19.89%,HYAL2;OVGP1;GUSB;SDC4;FUCA1;GPC5;SGSH;NAGLU;HPSE;SDC3;HPSE2;HSPG2;AGRN
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.43483454171732433,1.007829172281823,0.48119325551232167,0.7754705511248607,1.0,9/20,19.10%,CALM1;CALM3;GSTO1;GSTM2;ATP1B1;SLC8A1;RYR2;FKBP1B;CALM2
prerank,protein localization to chromosome (GO:0034502),-0.28882169810760044,-1.0076833857066514,0.42948717948717946,0.7770546085984145,1.0,9/34,16.48%,WAPL;PARP3;ESR1;MRNIP;TNKS2;TERF2;TINF2;PINX1;IFFO1
prerank,activation of protein kinase activity (GO:0032147),0.35106542939882085,1.0075781170314058,0.48767967145790553,0.7756483527291624,1.0,24/106,14.73%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;EMP2;PDGFB;ANG;TIRAP;PAK1;PRKAR1A;PAK3;PRKAR1B;WNT5A;SLC11A1;GAS6;ADCY4;CCDC88A;STK11;TLR6;PRR5;COPS8
prerank,early endosome to Golgi transport (GO:0034498),0.489852066994669,1.0072405619538138,0.47017045454545453,0.7760300939416034,1.0,3/11,10.72%,LMAN1;SURF4;TMED9
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36073508709759805,1.0066639847405472,0.4919093851132686,0.7769789068729069,1.0,18/67,16.26%,HSP90AA1;HSPB1;CYBA;RAC1;ELMO1;CYBB;KDR;CLEC14A;PDCD6;AAMP;FLT4;VAV1;RHOA;VAV3;MAPK11;NCF1;DAB2IP;FLT1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3416148367413005,1.006425754450894,0.48893360160965793,0.7771487920899834,1.0,54/199,21.30%,RPS19;MDK;GRN;CALR;GPNMB;ATF4;ID1;TNF;NR1D1;SPI1;LRP4;RGS2;ALPK2;ARHGDIB;LRPAP1;CORO1C;SYT11;TIMP1;HS3ST5;PROCR;SRGN;ATP2B1;PTPRR;SLC11A1;SOX9;GJA1;SPRY1;BMP2;GAS6;WNT10B;STK11;ARRDC3;IFNGR1;GDF15;NR1H2;PLCL2;HEY1;DAB2IP;HDAC9;PFN2;BRCA2;ADAM17;IP6K1;VASN;NOTCH1;EFNA1;TGFB1;MEF2C;FOXA2;SFRP1;TWSG1;PTPRO;DDIT3;FOXA1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.45636061146356455,1.0061574483217384,0.47774869109947643,0.777378219907286,1.0,7/14,25.99%,RFK;ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,miRNA metabolic process (GO:0010586),-0.3395684498904795,-1.0059460407627585,0.42857142857142855,0.7798388172817761,1.0,9/20,16.50%,TENT4B;DICER1;PARN;DROSHA;TUT7;DDX17;TARBP2;TUT4;AGO2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.38889755320731356,-1.0059041764921501,0.42657342657342656,0.7781595654452844,1.0,3/12,8.03%,FOXP1;FNIP1;NOC2L
prerank,positive regulation of TORC1 signaling (GO:1904263),0.44749752520457925,1.0056808052137738,0.47167325428194995,0.7781017058115094,1.0,6/16,16.15%,LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;RRAGD
prerank,actin filament depolymerization (GO:0030042),0.47782863443830353,1.005603695681572,0.4904891304347826,0.7778729681139228,1.0,4/11,12.83%,GSN;CFL1;MICAL1;DSTN
prerank,regulation of myoblast differentiation (GO:0045661),0.3972693239832223,1.0054883112697013,0.48702830188679247,0.7777344438969107,1.0,10/32,20.07%,LRRC8A;IGFBP3;ZFP36L1;BTG1;SOX8;SOX9;DLL1;NOTCH1;TGFB1;MEF2C
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.27714242003119965,-1.0054475986994202,0.3870967741935484,0.7776617500969855,1.0,10/43,11.42%,SMAD3;TEAD1;NFIB;PPARA;FOXO3;NFATC4;STAT3;PPARG;TERT;NFATC3
prerank,regulation of ossification (GO:0030278),0.39621895298179105,1.0050077297775506,0.4700352526439483,0.7784696394873998,1.0,14/36,20.17%,MDK;ECM1;LRP4;S1PR1;WNT5A;SOX9;BMP2;TWIST1;DDR2;NOTUM;SOX11;NOTCH1;MEF2C;SFRP1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4620105796627357,1.004877683116304,0.4639580602883355,0.7783680409771151,1.0,3/14,18.30%,CD81;SYK;CCR2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3451117291182114,1.0046960834270504,0.49443882709807885,0.7783767403539031,1.0,31/140,18.30%,CD52;CHRNA9;GPER1;TAC1;C5AR1;GRIN1;CACNA1A;CCR5;P2RX7;TACR1;HTR2C;P2RY1;CD24;HMGB1;GRM1;GPR18;JPH4;CXCR4;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1D;ADRA1A;ADCY8;CAV1;CCKBR;BCAP31;PTGIR;ADCYAP1;CCR2
prerank,proteoglycan metabolic process (GO:0006029),-0.3022782016002783,-1.0042826673674181,0.4444444444444444,0.7789158973276958,1.0,4/26,8.26%,SULF1;ADAMTS12;IGF1;CHST11
prerank,regulation of actin filament-based movement (GO:1903115),0.4926602742847988,1.00426779135315,0.497907949790795,0.7789632184441725,1.0,3/10,17.63%,PDE4B;PLN;SRI
prerank,amyloid precursor protein catabolic process (GO:0042987),0.458946474076614,1.0039552596485393,0.458950201884253,0.7792757166850933,1.0,6/14,17.76%,PSENEN;ABCG1;BACE1;PSEN2;ADAM17;APH1B
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3350372312399663,1.0038357184895108,0.4894894894894895,0.7791467918715201,1.0,96/390,19.98%,ACTB;ACTG1;ATP6V0C;HSP90AA1;COL1A1;POLR2E;MAPK3;AKT1;ATP6V1F;CYBA;NRG1;POLR2D;ERBB4;ANKS1B;POLR2F;PDGFB;RAC1;GRB14;NTRK2;ATP6V1G1;CAV2;PSENEN;ATP6AP1;ATP6V0E2;GRIN1;RARRES2;ELMO1;AP2M1;LTK;CYBB;SHC3;MUSK;RAB14;NAMPT;PTK6;PAK1;KDR;MPZL1;CDK5R1;AP2S1;EPHA5;ARPC1B;HCK;ARHGEF7;PAK3;POLR2G;CSF1R;HAP1;ATP6V0D2;FGFRL1;AAMP;ARPC3;PLAT;FLT4;HRAS;ARPC5;POLR2K;VAV1;RHOA;TIE1;STMN1;VAV3;SDCBP;HNRNPA1;SORT1;SH2B2;TIAM1;ARPC4;MAPK11;GDF15;IGF2;PDGFA;EPHB1;NCF1;GFRA2;FLT1;TYRO3;CASS4;PSEN2;LCP2;EFNB1;ARPC2;APH1B;SYK;DDR2;ERBB3;GRIN2B;SRMS;SLA;KLB;SOS1;FLT3;HGF;EFNA1;GIT1;DDIT4
prerank,regulation of fibrinolysis (GO:0051917),0.47157306568629725,1.0036570139144485,0.4825268817204301,0.7791602657993338,1.0,1/13,1.91%,THBD
prerank,external encapsulating structure organization (GO:0045229),0.33909138076341505,1.0035452142282835,0.48092369477911645,0.7790112291281791,1.0,33/205,11.77%,BSG;SPARC;VTN;BGN;SPP1;COL1A1;BCAN;LAMC1;LAMB2;SPOCK2;LUM;ITGB2;ADAM15;HRNR;PDGFB;ADAMTS4;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;COL6A1;COL4A1;KDR;COL3A1;LAMC2;DCN;COL9A1;PECAM1;MMP3;MFAP2
prerank,positive regulation of cartilage development (GO:0061036),0.44167185748259535,1.0034575031727004,0.4869451697127937,0.7788222704713268,1.0,4/17,13.45%,MDK;ACVRL1;SOX9;BMP2
prerank,negative regulation of lipid storage (GO:0010888),0.43537493365885227,1.0032026848183127,0.4664131812420786,0.7789878133845772,1.0,4/19,5.54%,PNPLA2;TREM2;TNF;ABCG1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.40626955938248366,1.0029999910217995,0.4891304347826087,0.7790445022847345,1.0,11/28,21.63%,MAP1A;STMN3;CLASP1;MAPT;MAP2;STMN4;STMN1;ARL2;MAPRE3;MAP1B;FKBP4
prerank,regulation of gene expression (GO:0010468),0.3309358064868688,1.0026974811553928,0.485,0.7793152495351084,1.0,191/903,20.17%,APOE;RPL23;RPS3;ACTG1;CRIP1;RPL11;RPS7;RPL5;CD74;CLU;PFDN5;RACK1;CLDN5;RPL6;GSN;RAMP2;TYROBP;PCBP1;GPX1;CALR;CXXC1;ACTA2;MT3;PARK7;MAPK3;HNRNPAB;ATF4;LGMN;AKT1;CNPY2;SOX18;TREM2;HINT1;CD34;LYL1;HNRNPK;PINK1;ANK3;SLC7A5;GPER1;MAGED1;TNF;PDGFB;DRAP1;LAMTOR5;PTPRC;HCLS1;ACVRL1;BTN3A3;TAPBP;NTRK2;CHEK2;ZFP36L1;SPI1;PIN1;AMH;MIF;HSPA1B;PPP2R1A;TLE5;SIRPA;SH3GL2;APLNR;AHNAK;PCBP4;ALPK2;MYADM;FN1;BTG1;MUSK;FADS1;TFRC;MSN;RIMS2;RNF187;TBX22;CEBPB;PQBP1;HES6;NELL1;RIMS1;PRDM12;EDF1;CEBPA;P2RX7;PROX1;KDR;VSIR;MAPT;BCL6B;MOG;YBX1;MLXIPL;MLX;EGR1;RRP1B;GATA2;ATP13A2;ICOSLG;TAF5L;TARDBP;HOXB7;LRP3;APBB1;SUPT4H1;WNT5A;SOX17;ATF5;RAMP3;POU3F1;KDM6B;ATRAID;WARS1;FAM50A;HRAS;TMEM119;CAMK2N1;MSR1;AIF1;KLF4;SLC11A1;SOX9;HSPA1A;FBXW7;METTL18;GJA1;LILRB1;BMP2;GAS6;HDAC5;SFRP4;UBE2V1;RO60;MAFA;CTSH;TLR6;SORT1;NONO;PF4;SPIN4;IFNGR1;TRAF3;MAPK11;ATP1B1;DHH;SLC8A1;IGF2;YBX3;GLRX2;HEY1;DNAJA4;CCL3;DNMT3B;EPB41L4B;VHL;GATA4;PRX;CDH5;PIK3CD;TWIST1;PDCD5;BRCA2;PPARGC1A;NOS2;RLIM;AGO1;MLF2;CNBP;ZNF22;TERF2IP;MAP2K2;MAZ;HMGN5;EDN3;SOX11;CCAR2;DDRGK1;ANKRA2;HIC1;INHBA;ESRRB;NOTCH1;IL6;ERP29;MLF1;TGFB1;CHD3;POU4F1;CITED2;MEF2C;SFRP1
prerank,cardiolipin metabolic process (GO:0032048),-0.37823576455476604,-1.0023956017670006,0.4580152671755725,0.7823184587921864,1.0,6/13,26.19%,PLA2G4A;CRLS1;PLSCR3;HADHB;PLA2G5;PGS1
prerank,negative regulation of cell motility (GO:2000146),0.35065250755319377,1.0017338595922713,0.5035897435897436,0.7812203484639807,1.0,17/108,9.80%,CD74;CLDN5;IFITM1;RHOB;ADAM15;ACVRL1;IGFBP5;DNAI3;PIN1;MIF;DUSP3;FRMD5;ADORA3;NAV3;THY1;SPOCK3;EPPK1
prerank,autophagy of peroxisome (GO:0030242),0.47214718645634823,1.0011541133124906,0.49375866851595007,0.7821744032760587,1.0,3/12,16.86%,MAP1LC3B;PJVK;SQSTM1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.416566631375987,1.0009496322997895,0.5024213075060533,0.7818251178955253,1.0,9/23,21.72%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.416566631375987,1.0009496322997895,0.5024213075060533,0.7818251178955253,1.0,9/23,21.72%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1
prerank,embryonic hemopoiesis (GO:0035162),0.48047679171369423,1.000948833428208,0.4884979702300406,0.7814094769539878,1.0,3/12,10.12%,ATF4;KDR;KITLG
prerank,regulation of glycogen metabolic process (GO:0070873),0.471375534321954,1.0009337482022191,0.4986225895316804,0.7810341686954031,1.0,3/12,21.21%,AKT1;PPP1R3D;KHK
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.34776275429051984,1.0009260144994332,0.5020449897750511,0.7806395854009794,1.0,36/113,23.83%,MDK;GRN;LAMC1;AKT1;NME1;PTPRN;PDGFB;ANG;C5AR1;ECM1;RTN4;EMC10;PROX1;KDR;TNFSF12;PDCD6;WNT5A;FLT4;HRAS;SOX9;BMP2;NME2;BAD;EGFL7;PIK3CD;SOX11;SFRP1;MYC;TGFA;SCG2;MYDGF;AGGF1;WNT7A;PTN;TEK;OSR2
prerank,cellular response to increased oxygen levels (GO:0036295),0.4876525074764213,1.0009055520048997,0.4773371104815864,0.780272849585304,1.0,4/11,22.08%,ATP6V1G1;ATP6AP1;CAV1;ATP6V1A
prerank,proteolysis (GO:0006508),0.3375101944772867,1.0007938668925562,0.506519558676028,0.7800952880730755,1.0,72/252,25.64%,CTSD;CTSB;CTSL;CTSZ;CTSS;TMPRSS6;LGMN;CPXM1;CPD;PSENEN;PSMD6;CPE;SPPL2B;F9;SPCS1;VASH1;METAP2;TINAGL1;NEDD8;PGPEP1L;TMPRSS5;PCSK2;SRGN;AEBP1;CPXM2;MMP3;PLAT;CTSA;ERMP1;PSMB11;LAP3;CTSH;SPG7;LRP8;RNPEPL1;PSMB5;NAPSA;VHL;BACE1;PLAU;PSEN2;MMP14;ADAM17;APH1B;CTSC;PSMA6;DESI2;DESI1;HGF;PGPEP1;CAPN3;ATG4D;FAM111A;SPPL2A;CTSE;ACAN;ECE2;ST14;DPP7;ERAP1;LONP1;PRCP;CAPN11;CPZ;FBXO3;THOP1;FBXO2;APH1A;PCSK6;MMP1;CASP1;MMP24
prerank,cardiac cell development (GO:0055006),0.47924715099199644,1.0007293577332161,0.4843110504774898,0.7798450269497158,1.0,4/11,19.63%,ALPK2;MYH11;SLC8A1;NOTCH1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.43211049015448255,1.0006235319588248,0.48079306071871125,0.7796818318666076,1.0,4/20,13.45%,MT3;ATF4;CREB3;BMP2
prerank,photoperiodism (GO:0009648),-0.299453834719546,-1.0004765720767805,0.45348837209302323,0.7859445846659896,1.0,9/28,16.26%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,phosphorylation (GO:0016310),-0.2737267184270693,-1.0,1.0,0.7782837632026518,1.0,114/384,16.83%,PRKAG2;ROCK2;GRK5;EPHA7;FER;ABL1;STK3;ACVR1;DAPK1;BMPR1A;BIRC6;LRRK2;PDK1;PI4KA;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K13;GRK3;CLK2;MARK1;EIF2AK4;PDPK1;TLK2;TGFBR1;CCNT1;AGK;IRAK3;STK24;WNK4;PPP4R1;SNRK;CDK12;CDK6;EIF2AK3;INSR;STAT3;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MARK3;DGKA;TYK2;TRIB2;TOP1;SIK1;MAML1;TAOK3;GK5;BCR;PRKAA2;NEK6;AAK1;STK10;MAPK9;FRK;HIPK3;NEK7;MAP4K4;CDC25B;NRK;FGGY;MAP4K3;TESK2;DMPK;MORC3;EPHB2;CDK13;GRK4;TBCK;NUAK1;DAPK2;TBK1;DGKQ;LATS2;MAPK6;NEK3;STK38;ATM;CSNK2A1;NLK;COQ8B;PRKD1;WNT11;SRPK2;GSK3B;MARK2;PRKAG1;PRKCI;CDK7;CDKL3;TAOK1;PRKCB;PANK2;ACVR2A;SPHK1;DCLK1;LIMD1;PASK;STK39;BMPR2;JAK1;RYK;PPP3CB;ULK1;ACVR2B;COQ8A
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.22275231197424478,-1.0,1.0,0.7782837632026518,1.0,381/1646,16.30%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;WWC2;MLLT3;GLIS3;EGFR;HIVEP2;BNC2;BAZ2B;ZNF148;ATXN1;NR3C2;RBFOX2;ARID1B;TCF4;TCF7L2;PKNOX2;HOXB6;ABL1;SMAD6;BRWD1;PRDM5;SCMH1;ZNF423;KDM3B;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;ACVR1;TSHZ3;SOX5;SETD5;KAT6B;DENND4A;ZMIZ1;CREBBP;FOXD1;PBX3;KDM2A;ZHX2;ARHGEF11;STAT5B;MED13;MXI1;SSBP2;VGLL4;FOXN3;SNX6;ATF7IP;CUX1;IL31RA;TRAK1;BBX;KDM7A;GLI3;HLF;ZBTB16;NR6A1;ZIC4;BICRA;NCOA1;BRD4;SMURF2;SUFU;HOXA3;GLI2;CAMK2D;MIDEAS;NIPBL;BAZ2A;DHX36;LRP5;CCAR1;WWP1;ARNT2;JMJD1C;USP47;MGA;LRP6;DPF3;ZMYND11;HOXB4;ELF1;MNAT1;NR2F2;ATF7;HDAC4;PER2;NFYC;CHD2;TAF15;DKK3;NFXL1;PIAS1;HMG20A;OGT;YAF2;MED13L;HOXA5;PARP9;PIAS2;CBFA2T2;HIVEP3;ZKSCAN2;NIBAN2;PRDM11;MTA3;YAP1;KLF3;THRAP3;NRF1;EHMT1;URI1;ZNF292;KMT2A;TEF;PPARA;NFIX;HOXC4;CREB5;ZFP90;ELP4;EPC1;NFATC1;AXIN1;FOXO3;LIMS1;KDM5B;PHC3;ARID1A;KAT7;APBB2;NFATC4;L3MBTL3;ZNF182;SMAD9;NCOR1;BICRAL;TGFBR1;CCNT1;JARID2;KDM3A;TBX15;TFCP2;FOXP4;EFEMP1;TBL1X;LCOR;TLE1;VGLL3;MEOX2;UIMC1;FBXL19;SP1;NFKB1;ZFPM2;NR1D2;BCOR;FOXK2;HOXB5;ZSCAN26;SMARCE1;ARID4B;MDM4;ELF2;INSR;STAT3;HDGFL3;HIF3A;MTDH;VSX1;NEK4;RCOR1;CRLF3;NAA16;DYRK1A;CHD1;ARID5B;MDFIC;PML;SMARCA5;SMAD1;CCNL1;ZIC2;RUNX1T1;ZFHX3;MBTD1;ZBTB38;CCNL2;BAZ1B;ZFP30;CEP290;RBBP8;ZBTB1;SPEN;MYNN;USP16;ZFHX4;EBF4;IGF1;ZFX;LOXL3;MEF2A;JMY;STAT2;NSD3;RBAK;PRDM15;MMS19;BTAF1;ZBTB26;SMAD7;EBF1;TFDP1;NFX1;TADA1;BTRC;MYBL1;ATF2;SPINDOC;TBL1XR1;SP100;TEAD2;CBX4;PPARG;PICALM;CREBRF;ETV6;KDM5C;SP4;KLF8;NAA15;ESR1;NR2C2;PCGF5;FOXK1;CCNK;IFRD1;HOXC6;ZFP91;ASCC1;CNOT7;ZNF23;SMAD4;MED26;FBXW11;ZKSCAN3;PDCD4;ZIC1;ATF6;ELF4;TULP3;CDH1;HOXA6;CREB3L2;GMEB1;DGKQ;BRD7;ACTR8;YEATS2;PRRX2;PSEN1;MZF1;NFATC3;KMT2D;DNM2;RBPJ;DDX17;ZHX3;ILF2;KDM4C;CD80;RCOR3;ZBTB34;NLK;GPBP1;SLTM;QRICH1;RNF14;AR;POLR2A;HOXC5;TIAL1;PHF20L1;HIVEP1;ATP8B1;IKZF2;ZBTB8A;ZNF8;RREB1;MKX;SIX1;FUS;NR2F1;HSF2;APBB3;KLF7;SIX5;ZKSCAN7;DVL3;TGFB1I1;TASP1;KAT6A;RORA;CBFB;PHF8;SIRT1;PCBD2;WNT11;NFIC;SCML4;BCLAF1;BMP4;PPARGC1B;SMAD2;ORC1;PHIP;ZBTB21;RLF;TGFB3;WWP2;ZFP62;TFCP2L1;ZNF276;PBX4;NPAT;MLXIP;RSF1;CREBL2;EDRF1;GMEB2;GON4L;CARM1;RUNX2;HEY2;EZH2;GATAD2A;SRRT;CRY1;FOXN2;STAT5A;ZBTB5;KIT;MDM2;PRKCB;SOX13;IRF2;ZBTB46;LDB1;NFYB;ZSCAN12;ZBTB6;BRWD3;HOXA2;BATF;RNF111;CAMTA2;MECP2;LIMD1;ING2;HINFP;WNT4;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NUP35
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2304149358348436,-1.0,1.0,0.7782837632026518,1.0,396/1668,16.29%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;AUTS2;NFAT5;BMP6;PRDM6;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;PID1;PHF21A;WWOX;WWC2;GLIS3;EGFR;HIVEP2;BAZ2B;ZNF148;ATXN1;MLLT10;NR3C2;DNMT3A;ARID1B;FHL2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;SMAD6;BRWD1;PRDM5;KDM3B;KLF12;HOXB3;KMT2C;ZBTB7C;PRRX1;TCF12;ARNT;ACVR1;TSHZ3;SOX5;KAT6B;TNRC6B;SLC9A1;ZMIZ1;BMPR1A;CREBBP;FOXD1;MAML2;PBX3;KDM2A;GABPB2;ZHX2;NRIP1;STAT5B;DAB2;MED13;BCAS3;MXI1;SSBP2;KANK2;CUX1;TRAK1;TET2;BBX;KDM7A;GLI3;HLF;ZBTB16;NR6A1;ZIC4;ZFP64;NCOA1;BRD4;SMURF2;SUFU;HOXA3;GLI2;CAMK2D;MIDEAS;FGF1;NIPBL;TNRC6A;ZMYM5;DHX36;PPP1R12A;LRP5;ARNT2;JMJD1C;MGA;SKI;LRP6;DPF3;HOXB4;ELF1;MNAT1;NR2F2;ATF7;HDAC4;PER2;NFYC;THRB;CHD2;PIAS1;OGT;MED13L;HOXA5;PARP9;ASXL2;PIAS2;HIVEP3;ZKSCAN2;MCPH1;CRTC3;PRKN;MTA3;YAP1;PER3;PPM1D;KLF3;THRAP3;TET3;NRF1;ATAD2B;URI1;ZNF292;KMT2A;TEF;PPARA;DCAF6;NFIX;HOXC4;CREB5;OTUD7B;ZFP90;RARG;ELP4;SSBP3;IL18;EPC1;NFATC1;TNRC6C;FOXO3;FNIP1;KDM5B;HDAC8;MED15;DLG1;ARID1A;KAT7;CNOT1;NFATC4;DICER1;ZNF182;SMAD9;NCOR1;KAT2B;CCNT1;KDM3A;TBX15;TFCP2;FOXP4;MYSM1;TBL1X;ASXL1;LCOR;VGLL3;MEOX2;BCLAF3;FBXL19;SP1;NFKB1;ZFPM2;NR1D2;BCOR;FOXK2;HOXB5;ZSCAN26;SMARCE1;ARID4B;CDK12;MDM4;BCL9L;ELF2;TCERG1;STAT3;HDGFL3;HIF3A;MTDH;RCOR1;CRLF3;CHD1;ARID5B;SMARCA5;SMAD1;CCNL1;ZIC2;ZNF462;ZFHX3;ZBTB38;KCNIP3;CCNL2;BAZ1B;ZFP30;RBBP8;MAML1;ZBTB1;MET;SPEN;DNAJA3;MYNN;NOC2L;USP16;CPEB3;ZFHX4;EBF4;IGF1;POGZ;ZFX;MEF2A;JMY;FGFR2;STAT2;RBAK;PRDM15;MOV10;ZBTB26;MIER1;SMAD7;FRK;EBF1;TFDP1;NFX1;TADA1;MYBL1;ATF2;INO80;TBL1XR1;SP100;TEAD2;CBX4;PPARG;CREBRF;ETV6;PTEN;RIPK1;DCAF1;SP4;KLF8;ESR1;NR2C2;PCGF5;PPID;FOXK1;SENP1;CCNK;ECD;IFRD1;HOXC6;ZFP91;RGMA;PKD1;ZNF23;SMAD4;MED26;BCL2L12;ZKSCAN3;CDK13;ZIC1;ATF6;NCK1;ELF4;SETX;HOXA6;CREB3L2;GMEB1;TBK1;DGKQ;BRD7;YEATS2;PRRX2;PSEN1;MZF1;NFATC3;KMT2D;RBPJ;DDX17;ZHX3;KDM4C;SAP130;KANSL3;RCOR3;ATM;ZBTB34;CAPRIN2;AKAP8L;BRD8;SLTM;RNF14;AR;HOXC5;TIAL1;PHF20L1;HIVEP1;ARHGEF2;IKZF2;ZNF507;JAG1;ZBTB8A;ZNF8;RREB1;CXXC5;RPAP2;MKX;PRKD1;SIX1;FUS;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;DVL3;KAT6A;RORA;CBFB;PHF8;SIRT1;NFIC;BCLAF1;BMP4;PPARGC1B;SMAD2;PHIP;ZBTB21;EHMT2;RLF;TGFB3;WWP2;ZFP62;GTF2H4;TFCP2L1;ZNF276;PBX4;NPAT;MLXIP;METTL23;CDK7;RSF1;GMEB2;RUNX2;HEY2;EZH2;GATAD2A;EZH1;CRY1;N4BP2L2;STAT5A;ZBTB5;KIT;MDM2;PRKCB;SOX13;IRF2;ACVR2A;ZBTB46;LDB2;LDB1;NFYB;CDC73;ZSCAN12;RHOQ;ZBTB6;BRWD3;HOXA2;BATF;RNF111;CAMTA2;MECP2;HINFP;SIRT7;ZNF483;ESRRA;FOXO1;FOXL1;TP53;BMPR2
prerank,protein phosphorylation (GO:0006468),-0.23718307235194627,-1.0,1.0,0.7782837632026518,1.0,140/478,17.68%,PRKAG2;ROCK2;GRK5;TGFBR3;EGFR;FER;ABL1;STK3;ACVR1;DAPK1;BMPR1A;BIRC6;LRRK2;EPHA3;PDK1;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K3;MAP3K13;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RICTOR;TLK2;TGFBR1;CCNT1;EPHA4;EFEMP1;IRAK3;STK24;WNK4;PPP4R1;SNRK;CDK12;CDK6;EIF2AK3;INSR;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MARK3;MAPKAPK3;TYK2;TRIB2;BAZ1B;TOP1;SIK1;MAML1;TAOK3;BCR;PRKAA2;FGFR2;NEK6;AAK1;STK10;SMAD7;MAPK9;FRK;PDGFRB;HIPK3;NEK7;MAP4K4;CDC25B;ABI1;NRK;RIPK1;MAP4K3;ABL2;TESK2;DMPK;PKD1;MORC3;PTK2;EPHB2;CDK13;GRK4;TBCK;NUAK1;SLK;DAPK2;TBK1;DGKQ;LATS2;MAPK6;NEK3;STK38;ATM;CSNK2A1;CSNK2A2;NLK;COQ8B;ULK2;PRKD1;WNT11;SRPK2;GSK3B;BMP4;SMAD2;MARK2;GTF2H4;PRKAG1;PRKCI;CDK7;CDKL3;TAOK1;CRY1;KIT;PRKCB;CLSPN;ACVR2A;DCLK1;PASK;STK39;BMPR2;ABI3;JAK1;RYK;PPP3CB;ULK1;ACVR2B;PKDCC;COQ8A;STRADB;MAPK14;STK26;ABI2;PDGFRA;VRK3;EPHA8
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.19764754752522065,-1.0,1.0,0.7782837632026518,1.0,89/336,18.11%,FOXP1;UBE2E2;ABL1;SUSD6;BABAM2;USP3;PDS5A;TRIP12;NIPBL;STXBP4;PARP4;USP47;UBR5;MNAT1;YAP1;KMT5C;BRAT1;UVRAG;TLK2;SPIDR;PDS5B;PARP3;KMT5B;NEK4;MSH3;RNF8;UFL1;PML;ASH2L;ZBTB38;BAZ1B;RBBP8;ZBTB1;RNF169;TAOK3;USP16;DDB2;SLX4;MMS19;ALKBH8;PSME4;ATF2;INO80;FBH1;TOPORS;CCNK;XPA;MRNIP;SETX;CUL4B;BCL2L11;RAD51B;PSEN1;CUL4A;ATM;RAD17;BCL2;MTREX;USP28;SETD7;ERCC8;SIRT1;GTF2H4;BOD1L1;CGAS;TAOK1;MGMT;CRY1;TDP1;FANCC;ETAA1;BATF;HINFP;SIRT7;FOXO1;ALKBH3;TP53;USP45;FANCG;INIP;CEP63;RTEL1;MAPK14;RMI2;WAC;FMR1;ERCC3;INTS3;TIGAR
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3030321097855718,-0.9999125325412036,0.4271356783919598,0.7767503713785037,1.0,10/25,16.97%,SCAF8;SETD5;ZMYND11;KAT7;CCNT1;CCNK;ELL;THOC5;LDB1;WDR43
prerank,striated muscle cell differentiation (GO:0051146),0.4416711894030745,0.9993704653501453,0.4725568942436412,0.7823021568770311,1.0,8/16,20.07%,NRG1;PLD3;MTLN;KDM6B;BMP2;SORT1;MYEF2;MEF2C
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33338019346684733,0.9991427274857734,0.5125376128385155,0.7824196292056526,1.0,52/248,16.71%,APOE;IGFBP6;PFDN5;PSMB4;MDK;COL1A1;PPP1CA;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;FZD9;PSMD1;PIN1;LRP4;PSMC3;TLE5;CTNNB1;PSMD6;ANKRD6;VCP;SFRP5;PSMA7;OTULIN;JADE1;PSMD5;RBX1;LGR6;PSMB9;PSMD13;GPC5;WNT5A;SOX17;PSMB3;ATP6AP2;PSMB11;IGFBP2;SOX9;BMP2;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1;USP8
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2722917227329493,-0.9990607569215465,0.41935483870967744,0.7773310555953876,1.0,5/45,1.92%,BMP6;RBPMS;ACVR1;BMPR1A;DAB2
prerank,development of primary male sexual characteristics (GO:0046546),0.3993065229983308,0.9990275362396943,0.48766157461809634,0.7822383040402285,1.0,13/34,28.28%,KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4394069818301387,0.999010642939622,0.4849246231155779,0.7818612553147293,1.0,6/19,15.97%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B
prerank,inorganic ion transmembrane transport (GO:0098660),0.4741408149028725,0.9990099982725223,0.48599439775910364,0.7814464748079311,1.0,3/12,19.69%,ASIC2;ABCC8;PKD2L1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.416675580942867,0.9983665771650527,0.4759493670886076,0.7825596888694849,1.0,7/22,20.96%,ERBB4;TNF;HES1;NOTCH1;IL6;IL10RB;CRLF2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.41288826248340477,0.9982125170388163,0.4823232323232323,0.782507361069633,1.0,7/24,19.07%,VKORC1;PARP1;AGBL4;NAA10;TTLL7;TTLL10;TTLL5
prerank,mammary gland development (GO:0030879),0.4275463170474117,0.9981856411111049,0.4969173859432799,0.782157206955676,1.0,2/21,2.95%,NRG1;ERBB4
prerank,neuron projection extension (GO:1990138),0.39820126446875764,0.9980899793908479,0.4859154929577465,0.7819375171559164,1.0,5/32,5.39%,HSP90AA1;HSP90AB1;SEMA3F;CTNNB1;SH3GL2
prerank,cell proliferation in forebrain (GO:0021846),-0.4028890679074546,-0.9978716581981438,0.4360655737704918,0.7788594901469595,1.0,4/10,15.27%,DOCK7;PCM1;NUMBL;NUMB
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34926375892843897,0.9974092095311841,0.5150259067357513,0.7831534714224608,1.0,24/112,13.63%,RPS27A;UBC;CLDN5;UBB;ID1;ACVRL1;FKBP1A;ZFP36L1;ZFP36L2;HYAL2;LEFTY2;WFIKKN2;UBA52;ZYX;CLEC3B;COL3A1;JUN;WNT5A;AMHR2;ZMIZ2;COL1A2;SOX9;RHOA;LEFTY1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3230798644696632,-0.9973109654666856,0.43724696356275305,0.7751334988234445,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3230798644696632,-0.9973109654666856,0.43724696356275305,0.7751334988234445,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3230798644696632,-0.9973109654666856,0.43724696356275305,0.7751334988234445,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3449599004270521,0.9970643784492038,0.507201646090535,0.7835724802305328,1.0,31/118,20.17%,SPARC;GPNMB;CFL1;HMOX1;EMP2;ADGRB3;KNDC1;CTNNB1;LRRC4C;TNFAIP3;VASH1;PAK1;PPFIA2;CLASP1;MAPT;CDK5R1;PAK3;RNH1;WARS1;FLT4;SRCIN1;ZMYM3;CDK5;DLL1;BRSK2;NSMF;HECW1;IL6;TGFB1;MEF2C;SFRP1
prerank,respiratory tube development (GO:0030323),-0.2960002616428858,-0.9969911449189534,0.4025157232704403,0.7742627415050384,1.0,8/28,13.72%,GLI2;FGF1;PCSK5;LOXL3;FGFR2;NPHP3;ITGA3;BMP4
prerank,negative regulation of ATPase activity (GO:0032780),0.4466214573472995,0.996668838698066,0.4915032679738562,0.7841173396969641,1.0,3/16,8.67%,ATP5IF1;PLN;IFIT1
prerank,tube closure (GO:0060606),-0.2968065137969382,-0.9961975193933679,0.45,0.7747313773633762,1.0,7/31,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,embryonic digit morphogenesis (GO:0042733),-0.33220341413029986,-0.9957518149284529,0.4090909090909091,0.7741584351143233,1.0,3/18,5.80%,CREBBP;GLI3;WDPCP
prerank,insulin receptor signaling pathway (GO:0008286),0.3620140708224267,0.9957129146936723,0.5037513397642015,0.7859875187493176,1.0,10/69,7.56%,ATP6V0C;AKT1;ATP6V1F;GRB14;ATP6V1G1;CAV2;ATP6AP1;ATP6V0E2;RARRES2;NAMPT
prerank,positive regulation of protein depolymerization (GO:1901881),0.4837706906215968,0.9956430708347545,0.4922425952045134,0.7857381800181329,1.0,6/11,33.96%,NES;F2RL1;WDR1;STMN2;KATNB1;SEMA5A
prerank,intracellular protein transport (GO:0006886),0.3336514836453356,0.9956119460645384,0.522,0.7853835138253569,1.0,77/304,22.47%,RPL11;CD74;GABARAP;CALR;LAPTM5;AKT1;SNX17;NLGN1;AKAP6;NPM1;RAN;ARF5;SORL1;YWHAH;FAM53C;TMED7;LMAN1;SAR1A;RAB14;SURF4;TMED2;ARL11;CLTC;PTTG1IP;SCG5;XPO1;ARF6;TICAM2;TMED3;ARL4C;TMED9;PDCD6;HAP1;CDC37;CTSA;SGSM1;ARL4D;ARL1;VPS28;TMED1;SYNDIG1;IPO4;CLIP3;NUP85;ARF1;EHD1;TBC1D22B;NUP88;UNC93B1;ARF4;RAB20;NAPA;TBC1D9;RAB5C;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2;STX4;RAB18;RAB31;DESI1;TBC1D10C;ERP29;TGFB1;CTTN;RAB6B;C2CD5;IFT27;TMED10;HEATR3;COPB2;AP2A1;STX1B;VPS36;RAB28
prerank,positive regulation of neuron projection development (GO:0010976),0.3549502091425601,0.9949665533747335,0.5227513227513227,0.7864923661455745,1.0,13/85,11.11%,APOE;MDK;PACSIN1;NTRK2;S100A9;CAMK1D;NDRG4;TENM3;LTK;ATP1B2;PTK6;CAMK1;WNT5A
prerank,positive regulation of insulin secretion (GO:0032024),0.38919946042753595,0.9949127838285547,0.48842592592592593,0.7861940002020903,1.0,14/36,26.57%,RBP4;TRH;LRRC8A;GPER1;BAD;ADCY8;DOC2B;GLUD1;STX4;NNAT;PSMD9;ACSL4;PLA2G6;TM7SF3
prerank,positive regulation of myelination (GO:0031643),-0.39636320504739286,-0.9937049806202201,0.4557823129251701,0.7779475779365139,1.0,2/11,5.39%,PARD3;DICER1
prerank,actin filament organization (GO:0007015),0.34069482151683117,0.9930360947002643,0.5221774193548387,0.7901896622310499,1.0,34/151,17.68%,ALDOA;GSN;RHOB;MARCKS;TPM2;RHOC;ARHGAP25;EMP2;RAC1;FLNA;ELMO1;RFLNB;RHOG;CORO1C;CORO1A;MYO5A;PROX1;MYO7B;LCP1;MYO1F;MARCKSL1;ACTN1;AIF1;DSTN;RHOA;FLII;CAPG;ARPC4;TMOD1;DMTN;CASS4;FHOD3;RAC2;SCIN
prerank,peptidyl-lysine modification (GO:0018205),-0.23803865907073424,-0.9928594248036945,0.46875,0.7785240051461866,1.0,28/99,18.53%,EYA1;PLOD2;RANBP2;NSMCE2;HDAC4;SENP6;PIAS1;PIAS2;LOXL1;NUP98;SAE1;KAT2B;ATP7A;SENP7;LOXL3;TOPORS;SENP1;TRPM4;ESCO1;STX1A;SIRT1;AAAS;SIRT7;NUP214;NUP35;NDC1;VCPKMT;METTL21A
prerank,O-glycan processing (GO:0016266),-0.25811922664807035,-0.992843151835685,0.44680851063829785,0.7768127080829541,1.0,7/54,7.17%,GXYLT2;ST3GAL4;ST3GAL3;GALNT11;B3GNT2;ST6GAL1;GALNT12
prerank,protein targeting to membrane (GO:0006612),0.3537088263780978,0.9926328816103452,0.5323435843054083,0.7907126608259125,1.0,32/83,32.42%,NACA;SSR2;ARL6IP1;SRP14;PXMP2;SSR1;ICMT;GDAP1;GOLGA7B;SEC61A1;YIF1B;SDCBP;SGTA;GOLGA7;NCF1;VPS37C;ZDHHC12;TRAM1;FIS1;NACAD;PEX11B;ZDHHC2;ARL6;RTP3;SRP19;ZDHHC14;SRPRA;ABCD2;ALDH3A2;PEX14;CHMP4A;CHMP4B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.32256372357729957,-0.992197062834741,0.4377880184331797,0.7769447011107257,1.0,5/21,10.73%,CGNL1;SLIT2;MAPKAP1;ARHGAP12;EPHB2
prerank,response to hexose (GO:0009746),0.4058037497853486,0.9921562514114382,0.49293966623876767,0.7914007464185895,1.0,8/25,21.40%,PFKL;GYS2;LPL;VAMP2;MAFA;EIF2B5;KHK;SELENOS
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3511686580608493,0.9918469750425103,0.511482254697286,0.791706933426263,1.0,27/90,23.36%,GATM;UCP2;EPAS1;FABP5;BSCL2;OMA1;CEBPB;SCD;KDM6B;LCN2;MFAP2;THRA;HCRT;GJA1;CXCR4;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ADIPOR1;TSHR;PRLR;ELOVL6
prerank,regulation of p38MAPK cascade (GO:1900744),0.39100333715675545,0.9914296746310022,0.49881516587677727,0.792327383112809,1.0,13/35,25.38%,TREM2;SPI1;EMC10;PHLPP1;PRMT1;BMP2;RASGRP1;NCF1;DAB2IP;GADD45A;DUSP1;AGER;MFHAS1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.40024013972025274,-0.9914209230401781,0.43288590604026844,0.7773280404553986,1.0,2/10,5.34%,ACTN2;CARMIL1
prerank,negative regulation of bone mineralization (GO:0030502),0.4652691427498882,0.9913447408475277,0.5054347826086957,0.7921320383967928,1.0,4/13,16.36%,ECM1;RFLNB;SRGN;CCL3
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.47454698740144174,0.9911893246624702,0.5116918844566712,0.7921062696427931,1.0,7/12,24.11%,SYT1;RIMS2;RIMS1;SYT2;DOC2B;SYT5;UNC13A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.34575582353393736,0.9901559141628804,0.5260960334029228,0.794120578302994,1.0,26/95,20.01%,RPS27A;UBC;UBB;HSP90AB1;LTBP4;FKBP1A;PIN1;EID2;CDKN1C;HIPK2;WFIKKN2;UBA52;STRAP;ZBTB7A;SNW1;HSPA1A;SPRY1;STK11;SDCBP;CAV1;ADAM17;PEG10;SOX11;VASN;TGFB1;CITED2
prerank,glucose transmembrane transport (GO:1904659),0.4338606502039658,0.9901421254970347,0.5123537061118335,0.7937406282844179,1.0,9/18,36.98%,SLC2A1;SORT1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,RNA catabolic process (GO:0006401),0.3747761884705831,0.9900896997464281,0.4977578475336323,0.79345225046098,1.0,15/46,25.42%,LSM6;RNASEH2A;HSPA1B;ZFP36L2;ZFP36;RNASEH1;RNH1;HSPA1A;SND1;NUDT16;NANOS2;ISG20;LSM5;METTL3;PNPT1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4128451783202554,0.9900699316132275,0.5172839506172839,0.7930786489070498,1.0,9/23,26.53%,ELOVL1;ELOVL2;ELOVL7;ACOT7;ACSL3;DGAT1;ELOVL6;ACSL4;FAR2
prerank,activation of adenylate cyclase activity (GO:0007190),-0.28405175554457057,-0.9900350623457395,0.44370860927152317,0.7793310409832529,1.0,7/35,10.19%,ADCY9;ADCY1;LGR4;ADCY5;RAF1;EDNRA;ADCY7
prerank,superoxide anion generation (GO:0042554),0.4574925946085043,0.9898626734956394,0.4932249322493225,0.7931501445921901,1.0,3/13,15.91%,CYBA;CYBB;NCF1
prerank,skin development (GO:0043588),0.3604490361992588,0.9895318197288605,0.5010729613733905,0.793456007119949,1.0,15/65,16.89%,COL1A1;TXNIP;HRNR;ABCB6;COL3A1;DHCR24;KRT9;WNT5A;LSR;COL1A2;EVPL;STMN1;PDGFA;DLL1;FA2H
prerank,protein mannosylation (GO:0035268),-0.3145000135191555,-0.9894194714918444,0.4365482233502538,0.7792910328794702,1.0,3/22,1.53%,TMTC1;LARGE1;TMTC4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3897860102295264,-0.9893103587335348,0.460431654676259,0.7778247076669375,1.0,9/11,31.29%,GRK3;ADM;GTF2H2;SAG;ARRB1;ADRB2;DRD3;ADRB3;ARR3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4059181086799725,0.9891812780287335,0.5086633663366337,0.7938616815324595,1.0,10/26,19.83%,C3;ATF4;SARS1;FLT4;HPSE;GATA4;CCR2;CXCL17;IL6;TGFB1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.42924605128899107,0.9889200699169708,0.5006435006435006,0.7940489917123581,1.0,4/18,9.52%,HMOX1;KDR;JCAD;GATA2
prerank,organophosphate ester transport (GO:0015748),0.40794735582726344,0.9885382741147495,0.508641975308642,0.7945026762958629,1.0,3/24,4.13%,PLTP;NPC2;SCP2
prerank,response to growth factor (GO:0070848),0.37750402184250936,0.9879711323396189,0.48607888631090485,0.7953867437311583,1.0,5/41,5.33%,RACK1;AKT1;PDGFB;ACVRL1;CTNNB1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4325389149549916,0.9879452883454722,0.494750656167979,0.7950337865446752,1.0,8/18,19.75%,CLU;TNF;ABCG1;GSAP;IFNGR1;ABCA2;LRRTM3;EFNA1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4383612826989221,0.9877752264861362,0.49483204134366926,0.7950370821674921,1.0,7/18,20.07%,MDK;HMGB1;CCL2;IGF2;FLT1;ADAM17;MEF2C
prerank,negative regulation of organelle assembly (GO:1902116),-0.27745572177862704,-0.9876497015595572,0.4452054794520548,0.7804026617257794,1.0,7/35,10.54%,LRRK2;NBDY;YAP1;KAT2B;SCFD1;CEP97;SMAD4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.30028888099632395,-0.9874425236591814,0.45408163265306123,0.7793514610010153,1.0,11/23,24.14%,MTMR3;MTMR11;PTEN;SACM1L;MTMR10;PIP4P2;INPP5B;TPTE;MTMR1;SYNJ2;MTMR7
prerank,muscle cell development (GO:0055001),0.40233686164408405,0.9869083934379078,0.5105386416861827,0.7966156839761704,1.0,6/30,15.37%,RAMP2;SGCZ;HES1;ALPK2;MYH11;SLC8A1
prerank,regulation of intracellular pH (GO:0051453),-0.271357398487792,-0.9868002400457655,0.4492753623188406,0.7793540237860148,1.0,6/34,6.83%,SLC9A1;LRRK2;SLC4A10;SLC9A2;NOX1;TM9SF4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.26782971013635115,-0.9864398496162792,0.4479166666666667,0.7786421428106599,1.0,12/52,10.33%,SAMD4A;CNOT4;PAN3;CNOT1;DCP1A;PARN;DDX6;TUT7;PATL1;CNOT10;RC3H2;CNOT7
prerank,dermatan sulfate metabolic process (GO:0030205),0.4587604276223795,0.9864096723005082,0.5053619302949062,0.7973484222640381,1.0,3/13,9.63%,BGN;BCAN;DCN
prerank,protein glycosylation (GO:0006486),-0.22273930230637803,-0.9864014295341397,0.5,0.7770323898138988,1.0,27/125,13.25%,LARGE1;ST3GAL4;B4GALT1;MAN1C1;PLOD2;TRAK1;TET2;OGA;OGT;ST3GAL3;TET3;B3GNT2;PGM3;FUT8;B3GALT1;TUSC3;PMM2;GOLGA2;ALG5;MGAT3;STT3B;ENTPD5;GALNT1;GCNT2;FUT10;ST3GAL5;MGAT5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.36763881934734627,-0.986278144054788,0.45255474452554745,0.7757087577582789,1.0,8/12,28.98%,GOLGA2;BTRC;PTEN;CDC14B;GORASP1;RAB1A;PLK1;UBE2C
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.32052239068845245,-0.986063840443816,0.45226130653266333,0.7729139988843498,1.0,6/21,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.32052239068845245,-0.986063840443816,0.45226130653266333,0.7729139988843498,1.0,6/21,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,positive regulation of transmembrane transport (GO:0034764),0.4514741264412047,0.9859711209491712,0.4908616187989556,0.7979867563103346,1.0,4/13,13.79%,C3;CA2;P2RX7;CLIP3
prerank,skeletal muscle organ development (GO:0060538),0.4054204315546726,0.985654007722444,0.5241038318912238,0.798312790014275,1.0,4/26,11.06%,MYL6;FOXL2;BASP1;MYL6B
prerank,receptor catabolic process (GO:0032801),0.4108087899162068,0.9854028817754515,0.5073710073710074,0.7984802194924064,1.0,9/24,24.95%,LGMN;AP2M1;CLTC;AP2S1;CLTA;TGFB1;AP2A1;VLDLR;GPRASP1
prerank,regulation of response to external stimulus (GO:0032101),0.34457291016181946,0.9851578975101751,0.5444214876033058,0.7986353457413031,1.0,21/121,16.41%,TMSB4X;CALM1;GRN;PARK7;TREM2;METAP1;SEMA7A;TIRAP;BCL6B;METAP2;P2RY12;HCK;WNT5A;ELMOD2;CXCR4;F2RL1;AKNA;TRAF3;LRP8;CNGB1;CAV1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.42601724404797225,0.9851033851004182,0.505851755526658,0.7983473270748439,1.0,4/19,13.99%,MAF1;PRDX5;CEBPA;ZC3H8
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3033164825061536,-0.984854644080741,0.4427860696517413,0.774402750344995,1.0,10/25,16.97%,BRD4;ZMYND11;CDK12;TCERG1;RNF8;CDK13;ELL;LDB1;CDC73;WDR43
prerank,monocyte differentiation (GO:0030224),0.4739766040625136,0.984716171604595,0.4885057471264368,0.7987759897707004,1.0,1/10,0.45%,MT1G
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3938149309902883,-0.9844954796068606,0.4875,0.773595754375249,1.0,4/10,21.30%,SEC14L1;NPLOC4;DHX58;GPATCH3
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3621346465677591,0.9844298082463314,0.521978021978022,0.7990205372122803,1.0,16/52,19.59%,RACK1;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;RAMP3;CLIP3;SQSTM1;ACSL3;STX4;STAC3
prerank,regulation of cell division (GO:0051302),0.3562969667966906,0.9839747881786962,0.5138004246284501,0.7996445879052007,1.0,17/72,22.29%,RACK1;CALM1;CALM3;TXNIP;KLHL9;PIN1;CDK2AP2;DLL1;CETN2;INSC;CALM2;ESRRB;GIT1;MYC;SIRT2;CCP110;BLM
prerank,RNA metabolic process (GO:0016070),-0.22304343450106545,-0.9827955876574723,0.5357142857142857,0.7763812519207894,1.0,38/127,16.85%,CELF2;RBMS1;RBPMS;ATXN1;RBFOX2;RBM5;FTO;RBM39;DHX36;ATXN2;RNASE3;DICER1;PARN;HNRNPUL1;MPHOSPH10;RBM6;DROSHA;SIDT2;RNGTT;RBM4;WTAP;PABPN1;HNRNPR;SETX;HNRNPL;DDX17;POLR2A;MTREX;PRPF4;POLR2B;PABPC4;RBMS2;DUSP11;POLR2J;ADARB1;NOVA1;AGO2;HNRNPH3
prerank,regulation of calcium ion transport (GO:0051924),0.36478228182781947,0.9824619154417451,0.523093447905478,0.8027258065236986,1.0,13/54,17.63%,CD84;HOMER2;CTNNB1;PLN;LILRA5;WFS1;ATP2B1;LILRB1;EPB41;CCL3;SARAF;ORAI1;SRI
prerank,cGMP metabolic process (GO:0046068),0.4589698390572172,0.9820603996291876,0.511204481792717,0.803246527548068,1.0,1/12,2.33%,NPPC
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.48283746342941997,0.9819807022775372,0.49929278642149927,0.8030078719590984,1.0,7/10,34.74%,SYNGR1;SYP;APP;NETO1;CAMK2B;DRD2;NPTN
prerank,positive regulation of kinase activity (GO:0033674),0.3392355827061779,0.9817306965665492,0.5356037151702786,0.8031781273577313,1.0,28/107,18.23%,CD74;CCL19;TREM2;ERBB4;TNF;PTPRC;NTRK2;EEF1A2;LTK;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;GAS6;MMD2;EPHB1;MAPRE3;FLT1;TYRO3;LCP2;ADCYAP1;CAMKK1;AGAP2;DDR2;ERBB3
prerank,negative regulation of interleukin-1 production (GO:0032692),0.41528660422127384,0.9816382464691837,0.5163636363636364,0.8029890503105539,1.0,8/23,28.55%,TNFAIP3;GAS6;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4003034499225738,0.9814443394863912,0.51625,0.8030113279412545,1.0,5/28,7.50%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,sterol metabolic process (GO:0016125),0.3571406233311377,0.9813582646561709,0.5218818380743983,0.802789367861238,1.0,12/60,23.23%,APOE;ABCG1;PIP4P1;FDX2;SC5D;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;NSDHL;PMVK
prerank,cellular response to glucose stimulus (GO:0071333),0.39362949134325287,0.9812585803036197,0.5170789163722026,0.8026068119952674,1.0,7/30,16.34%,RACK1;PTPRN;GPER1;MLXIPL;PTPRN2;GAS6;ADCY8
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.43363554873027343,0.9811365807580099,0.5250320924261874,0.8024610893519223,1.0,4/17,15.07%,BTG1;SOX9;SFRP4;BAD
prerank,inorganic anion transmembrane transport (GO:0098661),0.36082460384768694,0.9809389522242253,0.5293478260869565,0.8024996487219199,1.0,14/63,18.83%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;SLC25A11;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;GABRB2;ANO4;GLRA3
prerank,cation transport (GO:0006812),0.33273090678396716,0.980822442510197,0.541033434650456,0.802333571938851,1.0,30/166,16.09%,SLC38A5;SLC39A1;SCN1A;GRIN1;KCNJ10;SLC25A29;SLC6A6;SGK1;CNGA3;AQP1;TMEM63C;SLC6A17;SCN4B;SLC3A2;KCNC1;KCNA2;TRPM2;KCNN2;ATP1A4;SLC1A1;KCNK9;ABCC8;NDUFA9;KCNF1;ATP1B1;SLC8A1;KCNK3;FGF13;CNGB1;KCNA1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4634479509687507,0.9803533083829414,0.5115961800818554,0.802997658489218,1.0,3/12,9.63%,BGN;BCAN;DCN
prerank,cytoskeleton organization (GO:0007010),0.3401408883280238,0.9795971258951132,0.5425641025641026,0.8043343293068934,1.0,26/114,17.41%,APOE;MDK;CFL1;RHOB;CNN2;RHOC;MAST3;RAC1;PACSIN1;TNFAIP3;RHOG;MAST1;THY1;MICAL1;ARAP3;RHOA;DES;RHOU;CCL2;ZMYM3;EPB41L3;SH3KBP1;DMTN;CCL3;FMNL3;RAC2
prerank,fatty acid transmembrane transport (GO:1902001),-0.3280864477035096,-0.9791469322717219,0.5321100917431193,0.7841036766139565,1.0,4/19,11.96%,PRKAG2;ABCD3;PRKAA2;CPT2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.41232324892952865,0.9782919647892745,0.5043370508054523,0.8068822839941202,1.0,6/22,17.58%,AKT1;NTRK2;SH3GL2;MAPT;EHD1;TMEM108
prerank,histone mRNA metabolic process (GO:0008334),0.3976750424402842,0.9781122358935779,0.5181159420289855,0.8068674225661118,1.0,9/27,23.65%,SNRPG;SNRPE;SNRPF;CPSF2;SNRPB;SLBP;SNRPD3;EXOSC4;ERI1
prerank,synaptic vesicle endocytosis (GO:0048488),0.3836373533174024,0.9778417951245331,0.5227272727272727,0.8070811543713796,1.0,8/33,9.25%,NLGN1;CANX;PACSIN1;DNM3;SNAP91;SYT1;AMPH;VAMP2
prerank,long-term synaptic potentiation (GO:0060291),0.41588934337753153,0.9776848720433945,0.5084745762711864,0.8070127151869556,1.0,6/21,18.77%,SLC24A2;MPP2;GRIN2A;VAMP2;GRIN2B;STX4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4524575405303313,0.9776716654652796,0.5055096418732782,0.8066225679865341,1.0,4/13,16.37%,CD2BP2;PRPF19;PRPF8;PRPF31
prerank,potassium ion transmembrane transport (GO:0071805),0.3349267884826373,0.9774419643639948,0.5544252288911495,0.8067501993810726,1.0,34/135,19.69%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;ATP1A3;ATP1B2;SLC12A5;KCNC1;KCNE4;KCNA2;KCNN2;ATP1A4;ATP1A1;KCNK9;ABCC8;KCNE5;KCNF1;ATP1B1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,potassium ion import across plasma membrane (GO:1990573),0.37459739287394955,0.9772247952335031,0.5137614678899083,0.8068113136605453,1.0,9/41,17.69%,KCNJ10;ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;KCNK9;ATP1B1;ATP1B3
prerank,protein deacetylation (GO:0006476),-0.2637075374789382,-0.9770807987113306,0.5137614678899083,0.7878738785115247,1.0,11/41,13.42%,PRDM5;MIDEAS;BAZ2A;HDAC4;MTA3;TBL1X;RCOR1;MIER1;TBL1XR1;RCOR3;SIRT1
prerank,extracellular structure organization (GO:0043062),0.33022142369417806,0.9770615245337205,0.5386158475426279,0.8067745834951163,1.0,32/204,11.77%,BSG;SPARC;VTN;BGN;SPP1;COL1A1;BCAN;LAMC1;LAMB2;SPOCK2;LUM;ITGB2;ADAM15;PDGFB;ADAMTS4;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;COL6A1;COL4A1;KDR;COL3A1;LAMC2;DCN;COL9A1;PECAM1;MMP3;MFAP2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.41521264801046287,0.9769004071919278,0.4930643127364439,0.8067344006306483,1.0,9/21,24.94%,HINT1;NUDT3;ACAT1;PNP;NUDT4;NUDT16;NUDT10;NUDT11;PDE2A
prerank,male gonad development (GO:0008584),0.3899322759706979,0.9764778178073515,0.5318396226415094,0.807329685997939,1.0,13/34,28.28%,KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3517031062035254,0.9759694390534005,0.5235546038543897,0.8080922267638294,1.0,9/65,7.22%,RPS27A;UBC;UBB;FKBP1A;PIN1;EID2;WFIKKN2;UBA52;STRAP
prerank,P-body assembly (GO:0033962),-0.36990206274587695,-0.975893218934999,0.48771929824561405,0.789389803990617,1.0,4/12,8.40%,ATXN2;LSM14A;DDX6;PATL1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.41435554702804384,0.9755977065405791,0.5271122320302648,0.8084980136318491,1.0,4/22,4.63%,TNF;LGALS3;FKBP1A;PPP1R1B
prerank,positive regulation of histone methylation (GO:0031062),-0.3096912252987827,-0.9754550592332468,0.4734042553191489,0.7888451800452166,1.0,4/24,5.59%,AUTS2;OGT;KMT2A;JARID2
prerank,regulation of viral release from host cell (GO:1902186),0.41654705097219513,0.974837791045901,0.506265664160401,0.8097806679415138,1.0,6/21,19.64%,CHMP2B;TRIM28;DDB1;TRIM32;VPS4A;TRIM13
prerank,vesicle transport along actin filament (GO:0030050),0.4240876130964236,0.9743766718351566,0.5224438902743143,0.8103766557713131,1.0,4/19,11.02%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,embryonic skeletal system development (GO:0048706),-0.2723875368852689,-0.9741143296023803,0.4966887417218543,0.79090122476027,1.0,7/35,7.67%,SULF1;HOXB3;HOXA3;HOXB4;HOXC4;KIAA1217;PCSK5
prerank,negative regulation of protein polymerization (GO:0032272),0.3961500711993008,0.9737103184792478,0.5097087378640777,0.8114353297103226,1.0,14/27,25.37%,MYADM;PFN1;TUBB4A;MAP2;CLIP3;STMN1;PFN2;CDH5;SNCA;TWF1;SSH2;TWF2;TBCD;MAPRE1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3405983696635803,0.9734118870705631,0.5413612565445026,0.8116964787472917,1.0,30/93,25.38%,CCL19;SPI1;TIRAP;ANKRD6;SEMA4C;EMC10;HIPK2;CCN2;HMGB1;FLT4;HRAS;PRMT1;MAPK8IP1;BMP2;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.23961914443367946,-0.972747010684446,0.582089552238806,0.7927748443224063,1.0,19/67,18.10%,PLD1;FER;DCDC2;TBC1D19;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;SDCCAG8;FXR2;IFT140;ATP8B1;MYO10;DYNC2LI1;SGSM3;ABITRAM;FMR1;CDKL1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4272665040637734,0.972436051350572,0.5112219451371571,0.8134749415370449,1.0,13/18,38.36%,PCNA;RFC4;GINS3;LIG1;MCM7;POLE3;POLD3;GINS1;RFC3;POLD2;MCM4;LIG3;MCM3
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.35144943958098107,0.9724115176959457,0.5485232067510548,0.813115353125479,1.0,17/67,17.08%,MDK;CALR;S100A10;EMP2;PDGFB;RAC1;FLNA;MYADM;FN1;P4HB;ARHGEF7;ARL2;DMTN;CCL28;CASS4;SKAP1;FBLN2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.46144789449134227,0.9723720254032863,0.5238784370477568,0.8127987951816552,1.0,4/11,25.94%,CLEC6A;NFKBID;IL12RB1;PRKCQ
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.38242558852201713,0.9722537294363992,0.5285880980163361,0.8126412260506536,1.0,18/32,33.02%,MID1IP1;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;FGF13;CDH5;SNCA;FKBP4;TBCD;MAPRE1;CAMSAP3;CLASP2;STMN2;KATNB1;APC
prerank,histone lysine methylation (GO:0034968),-0.2836162895696506,-0.9720213047702614,0.5341614906832298,0.7930062899818997,1.0,18/33,25.60%,PRDM5;SMYD3;KMT2A;ASH2L;SETDB1;KMT2D;WDR82;EHMT2;EZH2;PRDM9;SETD1B;WDR5B;SETD3;SETD6;KDM6A;SMYD1;DYDC2;N6AMT1
prerank,intestinal lipid absorption (GO:0098856),-0.38488364712386225,-0.9717709319363514,0.49818181818181817,0.7920119030484524,1.0,1/11,1.11%,LIMA1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.39546175671372075,-0.9709355807655868,0.4894366197183099,0.7925052114107216,1.0,3/10,15.98%,DNMT3A;PCGF5;MECP2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.338695249764401,0.9707681453347723,0.5379098360655737,0.8155747321896626,1.0,26/117,21.68%,BSG;CKB;GATM;AGXT;SCP2;GLO1;LDHA;CKMT1A;GRHPR;LPL;ALKBH7;FASN;ACOT1;ACOT7;GLYAT;NAAA;SLC16A1;ACOT4;FA2H;BCO2;ACSL3;GAMT;THEM4;ALDH4A1;MTHFS;SGPL1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.45626567846696714,0.970683771387284,0.5108695652173914,0.8153579552343604,1.0,6/12,25.99%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,T cell differentiation (GO:0030217),0.3786592441642521,0.970654285140263,0.5454545454545454,0.8150062446142224,1.0,9/40,17.48%,PTPRC;FCER1G;ZFP36L1;SPI1;ZFP36L2;IL2;JAG2;PIK3CD;ADAM17
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.39262279207072115,0.970291728091885,0.511543134872418,0.8154337386061389,1.0,6/28,10.03%,CXCL12;HCLS1;PFN1;ESAM;COTL1;PAK3
prerank,smooth muscle contraction (GO:0006939),-0.3434512827218095,-0.9697830227440762,0.48880597014925375,0.7938597694654614,1.0,4/14,7.39%,ROCK2;ROCK1;MYLK;EDNRA
prerank,catecholamine biosynthetic process (GO:0042423),-0.382490357558447,-0.9695767735778748,0.509090909090909,0.7926932770560267,1.0,1/11,2.16%,MOXD1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.36288387743583045,0.9692308260830048,0.5179372197309418,0.8173989031136911,1.0,13/47,20.52%,PPIA;MAPK3;SEMA4C;PHLPP1;MAPK8IP1;F2RL1;MAPK8IP2;RASGRP1;EPHB1;DAB2IP;MAP2K2;QARS1;MYC
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.2466778219943515,-0.9690741233688492,0.5697674418604651,0.7923390049412575,1.0,11/58,13.42%,BABAM2;KDM2A;NSMCE2;UVRAG;MDC1;UIMC1;RNF8;NHEJ1;ATM;ERCC8;CYREN
prerank,regulation of cell adhesion (GO:0030155),0.3321254483958214,0.9689058124634451,0.5695296523517382,0.8176932562746955,1.0,28/129,19.75%,ARHGDIA;MDK;CXCL12;TGM2;TNF;ACVRL1;DSCAM;PPP2R1A;PDE3B;MYADM;ARHGDIB;FRMD5;ADGRG1;P4HB;PODXL;DUSP26;ARHGDIG;CXCR4;DLL1;EPB41L4B;TMEM102;PLAU;RAC2;ERBB3;STX4;PPP3CA;LPXN;EFNA1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3842060787366917,-0.9688356960671353,0.5089605734767025,0.7912685368759624,1.0,5/10,31.63%,IL18;LGALS9;PRKCZ;GATA3;IL4
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3521682430502887,-0.9687670327237962,0.4859437751004016,0.789782809318804,1.0,5/14,14.22%,TNKS2;TERT;TERF2;TINF2;PINX1
prerank,alpha-amino acid metabolic process (GO:1901605),0.36589109773280565,0.968082093360715,0.5302013422818792,0.8190994495757622,1.0,12/45,20.39%,SLC25A13;OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;NAT8L;ASNS;GLUD1;GOT1
prerank,activation of protein kinase A activity (GO:0034199),-0.3434960305688409,-0.9677741089229521,0.4868421052631579,0.7907123905595107,1.0,3/16,2.23%,ADCY9;ADCY1;ADCY5
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4748471865696049,0.9677280140333478,0.5302197802197802,0.8194854758448853,1.0,2/11,4.80%,ARL6IP1;RTN4
prerank,cellular glucose homeostasis (GO:0001678),0.36926729429591315,0.9676573944294317,0.5309633027522935,0.8192294784609133,1.0,5/41,5.90%,RACK1;LRRC8A;GPER1;NR1D1;NUCKS1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.271153608501266,-0.9672859480726186,0.47183098591549294,0.7902589423652021,1.0,6/31,8.06%,BABAM2;OTUD4;OTUD7B;USP50;UIMC1;USP16
prerank,ERBB signaling pathway (GO:0038127),0.3497476173167769,0.9672519256576919,0.5395449620801733,0.8197433076847989,1.0,18/64,21.65%,HSP90AA1;AKT1;NRG1;ERBB4;SHC3;MATK;PTK6;CDC37;AAMP;PTPRR;SOX9;ERBIN;ADAM17;ERBB3;SOS1;TGFB1;STUB1;TGFA
prerank,carboxylic acid transmembrane transport (GO:1905039),0.37774231042904693,0.9671834870744538,0.535632183908046,0.8194889185020361,1.0,13/40,27.82%,SLC38A5;SLC7A5;SLC25A11;SLC25A21;SLC19A1;SLC16A1;SLC38A10;SLC7A10;SLC25A14;SLC7A6;SLC38A3;ABCC5;SLC16A7
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4477354056570978,0.967056331143275,0.5235531628532974,0.8193436987575348,1.0,4/13,19.00%,SOD1;CLPTM1;ZC3H8;TOX
prerank,regulation of multicellular organism growth (GO:0040014),0.44192679626291087,0.9669932027774438,0.544137022397892,0.8190538132326037,1.0,3/15,8.69%,PPIB;SOD1;MFSD2A
prerank,cellular response to glucagon stimulus (GO:0071377),-0.33849677102254694,-0.9668128062170506,0.502127659574468,0.7899487816413002,1.0,3/17,2.23%,ADCY9;ADCY1;ADCY5
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42056366127833755,0.9666215263480578,0.5424164524421594,0.8194849660131082,1.0,5/19,12.78%,TLE5;CD24;TAF9;WNT5A;KLF4
prerank,negative regulation of anoikis (GO:2000811),-0.348983586940335,-0.9665100397962634,0.502092050209205,0.7890566801382588,1.0,4/14,12.48%,ITGA5;TLE1;PTK2;BCL2
prerank,positive regulation of intracellular transport (GO:0032388),0.3761009600250598,0.9663801054375099,0.5506402793946449,0.8195958414106654,1.0,16/38,28.06%,OAZ1;SORL1;PRR5L;MLC1;VAMP2;CEP131;B3GAT3;STK11;EHD1;EHD2;OAZ2;KIF20B;ICE1;PCNT;PGAP1;TENM1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.40555969750579957,0.965638214291975,0.5428571428571428,0.8208338404781441,1.0,10/22,24.49%,CLU;TNF;ABCG1;GSAP;IFNGR1;ABCA2;LRRTM3;EFNA1;RELA;AGER
prerank,phosphate-containing compound metabolic process (GO:0006796),0.32875171591597957,0.9653787510185292,0.5863453815261044,0.8209793136579063,1.0,54/198,25.57%,ALDOA;GPX4;CALM1;ALDOC;PPP1CA;MAPK3;AKT1;PFKL;TOLLIP;PTPRC;DUSP3;PLAAT3;PGK1;PAK1;DUSP28;LPL;PIP4P1;BCKDK;NUDT3;PLA2G4F;PTPRD;GDE1;PTPRB;INPP5J;NUDT4;CDK5;PPA1;PIK3CD;NT5C;CLN8;G6PC3;CERKL;IP6K1;PPP3CA;PLPPR2;NUDT10;PGP;TGFB1;SPHK2;PLCH1;DUSP23;DUSP12;INPP5D;DUSP15;AGPAT2;PNKP;NUDT11;ACP2;PLA2G3;PLPPR4;GPD2;TNK2;INPP4B;DUSP8
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3737742892496745,0.965206761068181,0.5397008055235903,0.8209418702293423,1.0,6/37,12.08%,DYNLL2;DYNLL1;IFT20;DYNLRB1;CEP131;DYNLRB2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3255201308879983,-0.9651767744614942,0.5045045045045045,0.7909446115172496,1.0,7/18,16.26%,EGFR;NCOR1;RIPK1;ESR1;TERT;BMP4;TP53
prerank,coenzyme A metabolic process (GO:0015936),0.440619776237521,0.9651428599135651,0.5282258064516129,0.8206731719547582,1.0,6/14,23.83%,ACAT1;ACOT7;COASY;PPCS;ACLY;SLC25A16
prerank,regulation of lipase activity (GO:0060191),0.45894372198254374,0.9651141510474318,0.5416666666666666,0.8203262141613935,1.0,5/13,25.25%,RHOC;LPL;RHOA;SNCA;PCSK6
prerank,negative regulation of protein depolymerization (GO:1901880),-0.29159588158736155,-0.9647768820804837,0.48205128205128206,0.7903656279327343,1.0,7/24,14.72%,PLEKHH2;LIMA1;HDGFL3;CAMSAP1;SPEF1;ARHGEF2;TAOK1
prerank,neuron apoptotic process (GO:0051402),0.4160909888505606,0.9646003413664545,0.54296875,0.821046108811775,1.0,5/19,26.73%,GAPDH;CDK5;ERBB3;APP;SCN2A
prerank,negative regulation of leukocyte migration (GO:0002686),0.4723033694212763,0.9645384996648513,0.5233918128654971,0.8207674680344461,1.0,1/10,1.73%,HMOX1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3749374641744766,-0.964453975648019,0.4962962962962963,0.7895716810808404,1.0,8/12,21.61%,PTPN14;RBM4;BMP4;AAAS;SIRT7;NUP214;KHDRBS1;TPR
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3475474123543241,-0.9643362163517484,0.4581673306772908,0.7882585641119414,1.0,7/16,14.98%,DPYSL3;TET2;DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,regulation of ion transmembrane transport (GO:0034765),0.38029209244554113,0.9638142541235852,0.5451348182883939,0.821917190655999,1.0,6/33,14.60%,AKAP6;YWHAE;KCNJ10;P2RX7;CHRM3;KCNE5
prerank,phagolysosome assembly (GO:0001845),0.4586661842676161,0.9633522439773915,0.5081521739130435,0.8225024502068037,1.0,7/12,34.89%,RAB14;CORO1A;RAB20;SYT7;RAB34;RAB39A;ARL8B
prerank,mesenchymal cell development (GO:0014031),0.41778941578700546,0.9630729014024618,0.5112881806108898,0.8226837040177835,1.0,11/18,37.13%,NRG1;PDCD6;SOX8;SOX11;NOTCH1;NOLC1;KBTBD8;CDH2;TBX20;TCOF1;KLHL12
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4274539800011687,0.9630230930510378,0.5464052287581699,0.8223739716058794,1.0,6/16,17.97%,GABARAP;STMN3;CADM4;ARF6;KBTBD7;RASGRF1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.39680416041302324,0.9629149908012612,0.5433734939759036,0.8222054087994197,1.0,9/26,25.11%,LGMN;DUSP3;HES1;ASNS;USP22;FOXA1;MEIS2;APP;PRKCA
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4044260804220794,0.9625680822566137,0.5202020202020202,0.8225639884724597,1.0,5/21,8.20%,ACTG1;DUSP3;GPM6B;CORO1C;CLASP1
prerank,regulation of type I interferon production (GO:0032479),0.34133368034284317,0.9621456165940496,0.5620437956204379,0.8230805128807569,1.0,30/84,30.38%,GAPDH;POLR2E;POLR2F;PIN1;TIRAP;CTNNB1;TNFAIP3;ISG15;PQBP1;IRF8;POLR2K;IRF7;TRAF3;G3BP1;TRIM32;CD14;POLR2H;POLR3K;IRF5;POLR3D;PCBP2;RELA;NLRP4;DHX9;XRCC6;TRIM25;TRIM56;ACOD1;POLR3C;POLR3E
prerank,regulation of lymphocyte differentiation (GO:0045619),0.42216014438779415,0.9619746644078239,0.5412719891745602,0.8230363787272575,1.0,7/18,28.69%,ZFP36L1;ZFP36L2;IKZF3;CCR2;PRELID1;METTL3;XRCC6
prerank,membrane lipid catabolic process (GO:0046466),0.46851176416976853,0.9619398732999529,0.5190735694822888,0.8226994252659683,1.0,4/10,24.79%,ENPP2;FUCA1;SGPL1;NAGA
prerank,lamellipodium assembly (GO:0030032),0.3928511716342712,0.9617393955728819,0.5508905852417303,0.8227048008071991,1.0,7/26,16.20%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.2928832180139976,-0.961382428629695,0.5144508670520231,0.7943780335742053,1.0,5/24,5.77%,ADAMTS12;SOX5;ZBTB16;TGFBR1;EFEMP1
prerank,regulation of axonogenesis (GO:0050770),0.3580139849803987,0.9612738894032872,0.5525423728813559,0.8233538241238805,1.0,13/51,16.84%,ARHGDIA;NTRK2;RTN4;LRP4;LRRC4C;PAK1;THY1;PAK3;GDI1;RHOA;TIAM1;ROBO2;BRSK2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.38112262810168207,0.9612180195578895,0.5399515738498789,0.823063031497119,1.0,8/30,17.41%,TOMM7;PINK1;UBL5;LEPROT;FBXW7;RHOU;PDCD5;RAC2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.4283004768351756,0.9611927736581615,0.5152317880794702,0.8227106654145062,1.0,4/16,24.49%,PTPRC;LILRB1;IL12RB1;AGER
prerank,calcium import into the mitochondrion (GO:0036444),-0.3799221022921745,-0.9610443205844709,0.4657534246575342,0.7935830613008285,1.0,3/10,6.11%,MCU;MICU1;MICU2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3365385666629167,-0.9606448228381635,0.5132743362831859,0.7930764613180871,1.0,6/16,11.61%,TGFBR3;BMPR1A;ZFPM2;IGF1;FGFR2;RBPJ
prerank,transcription by RNA polymerase III (GO:0006383),0.39458008255132093,0.9605450743065393,0.5372405372405372,0.8237326357936827,1.0,10/27,26.43%,GTF3C6;POLR2K;IVNS1ABP;ZC3H8;RO60;TBP;GTF3A;POLR3K;ICE1;GTF3C2
prerank,cytoplasmic translational initiation (GO:0002183),0.4296039310914712,0.9603536211523528,0.5481283422459893,0.8237384535062908,1.0,5/17,20.28%,EIF3D;EIF3I;EIF4A1;EIF4H;EIF3M
prerank,contractile actin filament bundle assembly (GO:0030038),-0.33963499718384,-0.9600628620778517,0.5121951219512195,0.7914392330732094,1.0,2/15,0.95%,SORBS1;PHACTR1
prerank,stress fiber assembly (GO:0043149),-0.33963499718384,-0.9600628620778517,0.5121951219512195,0.7914392330732094,1.0,2/15,0.95%,SORBS1;PHACTR1
prerank,cell-cell junction maintenance (GO:0045217),0.4612860084220976,0.9596928464335024,0.5282758620689655,0.824808011625796,1.0,4/11,22.93%,MYADM;CSF1R;F2RL1;PARD6A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3412914554703111,0.9596686425572246,0.5613660618996799,0.8244486714931747,1.0,9/72,12.90%,RPL26;RPS27L;CHEK2;PCBP4;HIPK2;NDRG1;BAX;PCNA;PRMT1
prerank,synaptic vesicle membrane organization (GO:0048499),0.4341726909294845,0.959500894962671,0.5445026178010471,0.8243904682604781,1.0,6/17,22.10%,SNAP25;SYNGR2;SYNGR1;SYP;STX4;STX1B
prerank,regulation of necroptotic process (GO:0060544),0.4056091238586111,0.9592705449318422,0.539015606242497,0.8244809368971705,1.0,7/23,15.64%,HSP90AA1;FZD9;SLC25A4;FLOT1;CDC37;SDCBP;YBX3
prerank,regulation of lipid metabolic process (GO:0019216),0.3380679137758452,0.9591955236729213,0.5646328852119958,0.82423054825974,1.0,14/88,12.48%,PSAP;NPC2;APOC1;CERS2;NR1D1;MID1IP1;RARRES2;EDF1;LSS;SIN3B;FASN;SCD;SC5D;NCOR2
prerank,regulation of mast cell degranulation (GO:0043304),-0.3482793780601621,-0.9589494416212021,0.5,0.7926817967456596,1.0,2/14,1.00%,GAB2;FER
prerank,oligodendrocyte differentiation (GO:0048709),0.40979246344620657,0.9588597303691122,0.5363636363636364,0.8245446745605178,1.0,7/19,21.29%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;EIF2B5;SOX10
prerank,hematopoietic stem cell proliferation (GO:0071425),0.4608332038004007,0.9587589506404695,0.5135908440629471,0.8243459075614572,1.0,3/11,13.56%,CD34;WNT5A;WNT10B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.23921027675727113,-0.9584571603542458,0.6,0.7922731135463001,1.0,18/60,16.26%,TCF7L2;TNRC6B;MED13;ATF7IP;TNRC6A;DHX36;PPM1D;TNRC6C;MED15;NFKB1;MOV10;PTEN;MED26;CBFB;RUNX2;HEY2;MECP2;TP53
prerank,cellular response to cAMP (GO:0071320),0.3812228909822615,0.9583140885701191,0.5362149532710281,0.8249165517755638,1.0,11/30,27.61%,AKAP6;IGFBP5;ZFP36L1;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3565418233038236,-0.9581571629161966,0.47244094488188976,0.7914897915139875,1.0,6/15,15.83%,PIEZO2;ADGRV1;COL11A1;TMEM120A;KIT;PDZD7
prerank,protein modification process (GO:0036211),0.3453543006580777,0.9580527983960233,0.582089552238806,0.8250893741280578,1.0,15/76,13.08%,RPN1;RPN2;UBL5;PARP1;CPE;LOX;CDC34;UBA52;UBE2M;NEDD8;ICMT;CHRM3;PLAT;SERP1;ST8SIA4
prerank,positive regulation of lyase activity (GO:0051349),0.44620548952287353,0.9576103653147919,0.5287049399198932,0.8256222786001419,1.0,5/14,17.55%,PARK7;DRD5;ISCU;ORAI1;NOS2
prerank,pharyngeal system development (GO:0060037),-0.34242266706980395,-0.9570030032847819,0.5086505190311419,0.7927384459951066,1.0,6/15,21.22%,BMPR1A;TGFBR1;BMP4;BMPR2;BMP5;PTCH1
prerank,cytosolic calcium ion transport (GO:0060401),-0.29534641081548574,-0.956737088564504,0.4936708860759494,0.7917950980822915,1.0,6/28,8.41%,MCU;CACNA1C;MICU1;MICU2;SLC35G1;JPH1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.331010351863976,-0.9566623186633153,0.5391304347826087,0.790365221860576,1.0,4/17,5.49%,PID1;HDAC4;PPARA;NCOR1
prerank,response to cytokine (GO:0034097),0.3299763212487863,0.9565005905860277,0.5800203873598369,0.8276462527281857,1.0,37/141,22.39%,IFITM3;CD74;IFITM2;IFITM1;TIMP2;AKAP6;SHFL;HCLS1;TLE5;DDOST;ISG15;CXCL16;IL1RAPL1;COL3A1;TIMP1;TAF9;SMPD1;CSF1R;TIMP3;SLC11A1;BST2;RHOA;CXCR4;SIGIRR;TMEM102;TRIM32;SNCA;FLT3;POU4F1;FOXA2;TIMP4;SHMT2;PTPN6;ASAH2;CDK9;MAP2K7;PTPN5
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3705303092370157,-0.9564401176795607,0.5,0.7893052637961931,1.0,4/11,6.10%,SLC30A10;PPARA;COA8;ABCB7
prerank,regulation of T cell differentiation (GO:0045580),0.3744065553538225,0.9562627959180052,0.5620608899297423,0.827724097451088,1.0,7/33,19.11%,MDK;SOD1;CLPTM1;IL2;CTLA4;CCR2;PRELID1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.45299799581909184,0.9560728627327738,0.5287049399198932,0.8277433624035775,1.0,3/12,13.00%,AGT;SOX8;SOX9
prerank,negative regulation of interferon-beta production (GO:0032688),0.46497960731736626,0.9557300757292474,0.5251141552511416,0.8280598065243128,1.0,3/10,20.94%,SIRPA;LILRB1;PYCARD
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4134416985492268,0.9554409108056306,0.5542784163473818,0.8282865792620342,1.0,6/21,18.21%,TALDO1;PGLS;RPIA;PGD;G6PC3;TKT
prerank,regulation of store-operated calcium entry (GO:2001256),0.4811955783913056,0.955382845209548,0.573632538569425,0.8280042880936939,1.0,2/10,3.99%,CD84;HOMER2
prerank,renal water homeostasis (GO:0003091),0.3969879674285895,0.9543733860879676,0.546353522867738,0.8297715786352953,1.0,9/23,19.55%,AQP4;AQP1;PRKAR1A;PRKAR1B;WFS1;ADCY4;ADCY8;PRKAR2B;TFAP2B
prerank,melanocyte differentiation (GO:0030318),-0.3663709055462957,-0.9542461953403873,0.5056603773584906,0.7933330799305949,1.0,4/11,16.61%,LRMDA;ENPP1;KIT;MITF
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4027102854447711,0.9542322905870283,0.5595854922279793,0.8296614901159847,1.0,9/20,27.73%,YWHAB;RGS2;APLP1;STMN1;SNCA;GRK2;GPRASP1;RNF157;ADA
prerank,positive regulation of catabolic process (GO:0009896),0.3448748180696151,0.9541615666828089,0.5659163987138264,0.8294117163079138,1.0,16/65,19.93%,NDUFA13;OAZ1;TNF;SORL1;VCP;TNFAIP3;TNFSF12;VSIR;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;TRIM32;HECW1;OAZ2
prerank,regulation of neuroblast proliferation (GO:1902692),0.4336351913786332,0.954115821688275,0.5450980392156862,0.8290952185502289,1.0,6/15,26.32%,TAFA1;CTNNB1;CX3CR1;PTN;CX3CL1;FZD3
prerank,determination of heart left/right asymmetry (GO:0061371),0.3662060274315345,0.9537390629253167,0.5690866510538641,0.8294907983518938,1.0,10/42,20.07%,SOX18;NDRG4;APLNR;MMP21;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C
prerank,regulation of establishment of cell polarity (GO:2000114),0.42245452838619546,0.9532488660393907,0.5570469798657718,0.8301155822167846,1.0,2/16,0.88%,RACK1;GSN
prerank,multivesicular body assembly (GO:0036258),0.3872157452238084,0.9530598308372792,0.5555555555555556,0.830118653310937,1.0,16/30,32.42%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,cochlea morphogenesis (GO:0090103),0.4723164968578826,0.952668321104617,0.5633187772925764,0.8305487223853911,1.0,2/10,13.00%,MYO3A;SOX9
prerank,regulation of ATP metabolic process (GO:1903578),0.35101213568395717,0.9526611285617783,0.5647840531561462,0.8301536235262169,1.0,15/54,21.42%,UQCC2;PGAM1;PINK1;COX7A2L;COX7A2;ATP5IF1;AK4;ZBTB7A;NUP85;NUP88;NUP50;SPHK2;SHMT2;RAE1;FIS1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32629351790109523,0.9526605214104942,0.5897959183673469,0.8297440236443062,1.0,23/128,13.63%,RPS27A;UBC;CLDN5;UBB;MAPK3;ID1;ACVRL1;FKBP1A;AMH;EID2;LEFTY2;WFIKKN2;UBA52;ZYX;COL3A1;JUN;SLC33A1;AMHR2;ZMIZ2;COL1A2;RHOA;BMP2;LEFTY1
prerank,visual system development (GO:0150063),0.36790168180109667,0.9524647393142414,0.5653669724770642,0.8297746405366905,1.0,7/37,13.25%,C1QA;C3;RBP4;HIPK2;SALL2;BLOC1S3;MAB21L1
prerank,sodium ion transport (GO:0006814),0.334821346007222,0.9524061530274007,0.5644490644490644,0.8295052854906472,1.0,19/85,17.69%,ASIC2;SLC24A4;SLC24A2;SCN1A;SLC6A6;SGK1;SLC6A17;SLC6A5;SLC6A2;SCN4B;SLC6A16;ATP1A4;NDUFA9;ATP1B1;SLC8A1;HCN1;FGF13;HCN3;ATP1B3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4319367642453765,0.9519022661620925,0.5335120643431636,0.8301840238101129,1.0,7/14,32.50%,SCP2;HSD17B4;CRAT;ACOX3;EHHADH;DECR2;ACOX1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4481781692281816,0.9517574856018794,0.5405405405405406,0.8301055469106912,1.0,7/12,27.81%,BAX;DAB2IP;TMEM33;BAK1;PTPN1;BOK;XBP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.39144129924889726,0.9512921178578628,0.5439024390243903,0.830693709668558,1.0,7/26,20.23%,PARK7;CYBA;GRIN1;ADGRB1;TLR6;SNCA;SPHK2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.44287522855350214,0.9512152095111729,0.574468085106383,0.8304617915953242,1.0,4/13,12.73%,ELOF1;SPI1;SERTAD1;ZMIZ2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3322250601762077,-0.9511161095825207,0.5064935064935064,0.7997159335260242,1.0,5/15,12.34%,PRKCE;IRS1;PPARA;PPARG;ADM
prerank,mitotic nuclear membrane organization (GO:0101024),0.358211243980726,0.9509955337944924,0.5673289183222958,0.8301077362424262,1.0,23/51,32.42%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.358211243980726,0.9509955337944924,0.5673289183222958,0.8301077362424262,1.0,23/51,32.42%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,positive regulation of dendrite development (GO:1900006),0.45869237537749885,0.9507736959722803,0.5553956834532374,0.8301930525118009,1.0,6/10,26.38%,PACSIN1;LRP8;DAB2IP;PTN;VLDLR;ALK
prerank,cellular response to estradiol stimulus (GO:0071392),-0.31444213592958364,-0.9506638622447456,0.5621890547263682,0.7992838843967656,1.0,4/18,9.87%,EGFR;NRIP1;LCOR;ESR1
prerank,positive regulation of cell projection organization (GO:0031346),0.33044276445699816,0.9506091124842045,0.6139630390143738,0.8301540003107577,1.0,22/115,16.53%,APOE;ARHGDIA;MDK;NTRK2;S100A9;CAMK1D;NDRG4;TENM3;LTK;ATP1B2;PTK6;IL1RAPL1;CAMK1;WNT5A;SS18L2;PTPRD;RHOA;LRRC7;TIAM1;ROBO2;DAB2IP;FUT9
prerank,sensory perception of smell (GO:0007608),0.4612050177233726,0.9503634363786132,0.5478502080443828,0.8302578433968054,1.0,2/11,15.44%,SLC24A4;SYT10
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.28102083491800184,-0.9500298644609648,0.5259259259259259,0.7992532001617345,1.0,8/34,11.93%,PTPN13;PTPN9;TNS2;DUSP16;DUSP10;PTPN12;DUSP7;PTPN2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.34256568756625516,-0.9498169847221244,0.5056603773584906,0.7982108812309744,1.0,5/14,14.18%,ARID2;MMS19;MRNIP;FUS;FANCB
prerank,aorta morphogenesis (GO:0035909),-0.32072856457250076,-0.9497370167953019,0.5413223140495868,0.7968218819928672,1.0,8/17,14.92%,BMPR1A;ADAMTS9;MYLK;PDGFRB;LRP1;RBPJ;JAG1;HEY2
prerank,neurogenesis (GO:0022008),0.36280717735935647,0.9496332121642589,0.5684931506849316,0.8314637634794799,1.0,16/43,26.70%,SPOCK1;PRDM12;MAPT;NDUFS2;HAP1;CLN5;CXCR4;DCHS1;EPHB1;ERCC6;BTBD6;ROGDI;METTL3;METTL14;NTN5;TGFB2
prerank,cellular protein localization (GO:0034613),0.3203381331963687,0.9494579543359083,0.6533066132264529,0.8314403730498279,1.0,72/285,22.10%,CD74;CD63;LAPTM5;SNX17;ID1;NPM1;LAMTOR2;GRID2;EMP2;CNTNAP2;ARF5;PACSIN1;YWHAH;CTNNB1;FLNA;CPE;ATG9A;TMED7;SAR1A;RAB14;ESAM;TMED2;ARL11;CLTC;PRPF19;SCG5;ARF6;TICAM2;ABHD17A;TMED3;ARL4C;TMED9;PDCD6;WNT5A;CTSA;SGSM1;ARL4D;ARL1;TMED1;SYNDIG1;GJA1;LAMTOR3;ARF1;EHD1;TBC1D22B;JAM3;UNC93B1;RRAGC;ARF4;EPB41L3;RRAGD;RAB20;NAPA;TBC1D9;AMOT;RAB5C;STX4;WDR45;RAB18;RAB31;HPS6;TBC1D10C;ERP29;CTTN;CAPN3;RAB6B;PTPRU;IFT27;TMED10;COPB2;AP2A1;STX1B
prerank,positive regulation of macroautophagy (GO:0016239),0.3563448050395513,0.9493458823330913,0.5701657458563536,0.83128819449149,1.0,8/48,9.63%,SLC25A5;PINK1;SLC25A4;BNIP3L;SCOC;KDR;HSPB8;DCN
prerank,regulation of lymphocyte activation (GO:0051249),0.45762830450095293,0.94908221135266,0.5641025641025641,0.8314456370791227,1.0,2/12,14.37%,DCAF15;IKZF3
prerank,peptidyl-lysine methylation (GO:0018022),-0.28565725667380454,-0.9485894053282488,0.5224719101123596,0.7982371793287875,1.0,14/26,27.55%,SETD2;SMYD3;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6;SMYD1;N6AMT1;ETFBKMT;SUV39H1
prerank,ceramide metabolic process (GO:0006672),0.3539982283217981,0.9485525208396537,0.5437219730941704,0.8321705676530557,1.0,15/49,22.53%,CERS2;ORMDL3;PPP2R1A;SMPD1;CLN6;SPTLC1;ST6GALNAC3;DEGS1;ABCA2;FA2H;CLN8;SPTSSA;ASAH2;SGPL1;ORMDL2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2545200866272406,-0.9485468312351154,0.5588235294117647,0.7967595502645294,1.0,11/46,21.01%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PLD2;PNPLA3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.30359654248524626,-0.948472985917872,0.5168539325842697,0.7953883610721751,1.0,9/24,19.49%,SORBS1;IRS1;INSR;IGF1;ENPP1;GSK3B;PASK;PPP1R3B;PPP1R3F
prerank,sodium ion transmembrane transport (GO:0035725),0.3374795944451191,0.9483741749021501,0.5976890756302521,0.8321487819718837,1.0,20/84,17.76%,ASIC2;SLC24A4;SLC24A2;SCN1A;ATP1A3;ATP1B2;SLC6A6;SLC6A17;SLC6A5;SLC6A2;SCN4B;SLC6A16;ATP1A4;ATP1A1;ATP1B1;SLC8A1;HCN1;HCN3;ATP1B3;SLC9A9
prerank,positive regulation of filopodium assembly (GO:0051491),-0.2959741005028011,-0.9480988062941008,0.5240641711229946,0.7948124022661792,1.0,4/24,3.56%,DPYSL3;DOCK11;BCAS3;NRP1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4010816085509778,0.9479575790844039,0.556390977443609,0.8326483939289903,1.0,8/22,25.38%,SPI1;EMC10;PRMT1;BMP2;NCF1;GADD45A;AGER;MFHAS1
prerank,positive regulation of cell differentiation (GO:0045597),0.3220746246039344,0.9479217499261842,0.6396396396396397,0.8323122952567339,1.0,62/237,20.17%,IFITM1;MDK;HSP90AB1;COL1A1;NBL1;AKT1;CD34;CTNNA2;LRRC8A;AGT;IGFBP3;ACVRL1;CDS1;ZFP36L1;DNAI3;BNIP2;ATP6AP1;CTNNB1;RARRES2;BTG1;BRINP3;CEBPB;NELL1;SLC6A6;NRCAM;KDR;CCN2;LPL;CAMK1;ZFP36;KITLG;LRP3;BRINP1;ATRAID;TMEM119;MSR1;BRINP2;BLOC1S5;SOX9;RHOA;GJA1;BMP2;FBXO5;SDCBP;MMD2;PCP4;RRAS;TIAM1;PF4;MAPK11;BEND6;VHL;TRIM32;TWIST1;DDR2;EDN3;SOX11;HGF;IL6;TGFB1;MEF2C;SFRP1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4158447931223487,0.9475897437091234,0.5564304461942258,0.8325777807042857,1.0,3/16,6.32%,LRRC8A;IGFBP3;BTG1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4086039342855132,0.9471415897460778,0.5391527599486521,0.833112107297588,1.0,4/18,12.34%,NLGN1;RIMS2;RIMS1;SYN1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4513670777887059,0.946463250704543,0.5391061452513967,0.8341657918294364,1.0,4/11,18.56%,NT5C3A;SLC19A3;SLC25A19;SLC19A2
prerank,lymphocyte differentiation (GO:0030098),0.34083657796613337,0.9460548165716494,0.5773305084745762,0.8346508464860158,1.0,24/68,26.79%,SLC25A5;LYL1;NFAM1;PTPRC;IL2;IKZF1;IL11;ZBTB7A;HDAC5;JAG2;HDAC9;VCAM1;PIK3CD;ADAM17;DNAJB9;TOX;FLT3;LFNG;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,endoderm formation (GO:0001706),0.3717312931409001,0.9458316250500852,0.580908032596042,0.8347029330154246,1.0,10/35,22.49%,VTN;ITGB2;FN1;COL6A1;SOX17;MMP14;INHBA;COL7A1;DUSP2;DUSP1
prerank,negative regulation of myotube differentiation (GO:0010832),0.45240675302802147,0.945620460009321,0.5612813370473537,0.8347321919589401,1.0,6/12,27.81%,BHLHE41;TMEM119;HDAC5;NOTCH1;CCN3;XBP1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3766328620887919,-0.9447848910897606,0.534965034965035,0.8001188054700846,1.0,5/11,23.89%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.3766328620887919,-0.9447848910897606,0.534965034965035,0.8001188054700846,1.0,5/11,23.89%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.39279799779276475,-0.9440106526833902,0.5296167247386759,0.8005727696926537,1.0,5/10,19.29%,ST6GAL1;GNE;RENBP;NPL;NAGK
prerank,positive regulation of protein import (GO:1904591),0.379119759351865,0.9435879846868932,0.5705521472392638,0.8386780495987184,1.0,5/30,7.50%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3489240577707024,0.9434476932669856,0.5772179627601315,0.8385645467138199,1.0,4/50,3.71%,RPS3;LAPTM5;CCL19;TNF
prerank,replication fork processing (GO:0031297),0.3658486721703469,0.9429261739983349,0.5823798627002288,0.8392504890279913,1.0,11/38,22.29%,NUCKS1;CENPX;PCNA;DDX11;BRCA2;TRAIP;MMS22L;ALYREF;FAM111A;CDK9;BLM
prerank,dicarboxylic acid catabolic process (GO:0043649),0.43848530930111734,0.9428723873035991,0.553072625698324,0.8389639577160318,1.0,6/13,21.67%,GLUL;ACOT4;GLUD1;GOT1;GAD1;MTHFS
prerank,regulation of nervous system development (GO:0051960),0.36356976365792376,0.9424098338690599,0.5803048065650644,0.8395150764378729,1.0,9/37,15.99%,CTNNB1;HES1;HES6;BHLHE41;TENM4;CX3CR1;PTPRZ1;HEY1;DLL1
prerank,cAMP-mediated signaling (GO:0019933),-0.292662450140448,-0.9416719520509683,0.5497382198952879,0.8047926216667984,1.0,7/24,11.31%,PDE7B;ADCY1;RAPGEF2;KSR1;PDE7A;RAPGEF3;DGKQ
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2920308859819782,-0.941565925426175,0.5502958579881657,0.8034947199020332,1.0,6/26,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,vesicle transport along microtubule (GO:0047496),-0.296269236123804,-0.9413554347440855,0.5435897435897435,0.8024356122792065,1.0,6/23,15.20%,TRAK1;PAFAH1B1;FBXW11;KIF13A;CLN3;NDEL1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.45254010955784424,0.9409541789136783,0.5607344632768362,0.8413982393347602,1.0,5/11,23.83%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.45254010955784424,0.9409541789136783,0.5607344632768362,0.8413982393347602,1.0,5/11,23.83%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.45254010955784424,0.9409541789136783,0.5607344632768362,0.8413982393347602,1.0,5/11,23.83%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,cellular senescence (GO:0090398),0.38723942405985434,0.9405546325163776,0.5685096153846154,0.8418233232715044,1.0,5/27,12.02%,CALR;SPI1;ECRG4;ULK3;HRAS
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.345610796761471,-0.9397711511777986,0.5313653136531366,0.8049744482982639,1.0,4/13,13.42%,SORBS1;IRS1;ECHDC3;SIRT1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4433043112471966,0.9397105464075428,0.5521557719054242,0.8431617157206381,1.0,6/12,27.73%,GART;PRPS1L1;PRPS1;PRPSAP1;ADSL;ADA
prerank,response to organic cyclic compound (GO:0014070),0.35010883407830723,0.9396894537952792,0.5852585258525853,0.842795910123629,1.0,14/52,21.30%,SPP1;TNF;IGFBP5;CTNNB1;TRPM2;PMAIP1;SLC1A1;PAQR7;CCL2;ABCA2;CCL3;TGFB1;SFRP1;FOXA1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33505687379437615,0.9395854057932215,0.6126609442060086,0.8425960437424124,1.0,22/75,25.01%,CALM1;RGS5;C3;GPER1;METAP1;YWHAB;RGS2;KLK6;METAP2;RGS12;RAMP3;SYP;FRMPD1;CNGB1;ADCYAP1;GIT1;PPEF1;RGS6;KCTD8;RGS4;PDE6G;RNF157
prerank,negative regulation of developmental growth (GO:0048640),0.38098387274039147,0.9395630123559364,0.5590361445783133,0.8422332254943975,1.0,6/30,15.84%,MT3;DCC;RTN4;MAP2;GDF15;FGF13
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3738615524265658,0.9395349141085019,0.5668639053254438,0.8418929100123262,1.0,12/30,20.17%,PTPRC;SBDS;KDR;CSF1R;FLT4;ARMC6;FLT1;INHBA;FLT3;MLF1;TGFB1;SFRP1
prerank,cardiac myofibril assembly (GO:0055003),-0.32681714161653597,-0.939455683453011,0.5742971887550201,0.8041296385681042,1.0,5/15,17.51%,NEBL;MEF2A;PDGFRB;OBSL1;PDGFRA
prerank,cellular response to arsenic-containing substance (GO:0071243),0.43089743075582104,0.9393750907210837,0.5497311827956989,0.8418322647551403,1.0,3/15,14.41%,VCP;GSTO1;HNRNPA1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3271980974885542,-0.9392447384755146,0.5230125523012552,0.8030929958344052,1.0,4/16,10.54%,AUTS2;KMT2A;BCOR;SMAD4
prerank,modulation by host of viral genome replication (GO:0044827),0.44597721877144963,0.9391604986237313,0.5557065217391305,0.841869140990365,1.0,5/13,21.78%,PPIB;NUCKS1;CCL8;VAPA;IFI27
prerank,7-methylguanosine RNA capping (GO:0009452),0.3789033903303871,0.9387544692100165,0.5901060070671378,0.8419112709695066,1.0,6/31,12.82%,POLR2E;POLR2D;POLR2F;POLR2G;CMTR1;POLR2K
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3789033903303871,0.9387544692100165,0.5901060070671378,0.8419112709695066,1.0,6/31,12.82%,POLR2E;POLR2D;POLR2F;POLR2G;CMTR1;POLR2K
prerank,sulfur compound biosynthetic process (GO:0044272),0.3276870452193002,0.9383855973069232,0.6167355371900827,0.8422766906896648,1.0,32/104,25.43%,BGN;BCAN;FMOD;GSTM1;LUM;MPST;MGST1;GSTO1;DCN;CHST1;B4GALT6;GSTM5;MGST3;GSTM2;CHPF2;CHPF;HPGDS;UGDH;VCAN;MAT2A;B3GNT3;AKR1A1;ESD;OPLAH;CSGALNACT2;CHSY3;ACAN;B4GALT3;CHST14;PRELP;CHST9;CSPG5
prerank,nucleoside catabolic process (GO:0009164),-0.37058647712835835,-0.9381244689772881,0.50814332247557,0.8044408838035568,1.0,6/11,14.98%,DPYD;UPP2;UPB1;DERA;NT5C1A;NT5M
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3068182431432422,-0.9380783285691363,0.5097087378640777,0.8030123831300678,1.0,2/21,3.64%,OSBPL8;PLA2G4A
prerank,substrate-dependent cell migration (GO:0006929),0.42162307300307456,0.9380737767234744,0.5681198910081744,0.8425383737418322,1.0,5/14,14.29%,PTPRC;NTN1;P2RY12;SHTN1;SDCBP
prerank,regulation of glucose metabolic process (GO:0010906),-0.2698257859030602,-0.9378252186846413,0.5133333333333333,0.8020906830553052,1.0,9/34,13.42%,PDK1;OGT;PRKN;IRS1;FOXK2;FOXK1;DGKQ;RORA;SIRT1
prerank,stabilization of membrane potential (GO:0030322),0.4214038294179603,0.9370988506413194,0.5597897503285151,0.8441417249435632,1.0,5/16,19.26%,CHCHD10;KCNK9;KCNK3;KCNK10;KCNK13
prerank,positive regulation of translational initiation (GO:0045948),0.4078831519714245,0.9369760506174772,0.572538860103627,0.8439966324930129,1.0,5/18,18.62%,POLR2D;UHMK1;POLR2G;YTHDF1;EIF2B5
prerank,regulation of macrophage differentiation (GO:0045649),0.44120306717446045,0.9368781983298595,0.5733157199471598,0.843790678755132,1.0,6/15,25.30%,C1QC;PF4;INHBA;ID2;PRKCA;INHA
prerank,osteoclast differentiation (GO:0030316),0.3904024833834887,0.9368208398263523,0.5670498084291188,0.8435159786281772,1.0,7/22,19.49%,TYROBP;TREM2;GLO1;CSF1R;OSTM1;OSCAR;GPR183
prerank,synaptic membrane adhesion (GO:0099560),-0.343271666550132,-0.936358143432015,0.5588235294117647,0.8041179592326417,1.0,2/14,1.97%,GPC6;GPC4
prerank,gonad development (GO:0008406),0.3625892613458653,0.9358833484247903,0.5888382687927107,0.845076853239534,1.0,15/41,29.19%,BASP1;KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK;IRX5
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3576758225773849,0.9356088459470072,0.6121495327102804,0.8452455268830066,1.0,11/43,20.07%,SOX18;NDRG4;APLNR;HES1;TBX22;SOX17;RYR2;DLL1;GATA4;NOTCH1;MEF2C
prerank,serine family amino acid catabolic process (GO:0009071),0.4563859772856474,0.9354193556259192,0.5493741307371349,0.8452697900434021,1.0,5/10,34.77%,SDS;SHMT2;DLD;THNSL2;GCSH
prerank,negative regulation of cholesterol transport (GO:0032375),0.4546123105528321,0.9352537961953451,0.5632022471910112,0.8452018118721655,1.0,3/10,25.65%,APOC1;ABCA2;ABCG5
prerank,response to glucagon (GO:0033762),-0.31864030223515605,-0.9352440301058995,0.5387931034482759,0.8054513602534281,1.0,3/19,2.23%,ADCY9;ADCY1;ADCY5
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3600203549335791,-0.9349172672283353,0.48951048951048953,0.8047556550919586,1.0,4/11,19.26%,ITPKB;IP6K2;PPIP5K1;FGF2
prerank,regulation of RNA splicing (GO:0043484),0.33702559676778654,0.9345763421344639,0.6182396606574762,0.8462193945041419,1.0,11/69,13.09%,RPS13;RPS26;TMBIM6;HNRNPK;QKI;AHNAK;PQBP1;RRP1B;KHDRBS3;FAM50A;HSPA1A
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4621139547642605,0.9337456165827549,0.5613540197461213,0.8475109817349284,1.0,1/10,1.79%,SOD1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3222414970069546,0.9332343983383297,0.621840242669363,0.8481628088467529,1.0,16/132,9.82%,APOE;HSP90AA1;LAPTM5;PNPLA2;TNF;TMEM59;ORMDL3;PRR5L;MSN;LIN28B;P2RX7;MTLN;PTTG1IP;MLXIPL;DCN;HMGB1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.44764034422511245,0.9330085076720362,0.576072821846554,0.848264569057082,1.0,5/12,28.23%,MCM5;MUS81;CDC45;MCM7;MCM2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.31100483991885713,-0.9329860878397135,0.5695067264573991,0.8081569370836458,1.0,6/18,14.01%,SMAD3;ITGB8;LTBP1;SMAD4;CD46;LGALS9
prerank,negative regulation of cell cycle process (GO:0010948),-0.23481885179258227,-0.932890447403635,0.6338028169014085,0.8068391628175283,1.0,15/61,14.95%,TOM1L2;MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;WAPL;RBBP8;TFDP1;TERF2;BMP4;NME6;EHMT2;EZH2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.34323672003949446,-0.932715465395816,0.5263157894736842,0.8056944703890505,1.0,5/13,17.26%,PTGIS;PARP9;PARP16;PARP10;NUDT12
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.40875269824534544,0.9325418513406659,0.5739130434782609,0.8488532979551204,1.0,7/19,28.55%,TNFAIP3;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,Golgi localization (GO:0051645),-0.353391671320057,-0.932359579593115,0.5141843971631206,0.8050466044043474,1.0,2/11,5.32%,ARHGAP21;UVRAG
prerank,dicarboxylic acid transport (GO:0006835),0.3777959816787576,0.9318958197675162,0.5822485207100592,0.8498106695647976,1.0,8/28,19.06%,SLC1A2;SLC25A13;SLC1A1;SLC25A22;GJA1;SLC19A1;FOLR2;SLC25A18
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.380901697768266,0.931803010670843,0.5804111245465539,0.8495886476915138,1.0,4/26,9.13%,ACADVL;APOC1;MID1IP1;MLXIPL
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.23236024900323252,-0.9317718195366281,0.6935483870967742,0.8049657162954221,1.0,12/69,10.41%,GAB2;PLCE1;PI4KA;PITPNM2;OGT;IRS1;PLCL1;PLCD3;IGF1;PDGFRB;PTEN;NGF
prerank,cardiac muscle cell differentiation (GO:0055007),0.3973899386147531,0.931703976633794,0.5708908406524467,0.8493966830613566,1.0,7/21,15.37%,NRG1;ALPK2;KDM6B;MYH11;IRX3;BMP2;SLC8A1
prerank,protein import into nucleus (GO:0006606),0.3337489531613547,0.930748325481277,0.6032608695652174,0.8510319746896184,1.0,12/66,18.25%,RPL23;AKT1;RAN;FAM53C;PTTG1IP;IPO4;NUP85;NUP88;SPRN;EIF4ENIF1;SYK;NUP50
prerank,canonical Wnt signaling pathway (GO:0060070),-0.23594363047894995,-0.9303678409590249,0.5857142857142857,0.8068947015588598,1.0,19/68,16.63%,TCF7L2;LRRK2;PLPP3;LRP5;LRP6;CSNK1A1;FZD6;RARG;AXIN1;WNT5B;BCL9L;PTEN;WNT16;DVL3;WNT11;GSK3B;WNT4;WNT9A;RYK
prerank,B cell homeostasis (GO:0001782),0.453351422416661,0.9297981201517792,0.574792243767313,0.852611657206699,1.0,5/10,24.10%,TNFAIP3;DOCK10;MEF2C;PPP2R3C;TNFRSF13B
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.36297552841911895,0.9291953866315584,0.5766081871345029,0.8534652847685871,1.0,18/35,33.19%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ;AURKB;HNRNPA2B1;ACD;PKIB;CCT6A
prerank,generation of neurons (GO:0048699),0.3148147502947284,0.9291554801442615,0.683049147442327,0.8531210345267416,1.0,49/190,23.67%,ITM2C;TAFA1;RAC1;NTRK2;PIN1;CTNNB1;ADGRL3;SPOCK1;HES1;HES6;NRCAM;IL1RAPL1;MAPT;TUBB2B;CDK5R1;BHLHE41;DNER;WNT5A;ELP3;PTPRD;IRX3;CCK;WNT10B;CX3CR1;CDK5;HEY1;FGF13;OLIG1;DLL1;MYEF2;FUT9;BRSK2;TUBB2A;ERCC6;GPM6A;MYT1L;BTG4;ACSL3;SOX11;DCX;DDIT4;MEF2C;MAP1B;FZD2;FZD1;IER2;WNT7A;ACSL4;PLXNB2
prerank,cell-cell junction organization (GO:0045216),0.3295409516371771,0.9289654092873465,0.6118769883351007,0.8531288028916505,1.0,20/79,19.84%,CLDN5;GJA4;CADM2;ANG;CDH20;MYADM;CDH18;CSF1R;CADM3;CDH12;CDH19;DCHS1;F2RL1;CDH7;CDH24;CDH10;CDH5;CTNND2;TGFB1;MARVELD2
prerank,regulation of mitochondrial fusion (GO:0010635),0.44549942136742565,0.928599658160958,0.5645390070921986,0.8535341167796198,1.0,3/11,6.55%,VAT1;TFRC;OMA1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.457420400898227,0.9285177602515841,0.5789473684210527,0.8532823485888182,1.0,4/10,26.20%,WNT5A;ADAM17;CCR2;OXSR1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3120020669715048,-0.9283615276369982,0.5204081632653061,0.8102426703888566,1.0,3/20,3.29%,CAMK2D;ACTN2;PRKCE
prerank,negative regulation of signal transduction (GO:0009968),0.31332678395450164,0.928294369805106,0.687374749498998,0.853326726490695,1.0,64/249,20.17%,RACK1;APOD;CALR;DCC;LGMN;AKT1;TMBIM6;AGT;IGFBP3;TNF;YWHAB;PTPRC;IGFBP5;GRB14;NDRG4;RGS2;VCP;SFRP5;TNFAIP3;LRPAP1;ARRDC1;PTK6;LEPROT;NTN1;CADM4;GATA2;DCN;SMPD1;KIF26A;PDCD6;ULK3;ZBTB7A;FBXW7;SPRY1;BMP2;NLRP2B;SFRP4;CX3CR1;GDF15;MAPK8IP2;HEY1;SIGIRR;BEND6;DLL1;EGFL7;DACT3;DAB2IP;TYRO3;GATA4;GLIS2;PTGIR;APCDD1;MMP14;TMBIM1;ERBB3;NOTUM;SRMS;MAZ;QARS1;SNCA;HIC1;SPRY3;DDIT4;SFRP1
prerank,membrane protein proteolysis (GO:0033619),0.3639332489367057,0.9281203687185766,0.5882352941176471,0.8532563780301496,1.0,15/37,25.94%,TMPRSS6;PSENEN;SPPL2B;CTSH;NAPSA;BACE1;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;ERAP1;RELA;APH1A;PRKCQ
prerank,positive regulation of response to stimulus (GO:0048584),0.3627025855580307,0.9276140263452172,0.5805714285714285,0.8538413856530371,1.0,9/40,21.22%,B2M;YPEL3;TAF9;WNT5A;NSMCE1;IER5;SELENON;MYC;RSAD2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.399994616406741,0.9268716566132257,0.5830164765525983,0.8549532478622845,1.0,4/21,8.99%,CD81;NFAM1;SLC39A10;CD22
prerank,positive regulation of receptor internalization (GO:0002092),0.38966215756410283,0.9266856322684232,0.5716034271725826,0.85493183351019,1.0,3/22,15.91%,CD63;SFRP4;ARRB2
prerank,snRNA processing (GO:0016180),-0.33605546259326313,-0.9266508903720864,0.5584415584415584,0.8128864886142202,1.0,5/16,18.66%,INTS8;INTS6;TUT1;INTS3;INTS11
prerank,positive regulation of nervous system process (GO:0031646),0.4044517769515687,0.9265114422142968,0.5795006570302234,0.8549039516927258,1.0,5/18,12.91%,RIMS2;RIMS1;MYRF;TENM4;HCRT
prerank,negative regulation of centrosome duplication (GO:0010826),0.4450168086510191,0.9261865647836643,0.5708092485549133,0.8551655966912979,1.0,1/11,3.04%,NPM1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4246146743829462,0.9258523155224779,0.5813953488372093,0.8554404186743273,1.0,4/13,21.55%,CPE;RYR2;NOTCH1;NPY5R
prerank,inner dynein arm assembly (GO:0036159),0.45280137064802806,0.9256208966848901,0.5738161559888579,0.8554984075831324,1.0,2/10,11.99%,DNAI3;DNAH1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3450472421309644,0.9254023203362516,0.594475138121547,0.8555304391003694,1.0,9/49,13.76%,ERBB4;TNF;HCLS1;ARL2BP;HES1;PTK6;IL2;CSF1R;TNFRSF1A
prerank,positive regulation of organelle assembly (GO:1902117),0.35169596050076013,0.9248891545948955,0.6,0.8561514338845189,1.0,10/44,15.60%,IL5;TNF;KCTD17;LCP1;SDC4;CAPG;CCDC88A;SDCBP;G3BP1;G3BP2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.2907747195549778,-0.9242893187146359,0.5779816513761468,0.8169391231408313,1.0,5/23,11.01%,TGFBR3;ADAMTS9;FGFR2;SMAD7;TPM1
prerank,negative regulation of DNA recombination (GO:0045910),0.34988852642211393,0.9239202738324263,0.608843537414966,0.8577450173533356,1.0,11/43,22.29%,POLR2E;POLR2D;TERF1;POLR2F;H1-0;POLR2G;POLR2K;TERF2IP;POLR2H;RADX;BLM
prerank,telomere capping (GO:0016233),0.4089002958979036,0.9236117239773205,0.5830013280212484,0.8579740809008182,1.0,4/16,18.53%,TERF1;DCLRE1C;CTC1;TERF2IP
prerank,cellular response to insulin stimulus (GO:0032869),0.32001490751556333,0.9234394542378064,0.6560574948665298,0.8579222378574669,1.0,31/124,22.64%,ATP6V0C;AKT1;ATP6V1F;PKM;GRB14;ZFP36L1;ATP6V1G1;CAV2;PARP1;ATP6AP1;ATP6V0E2;PDE3B;RARRES2;RAB15;NAMPT;MYO5A;VAMP2;ATP6V0D2;HDAC5;SH2B2;IGF2;HDAC9;EPRS1;RAB31;SOS1;GOT1;C2CD5;SELENOS;INHBB;ATP6V1A;ATP6V0A1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3431772901921735,0.9230962145877266,0.6086474501108647,0.8582303672531361,1.0,19/51,26.23%,MAPK3;TERF1;CCT2;CTNNB1;CCT7;CCT8;HNRNPU;HNRNPA1;CTC1;MAPK15;GNL3L;MAP2K7;CCT4;NAF1;PNKP;CCT3;PIF1;PRKCQ;HNRNPC
prerank,cellular response to mechanical stimulus (GO:0071260),0.34121311688802214,0.9230202655193173,0.5894263217097863,0.8579810492178366,1.0,14/46,25.85%,MAPK3;CNN2;AQP1;TMEM150C;SOX9;TNFRSF1A;BAD;TLR5;LTBR;BAK1;GADD45A;PDE2A;CASP1;TLR7
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.33063797486155916,0.922990378715747,0.6332622601279317,0.8576397674453756,1.0,14/87,14.41%,POLR2E;MAPK3;POLR2D;POLR2F;ZFP36L1;ZFP36L2;HYAL2;RAB14;ZFP36;POLR2G;FGFRL1;POLR2K;CCL2;HNRNPA1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3833050459122248,0.9220393133138205,0.5757946210268948,0.8591769621133512,1.0,4/22,10.02%,MDK;ZFP36L1;EPPK1;ZFP36
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2840722808144387,-0.9217276396561074,0.6263157894736842,0.8216165346651928,1.0,7/23,21.09%,WEE1;PRCC;PABIR1;CHFR;INTS3;PLK2;ZWILCH
prerank,neuromuscular synaptic transmission (GO:0007274),0.4006573307324627,0.9215742870063295,0.5935897435897436,0.8596957719679023,1.0,8/18,24.52%,ERC2;CHAT;DTNA;STAC3;RIMBP2;CHRNA3;SLC5A7;TBC1D24
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4531521048831042,0.9215740395776572,0.5901408450704225,0.859288333213415,1.0,5/11,35.81%,PKD2L1;LPO;RTP3;PKD1L3;RTP4
prerank,regulation of intracellular signal transduction (GO:1902531),0.30651153640799533,0.9214831097954238,0.769,0.8590662521094966,1.0,103/420,20.94%,TMSB4X;RPL11;RPL5;ARHGDIA;HSPB1;RHOB;MAPK3;AKT1;A2M;RCN3;NLGN1;AKAP6;TREM2;CSNK2B;IER3;TNF;RHOC;MBD3;ARHGAP25;RAC1;NTRK2;CHEK2;PEX5L;PIN1;ARHGAP9;RPA2;ARHGDIB;RHOG;HIPK2;TTC5;BRPF1;CLEC6A;ARHGEF4;SGK1;PAK1;ARHGAP15;TAF10;PRKAR1A;MAPT;NET1;SLC15A4;CD24;CDK5R1;RHOV;PIP4P1;ARHGEF7;PAK3;TAF9;ARAP3;ARHGDIG;GNAI1;PRKAR1B;WNT5A;ATP6AP2;SSRP1;TAGAP;PHLPP1;CCNG1;MCF2L;VAV1;RHOA;RFC2;ARHGAP45;DEPDC7;RHOU;VAV3;ABR;STK11;PRR5;RRAS;TIAM1;F2RL1;L3MBTL1;TRAF3;MAPK11;RRAGC;SLC15A2;DLC1;CDK5;DAB2IP;GATA4;SQSTM1;PRKAR2B;RAC2;FAM83D;NOP53;MTA2;ARHGEF19;TBP;LBH;SOS1;ING5;CHD3;POU4F1;DDIT4;RFC4;SPHK2;ARHGAP33;CAPN3;ARAP2;NFKBIA;PAK5;PYCARD
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4107722468268089,0.9214029889795111,0.5879265091863517,0.8588223056016688,1.0,5/16,16.07%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,regulation of fat cell differentiation (GO:0045598),0.33219279636022403,0.9210938662169954,0.620616365568544,0.859029548754271,1.0,17/74,13.56%,AKT1;CCDC85B;GPER1;TNF;NR1D1;CDS1;ZFP36L1;ZFP36L2;RARRES2;CEBPB;LPL;GATA2;ZFP36;LRP3;WNT5A;BMP2;WNT10B
prerank,sensory organ development (GO:0007423),-0.24127524064780964,-0.9207566429808939,0.6631578947368421,0.8224010788149652,1.0,4/51,2.84%,PBX1;SMOC1;PBX3;SHROOM2
prerank,diol biosynthetic process (GO:0034312),0.41917886933876114,0.9206549815277761,0.5889029003783102,0.8595274438143935,1.0,6/15,21.11%,SPR;QDPR;SPTLC1;ABCA2;SPHK2;ASAH2
prerank,peptidyl-methionine modification (GO:0018206),0.43993276261500747,0.9205849262890833,0.5691056910569106,0.859263877168651,1.0,4/12,19.99%,METAP1;METAP2;PDF;NAA25
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.39727519918051113,0.9203492958962123,0.5912698412698413,0.8593462176544099,1.0,2/19,3.71%,CLDN5;TNF
prerank,cellular response to drug (GO:0035690),0.3785157193672702,0.9200716120993567,0.5899632802937577,0.8595096922605359,1.0,9/25,28.27%,PDE4B;TFRC;GAS6;MEF2C;MYC;PPM1F;REST;KCNQ1;RAP2A
prerank,cellular response to misfolded protein (GO:0071218),0.38898768841937464,0.9197168153209804,0.5986928104575163,0.859780326706229,1.0,2/20,5.80%,AUP1;VCP
prerank,amino acid transmembrane transport (GO:0003333),0.35053244723055066,0.9193101209375845,0.6038374717832957,0.8601914318430843,1.0,14/45,25.62%,SLC38A5;SLC7A5;SLC25A13;TSPO2;SLC6A6;SLC3A2;SLC25A22;SLC38A10;SLC25A18;MFSD12;SLC7A10;SFXN1;SLC7A6;SLC38A3
prerank,heart trabecula morphogenesis (GO:0061384),0.398543706356088,0.9192689930362681,0.5861182519280206,0.8598686108556083,1.0,4/18,5.77%,NRG1;RBP4;FKBP1A;S1PR1
prerank,nuclear body organization (GO:0030575),-0.34583792723727946,-0.9192068283945335,0.5709342560553633,0.8245956064646195,1.0,4/12,13.51%,USP50;PML;AFF2;SRPK2
prerank,regulation of insulin secretion (GO:0050796),0.3216761975027399,0.9190688177762927,0.6455958549222798,0.8598973488662741,1.0,32/101,23.48%,UQCC2;MTNR1B;SLC2A1;SNAP25;RBP4;TRH;LRRC8A;GPER1;TNF;NR1D1;CACNA1A;EPHA5;CHGA;ABCC8;BAD;SLC2A2;BRSK2;NOS2;DOC2B;GLUD1;TFAP2B;IL6;NNAT;FOXA2;SFRP1;KCNC2;INHBB;CCN3;REST;CACNA1E;PSMD9;ACSL4
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2139884899199902,-0.9190238109548149,0.72,0.8235744398479886,1.0,20/80,16.16%,SNX6;DENND2A;VPS54;SGSM2;VTI1A;SNX12;DENND5A;SPAG9;STX16;ANKFY1;GBF1;TRAPPC10;TBC1D23;TMEM87B;RIC1;SNX2;WASHC1;VPS50;SNX1;HEATR5B
prerank,fatty acid metabolic process (GO:0006631),0.319057507514942,0.9189071567370746,0.6485097636176773,0.8597974339412426,1.0,46/115,34.98%,GPX4;GPX1;NUDT19;LIPG;LPL;ALKBH7;FASN;OXSM;ACOT1;ACOT7;CRAT;ALOX5AP;NAAA;ACOT4;FA2H;FAAH;LTC4S;PPARGC1A;ACSL3;THEM4;SGPL1;ACSM5;ADIPOR1;NDUFAB1;ACSL4;ACLY;PON2;ACAD9;GPAM;XBP1;HSD17B8;GGT5;CYP4B1;AOAH;ABCD2;PNPLA8;ELOVL4;GNPAT;CEL;ACOX1;ACSF3;CD36;ADIPOR2;CPT1B;PEX2;PLA2G15
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.3675839912637535,-0.9185620506997073,0.5562913907284768,0.8232429698747388,1.0,3/10,13.24%,PARD3;PRKD3;PLPP1
prerank,mRNA catabolic process (GO:0006402),0.3485842935946135,0.9182561637995469,0.6067415730337079,0.8607261352470544,1.0,15/44,25.42%,LSM6;HSPA1B;ZFP36L2;ZFP36;RNH1;HSPA1A;PDE12;NUDT16;NANOS2;AGO1;EXOSC9;EXOSC4;LSM5;METTL3;PNPT1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.28689872707294206,-0.9180600432646226,0.5988372093023255,0.8230285913451312,1.0,12/27,20.34%,SMG6;PARP4;NIBAN2;PDGFRB;TERF2;ATM;SMOC2;PINX1;BMPR2;FGF2;PRKD2;TOM1L1
prerank,neuron migration (GO:0001764),0.3498047010746324,0.9179988700335269,0.6109289617486339,0.8608275988913328,1.0,18/48,20.37%,RAC1;NTRK2;ADGRL3;SPOCK1;NRCAM;TUBB2B;CDK5R1;DNER;ELP3;CCK;CDK5;FGF13;TUBB2A;GPM6A;DCX;DDIT4;MEF2C;MAP1B
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.44765675079214895,0.9176446056653778,0.599721059972106,0.8611346606959958,1.0,4/11,15.64%,FZD9;SLC25A4;NUPR1;YBX3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31402767288136263,0.9174381348288164,0.6547131147540983,0.8611481153874064,1.0,34/129,20.35%,PSMB4;COL1A1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;PSMA7;PSMD5;LGR6;PSMB9;PSMD13;GPC5;PSMB3;ATP6AP2;PSMB11;PSMB10;SFRP4;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;PSMA6;TGFB1;SFRP1;PSMA4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.33662122607622547,0.9172083660820288,0.6241830065359477,0.8612122474875694,1.0,9/57,10.71%,ERBB4;TNF;HCLS1;ARL2BP;PPP2R1A;HES1;PTK6;IL2;CSF1R
prerank,cilium organization (GO:0044782),-0.2002958835119859,-0.9168470554832647,0.6666666666666666,0.8245033767008102,1.0,78/209,26.76%,PARVA;ASAP1;DCDC2;CC2D2A;EXOC4;CYS1;GALNT11;BBS9;ATP6V0D1;EXOC2;WDPCP;PCM1;ARL3;TTLL3;CCDC66;CDC14A;DZIP1L;PIBF1;CEP290;OFD1;IFT88;CCDC57;FAM161A;GBF1;DYNC2H1;NPHP3;ABLIM1;PKD1;CFAP44;WDR35;CEP162;CEP89;PDE6D;IFT140;INTU;IFT122;WDR11;CLUAP1;WDR19;DYNC2I2;CEP78;AVIL;TTC17;CEP41;RFX3;CEP19;TCTN2;POC1B;RAB8B;PKD2;CDC14B;CFAP70;CPLANE2;RTTN;RFX2;TMEM138;IFT80;IFT81;RAB1A;TMEM231;FOXJ1;RILPL2;CFAP61;CCDC65;MNS1;IFT52;RAB3IP;TEKT2;MAK;PTPDC1;EXOC1;RILPL1;CFAP43;BBS5;ARL13B;CFAP52;KIF3B;SNX10
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.4217728098206585,0.9168250231412561,0.6021505376344086,0.8615903587079993,1.0,4/14,12.35%,IGFBP3;IGFBP5;NDRG4;AIF1
prerank,lamellipodium organization (GO:0097581),0.3656854169356751,0.9160765996745,0.5822942643391521,0.8626588593792044,1.0,9/29,21.09%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN;CTTN;PTPRO
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.40954039950642135,0.9159182267470395,0.5846153846153846,0.8625694238380558,1.0,7/16,19.86%,HSPA5;GABARAPL2;RYR2;BCAP31;PPP1R15A;DDRGK1;VAPA
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.369242865089025,-0.9157330836447737,0.56,0.8256390007250628,1.0,2/10,2.44%,SOX5;ZBTB16
prerank,heart looping (GO:0001947),0.3532102130100011,0.9152334481602372,0.6184834123222749,0.8635494025400536,1.0,13/39,28.21%,SOX18;NDRG4;APLNR;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C;SRF;VANGL2;ENG;TBX2
prerank,meiosis I (GO:0007127),-0.292722093207594,-0.9151514693511231,0.5671641791044776,0.8254967884146819,1.0,9/23,25.97%,MYBL1;BCL2L11;ING2;ZCWPW1;ZSCAN21;SYCP3;SGO1;FOXJ3;MEIOB
prerank,body fluid secretion (GO:0007589),0.4144693896587107,0.915130834340002,0.5852660300136425,0.8633666915641239,1.0,1/15,2.95%,ERBB4
prerank,potassium ion transport (GO:0006813),0.31574822223227406,0.9147028484778529,0.678974358974359,0.863828973711617,1.0,29/120,19.69%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;AQP1;KCNC1;KCNA2;KCNN2;ATP1A4;KCNK9;ABCC8;KCNF1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNMA1;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3571159311043748,0.9147004914191186,0.6029919447640967,0.863430097578185,1.0,10/35,19.48%,KCTD10;RASIP1;STMN3;TNFAIP1;SPRY1;STMN1;DLC1;DAB2IP;KCTD13;SPRY3
prerank,protein export from nucleus (GO:0006611),-0.27767641548303823,-0.9146184621444832,0.5815217391304348,0.8252861016596562,1.0,12/27,17.19%,RANBP3L;SMURF1;DUSP16;NUTF2;PKD1;RANBP17;XPO4;XPO7;CCHCR1;CSE1L;NUP214;STRADB
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3202398548112785,0.9145255339215657,0.6649431230610134,0.8633773616917279,1.0,12/104,7.22%,RPS27A;UBC;UBB;NBL1;FKBP1A;PIN1;SORL1;EID2;HIPK2;WFIKKN2;UBA52;STRAP
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.41985344038348915,0.9144141145060296,0.5935828877005348,0.8631818858662489,1.0,5/14,26.20%,WNT5A;CCL3;ADAM17;CCR2;OXSR1
prerank,regulation of actin filament-based process (GO:0032970),0.3343738168994844,0.914310289854717,0.6381578947368421,0.8629825022126413,1.0,19/70,17.41%,RHOB;CNN2;RHOC;RAC1;GPM6B;IQGAP2;RHOG;FAM107A;CORO1A;PAK1;EPHA5;PAK3;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN;RAC2
prerank,regulation of cell cycle process (GO:0010564),0.31852781892517396,0.914229836859206,0.6507772020725389,0.8627365103545052,1.0,27/104,26.14%,CALM1;CALM3;GPER1;KLHL9;PIN1;CAV2;CTNNB1;USP51;ATF5;SOX9;FBXO5;SND1;L3MBTL1;NUDT16;CETN2;CALM2;GIT1;SFRP1;CCP110;IHO1;CCDC8;NUGGC;ECT2;RCC1;CDKN2B;KIF20B;KLHL21
prerank,sphingolipid catabolic process (GO:0030149),0.4068893907847415,0.9139451005463853,0.6018396846254928,0.862912158184152,1.0,5/15,21.68%,ENPP2;SMPD1;SMPDL3A;ASAH2;SGPL1
prerank,regulation of metal ion transport (GO:0010959),-0.31205483169150616,-0.913915323772263,0.5964125560538116,0.8255186484029332,1.0,6/16,14.26%,ANK2;SLC30A10;DLG1;IL16;BCL2;STIM1
prerank,epidermis development (GO:0008544),0.3411737658156321,0.9138073763845765,0.6359696641386782,0.8628107670895083,1.0,17/56,31.95%,GJB5;FABP5;CCN2;YBX1;LAMC2;KRT9;EVPL;DLL1;COL7A1;GRHL2;ATP2A2;PLOD1;PTHLH;POU2F3;ATP2C1;ALDH3A2;EMP1
prerank,regulation of response to interferon-gamma (GO:0060330),0.41553080672572407,0.9135349088394505,0.6080729166666666,0.8629272376178614,1.0,5/14,23.58%,HSP90AB1;CDC37;IFNGR1;IFNGR2;SOCS3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4331832806261998,0.9131453447664449,0.5895020188425303,0.8629205325378053,1.0,2/12,3.99%,PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4331832806261998,0.9131453447664449,0.5895020188425303,0.8629205325378053,1.0,2/12,3.99%,PRNP;HOMER2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.40392153018770627,0.9130823202200847,0.578042328042328,0.8622345874080047,1.0,4/16,7.14%,APOD;ACVRL1;FAM107A;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.40392153018770627,0.9130823202200847,0.578042328042328,0.8622345874080047,1.0,4/16,7.14%,APOD;ACVRL1;FAM107A;CORO1C
prerank,regulation of cytoskeleton organization (GO:0051493),0.3187950954133497,0.9129838227669407,0.65439672801636,0.8620247131399541,1.0,25/108,16.20%,RHOB;MAPK3;RHOC;RAC1;S100A9;S100A8;GPM6B;STMN3;IQGAP2;RHOG;FAM107A;CORO1A;PAK1;P2RX7;CLASP1;MAPT;CDK2AP2;EPHA5;PAK3;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3737024376274266,0.91272195537919,0.5992865636147443,0.8621068408938671,1.0,6/27,18.08%,NME1;AK4;NME4;NME2;NME3;GUK1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.24376924987956652,-0.9124468914619238,0.6203703703703703,0.8275544013407135,1.0,18/45,22.35%,EGFR;NFKB1;DYRK1A;RIPK1;HEATR1;SETX;POLR2A;BMP4;ZC3H18;DIMT1;SIRT7;TP53;WDR43;SUPV3L1;BUD23;RBM20;DXO;PIK3R1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3407344731539298,-0.9124175255878191,0.5719557195571956,0.8260955431483652,1.0,2/13,3.19%,CACNA1C;ANK2
prerank,regulation of isotype switching (GO:0045191),-0.3405435193195273,-0.9122966055541106,0.569620253164557,0.8248412931384671,1.0,4/14,7.38%,KMT5C;PARP3;KMT5B;SHLD1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.41571058858712606,0.9110285184905759,0.5699208443271768,0.864945971335984,1.0,3/14,14.26%,GPER1;ECSCR;CCL2
prerank,mismatch repair (GO:0006298),-0.27035953402807394,-0.9108068868850525,0.5977011494252874,0.8268940341699395,1.0,6/27,8.98%,ABL1;SETD2;MLH3;MLH1;MSH3;TDG
prerank,response to interleukin-1 (GO:0070555),0.3305219911993873,0.9106647508277491,0.6475054229934925,0.8652675751205926,1.0,21/73,26.21%,CCL19;NR1D1;TLE5;SIRPA;HYAL2;TAF9;SMPD1;SOX9;CCL2;MAPK11;DAB2IP;CCL3;CCL8;SNCA;SFRP1;PYCARD;RELA;TNFRSF11A;APP;PRKCA;CX3CL1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3602860909038962,0.9106165726653307,0.6180722891566265,0.8649590957272717,1.0,7/33,15.99%,S100A1;KLF2;PKM;GLUL;EPN1;KLF4;DLL1
prerank,cellular response to nutrient levels (GO:0031669),0.33388394629213997,0.909947915626555,0.6457204767063922,0.8658687925654581,1.0,15/62,21.55%,HSPA8;MAP1LC3B;MAP1LC3A;FADS1;FAM107A;MFSD2A;LPL;CD68;RRAGC;RRAGD;LAMP2;WDR45;SFRP1;RALB;INHBB
prerank,regulation of bone mineralization (GO:0030500),0.33549642004367236,0.9096939303976613,0.6124454148471615,0.8659588731851401,1.0,19/55,20.07%,FZD9;ECM1;GPM6B;S1PR1;ISG15;NELL1;P2RX7;SRGN;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;CCL3;TWIST1;DDR2;NOTUM;TGFB1;MEF2C
prerank,regulation of blood circulation (GO:1903522),0.3613937870251922,0.9096052823802266,0.6351039260969977,0.8657276496055653,1.0,7/34,14.60%,S100A1;FXYD1;AGT;ADORA3;PLN;DES;KCNE5
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4096110066713863,0.9094056169073622,0.5802631578947368,0.8656941537378987,1.0,4/15,20.57%,NLGN1;HAP1;ADRA1A;ZDHHC12
prerank,metallo-sulfur cluster assembly (GO:0031163),0.38611072342591873,0.9093967510163584,0.6201743462017435,0.865312722530508,1.0,9/22,28.68%,GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B;HSCB;CIAO3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.32431883024747615,-0.9091860679693495,0.5919117647058824,0.829301166174062,1.0,1/14,0.47%,ZEB1
prerank,cellular response to alkaloid (GO:0071312),0.40357015233649873,0.9091560969574126,0.609254498714653,0.8653772140369844,1.0,6/17,25.76%,TGM2;GSTM2;SLC8A1;RYR2;BLM;RAD51
prerank,negative regulation of cell aging (GO:0090344),-0.3303586405744714,-0.9080886872082168,0.6101694915254238,0.8304857599661537,1.0,7/16,13.42%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,phosphatidylserine metabolic process (GO:0006658),0.35750447721624007,0.9075802204777358,0.607773851590106,0.8680548282547547,1.0,8/32,25.29%,SERINC1;PLAAT3;PLA2G4F;PTDSS1;SERINC5;ABHD16A;PLA2G3;ABHD12
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2999817867405393,0.907501376470335,0.809,0.8678069653060325,1.0,121/497,22.16%,MRPL13;RPS3;HSPA8;PFDN5;RACK1;GAPDH;DBI;RPL13A;CALR;MT3;NDUFA13;TMPRSS6;S100A11;ID3;SOX18;NRG1;ID1;CRYAB;TERF1;EID1;CCDC85B;TNF;PDGFB;NR1D1;ACVRL1;IGFBP5;NCL;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;GMNN;ARID4A;TRIM28;FOXL2;CREBZF;CEBPA;PROX1;BASP1;RBM15B;YBX1;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;CTBP1;WNT5A;PCIF1;ATF5;L3MBTL4;ZBTB7A;BCL7A;SOX8;MAEL;SNW1;NCOR2;THRA;KLF4;SOX9;YWHAQ;BMP2;GAS6;FOXS1;HDAC5;ZC3H8;HEXIM1;NONO;L3MBTL1;SAMD11;NR1H2;CDK5;HEY1;ENC1;EIF4A3;DAB2IP;HDAC9;TCEAL7;PAX9;GLIS2;TWIST1;EIF4ENIF1;NANOS2;RLIM;ZHX1;COMMD7;CIR1;QARS1;EPRS1;CCAR2;ZBTB14;LBH;TFAP2B;NOTCH1;BEND5;TGFB1;CITED2;SFRP1;SAMD1;CAPN3;PUS7;CBX3;TFAP4;ID2;DDIT3;SIRT2;SELENOS;IGF2BP3;SUDS3;DACH1;MEN1;PPM1F;REST;EIF4E2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.33371800884298275,0.907294571655922,0.6259625962596259,0.8678189234783041,1.0,16/52,19.59%,AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;GNAI1;RAMP3;CLIP3;EPB41;SQSTM1;STX4;STAC3
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3571427959755399,-0.9062648967123896,0.5567765567765568,0.8318671490611287,1.0,5/11,19.22%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3571427959755399,-0.9062648967123896,0.5567765567765568,0.8318671490611287,1.0,5/11,19.22%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32838694397117624,0.9062224776221258,0.6659505907626209,0.869513611859835,1.0,21/70,24.56%,LAMC1;LAMB2;ATF4;RAC1;SPI1;FN1;PROX1;VAMP3;ACTN1;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1;MEF2C;GRHL2;USH2A;TEK;TBCD;METTL3
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3297303549164625,0.9061267634886875,0.6215005599104143,0.8693072198052899,1.0,25/54,26.06%,HEXA;HYAL2;GUSB;HS3ST6;HS3ST5;SDC4;FUCA1;GPC5;B3GAT3;CLN6;SGSH;NAGLU;UGDH;XYLT1;HPSE;SDC3;HPSE2;HS3ST2;HSPG2;AGRN;HS6ST1;B3GAT1;CHST9;HS6ST2;GPC1
prerank,macromolecule catabolic process (GO:0009057),0.3760577555167987,0.9054162933654357,0.6042908224076281,0.8702969870056004,1.0,7/26,20.40%,LGMN;USE1;CLN5;CLN6;CLN8;TGFB1;CAPN3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.32842404522687196,-0.9052544932058104,0.6021897810218978,0.8327593797224127,1.0,2/14,5.54%,MOXD1;DAGLA
prerank,clathrin-dependent endocytosis (GO:0072583),0.37156437562516886,0.9050720473269072,0.6285362853628537,0.8705965217270759,1.0,10/26,15.99%,CANX;SNAP91;AP2M1;CLTC;SIGLEC1;AP2S1;FNBP1L;FCHO1;CLTA;DLL1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.32522660501299405,-0.9050605475475567,0.5785123966942148,0.8301894288407109,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.32522660501299405,-0.9050605475475567,0.5785123966942148,0.8301894288407109,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4416690960380092,0.904931092813273,0.5891364902506964,0.8704653237112198,1.0,6/10,40.56%,SMOX;SLC44A1;DMGDH;CHDH;SARDH;COMT
prerank,regulation of response to oxidative stress (GO:1902882),0.43088368603198757,0.904502374678191,0.6102635228848821,0.870891023780747,1.0,5/11,31.22%,PINK1;SELENON;HEBP2;GGT7;MCTP1
prerank,C-terminal protein amino acid modification (GO:0018410),0.4343186089223496,0.9043129832722787,0.5913528591352859,0.870870128330546,1.0,2/11,10.21%,AGBL4;ICMT
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4424405674421513,0.9036928164298808,0.6105263157894737,0.8717130062626935,1.0,4/10,19.75%,NELL1;ATRAID;DAB2IP;EFNA1
prerank,positive regulation of histone acetylation (GO:0035066),0.37600928250546717,0.9032791178780217,0.6240963855421687,0.8721200685565458,1.0,8/23,27.18%,MAPK3;PIH1D1;WBP2;PPARGC1A;MUC1;SPHK2;PAXIP1;RUVBL2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3528288584057534,0.9028692371078468,0.6236933797909407,0.8725249642071559,1.0,7/35,17.02%,SCD5;FASN;SCD;ACAT1;ALOX5AP;SLC25A1;LTC4S
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3319935897581717,0.9026814475749602,0.6531284302963776,0.8724948495631758,1.0,6/54,12.90%,RPL26;CHEK2;PCBP4;BAX;PCNA;PRMT1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3245370311407565,-0.902632555006163,0.6041666666666666,0.8344448248761303,1.0,8/17,22.76%,CCNT1;CPEB3;VIRMA;ZC3H14;CPSF6;ZC3H3;RNF20;CTR9
prerank,cellular response to alcohol (GO:0097306),-0.24572358952606121,-0.9025013101508477,0.6495726495726496,0.8332409318025628,1.0,7/42,5.78%,ADCY1;SMO;ADCY5;LRP6;GRAMD1C;LARP1;SPIDR
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.36497042151537035,0.9023423099315694,0.6220379146919431,0.8727618441378888,1.0,12/30,32.50%,ELOVL1;ELOVL2;TECRL;ELOVL7;ACOT1;ACOT4;ELOVL6;HACD4;ABCD2;ELOVL4;ELOVL5;ACOX1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.36372675338818244,0.9020459716512571,0.6361474435196195,0.872938704481216,1.0,8/30,15.89%,SCN1A;SCN4B;KCNE4;FGF12;ATP1A1;GJA1;KCNE5;RYR2
prerank,multivesicular body organization (GO:0036257),0.3640302509135551,0.9018643959291563,0.6066350710900474,0.8729026300115067,1.0,16/31,32.42%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3159427344645818,0.901756675775023,0.6801661474558671,0.8726994876017492,1.0,33/94,29.04%,CRIP1;ATF4;HINT1;CHEK2;HIPK2;CEBPB;SELENOK;CD24;BAX;PMAIP1;STK11;BBC3;BAD;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;HIC1;POU4F1;BAK1;PYCARD;DDIT3;PPM1F;C1QBP;BOK;CUL2;SCN2A;TRIB3;CDKN1A;TNFRSF1B;PDK2;MCL1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3280539148624572,-0.9011345997036572,0.5902255639097744,0.8348693313382279,1.0,3/13,8.79%,PLXNA2;NRP1;NRP2
prerank,regulation of neurotransmitter transport (GO:0051588),0.4028976343639652,0.9011331885119606,0.6007653061224489,0.8735219004142054,1.0,8/16,31.22%,FLOT1;RIMS1;SYN1;HCRT;MEF2C;KCNMB4;CPLX1;MCTP1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.40921017549070515,0.9009366350251213,0.62,0.8734923034236992,1.0,8/16,29.08%,PPP2R1A;LEPROT;CAV1;VHL;ADIPOR1;SOCS3;HGS;PPP2CA
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.38348660602199236,0.9007650586637345,0.6038461538461538,0.873437301434734,1.0,9/20,24.86%,PSENEN;SPPL2B;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;RELA;APH1A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3552367902303266,0.9007147778969925,0.6142011834319526,0.873143753916846,1.0,9/32,19.63%,HMOX1;KDR;JCAD;GATA2;KLF4;RHOA;HDAC5;HDAC9;NOTCH1
prerank,retinoic acid metabolic process (GO:0042573),-0.32573646082108587,-0.9003330478951056,0.5893536121673004,0.8352835266207149,1.0,1/14,2.19%,ALDH1A2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.41202556523018663,0.8998147576305968,0.6263297872340425,0.8744677265972726,1.0,3/14,8.69%,AKT1;MTLN;MFSD2A
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.33902280119168127,0.8997850513591337,0.6405733186328556,0.8741231813356322,1.0,12/51,17.88%,UBB;NBL1;CNTNAP2;PACSIN1;KLK8;SGK1;PAK1;NYAP2;SHTN1;EPB41L3;DAB2IP;GPM6A
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.39341742803491325,0.8995680596872968,0.6010230179028133,0.8741503826447151,1.0,13/18,35.51%,CLASP1;BMP2;IER3IP1;DDR2;IL6;TGFB1;COLGALT1;EFEMP2;CLASP2;RGCC;FSCN1;RUNX1;MELTF
prerank,COPII-coated vesicle budding (GO:0090114),0.3238927986074046,0.8989227362037464,0.6443736730360934,0.8749641502882682,1.0,17/68,21.65%,CTSZ;TRAPPC2L;LMAN1;SAR1A;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;VAPA;COL7A1;TMED10;TGFA
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4298201790089773,0.8985517479964251,0.6260623229461756,0.8748771674716422,1.0,2/12,3.71%,AKAP6;TNF
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4298201790089773,0.8985517479964251,0.6260623229461756,0.8748771674716422,1.0,2/12,3.71%,AKAP6;TNF
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4313074084016201,0.8985237035063013,0.6080332409972299,0.8745314450753695,1.0,5/12,19.83%,TNF;LIN28B;NCOR2;IL6;TGFB1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.26738288134844174,-0.8984763271288364,0.6569767441860465,0.836607297292479,1.0,15/29,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.26738288134844174,-0.8984763271288364,0.6569767441860465,0.836607297292479,1.0,15/29,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,actin polymerization or depolymerization (GO:0008154),0.3358369079436801,0.8983096662618061,0.6304824561403509,0.8745317368970937,1.0,11/50,13.99%,GSN;CFL1;RAC1;ANG;FAM107A;MICAL1;AIF1;DSTN;MSRB1;FLII;CAPG
prerank,positive regulation of actin nucleation (GO:0051127),0.4371313510914539,0.8981466922405963,0.6115107913669064,0.8744574131646023,1.0,1/11,0.88%,GSN
prerank,positive regulation of integrin activation (GO:0033625),0.42838437887892583,0.8978520489326188,0.6286919831223629,0.8746242144150391,1.0,3/11,17.00%,RASIP1;P2RY12;SKAP1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.37646965537544763,0.8972036475336044,0.618020304568528,0.875477317944432,1.0,6/24,9.28%,S100A10;RAC1;DUSP3;THY1;KDR;ARF6
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.24100012563604076,-0.8972027903784644,0.6761904761904762,0.8381675547134677,1.0,14/48,17.34%,ADCY9;ADCY1;ADCY5;AMPD3;PANK1;ADCY7;PAPSS2;PAPSS1;ADSS2;SLC26A2;AMPD2;PANK2;GUCY2C;PANK4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.40691134123605294,0.8970837229208658,0.6131105398457584,0.8753019828963213,1.0,3/15,13.00%,AGT;SOX8;SOX9
prerank,regulation of cellular metabolic process (GO:0031323),0.3406347752569646,0.8969648596191587,0.6506159014557671,0.8751214879651802,1.0,17/45,28.38%,NPC2;PINK1;FLOT1;ABCG1;FASN;NCOR2;ARF1;ARF4;ABCA2;BCO2;STUB1;MPV17;ACLY;FOXM1;EIF6;MBOAT7;PDK2
prerank,fatty acid beta-oxidation (GO:0006635),0.3339468293878897,0.8966097144720044,0.6363636363636364,0.8754113139014854,1.0,8/51,13.88%,ACADVL;SCP2;ETFB;MTLN;HSD17B4;ACAT1;ACAA2;CRAT
prerank,rRNA methylation (GO:0031167),0.3788474736500979,0.8963673069112483,0.6104060913705583,0.8754665690074506,1.0,4/22,12.71%,TRMT112;EMG1;FBL;ZCCHC4
prerank,positive regulation of exosomal secretion (GO:1903543),0.41004892116089003,0.8961804119904396,0.6347708894878706,0.875434557592437,1.0,6/15,26.88%,ATP13A2;SDC4;SDCBP;VPS4A;HGS;SNF8
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.40935557358958063,0.8961541231201557,0.6123822341857336,0.8750879437055427,1.0,2/14,7.06%,PCBP4;SRSF9
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.387034489923899,0.8959322880012306,0.6179921773142112,0.8751012503349594,1.0,5/19,19.31%,ITGB2;TIRAP;TICAM2;TRIL;CD14
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3434102232426469,0.8953258344371082,0.6372093023255814,0.8758555330209994,1.0,8/38,13.96%,TOMM7;PINK1;UBL5;ATP5IF1;LMAN1;LEPROT;FBXW7;RHOU
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3665040108638412,0.8953179918159293,0.6322815533980582,0.8754676605981656,1.0,5/25,16.62%,ITGB2;CTNNA3;NINJ1;JAM3;VCAM1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.39465087583749286,0.894442680551968,0.6274509803921569,0.8767573325712004,1.0,3/16,7.19%,PUF60;SRSF9;PQBP1
prerank,response to sterol (GO:0036314),0.42437364558078994,0.8944111864148301,0.6098591549295774,0.8764210600074589,1.0,5/11,23.23%,CCR5;ABCA2;CCL3;TGFB1;PMVK
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3188377136512225,0.8942069347788016,0.6993801652892562,0.8764257870775058,1.0,23/91,19.61%,MAPK3;SNX17;PTPRC;PACSIN1;SYT1;RIMS2;RAB15;RAB3C;CD22;VAMP2;AP2S1;HCK;STXBP5L;RAB3D;GAS1;HAP1;BET1L;RAB26;RAB5C;SYK;MAP2K2;STX4;RAB4A
prerank,termination of RNA polymerase II transcription (GO:0006369),0.35247524709081407,0.8941348281774435,0.6350710900473934,0.8761587841551048,1.0,9/33,21.12%,SNRPG;SNRPE;SNRPF;CPSF2;SNRPB;SLBP;SNRPD3;MAZ;CPSF4
prerank,circulatory system development (GO:0072359),0.309897909864631,0.894115448844672,0.7027863777089783,0.8757985500941468,1.0,32/118,21.14%,CRIP1;RAMP2;PRICKLE4;SOX18;RBP4;ERBB4;PDGFB;ACVRL1;APLNR;FN1;COL3A1;FGF12;SOX17;KDM6B;FLT4;SOX9;FBXW7;BMP2;STK11;HEY1;HDAC9;CDH5;TCF25;ERBB3;NOTCH1;HSPG2;TGFB1;POU4F1;CITED2;MEF2C;CACYBP;ID2
prerank,negative regulation of biosynthetic process (GO:0009890),0.3978013895379874,0.894029331695272,0.6096938775510204,0.8755536689817477,1.0,2/16,3.42%,PARK7;GPER1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3455812024163152,0.8937751202959503,0.6486796785304249,0.8756490860149565,1.0,5/38,9.10%,GRN;CYBA;LY86;CD180;SLC15A4
prerank,urogenital system development (GO:0001655),0.43194552934175395,0.8932973481104987,0.6262626262626263,0.8761785654602972,1.0,8/11,40.05%,AMH;SOX9;OSR2;SHH;PAX2;EPHB3;LHX1;OSR1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3542587889819574,0.8932778511214883,0.6567695961995249,0.8758145741920104,1.0,5/32,7.14%,APOD;ADAM15;ACVRL1;FAM107A;CORO1C
prerank,regulation of postsynapse organization (GO:0099175),0.3589602254783067,0.8928094339393268,0.6264775413711584,0.876316224389864,1.0,8/28,15.69%,CFL1;IL1RAPL1;PPFIA2;CDK5R1;ABHD17A;WNT5A;SRCIN1;CDK5
prerank,endodermal cell differentiation (GO:0035987),0.3555558793623454,0.8919711948070624,0.6441073512252042,0.87747567424058,1.0,4/31,8.22%,VTN;ITGB2;FN1;COL6A1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.38744122604175446,0.8918319378480836,0.6238651102464332,0.8773313483300752,1.0,2/18,3.97%,COX17;COA3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3093926914552089,0.891183918616511,0.7214799588900308,0.8781431080085143,1.0,23/128,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,nuclear transport (GO:0051169),0.39484474467080555,0.890852860504496,0.6287581699346405,0.8783898658565558,1.0,4/16,11.38%,NPM1;RBM15B;XPO1;BANF1
prerank,endothelial cell development (GO:0001885),0.365999149551619,0.8905849187707877,0.630731102850062,0.8785121861847023,1.0,11/25,27.35%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1;MARVELD2;CNMD;PDE2A;STC1;RAP1B
prerank,protein trimerization (GO:0070206),0.4118108245336896,0.8901812968856115,0.6291834002677377,0.8784784711426101,1.0,4/14,14.28%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,protein homotrimerization (GO:0070207),0.4118108245336896,0.8901812968856115,0.6291834002677377,0.8784784711426101,1.0,4/14,14.28%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,COPII vesicle coating (GO:0048208),0.3265305470491928,0.8896258657857719,0.6568627450980392,0.8783281642964725,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,vesicle coating (GO:0006901),0.3265305470491928,0.8896258657857719,0.6568627450980392,0.8783281642964725,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3265305470491928,0.8896258657857719,0.6568627450980392,0.8783281642964725,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.20280175800761804,-0.8895518518606299,0.782608695652174,0.8543348993013928,1.0,30/119,19.26%,PTPN13;PI4KA;PITPNM2;MTMR3;TTC7B;PLEKHA4;SMG1;PLEKHA2;PGAP2;ITPKB;PIP5K1A;PTEN;SACM1L;VAC14;PIGM;IP6K2;PIP4K2C;SOCS5;PIGN;PLEKHA8;PGAP3;DPM1;PIGO;PIGF;PIGW;PIGL;PIP4K2A;PIGU;PLCG2;FGF2
prerank,positive regulation of neuron migration (GO:2001224),0.4338315280325766,0.8895364751570943,0.6251808972503617,0.8780908022921878,1.0,4/11,18.74%,MDK;SHTN1;DAB2IP;NSMF
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.37219232007031144,0.8893773308650399,0.6464646464646465,0.8779888529229366,1.0,3/25,3.34%,CALM1;CALM3;CTNNA3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3937434608133743,0.8890016366876485,0.6335078534031413,0.8782915344468577,1.0,9/18,26.09%,PINK1;KDR;DCN;MIEF2;MFF;DNM1L;FIS1;SPIRE1;RALBP1
prerank,cellular response to nitrogen compound (GO:1901699),-0.2955521070505751,-0.8882071470415335,0.6126126126126126,0.8558459837227526,1.0,2/20,5.78%,ROCK2;SPIDR
prerank,melanosome organization (GO:0032438),0.36641669329723386,0.887921918845263,0.6289537712895377,0.8799403431458932,1.0,5/26,12.70%,BLOC1S4;ABCB6;BLOC1S1;BLOC1S3;BLOC1S5
prerank,lysosome localization (GO:0032418),0.34663902152797765,0.8875540347302315,0.6442080378250591,0.8802239596988398,1.0,17/37,34.89%,S100A13;PIP4P1;BLOC1S1;CHGA;DEF8;TMEM106B;PIK3CD;BORCS5;HPS6;BLOC1S2;BORCS6;RAB3A;RAB34;LAMTOR1;MILR1;KLC2;ARL8B
prerank,chromosome condensation (GO:0030261),0.3430375214154062,0.8874471650646454,0.6322505800464037,0.880027333370295,1.0,6/36,13.98%,CSNK2B;GPER1;SET;H1-0;BANF1;NCAPG
prerank,triglyceride biosynthetic process (GO:0019432),-0.3014360554458023,-0.8872352303444908,0.6,0.8566404400866671,1.0,8/18,26.39%,AGMO;MOGAT3;GPAT3;GK;PNPLA3;LPIN2;DGAT2;LPIN3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4175052081655538,0.8871619238317907,0.6217331499312242,0.8801521870327834,1.0,1/13,1.43%,GNAI2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3204396002654893,0.8870925905740402,0.6569264069264069,0.8798833343134923,1.0,15/66,19.83%,RPS3;TNF;PDGFB;PAK1;CD24;HRAS;NEK10;TLR6;PDGFA;RASGRP1;DAB2IP;FLT1;EDN3;FLT3;TGFB1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.33505848389619913,-0.8869987496089557,0.5783582089552238,0.8556891721167161,1.0,2/12,4.53%,SORBS1;IRS1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3560124138140812,-0.8869892907448508,0.5639344262295082,0.8542007052681995,1.0,5/10,16.50%,DICER1;DROSHA;TERT;TARBP2;AGO2
prerank,sister chromatid segregation (GO:0000819),-0.25955102288146203,-0.8868138911769017,0.66875,0.8530432632605279,1.0,16/31,28.90%,TOP2B;INO80;CENPK;DSN1;KLHL22;SMC4;KIF18B;NDC80;TUBG1;SMC1A;MIS12;SGO1;PLK1;TUBG2;CDCA8;KIFC1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.31599367139077644,0.8864386772416736,0.6820566631689402,0.8806671801903583,1.0,14/75,17.76%,SLC24A2;SLC39A10;KCNJ10;ATP1A3;ATP1B2;SLC12A5;TRPM2;ATP1A4;ATP1A1;KCNK9;ATP1B1;SLC8A1;ATP1B3;SLC9A9
prerank,nucleotide biosynthetic process (GO:0009165),0.3895837784211467,0.886329906115924,0.6361323155216285,0.8804776833875064,1.0,7/18,27.35%,GART;PNP;PRPS1L1;PRPS1;PRPSAP1;ADSL;RRM2B
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31650577253534123,0.8859475599255706,0.6840981856990395,0.8808278397739658,1.0,12/76,14.26%,UBB;LAPTM5;PINK1;FKBP1A;FAM107A;CENPX;PTTG1IP;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1
prerank,negative regulation of GTPase activity (GO:0034260),-0.2820435372144552,-0.885790032835138,0.6511627906976745,0.8539767105109461,1.0,3/22,2.28%,LRRK2;BCAS3;ARFGEF1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.42407274028953007,0.8857439917361252,0.6283687943262412,0.8808065726385769,1.0,3/11,21.02%,VSIR;HMGB1;TWSG1
prerank,positive regulation of signal transduction (GO:0009967),0.2991755819808304,0.8856501821589664,0.7781124497991968,0.880592016172427,1.0,38/238,13.55%,RPS3;CD74;CD63;VTN;ATP6V0C;MT3;C3;KLF2;NRXN1;NLGN1;TREM2;GPER1;EMP2;PTPRC;SORL1;CAV2;LY86;FLNA;CD180;GRIN1;TNFAIP3;RIMS2;RIMS1;CLEC6A;P2RY6;KLK6;LGR6;JCAD;ZDHHC5;PIH1D1;HAP1;ULK3;BAX;ATP6AP2;SNW1;BMP2;PDCL;GAS6
prerank,regulation of osteoclast differentiation (GO:0045670),0.3479816529863951,0.8847265702800351,0.662004662004662,0.8819229910823387,1.0,7/33,19.95%,TNF;CEBPB;GPR137B;PRXL2A;LILRB3;CCL3;POU4F1
prerank,histone H3 acetylation (GO:0043966),0.3415332927045575,0.8845852273160828,0.6582278481012658,0.8818025195039323,1.0,7/40,10.15%,SPI1;BRD1;BRPF1;TAF10;JADE1;TAF5L;TAF9
prerank,regulation of axon guidance (GO:1902667),0.43528966108334244,0.8845200652356158,0.6380813953488372,0.8815286732821646,1.0,3/10,15.81%,TUBB2B;ZSWIM8;YTHDF1
prerank,negative regulation of autophagy (GO:0010507),0.3265607553317687,0.8845158487521021,0.6870229007633588,0.8811407722951347,1.0,9/54,11.66%,MT3;AKT1;EIF4G2;TREM2;PINK1;RASIP1;NUPR1;MTMR9;CTSA
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3413091804089605,0.8840927264216967,0.6712328767123288,0.8815538279780102,1.0,17/40,24.73%,FZD9;GPM6B;ISG15;CEBPB;NELL1;P2RX7;ATRAID;ATP2B1;TMEM119;BMP2;FBXO5;SLC8A1;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,leukotriene metabolic process (GO:0006691),0.38021866860021275,0.8837128280517292,0.6274007682458387,0.8818531851620623,1.0,4/19,17.02%,DPEP2;MGST3;ALOX5AP;LTC4S
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3246619953586854,-0.8835660406799735,0.6138211382113821,0.8576292823373256,1.0,5/15,18.43%,RICTOR;UBR3;RAI2;CELF1;NR5A2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.311057213783158,-0.8819035949547792,0.6593886462882096,0.8600304775579796,1.0,5/16,15.37%,TIPIN;RAD17;ORC1;NAE1;CLSPN
prerank,regulation of extracellular matrix organization (GO:1903053),0.4011915507241882,0.8817975729054267,0.6345381526104418,0.8849512536422167,1.0,5/15,19.63%,AGT;AEBP1;TIE1;DDR2;NOTCH1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.36447827153513146,0.881703867552095,0.6348808030112923,0.8847312744244867,1.0,7/23,23.30%,ERBB4;TNF;HES1;NOTCH1;IL6;IL10RB;PRLR
prerank,neurotrophin signaling pathway (GO:0038179),-0.2794090814670638,-0.881633858856889,0.6764705882352942,0.8591229661964802,1.0,7/21,15.41%,RAPGEF2;FRS2;RAPGEF1;NGF;KIDINS220;CASP3;BDNF
prerank,cell cycle G2/M phase transition (GO:0044839),0.30571714427464136,0.8815669097046407,0.7430910951893551,0.8845908459027978,1.0,23/129,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,nuclear membrane reassembly (GO:0031468),0.3291073344180183,0.881390186566359,0.6757940854326396,0.8845099235055078,1.0,24/54,32.42%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NSFL1C;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,regulation of cytoplasmic transport (GO:1903649),0.4323891853816773,0.88127215517388,0.6310013717421125,0.8843354927746334,1.0,1/11,1.89%,MAPK3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.31872647236025997,0.8811706219120983,0.6915584415584416,0.884120077827122,1.0,13/65,16.24%,AKT1;AGT;GPER1;DUSP3;SH3GL2;PTK6;EPN1;ARHGEF7;HAP1;SPRY1;CCDC88A;SH3KBP1;DAB2IP
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36476278771953063,0.8805461287355805,0.6466257668711657,0.8848796488790454,1.0,9/24,21.19%,TMEM59;AP2M1;CLTC;GDI1;RSC1A1;DMTN;TMBIM1;TGFB1;PPP2R5A
prerank,regulation of mitochondrion organization (GO:0010821),0.33261256305626424,0.8804245700742562,0.6770114942528735,0.8847174011499779,1.0,12/47,17.36%,TREM2;PINK1;OMA1;MAPT;ATP13A2;FBXW7;MIEF2;MFF;TMEM102;SQSTM1;DNM1L;PPARGC1A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3261343669079273,-0.88022576902377,0.625,0.8607563703893658,1.0,1/14,0.28%,SULF1
prerank,glycogen metabolic process (GO:0005977),0.3560186609449039,0.8799631074378611,0.6597307221542228,0.885164217871737,1.0,5/27,10.43%,CALM1;NR1D1;GYS2;NHLRC1;GAA
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3809715400022809,0.8797519626924081,0.6354166666666666,0.8851455045746736,1.0,7/18,23.19%,CRH;CHGA;SFRP1;INHBB;CCN3;REST;PSMD9
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.42324297163257596,0.879684807618073,0.6285329744279946,0.8848675558397922,1.0,3/12,16.01%,RAN;SEC14L2;ABCA2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3586080962427456,0.8795645387129167,0.6486810551558753,0.8846861667955379,1.0,8/29,24.56%,HSP90AB1;ISG15;WNT5A;CDC37;OAS3;PTPN6;PTPN1;METTL3
prerank,organelle organization (GO:0006996),0.2939137692646057,0.8788859256031272,0.852,0.8855893762536282,1.0,81/388,20.79%,APOE;PPIA;CHCHD10;ATP5F1B;MDK;CHCHD2;CFL1;PARK7;PINK1;CNN2;MAST3;LMAN2;PACSIN1;AUP1;ATP8B4;CAV2;BSCL2;PARP1;CHMP2B;PLAAT3;REEP5;BAG5;TNFAIP3;TMED7;LMAN1;SAR1A;RAB14;TSPO2;SURF4;REEP6;HSD17B13;TMED2;CLASP1;MAST1;THY1;TICAM2;MICAL1;TMED3;ARHGEF7;ARAP3;CHMP5;CHMP6;CHGA;TMED9;FNBP1L;ARL1;TMED1;SEC61A1;SNX11;VMP1;DES;RHOU;CCL2;MIEF2;SORT1;ZMYM3;PEX6;YTHDF1;CHMP1B;SH3KBP1;DMTN;ATAD3A;CCL3;CAV1;DNM1L;SYNE1;LNPK;PPARGC1A;FMNL3;KIF5C;STX4;VPS4A;RAB18;RAB31;HPS6;MAPK15;VAPA;CFAP410;MYC;CHMP7;PAK5
prerank,response to cholesterol (GO:0070723),-0.29597833361794906,-0.8787728850635824,0.6784140969162996,0.8623979065496957,1.0,4/17,5.54%,SMO;LRP6;GRAMD1C;TGFBR1
prerank,cell part morphogenesis (GO:0032990),-0.3275655019316156,-0.8785685333887765,0.6053639846743295,0.861378488678871,1.0,2/13,3.98%,PID1;PACSIN2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3317172855483023,0.8782826962307595,0.6666666666666666,0.886315295236455,1.0,7/45,13.19%,RPL10;GRM5;METAP1;MEX3D;PCIF1;RBM4B;METTL18
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3988004632927411,0.8776867862655982,0.6433378196500673,0.8869607754533118,1.0,4/15,19.83%,TNF;CUEDC2;LILRB1;TGFB1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4390109980023873,0.8774042130171953,0.6265912305516266,0.8870797066399515,1.0,6/10,35.63%,SIRT2;RCC2;ECT2;SPAG5;APC;KNSTRN
prerank,determination of left/right symmetry (GO:0007368),-0.2464543825512419,-0.8772396565234741,0.7142857142857143,0.8630053385501698,1.0,20/36,32.03%,SMO;GALNT11;OFD1;NPHP3;CCDC39;RFX3;CFAP53;PKD2;DAND5;ODAD2;ODAD3;FOXJ1;ODAD4;KIF3B;MKKS;CCDC40;DNAAF4;STIL;PKD1L1;BBS7
prerank,monocarboxylic acid catabolic process (GO:0072329),0.37162742484087485,0.8772145717909048,0.6363636363636364,0.8870597707045387,1.0,2/21,4.78%,AGXT;NUDT19
prerank,chromatin remodeling at centromere (GO:0031055),-0.2550355493052341,-0.8770754663998492,0.6993865030674846,0.8618605370101579,1.0,15/31,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3838541853643403,0.8768570932478612,0.6449864498644986,0.8873314671688299,1.0,2/17,3.71%,CLDN5;TNF
prerank,protein-containing complex assembly (GO:0065003),0.29386304228422877,0.876669706570202,0.8042168674698795,0.8872864651450143,1.0,61/259,21.72%,CD74;CHCHD10;CTSZ;ELOB;CXCL12;LAMC1;SLC2A1;CSNK2B;TNF;TAPBP;PPP2R1A;CTNNB1;IL2RB;HES1;AP2M1;ADD2;FN1;OTX2;TRAPPC2L;LMAN1;TRAPPC5;RIMS1;TRAPPC1;TMED2;P2RX7;CAPZA2;RBX1;VAMP3;VAMP2;PDCD6;GRIA1;SOX9;MAGI1;TNFRSF1A;TSPAN4;CAPG;MCFD2;TIAM1;SPG7;BAD;PDE4DIP;DMTN;NAPA;ADCY8;DNM1L;PPARGC1A;RBBP5;TRAPPC3;CTSC;EPRS1;LPXN;SKP1;IL1RAP;CAPN3;TFAP4;MYC;COL7A1;TMED10;COL16A1;TGFA;MEN1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3456581071770704,0.8762820317595861,0.6704675028506272,0.8875995657007153,1.0,13/35,24.37%,ZFP36L1;SPI1;HSPA1B;BRD1;ZFP36;PRMT1;HSPA1A;ABCB10;MAPK11;INHBA;HSPA9;MAFB;ANKRD54
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.41634581673749516,0.8760875317353574,0.6685633001422475,0.8875613675758975,1.0,3/11,19.63%,RGS2;LMNA;NOTCH1
prerank,nucleus organization (GO:0006997),0.33496001824880917,0.8755176745013837,0.68,0.8882498742062936,1.0,13/47,25.87%,RPS19;CHMP2B;CTDNEP1;CHMP5;CHMP6;CHMP1B;SYNE1;VPS4A;CHMP7;SUN2;SPAG4;CHMP1A;CHMP4C
prerank,nucleotide metabolic process (GO:0009117),0.3690781294445311,0.8754582989396433,0.6674876847290641,0.8879617126694452,1.0,6/23,18.08%,PARK7;AK4;PNP;NME2;CMPK2;GUK1
prerank,smoothened signaling pathway (GO:0007224),-0.25726313393777733,-0.8754220917611081,0.6594202898550725,0.8639797222930552,1.0,4/32,2.67%,SMO;CC2D2A;GLI3;GLI2
prerank,hexose transmembrane transport (GO:0008645),0.3714483249862517,0.8752275648898082,0.6265822784810127,0.8879912822444589,1.0,4/21,18.03%,SLC2A1;SLC50A1;SLC2A2;SLC2A3
prerank,mitochondrial fission (GO:0000266),0.39230271103094805,0.8749707686072105,0.6444444444444445,0.8880440139516664,1.0,7/16,23.35%,DNM3;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L
prerank,axon extension (GO:0048675),0.37088509438530975,0.8745526250924758,0.6524466750313677,0.8883692555208678,1.0,3/23,3.78%,HSP90AA1;HSP90AB1;SEMA3F
prerank,monoacylglycerol metabolic process (GO:0046462),0.41482582683733304,0.874482704532315,0.6492220650636492,0.8881077213979175,1.0,7/13,28.06%,MOGAT2;DGAT2L6;FAAH;DGAT1;ABHD16A;ABHD12;MGLL
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3631456707758395,0.8744524742716675,0.6418663303909206,0.8877700840181484,1.0,8/24,19.83%,C3;ATF4;FLT4;HPSE;GATA4;CXCL17;IL6;TGFB1
prerank,response to glucose (GO:0009749),0.3284821572116218,0.8743153800170798,0.6700680272108843,0.8876277824497752,1.0,12/46,21.40%,RACK1;GPER1;PFKL;GYS2;LPL;VAMP2;GAS6;MAFA;ADCY8;EIF2B5;KHK;SELENOS
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2756623077622144,-0.8739973628973596,0.6347305389221557,0.8655053848155099,1.0,5/26,5.22%,ACTN2;ANK2;FHL1;AKAP9;DLG1
prerank,glycerophospholipid metabolic process (GO:0006650),0.3119798448883087,0.8738366798018297,0.7070063694267515,0.888103025121468,1.0,22/75,26.52%,SERINC1;PRDX6;PIGZ;PIGQ;DGKH;PLA2G7;PLA2G4F;CSF1R;GDE1;SERINC5;GPCPD1;CPNE6;GDPD1;DPM2;ENPP6;PGP;GDPD3;PLA2G3;ABCA3;ABHD12;CPNE3;PLA2G6
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3533167967112235,-0.8735680824812447,0.6225806451612903,0.86497671890338,1.0,2/10,10.54%,INO80;SSBP1
prerank,modified amino acid transport (GO:0072337),0.39193849361498523,0.8728622364829126,0.6378162450066578,0.8894451086644732,1.0,4/15,15.30%,SLC1A4;MGST1;SLC19A1;FOLR2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.32773554265007726,0.8726690286245118,0.6926454445664105,0.8890183245071587,1.0,12/50,21.13%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;POLR2H
prerank,regulation of gene silencing by RNA (GO:0060966),0.32773554265007726,0.8726690286245118,0.6926454445664105,0.8890183245071587,1.0,12/50,21.13%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;POLR2H
prerank,positive regulation of viral genome replication (GO:0045070),0.34971214841488896,0.8722165301727456,0.6614832535885168,0.8894549069750154,1.0,5/29,13.84%,PPIA;IFIT1;DDB1;PABPC1;PDE12
prerank,myelination in peripheral nervous system (GO:0022011),-0.32363975269981826,-0.8719276864168725,0.6240601503759399,0.8670795419449269,1.0,3/13,5.39%,PARD3;SKI;DICER1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.30123469746539017,-0.8716605208659666,0.6502242152466368,0.8661287161238851,1.0,3/17,5.81%,SULF1;SLIT2;CASK
prerank,sodium-independent organic anion transport (GO:0043252),0.42311680569491406,0.8716384273940923,0.630057803468208,0.8900847728260699,1.0,4/10,19.96%,SLCO1C1;SLCO4C1;MFSD10;SLCO1B1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.34941549091287505,-0.8711320611825998,0.6548042704626335,0.8657613579948022,1.0,3/10,16.08%,OGT;DGKQ;SIRT7
prerank,regulation of synapse organization (GO:0050807),0.35787605945844964,0.8710783178377003,0.6574185765983113,0.8907256224911956,1.0,7/26,13.60%,CTNNA2;TNF;KLK8;IL1RAPL1;ABHD17A;WNT5A;YWHAZ
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4235592715401037,0.8707587787921963,0.6498599439775911,0.890908861764381,1.0,2/11,6.44%,SORL1;MSN
prerank,T-helper cell differentiation (GO:0042093),-0.31556079623794714,-0.87058269363019,0.6356877323420075,0.8655254845726418,1.0,2/14,6.77%,FOXP1;ATP7A
prerank,regulation of JNK cascade (GO:0046328),0.30056469745808245,0.8701019861263795,0.7067901234567902,0.8916555254952514,1.0,33/101,25.75%,CCL19;PINK1;DUSP3;TIRAP;SIRPA;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;PHLPP1;MAPK8IP1;SDCBP;F2RL1;TRAF3;MAPK8IP2;RASGRP1;EPHB1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;MEN1;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1;FKTN
prerank,tRNA methylation (GO:0030488),-0.25320720112076733,-0.870031524137093,0.68125,0.8651914659032236,1.0,10/34,14.41%,TRMT13;NSUN6;ALKBH8;THADA;THUMPD3;TRMT5;FTSJ1;TRMO;PRORP;TRMT1L
prerank,lipid phosphorylation (GO:0046834),0.4236049093857435,0.8693897617480643,0.6642547033285094,0.8925436479018409,1.0,6/10,30.98%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,microtubule polymerization (GO:0046785),0.3523904264047788,0.8681793085168603,0.6604708798017348,0.894225715714732,1.0,4/28,8.71%,TPPP3;PIN1;CLASP1;MAPT
prerank,embryonic organ development (GO:0048568),0.31808066845328564,0.867237100827768,0.6889848812095032,0.8954939813507224,1.0,12/61,11.29%,RPL10;ATF4;SOX18;RBP4;NES;TNF;NDRG4;RARRES2;KDR;MFSD2A;KITLG;SOX17
prerank,protein homooligomerization (GO:0051260),0.29994054064555686,0.8669918153190708,0.7625383828045036,0.895539191724674,1.0,23/114,21.10%,ALDOA;B2M;AQP4;SLC1A2;MPP2;MIF;STEAP4;ALAD;NINJ1;TRPM2;RS1;PRMT1;GLS;ALOX5AP;EHD1;G3BP2;HCN1;ADCY8;GLRA3;PKD2L1;SHMT2;PYCARD;KCNC2
prerank,acyl-CoA metabolic process (GO:0006637),0.33363129322671836,0.866675260902515,0.6605080831408776,0.8957108911035386,1.0,8/35,22.00%,DBI;OXSM;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5
prerank,replicative senescence (GO:0090399),0.41328252989585323,0.8663514576117903,0.634453781512605,0.8958828657706075,1.0,2/12,4.36%,ROMO1;CHEK2
prerank,cranial nerve development (GO:0021545),0.41686784656081455,0.866340937837932,0.6409537166900421,0.8955077306748296,1.0,3/11,19.95%,TMEM126A;ERBB3;POU4F1
prerank,positive regulation of cilium assembly (GO:0045724),0.38482080385363837,0.8659633018302619,0.6505867014341591,0.8958153662478882,1.0,5/18,24.77%,KCTD17;HAP1;CCDC88A;CCP110;WRAP73
prerank,negative regulation of cell junction assembly (GO:1901889),0.3537258977887903,0.8650671144440577,0.6505576208178439,0.8970132610852976,1.0,9/25,16.95%,APOD;TNF;ACVRL1;FAM107A;CORO1C;ROBO2;DLC1;DMTN;SLIT1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3785669107431357,0.8649344745868675,0.6631299734748011,0.8968583205393538,1.0,3/16,13.34%,GPR37L1;KLK1;DDAH1
prerank,gland development (GO:0048732),0.31585922768967645,0.864168432193395,0.6954148471615721,0.8977844720013372,1.0,9/59,13.00%,MDK;SOD1;NRG1;HES1;MSN;CEBPA;PROX1;LSR;SOX9
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34752212737050897,-0.8641544601995678,0.6068965517241379,0.8765229661449598,1.0,4/10,14.98%,DUSP10;HIPK3;PDCD4;PTPN22
prerank,tRNA processing (GO:0008033),0.3136451845929069,0.8638436824280636,0.7016216216216217,0.8979720775460419,1.0,19/61,25.97%,METTL1;ELAC2;SARS1;KARS1;AARS2;POP7;RTRAF;TSEN15;RTCB;CTU1;TSEN54;CPSF4;ADAT2;URM1;TRNT1;THUMPD1;TRMT10C;CTU2;LCMT2
prerank,Golgi to endosome transport (GO:0006895),-0.2974538312515877,-0.86283965089854,0.6367713004484304,0.8778903045076913,1.0,4/16,10.18%,VPS13A;MON2;GBF1;KIF16B
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3658285060829884,0.8626617114595985,0.6662546353522868,0.899640714199123,1.0,9/22,27.11%,DYNLL1;CDKN1C;PRKRIP1;INHBA;CDA;TESK1;CDKN2B;INHA;CDKN1A
prerank,regulation of cellular senescence (GO:2000772),0.34824542349035315,0.8625143760761634,0.6690997566909975,0.8994967782758562,1.0,4/28,8.92%,B2M;YPEL3;VASH1;YBX1
prerank,positive regulation of blood coagulation (GO:0030194),-0.2889296810451051,-0.8623444498787749,0.6545454545454545,0.8773998406396532,1.0,3/17,7.65%,ST3GAL4;ANO6;F3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3112277768173251,0.8623197088860841,0.7122692725298588,0.899445859555206,1.0,12/66,14.26%,GPNMB;PSME1;AKT1;PSME2;CCND2;FAM107A;CCND1;JADE1;CDK2AP2;AIF1;KLF4;CCL2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.38967207079837285,0.862221162756228,0.6689280868385346,0.8992368418899849,1.0,4/15,15.99%,S100A1;PKM;KLF4;DLL1
prerank,prostanoid metabolic process (GO:0006692),0.39837240286319014,0.8613874408426097,0.6563814866760168,0.9003379475337288,1.0,2/13,13.37%,GSTM1;HPGDS
prerank,cognition (GO:0050890),0.3330620060918763,0.8613572406435752,0.699666295884316,0.8999974049188495,1.0,13/42,20.75%,GRM5;SLC1A4;TNF;C5AR1;CHMP2B;FAM107A;MFSD2A;CHRNA4;MAGT1;CBR3;PTCHD1;JAKMIP1;GPR155
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.40879366191715966,0.8607253490027817,0.6407103825136612,0.9003190142820892,1.0,4/12,22.68%,CORO1C;DMTN;RCC2;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.40879366191715966,0.8607253490027817,0.6407103825136612,0.9003190142820892,1.0,4/12,22.68%,CORO1C;DMTN;RCC2;AP1AR
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.2923586590594516,0.8605922350925757,0.7763157894736842,0.9001506846500253,1.0,37/152,20.35%,PSMB4;ATP6V0C;COL1A1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;TNFAIP3;PSMA7;PSMD5;LGR6;PSMB9;PSMD13;GPC5;PSMB3;ATP6AP2;PSMB11;BMP2;PSMB10;SFRP4;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;PSMA6;TGFB1;SFRP1;PSMA4
prerank,negative regulation of receptor internalization (GO:0002091),0.41401775086429815,0.8603273113307822,0.656121045392022,0.900219308480747,1.0,4/12,15.35%,LRPAP1;UBQLN2;SDCBP;ANKRD13D
prerank,respiratory chain complex IV assembly (GO:0008535),0.3662036873160458,0.8603099351726734,0.6687898089171974,0.8998626510295203,1.0,2/21,3.97%,COX17;COA3
prerank,nuclear membrane organization (GO:0071763),0.37836357713960284,0.8602256555385778,0.6726572528883183,0.8996123517487553,1.0,6/19,22.40%,GPER1;TARDBP;DCTN1;VPS4A;CHMP7;TMEM43
prerank,organophosphate biosynthetic process (GO:0090407),0.3330338603224857,0.8596321324001592,0.6867052023121387,0.900247870738833,1.0,8/37,18.57%,TPI1;FADS1;GPHN;PCYT2;PNPO;AGPAT5;TKT;IP6K1
prerank,protein hydroxylation (GO:0018126),-0.30766493966907293,-0.8591096821809555,0.6777777777777778,0.8828656664346061,1.0,2/15,5.98%,PLOD2;ASPH
prerank,regulation of cilium assembly (GO:1902017),-0.21689927931129238,-0.8590096348651766,0.7666666666666667,0.8815854293398124,1.0,11/62,12.10%,DCDC2;TBC1D19;YAP1;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;CEP97;SDCCAG8;IFT140
prerank,negative regulation of cellular component movement (GO:0051271),0.3878676935954519,0.8588079424103443,0.6622864651773982,0.9013028610273075,1.0,4/15,12.27%,PIN1;FRMD5;SPOCK3;ACTN1
prerank,organelle disassembly (GO:1903008),-0.2481150328060713,-0.8583933439278965,0.7423312883435583,0.8814176780129584,1.0,8/33,12.61%,UFL1;ATG2B;GOLGA2;RB1CC1;GBF1;ATG2A;KLC1;ULK2
prerank,cellular response to amino acid stimulus (GO:0071230),0.34337533220288086,0.8582269226160141,0.675,0.9018788642718836,1.0,9/33,18.74%,LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.360134711355374,0.8580511746050079,0.6601466992665037,0.9017964095908875,1.0,2/23,2.58%,CALM1;CALM3
prerank,DNA modification (GO:0006304),0.365631910518721,0.8580150361043827,0.6788874841972187,0.9014631835879775,1.0,6/22,21.53%,TERF1;PARP1;NEIL1;NEIL2;TERF2IP;EXOSC4
prerank,microtubule depolymerization (GO:0007019),0.3825958980339619,0.8578673148872312,0.6736842105263158,0.9013283055647375,1.0,7/17,32.85%,STMN3;STMN4;STMN1;NCKAP5;CCSAP;STMN2;KATNB1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.35189641958320717,-0.857583108551483,0.6335616438356164,0.8816512031789066,1.0,2/10,9.45%,ATP7A;THAP4
prerank,pyroptosis (GO:0070269),0.3776067546943611,0.8575706705067954,0.6455026455026455,0.9014395364523533,1.0,1/15,2.84%,TREM2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3312834603186828,0.8575699009332194,0.6784492588369442,0.9010492164673941,1.0,13/39,27.24%,ADAM15;SPOCK1;CORO1C;RHOA;DMTN;NOTCH1;PTPRO;RCC2;AP1AR;TBCD;CX3CL1;MYOC;CORO2B
prerank,cellular response to organic substance (GO:0071310),0.29500097874692677,0.856836627470546,0.7448770491803278,0.9019466272588403,1.0,31/116,21.24%,RACK1;RAMP2;PARK7;AKAP6;TNF;PDGFB;HCLS1;ACVRL1;IGFBP5;CTNNB1;IL1RAPL1;CLEC3B;CSF1R;RAMP3;SLC1A1;AMHR2;KLF4;RHOA;CXCR4;CCL2;ROBO2;SIGIRR;CCL3;SLIT3;FLT3;TGFB1;POU4F1;SFRP1;PTPN6;ASAH2;CDK9
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3809018343754827,0.8567073966319766,0.6640106241699867,0.9017903192571263,1.0,5/17,20.03%,PTPRC;GJA1;HNRNPU;SOX11;THPO
prerank,positive regulation of hemostasis (GO:1900048),-0.3403347514306768,-0.8564195779199238,0.6456140350877193,0.8812904275062029,1.0,1/10,1.41%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),-0.3403347514306768,-0.8564195779199238,0.6456140350877193,0.8812904275062029,1.0,1/10,1.41%,ST3GAL4
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4272973135236999,0.8564104656122333,0.658008658008658,0.9018889633306157,1.0,1/10,1.76%,PARK7
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3787505442513191,0.8560007390290766,0.6782496782496783,0.9022018789744387,1.0,6/18,18.75%,KCTD10;RASIP1;TNFAIP1;STMN1;DLC1;KCTD13
prerank,cellular response to interleukin-2 (GO:0071352),0.4126268004268385,0.8559912977251717,0.6465753424657534,0.9014385627133514,1.0,4/11,17.99%,IL2RB;IL2;IL2RG;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4126268004268385,0.8559912977251717,0.6465753424657534,0.9014385627133514,1.0,4/11,17.99%,IL2RB;IL2;IL2RG;SYK
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3232306688373882,0.8559490936686475,0.6903954802259887,0.9011220428592551,1.0,15/44,27.61%,AKAP6;FLNA;KCNJ10;ATP1B2;KCNN2;KCNE5;ATP1B1;ATP1B3;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27631070480716935,-0.8549709705870815,0.68,0.8827819773913439,1.0,8/23,21.33%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;NDC80
prerank,myeloid cell development (GO:0061515),-0.28746005200396696,-0.8544767607244841,0.6885964912280702,0.8822936926608608,1.0,1/18,0.16%,FOXP1
prerank,cardiac muscle cell action potential (GO:0086001),0.3480589157910079,0.8542611505385412,0.6706443914081146,0.9036035658375122,1.0,7/30,15.37%,SCN1A;YWHAE;SCN4B;FGF12;ATP1A1;ATP1B1;SLC8A1
prerank,regulation of protein export from nucleus (GO:0046825),0.3581325806365487,0.8539599973016356,0.6807151979565773,0.9037062042386333,1.0,9/23,24.59%,PARK7;YWHAE;UHMK1;CAMK1;GAS6;RANGAP1;IFI27;ANP32B;BARD1
prerank,positive regulation by host of viral transcription (GO:0043923),0.3877926378006885,0.8538312714758214,0.6621438263229308,0.9035064969181642,1.0,4/15,12.39%,NUCKS1;RRP1B;JUN;SNW1
prerank,establishment of endothelial barrier (GO:0061028),0.3425728296904595,0.8536656216803697,0.6862275449101797,0.903392864792116,1.0,6/29,14.62%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1
prerank,positive regulation of ion transport (GO:0043270),0.3187977346542714,0.8533964259766675,0.7216035634743875,0.9034849898284499,1.0,11/48,16.88%,ANK3;P2RX7;LILRA5;SCN4B;WFS1;VAMP8;ATP2B1;CNKSR3;PRSS8;CCL3;ORAI1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3048820740270132,-0.8531527925807557,0.6641221374045801,0.8834591494111055,1.0,4/15,11.93%,YTHDF3;STAT2;CNOT7;PTPN2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3924780051711619,0.8531471711602969,0.6745152354570637,0.9035117218002654,1.0,6/13,32.60%,CCL19;ABCA2;IL33;CHP1;ALG10B;RAMP1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.29457111776256273,-0.852589903522536,0.6880733944954128,0.8832256938144856,1.0,6/18,13.89%,OGA;ADAMTS9;NGLY1;STT3B;DERA;MANBA
prerank,regulation of chromatin binding (GO:0035561),-0.33956374101239006,-0.8515929444320991,0.6402640264026402,0.883792618296067,1.0,4/10,14.04%,PARP9;WAPL;BTAF1;KDM4D
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.304418858197653,0.8515488298944306,0.7288317256162915,0.9058661101270377,1.0,20/70,26.70%,GABARAP;DCC;TNF;P2RX7;TNFSF12;BAX;TNFRSF1A;SORT1;BAD;DAB2IP;SIVA1;ERBB3;INHBA;TGFB1;BAK1;IFI27;BLOC1S2;BOK;FGFR3;TGFB2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.38797229414720735,0.8510780681879428,0.6697127937336814,0.9062753899375885,1.0,4/15,17.36%,MID1IP1;MLXIPL;NR1H2;PPARGC1A
prerank,nucleosome organization (GO:0034728),0.3130825081278526,0.850713373455497,0.7130044843049327,0.906470231474738,1.0,8/55,13.00%,H3-3A;VPS72;NPM1;ZNHIT1;BRD2;SET;H1-0;SOX9
prerank,DNA replication initiation (GO:0006270),0.3352643384349935,0.8505460887966904,0.713963963963964,0.9063489301403329,1.0,5/37,12.19%,MCM5;RPA2;CDC34;GMNN;POLE4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3305622462655071,0.8498634087777867,0.6786127167630058,0.9071054822905088,1.0,8/37,20.07%,GPER1;PDGFB;IGFBP5;P2RY6;JUN;GJA1;ADAMTS1;MEF2C
prerank,positive regulation of axonogenesis (GO:0050772),0.321851600403453,0.8495797485858055,0.6921322690992018,0.9072036682894923,1.0,9/43,15.46%,ARHGDIA;NTRK2;SEMA7A;MAPT;NTN1;RHOA;SHTN1;TIAM1;ROBO2
prerank,nucleosome assembly (GO:0006334),0.33967772137852253,0.8494506933895086,0.7010804321728692,0.907043388300215,1.0,6/31,16.59%,H3-3A;NPM1;BRD2;SOX9;IPO4;NAP1L2
prerank,Ras protein signal transduction (GO:0007265),0.2910601106825904,0.8492982069716448,0.7928934010152284,0.9069258043321646,1.0,28/137,15.62%,ARHGDIA;CFL1;PARK7;RHOB;RAC1;ELMO1;ARHGDIB;SHC3;RHOG;ADGRG1;TRIM28;NTN1;JUN;GRAP;ARHGDIG;RASGRP3;GDI1;HRAS;AIF1;COL1A2;RHOA;SHTN1;RRAS;TIAM1;G3BP1;MAPK11;G3BP2;RASGRP1
prerank,tyrosine metabolic process (GO:0006570),-0.3412432717446028,-0.8482138835423516,0.6462585034013606,0.8893798803316264,1.0,3/11,24.98%,THAP4;GSTZ1;HGD
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36619633169960975,0.8480568131955734,0.6696428571428571,0.9086216952520483,1.0,3/19,17.05%,PNPLA2;MTLN;TWIST1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3759209284451303,0.8479248756827057,0.6861499364675985,0.9084322482943429,1.0,2/18,6.44%,MAPK3;MSN
prerank,axoneme assembly (GO:0035082),-0.24798275704556813,-0.8477141569614707,0.7151515151515152,0.8889148718580501,1.0,11/30,24.61%,DNAI4;TTLL3;SPEF1;GAS8;CCDC39;LRGUK;SPAG17;RP1;FOXJ1;CCDC65;DNAAF2
prerank,regulation of transferase activity (GO:0051338),0.3728778819497366,0.8469667047357469,0.6788036410923277,0.9096305798127869,1.0,3/17,7.78%,EMP2;BAG5;FEM1A
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3597598503316116,0.8468439709797775,0.6846153846153846,0.9094491931605625,1.0,7/21,20.94%,MT3;GRIN1;BEX3;PSMB9;PCID2;GRIN2B;PYCARD
prerank,regulation of pH (GO:0006885),0.4113279064088492,0.8468433941840463,0.6822558459422283,0.9090614552534027,1.0,3/11,11.96%,ATP6AP1;SLC26A4;ATP1A4
prerank,reticulophagy (GO:0061709),-0.32401332584666076,-0.8464892152360808,0.6453900709219859,0.8899841688484845,1.0,6/12,16.72%,UFL1;ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,negative regulation of defense response to virus (GO:0050687),-0.35218558919888726,-0.8460818708674366,0.6338461538461538,0.8893484247833888,1.0,3/10,15.47%,ITCH;ILRUN;TARBP2
prerank,heart development (GO:0007507),0.2898773929680491,0.8458427680399648,0.8036998972250771,0.9102941833479623,1.0,36/150,21.14%,CRIP1;RAMP2;PRICKLE4;SOX18;RBP4;ERBB4;SGCZ;PDGFB;ACVRL1;FKBP1A;NDRG4;APLNR;ALPK2;FN1;MMP21;COL3A1;FGF12;SOX17;KDM6B;SOX9;BMP2;LEFTY1;DLC1;HDAC9;GATA4;SGCG;CRELD1;TCF25;ERBB3;NOTCH1;TGFB1;POU4F1;CITED2;MEF2C;CACYBP;ID2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.32516765290498467,0.8453939743802232,0.7142857142857143,0.910649785592017,1.0,5/38,9.75%,TREM2;NR1D1;TNFAIP3;OTUD7A;TRIM59
prerank,wound healing (GO:0042060),0.3122025046772599,0.845218240405506,0.7257889009793254,0.9105518509527424,1.0,18/62,19.08%,HMOX1;NRG1;PLEC;PAK1;SYT11;COL3A1;EPPK1;SMPD1;WNT5A;SLC11A1;EVPL;PDGFA;HPSE;EPB41L4B;GATA4;ERBB3;ANXA6;PPP3CA
prerank,glycoprotein metabolic process (GO:0009100),-0.2181960296149401,-0.8448418884633879,0.8181818181818182,0.8903927796144145,1.0,12/53,16.21%,LARGE1;ST3GAL4;MAN1C1;OGA;ADAMTS9;FUT8;NGLY1;STT3B;MANBA;ST6GALNAC6;MAN2A1;ST3GAL2
prerank,double-strand break repair (GO:0006302),-0.19256862241948283,-0.8435421591086539,0.9230769230769231,0.8915574818561952,1.0,32/158,15.13%,EYA1;BABAM2;KDM2A;NSMCE2;DDX1;PARP9;MDC1;SPIDR;UIMC1;SMARCAD1;PARP3;RNF8;SMARCA5;BAZ1B;RBBP8;NHEJ1;SLX4;INO80;FBH1;RNF138;ERCC5;SETX;RAD51B;ACTR8;EYA3;ATM;TNKS1BP1;CYREN;KDM4D;PALB2;KPNA2;TDP1
prerank,barbed-end actin filament capping (GO:0051016),0.36731946532277193,0.8434781795152905,0.6879895561357703,0.9126254420490858,1.0,8/18,22.96%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,actin filament capping (GO:0051693),0.36731946532277193,0.8434781795152905,0.6879895561357703,0.9126254420490858,1.0,8/18,22.96%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,dendritic spine morphogenesis (GO:0060997),0.3775009573274315,0.843377862959101,0.6684563758389261,0.9123997138292846,1.0,5/15,23.04%,PAK3;DOCK10;EPHB1;CTNND2;WNT7A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.36560005090876646,0.8433555858617278,0.6876640419947506,0.9120500640035801,1.0,5/20,21.67%,GATM;PTDSS1;GAMT;OPLAH;MTHFS
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.37509307094280353,0.842470474254095,0.6711956521739131,0.9131085414295524,1.0,3/15,14.24%,TREM2;NLRP2B;TLR6
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.384577247136354,0.8424617436954936,0.6515151515151515,0.9127344176218333,1.0,3/13,9.45%,RAN;AK4;AK3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3933707249362498,0.8424237010628335,0.6666666666666666,0.9124041427336647,1.0,7/13,27.91%,LGMN;SHISA7;ADCY8;SQSTM1;APP;ZDHHC2;CHRNA7
prerank,glucose homeostasis (GO:0042593),0.29989981730245974,0.8420772791475147,0.7579617834394905,0.9125768052330224,1.0,16/83,19.67%,PARK7;MTNR1B;RPS6;RBP4;LRRC8A;NR1D1;NUCKS1;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;PPARGC1A;TFAP2B;IL6
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.35629181772865687,0.8416380277277724,0.6742138364779874,0.9129054790411475,1.0,6/21,21.50%,PPP1CA;CTNNB1;FRAT2;CAV1;FZD2;FZD1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.38416220415134583,0.8410263564137276,0.6790450928381963,0.9135427443630363,1.0,2/15,12.49%,IDO2;QDPR
prerank,histone exchange (GO:0043486),0.3272180553401188,0.8406316679578267,0.7080890973036342,0.9137945761521608,1.0,4/37,7.60%,VPS72;NPM1;ZNHIT1;CENPX
prerank,positive regulation of cyclase activity (GO:0031281),0.3903861276890711,0.8406060401815589,0.683377308707124,0.9134488330494092,1.0,4/14,17.55%,MAPK3;DRD5;ORAI1;NOS2
prerank,"phototransduction, visible light (GO:0007603)",0.382339863179699,0.8404548484708715,0.6657789613848203,0.9132923576445597,1.0,3/14,24.44%,GNA11;CNGB1;PDE6G
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.31448776439880094,-0.840371040634229,0.6403162055335968,0.8966681102373106,1.0,4/14,15.20%,AUTS2;KMT2A;SMAD4;PRDM9
prerank,apical junction assembly (GO:0043297),0.311706141241405,0.8401509765698727,0.7276785714285714,0.9134009614817629,1.0,15/53,24.27%,CLDN5;RAMP2;RHOC;CLDN11;ESAM;PECAM1;RHOA;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,negative regulation of blood pressure (GO:0045776),0.3901603761972294,0.8397065842818997,0.684931506849315,0.9137540616328425,1.0,3/13,23.55%,GPR37L1;NOS2;PRCP
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.2790946702944075,-0.8395339987083394,0.7453703703703703,0.8968089372067508,1.0,5/17,17.44%,IL18;STAT3;CD46;JAG1;CD55
prerank,N-terminal protein amino acid modification (GO:0031365),0.3879630279886987,0.8392641762054173,0.6714285714285714,0.9140758879588142,1.0,4/14,15.29%,METAP1;METAP2;NAA10;PDF
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.35359252414962705,0.8388704636583161,0.688039457459926,0.9143598754461018,1.0,6/23,20.07%,AKAP6;NRG1;PROX1;MMP14;TGFB1;MEF2C
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.413038755009031,0.838468580305392,0.6894049346879536,0.914642383762434,1.0,3/10,19.11%,SET;CTBP1;SNCA
prerank,regulation of cell aging (GO:0090342),0.39409576632770404,0.8382968920431538,0.6898016997167139,0.91454849334133,1.0,5/11,25.42%,MIF;VASH1;LMNA;FOXM1;PNPT1
prerank,regulation of microtubule depolymerization (GO:0031114),0.34740740161597317,0.838096377607372,0.7014742014742015,0.9144748843324749,1.0,4/25,8.20%,MAP1A;MID1IP1;NAV3;CLASP1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3204582452519578,0.8378531201855407,0.7001127395715896,0.9145014792641353,1.0,14/43,20.07%,IFITM1;DNAI3;ATP6AP1;NELL1;LRP3;ATRAID;TMEM119;BMP2;FBXO5;DDR2;SOX11;HGF;IL6;MEF2C
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2270648077971705,-0.8375836074380245,0.8210526315789474,0.8992396686719437,1.0,11/48,21.01%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PLD2;PNPLA3
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.23034490250685383,-0.8369113932282235,0.8203125,0.8991875749172633,1.0,12/43,16.93%,EGFR;SNX6;CBLB;ERRFI1;PTPN3;STAM2;RNF115;PTPN2;SOCS5;GPRC5A;STAM;EPS15L1
prerank,atrioventricular valve development (GO:0003171),-0.3046483379668628,-0.8368687453644521,0.6537102473498233,0.8978221385674489,1.0,3/14,6.73%,ACVR1;BMPR1A;MDM4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.36649529858810104,0.8364289222619424,0.690537084398977,0.9163743223003247,1.0,6/18,21.70%,BHLHE41;TMEM119;BMP2;HDAC5;NOTCH1;CCN3
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.24895618557606972,-0.8359420315685817,0.7697368421052632,0.8983093455214533,1.0,4/32,6.44%,AUTS2;PLCE1;CARMIL1;NCKAP1
prerank,protein import into peroxisome matrix (GO:0016558),0.39306250818194105,0.8357633434891073,0.6895161290322581,0.9170584864914914,1.0,6/12,35.64%,PEX5L;PEX6;PEX1;PEX14;PEX2;PEX13
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4132958743150965,0.8355701905637732,0.6859154929577465,0.9169781765532998,1.0,3/10,12.78%,PSMC3;HMGB1;THRA
prerank,mitotic nuclear division (GO:0140014),-0.21174208460965968,-0.8354695202425488,0.7636363636363637,0.897825103169607,1.0,30/71,23.71%,EPS8;STAG1;LSM14A;KLHDC8B;PIBF1;OFD1;GOLGA2;INO80;CENPK;AAAS;NDEL1;DSN1;KIF2A;KLHL22;CCDC61;SMC4;MISP;TPX2;KIF18B;CEP192;ARHGEF10;ABRAXAS1;NUP62;NDC80;TUBG1;SMC1A;MIS12;MAP9;SGO1;SMC3
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34662452084495465,0.8349571653439709,0.7105590062111802,0.9175697617400673,1.0,4/23,10.22%,ENDOG;FOXL2;HMGB1;H1-0
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3462266669994168,0.8348475381593665,0.6939281288723668,0.9173667560616243,1.0,4/23,11.19%,RACK1;VCP;RFX4;ULK3
prerank,regulation of endocytic recycling (GO:2001135),0.4077973582977802,0.8346736948891081,0.6873239436619718,0.9172712084626816,1.0,4/11,24.66%,SORL1;EHD1;EHD2;PLA2G3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.35902487942896283,0.8344805830513706,0.6984924623115578,0.9172008056587602,1.0,6/20,19.83%,TNF;HCK;CCL2;CCL3;CD14;TGFB1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.34167559811547044,0.834069498117564,0.7046004842615012,0.9174812094547791,1.0,7/24,18.66%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A;ANXA6
prerank,ethanol metabolic process (GO:0006067),-0.31596028197317455,-0.8339858077646516,0.6962962962962963,0.8993215564985536,1.0,1/12,1.42%,ALDH1A1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21437655306914621,-0.8336683334200661,0.8383838383838383,0.8985119346447478,1.0,13/49,14.83%,OGA;PRKN;RNASE3;ADAMTS9;SIDT2;NGLY1;RIPK1;STT3B;DNASE1L1;DENND3;MTREX;MANBA;PABPC4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3448531596743217,0.8330614927864792,0.709832134292566,0.9187934668885398,1.0,10/26,30.01%,C1QC;GPR137B;LILRB3;CCL3;INHBA;MYC;MAFB;INHA;ZFPM1;TMEM178A
prerank,bile acid and bile salt transport (GO:0015721),0.34658591449784715,0.8326347045394754,0.7027363184079602,0.9190643432561683,1.0,5/24,20.82%,SLCO1C1;SLC10A3;ABCC3;SLCO1B1;SLC10A6
prerank,regulation of exosomal secretion (GO:1903541),0.3605409070497516,0.8322238495167604,0.7164556962025317,0.9193325296999608,1.0,7/19,26.88%,ATP13A2;SDC4;CHMP6;SDCBP;VPS4A;HGS;SNF8
prerank,neuron fate commitment (GO:0048663),0.3856153881503759,0.8321938115489799,0.6930555555555555,0.9189912039175859,1.0,7/14,32.28%,DLL1;MYT1L;POU4F1;ID2;DLL4;POU3F2;SHH
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.38000152389496017,0.8318458810687936,0.6912928759894459,0.9191710783651386,1.0,5/15,19.98%,NTRK2;HAP1;SORT1;SOS1;DDIT4
prerank,early endosome to late endosome transport (GO:0045022),-0.2679530962861971,-0.8315465454692011,0.7175925925925926,0.9013845342944546,1.0,4/20,10.18%,STX8;EEA1;ANKRD27;KIF16B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3783595899190071,0.8305899064245852,0.6874172185430464,0.9207907964432663,1.0,4/15,14.72%,AGT;LPL;MSR1;PF4
prerank,regulation of nervous system process (GO:0031644),0.3660525166230149,0.8300179183809707,0.6961538461538461,0.921276475145009,1.0,9/18,24.59%,DLGAP2;DLGAP1;HTR2C;BEGAIN;TMEM108;NPTXR;CACNG5;APP;NPTX1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.41363392119827236,0.8300082158808662,0.6987270155586988,0.9208992941361347,1.0,1/10,3.60%,PFKL
prerank,negative regulation of ion transport (GO:0043271),0.34982633036893274,0.8298151609292876,0.7096774193548387,0.9208149758632469,1.0,5/24,19.11%,GPM6B;SYT11;PLN;LILRB1;SNCA
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3057761221832925,0.8296840161284327,0.7740174672489083,0.9206493412692759,1.0,10/62,12.82%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,response to cAMP (GO:0051591),0.32062142536562166,0.8295855391827646,0.7158962795941376,0.9204016754075299,1.0,11/37,27.61%,AKAP6;IGFBP5;ZFP36L1;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,mesenchyme development (GO:0060485),-0.2968838867821839,-0.8291102046761909,0.6934865900383141,0.904584921604407,1.0,6/15,19.40%,TGFBR1;FGFR2;WNT11;BMP4;BMPR2;PKD2
prerank,mitotic DNA replication (GO:1902969),0.41131639237323214,0.8282236497043567,0.6982167352537723,0.9221463253617478,1.0,7/10,38.36%,GINS3;CDC45;LIG1;MCM2;GINS1;MCM4;MCM3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.30299541170961486,0.827849227328026,0.7664155005382132,0.9223606213212623,1.0,10/64,12.82%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3631142567566448,0.8277161497195076,0.7094682230869002,0.9221762422931203,1.0,2/17,10.56%,PLAAT3;PLA2G4F
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.33402897174408097,0.8276191542164002,0.7218934911242604,0.9219426354031057,1.0,7/33,12.78%,TNF;PDGFB;SPI1;EGR1;GATA2;JUN;KLF4
prerank,skeletal system development (GO:0001501),0.28395852120266374,0.8274540475737722,0.8301314459049545,0.9218026455006755,1.0,13/148,6.12%,RPL13;COL1A1;PPIB;BCAN;VKORC1;RBP4;TGM2;ETS2;ADAMTS4;HYAL2;BPNT2;HAPLN2;RFLNB
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.40108516016471407,0.8272370506878454,0.6862745098039216,0.921742697951507,1.0,3/10,19.11%,AKT1;PMAIP1;SNCA
prerank,DNA packaging (GO:0006323),0.372728060194766,0.8269388323932761,0.6892430278884463,0.9218425832627777,1.0,3/16,11.38%,H1-0;NAA10;BANF1
prerank,negative regulation of nuclear division (GO:0051784),0.4039237195563271,0.8266459479089392,0.6895104895104895,0.9219366806517577,1.0,3/11,17.56%,AURKAIP1;FBXO5;NANOS2
prerank,positive regulation of isotype switching (GO:0045830),-0.29536381906060105,-0.8263755442622646,0.7407407407407407,0.9083377345750969,1.0,6/15,22.49%,KMT5C;KMT5B;SHLD1;HMCES;SHLD2;SHLD3
prerank,regulation of response to stress (GO:0080134),0.40390924824716057,0.8260505274047475,0.689900426742532,0.9225116811413515,1.0,3/10,27.24%,MLC1;ADCY8;CORO2B
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.2982328133134363,0.825815045261203,0.7597883597883598,0.9224983529706243,1.0,8/74,6.09%,GPX1;HMOX1;PARK7;AKT1;TNF;LGALS3;HSPA1B;TNFAIP3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3083147314271536,0.8257316876716453,0.7541528239202658,0.922249019181363,1.0,9/47,13.74%,AKT1;CDS1;ZFP36L1;RARRES2;CEBPB;LPL;ZFP36;BMP2;HNRNPU
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.27629389755856043,0.8251838834842005,0.923923923923924,0.9227003264767754,1.0,82/341,21.86%,PSMB4;UBXN1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PINK1;KCTD10;TOLLIP;PSMD1;UBE2G2;PSMC3;UCHL1;CTNNB1;PSMD6;VCP;TNFAIP3;CDC34;RNF187;ARRDC1;PSMA7;KCTD2;FEM1A;FEM1C;FBXL14;UBAP1L;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;NEDD8;TRIM2;OTUD7A;TNFAIP1;RNF128;DDB1;PSMB9;PSMD13;RBCK1;BUB3;PSMB3;FBXW5;SYVN1;VPS28;PSMB11;ZSWIM8;FBXW7;UBQLN2;PSMB10;RNF40;KBTBD7;RNF150;SPSB3;PSMB1;ARRB2;RNF7;PSMB5;HERPUD1;SQSTM1;TRIM32;RNF149;RLIM;KCTD13;VPS4A;VPS37C;PSMA6;RNF144B;HECW1;TRIM13;RAD23A;RNF11;PSMA4;KLHL25;DDIT3;SIRT2;UBXN11;STUB1;ELOC;IFI27;AMFR
prerank,regulation of protein sumoylation (GO:0033233),0.36195923590652224,0.8249509920209955,0.6890322580645162,0.9226836834002158,1.0,3/17,9.30%,PARK7;CTNNB1;EGR1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3915386657111697,0.824708896635222,0.6850828729281768,0.9226593323714708,1.0,2/11,11.44%,CD34;ATP6AP2
prerank,mitochondrial protein processing (GO:0034982),0.39437513032523397,0.8244819121195011,0.6964539007092199,0.9226419078720568,1.0,3/11,14.65%,OMA1;PMPCB;SPG7
prerank,extracellular transport (GO:0006858),-0.3138281638642419,-0.8244329994406574,0.7147887323943662,0.9105376746678484,1.0,9/12,30.04%,WWP2;SPAG17;TSG101;SPA17;DNAAF2;ROPN1L;CCDC40;DNAAF4;ADCY10
prerank,cell cycle G1/S phase transition (GO:0044843),-0.21412282695076865,-0.8243217060301686,0.8387096774193549,0.9092580946053535,1.0,18/61,19.26%,ACVR1;MNAT1;CDK6;CRLF3;NASP;CUL4B;CUL4A;LATS2;PHF8;PPP6C;CDK7;HINFP;USP37;CUL5;PLK2;POLE;KHDRBS1;CACUL1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.32997521571471045,0.8235428494870523,0.7261761158021713,0.923708717914072,1.0,5/30,12.48%,H3-3A;PARK7;PKN1;ZBTB7A;NCOR2
prerank,bicellular tight junction assembly (GO:0070830),0.31042547731273384,0.8229572625418808,0.7437923250564334,0.9242571072130645,1.0,13/46,24.27%,CLDN5;RAMP2;CLDN11;ESAM;PECAM1;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,glycerol metabolic process (GO:0006071),0.4028250415405762,0.8226383254462001,0.7071742313323572,0.9243498029738741,1.0,4/10,26.80%,TPI1;PGP;GOT1;COQ2
prerank,cellular protein modification process (GO:0006464),0.27122346399965896,0.8225854393708728,0.99,0.9240522666014399,1.0,248/982,25.11%,APOE;CST3;PSMB4;ELOB;SPARCL1;SPP1;F13A1;LGALS1;PPP1CA;MT3;PARK7;C3;LAMC1;LAMB2;MAPK3;PSME1;AKT1;PSMB6;PNPLA2;PSME2;PSMB8;CKAP4;PSMD2;RPN1;COPS7A;TGM2;RCE1;PINK1;IGFBP3;MFGE8;COPS6;IGFBP4;METAP1;FBXO15;HSP90B1;PDGFB;KLHL9;PTPRC;CTDSP2;ACVRL1;IGFBP5;CHEK2;PSMD1;RPN2;SHISA5;EPAS1;UBL5;PSMC3;PDIA6;PPP2R1A;DAD1;PARP1;PSMD6;CPE;LOX;CTDNEP1;LTK;CDC34;PENK;FN1;MATK;HIPK2;CDK8;DDOST;UBA52;BRD2;PSMA7;ISG15;P4HB;EPB42;PTK6;SGK1;FN3KRP;FEM1A;FEM1C;PKN1;PAK1;FBXL14;DUSP26;APLP2;MAST1;UBE2M;VWA1;LIPE;METAP2;PSMD5;COL3A1;RBX1;NEDD8;FBXO27;TIMP1;PTPRN2;HS3ST5;CAMK1;CTDSP1;HCK;PHPT1;BCKDK;PAK3;DDB1;ICMT;PSMB9;PSMD13;PRKAR1B;AATK;CTBP1;CHRM3;B3GNT9;PSMB3;PLAT;FBXW5;WFS1;PTPRD;SERP1;CDK19;MAP3K21;PSMB11;PTPRB;MXRA8;PTPRR;AMHR2;CDKL4;ASB13;ST8SIA4;FBXW7;FBXO30;NEK10;BMP2;FBXO31;GAS6;PSMB10;YWHAZ;EVPL;KBTBD7;TIMM50;CDC42BPA;MAPK10;STK11;CCL2;SPSB3;PTPRZ1;COPS8;PIGS;TSSK6;TSSK4;ALG3;PDF;ARF4;CDK5;PSMB1;RNF7;ERO1A;GMFB;PSMB5;VCAN;FUT9;VHL;PDP2;PIM3;BRSK2;PIK3CD;EVA1A;SCG3;CSNK1G2;PPP2R5D;B3GNT3;PPM1J;MAP4K2;RBBP5;SYK;PDP1;NOTUM;ST6GALNAC2;STT3A;WDR45;TAB1;SLC35A1;PPP3CA;MKNK1;PSMA6;ST8SIA5;GRK2;FBXL16;IL6;TGFB1;PPEF1;NEK1;PORCN;SKP1;PRSS23;QSOX1;PSMA4;KLHL25;BTBD6;GAD1;SSH2;PAK5;PTPN6;PTPRU;PTPRO;PPP2R5A;CDK9;SIRT2;DUSP2;QPCT;ELOC;MEN1;SCG2;PPM1F;ENGASE;PTPN5;DUSP12;DUSP1;B3GALT5;MGAT1;CCDC8;CDK18;PSMC1;KCTD7;PTPN1;PSMD9;NUS1;B3GALT2;TGM7;PTPRE;SOCS3;CDK10;SBF1;DYRK2;PAK4;NPC1;DYRK1B;RCN1;APP;FBXO2;LMTK3;CCN1;BAP1;WSB2;PPP1CB;PRRT1;MACROD2;VRK1;FBXL3;DNAJC3;PSMB2;PRKCA;PRKACA
prerank,establishment of epithelial cell polarity (GO:0090162),-0.27774366056296945,-0.8220642783477701,0.7807017543859649,0.9122621217877376,1.0,5/19,14.40%,PARD3;SIPA1L3;OPHN1;MYO18A;MYO9A
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3896868109992769,0.8219000562866766,0.7021563342318059,0.9247538767355444,1.0,4/11,21.53%,FBL;EXOSC2;DKC1;EXOSC4
prerank,regulation of programmed necrotic cell death (GO:0062098),0.35626905218901617,0.8215553838995522,0.7245657568238213,0.924901360222586,1.0,5/20,14.29%,HSP90AA1;FLOT1;NUPR1;CDC37;SDCBP
prerank,primary alcohol metabolic process (GO:0034308),0.33529309776304045,0.8213559787861199,0.717632552404439,0.9248190523293986,1.0,9/25,30.92%,RBP4;GDE1;NAAA;LRAT;GDPD1;GDPD3;GPD2;ALDH3A2;ADH1A
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3220562176408907,0.8213192867199336,0.7406989853438557,0.9244857812440276,1.0,7/39,11.11%,MYO5A;PPFIA2;MYO7B;MYO1F;SYT4;FNBP1L;HAP1
prerank,ether lipid metabolic process (GO:0046485),-0.30377653818375405,-0.8211990763954983,0.7242798353909465,0.9124622884702678,1.0,4/14,10.78%,AGMO;PAFAH1B1;FAR1;PEX7
prerank,negative regulation of mRNA processing (GO:0050686),0.37275646070847346,0.8210905494358613,0.7035040431266847,0.9244696846726882,1.0,2/15,7.06%,PCBP4;SRSF9
prerank,negative regulation of histone methylation (GO:0031061),-0.33109037523241447,-0.8208788866307958,0.6883116883116883,0.9115817103965991,1.0,2/10,6.41%,JARID2;BCOR
prerank,regulation of anoikis (GO:2000209),-0.2736549160013502,-0.8208637005469083,0.7107843137254902,0.9101392866882764,1.0,5/19,12.48%,ITGA5;TLE1;SIK1;PTK2;BCL2
prerank,regulation of spindle assembly (GO:0090169),0.3440781979341642,0.8206133234496924,0.7049763033175356,0.9248148671148002,1.0,12/25,32.42%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B;CHMP1A;CHMP4C;CCSAP;SPAG5;DYNC1H1;CHMP4B
prerank,negative regulation of histone modification (GO:0031057),0.37824543387620735,0.8206005935071865,0.7140939597315437,0.9244423843498446,1.0,5/14,20.23%,SET;CTBP1;TWIST1;SNCA;SPHK2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.40365349781002685,0.8203305462306156,0.7067988668555241,0.9244711939143387,1.0,5/10,31.37%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.39177101120278723,0.8194063556561934,0.7052186177715092,0.9255137356916464,1.0,4/12,18.66%,MTLN;RYR2;FKBP1B;ANXA6
prerank,cellular amino acid catabolic process (GO:0009063),0.2915096680500709,0.81921612448782,0.7970863683662851,0.9254124303829373,1.0,19/87,21.19%,BCAT2;GLUL;SDS;BCKDK;IDO2;ACAT1;QDPR;SLC25A21;DDAH1;CRYM;GLS2;GLS;ECHS1;NOS2;GLUD1;GOT1;SHMT2;GAD1;ALDH4A1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.3983056089495552,0.8191671995558629,0.6949860724233984,0.9250984530434123,1.0,2/10,10.24%,ENPP2;PLA2G7
prerank,activation of phospholipase C activity (GO:0007202),0.32773299769564906,0.8191463687263496,0.7326968973747017,0.9247488211472646,1.0,5/29,9.31%,NTRK2;ANG;C5AR1;P2RY6;P2RY12
prerank,glial cell differentiation (GO:0010001),0.33065631936259027,0.819084625094427,0.7331701346389229,0.9244680536861343,1.0,16/28,32.84%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;ERBB3;EIF2B5;SOX11;SOX10;MMP24;GPC1;SOX4;CDH2;SHH;RELN;PAX2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.222689778536147,-0.8186925026004146,0.8106060606060606,0.9127497605111455,1.0,4/41,5.12%,PRKAG2;RANBP2;OGT;NUP98
prerank,RNA biosynthetic process (GO:0032774),-0.24132826164866947,-0.8184538911622806,0.8382352941176471,0.9117113635175629,1.0,9/31,23.43%,TTF1;SMARCA5;SETX;TERT;POLR2A;RSF1;TAF7;NCOA6;BRF1
prerank,regulation of phosphorylation (GO:0042325),0.2847119473224224,0.8182345742609004,0.8290685772773797,0.9253858572987809,1.0,42/120,29.08%,HSPB1;PGAM1;DYNLL1;GRM5;EMP2;ANG;DSCAM;PIN1;MIF;CDKN1C;FN1;CORO1C;CD24;CADM4;ZBTB7A;CCDC88A;NUP85;SDCBP;NUP88;PTGES3;CDH5;PRKRIP1;NOP53;NUP50;INHBA;RAE1;SIRT2;TESK1;PLXNB2;APP;BARD1;CDKN2B;INHA;EIF6;SLC2A6;CDKN1A;ITGA6;MCM7;CCDC88C;NUP205;NUP188;PPP2CA
prerank,protein methylation (GO:0006479),-0.22608317786759766,-0.8179754295647282,0.8115942028985508,0.9111784392644945,1.0,12/40,18.53%,NSD1;EHMT1;NSD3;CAMKMT;EHMT2;CARM1;EZH2;PRMT6;METTL22;SETD3;VCPKMT;METTL21A
prerank,amino sugar biosynthetic process (GO:0046349),-0.3139351548391283,-0.8178436744424785,0.6856060606060606,0.9099811787449926,1.0,4/12,19.29%,PGM3;GFPT2;RENBP;NAGK
prerank,myofibril assembly (GO:0030239),-0.21492404190746914,-0.8176332513517932,0.8120300751879699,0.9089124266501819,1.0,7/42,14.99%,TMOD3;CFLAR;ACTN2;PDGFRB;TPM1;OBSL1;TNNT3
prerank,pinocytosis (GO:0006907),0.40050012800751034,0.817432625951602,0.7063953488372093,0.9262279334419768,1.0,4/10,24.63%,DOCK2;SNX33;PYCARD;SNX5
prerank,regulation of integrin activation (GO:0033623),0.3651253122326936,0.8172193692093215,0.7496635262449529,0.9261628427486652,1.0,4/15,19.07%,RASIP1;JAM3;SKAP1;FBLIM1
prerank,gliogenesis (GO:0042063),-0.2889999225774772,-0.8170794347051266,0.7300884955752213,0.9085362584576756,1.0,2/15,6.80%,NFIB;CDK6
prerank,negative regulation of fat cell differentiation (GO:0045599),0.32741131680729485,0.8166875863075882,0.7420494699646644,0.9266168963486681,1.0,8/34,13.56%,CCDC85B;GPER1;TNF;ZFP36L2;GATA2;LRP3;WNT5A;WNT10B
prerank,regulation of phosphatase activity (GO:0010921),-0.2495828980164938,-0.8166344539439698,0.7401960784313726,0.9079019082935278,1.0,8/24,17.56%,PPP6R3;URI1;GPATCH2;PPP6R2;SH3RF2;TSC1;ZCCHC9;SH2D4A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3054212222367744,0.8160065706454099,0.7644394110985278,0.9272601703652001,1.0,7/46,9.68%,RAN;HCLS1;FLNA;YWHAE;HYAL2;TRIM28;CAMK1
prerank,signal peptide processing (GO:0006465),0.3995159284738408,0.815826163804773,0.7051460361613352,0.9271440338185692,1.0,4/11,18.38%,SPCS1;CLN5;SPCS2;SEC11C
prerank,positive regulation of protein maturation (GO:1903319),-0.31462501451148106,-0.8158052991140737,0.6923076923076923,0.9079080021876482,1.0,4/11,24.19%,RHBDD1;CCBE1;BAG2;NLRC4
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3653238782812519,0.8147673109573534,0.726552179656539,0.928386650440612,1.0,2/16,3.71%,SHFL;TNF
prerank,cellular response to fluid shear stress (GO:0071498),0.38968191265746,0.8147057575607833,0.7053206002728513,0.9280932457178321,1.0,3/12,20.07%,KLF2;KLF4;MEF2C
prerank,magnesium ion transport (GO:0015693),0.37947573823975483,0.8143261145437402,0.7327001356852103,0.9282847446681891,1.0,6/12,31.06%,NIPAL4;MAGT1;NIPA1;NIPAL1;NIPAL3;MMGT1
prerank,pigment granule transport (GO:0051904),0.361507194481774,0.8142413222003277,0.7155388471177945,0.9276481528806749,1.0,7/18,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,melanosome transport (GO:0032402),0.361507194481774,0.8142413222003277,0.7155388471177945,0.9276481528806749,1.0,7/18,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3806622285583883,0.8139785865294594,0.7282913165266106,0.9276734284836468,1.0,2/13,5.34%,YWHAB;FLNA
prerank,cellular response to hexose stimulus (GO:0071331),0.3387192291570531,0.8137966115013128,0.7238805970149254,0.9275706969868721,1.0,2/23,3.42%,RACK1;GPER1
prerank,mitotic cell cycle phase transition (GO:0044772),0.27537034347654643,0.8130941965119823,0.8639112903225806,0.9283038282408832,1.0,32/203,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;CCNI;CCND2;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CDC34;GPR132;CCND1;CLASP1;YWHAG;TUBB4A;TACC3;CEP131;USP29;CCNG1;DCTN1;SSNA1;HAUS2;USP26;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3348845145709233,-0.8129073345677994,0.7175572519083969,0.9117008525974092,1.0,3/11,14.01%,RAPGEF2;SIRT1;LGALS9
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3458491519418355,0.8126300416169276,0.7157490396927016,0.9286238492938027,1.0,6/20,29.04%,DCC;BAX;ERBB3;BAK1;BOK;MCL1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3221495729470634,0.8126084459634927,0.7226890756302521,0.928273612208455,1.0,15/31,34.73%,LSM4;LSM6;POLR2G;EXOSC2;EDC4;EXOSC9;LSM7;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,programmed necrotic cell death (GO:0097300),0.35859322788137027,0.8126022563074223,0.7193877551020408,0.9278996310427317,1.0,9/18,36.22%,ALKBH7;TICAM2;DNM1L;CD14;PGAM5;MLKL;PPIF;IPMK;ITPK1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.33693908811587914,0.8124875536028142,0.7162162162162162,0.9276961213121505,1.0,8/25,19.95%,PARK7;H1-0;ZBTB7A;HEY1;TWIST1;SOX11;TGFB1;POU4F1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2972644746972828,0.8123404968500334,0.7926167209554832,0.9275312002960276,1.0,8/64,8.34%,ACTG1;ADAM15;EMP2;DUSP3;GPM6B;CORO1C;CLASP1;THY1
prerank,toxin transport (GO:1901998),-0.3301324295487353,-0.8118344404140619,0.703125,0.912095297567703,1.0,10/10,67.01%,ANTXR2;RAB29;ANTXR1;ANTXRL;SLC22A1;SLC22A3;SLC22A2;ADAM10;RAB40B;SLC29A4
prerank,regulation of chromosome segregation (GO:0051983),-0.2835984885515606,-0.8117659984669289,0.7394957983193278,0.9107756084146175,1.0,5/16,17.49%,CSNK2A1;CSNK2A2;NUMA1;PUM2;RMI2
prerank,positive regulation of axon extension (GO:0045773),0.3400150610439858,0.8115799184217487,0.7232472324723247,0.92833614606446,1.0,5/22,13.44%,DSCAM;SEMA7A;MAPT;NTN1;SHTN1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.399819331379141,0.8114397899154495,0.7175792507204611,0.9281690979019904,1.0,3/10,18.53%,APEX1;DCLRE1C;TERF2IP
prerank,inorganic anion transport (GO:0015698),0.3076775117136292,0.8112699892958388,0.7555066079295154,0.9280609467665053,1.0,8/53,12.88%,FXYD1;TTYH1;SLC26A4;SLC25A11;GLRA1;CLIC1;TTYH3;SLC11A1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2967122343136546,0.8110291782071041,0.7869379014989293,0.928043984361904,1.0,16/62,23.94%,H3-3A;POLR2E;POLR2D;POLR2F;ZFP36;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;TGFB1;RAE1;POLR2H;ELAVL1;DND1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.35628437492142917,0.8109961691127241,0.712998712998713,0.92770791847658,1.0,5/18,16.34%,CAMK1D;EPHA5;TSSK4;LRP8;ADCY8
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.31877763871866965,-0.8109189090782476,0.7071428571428572,0.9108611140164854,1.0,4/11,19.29%,PGM3;GFPT2;RENBP;NAGK
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.31019616125307103,-0.8102797397922754,0.7335907335907336,0.9105217095250046,1.0,4/13,15.43%,RREB1;SIX1;NAPEPLD;SOX13
prerank,filopodium assembly (GO:0046847),0.35933972921927304,0.8095276035674336,0.7170795306388527,0.9295742918689406,1.0,2/16,7.71%,DNM3;ARHGEF4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.40189658427758357,0.8093721452333112,0.7221418234442837,0.9294246371599084,1.0,3/10,21.50%,CTNNB1;WNT5A;FZD1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.39824853638946484,0.8091133602411137,0.7301136363636364,0.9294394538035553,1.0,1/11,1.37%,H3-3A
prerank,glucan catabolic process (GO:0009251),0.3632066202266268,0.8090586833223611,0.7315789473684211,0.9291360635949596,1.0,2/15,10.43%,CALM1;GAA
prerank,muscle tissue morphogenesis (GO:0060415),-0.28355094817762044,-0.8090582598189385,0.7361111111111112,0.9112718054053452,1.0,4/16,14.92%,TGFBR3;MYLK;BMP4;HEY2
prerank,plasma membrane tubulation (GO:0097320),0.37821484855457843,0.8090180631288896,0.7169559412550067,0.9288094063541469,1.0,5/13,24.61%,PACSIN1;FNBP1L;SNX33;EHD2;CAVIN2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.2954463110135592,-0.8086712125574173,0.7182539682539683,0.9105255248022696,1.0,5/12,19.09%,SDK2;STAT3;CEP290;NKD1;AGTPBP1
prerank,calcium-mediated signaling (GO:0019722),0.2832036771289572,0.8073660765675317,0.8228511530398323,0.9309185163990903,1.0,23/93,19.08%,RCAN3;PRNP;GRM5;PTPRC;CCR5;P2RX7;KDR;P2RY12;CHRM3;TRPM2;CXCR4;CX3CR1;NUDT4;ATP1B1;SLC8A1;RYR2;DMTN;CCL3;VCAM1;BCAP31;FKBP1B;CCR2;PPP3CA
prerank,liver development (GO:0001889),-0.23066116146320595,-0.8071941943612179,0.8333333333333334,0.9117740353029762,1.0,5/32,8.84%,TGFBR3;COBL;ARID5B;MET;NPHP3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.238516230723875,-0.8066793692272398,0.7833333333333333,0.9112651181996282,1.0,3/26,4.62%,SNX6;CBLB;ERRFI1
prerank,regulation of double-strand break repair (GO:2000779),-0.22854760485568412,-0.806411294333074,0.8503937007874016,0.9102815987749978,1.0,13/39,19.20%,TRIP12;SETD2;UBR5;SPIDR;PML;RNF169;PPP4R2;MRNIP;MGMT;SIRT7;RTEL1;ZCWPW1;SHLD2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.32432322989023155,0.8062900869810158,0.7351154313487241,0.9321182857658817,1.0,9/27,25.73%,CCL19;PDGFB;P2RY12;FLT1;AGAP2;FLT3;TGFB1;TEK;FGFR3
prerank,RNA interference (GO:0016246),-0.27355854900762955,-0.8052000046243024,0.759825327510917,0.9111941199515503,1.0,8/17,21.82%,DICER1;DROSHA;TERT;TARBP2;AGO2;CELF1;AGO4;CLP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.35242501465082227,0.8050427151974365,0.7222222222222222,0.9335861782144677,1.0,7/17,33.58%,MPDU1;DOLK;ALG3;NUS1;DPAGT1;ALG6;ALG2
prerank,histone H2A monoubiquitination (GO:0035518),-0.27537525993754147,-0.8048680646866976,0.7868852459016393,0.9104061343535231,1.0,4/17,11.00%,BCOR;DDB2;PCGF5;CUL4B
prerank,retinol metabolic process (GO:0042572),0.36728552118845026,0.8048039857851637,0.7305061559507524,0.9335702051756217,1.0,2/14,16.23%,RBP4;LRAT
prerank,regulation of receptor recycling (GO:0001919),0.3635716203101257,0.8047113589073464,0.7283783783783784,0.9333279194917965,1.0,9/16,35.29%,VAMP3;RAMP3;SNCA;TRAT1;AP1AR;ECE1;ANXA2;LAMTOR1;NSF
prerank,protein polyubiquitination (GO:0000209),0.26887967353972975,0.8035519081512044,0.935,0.9347076331275443,1.0,45/297,14.04%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FBXO15;PSMD1;UBE2G2;ANAPC13;PSMC3;CTNNB1;PSMD6;IRF2BP1;UBE2Q1;MAGEL2;TNFAIP3;CDC34;DCAF15;RNF187;UBA52;PSMA7;FBXL14;NHLRC1;PRPF19;PSMD5;RBX1;FBXO27;TRIM2;PSMB9;PSMD13;RBCK1;PSMB3;FBXW5;SYVN1;PSMB11;FBXW7;FBXO30;FBXO31;PSMB10;KBTBD7;UBE2V1
prerank,Wnt signaling pathway (GO:0016055),0.2827177619555723,0.8035191025570703,0.8303664921465969,0.9343728753963798,1.0,10/92,9.26%,RPS27A;UBC;UBB;FZD9;CTNNB1;CPE;SFRP5;UBA52;RBX1;CD24
prerank,response to molecule of bacterial origin (GO:0002237),0.2903538629043369,0.8028519263448871,0.8012889366272825,0.9349699954015648,1.0,24/69,29.83%,C4B;S100A9;S100A8;TIRAP;TNFAIP3;HNRNPA0;CD24;SLC11A1;ERBIN;ADAM17;NOS2;SNCA;CD14;IL6;SIRT2;IRF5;TNFRSF11A;LBP;TRIB1;FZD5;GGT5;GGT7;ACOD1;IFNAR1
prerank,indolalkylamine catabolic process (GO:0046218),0.3956502030538535,0.8025581391019772,0.7208976157082749,0.9350198066432921,1.0,1/10,11.01%,IDO2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3953332555631014,0.802251747881563,0.6957746478873239,0.9350910123515865,1.0,4/10,20.23%,CAMK1;PIH1D1;HDAC5;SPHK2
prerank,homocysteine metabolic process (GO:0050667),0.3841602317360424,0.8018698778686465,0.743448275862069,0.9352458816471021,1.0,2/11,15.82%,MPST;TST
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.22104114602033104,-0.8016333504383707,0.8333333333333334,0.9145946452162067,1.0,4/41,5.12%,PRKAG2;RANBP2;OGT;NUP98
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3489302001578182,0.8011746880065946,0.7522935779816514,0.9358956106969223,1.0,9/19,31.73%,MDK;GAS6;MMP14;SYK;PPP2R3C;XBP1;XRCC6;ZAP70;BTK
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3704687061589035,0.8008472066346461,0.7489597780859917,0.9359854019048437,1.0,5/14,21.12%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,regulation of centrosome duplication (GO:0010824),0.3263941841948245,0.8002006072756003,0.7431629013079667,0.9365554353702185,1.0,6/29,15.97%,NPM1;CHMP2B;CHMP5;CEP131;FBXW5;CHMP1B
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.26159373834192945,-0.800011784121312,0.7745098039215687,0.9159606379066286,1.0,4/20,7.42%,MCU;MICU1;MICU2;SLC8B1
prerank,long-chain fatty acid import into cell (GO:0044539),0.39470432976994885,0.7994795740980648,0.71671388101983,0.9371955165019917,1.0,1/10,2.52%,SLC2A1
prerank,organelle assembly (GO:0070925),0.26783673810714514,0.7992239860531015,0.955955955955956,0.937165874923597,1.0,69/384,20.65%,RPS23;RPS3;GABARAP;GSN;DYNLL2;DYNLL1;MAP1LC3B;CD34;NPM1;MAP1LC3A;EMC6;GABARAPL2;CDS1;AUP1;LSM4;GABARAPL1;BSCL2;IFT20;ABCB6;FLNA;CHMP2B;ATG9A;CORO1A;CNGA4;MAPT;CHMP5;CHMP6;FNBP1L;CEP131;FHDC1;TCTN3;VPS28;SAC3D1;ANLN;ATXN2L;UBQLN2;FLII;VMP1;HAUS2;EHD1;CSDE1;ATG101;G3BP1;ARF4;CIRBP;MAPRE3;YTHDF1;TMOD1;CNGB1;CHMP1B;TMEM17;E2F4;CCDC28B;EIF4ENIF1;TCTN1;EXOC7;EHD2;VPS4A;WDR45;VPS37C;NOTCH1;BBIP1;NEK1;EXOC5;CAPN3;CFAP410;CFAP54;CHMP7;EXOC8
prerank,sterol biosynthetic process (GO:0016126),0.31373022683746077,0.7989147534460149,0.753757225433526,0.9372276908754053,1.0,13/33,28.43%,LSS;DHCR24;ACAA2;SC5D;CH25H;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3625438416782156,0.7985738523227767,0.7401685393258427,0.9373614655390842,1.0,4/14,20.76%,CCL19;CD86;NLRP3;NFKBID
prerank,regulation of peptide hormone secretion (GO:0090276),0.28975859454588326,0.7985144865225039,0.8145766345123259,0.937063252757079,1.0,14/67,21.10%,UQCC2;MTNR1B;SLC2A1;SNAP25;TNF;CACNA1A;HTR2C;RASL10B;ABCC8;SLC2A2;NOS2;TFAP2B;IL6;KCNC2
prerank,regulation of cellular pH (GO:0030641),0.3189986797135001,0.7975694862109416,0.7520858164481525,0.9380192763762298,1.0,3/29,5.28%,ATP5F1B;CA2;ATP6AP1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.30000285823162015,-0.7975522183412765,0.7483221476510067,0.9188716197723552,1.0,4/12,14.98%,ELF1;ELF2;CBFB;PTPN22
prerank,regulation of dendrite morphogenesis (GO:0048814),0.31749053357745355,0.7973459588112481,0.761501210653753,0.9379557703959447,1.0,10/32,22.37%,ADGRB3;YWHAH;KNDC1;IL1RAPL1;SS18L2;PTPRD;NSMF;HECW1;SS18L1;CHRNA3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.34007649525043293,0.7970992730457396,0.7462871287128713,0.9379322121416647,1.0,8/20,25.99%,ADSS1;GART;AK4;AK3;IMPDH1;PAICS;IMPDH2;ADSL
prerank,heterochromatin assembly (GO:0031507),0.3448826087011516,0.796054754480578,0.7522349936143039,0.939060845519963,1.0,1/20,1.37%,H3-3A
prerank,positive regulation of potassium ion transport (GO:0043268),0.3043641006938379,0.7960535432026851,0.7717265353418308,0.9386800579607524,1.0,12/38,27.61%,AKAP6;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.26202321922668215,-0.795352785378719,0.8055555555555556,0.9212386739871026,1.0,9/23,23.02%,CAMK2D;ANK2;ATP1A2;DIAPH1;NOS1AP;NOS1;PTK2B;CACNB1;CASQ1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3077590189219016,0.7953035785104623,0.7745664739884393,0.9394220156089764,1.0,12/40,25.76%,NUCKS1;CENPX;PCNA;DDX11;TRAIP;MMS22L;ALYREF;FAM111A;CDK9;BLM;POLD1;RAD51
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3415247165712942,0.7944625917725038,0.7378768020969856,0.940291540739495,1.0,9/21,25.94%,PSENEN;SPPL2B;BACE1;PSEN2;ADAM17;SPPL2A;ERAP1;APH1A;PRKCQ
prerank,keratinocyte differentiation (GO:0030216),-0.22905676498801616,-0.7942172011096359,0.7919463087248322,0.9217422761565257,1.0,7/29,14.38%,ADAM9;BCR;PIP5K1A;WNT16;JAG1;CASP3;CLIC4
prerank,positive regulation of bone mineralization (GO:0030501),0.312862076418662,0.7937175403163547,0.7728337236533958,0.9409955806948819,1.0,15/35,24.73%,FZD9;GPM6B;ISG15;NELL1;P2RX7;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3483277177210041,0.7932865850233396,0.7407894736842106,0.9412577143746418,1.0,5/18,16.36%,GPR137B;FBXW7;LILRB1;LILRB3;CCL3
prerank,myoblast differentiation (GO:0045445),0.36374838315293867,0.7932026921282991,0.7187079407806191,0.9409926114980904,1.0,2/14,4.55%,NRG1;EPAS1
prerank,tRNA wobble base modification (GO:0002097),0.36752048307577256,0.7923133037867071,0.7178807947019867,0.9418990693759023,1.0,6/14,24.68%,DPH3;ELP3;CTU1;ADAT2;URM1;CTU2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.36195199803345374,0.7919007130236315,0.7510373443983402,0.9421152577671187,1.0,5/15,21.12%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,chromatin assembly (GO:0031497),0.3078065531242196,0.7915527338135385,0.7691401648998822,0.9422171819174789,1.0,6/38,16.59%,H3-3A;NPM1;BRD2;H1-0;SOX9;NAP1L2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3213409876767992,0.790997036604132,0.7755102040816326,0.9426367707326121,1.0,6/30,14.62%,RAC1;ADGRG1;COL3A1;NET1;GPR18;F2RL1
prerank,spliceosomal complex assembly (GO:0000245),0.30188953192655094,0.7908548392901944,0.8004509582863585,0.9424648090705061,1.0,17/46,25.45%,SNRPG;DDX39B;SNRPD2;SNRPE;PUF60;SRSF9;PRPF19;SF3A2;SF3A3;CELF3;TXNL4A;SF3A1;SRSF1;SNRNP200;LUC7L3;CELF4;CELF5
prerank,sympathetic nervous system development (GO:0048485),0.36484494710586873,0.7908219182606506,0.7516254876462939,0.9421362061438112,1.0,4/15,19.55%,SEMA3F;CTNNB1;SOX11;TFAP2B
prerank,chordate embryonic development (GO:0043009),0.2939315929019958,0.7907836641044212,0.7924528301886793,0.9418117967138273,1.0,10/55,15.42%,COL1A1;RBP4;FOXD3;PROX1;WNT5A;SOX8;PTPRR;BMP2;XYLT1;IGF2
prerank,regulation of spindle organization (GO:0090224),0.3456130333570954,0.7907144612493103,0.7335907335907336,0.9415257332581932,1.0,4/18,12.87%,CLTC;TACC3;GNAI1;DCTN1
prerank,establishment of vesicle localization (GO:0051650),0.3428792452224784,0.7905541361084829,0.7425227568270482,0.9413913893788548,1.0,7/18,31.29%,SYT11;KIF5A;CDK5;KIF5C;TESK1;IKBKG;SPG11
prerank,organic acid transport (GO:0015849),0.2792262565626454,0.7905020605346164,0.8362877997914494,0.941091604038244,1.0,22/94,25.80%,SLC38A5;SLC1A4;SLCO1C1;SLC25A29;SLC6A6;MFSD2A;SLC25A11;SLC3A2;SLC10A3;SLC7A14;SLC19A1;FOLR2;SLC16A1;ABCC3;SLCO1B1;SLC10A6;SLC7A10;SLC25A14;SLC7A6;SLC43A2;SLC38A3;SFXN5
prerank,protein monoubiquitination (GO:0006513),-0.22551253803956636,-0.7902866233520947,0.8111888111888111,0.926933406134505,1.0,9/36,18.97%,PRKN;UBE2R2;HUWE1;TOPORS;CDC73;UBE2E1;KLHL22;WAC;RNF20
prerank,DNA metabolic process (GO:0006259),0.2666188554194205,0.789701389830161,0.933933933933934,0.9418775046877876,1.0,59/270,25.76%,RPS27A;UBC;UBB;PARK7;TERF1;NPM1;ENDOG;RAN;RNASEH2A;LTO1;MCM5;PARP1;HMGB3;VCP;RPA2;CDC34;UBA52;GMNN;TRIM28;HMGB1;DDB1;NEIL1;RNASEH1;APEX1;PCNA;NSMCE3;POLE4;CHRNA4;RFC2;TSN;PTGES3;GLRX2;RECQL5;POLD4;MUS81;CNBP;CTC1;NOP53;TERF2IP;RFC4;ERCC1;GADD45A;POLG;MEN1;ZNF445;BLM;CDC45;LONP1;POLD1;PNKP;BARD1;ATRIP;RPA3;RPAIN;DOT1L;XPC;LIG1;UBE2A;RAD51
prerank,negative regulation of insulin secretion (GO:0046676),0.3445527420889194,0.7896005796808314,0.7399219765929779,0.9416479298925615,1.0,7/17,23.19%,CHGA;PIM3;SFRP1;INHBB;CCN3;REST;PSMD9
prerank,mitochondrial fusion (GO:0008053),0.3425097791065971,0.7894454555607271,0.7594278283485045,0.941486325826974,1.0,6/18,21.42%,BAX;GDAP1;MIEF2;SPG7;MFF;FIS1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2618811255318787,0.7890902091122781,0.955955955955956,0.9416052847906189,1.0,98/417,21.84%,HSPA8;PFDN5;CALR;MT3;NDUFA13;TMPRSS6;ID3;SOX18;NRG1;ID1;CRYAB;EID1;CCDC85B;TNF;PDGFB;NR1D1;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;GMNN;ARID4A;TRIM28;FOXL2;CREBZF;CEBPA;PROX1;BASP1;RBM15B;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;CTBP1;WNT5A;ATF5;L3MBTL4;ZBTB7A;BCL7A;SOX8;MAEL;SNW1;NCOR2;THRA;KLF4;SOX9;YWHAQ;BMP2;GAS6;FOXS1;HDAC5;ZC3H8;HEXIM1;NONO;L3MBTL1;SAMD11;NR1H2;CDK5;HEY1;DAB2IP;HDAC9;TCEAL7;PAX9;GLIS2;TWIST1;RLIM;ZHX1;COMMD7;CIR1;QARS1;CCAR2;ZBTB14;LBH;TFAP2B;NOTCH1;BEND5;TGFB1;CITED2;SFRP1;SAMD1;CAPN3;CBX3;TFAP4;ID2;DDIT3;SIRT2;SUDS3;DACH1;MEN1;PPM1F
prerank,AMP metabolic process (GO:0046033),0.36851435208818895,0.7888990314623738,0.7457865168539326,0.9415002053276219,1.0,3/13,9.45%,ADSS1;AK4;AK3
prerank,histone H2A acetylation (GO:0043968),-0.26899968556798715,-0.7886964931905016,0.7689075630252101,0.9282087195144473,1.0,4/16,12.30%,NAA40;EPC1;EP400;BRD8
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3001003130535424,0.78869260088674,0.7782857142857142,0.9414574352167564,1.0,11/46,19.75%,LAMC1;LAMB2;RAC1;FN1;VAMP3;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1
prerank,regulation of defense response to virus (GO:0050688),0.363525536067093,0.7885757776710796,0.7531380753138075,0.9412484427139853,1.0,7/14,30.36%,TNFAIP3;ELMOD2;TRAF3;C1QBP;PCBP2;DHX9;IFNLR1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.36652244022098995,0.788415909654043,0.748,0.9410861516572756,1.0,5/14,22.79%,GAS6;NLRP2B;F2RL1;TRAIP;PELI3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3275344064230029,-0.7883911419371106,0.7246835443037974,0.9273101103490169,1.0,5/10,14.98%,DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3039447463478426,0.7883524324743952,0.7799539170506913,0.9407934380563258,1.0,8/39,16.24%,LGMN;DUSP3;SH3GL2;EPN1;ARHGEF7;SPRY1;SH3KBP1;DAB2IP
prerank,DNA recombination (GO:0006310),0.30600845626749273,0.7881311760978282,0.7848101265822784,0.9407545375464565,1.0,9/37,25.76%,ENDOG;HMGB3;HMGB1;TSN;RECQL5;ERCC1;BLM;RPAIN;RAD51
prerank,serine family amino acid metabolic process (GO:0009069),0.3550118951400545,0.7878494841799443,0.7867360208062418,0.9407832357861663,1.0,4/16,20.45%,SARS1;GLYAT;SEPSECS;SHMT2
prerank,cellular response to ketone (GO:1901655),0.3120135027766609,0.7877458007580922,0.7746806039488966,0.9405479962225036,1.0,9/35,20.23%,SPP1;ADAM15;MSN;AQP1;GNAI1;ADCY8;NCOA4;SFRP1;SPHK2
prerank,base-excision repair (GO:0006284),0.29431399790064533,0.7873934101413538,0.7829457364341085,0.9406579262919944,1.0,15/48,25.41%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;NEIL2;ERCC6;RFC4;POLG;POLD1;PNKP;RPA3;LIG1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3321674580851891,0.7873742622263143,0.7629911280101395,0.9403062882441424,1.0,8/22,27.11%,CDKN1C;CEBPA;CAMK2N1;HEXIM1;TFAP4;MEN1;HHEX;CDKN1A
prerank,amino sugar metabolic process (GO:0006040),-0.31760893486211006,-0.7873705757183029,0.7474048442906575,0.9277368822361217,1.0,3/10,15.55%,ST6GAL1;GNE;GFPT2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.29695703716910643,0.7873613146495019,0.7854785478547854,0.9399483036071786,1.0,8/47,16.41%,ACADVL;APOC1;CD34;SIRPA;PROX1;FBXW7;ABCA2;CAV1
prerank,mRNA modification (GO:0016556),0.32757923559196017,0.7868648132275586,0.7715355805243446,0.9402547909811182,1.0,8/22,25.03%,PCIF1;CMTR1;TRUB2;DKC1;PUS7;TRMT10C;METTL3;METTL14
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3636634267042598,0.7863192303483499,0.7245033112582782,0.9406288269493566,1.0,6/14,32.08%,RASL10B;EDN3;CORIN;ECE1;ENPEP;ACE
prerank,dephosphorylation (GO:0016311),0.26942222210448963,0.7860866720212076,0.8734693877551021,0.9405979065670788,1.0,52/147,25.90%,PPP1CA;PTPRC;CTDSP2;PPP2R1A;DUSP3;CTDNEP1;DUSP28;DUSP26;PTPRN2;CTDSP1;PHPT1;PTPRD;PTPRB;PTPRR;TIMM50;STK11;PTPRZ1;PDP2;NT5C;PPP2R5D;PPM1J;PDP1;PLPP6;TAB1;PPP3CA;PLPPR2;PGP;PPEF1;SGPP1;SSH2;SGPP2;PTPN6;PTPRU;PTPRO;PPP2R5A;DUSP2;DUSP23;PPM1F;PTPN5;DUSP12;DUSP1;PTPN1;PTPRE;DUSP15;SBF1;PNKP;ACP2;PPP1CB;PLPPR4;PTPRT;DUSP8;DUSP6
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.17793105056314326,-0.7855991215324775,0.9655172413793104,0.9292726764863692,1.0,24/109,19.26%,PTPN13;PI4KA;PITPNM2;MTMR3;PLA2G4A;PLEKHA4;PLEKHA2;MTMR11;PDGFRB;PIP5K1A;PTEN;SACM1L;VAC14;PIP4K2C;MTMR10;PLCD1;PIP4P2;PLEKHA8;PLA2G4C;PGAP3;PIGW;PIP4K2A;PLCG2;FGF2
prerank,regulation of DNA replication (GO:0006275),0.29932169238125955,0.7849486639797251,0.8105975197294251,0.9418408368332882,1.0,9/49,14.18%,S100A11;TERF1;ACVRL1;PPP2R1A;NUCKS1;GMNN;PCNA;FBXO5;CCDC88A
prerank,membrane lipid biosynthetic process (GO:0046467),0.2887600422755271,0.784785887678674,0.8120879120879121,0.941688428407265,1.0,27/58,32.48%,CERS2;ELOVL1;ELOVL2;ELOVL7;SPTLC1;DEGS1;SCCPDH;FA2H;CSNK1G2;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;SGPL1;ELOVL6;ALDH3B1;VAPB;HACD4;SAMD8;CERT1;SPNS2;ALDH3A2;ST8SIA6;ELOVL4;ELOVL5;CERS6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3828062719409236,0.7847281463782623,0.7568345323741007,0.941390656331361,1.0,4/10,22.51%,B3GAT3;XYLT1;CSGALNACT2;B3GAT1
prerank,ruffle organization (GO:0031529),0.3454649202005865,0.7842403021046033,0.7509986684420772,0.9417004962660885,1.0,4/16,12.35%,RAC1;ARF6;CSF1R;AIF1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3497022352643724,0.7840720222215298,0.765625,0.9415735916778735,1.0,1/16,0.80%,CALM1
prerank,regulation of hemopoiesis (GO:1903706),-0.3248838809442804,-0.7840596240114407,0.7375886524822695,0.9303925774978798,1.0,5/10,16.58%,CREBBP;MYSM1;CBFB;PRKCB;IL17D
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3030178157465442,0.7837005584922452,0.7873090481786134,0.9417133218812592,1.0,8/34,19.83%,CCL19;PDGFB;P2RY12;PIK3IP1;DAB2IP;FLT1;FLT3;TGFB1
prerank,regulation of muscle cell differentiation (GO:0051147),0.31675808044504855,0.7833779162252065,0.7713950762016413,0.9417935186473945,1.0,12/31,24.83%,CTNNA2;BNIP2;CTNNB1;CAMK1;MAPK11;IGF2;HDAC9;MEF2C;ID2;CDK9;TCF3;SRF
prerank,positive regulation of ossification (GO:0045778),0.30420007828884676,0.7832148782793189,0.7958477508650519,0.9416484826152426,1.0,17/39,24.73%,FZD9;GPM6B;ISG15;NELL1;P2RX7;WNT5A;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;SOX11;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,amino acid import (GO:0043090),0.33333017789906483,0.7828090403338425,0.747141041931385,0.9418023738937589,1.0,4/21,12.43%,SLC7A5;TSPO2;SLC6A6;SLC1A1
prerank,neuromuscular process (GO:0050905),0.3511924887566298,0.7824604044558585,0.7519685039370079,0.9418921368086451,1.0,3/16,16.09%,NRXN1;DCTN1;KCNA1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.221574655023284,-0.7821356581531601,0.8769230769230769,0.932217554758648,1.0,8/38,14.17%,CACNA1C;CAMK2D;ANK2;AKAP9;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.24891316337938288,-0.7819444442996434,0.831275720164609,0.931082725241186,1.0,10/21,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,defense response to protozoan (GO:0042832),0.37081762011471436,0.7816788222320079,0.765814266487214,0.9426146473934598,1.0,4/12,23.94%,SLC11A1;PF4;BATF2;LYST
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3313450983921306,0.7815703200339095,0.7716129032258064,0.942385405517549,1.0,5/21,15.99%,CTSL;ZFP36L1;ZFP36;SFRP4;DLL1
prerank,histone monoubiquitination (GO:0010390),-0.23494604843373534,-0.7815099019670334,0.8348623853211009,0.9303969267824771,1.0,9/24,23.84%,BCOR;DDB2;CUL4B;CDC73;UBE2E1;WAC;RNF20;CTR9;RYBP
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.31454779165584695,0.7810315639278567,0.7564259485924113,0.9427522409430045,1.0,9/29,28.00%,FKBP1A;S1PR1;PROX1;BMP2;NOTCH1;TGFB1;TCAP;ZFPM1;ENG
prerank,organic cation transport (GO:0015695),-0.2573021223744669,-0.7810222846856315,0.8,0.9298166811992621,1.0,3/19,7.87%,SLC47A1;SLC22A4;SEC14L1
prerank,regulation of stem cell population maintenance (GO:2000036),0.33949303180692264,0.7810011554003446,0.7557840616966581,0.9424224308018831,1.0,6/18,23.63%,TAF5L;ESRRB;MYC;REST;PTN;ELAVL1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.26031635385588603,0.7809882487293094,0.982,0.9420611381840265,1.0,108/476,22.29%,APOE;CD74;CXXC1;SPP1;COL1A1;ACTA2;MT3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;ERBB4;LYL1;NPM1;AGT;ETS2;TNF;PDGFB;NR1D1;ACVRL1;CHEK2;YWHAH;CTNNB1;HES1;CDKN1C;RHOG;HIPK2;RNF187;OTX2;FOXF2;CEBPB;BRPF1;TRIM28;EDF1;FOXL2;SEC14L2;MLXIPL;EGR1;JUN;KARS1;NPAS3;APBB1;MYRF;WNT5A;SOX17;ATF5;POU3F1;WBP2;SOX8;KLF4;SOX9;PAX3;BMP2;RAI1;NME2;UBE2V1;ATMIN;NUP85;IRF7;MED30;NR1H2;MAPRE3;EBF3;HEY1;NCF1;ING1;VHL;GATA4;SKAP1;GLIS2;PCID2;BRCA2;PPARGC1A;MRPL12;CNBP;USP22;MAP2K2;MAZ;HMGN5;SOX11;CD86;INHBA;LBH;ESRRB;TFAP2B;NOTCH1;IL6;TGFB1;ING5;CITED2;MEF2C;FOXA2;SFRP1;CAPN3;TFAP4;MYC;FZD2;ID2;DDIT3;SOX10;FZD1;ZXDC;SS18L1;MAP2K7;REST;ESRRG;BLM
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.31131877708885264,0.7809088897095067,0.7558962264150944,0.9417949446567343,1.0,8/29,23.94%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;ELAVL1;DND1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2993557874108576,-0.7806941415434226,0.7525773195876289,0.9289007404345729,1.0,3/12,16.58%,IL18;CD80;IL17D
prerank,protein deacylation (GO:0035601),0.32188030852002947,0.7806869347493064,0.7399497487437185,0.9417274071500297,1.0,5/23,21.36%,LYPLA2;ABHD17A;HDAC5;NOTUM;SIRT2
prerank,secretion (GO:0046903),-0.2789332173870194,-0.7801609108148198,0.774074074074074,0.928331408858665,1.0,3/14,14.26%,SLC22A4;SLC22A6;PRKCI
prerank,blood vessel diameter maintenance (GO:0097746),0.30483409329625843,0.7800277569340672,0.7787913340935005,0.9422256310085465,1.0,3/34,3.42%,KLF2;AGT;GPER1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3013228051632624,-0.7797624136818588,0.7431906614785992,0.927569838706282,1.0,4/13,11.85%,FBN1;LTBP1;CHRDL1;CD46
prerank,protein localization to centrosome (GO:0071539),-0.27357935400094063,-0.7791973482035047,0.8018018018018018,0.9270231019757346,1.0,6/17,20.57%,PCM1;GOLGB1;PIBF1;C2CD3;CCDC14;CEP192
prerank,protein O-linked glycosylation via serine (GO:0018242),0.38763780468709536,0.77833078776391,0.7468354430379747,0.94417601006764,1.0,4/10,30.94%,POGLUT3;GALNT13;GALNT2;POGLUT1
prerank,smooth muscle tissue development (GO:0048745),-0.3183554925718898,-0.7782161963386645,0.7321428571428571,0.9270701374424224,1.0,5/10,21.22%,SMO;MYLK;BMP4;NF1;PTCH1
prerank,positive regulation of histone modification (GO:0031058),0.3062271727086955,0.777969224659037,0.8011976047904191,0.9443027222739585,1.0,8/33,27.18%,MAPK3;APLNR;CTBP1;PPARGC1A;SAP30BP;CDK9;PAXIP1;RUVBL2
prerank,glycogen catabolic process (GO:0005980),0.35181291222432365,0.7777599383623851,0.7646276595744681,0.9442188464477137,1.0,1/15,0.80%,CALM1
prerank,negative regulation by host of viral process (GO:0044793),-0.3128345748877421,-0.7771818318208819,0.7615894039735099,0.9273699240917934,1.0,3/10,10.17%,PRKN;EIF2AK4;CCNK
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3069986392344426,-0.7771716616715902,0.76,0.9259899438639897,1.0,2/11,5.66%,FRS2;EFNB2
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2526052281275235,-0.7768137648246113,0.7980769230769231,0.9251507515576319,1.0,3/23,3.64%,PLCE1;AGMO;PLA2G4A
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.31152302963691214,0.7767881649859585,0.7733333333333333,0.9451627334499827,1.0,14/29,34.73%,LSM4;LSM6;EXOSC2;EDC4;EXOSC9;LSM7;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,male meiosis I (GO:0007141),-0.2707957134911585,-0.7763071631448141,0.7865612648221344,0.9245607324603149,1.0,12/16,43.18%,MYBL1;ING2;ZSCAN21;SYCP3;FOXJ3;SLC25A31;BRDT;MOV10L1;CCNA1;DNMT3L;MEIOC;BTBD18
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.33957913589478006,0.7756176231227987,0.7583001328021248,0.9463891271233226,1.0,1/18,0.84%,APOD
prerank,t-circle formation (GO:0090656),0.38307563087868857,0.775515393824968,0.7610872675250357,0.9454089439709981,1.0,3/10,22.29%,TERF1;ERCC1;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.38307563087868857,0.775515393824968,0.7610872675250357,0.9454089439709981,1.0,3/10,22.29%,TERF1;ERCC1;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),0.38307563087868857,0.775515393824968,0.7610872675250357,0.9454089439709981,1.0,3/10,22.29%,TERF1;ERCC1;BLM
prerank,protein import into peroxisome membrane (GO:0045046),0.323888104886381,0.7749193956647619,0.7521472392638037,0.9458322637653742,1.0,10/22,35.64%,PXMP2;GDAP1;FIS1;PEX11B;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3191312968305173,0.7746326129394971,0.7858002406738869,0.9458616315073053,1.0,12/25,31.95%,APRT;GART;PNP;PRPS1L1;PRPS1;PAICS;SHMT2;PRPSAP1;ADSL;ADA;DGUOK;DCK
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2915624151980609,-0.7744009527517498,0.7253521126760564,0.9261023737335571,1.0,5/12,25.75%,BDH2;GGCT;GGT1;GCLC;MGST2
prerank,regulation of TORC1 signaling (GO:1903432),0.3047409016948802,0.7742973637031855,0.7768496420047732,0.9459568093528419,1.0,8/33,16.15%,LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;STK11;RRAGC;RRAGD
prerank,regulation of vacuole organization (GO:0044088),0.3338044053237008,0.7739633774188949,0.7455919395465995,0.9460365182594938,1.0,4/20,16.28%,ENO1;IFT20;UBQLN2;ENO3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.34477290176902553,0.7737917022097475,0.7598425196850394,0.945883429239659,1.0,2/16,5.85%,PIGZ;PIGQ
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3563833478218355,0.773353551383052,0.7503429355281207,0.9461219163441758,1.0,6/13,33.58%,MPDU1;ALG3;ALG11;DPAGT1;ALG6;ALG2
prerank,respiratory system development (GO:0060541),0.3058903237597048,0.7733258286610496,0.7941860465116279,0.94578287421896,1.0,4/32,8.19%,RBP4;CEBPA;PROX1;BASP1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2720795551127144,0.7732574827086911,0.8652037617554859,0.9454998135420021,1.0,35/95,26.25%,BGN;BCAN;FMOD;LUM;HEXA;HS3ST6;HS3ST5;DCN;CHST1;B4GALT6;SDC4;GPC5;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;B3GNT3;SDC3;HS3ST2;HSPG2;AGRN;CSGALNACT2;HS6ST1;CHSY3;ACAN;B4GALT3;CHST14;PRELP;CHST9;CSPG5;HS6ST2;GPC1;ABCC5
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.31543877597604364,0.773019122803482,0.7961630695443646,0.9454385892413518,1.0,6/26,16.17%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.31654824269553633,0.7728217228028859,0.793939393939394,0.9453163692077123,1.0,6/25,19.11%,ANG;DSCAM;MIF;SDCBP;PTGES3;SNCA
prerank,positive regulation of T cell differentiation (GO:0045582),-0.21621721678600364,-0.7722867626991584,0.8943661971830986,0.9279565311678748,1.0,5/36,7.93%,ZMIZ1;GLI3;GLI2;DUSP10;ZBTB1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.3241984826766417,0.7722838761467826,0.760248447204969,0.9456532390583395,1.0,6/23,23.58%,HSP90AB1;CDC37;IFNGR1;NR1H2;IFNGR2;SOCS3
prerank,dendrite morphogenesis (GO:0048813),0.29773307259909937,0.7718958544885602,0.8145539906103286,0.9458053205900491,1.0,11/35,23.14%,CTNNA2;LRP4;MAP2;PAK3;DOCK10;TMEM106B;MAPK8IP2;EPHB1;CTNND2;WNT7A;PTN
prerank,regulation of glucose transmembrane transport (GO:0010827),0.3400363763514539,0.7715004865490734,0.7737321196358907,0.9459937117531502,1.0,4/18,13.79%,C3;SLC2A1;RSC1A1;CLIP3
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3244323991981274,0.7712260110336064,0.7539975399753998,0.9459753451132114,1.0,6/22,20.06%,GNAI2;DRD5;CAP1;ORAI1;CCR2;GABBR2
prerank,regulation of vasoconstriction (GO:0019229),0.3165604756835389,0.7710576688798253,0.8043478260869565,0.9458416593634992,1.0,6/27,16.41%,AGT;CHRM3;ATP2B1;ADRA1D;ADRA1A;CAV1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.28749670064302446,-0.7709396581560756,0.7557251908396947,0.9286451647714632,1.0,2/13,13.39%,GLI3;CBFB
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.344232093099119,0.7708373135963221,0.7852437417654808,0.9457582542732216,1.0,6/17,27.90%,PODXL;P2RY12;SKAP1;SYK;TGFB2;CD3E
prerank,protein localization to phagophore assembly site (GO:0034497),0.3737019409660371,0.7706140205926226,0.7407407407407407,0.9456913781737551,1.0,4/11,32.45%,ATG9A;WDR45;WIPI2;ATG13
prerank,regulation of histone deacetylation (GO:0031063),-0.28362904683652984,-0.7700481187466168,0.7857142857142857,0.9286790680177178,1.0,5/13,16.75%,CAMK2D;NIPBL;AKAP8L;ING2;PRMT6
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3140355272107959,0.7699903276025616,0.794425087108014,0.9461817880902706,1.0,8/29,19.63%,TGM2;EPOR;VAV1;ERBIN;MMD2;RASGRP1;RASGRF1;NOTCH1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.31229657712912406,0.7698021266712954,0.7917174177831913,0.9460639167860987,1.0,3/28,5.31%,C3;RAC1;SIRPA
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3196193901632076,0.7694553747857464,0.7895377128953771,0.9461725272867326,1.0,6/27,15.47%,AGT;ABCG1;LPL;MSR1;PF4;NR1H2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.32823885954561816,0.768748810521377,0.7781954887218046,0.9463451668259388,1.0,4/21,10.13%,PARP1;RPA2;RBX1;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.32823885954561816,0.768748810521377,0.7781954887218046,0.9463451668259388,1.0,4/21,10.13%,PARP1;RPA2;RBX1;DDB1
prerank,tRNA 5'-leader removal (GO:0001682),0.3610528051230831,0.768638732524134,0.7669376693766937,0.94611817534764,1.0,2/13,13.83%,POP7;POP4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.25751217621401945,-0.7683167020742595,0.7920792079207921,0.9298626265748265,1.0,6/20,14.92%,TGFBR3;TGFBR1;PDCD4;RBPJ;BMP4;HEY2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2531490442516628,0.7682513234304007,0.994,0.9462601932542307,1.0,164/807,20.52%,RPL23;RPS27A;HSPA8;RPS14;UBC;PFDN5;UBB;CALR;MT3;HSBP1;VPS72;NDUFA13;RPL10;TMPRSS6;ATF4;KLF2;MAF1;ID3;SOX18;NRG1;ID1;CRYAB;PRDX5;EID1;CCDC85B;ETS2;TNF;PDGFB;DRAP1;NR1D1;SPI1;ENO1;PARP1;TLE5;CTNNB1;FLNA;HES1;TENM2;IRF2BP1;MAGEL2;EID2;CDKN1C;TBX22;UBA52;CCND1;CEBPB;GMNN;ARID4A;FOXD3;PRDM12;TRIM28;FOXL2;CREBZF;DUSP26;CEBPA;CBX6;PROX1;BASP1;NR2F6;RBM15B;BCL6B;IKZF1;MLXIPL;MLX;CDK5R1;SARS1;SET;JUN;SIN3B;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;APBB1;AEBP1;SUPT4H1;CTBP1;WNT5A;ATF5;L3MBTL4;ZBTB7A;WFS1;IRF2BPL;BCL7A;SOX8;MAEL;SNW1;NCOR2;IRX3;THRA;KLF4;THAP11;SOX9;YWHAQ;IRF2BP2;CRYM;BMP2;GAS6;LEFTY1;FOXS1;HNRNPU;HDAC5;ZC3H8;HEXIM1;SDCBP;IRF7;IKZF5;NONO;L3MBTL1;DNAJB1;SAMD11;IGF2;NR1H2;KDM1B;CDK5;HEY1;MIER2;DAB2IP;HDAC9;BATF3;CAV1;DNMT3B;TCEAL7;VHL;PAX9;GLIS2;TWIST1;RIPPLY2;BCL11A;RLIM;ZHX1;TCF25;CNBP;MYT1L;COMMD7;NOP53;CIR1;MAZ;MTA2;QARS1;SOX11;CCAR2;SNCA;MUC1;HIC1;ZBTB14;LBH;TFAP2B;NOTCH1;KLF11;EFNA1;BEND5;TGFB1;CHD3;POU4F1;CITED2;MEF2C;SFRP1;SAMD1;CAPN3;CBX3;TFAP4;MYC
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.36807312912822776,0.7682404206375696,0.7393103448275862,0.9458994499969164,1.0,3/11,12.73%,ELOF1;SERTAD1;ZMIZ2
prerank,organelle fission (GO:0048285),0.316367533441691,0.7674645080748801,0.7800480769230769,0.9465587733751356,1.0,9/24,26.04%,DNM3;CORO1C;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L;PEX11B
prerank,regulation of cartilage development (GO:0061035),0.3337342866424129,0.7671891505005539,0.7666666666666667,0.9465459990681248,1.0,4/18,17.68%,MDK;SOX9;BMP2;SCIN
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.3027613859843352,-0.7670772054810229,0.7689655172413793,0.9302739237361017,1.0,4/11,17.61%,STAT3;PUM2;LIMD1;FMR1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.31824773906802334,0.766932445546095,0.7930174563591023,0.9465187486876692,1.0,8/22,31.76%,SLC7A5;IL2;IL6;TGFB1;RFTN1;PRKCQ;NOD2;LY9
prerank,regulation of mitochondrial fission (GO:0090140),0.3230558121850771,0.7668659645311261,0.7888198757763976,0.9462381123853283,1.0,9/24,22.93%,PINK1;KDR;MAPT;DCN;MIEF2;MFF;DNM1L;FIS1;SPIRE1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.28752117258853715,-0.7667978254251524,0.7794117647058824,0.9293558646175863,1.0,2/13,7.68%,ADHFE1;DLST
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3156805508979515,0.7667716495813254,0.7817073170731708,0.9459813128688653,1.0,11/27,31.52%,HTR2C;GRM1;GPR18;F2RL1;F2RL3;C3AR1;GPR17;OPRL1;F2RL2;GPR35;DRD2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.2937960576741881,0.7664803188270133,0.8063420158550396,0.9459939154390491,1.0,10/40,19.83%,MDK;COL1A1;CTNNB1;BMP2;SDCBP;TIAM1;TWIST1;NOTCH1;IL6;TGFB1
prerank,positive regulation of telomere capping (GO:1904355),0.33934783360411125,0.7657528137487628,0.7637795275590551,0.9465667743766483,1.0,8/17,33.05%,MAPK3;MAPK15;MAP2K7;PNKP;PRKCQ;AURKB;HNRNPD;PKIB
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.2672836302849062,-0.7653529039935697,0.8063241106719368,0.9301347897788153,1.0,3/15,8.51%,DAB2;SMAP1;AAK1
prerank,ncRNA metabolic process (GO:0034660),-0.21392420088457273,-0.7652861504971499,0.9154929577464789,0.9288487535181832,1.0,10/37,16.50%,TENT4B;DICER1;PARN;DROSHA;ZCCHC8;TUT7;DDX17;TARBP2;TUT4;AGO2
prerank,negative regulation of JNK cascade (GO:0046329),0.3048218448179773,0.7651621797069614,0.7910798122065728,0.9469809104482717,1.0,6/31,14.62%,PINK1;DUSP3;SIRPA;DNAJA1;MAPK8IP1;F2RL1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3015687270382618,0.7649154496501713,0.806146572104019,0.9469322560139504,1.0,6/34,11.32%,MAP1A;SPI1;GPM6B;LEPROT;MAPT;DNAJA1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.18683672162961507,-0.7646479553417441,0.9824561403508771,0.9285267779632611,1.0,22/83,19.26%,ACVR1;BRD4;MNAT1;CDK6;CRLF3;NASP;TFDP1;CUL4B;CUL4A;LATS2;PHF8;PPP6C;ORC1;NPAT;CDK7;HINFP;USP37;CUL5;PLK2;POLE;KHDRBS1;CACUL1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.37400789936110734,0.7645895046738574,0.7672530446549392,0.9469984506272127,1.0,4/11,20.07%,GPER1;GATA4;TGFB1;MEF2C
prerank,regulation of mitotic nuclear division (GO:0007088),0.28331441908810945,0.7645605315102576,0.8394648829431438,0.9466640523520762,1.0,14/55,25.38%,AURKAIP1;PDGFB;PIN1;CAV2;FBXO5;L3MBTL1;IGF2;EDN3;TGFA;DUSP1;CCDC8;CD28;RCC1;KIF20B
prerank,V(D)J recombination (GO:0033151),0.37404970875668553,0.7643122121751398,0.7800289435600579,0.946631913389365,1.0,3/11,25.41%,HMGB1;TCF3;LIG1
prerank,intestinal absorption (GO:0050892),0.3556042179662152,0.7643103591998734,0.7596153846153846,0.9462629853518609,1.0,7/13,43.31%,SLC2A2;KCNQ1;CD36;SLC26A6;F11R;ADRA2A;UGCG
prerank,mitochondrion distribution (GO:0048311),0.36376352501106907,0.7639800282459039,0.78328611898017,0.9463244035631073,1.0,5/12,18.82%,MAPT;HAP1;DNM1L;ATCAY;ARMC1
prerank,endocrine system development (GO:0035270),0.3243889766540802,0.7638180208548656,0.7760617760617761,0.9461653271511681,1.0,1/21,1.22%,MDK
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.30758855747293945,0.7635511758012338,0.7997644287396938,0.9461561898089695,1.0,3/31,4.81%,RPS2;PINK1;PIN1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3194394282073882,0.7625888304535705,0.7987804878048781,0.9470330864930728,1.0,3/24,7.93%,H3-3A;SPI1;CREBZF
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3344966235271174,0.7621778899289101,0.7639429312581063,0.947199844391108,1.0,4/17,16.21%,CTNNA2;DNAI3;ARF1;GMFB
prerank,response to peptide (GO:1901652),0.3016326587983238,0.762074017608312,0.8198830409356725,0.9469683173609597,1.0,15/33,29.85%,PRNP;CACNA1A;GNAI1;MMP3;RAMP3;ERBIN;EIF2B5;IRF5;AGER;CACNA1B;STAT4;CHRNA7;NOD2;EIF2B1;MMP2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.31242821853491365,0.7617413163626138,0.8164014687882497,0.9470452217582023,1.0,6/26,18.07%,AKT1;CCND2;CCND1;AIF1;ADAM17;ADAMTS1
prerank,heart morphogenesis (GO:0003007),0.286403190824877,0.761662458152827,0.8325892857142857,0.9467711605334284,1.0,11/50,15.89%,ACVRL1;FKBP1A;HES1;ALPK2;SOX17;SOX9;BMP2;LEFTY1;DLC1;HEY1;RYR2
prerank,bile acid biosynthetic process (GO:0006699),0.31331863433637896,0.7615220451217585,0.7965260545905707,0.9465888835942313,1.0,6/24,22.20%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.3705217111648977,0.760814103150032,0.7861189801699717,0.9471624805624611,1.0,3/11,16.40%,GPM6B;LEPROT;SNX33
prerank,neuromuscular junction development (GO:0007528),0.3230440557373262,0.7606465608496475,0.7937888198757764,0.9470074161871981,1.0,6/24,12.87%,ANK3;LRP4;MUSK;GPHN;DOK7;DCTN1
prerank,regulation of interleukin-1 production (GO:0032652),0.3401608503361241,0.7603454993736095,0.7871222076215506,0.9470399356173123,1.0,4/15,21.29%,SIRPA;HMGB1;GAS6;TMED10
prerank,spindle assembly (GO:0051225),0.2717866127292898,0.7603306479106348,0.8390557939914163,0.9466931156795485,1.0,11/67,18.88%,RPS3;CHEK2;FLNA;ABRAXAS2;CLASP1;SAC3D1;RHOA;HAUS2;MAPRE3;TOGARAM2;KIFC2
prerank,epithelial to mesenchymal transition (GO:0001837),0.28446344353081077,0.7602753672214385,0.8325740318906606,0.946389240555151,1.0,14/47,19.83%,HNRNPAB;CTNNB1;FOXF2;TRIM28;WNT5A;SOX9;BMP2;AKNA;HEY1;S100A4;FAM83D;NOTCH1;HGF;TGFB1
prerank,iron ion transmembrane transport (GO:0034755),0.378757269632859,0.7602579684750176,0.7681564245810056,0.9460448306409762,1.0,4/10,26.25%,ABCB6;SLC40A1;SLC25A37;ABCC5
prerank,nuclear export (GO:0051168),0.2719187898366089,0.7600588207548151,0.8736842105263158,0.945938426727259,1.0,17/80,20.62%,CALR;MAGOHB;MAGOH;DDX39B;RAN;SRSF9;XPO1;SRSF2;HNRNPA1;THOC3;EIF4A3;U2AF1L4;DESI1;TGFB1;ALYREF;RAE1;SRSF1
prerank,regulation of DNA recombination (GO:0000018),-0.22018700502579006,-0.7598525014798918,0.8717948717948718,0.9343201771065217,1.0,10/32,20.89%,SETD2;SPIDR;SMARCAD1;MSH3;PPP4R2;KPNA2;RTEL1;ZCWPW1;SHLD2;SIRT6
prerank,protein neddylation (GO:0045116),0.3551218400851968,0.7591867650743265,0.7560975609756098,0.946680464198866,1.0,4/13,16.09%,UBE2M;RBX1;NEDD8;RNF7
prerank,"transcription, DNA-templated (GO:0006351)",0.257875078126691,0.7586024433862931,0.9375,0.9470376916867124,1.0,39/207,21.89%,PTMA;ELOB;TSC22D1;POLR2E;ATF4;POLR2D;POLR2F;DRAP1;BTF3;GTF3C6;PARP1;XAB2;TAF10;NELFCD;TAF5L;TAF9;POLR2G;DEK;SUPT4H1;SSRP1;THRA;POLR2K;IVNS1ABP;RO60;UBTF;RRAGC;ARRB2;NELFE;MRPL12;ERCC6;KLF13;TBP;MLF1;GTF3A;POLR2H;IRF9;CDK9;ELOC;POLR3K
prerank,negative regulation of metabolic process (GO:0009892),0.28264031628410874,0.7585335434860778,0.8353591160220994,0.9467531186023544,1.0,14/54,21.42%,ATF4;ID1;APOC1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;DDIT3;FIS1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28679792638421053,0.7578941381759124,0.8178770949720671,0.947198960148517,1.0,12/48,19.67%,TREM2;PTPRC;ISG15;GAS6;NLRP2B;F2RL1;NR1H2;SIGIRR;SLIT3;OAS3;TRAIP;IL6
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2935869364288687,0.7577576216085177,0.8122119815668203,0.9470207551379812,1.0,8/37,15.68%,STMN3;FAM107A;CLASP1;MAPT;STMN4;CDK2AP2;STMN1;MAPRE3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.35777733788226046,0.7573935410133043,0.7815934065934066,0.9471337111313266,1.0,5/12,23.94%,TNF;NCOR2;TGFB1;ELAVL1;DND1
prerank,lipid modification (GO:0030258),0.2904093349956464,0.7573545088421612,0.8120567375886525,0.9468179293899287,1.0,18/37,33.27%,DGKH;DGKI;PLA2G7;PLPP6;PLPPR2;PORCN;SGPP1;SGPP2;DGKK;DGKB;CYP2E1;PLPPR4;MBOAT7;PLPP4;DGKZ;DGKG;PLPPR5;MBOAT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.34319398433042575,0.7573254503073813,0.7620967741935484,0.9464963731578496,1.0,3/14,14.73%,TIRAP;TLR6;COPS8
prerank,cardiac atrium morphogenesis (GO:0003209),0.33745377844101954,0.7571475572619252,0.7640891218872871,0.9463574490283134,1.0,8/16,28.00%,PROX1;BMP2;GATA4;NOTCH1;TGFB2;ZFPM1;DLL4;ENG
prerank,mitochondrion morphogenesis (GO:0070584),-0.29494058766903714,-0.7570516866098691,0.7623762376237624,0.9369552095343322,1.0,1/11,0.51%,PID1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.30864262140214543,0.7566625714833503,0.8081841432225064,0.9466291175711963,1.0,3/25,6.55%,AUP1;VCP;OMA1
prerank,renal system development (GO:0072001),0.28385756773592247,0.756543691058165,0.8435754189944135,0.9464087103639051,1.0,8/52,11.69%,RBP4;AGT;LRP4;HYAL2;PROX1;C1GALT1;SOX17;WFS1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.27253776646498074,-0.7560892052285354,0.7686567164179104,0.9369380325078458,1.0,5/14,17.16%,GAB1;NRP1;VEGFB;VEGFC;VEGFD
prerank,regulation of innate immune response (GO:0045088),0.27736678045614027,0.7556357634817901,0.8378672470076169,0.9471969903011552,1.0,13/57,23.07%,HSP90AB1;TREM2;TIRAP;TNFAIP3;SLC15A4;CDC37;LRP8;TYRO3;PTPN6;POLR3D;AKIRIN2;ERAP1;PTPN1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.33017131395257504,0.755521226374687,0.7912371134020618,0.9469727793173548,1.0,2/19,6.02%,SULT4A1;BPNT2
prerank,sphingolipid biosynthetic process (GO:0030148),0.2699247168229165,0.7550885436784047,0.8465665236051502,0.9471668493708687,1.0,22/71,23.78%,CERS2;ELOVL1;ELOVL2;B4GALT6;SMPD1;ELOVL7;SPTLC1;DEGS1;FA2H;CSNK1G2;CLN8;ST8SIA5;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;ASAH2;SGPL1;ELOVL6;ALDH3B1;VAPB
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3620897536100721,0.7549217812048107,0.7946554149085795,0.9470058528313806,1.0,2/12,4.18%,PDGFB;IGFBP5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.30117747184412724,0.7545741519232592,0.8018867924528302,0.9470756248830733,1.0,6/31,14.26%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,regulation of GTPase activity (GO:0043087),0.25699417094540106,0.7541014771377493,0.9227642276422764,0.9473170411351571,1.0,40/177,21.45%,RACK1;SOD1;CCL19;S100A10;TGM2;RASIP1;NTRK2;PIN1;CAV2;STMN3;ARHGAP9;TMED2;ARHGAP15;THY1;NET1;GPR137B;RRP1B;EPHA5;ARHGEF7;RGS10;DOCK10;HRAS;VAV1;DOCK8;VAV3;CCL2;ARL2;F2RL1;RASGRP1;DAB2IP;CCL3;ADCYAP1;CCL8;RASGRF1;RGS7;AGRN;SFRP1;DOCK9;RGS6;PLXND1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3519472122395636,0.7539363351685386,0.7749667110519307,0.9471621688612076,1.0,2/13,9.04%,PINK1;NUPR1
prerank,telomere maintenance (GO:0000723),0.2800227020308581,0.7538758917656558,0.8243847874720358,0.9468785545234261,1.0,14/50,25.76%,TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;RAD51
prerank,epithelial cell development (GO:0002064),0.32605153173643586,0.7536413395056696,0.7882205513784462,0.9468063503622197,1.0,1/20,1.46%,ACTA2
prerank,positive regulation of mRNA processing (GO:0050685),0.3205479404113384,0.7534228007231882,0.7947103274559194,0.9467053800775718,1.0,5/21,16.07%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,fat cell differentiation (GO:0045444),0.27611989571192225,0.7533973845156842,0.8562091503267973,0.9463777438695232,1.0,14/57,17.36%,PSMB8;BSCL2;CEBPA;STEAP4;SDF4;CTBP1;IL11;ATF5;ZBTB7A;SOX8;KLF4;CLIP3;TRIM32;PPARGC1A
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.2978189696074819,-0.7527645146599011,0.7913669064748201,0.9402894711913082,1.0,3/12,10.62%,CACNA1C;DLG1;TRPM4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2692821632120225,0.7525560441450795,0.8664563617245006,0.947078916263178,1.0,19/80,20.52%,CCL19;NLGN1;RAC1;TENM2;PFN1;P2RX7;KCTD17;P2RY12;DEF8;FNBP1L;HRAS;ANLN;CCDC88A;F2RL1;RAC2;ARPC2;GPM6A;AGRN;CDC42EP2
prerank,microvillus organization (GO:0032528),0.35630895311260385,0.7524883896720755,0.776566757493188,0.9467947581728302,1.0,1/13,1.80%,FXYD5
prerank,positive regulation of vasoconstriction (GO:0045907),0.35923531503172845,0.7523444993253836,0.773841961852861,0.9466285445337542,1.0,3/13,16.41%,ADRA1D;ADRA1A;CAV1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.19505991356245497,-0.7521079312455855,0.925531914893617,0.9398049863875846,1.0,16/48,23.06%,PRKAG2;RANBP2;OGT;NUP98;PRKAG1;AAAS;NUP214;NUP35;NDC1;TIGAR;NOA1;JMJD8;NUP62;TPR;NUP93;NUP160
prerank,regulation of keratinocyte differentiation (GO:0045616),0.31224877765050596,0.7520849333600331,0.7911001236093943,0.9465797656672944,1.0,4/24,13.67%,CTSL;ZFP36L1;ZFP36;NME2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2972104249344069,0.7520113443745478,0.8105263157894737,0.9463050899193147,1.0,6/33,14.26%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.3505710697556525,0.7518999410701688,0.786774628879892,0.946085127353346,1.0,5/13,23.31%,B3GNT9;B3GNT3;B3GALT5;GAL3ST3;B3GALT2
prerank,cellular response to radiation (GO:0071478),0.2916141068554873,0.7510110721847274,0.8283410138248848,0.9468482328541401,1.0,14/40,33.42%,RHOB;EEF1D;NET1;NSMCE3;GADD45A;BLM;ECT2;RAD51;RAD9A;CDKN1A;RHNO1;GRB2;CLOCK;SWI5
prerank,transcription preinitiation complex assembly (GO:0070897),-0.29791783604924027,-0.7509432735638124,0.7943262411347518,0.9400511316970757,1.0,7/12,34.64%,BDP1;GTF2A2;TAF7;TAF1;POLR1E;GTF2B;TAF7L
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3209997221809712,0.7504734898990827,0.811704834605598,0.9471318009473562,1.0,7/20,21.19%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.3647584250276015,0.7501278650451053,0.7905982905982906,0.947195529814342,1.0,1/11,3.61%,CANX
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.316884186727272,0.7496727145909104,0.7916152897657214,0.9474135194790728,1.0,4/21,14.60%,FLNA;SCN4B;KCNE4;KCNE5
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3336422108219429,0.7492079773431702,0.7828947368421053,0.9476317144954807,1.0,4/17,18.53%,TERF1;NEIL1;NEIL2;TERF2IP
prerank,genitalia development (GO:0048806),0.35273434927813224,0.7491827524350605,0.7821917808219178,0.947298154210823,1.0,2/12,11.11%,FOXF2;WNT5A
prerank,regulation of hydrolase activity (GO:0051336),0.26938880807349486,0.7491567569633742,0.8733905579399142,0.946962243524674,1.0,13/71,16.41%,SOD1;RASIP1;NTRK2;ATP5IF1;STMN3;ARHGAP9;ARHGAP15;GPR137B;EPHA5;VAV1;VAV3;DAB2IP;CAV1
prerank,endomembrane system organization (GO:0010256),0.2557339885661694,0.7485727523518201,0.934077079107505,0.9473087549924691,1.0,34/178,17.51%,ANK3;LMAN2;ATP8B4;SYNGR2;CAV2;CHMP2B;CTDNEP1;REEP5;BAG5;TMED7;SYNGR1;LMAN1;SURF4;REEP6;TMED2;CLASP1;TICAM2;TMED3;ARHGEF7;SRGN;TMED9;SERP1;ARL1;TMED1;SEC61A1;VMP1;SYP;SNX33;USP8;SQSTM1;DNM1L;SYNE1;LNPK;HOOK1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.34124111702349486,0.7475832161874896,0.78515625,0.9482167436780351,1.0,2/15,4.23%,CSNK2B;FKBP1A
prerank,calcium ion transmembrane transport (GO:0070588),0.2649128167601906,0.7474991628075128,0.8735751295336788,0.9479649103206749,1.0,17/86,15.37%,SMDT1;SLC24A4;SLC24A2;FKBP1A;GRIN1;CACNA1A;TMCO1;P2RX7;GRIN2A;PMPCB;TRPM2;TRPC7;ATP2B1;GAS6;TRPC1;SPG7;SLC8A1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.1923459187638455,-0.7471195393097535,0.9813084112149533,0.9438526552629352,1.0,15/57,17.54%,BABAM2;FOXN3;RINT1;MDC1;UIMC1;TAOK3;ATF2;MRNIP;TIPIN;ATM;RAD17;TAOK1;CLSPN;TP53;WAC
prerank,lung development (GO:0030324),0.29407505848218807,0.7470779017124035,0.7950819672131147,0.9481318379825004,1.0,4/33,8.17%,RCN3;RBP4;CEBPA;PROX1
prerank,membrane lipid metabolic process (GO:0006643),0.31509959717682756,0.7465725381483571,0.8133333333333334,0.9483748134755055,1.0,5/22,20.23%,SERINC1;GAL3ST1;SPTLC1;CERKL;SPHK2
prerank,regulation of lipid kinase activity (GO:0043550),0.35250184488339864,0.7465363983747078,0.7865329512893983,0.9480552339726683,1.0,1/11,5.39%,EEF1A2
prerank,protein ubiquitination (GO:0016567),0.24892276525168258,0.7465080213497458,0.994,0.9477284727175295,1.0,86/471,20.67%,RPS27A;UBC;RACK1;UBB;PSMB4;ELOB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;UBE2Z;PINK1;KCTD10;FBXO15;KLHL9;PSMD1;EPAS1;UBE2G2;PSMC3;CTNNB1;PSMD6;VCP;IRF2BP1;UBE2Q1;CDC34;DCAF15;RNF187;UBA52;ARRDC1;PSMA7;ISG15;USP5;FBXL14;OTULIN;NHLRC1;PRPF19;PSMD5;RBX1;NEDD8;FBXO27;TRIM2;TNFAIP1;DDB1;PSMB9;PSMD13;RBCK1;KLHL7;PSMB3;FBXW5;SYVN1;PCNA;PSMB11;ZSWIM8;FBXW7;FBXO30;FBXO31;PSMB10;RNF40;UBE2V1;RNFT1;PSMB1;ARRB2;RNF7;ENC1;PSMB5;VHL;TRIM32;RUSC1;RNF181;RLIM;USP22;TRAIP;RNF208;KCTD13;PSMA6;RNF144B;FBXL16;HECW1;TRIM13;RNF11;SKP1;PSMA4;UBE2QL1;KLHL25;BRAP
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2636872592158075,0.7464371134387485,0.8794549266247379,0.9474516969025094,1.0,18/84,16.07%,MAGOH;HNRNPK;PRDX6;QKI;NCL;PUF60;RBFOX3;PCBP4;SRSF9;RBM15B;KHDRBS3;ZBTB7A;SNW1;HNRNPU;HNRNPA1;RBFOX1;CIRBP;CELF3
prerank,actin filament-based transport (GO:0099515),0.3195683294177503,0.746239216535925,0.8149068322981367,0.947317604324215,1.0,4/21,11.02%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,regulation of epithelial cell migration (GO:0010632),0.27498265033024866,0.7461978112962342,0.8510405257393209,0.9470055923997996,1.0,12/51,16.75%,EMP2;RTN4;PFN1;GLUL;CORO1C;ENPP2;CLASP1;PTPRR;SOX9;CTSH;DAB2IP;PFN2
prerank,cardiocyte differentiation (GO:0035051),0.36711683491695435,0.7454611628360582,0.7807637906647807,0.9475509627829288,1.0,3/10,13.45%,NRG1;KDM6B;BMP2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.2908667341122273,-0.7452471830361287,0.7900763358778626,0.9450742802807828,1.0,4/12,15.12%,YTHDC1;CDYL;PCGF5;SMCHD1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24604584921915218,0.7452230673854939,1.0,0.9474792458800563,1.0,231/1082,22.30%,APOE;RPS27A;CD74;UBC;UBB;CHCHD10;CD81;PCBP1;CXXC1;SPP1;COL1A1;ACTA2;MT3;CHCHD2;JUND;PARK7;TMPRSS6;MAPK3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;PTPRN;ELOF1;ERBB4;LYL1;POMC;NPM1;AGT;DDX39B;GPER1;EIF5A;ETS2;BEX1;TNF;PDGFB;DRAP1;NR1D1;HCLS1;ACVRL1;CHEK2;SPI1;EPAS1;GLMP;JUNB;PIN1;YWHAH;PSMC3;PARP1;MRTFA;CTNNB1;ST18;GRIN1;SERTAD1;HES1;HYAL2;CDKN1C;HMGN1;RHOG;HIPK2;CDK8;RNF187;OTX2;UBA52;FOXF2;CEBPB;FOXD3;BRPF1;TRIM28;EDF1;NAMPT;SALL2;FOXL2;CEBPA;PROX1;SEC14L2;CXCL10;CREB3L4;CREB3;CSRNP3;YBX1;MLXIPL;MLX;EGR1;RRP1B;HOXD4;GATA2;JUN;DCN;CAMK1;KARS1;HMGB1;ZBTB49;TAF9;RFX4;RTRAF;H1-0;HOXB7;PHOX2A;MC1R;NPAS3;IRF8;APBB1;SUPT4H1;MYRF;APEX1;WNT5A;IL11;SOX17;ATF5;POU3F1;KDM6B;SS18L2;IRF2BPL;WBP2;HRAS;PTOV1;SOX8;SNW1;IRX3;ZMIZ2;DBP;THRA;KLF4;HOXD8;SLC11A1;SOX9;PAX3;LILRB1;BMP2;RIPK2;RAI1;NME2;HNRNPU;TNFRSF1A;HDAC5;ZC3H8;UBE2V1;ATMIN;NUP85;IRF7;MED30;F2RL1;PF4;AKNA;LAGE3;UBTF;IGF2;ARF4;NR1H2;KDM1B;MAPRE3;EBF3;HEY1;NCF1;DLL1;IER5;ING1;DAB2IP;E2F4;VHL;GATA4;BCL11B;SQSTM1;SKAP1;GLIS2;TWIST1;PCID2;ADCYAP1;BRCA2;PPARGC1A;MED21;MRPL12;ERCC6;AGO1;CNBP;TOX2;LMO1;USP22;MAP2K2;MAZ;HMGN5;NRL;SOX11;PPP3CA;DDRGK1;CD86;INHBA;LBH;NLRP3;ESRRB;TFAP2B;NOTCH1;HGF;IL6;TGFB1;AGRN;ING5;ALYREF;POU4F1;CITED2;MEF2C;FOXA2;SFRP1;CAPN3;TFAP4;MYC;NFKBIA;FOSL2;FZD2;CDC5L;ID2;DDIT3;CEBPZ;CDK9;SOX10;FOXA1;CKAP2;SIRT2;FZD1;ZXDC;MEN1;SS18L1;MAP2K7;IRF5;REST;ESRRG;BLM;GRHL2;TNIP1
prerank,lymphocyte mediated immunity (GO:0002449),0.3500582908681753,0.7422216075600933,0.8034993270524899,0.9507920540849346,1.0,1/12,4.16%,BTN3A3
prerank,ncRNA 3'-end processing (GO:0043628),0.34733459614179013,0.740585903424414,0.8116531165311653,0.9524381494378997,1.0,7/14,32.11%,ELAC2;TOE1;TRNT1;ERI1;INTS12;INTS5;INTS6L
prerank,cell chemotaxis (GO:0060326),0.2705133951021836,0.7405706891927376,0.8515709642470206,0.952095537038466,1.0,16/60,26.78%,CXCL12;PDGFB;RHOG;CCR5;CXCR4;CX3CR1;EPHB1;ARRB2;CCL28;CCR2;HGF;CCN3;PRKCQ;PLXNB3;CX3CL1;LEF1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.31641623477946507,0.7404531651448454,0.8107416879795396,0.9518727056625313,1.0,1/20,1.89%,MAPK3
prerank,metanephros development (GO:0001656),-0.23152604187566292,-0.7403871518405025,0.845771144278607,0.9499769528667528,1.0,10/26,24.71%,FOXD1;NIPBL;PKD1;SIX1;BMP4;NF1;PKD2;PTCH1;GDNF;FGF10
prerank,positive regulation of RNA splicing (GO:0033120),0.292422584101113,0.7397561831490491,0.8352941176470589,0.9523402587462948,1.0,6/29,16.07%,PRDX6;NCL;SNW1;HSPA1A;CIRBP;CELF3
prerank,vitamin transport (GO:0051180),0.29949469046717814,0.7397015451949487,0.8270142180094787,0.9520428145224238,1.0,10/29,32.18%,GC;SLC19A1;FOLR2;SLC2A2;SLC52A1;SLC19A2;TCN2;SLC2A6;SLC52A3;SLC52A2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.3373486529716512,0.7395396873673588,0.8008021390374331,0.9518568488240489,1.0,3/15,14.62%,CXCL12;KDR;F2RL1
prerank,endocardial cushion development (GO:0003197),0.3145419955986079,0.7385946618437769,0.8069053708439897,0.9526490061720853,1.0,10/21,28.21%,ACVRL1;SOX9;BMP2;HEY1;GATA4;CRELD1;NOTCH1;TGFB2;ENG;TBX2
prerank,tRNA metabolic process (GO:0006399),0.33173176450835173,0.7384965385408592,0.8130489335006273,0.95239314851635,1.0,3/17,10.05%,SARS1;KARS1;POP7
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30772411748282213,0.7384913986539591,0.8295042321644498,0.9520352205399716,1.0,7/25,19.43%,HSPA1B;BRD1;PRMT1;HSPA1A;ABCB10;MAPK11;INHBA
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3603973398599757,0.738208756731914,0.7913043478260869,0.9520126590306818,1.0,2/10,24.44%,CNGB1;PDE6G
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3492625369023392,0.7376554030650627,0.8010825439783491,0.952302947479372,1.0,8/12,38.64%,GLUD1;IDH3G;ACLY;IDH1;ASS1;IDH3A;SIRT4;IDH3B
prerank,isotype switching (GO:0045190),0.36403577837385753,0.7368601778647758,0.7924791086350975,0.9528939290345932,1.0,1/10,7.89%,HSPD1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.23134078917306788,-0.7364471285791724,0.8820224719101124,0.9538596299744033,1.0,4/25,9.77%,SLIT2;YAP1;CEP97;KANK1
prerank,cellular response to UV-A (GO:0071492),0.3481623145807295,0.7358167975985451,0.8126721763085399,0.9537933711369567,1.0,2/11,11.31%,TIMP1;MMP3
prerank,negative regulation of cilium assembly (GO:1902018),0.3462891075870007,0.7357778072652984,0.7808599167822469,0.953469491674685,1.0,7/12,30.11%,CCP110;EVI5L;TESK1;CDK10;TCHP;TBC1D7;MAP4
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3222566049708414,0.7355816947948671,0.814621409921671,0.9533466069930009,1.0,4/19,8.38%,S100A10;RAC1;THY1;KDR
prerank,megakaryocyte differentiation (GO:0030219),0.3533724837872877,0.7347560960799673,0.7751724137931034,0.9539631759585003,1.0,4/11,27.86%,IL11;THPO;CDKN2B;ZFPM1
prerank,GTP metabolic process (GO:0046039),0.32872739223269587,0.7346460030432598,0.7937158469945356,0.9537268324251543,1.0,3/15,9.45%,RAN;AK4;AK3
prerank,organelle fusion (GO:0048284),0.3075853417879141,0.7346205934911166,0.8050955414012739,0.9533953744671371,1.0,7/22,21.42%,BAX;GDAP1;MIEF2;SPG7;MFF;STX4;FIS1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.303564778589338,0.7341309409284665,0.8385093167701864,0.9536121733555508,1.0,4/26,10.09%,FMOD;LUM;CHST1;B4GALT6
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2802902193683996,0.7340193864508432,0.8497175141242937,0.953374392796257,1.0,10/40,22.22%,IER3;RPA2;USP51;MAPT;NSMCE1;FBXO5;UBE2V1;MYC;CDK9;RADX
prerank,microvillus assembly (GO:0030033),0.34391377400373907,0.7331986347210234,0.8061911170928667,0.9539725118204989,1.0,1/14,1.80%,FXYD5
prerank,negative regulation of DNA binding (GO:0043392),-0.2256259078144813,-0.7328220061930887,0.8765432098765432,0.9569411366962746,1.0,6/28,14.92%,SMO;PER2;SP100;ILRUN;RSF1;HEY2
prerank,dorsal/ventral pattern formation (GO:0009953),0.3208596362015942,0.732401009584056,0.8352490421455939,0.9545327064818488,1.0,2/20,4.15%,NBL1;ACVRL1
prerank,plasma membrane repair (GO:0001778),-0.2778711245686294,-0.7317952327952483,0.8107142857142857,0.9568539291683188,1.0,2/13,5.20%,MYOF;MYH9
prerank,response to prostaglandin E (GO:0034695),0.36102101183002605,0.7317935049350455,0.8154929577464789,0.9548655275927809,1.0,1/10,2.23%,CCL19
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.24458742215758708,0.7317099000762936,0.983,0.9546070755382204,1.0,87/366,25.25%,PFDN5;RPL6;CALR;CXXC1;RPL10;ATF4;SOX18;HINT1;GRM5;LYL1;MAGED1;METAP1;DRAP1;HCLS1;ACVRL1;CHEK2;SPI1;PPP2R1A;NUCKS1;BTG1;FADS1;TBX22;CEBPB;GMNN;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;PCIF1;SOX17;ATF5;RBM4B;METTL18;BMP2;FBXO5;UBE2V1;MAFA;CCDC88A;NONO;SPIN4;IGF2;PDGFA;GLRX2;VHL;GATA4;BRCA2;PPARGC1A;MLF2;CNBP;ZNF22;TERF2IP;HMGN5;SOX11;CCAR2;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;ACTR5;DDIT3;USP13;PHF1;REST;ESRRG;POU6F2;SOX1;TAF5;SP3;RELA;MAFB;APP;TCF7L1;TCF3;CCNA2;EIF2A;PPIE;RORB;MYCBP
prerank,positive regulation of DNA repair (GO:0045739),0.2780548224571291,0.7312472411002882,0.855039637599094,0.9548163200423782,1.0,7/46,12.09%,RPS3;PARP1;TRIM28;FMN2;HMGB1;PCNA;DDX11
prerank,sphingosine metabolic process (GO:0006670),0.3218821923612368,0.7311821134228202,0.8106060606060606,0.9545276359735042,1.0,7/17,21.11%,SPTLC1;NAAA;ABCA2;SGPP1;SPHK2;SGPP2;ASAH2
prerank,bicarbonate transport (GO:0015701),0.3022442591018556,0.7309798982168144,0.826302729528536,0.9544049085103483,1.0,6/25,20.84%,CA2;AQP1;CA4;SLC4A2;CYB5R1;CA3
prerank,small GTPase mediated signal transduction (GO:0007264),0.2562136606832463,0.7305616318721814,0.9008264462809917,0.9545117277474454,1.0,37/103,27.11%,PARK7;RAC1;SHC3;TRIM28;RGS19;NTN1;JUN;GRAP;RASGRP3;HRAS;RHEBL1;RUNDC3A;SHTN1;ABR;CCDC88A;RRAS;TIAM1;G3BP1;MAPK11;RRAGC;G3BP2;RASGRP1;USP8;RAB18;SOS1;ARHGAP33;BRAP;RALB;RERG;CCNA2;RAB42;TNK2;KSR2;RGL2;RALBP1;CHP1;CDKN1A
prerank,endothelial cell migration (GO:0043542),0.28589805443623595,0.7300153389082137,0.8564814814814815,0.9548064305161033,1.0,11/37,22.56%,SOX18;ID1;EMP2;TNFSF12;RHOA;CDH5;LPXN;PLXND1;CCN3;SCG2;LGALS8
prerank,proteoglycan biosynthetic process (GO:0030166),-0.21140916592398362,-0.7296574171475682,0.8947368421052632,0.9579787240094522,1.0,9/31,20.76%,EXT1;IGF1;CHST11;GLCE;EXT2;FOXL1;BMPR2;B3GALT6;PXYLP1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.24176029631598256,0.7295280237967786,0.996,0.9550236294090175,1.0,119/572,21.78%,RPL23;RPS27A;RPS14;UBC;UBB;CALR;HSBP1;VPS72;RPL10;TMPRSS6;ATF4;KLF2;ID3;SOX18;ID1;EID1;ETS2;TNF;PDGFB;DRAP1;NR1D1;SPI1;ENO1;PARP1;TLE5;HES1;TENM2;IRF2BP1;TBX22;UBA52;CCND1;CEBPB;FOXD3;PRDM12;DUSP26;CBX6;PROX1;NR2F6;BCL6B;MLX;SARS1;JUN;SIN3B;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;APBB1;AEBP1;SUPT4H1;CTBP1;ZBTB7A;WFS1;IRF2BPL;SOX8;SNW1;NCOR2;IRX3;THRA;KLF4;THAP11;SOX9;HSPA1A;IRF2BP2;CRYM;BMP2;LEFTY1;HNRNPU;HDAC5;HEXIM1;SDCBP;IRF7;IKZF5;DNAJB1;IGF2;NR1H2;KDM1B;HEY1;MIER2;DAB2IP;HDAC9;BATF3;CAV1;DNMT3B;VHL;GLIS2;TWIST1;RIPPLY2;BCL11A;ZHX1;TCF25;CNBP;MYT1L;NOP53;CIR1;MAZ;MTA2;SOX11;SNCA;HIC1;TFAP2B;NOTCH1;KLF11;EFNA1;CHD3;POU4F1;CITED2;MEF2C;MYC;GADD45A;ID2;DDIT3;SOX10;SIRT2;SUDS3;DACH1;MEN1;IFI27
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.35389228072660317,0.729481925719267,0.8137254901960784,0.9547130776095538,1.0,4/11,20.52%,WNT5A;SOX9;PDGFA;MYC
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3590292842233315,0.7294537208034518,0.8058394160583942,0.9543840944667895,1.0,3/11,21.50%,CTNNB1;WNT5A;FZD1
prerank,eye photoreceptor cell development (GO:0042462),-0.265814692415972,-0.7293872194285511,0.8325991189427313,0.9569331073025052,1.0,3/15,9.39%,CEP290;RPGRIP1L;TOPORS
prerank,DNA conformation change (GO:0071103),0.3204554058461874,0.7292026484685725,0.8277634961439588,0.9543151124855105,1.0,3/17,10.81%,HMGB3;HMGB1;NAA10
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2834056932915071,0.7284608935137483,0.8532423208191127,0.9548046247181133,1.0,7/39,13.45%,RASIP1;CTNNB1;PAK1;COL4A1;KDR;TIE1;BMP2
prerank,natural killer cell activation (GO:0030101),0.3077047737064265,0.7284272238132539,0.8375314861460957,0.9544796343167241,1.0,7/23,19.00%,PTPRC;IL2;PRDX1;NCR1;RASGRP1;PIK3CD;TOX
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.22359061878013398,-0.7283299271511438,0.8511904761904762,0.956865963354055,1.0,2/26,1.41%,LARGE1;ST3GAL4
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.28759603663302213,-0.728316447359394,0.8145454545454546,0.9554893931091393,1.0,6/11,17.84%,P4HTM;EGLN1;P4HA1;EGLN3;P4HA2;P4HA3
prerank,regulation of TOR signaling (GO:0032006),0.264269854923017,0.7279028977209238,0.8821007502679529,0.954729355183477,1.0,13/67,19.98%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;PIH1D1;PDCD6;LAMTOR3;GAS6;RRAGC;RRAGD;FAM83D;AKT1S1;DDIT4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.273572617871237,-0.7278554668065381,0.8686868686868687,0.9546382579786284,1.0,6/14,19.18%,DPYD;UPP2;UPB1;NT5C1A;NT5M;DHODH
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.23863408324782115,-0.7274624717052584,0.8898678414096917,0.9537030672559365,1.0,6/20,21.04%,SULF1;SMOC2;FGF2;PRKD2;SULF2;CREB3L1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.1765193926299523,-0.7265196815348988,1.0,0.9535187183421866,1.0,30/98,23.41%,EML4;PDS5A;NIPBL;PDCD6IP;MCPH1;PDS5B;PIBF1;POGZ;INO80;CSNK2A1;CSNK2A2;AKAP8L;CENPK;PHF8;PINX1;DSN1;CENPE;KLHL22;SMC4;KIF18B;NUP62;NDC80;KIF23;DIS3L2;TUBG1;KIF22;SMC1A;NCAPD3;MIS12;SGO1
prerank,arachidonate transport (GO:1903963),-0.2881441034331262,-0.726407684504183,0.8120567375886525,0.9509038674725326,1.0,10/10,71.21%,ANXA1;PLA2G5;DRD3;BDKRB2;DRD4;PLA2G1B;ACE;DRD2;PNPLA8;NMUR2
prerank,arachidonic acid secretion (GO:0050482),-0.2881441034331262,-0.726407684504183,0.8120567375886525,0.9509038674725326,1.0,10/10,71.21%,ANXA1;PLA2G5;DRD3;BDKRB2;DRD4;PLA2G1B;ACE;DRD2;PNPLA8;NMUR2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26372478658736226,0.7263285708646435,0.8879310344827587,0.9561661113267053,1.0,9/72,14.41%,POLR2E;MAPK3;POLR2D;POLR2F;RAB14;POLR2G;FGFRL1;POLR2K;HNRNPA1
prerank,fibrinolysis (GO:0042730),0.3440036809404322,0.7263127261201935,0.8139223560910308,0.9558307510803378,1.0,2/13,16.74%,PLAT;PLAU
prerank,brain morphogenesis (GO:0048854),0.3417294154107335,0.7258719798612319,0.8276797829036635,0.9559694451575113,1.0,1/12,3.10%,CTNNA2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3462696372986963,0.7253700781362724,0.8074277854195323,0.956175904150536,1.0,2/12,12.09%,CTNNB1;DDX11
prerank,organonitrogen compound catabolic process (GO:1901565),0.27156343899922325,0.7250259320117055,0.8712121212121212,0.9562056687405422,1.0,15/57,24.30%,USE1;MPST;ENPP2;AMDHD2;BCKDK;PLA2G7;CLN5;CLN6;TXN2;TST;CLN8;CAPN3;SGPL1;ERAP1;ADO
prerank,axonemal dynein complex assembly (GO:0070286),0.2937967397890242,0.7248838322007108,0.8364928909952607,0.9560148196384518,1.0,4/27,13.35%,DNAI3;DNAAF3;DNAH1;LRRC49
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.32091290403184125,0.7244744351390213,0.8168831168831169,0.9561146019156592,1.0,3/17,11.97%,GPER1;ATP1A3;ATP1A1
prerank,regulation of oxidoreductase activity (GO:0051341),0.3371772686619877,0.7243062057200984,0.8098495212038304,0.9559508913245323,1.0,1/13,1.51%,MT3
prerank,carboxylic acid catabolic process (GO:0046395),0.34739307054726803,0.7240444125275526,0.7997198879551821,0.9558699777309825,1.0,3/12,16.68%,AMDHD2;BCKDK;ACOT4
prerank,lung epithelium development (GO:0060428),0.35759249115615976,0.7238867495787209,0.8002832861189801,0.9556908266622913,1.0,1/10,2.36%,RCN3
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2734061820714714,-0.7237972909374988,0.8301886792452831,0.9525257845566977,1.0,4/13,15.22%,CNOT1;MOV10;CNOT7;ZC3HAV1
prerank,carbohydrate homeostasis (GO:0033500),0.26380438290925007,0.7234977480459276,0.8887677208287895,0.955761466328693,1.0,14/67,22.34%,PARK7;MTNR1B;RPS6;RBP4;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;TFAP2B;IL6;PYGL;ADIPOR1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3039960807126745,0.7229584719665431,0.8176020408163265,0.9556585723029963,1.0,7/22,28.67%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3039960807126745,0.7229584719665431,0.8176020408163265,0.9556585723029963,1.0,7/22,28.67%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,oligosaccharide metabolic process (GO:0009311),0.269747587703742,0.7227481877133478,0.8820861678004536,0.9555252088105108,1.0,20/46,32.56%,MAN2B2;MAN1B1;MPDU1;ST8SIA4;ST6GALNAC3;MAN2C1;NEU1;ST6GAL2;FUT9;ST8SIA5;B3GALT5;GAL3ST3;B3GALT2;NAGA;NEU3;MAN2B1;ST8SIA6;AMY1A;AMY1C;AMY1B
prerank,response to laminar fluid shear stress (GO:0034616),0.3603976485154325,0.7225692313818551,0.8099290780141843,0.955363964370899,1.0,2/10,12.78%,KLF2;KLF4
prerank,adipose tissue development (GO:0060612),0.35157374956529636,0.7212555260676743,0.8326118326118326,0.9564440666152946,1.0,3/11,12.21%,NAMPT;PGRMC2;SOX8
prerank,autophagy of nucleus (GO:0044804),-0.2513371236350556,-0.7205968598543221,0.8938053097345132,0.9549549792373909,1.0,5/16,16.72%,ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.30995753017980354,0.7204844153067289,0.8354922279792746,0.9569674330850351,1.0,7/20,21.19%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2891489999209062,0.7204710839594278,0.8478260869565217,0.9566261559806724,1.0,11/30,27.11%,TERF1;ACVRL1;HNRNPU;HNRNPA1;CTC1;DACH1;MEN1;GNL3L;PIF1;HNRNPC;CDKN1A
prerank,peroxisomal membrane transport (GO:0015919),0.29354940111143063,0.7204666426240123,0.8389021479713604,0.9562753370806887,1.0,12/27,35.64%,PXMP2;GDAP1;PEX6;FIS1;PEX11B;PEX1;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28438836790901834,0.7198189786330503,0.851140456182473,0.9566650665442977,1.0,7/31,15.69%,CFL1;NLGN1;PPFIA2;CDK5R1;SRCIN1;LRP8;CDK5
prerank,B cell activation involved in immune response (GO:0002312),0.3347831416790267,0.7194820555343233,0.8066225165562914,0.9566966462112261,1.0,2/13,19.49%,CD180;GPR183
prerank,response to lipid (GO:0033993),0.2522840956267497,0.7188513842761928,0.9237113402061856,0.9570601946002817,1.0,20/105,19.83%,SPP1;RBP4;S100A9;S100A8;TIRAP;CTNNB1;ABCG1;HNRNPA0;GPX3;SCD;SLC11A1;SOX9;PAQR7;ERBIN;CTSH;ABCA2;ADAM17;NOS2;SNCA;TGFB1
prerank,fatty acid oxidation (GO:0019395),0.2651763959920023,0.7187340139508087,0.8800436205016358,0.9568325575344222,1.0,8/57,17.37%,ACADVL;SCP2;MTLN;HSD17B4;ACAT1;ACAA2;PPARGC1A;ECHS1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.29159682642926404,0.7185928640397344,0.8437118437118437,0.9566405825591534,1.0,7/27,17.63%,PDE4B;CTNNA3;PLN;FGF13;RYR2;CAV1;SRI
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2604001343263531,0.7185376169147715,0.8806451612903226,0.9563437614847641,1.0,28/68,33.86%,SLC2A1;RFK;CYB5R3;GSTO1;SLC19A1;PNPO;SLC19A3;FOLR2;SLC25A19;SLC2A3;SLC52A1;SLC19A2;SHMT2;MTHFS;CYB5A;TCN2;DHFR;ACP5;AASDHPPT;SLC52A3;ALDH1L1;SLC52A2;PCCB;MTHFD2L;MTRR;LMBRD1;MTR;NNMT
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.25049041570014663,-0.7177744897131038,0.8237704918032787,0.9569241021871465,1.0,1/15,2.16%,MOXD1
prerank,modification-dependent protein catabolic process (GO:0019941),0.24301646957343628,0.7177504529359885,0.9697275479313825,0.956816554296334,1.0,30/193,17.66%,RPS27A;UBC;UBB;PINK1;KCTD10;TOLLIP;UBE2G2;CDC34;UBA52;ARRDC1;ISG15;FEM1A;FEM1C;FBXL14;RBX1;NEDD8;RNF128;DDB1;PSMD13;BUB3;SYVN1;UBQLN2;RNF40;RNF150;RNF7;HERPUD1;SQSTM1;TRIM32;RNF149;RLIM
prerank,motile cilium assembly (GO:0044458),0.33527810960159354,0.7162507467297036,0.811141304347826,0.9581018743002527,1.0,3/12,20.35%,DNAAF3;E2F4;BBOF1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3055745983564849,0.7157061755871758,0.8378378378378378,0.9583729573249884,1.0,3/21,8.20%,MID1IP1;NAV3;CLASP1
prerank,negative regulation of type I interferon production (GO:0032480),0.2726898751120522,0.7154825413475112,0.8662053056516724,0.9582602947160697,1.0,4/40,6.97%,PIN1;SIRPA;TNFAIP3;ISG15
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3067371252845412,0.7154793536449061,0.8455696202531645,0.9579088580871271,1.0,8/21,19.83%,ECM1;SRGN;SOX9;GAS6;HEY1;CCL3;NOTCH1;TGFB1
prerank,plasma membrane organization (GO:0007009),0.26373044073848373,0.7153302008771739,0.886117136659436,0.9577238458549412,1.0,15/61,18.77%,ANK3;PACSIN1;P2RX7;SYT11;SMPD1;FNBP1L;SERP1;CXCR4;DEGS1;EPB41L3;SNX33;FA2H;EHD2;ANXA6;STX4
prerank,cardiac muscle cell development (GO:0055013),0.3043878644639232,0.714464344338707,0.8407407407407408,0.9583026757824451,1.0,5/20,17.41%,ALPK2;MYH11;SORBS2;SLC8A1;FHOD3
prerank,amyloid-beta metabolic process (GO:0050435),0.32081080788707866,0.7133737955672869,0.8244473342002601,0.9591398805801318,1.0,8/16,32.12%,PSENEN;BACE1;PSEN2;APH1B;APH1A;IDE;ACE;NCSTN
prerank,nucleoside phosphate catabolic process (GO:1901292),0.32180488446129707,0.7129150243245338,0.8173207036535859,0.9592836863361451,1.0,2/13,13.49%,ENTPD3;SMPDL3A
prerank,regulation of phosphate metabolic process (GO:0019220),0.3186519243800251,0.7121350729835286,0.8396349413298566,0.9597689562543624,1.0,2/16,9.26%,PGAM1;CD24
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3459154580699219,0.7116030867670813,0.8224431818181818,0.9599942673868309,1.0,2/10,16.47%,PRDM12;DNMT3B
prerank,regulation of cilium movement (GO:0003352),-0.2864495073118684,-0.7112714191493655,0.863481228668942,0.9626366687718861,1.0,10/10,71.38%,CCDC39;ODAD2;CCDC65;CFAP43;CCDC40;DNAAF1;CFAP298;DNAH11;DRC1;CFAP206
prerank,regulation of defense response to virus by host (GO:0050691),0.28515906146223935,0.7112247636458158,0.8552787663107948,0.960046770265585,1.0,3/30,7.19%,HSP90AA1;TNFAIP3;PQBP1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.24905226574849076,-0.7111703738265306,0.8647540983606558,0.9613989838309409,1.0,5/17,14.11%,PPARG;PTEN;PDCD4;TPM1;TGFB3
prerank,protein complex oligomerization (GO:0051259),0.2534779273008718,0.7105360378672512,0.92534174553102,0.9604415059292141,1.0,26/85,26.37%,LRRC8A;KCNC3;MPP2;ALAD;NINJ1;KCNC1;RS1;PRMT1;EHD1;UGDH;G3BP2;ADCY8;MAT2A;DNM1L;GLRA3;SNCA;SHMT2;PYCARD;KCNC2;BLM;ELAVL1;ECT2;BOK;PNPT1;EHD3;STOML2
prerank,visual perception (GO:0007601),0.2512854942478279,0.7101844966027424,0.9065420560747663,0.9604801182525172,1.0,9/84,13.24%,COL1A1;OAT;SFRP5;RD3;GRM8;REEP6;WFS1;RS1;CRYBA1
prerank,RNA processing (GO:0006396),0.24273017426204468,0.709753656310101,0.9516616314199395,0.9605989861807512,1.0,42/176,21.23%,SNRPG;AURKAIP1;MAGOHB;MAGOH;HNRNPK;DDX39B;SNRPD2;LSM4;LSM6;PPP2R1A;SNRPF;SRSF9;LIN28B;HNRNPA0;TARDBP;PRPF8;SUPT4H1;SRSF2;SF3A2;ELAVL4;SF3B2;IVNS1ABP;HNRNPU;MRPL44;NONO;SNRPB;SF3A3;RRAGC;PDCD7;CELF3;PPARGC1A;SNRPD3;APOBEC1;CCAR2;USB1;SF3A1;DKC1;TSEN54;SRSF1;SRRM4;SNRNP35;HNRNPF
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.252697323186312,-0.7097304036470717,0.8774703557312253,0.9616456781245059,1.0,3/15,12.42%,GGACT;PRODH;HOGA1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3260226687537444,0.7095324007223578,0.8340192043895748,0.9604895985751539,1.0,6/14,27.99%,KLF4;RHOA;HDAC5;NOTCH1;MMRN2;DLL4
prerank,regulation of keratinocyte migration (GO:0051547),0.33215683500758386,0.7094063506476036,0.8118948824343015,0.9602712870570946,1.0,3/12,16.56%,ARF6;EPPK1;EPB41L4B
prerank,response to organophosphorus (GO:0046683),-0.24521148006280907,-0.7090556218137322,0.8836206896551724,0.9610050662640106,1.0,6/16,26.29%,DGKQ;TRPC3;VGF;ABCC9;NDUFS4;TYMS
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.24536537966655525,-0.7089953368279147,0.8864628820960698,0.959709094504272,1.0,4/17,14.72%,TAOK3;MID1;KLHDC10;TAOK1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3015977498752115,0.7081263460103991,0.8695652173913043,0.9612812363701683,1.0,5/21,22.31%,NPM1;CCND1;FBXO5;CDC25A;RCC2
prerank,xenobiotic transport (GO:0042908),0.3211399494830286,0.707810614119268,0.8269986893840104,0.9612414580006882,1.0,6/16,26.25%,SLC7A5;GJA1;SLC15A2;ABCC3;ABCA3;ABCC5
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.2544010246801322,0.7071066631283914,0.9144385026737968,0.9616350887785499,1.0,19/74,22.34%,MDK;COL1A1;MCRIP1;CTNNB1;CLASP1;SPRY1;BMP2;SDCBP;TIAM1;DAB2IP;TWIST1;VASN;IL6;EFNA1;TGFB1;FOXA2;SFRP1;FOXA1;ADIPOR1
prerank,regulation of T cell mediated immunity (GO:0002709),0.3433840098218622,0.7068134802276858,0.8264580369843528,0.9615916167673602,1.0,4/10,28.03%,HMGB1;CCR2;AGER;TNFRSF1B
prerank,mRNA 3'-end processing (GO:0031124),0.25181826852359346,0.7067644815979263,0.912041884816754,0.9612903522154513,1.0,16/78,22.07%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;SRSF2;PABPC1;CPSF2;THOC3;EIF4A3;SLBP;U2AF1L4;ALYREF;SRSF1;CPSF4;DHX38
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.31143802860058245,0.7064888346692257,0.8437917222963952,0.9612369890026162,1.0,5/16,19.16%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3;ST8SIA5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3080578021376214,0.7064519223746961,0.8506493506493507,0.9609238780885804,1.0,8/20,24.15%,ZFP36L1;ZFP36;PRMT1;PF4;HSPA9;HOXB8;MEIS2;MAFB
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.23597250115832114,-0.7051878225621294,0.8907563025210085,0.962444138135118,1.0,7/19,17.93%,CUX1;DHX36;CAPRIN2;OBSL1;CDKL3;FBXW8;CUX2
prerank,phosphate ion homeostasis (GO:0055062),0.3512091988243017,0.7045576978850251,0.8285302593659942,0.9626160726981281,1.0,2/10,19.55%,SFRP4;TFAP2B
prerank,sphingosine biosynthetic process (GO:0046512),0.34159613282722123,0.7041275471918477,0.8333333333333334,0.962378417215926,1.0,4/11,21.11%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.34159613282722123,0.7041275471918477,0.8333333333333334,0.962378417215926,1.0,4/11,21.11%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.27394732665289195,0.7036928679732231,0.8710801393728222,0.9624820415082571,1.0,5/38,15.49%,H3-3A;NPM1;CENPX;IPO4;CENPL
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.32165814078822175,0.7027984463331802,0.8446866485013624,0.9630612264644547,1.0,3/15,16.28%,POP7;RNASEH1;NUDT16
prerank,tRNA 5'-end processing (GO:0099116),0.31910201944268995,0.702785801632772,0.8412698412698413,0.962721641507965,1.0,5/15,33.22%,POP7;POP4;TRMT10C;POP5;HSD17B10
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.2789477743842502,-0.7020598252690161,0.8432055749128919,0.9643382664749551,1.0,4/11,20.93%,PTGIS;FAP;TP53;DFFA
prerank,response to insulin (GO:0032868),0.2496747276828423,0.7020111309987614,0.9164882226980728,0.9631839949998661,1.0,26/80,28.30%,AKT1;PKM;ZFP36L1;PARP1;PDE3B;RAB15;MYO5A;VAMP2;HDAC5;SORT1;HDAC9;EPRS1;RAB31;EPM2AIP1;GOT1;C2CD5;KHK;SELENOS;INHBB;ZBED3;EIF6;INSIG2;TRIB3;RAB8A;XBP1;USF1
prerank,protein localization to cell surface (GO:0034394),0.285517591339372,0.7015745243027263,0.8635265700483091,0.9632850233209777,1.0,9/26,25.82%,EMP2;CTNNB1;FLNA;ARF6;JAM3;PTPRU;UNC50;PRRT1;MESD
prerank,positive regulation of autophagy (GO:0010508),0.2516807273044037,0.7014301827899477,0.9194915254237288,0.9630776976254822,1.0,12/81,15.07%,PARK7;PINK1;TMEM59;ORMDL3;BNIP3L;SCOC;KDR;DCN;HMGB1;SVIP;STK11;BAD
prerank,regulation of smooth muscle contraction (GO:0006940),0.29775409561453775,0.7012904210988122,0.8547770700636943,0.9628637320181412,1.0,9/20,31.79%,CHRM3;ATP2B1;CHRM2;CAV1;CTTN;CHRNA3;SRF;NMUR2;NMU
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.27860493574078843,0.7003734119881061,0.8764705882352941,0.9635226209372192,1.0,8/33,19.19%,AKT1;CCND2;CCND1;AIF1;ADAM17;FAM83D;ADAMTS1;DDRGK1
prerank,DNA damage checkpoint signaling (GO:0000077),0.28419504144536445,0.6998061860057678,0.8514970059880239,0.9637698438272276,1.0,11/28,33.32%,CHEK2;PRPF19;ERCC6;CDC5L;STK33;ATRIP;DOT1L;RAD9A;RHNO1;CLOCK;DONSON
prerank,glycoprotein catabolic process (GO:0006516),0.31420457300861565,0.6994977735544409,0.8617571059431525,0.9637411983000962,1.0,2/17,9.13%,CTSL;FBXO27
prerank,regulation of phospholipid metabolic process (GO:1903725),0.33809061019718784,0.6992570011733075,0.8186889818688982,0.9636386798375458,1.0,2/10,10.44%,MFSD2A;MTMR9
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.296288038931816,0.6984393811908989,0.8544542032622334,0.9641196777120193,1.0,10/21,26.06%,HS6ST3;HS3ST5;B3GAT3;SGSH;UGDH;XYLT1;HPSE;HS6ST1;HS6ST2;GPC1
prerank,renal filtration (GO:0097205),0.3390762083636554,0.6980331886059531,0.8394366197183099,0.9641843942356957,1.0,3/10,11.09%,CD34;TMEM63C;MCAM
prerank,negative regulation of macroautophagy (GO:0016242),0.28669731818987376,0.6979555575795825,0.8690330477356181,0.9639088833910044,1.0,3/26,9.04%,AKT1;PINK1;NUPR1
prerank,regulation of cellular catabolic process (GO:0031329),0.2560998530370688,0.6972670644228718,0.9153094462540716,0.9642584347591583,1.0,6/62,9.11%,PSAP;HSPB1;DEPP1;MAPT;NUPR1;GPR137B
prerank,negative regulation of telomere maintenance (GO:0032205),0.3167427477027475,0.6968736856487543,0.8458498023715415,0.9642959487611469,1.0,2/15,5.17%,TERF1;PARP1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.30243930576669376,0.6955632593533645,0.8663239074550129,0.9653086844955842,1.0,7/19,26.23%,TERF1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,mesenchymal to epithelial transition (GO:0060231),0.34633891445897913,0.6949022276829603,0.8387553041018387,0.9656106945015547,1.0,1/10,8.19%,BASP1
prerank,negative regulation of phosphatase activity (GO:0010923),0.28545650471235856,0.694715457927247,0.8669064748201439,0.9654298429973602,1.0,11/25,33.07%,FKBP1A;PPP1R1B;PPP1R35;FKBP1B;PPP1R15A;CHP1;TGFB2;PPP1R11;BOD1;PTPA;SEMA4D
prerank,fatty acid catabolic process (GO:0009062),0.25202777809688104,0.6940407418887578,0.9351063829787234,0.9657543585033942,1.0,7/67,11.50%,ACADVL;SCP2;NUDT19;MTLN;HSD17B4;ACAT1;ACAA2
prerank,bile acid metabolic process (GO:0008206),0.2801372306575602,0.6938182152454427,0.8686746987951808,0.9656397412112677,1.0,7/27,24.21%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A;NPC1
prerank,sensory perception of light stimulus (GO:0050953),0.24475434644347108,0.6937992688228406,0.9332638164754953,0.9653093959636931,1.0,9/87,13.24%,COL1A1;OAT;PCDH15;SFRP5;RD3;GRM8;WFS1;RS1;CRYBA1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.28141117578377206,-0.6936528606499923,0.8310344827586207,0.9714221669011296,1.0,2/10,9.43%,ERRFI1;ENPP1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.2884511970052905,-0.6932545508298457,0.840531561461794,0.9704990606419296,1.0,2/10,6.10%,LRP6;ARHGAP12
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2550139393334221,0.6931450063826349,0.9039735099337748,0.9656236478869525,1.0,16/56,24.04%,RHOB;ANK3;RHOC;DCTN3;ANLN;RHOA;STMN1;SNX33;USP8;VPS4A;UNC119;CKAP2;SPIRE1;INCENP;RTKN;ECT2
prerank,in utero embryonic development (GO:0001701),0.2856019873845421,0.692020287213277,0.875,0.9663910051669324,1.0,5/25,15.42%,FOXD3;SOX8;PTPRR;BMP2;IGF2
prerank,icosanoid secretion (GO:0032309),0.325276407823746,0.6910108835289336,0.8371777476255088,0.9670469949756948,1.0,5/12,32.08%,NOS2;NMUR2;PNPLA8;DRD2;ACE
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2764530482476315,0.6905665833470293,0.8872266973532796,0.9671153043371077,1.0,9/33,20.03%,HSPA1B;BRD1;PRMT1;HSPA1A;ABCB10;MAPK11;SCIN;INHBA;THPO
prerank,cilium movement (GO:0003341),-0.18637596116937574,-0.6904491526184562,0.9439252336448598,0.9719717561425085,1.0,24/47,30.30%,DNAI4;CFAP251;SPEF1;GAS8;ODAD1;CCDC39;CFAP53;CFAP70;DNAAF5;ODAD2;SPAG17;ODAD3;CFAP61;SPA17;DNAAF2;ODAD4;TEKT2;ROPN1L;CCDC40;DNAAF4;CCDC63;TTC29;ADCY10;TEKT5
prerank,regulation of protein acetylation (GO:1901983),0.32689624106662296,0.6898273195085044,0.8616010854816825,0.967489478087903,1.0,2/12,9.68%,PARK7;CAMK1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.30580325136553754,0.6895765211029626,0.8758344459279038,0.9673865819282113,1.0,3/17,15.89%,KCNE4;KCNE5;RYR2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.29333550625014615,0.6892497221521469,0.8651399491094147,0.9673607155794584,1.0,2/21,2.94%,SMDT1;TGM2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3123086866951179,0.6880496004667159,0.856020942408377,0.9681952406310778,1.0,3/15,10.90%,MAPK3;KDR;AATK
prerank,inositol phosphate catabolic process (GO:0071545),0.3240282538156097,0.6880051247418993,0.8310439560439561,0.9678845381493304,1.0,2/12,13.53%,NUDT3;INPP5J
prerank,mitotic spindle organization (GO:0007052),0.23342388280536377,0.6875109301736816,0.9645030425963489,0.9680452039521407,1.0,20/153,17.38%,RPS27;DYNLL2;DYNLL1;RAN;CHEK2;FLNA;VCP;SBDS;ABRAXAS2;CLASP1;XPO1;BUB3;RHOA;STMN1;NUP85;DCTN2;CENPL;NUDC;RANGAP1;TOGARAM2
prerank,phosphate ion transmembrane transport (GO:0035435),0.3308022005929156,0.6867977073071941,0.8439226519337016,0.9684033474986061,1.0,8/12,40.29%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,cilium assembly (GO:0060271),0.230826983453594,0.6864417681162382,0.99,0.9684029985478934,1.0,48/296,20.65%,TUBB;GSN;TUBA1A;HSP90AA1;TUBB4B;DYNLL2;DYNLL1;TUBA4A;DCTN3;PPP2R1A;IFT20;FLNA;YWHAE;DNAAF3;DYNLRB1;CLASP1;CNGA4;YWHAG;TUBB4A;FNBP1L;CEP131;FHDC1;TCTN3;DYNLRB2;DCTN1;SSNA1;HAUS2;EHD1;DCTN2;ARF4;CNGB1;TMEM17;E2F4;CETN2;PRKAR2B;CCDC28B;TCTN1;EXOC7;EHD2;DCX;NOTCH1;BBIP1;NEK1;EXOC5;BBOF1;CFAP410;CFAP54;EXOC8
prerank,protein acylation (GO:0043543),0.26553201831595963,0.6860112501548374,0.9036697247706422,0.9684826210136127,1.0,12/38,29.54%,GLUL;SELENOK;ZDHHC5;NAA10;NAT9;ING5;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2894222778860978,0.6857868383137552,0.8668310727496917,0.9683566707758126,1.0,8/22,28.79%,UBAP1L;VPS28;VPS4A;VPS37C;VPS36;RNF126;SNF8;MVB12A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.26367534163361717,0.684765857735864,0.9029345372460497,0.9689818524149468,1.0,16/42,27.90%,S100A10;EMP2;RAC1;THY1;KDR;RRAS;CCL28;SKAP1;SFRP1;COL16A1;PPM1F;TEK;EFEMP2;CX3CL1;MYOC;CD3E
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.27239757846867113,0.6847192164747001,0.8849347568208779,0.9686681204550608,1.0,7/33,19.75%,PDE3B;P2RY12;JAM3;PLAU;SYK;MUC1;EFNA1
prerank,signal transduction by p53 class mediator (GO:0072331),0.27276278090607686,0.6844020883262973,0.8794749403341289,0.9686146748506902,1.0,9/30,28.38%,HINT1;NDRG1;PMAIP1;STK11;POU4F1;PYCARD;BOK;PAXIP1;PDK2
prerank,cilium-dependent cell motility (GO:0060285),0.28991504032708487,0.6841037119594352,0.8816936488169365,0.9685591488478836,1.0,3/22,11.99%,DNAI3;DNAH2;DNAH1
prerank,detection of mechanical stimulus (GO:0050982),-0.22447766601349917,-0.6832012774770867,0.8938053097345132,0.9774950431707805,1.0,4/19,10.69%,PIEZO2;PIEZO1;PKD1;PTK2
prerank,phospholipid biosynthetic process (GO:0008654),0.2624865114084557,0.6830005923764532,0.9026047565118913,0.9693242279514889,1.0,14/36,33.27%,FADS1;PCYT2;DOLK;CPNE6;AGPAT5;SPHK2;FDPS;NUS1;CPNE3;GPAM;SAMD8;DPAGT1;GNPAT;MBOAT1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.27934204353482905,0.682497038916135,0.8936430317848411,0.9694537856526657,1.0,7/26,20.13%,NR1D1;EPHA5;ADCY8;PIM3;BRSK2;STX4;FOXA2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.29781724681504707,0.6824018801313536,0.8671775223499362,0.9691919647260737,1.0,3/18,8.00%,SPI1;ST18;CEBPA
prerank,positive regulation of rRNA processing (GO:2000234),0.3329385141751757,0.6817683066855003,0.8543689320388349,0.9694420991889006,1.0,1/10,4.39%,TRMT112
prerank,positive regulation of defense response to virus by host (GO:0002230),0.28520807866069897,0.680816779942772,0.8766954377311961,0.9699980830783862,1.0,3/24,13.39%,HSP90AA1;PQBP1;LILRB1
prerank,folic acid metabolic process (GO:0046655),0.29863413946206724,0.6802418089405979,0.8627204030226701,0.9701726733022744,1.0,8/18,32.90%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;ALDH1L1;MTHFD2L;MTRR
prerank,neural crest cell differentiation (GO:0014033),0.29885559206346657,0.6802101412944201,0.8626444159178434,0.9698457933017097,1.0,9/18,32.04%,NRG1;PDCD6;SOX8;SOX11;MEF2C;HTR2B;NOLC1;KBTBD8;CDH2
prerank,cardiac muscle tissue development (GO:0048738),0.2533426850129247,0.6795871335841139,0.9170353982300885,0.9701083588327647,1.0,10/50,17.12%,NRG1;RBP4;SGCZ;MSX1;KDM6B;GJA1;BMP2;HEY1;GATA4;SGCG
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.24694738372481811,-0.6786577161299886,0.898876404494382,0.9802201743196447,1.0,4/15,12.43%,MDC1;ATF2;TIPIN;RAD17
prerank,mesoderm formation (GO:0001707),-0.2313219324906592,-0.6780932484919749,0.9102564102564102,0.9793502695223957,1.0,4/17,16.29%,ITGB4;ITGA3;SMAD2;BMPR2
prerank,phagosome-lysosome fusion (GO:0090385),0.3324432737928947,0.6773963515372224,0.8636995827538247,0.971794813227952,1.0,7/10,39.87%,RAB20;SYT7;RAB34;RAB39A;ARL8B;RAB7A;RAB7B
prerank,purine-containing compound salvage (GO:0043101),-0.2608746296346141,-0.6768741287428177,0.8704453441295547,0.9790491905197662,1.0,4/12,16.79%,AMPD3;ADK;AMPD2;GMPR
prerank,mRNA methylation (GO:0080009),0.30436031094351224,0.6764899590176794,0.8640646029609691,0.9723133923783895,1.0,5/15,25.03%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,transport along microtubule (GO:0010970),0.31034459089124666,0.6761675740652537,0.8777923784494087,0.9722782080158348,1.0,6/13,31.29%,CLIP3;BORCS5;COPG1;APP;CAMSAP3;SPG11
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2522857778209974,0.6761182612234463,0.9323882224645583,0.9719708513352429,1.0,23/59,27.55%,CTNNB1;CDK8;CCND1;CEBPB;TRIM28;JUN;CSF1R;BAX;THRA;SOX9;MED31;MED30;TWIST1;AGO1;IL6;RELA;CCNC;MED7;LEF1;CDKN1A;MED16;MED25;MED12
prerank,positive regulation of phospholipase C activity (GO:0010863),0.26041686199237823,0.6751424894973913,0.9149425287356322,0.9725236071083458,1.0,8/40,16.26%,NTRK2;ANG;C5AR1;P2RY6;P2RY12;HRAS;ADRA1A;FLT1
prerank,RNA 3'-end processing (GO:0031123),0.2451119500395713,0.6748882210711127,0.9307774227902024,0.9724012321570875,1.0,14/69,22.07%,MAGOHB;MAGOH;DDX39B;SRSF9;LIN28B;SRSF2;CPSF2;THOC3;EIF4A3;U2AF1L4;ALYREF;SRSF1;CPSF4;DHX38
prerank,synaptic vesicle transport (GO:0048489),0.3231209344133861,0.6738180066683974,0.854493580599144,0.9730015598923486,1.0,3/11,18.47%,KIF5A;CDK5;KIF5C
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.28061445910310256,0.6724240229388228,0.8987654320987655,0.9739786081630677,1.0,8/24,26.23%,TERF1;PARP1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,amide biosynthetic process (GO:0043604),0.2551296359313031,0.6722832964985888,0.9166666666666666,0.9737596547471652,1.0,15/47,32.48%,CERS2;SMPD1;SPTLC1;DEGS1;FA2H;CLN8;SPTSSA;ASAH2;AANAT;ASL;SAMD8;ASS1;ARG2;PCSK1;CERS6
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.29898159970911276,0.672267131505896,0.8733681462140992,0.973422601370579,1.0,3/15,19.67%,TNF;TLR6;IL6
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2251970275390527,0.6720212307348804,0.993,0.9732952117007851,1.0,65/327,22.44%,PFDN5;RPL6;CALR;CXXC1;ATF4;SOX18;HINT1;LYL1;RALY;MAGED1;DRAP1;HCLS1;ACVRL1;CHEK2;SPI1;PPP2R1A;BTG1;FADS1;TBX22;CEBPB;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;SOX17;ATF5;BMP2;UBE2V1;MAFA;NONO;SPIN4;IGF2;GLRX2;VHL;GATA4;BRCA2;PPARGC1A;MLF2;CNBP;ZNF22;TERF2IP;HMGN5;SOX11;CCAR2;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;ACTR5;DDIT3;USP13;PHF1;REST;ESRRG;POU6F2;SOX1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2696515763918524,0.6714170169660848,0.9031476997578692,0.9734947301221092,1.0,11/33,29.26%,PSME1;PSME2;FBXW7;FAM83D;DDRGK1;PTPN6;ID2;CDKN1A;TRIM39;ATP2B4;PSME3
prerank,methylguanosine-cap decapping (GO:0110156),0.336790741228302,0.6702323780982647,0.8666666666666667,0.9742107924193784,1.0,2/10,11.69%,PNRC2;EDC4
prerank,mRNA transport (GO:0051028),0.23567499651507418,0.669731021772261,0.9537037037037037,0.9742987572358903,1.0,22/101,22.07%,MAGOHB;MAGOH;DDX39B;ZFP36L1;SRSF9;RBM15B;ZFP36;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;KIF5C;ALYREF;RAE1;SRSF1;CPSF4;DHX38
prerank,protein localization to Golgi apparatus (GO:0034067),-0.20197307459304825,-0.6692817798018742,0.9086021505376344,0.9842321911136948,1.0,7/27,17.05%,VPS13A;VPS13D;GBF1;OPTN;OBSL1;ARL5B;GBP5
prerank,peroxisome organization (GO:0007031),-0.203583078631095,-0.6689160554812524,0.945054945054945,0.9831483267797414,1.0,7/25,16.53%,LONP2;ABCD3;ACOT8;PEX7;TMEM135;SEC16B;PEX11A
prerank,sulfur amino acid metabolic process (GO:0000096),0.28106604719170913,0.6680663977989849,0.9023779724655819,0.9754683284951465,1.0,4/24,15.82%,MPST;SMS;TXN2;TST
prerank,protein alkylation (GO:0008213),0.2784387917962085,0.6674321082207954,0.8791615289765722,0.9756849839133668,1.0,5/22,22.90%,EEF1AKMT2;PRMT1;SNRPB;SNRPD3;ETF1
prerank,RNA modification (GO:0009451),0.24816450895909967,0.6673258107094655,0.9377777777777778,0.9754170427102169,1.0,14/54,25.97%,METTL1;NOP10;RBM15B;AARS2;CTU1;MEPCE;PUS7;FTSJ3;ADAT2;URM1;THUMPD1;METTL3;CTU2;LCMT2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.2760968842577366,-0.6663901792047519,0.89171974522293,0.9839664902201549,1.0,2/10,13.39%,SH3RF1;CBFB
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.23758897064826723,-0.6658285578428053,0.9224489795918367,0.9830942713900451,1.0,3/14,16.01%,FOXO3;EARS2;MTERF2
prerank,estrogen metabolic process (GO:0008210),0.29869019683950127,0.6655734891040467,0.8596256684491979,0.976620287401402,1.0,4/15,33.22%,HSD17B4;HSD17B11;HSD17B8;HSD17B10
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.28692107793583627,0.6649330341602853,0.8767833981841764,0.9768240517445562,1.0,6/20,25.82%,CDKN1C;CEBPA;HEXIM1;TFAP4;MEN1;HHEX
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.23095980678116707,0.6647643663596439,0.9565667011375388,0.9766150809231039,1.0,24/102,22.38%,AKT1;GPER1;PKM;ZFP36L1;PARP1;PDE3B;RAB15;MYO5A;PRKAR1A;VAMP2;PRKAR1B;ADCY4;HDAC5;ADCY8;HDAC9;CAV1;PRKAR2B;EPRS1;RAB31;GOT1;C2CD5;SELENOS;INHBB;TSHR
prerank,regulation of cytoplasmic translation (GO:2000765),0.2971054250416818,0.6646978761664774,0.8732970027247956,0.9763311125284609,1.0,3/14,17.90%,PKM;YBX3;CNBP
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2892779025879033,0.6644768662203919,0.88625,0.9761825661094874,1.0,8/19,32.90%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;ALDH1L1;MTHFD2L;MTRR
prerank,sulfur compound transport (GO:0072348),0.2721005501919408,0.664331945357812,0.9015990159901599,0.9759625253384144,1.0,6/27,18.56%,MGST1;SLC6A6;SLC26A4;SLC25A11;SLC25A19;SLC19A2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.25199049694331127,-0.6641909145686932,0.8953068592057761,0.9829775550435931,1.0,5/13,22.41%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,myotube cell development (GO:0014904),-0.2740453753358685,-0.6641114341124583,0.8725490196078431,0.9816922199334059,1.0,3/10,13.03%,SKI;IGF1;SIX1
prerank,DNA replication (GO:0006260),0.2341845416581192,0.6631347300597685,0.9678089304257529,0.9766511271760222,1.0,33/105,32.26%,PTMS;RNASEH2A;MCM5;RPA2;SET;RFC2;RECQL5;POLD4;ING5;RFC4;FAM111A;POLG;BLM;CDC45;POLD1;PNKP;BARD1;NAP1L1;ATRIP;RPA3;RPAIN;PIF1;RAD9A;RMI1;MCM7;MCM2;POLE3;KAT5;DNA2;RHNO1;UPF1;TOPBP1;TBRG1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.257591093587061,0.661453681727629,0.9321266968325792,0.9777489872126987,1.0,9/37,21.36%,CALM1;CALM3;CADM4;RIPK2;DMTN;CALM2;TGFB1;DDIT4;SIRT2
prerank,regulation of cytokinesis (GO:0032465),0.23650873757951438,0.660985686014495,0.9424686192468619,0.9778056456641042,1.0,4/78,4.81%,CALM1;CALM3;KLHL9;PIN1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3146020952012109,0.6607030362183727,0.8818791946308725,0.9777011305755366,1.0,3/12,16.24%,CADM4;DCN;DAB2IP
prerank,regulation of calcium-mediated signaling (GO:0050848),0.27399643188300216,0.6596602062387831,0.8963795255930087,0.9782266960399708,1.0,5/25,20.21%,TREM2;MAPT;CD22;CCL3;TRAT1
prerank,chemical homeostasis (GO:0048878),0.2412029274556159,0.659409235981234,0.9453376205787781,0.9780903893636846,1.0,8/61,13.10%,AQP4;PNPLA2;TREM2;RBP1;CEBPA;ATP13A2;ABHD8;FBXW7
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.24916874147752896,0.6594024409149932,0.9191011235955057,0.9777447938033929,1.0,8/44,18.10%,PARK7;SCP2;HSD17B4;OSBPL6;SC5D;PNPO;OSBPL3;CH25H
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22548566038823467,0.6588442800407692,0.9653414882772681,0.9778737928000235,1.0,15/125,17.27%,RPS27;DYNLL2;DYNLL1;RAN;SBDS;CLASP1;XPO1;TACC3;BUB3;STMN1;NUP85;DCTN2;CENPL;NUDC;RANGAP1
prerank,protein kinase A signaling (GO:0010737),0.3135423281623563,0.6586572481382919,0.8906030855539971,0.9776824037474666,1.0,3/12,30.61%,LCP1;PRKACA;PRKACB
prerank,cellular response to estrogen stimulus (GO:0071391),-0.23939694704931014,-0.6579891022055377,0.9247787610619469,0.9851928532576377,1.0,3/14,12.44%,BCAS3;TRIM24;AR
prerank,acetyl-CoA metabolic process (GO:0006084),0.29740455165219715,0.6566571844528065,0.893387314439946,0.979021755354793,1.0,5/15,28.43%,ACAT1;PPCS;PMVK;ACLY;HMGCS1
prerank,endocardial cushion morphogenesis (GO:0003203),0.2848403793036972,0.6563001717947796,0.8920676202860858,0.9789685556338216,1.0,8/18,28.21%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;ENG;TBX2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.25112108472824146,0.6559625430081873,0.9285714285714286,0.9789119162737268,1.0,12/46,21.15%,ATF4;ID1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;DDIT3
prerank,protein lipidation (GO:0006497),0.24195838500201117,0.6555768201805388,0.9321663019693655,0.9788845199685474,1.0,16/59,29.54%,PIGZ;PIGQ;GLUL;SELENOK;ZDHHC5;DPM3;DPM2;WDR45;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;WIPI2;PGAP4;ZDHHC14;ZDHHC16
prerank,intracellular lipid transport (GO:0032365),0.2778768885268352,0.6555513690178826,0.8923654568210263,0.9785565345208616,1.0,2/21,4.19%,NPC2;MID1IP1
prerank,membrane fusion (GO:0061025),0.25886905972509666,0.6553964886353014,0.910271546635183,0.9783420361712566,1.0,9/33,22.52%,DNM3;RIMS1;VAMP3;VAMP2;NAPA;DNM1L;GCA;VAPA;DNM1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3050909210474984,0.6547475180330612,0.8855172413793103,0.9785371296786911,1.0,3/14,23.84%,CD84;RASGRP1;PAEP
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.240682448954064,-0.654025049827409,0.9097744360902256,0.9868136341877047,1.0,5/14,22.41%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.30788618605432017,0.6531460131456325,0.8702702702702703,0.9795711499930567,1.0,4/12,23.31%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,chromatin remodeling (GO:0006338),0.22755740171994915,0.6518811837449218,0.9632352941176471,0.9802414402520673,1.0,17/100,21.30%,ACTB;NPM1;MBD3;PAK1;NPM3;PIH1D1;KDM6B;ZBTB7A;SOX9;HDAC5;ERCC6;MTA2;CHD3;CBX3;MYC;ACTR5;FOXA1
prerank,regulation of presynapse organization (GO:0099174),0.28451466651436974,0.6517693345341086,0.888745148771022,0.9796316806015305,1.0,8/18,24.37%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,regulation of presynapse assembly (GO:1905606),0.28451466651436974,0.6517693345341086,0.888745148771022,0.9796316806015305,1.0,8/18,24.37%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2735608338680515,0.6511902385505006,0.897908979089791,0.9797545545054156,1.0,7/23,33.27%,PLAAT3;PLA2G4F;PLA2G3;PLA2G6;PLBD1;PNPLA8;MBOAT1
prerank,leukotriene biosynthetic process (GO:0019370),0.301029497515917,0.6511528567210544,0.8957219251336899,0.9794375907429187,1.0,5/14,29.45%,MGST3;ALOX5AP;LTC4S;GGT5;GGT7
prerank,striated muscle cell development (GO:0055002),0.3021889986097189,0.6509747657624184,0.8845108695652174,0.9792369001128136,1.0,7/14,35.92%,FLII;TMOD1;CAPN3;KLHL41;LMOD1;LMOD3;SDC1
prerank,glycoprotein biosynthetic process (GO:0009101),0.23315307119706466,0.650699041169633,0.9544491525423728,0.9791146131267247,1.0,23/79,25.18%,DAD1;DDOST;B3GNT9;SERP1;ST8SIA4;GCNT1;ALG3;XYLT1;FUT9;B3GNT3;ST6GALNAC2;ST8SIA5;CANT1;TMEM106A;CSGALNACT2;TNIP1;B3GALT5;MGAT1;GAL3ST3;NUS1;B3GALT2;NPC1;CHST9
prerank,mesenchyme morphogenesis (GO:0072132),0.28787690809262734,0.6503345338292553,0.9102902374670184,0.9790432991460598,1.0,8/17,28.21%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;ENG;TBX2
prerank,negative regulation of viral release from host cell (GO:1902187),0.30452219267499997,0.6501686802222838,0.8743016759776536,0.9788346585394156,1.0,3/13,19.64%,TRIM28;TRIM32;TRIM13
prerank,RNA export from nucleus (GO:0006405),0.22925924867264857,0.6499943353101982,0.9658738366080661,0.9786337766815404,1.0,35/100,32.54%,MAGOHB;MAGOH;DDX39B;RAN;SRSF9;RBM15B;SRSF2;NUP85;HNRNPA1;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP205;NUP188;DDX25;HNRNPA2B1;NUP43;NUP210;SEH1L;XPO5;UPF1;POLDIP3;U2AF1
prerank,positive regulation of heart rate (GO:0010460),0.28805040808446425,0.649990080962304,0.8986842105263158,0.9782898797531979,1.0,6/17,27.61%,RYR2;ADRA1D;ADRA1A;EDN3;ATP2A2;KCNQ1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.25861686171829507,-0.6497869876628863,0.9365079365079365,0.9887041045668609,1.0,3/10,21.07%,UBXN2B;GSK3B;NUP62
prerank,endocytic recycling (GO:0032456),0.24501793965007237,0.6494427896614859,0.9367231638418079,0.9784049309500141,1.0,8/50,18.17%,SNX17;RAB14;ARF6;ARL4C;CMTM6;EHD1;DENND1C;EHD2
prerank,RNA stabilization (GO:0043489),0.2525754874270043,0.64916351825296,0.9241540256709452,0.9782883841483254,1.0,10/33,23.94%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;DKC1;NAF1;ELAVL1;DND1
prerank,protein targeting to peroxisome (GO:0006625),-0.19931501129759258,-0.6490735425803951,0.9746835443037974,0.9878263130664057,1.0,3/29,4.26%,LONP2;ZFAND6;ABCD3
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2880962099967715,0.6483153622962596,0.8926261319534282,0.9786202800664282,1.0,8/18,29.25%,SLC25A13;SMS;NAT8L;ASNS;GOT1;SLC25A12;ADI1;ASS1
prerank,regulation of phospholipase activity (GO:0010517),0.31499736669050793,0.647969940685651,0.8817663817663818,0.9785527722864168,1.0,4/10,25.73%,RGS2;RASGRP1;SNCA;FGFR3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.29304643263926805,0.6478851802783233,0.8866120218579235,0.9782826929462487,1.0,3/14,19.20%,ENTPD3;NUDT16;NUDT9
prerank,nuclear pore organization (GO:0006999),-0.2368631150692606,-0.6477451810677307,0.916,0.9874149821675577,1.0,6/14,22.27%,NUP98;AHCTF1;NUP35;NDC1;TPR;NUP93
prerank,RNA methylation (GO:0001510),0.2387965575940171,0.6477278370139594,0.9480088495575221,0.9780586978696009,1.0,15/60,26.12%,METTL1;TRMT112;FBL;RBM15B;PCIF1;CMTR1;ZCCHC4;MEPCE;FTSJ3;TRMT10C;METTL3;METTL14;WDR6;LCMT2;TYW3
prerank,integrin-mediated signaling pathway (GO:0007229),0.23504956760376308,0.6475630331169406,0.9565217391304348,0.9778390010756128,1.0,11/73,14.04%,ITGB2;ADAM15;SEMA7A;FN1;ISG15;ZYX;THY1;COL3A1;HCK;NME2;ERBIN
prerank,cellular response to interleukin-4 (GO:0071353),-0.26787171279733885,-0.6472633214434959,0.8966666666666666,0.9864118891016602,1.0,10/10,73.24%,STAT6;JAK3;GATA3;TCF7;RUFY4;XCL1;DCSTAMP;SHPK;XBP1;LEF1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.22263086082932954,0.6463875899415664,0.9777327935222672,0.9784773487609082,1.0,26/138,18.48%,NPPC;ERBB4;NTRK2;LTK;SHC3;MUSK;PTK6;KDR;MPZL1;EPHA5;HCK;CSF1R;FLT4;PTPRD;TIE1;EPHB1;GFRA2;FLT1;TYRO3;CASS4;LCP2;SYK;DDR2;ERBB3;SRMS;SLA
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3100759044398157,0.6456225054414896,0.8891891891891892,0.9787219542392985,1.0,1/12,3.71%,TNF
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.24122740356684774,0.6454256151653545,0.940983606557377,0.9785246527482013,1.0,10/49,20.07%,MYL9;H3-3A;PRMT1;PF4;L3MBTL1;SCIN;RBBP5;AGO1;THPO;MEF2C
prerank,modulation by symbiont of entry into host (GO:0052372),0.2875689208868567,0.645256994268601,0.8934531450577664,0.9783247356378743,1.0,9/16,37.83%,HS3ST5;CAV1;EXOC7;TRIM68;TRIM25;TRIM27;TRIM21;TRIM14;TRIM6
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2323165944083639,0.6444920928626406,0.9456289978678039,0.9785818749869798,1.0,18/69,27.29%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;POLR2H;CDK9;TAF5;INTS13;ICE1;RPRD1A;ELL2;POU2F2;INTS12;TAF13
prerank,sprouting angiogenesis (GO:0002040),0.24201609070131258,0.6440905518133169,0.9354120267260579,0.9785576210584987,1.0,5/51,8.38%,RAMP2;AKT1;ACVRL1;OTULIN;KDR
prerank,tRNA transport (GO:0051031),0.25240653314254596,0.6430739414926628,0.931924882629108,0.9789961687263408,1.0,14/35,31.91%,RAN;YBX1;TOMM20L;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L;TOMM20
prerank,establishment of spindle orientation (GO:0051294),-0.19998161334047812,-0.642860521063137,0.9545454545454546,0.9881226634998442,1.0,9/28,21.33%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;LLGL2;NDC80
prerank,cobalamin metabolic process (GO:0009235),-0.22987567499686049,-0.6427361483637068,0.9251101321585903,0.9868412832765598,1.0,17/17,77.04%,CUBN;MMADHC;MMAA;TCN1;AMN;ABCD4;ABCC1;CTRC;CBLIF;MMACHC;CD320;MMUT;MMAB;MTR;LMBRD1;MTRR;TCN2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.27703146753777264,0.6424220716235439,0.9145077720207254,0.9791527060158931,1.0,5/19,15.24%,HS6ST3;HS3ST5;B3GAT3;UGDH;XYLT1
prerank,regulation of Golgi organization (GO:1903358),0.2863350601290016,0.6420248391915758,0.8931788931788932,0.9791145224182801,1.0,4/17,18.59%,MAPK3;MYO5A;PDE4DIP;MAP2K2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2817501666854916,0.6419547460657354,0.9128686327077749,0.9788206438421082,1.0,2/18,13.44%,AQP4;NEK10
prerank,necroptotic process (GO:0070266),0.28879277328123254,0.6413354304939674,0.891644908616188,0.9789375641633588,1.0,7/16,36.22%,TICAM2;DNM1L;CD14;PGAM5;MLKL;IPMK;ITPK1
prerank,polyol metabolic process (GO:0019751),0.24209126499718153,0.6391594947533512,0.9495515695067265,0.980274404714081,1.0,10/46,25.49%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,cardiac ventricle morphogenesis (GO:0003208),0.24301183715271202,0.6387814866108211,0.939150401836969,0.9802132176451719,1.0,10/41,21.55%,FKBP1A;CPE;PROX1;HEY1;GATA4;SOX11;NOTCH1;TGFB1;MEF2C;NPY5R
prerank,response to estrogen (GO:0043627),0.26001068333124805,0.6386410998824187,0.9111880046136102,0.9799694772906165,1.0,9/31,23.99%,CD24;WBP2;CAV1;RBBP5;NCOA4;CITED2;SFRP1;SFR1;KRT19
prerank,cellular response to pH (GO:0071467),-0.2128957255564206,-0.6377229035786315,0.9271844660194175,0.9889259012928054,1.0,2/17,10.93%,SLC9A1;RAB11B
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2109783635702992,0.6376153866796547,1.0,0.9804230991332522,1.0,175/834,22.83%,RPS27A;UBC;UBB;CD81;PCBP1;CHCHD2;JUND;PARK7;TMPRSS6;MAPK3;ATF4;KLF2;SOX18;PTPRN;POMC;NPM1;GPER1;EIF5A;BEX1;TNF;PDGFB;DRAP1;NR1D1;HCLS1;ACVRL1;SPI1;EPAS1;GLMP;JUNB;PIN1;PSMC3;PARP1;MRTFA;CTNNB1;ST18;GRIN1;HES1;HYAL2;HIPK2;CDK8;OTX2;UBA52;FOXF2;CEBPB;FOXD3;NAMPT;SALL2;CEBPA;PROX1;CXCL10;CREB3L4;CREB3;CSRNP3;YBX1;MLXIPL;MLX;EGR1;RRP1B;HOXD4;GATA2;JUN;DCN;CAMK1;HMGB1;ZBTB49;TAF9;RFX4;RTRAF;HOXB7;PHOX2A;MC1R;IRF8;APBB1;SUPT4H1;APEX1;WNT5A;IL11;SOX17;ATF5;KDM6B;SS18L2;IRF2BPL;WBP2;HRAS;PTOV1;SOX8;SNW1;IRX3;ZMIZ2;DBP;THRA;KLF4;HOXD8;SLC11A1;SOX9;PAX3;LILRB1;BMP2;RIPK2;NME2;HNRNPU;TNFRSF1A;HDAC5;ATMIN;IRF7;MED30;F2RL1;PF4;AKNA;LAGE3;IGF2;ARF4;NR1H2;KDM1B;SUB1;HEY1;DLL1;IER5;MEPCE;DAB2IP;E2F4;GATA4;BCL11B;SQSTM1;SKAP1;GLIS2;TWIST1;ADCYAP1;PPARGC1A;MED21;AGO1;CNBP;TOX2;LMO1;NRL;SOX11;PPP3CA;DDRGK1;MUC1;INHBA;NLRP3;ESRRB;TFAP2B;NOTCH1;HGF;IL6;TGFB1;AGRN;POU4F1;CITED2;MEF2C;FOXA2;MYC;NFKBIA;FOSL2;CDC5L;DDIT3;CEBPZ;CDK9;FOXA1;CKAP2;SIRT2;PLXND1;MEN1;SS18L1;IRF5;REST;GRHL2;TNIP1;SOX1;MYDGF;CSRNP1;IER2;AKIRIN2;PPP3R1
prerank,histone acetylation (GO:0016573),0.23138407368203082,0.6373497465585567,0.9624060150375939,0.9802837239867586,1.0,9/69,10.79%,SPI1;BRD1;BRPF1;TAF10;JADE1;MORF4L2;TAF5L;TAF9;APBB1
prerank,snRNA transcription (GO:0009301),0.2300845355630728,0.6371908326821206,0.9507494646680942,0.9800673030376666,1.0,18/70,27.29%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;POLR2H;CDK9;TAF5;INTS13;ICE1;RPRD1A;ELL2;POU2F2;INTS12;TAF13
prerank,actin filament network formation (GO:0051639),0.3113480941142619,0.6367551471885373,0.9085948158253752,0.9800511962149987,1.0,4/11,22.93%,LCP1;ACTN1;FHOD3;SPIRE1
prerank,tRNA wobble uridine modification (GO:0002098),0.2941842984667287,0.6365274902215279,0.9062087186261559,0.9798846900407272,1.0,5/14,24.68%,DPH3;ELP3;CTU1;URM1;CTU2
prerank,lipoprotein transport (GO:0042953),-0.2503956050131468,-0.6361775335487253,0.9137931034482759,0.9886089848736206,1.0,3/10,15.34%,PPARG;LRP1;PRKCB
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.28362341546042524,0.6358624371925449,0.9108527131782945,0.9800361416664556,1.0,6/16,25.99%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,regulation of filopodium assembly (GO:0051489),0.24576676502485742,0.6356927560574508,0.9393592677345538,0.9798276454799462,1.0,9/38,19.89%,NLGN1;TENM2;ARF6;FNBP1L;TRPM2;GAP43;DMTN;GPM6A;AGRN
prerank,regulation of RNA metabolic process (GO:0051252),0.2336376430872619,0.635439488084715,0.9583789704271632,0.9796627631231035,1.0,15/59,23.75%,PCBP1;AHNAK;PCBP4;PQBP1;RRP1B;FAM50A;METTL18;PRX;OAS3;SRRM4;HNRNPF;IGF2BP3;HNRNPLL;HNRNPH2;PCBP2
prerank,regulation of mRNA processing (GO:0050684),0.25255554969127003,0.6353932815072032,0.92018779342723,0.9793501930971278,1.0,3/32,4.40%,HNRNPK;QKI;ZFP36L1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2499729228977292,-0.6346821958004037,0.920863309352518,0.9882650444900745,1.0,3/11,13.51%,IWS1;SLTM;SRPK2
prerank,tryptophan catabolic process (GO:0006569),0.30488747660014215,0.6340705293558667,0.8998609179415855,0.9799855750994751,1.0,1/11,11.01%,IDO2
prerank,regulation of myotube differentiation (GO:0010830),0.2615677634085306,0.632741868238122,0.924317617866005,0.9805938417924915,1.0,7/24,21.70%,BHLHE41;TMEM119;HDAC5;HDAC9;MMP14;NOTCH1;CCN3
prerank,inositol phosphate metabolic process (GO:0043647),0.23854078884511543,0.6306569507029496,0.9440715883668904,0.9818076516234228,1.0,10/46,25.49%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.2934432584561656,0.6293787232236262,0.9071618037135278,0.9823704340886567,1.0,3/14,16.89%,PRKAR1A;PRKAR1B;PRKAR2B
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30635694852755424,0.6285974558125593,0.9046961325966851,0.982613142178858,1.0,2/11,13.45%,EGR1;BMP2
prerank,protein K48-linked deubiquitination (GO:0071108),0.2659175542754304,0.6285203055599152,0.9347553324968633,0.9823298975839078,1.0,5/23,16.71%,TNFAIP3;USP5;OTUD7A;OTUB1;USP8
prerank,regulation of myelination (GO:0031641),0.2586036531799767,0.6279079313158373,0.9263024142312579,0.9824055551425966,1.0,8/25,28.03%,KLK8;MYRF;TENM4;PTPRZ1;SIRT2;PTN;TMEM98;TNFRSF1B
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2985949785294791,0.6277451460787921,0.898186889818689,0.9821826296059054,1.0,3/12,17.36%,MTLN;TWIST1;PPARGC1A
prerank,N-glycan processing (GO:0006491),-0.22179438476643637,-0.6274450248345591,0.9484978540772532,0.9915074831991209,1.0,2/18,5.76%,MAN1C1;FUT8
prerank,artery development (GO:0060840),0.264412275054108,0.6273463352487554,0.9142857142857143,0.982137551464202,1.0,3/23,5.71%,ACVRL1;APLNR;HES1
prerank,cellular response to hydroxyurea (GO:0072711),0.30579472001990465,0.6269864892151427,0.909985935302391,0.982042387143852,1.0,3/10,22.29%,NSMCE3;DDX11;BLM
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2332705586942875,-0.6267562021687004,0.9391634980988594,0.99055166106968,1.0,13/13,76.70%,PVR;NECTIN2;IL12A;IL23A;IL23R;IL12B;XCL1;SLC22A13;MR1;FADD;STX7;CYRIB;IL12RB1
prerank,microtubule bundle formation (GO:0001578),-0.16624346902158357,-0.62650790188037,0.9836065573770492,0.9893206661926799,1.0,17/42,29.03%,NAV1;TTLL3;CCDC66;SPEF1;NUMA1;GAS8;AAAS;MAP1S;LRGUK;CAPN6;RP1;FOXJ1;PLK1;NCKAP5L;PSRC1;CCDC40;SPAST
prerank,endodermal cell fate commitment (GO:0001711),-0.2508172968808248,-0.6263648851613878,0.9448051948051948,0.9880714497928265,1.0,4/10,22.76%,CDC73;RTF1;SOX2;CTR9
prerank,Golgi inheritance (GO:0048313),-0.24683890446031098,-0.6261228056873439,0.9565217391304348,0.9868656473225096,1.0,2/11,8.20%,GOLGA2;GBF1
prerank,digestive tract morphogenesis (GO:0048546),-0.23018603000399834,-0.6259388279764955,0.948905109489051,0.9856569737457346,1.0,2/14,8.39%,NIPBL;FGFR2
prerank,establishment of melanosome localization (GO:0032401),0.27579444536824593,0.6256052718972687,0.9167701863354037,0.982671868562592,1.0,7/19,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,ureteric bud morphogenesis (GO:0060675),-0.22669378890794029,-0.6255507691823928,0.9537815126050421,0.9845206484243306,1.0,7/16,27.15%,SIX1;WNT11;BMP4;FGF2;PKD2;GDNF;NPNT
prerank,response to ketone (GO:1901654),0.2616762588216739,0.6253055976671432,0.9107806691449815,0.9825360404767324,1.0,6/24,19.83%,CCL19;WBP2;HSD3B2;CAV1;SLIT3;TGFB1
prerank,peptidyl-serine modification (GO:0018209),0.21360644043724308,0.6249556116985926,0.9858585858585859,0.9824524162205809,1.0,29/166,19.17%,AKT1;PNCK;PINK1;MAST3;PDGFB;CAMK1D;PARP1;UHMK1;HIPK2;SGK1;PKN1;MAST1;CDK5R1;CAMK1;NAA10;POGLUT3;ULK3;GAS6;DCLK3;SBK1;STK32C;CAMKV;CDK5;HIPK4;GALNT13;CSNK1G2;STK32A;MKNK1;GRK2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.24783608249226516,0.624386843449057,0.9449003516998827,0.982516269579938,1.0,8/32,22.85%,PCNA;FBXO5;CDK5;ESRRB;KLF11;ID2;CDC45;CDK18
prerank,sphingoid metabolic process (GO:0046519),0.29604867475200647,0.6242902375084104,0.9105914718019257,0.9822438219987728,1.0,5/12,21.11%,NAAA;SGPP1;SPHK2;SGPP2;ASAH2
prerank,regulation of lamellipodium organization (GO:1902743),0.2858471219810409,0.623482113647731,0.9125827814569536,0.9824444725596518,1.0,4/14,22.96%,RAC1;DMTN;TWF1;TWF2
prerank,response to progesterone (GO:0032570),0.2747748051100204,0.6227265172182244,0.9097938144329897,0.9826062109873462,1.0,8/18,32.88%,WBP2;CAV1;TGFB1;TGFB2;UBE3A;ACOD1;NR1H3;CATSPER2
prerank,epidermal cell differentiation (GO:0009913),0.24073268408820375,0.6213347237608009,0.9317673378076062,0.983200634426875,1.0,4/41,13.69%,TXNIP;CTNNB1;WNT5A;EVPL
prerank,regulation of autophagosome assembly (GO:2000785),0.24416589745922698,0.6212924052798651,0.9423963133640553,0.9828838065254337,1.0,4/33,13.21%,PINK1;IFT20;NUPR1;UBQLN2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2795315206158672,0.6210821782071587,0.904887714663144,0.982670822505407,1.0,3/15,13.55%,YWHAE;CAMK1;GAS6
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.25920207851944743,0.6209658762907304,0.92125,0.982401609463323,1.0,7/22,25.90%,PPP1CA;PDP1;DUSP2;PPM1F;DUSP1;DUSP8;DUSP6
prerank,regulation of histone modification (GO:0031056),0.2968973105678885,0.6204980867982138,0.9100817438692098,0.9823753325272503,1.0,1/13,1.76%,PARK7
prerank,positive regulation of histone deacetylation (GO:0031065),0.2872426532055258,0.617080385180776,0.9219178082191781,0.9843199055386797,1.0,2/12,10.93%,APLNR;CTBP1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.20791463377550928,0.6170608391749348,1.0,0.9839923833555592,1.0,44/259,21.09%,GSN;DYNLL2;DYNLL1;FXYD5;EMP3;EMP2;RAC1;PMP22;IFT20;FLNA;S1PR1;DNM3;ARHGEF4;P2RX7;CNGA4;NTN1;ARF6;P2RY12;ARHGEF7;FNBP1L;CEP131;FHDC1;TCTN3;AIF1;SHTN1;CCDC88A;SDCBP;EHD1;ARF4;CNGB1;DMTN;TMEM17;CCDC28B;TCTN1;EXOC7;EHD2;NOTCH1;BBIP1;NEK1;EXOC5;CFAP410;CFAP54;EXOC8;PTPRO
prerank,organelle transport along microtubule (GO:0072384),0.2496031093913802,0.6163314790668915,0.9425556858147714,0.9841232841577171,1.0,3/31,11.11%,UBB;MAPT;HAP1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2613979909554386,0.6159207945075693,0.9340796019900498,0.9840584712160941,1.0,10/22,32.38%,PSMC3;MED30;SUB1;SRF;PAXIP1;MED16;MED12;PSMC5;PSMC2;MED4
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2946466701441002,0.6153776368582105,0.9182825484764543,0.984064197878576,1.0,1/11,4.40%,ZFP36L1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.2253537862640364,-0.6153759514728994,0.915057915057915,0.9889406310514061,1.0,5/13,21.61%,DYNC1LI1;MAD2L1;NDC80;XRCC3;TPR
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.29297887095123426,0.6127455338911747,0.9161028416779432,0.9854647480139476,1.0,4/12,26.54%,SNAP25;STX4;STX1B;STX3
prerank,protein oxidation (GO:0018158),0.29618517927602833,0.6125369219696587,0.9165487977369166,0.985257628664568,1.0,1/11,5.58%,LOX
prerank,protein polyglutamylation (GO:0018095),0.2888287842900974,0.6124170843557155,0.905160390516039,0.9849856500114728,1.0,4/11,27.01%,TTLL7;TTLL5;TPGS1;TTLL1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.3051257711233833,0.6123461180658251,0.9,0.9846928774301275,1.0,6/10,34.38%,PODXL;SKAP1;ADA;CD3E;CCL5;FERMT3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.2794754427153902,0.6121195086711234,0.9215938303341902,0.984496731433003,1.0,4/15,23.89%,PNP;SYK;CCR2;HSPH1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2851825873038634,0.6120917806639826,0.904054054054054,0.9841779528049781,1.0,1/13,3.61%,CANX
prerank,cardiac ventricle development (GO:0003231),0.26221051401134055,0.6119261405279336,0.9319640564826701,0.9839493278990259,1.0,8/20,28.11%,HES1;HEY1;GATA4;NOTCH1;PDE2A;DLL4;ENG;STRA6
prerank,photoreceptor cell development (GO:0042461),0.2793163232485958,0.6110157634175346,0.9415670650730412,0.9842143010204851,1.0,4/14,25.21%,MFSD2A;CDHR1;DCX;RORB
prerank,transepithelial transport (GO:0070633),0.2789560259785838,0.610685772209052,0.9139784946236559,0.98407738103405,1.0,2/15,12.43%,SLC1A2;SLC1A1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.23990339830240617,0.610541232522199,0.9519230769230769,0.9838291031060392,1.0,13/36,28.40%,CALM1;CTNNB1;GNAO1;WNT5A;AGO1;PPP3CA;FZD2;PPP3R1;PDE6G;FZD3;LEF1;FZD5;MAP3K7
prerank,cytosolic transport (GO:0016482),0.2138249829816919,0.6103088538241966,0.9753340184994861,0.9836397435569614,1.0,18/108,19.61%,LAMP1;LAPTM5;EMP2;MAGEL2;RAB14;CLTC;YKT6;VAMP3;BET1L;ARL1;DCTN1;CLN5;SORT1;HOOK1;PREPL;SYS1;SNX16;TBC1D10C
prerank,DNA strand elongation (GO:0022616),0.26934782441516053,0.6085571375034579,0.9376590330788804,0.9844039591370208,1.0,10/18,39.78%,RFC4;GINS3;MCM7;POLD3;GINS1;RFC3;POLD2;MCM4;MCM3;DCLRE1B
prerank,GPI anchor biosynthetic process (GO:0006506),0.2437676974049282,0.6081934119565937,0.9464922711058263,0.9842728990503433,1.0,5/30,16.85%,PIGZ;PIGQ;DPM3;PIGS;DPM2
prerank,phosphate ion transport (GO:0006817),0.2760921781883288,0.6062136503178595,0.9263565891472868,0.9851904954462057,1.0,8/16,40.29%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,mRNA export from nucleus (GO:0006406),0.2131134538035274,0.6054141942782644,0.9813857290589452,0.985344145670793,1.0,21/102,22.07%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;PCID2;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38
prerank,nuclear membrane disassembly (GO:0051081),0.28297613763687957,0.6047391668886778,0.9176626826029216,0.9854117456719093,1.0,4/14,25.11%,CTDNEP1;DCTN1;VRK1;PRKCA
prerank,skeletal muscle contraction (GO:0003009),0.2576487160628536,0.6032560550021616,0.9370179948586118,0.9859920861559772,1.0,5/19,28.86%,TNNI1;STAC3;MYH14;TCAP;STAC
prerank,protein heterooligomerization (GO:0051291),0.26872270505076074,0.603165427268859,0.9321808510638298,0.9857094794279887,1.0,4/17,21.10%,GRIN1;MAT2A;GRIN2B;KCNC2
prerank,response to steroid hormone (GO:0048545),0.2460730219537332,0.6020725488308445,0.9433293978748524,0.986012560771283,1.0,7/31,19.83%,ATP1A3;WBP2;ATP1A1;PAQR7;ABCA2;CAV1;TGFB1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.23557676123865745,0.6018709813660985,0.9552752293577982,0.9857967829784323,1.0,15/36,36.97%,CHEK2;PRPF19;ERCC6;CDC5L;CDC45;ATRIP;DOT1L;RAD9A;DNA2;RHNO1;CLOCK;DONSON;TIMELESS;SETMAR;RAD1
prerank,inner ear morphogenesis (GO:0042472),-0.19221921405420378,-0.601629383117134,0.9719626168224299,0.9947170944185413,1.0,4/22,13.03%,FGFR2;EPHB2;ZIC1;SIX1
prerank,UV-damage excision repair (GO:0070914),0.2754814249554135,0.6015686334106233,0.9210526315789473,0.985625229618007,1.0,5/12,25.37%,DDB1;MC1R;ERCC1;ACTR5;XPC
prerank,piRNA metabolic process (GO:0034587),0.2615977252872389,0.6005587000102219,0.9356499356499357,0.9858943919483668,1.0,3/19,21.87%,ASZ1;MAEL;TDRD9
prerank,DNA repair (GO:0006281),0.2027525998321178,0.6001964325558167,0.995995995995996,0.9857797442516067,1.0,63/284,25.98%,RPS27A;UBC;UBB;PARK7;UBXN1;NPM1;CHEK2;RNASEH2A;PARP1;VCP;NUCKS1;RPA2;UBA52;TRIM28;CENPX;DDB1;NEIL1;MC1R;APBB1;APEX1;PCNA;NSMCE1;NSMCE3;CHRNA4;RFC2;TEX264;UBE2V1;BABAM1;RECQL5;POLD4;CETN2;MUS81;BRCA2;DCLRE1C;NEIL2;ERCC6;NOP53;TRAIP;WDR48;RAD23A;RFC4;ERCC1;ACTR5;FAM111A;GADD45A;MEN1;FAAP20;BLM;POLD1;PNKP;ALKBH5;BARD1;ATRIP;BAP1;RPA3;RPAIN;DOT1L;XPC;LIG1;UBE2A;GTF2H5;RAD51;ALKBH2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.26636610641097314,0.6000121776125231,0.9326424870466321,0.9855498933404804,1.0,6/17,29.42%,SCN4B;KCNE4;KCNE5;CACNA2D1;KCNQ1;SCN1B
prerank,determination of bilateral symmetry (GO:0009855),0.250305882653874,0.5998760035969919,0.9449101796407186,0.9852892908679214,1.0,5/24,20.01%,MMP21;LEFTY1;DLL1;NOTCH1;CITED2
prerank,response to hydroxyurea (GO:0072710),-0.23607717387512867,-0.5995768651736368,0.9516728624535316,0.9944138778919821,1.0,2/11,5.78%,KAT7;SPIDR
prerank,mitochondrial transcription (GO:0006390),-0.2429656324503382,-0.5990315247680412,0.9346153846153846,0.9933283518089139,1.0,2/10,16.01%,FOXO3;MTERF2
prerank,female gamete generation (GO:0007292),0.24110606689545527,0.5988936637924623,0.9458794587945879,0.985530655872907,1.0,2/29,8.15%,MDK;FMN2
prerank,protein modification by small protein conjugation (GO:0032446),0.20098593203678108,0.5984974035797148,1.0,0.9854267007418415,1.0,61/361,21.86%,RPS27A;UBC;RACK1;UBB;ELOB;UBE2Z;PINK1;KCTD10;KLHL9;EPAS1;UBE2G2;VCP;CDC34;DCAF15;RNF187;UBA52;ARRDC1;ISG15;USP5;TRIM28;UFC1;UBE2M;OTULIN;RBX1;NEDD8;TNFAIP1;DDB1;SUMO2;SUMO3;KLHL7;FBXW5;SYVN1;PCNA;ZSWIM8;FBXW7;RNF40;NUP85;NUP88;ARRB2;RNF7;ENC1;VHL;TRIM32;BCL11A;RANGAP1;RNF181;RLIM;NUP50;TRAIP;KCTD13;DDRGK1;HECW1;TRIM13;SKP1;KLHL25;RAE1;BRAP;SELENOS;STUB1;ELOC;AMFR
prerank,nuclear envelope organization (GO:0006998),0.2580851738635086,0.597961653878091,0.9224030037546934,0.9853983355967176,1.0,5/20,23.68%,CTDNEP1;VPS4A;TMEM43;SUN2;SPAG4
prerank,DNA geometric change (GO:0032392),0.24748524996493526,0.5975045397573274,0.9434889434889435,0.9853179844073215,1.0,9/24,31.45%,HMGB3;HMGB1;DDX11;RECQL5;BLM;PIF1;DHX9;HNRNPA2B1;DNA2
prerank,lipoprotein localization (GO:0044872),-0.23318710802649095,-0.5969141548391649,0.9477611940298507,0.9929515988059271,1.0,3/11,15.34%,PPARG;LRP1;PRKCB
prerank,negative regulation of potassium ion transport (GO:0043267),-0.22248669305092944,-0.5961517345105685,0.9635627530364372,0.9919729673586907,1.0,4/13,20.58%,ACTN2;STK39;NOS1;PTK2B
prerank,membrane depolarization during action potential (GO:0086010),0.24776906791651157,0.5961378179676605,0.941747572815534,0.985781379246487,1.0,4/26,15.37%,SCN1A;YWHAH;SCN4B;SLC8A1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.2844016703305321,0.5959539535021313,0.925207756232687,0.9855524184466944,1.0,3/12,23.31%,SLC11A1;CCR2;IL12RB1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.2855856709604432,0.5953956644884656,0.9305555555555556,0.9855367856434019,1.0,3/12,20.79%,ABCG1;NR1H2;NFKBIA
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.27635209158208296,0.5947218238604388,0.9366197183098591,0.985569746935505,1.0,3/13,17.54%,NEIL1;NT5C;NEIL2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.21200896473771585,-0.5906795951609772,0.9754098360655737,0.9930890504006373,1.0,5/15,20.57%,PCM1;PIBF1;C2CD3;CCDC14;CEP192
prerank,melanosome localization (GO:0032400),0.25612912700264595,0.5906752186239607,0.9543209876543209,0.9874518990427836,1.0,7/21,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.28340802756368,0.5899044298933914,0.9400278940027894,0.9875374148392237,1.0,3/12,23.21%,GMNN;BLM;NUGGC
prerank,cellular response to osmotic stress (GO:0071470),0.25037796085865655,0.5889157921489038,0.9390862944162437,0.9877376775527276,1.0,6/21,26.73%,ZFP36L1;AQP1;YBX3;CAPN3;OXSR1;SCN2A
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.28250908301583666,0.5884021173738286,0.9415121255349501,0.9876724679519198,1.0,3/11,22.29%,GMNN;FBXO5;BLM
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2576024103466325,0.5879284233553832,0.9471649484536082,0.9872593104038551,1.0,4/20,17.37%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2576024103466325,0.5879284233553832,0.9471649484536082,0.9872593104038551,1.0,4/20,17.37%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,regulation of acute inflammatory response (GO:0002673),-0.19535321821036106,-0.5867587482424537,0.975609756097561,0.993485467130169,1.0,18/18,80.49%,OSMR;PTGES;KLKB1;IL4;GSTP1;CREB3L3;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;IL6ST;F12;DNASE1L3;C2CD4A;ADAM8;IL6;NLRP3
prerank,response to interleukin-4 (GO:0070670),0.2890855457227137,0.5860727316127259,0.9379407616361072,0.9878962582062761,1.0,10/10,71.11%,LEF1;XBP1;SHPK;DCSTAMP;XCL1;CITED1;RUFY4;TCF7;GATA3;JAK3
prerank,regulation of rRNA processing (GO:2000232),0.2592958794860958,0.5859935008968414,0.9404761904761905,0.9876008645994385,1.0,3/16,16.28%,TRMT112;METTL18;NUDT16
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2686567904697004,0.5845968478989633,0.9253731343283582,0.9879864076066521,1.0,6/14,33.26%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1;FSCN1
prerank,muscle tissue development (GO:0060537),-0.21718489276214747,-0.5845156716893766,0.9602888086642599,0.9930908113041071,1.0,4/13,21.22%,SMO;BMP4;NF1;PTCH1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.25281949994165154,0.5833164476714733,0.9229781771501926,0.9882855379211667,1.0,8/19,32.13%,HSPD1;RIPK2;IRF7;IRF5;TLR7;DHX9;MAVS;DDX3X
prerank,positive regulation of protein deacetylation (GO:0090312),0.26241710193387346,0.5825976157433269,0.953360768175583,0.9883187651920033,1.0,2/14,10.93%,APLNR;CTBP1
prerank,mitotic spindle assembly (GO:0090307),0.2208777096141353,0.5821486599842767,0.9784090909090909,0.9882205012473907,1.0,7/42,18.88%,CHEK2;FLNA;ABRAXAS2;CLASP1;RHOA;TOGARAM2;KIFC2
prerank,regulation of adaptive immune response (GO:0002819),-0.19615260141869045,-0.5820485661073235,0.9641255605381166,0.9927804988206711,1.0,3/18,13.42%,EIF2AK4;ADCY7;SIRT1
prerank,homeostasis of number of cells (GO:0048872),0.2773781636606954,0.5803837569556693,0.9479606188466948,0.9887650778441713,1.0,4/12,27.82%,CX3CR1;NOTCH1;CCN3;OCIAD2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2590476415771577,0.5797724351059823,0.9502551020408163,0.9887284158488332,1.0,9/16,39.01%,RECQL5;BLM;RAD51;MCM7;MCM2;TWNK;RECQL;MCM4;PURA
prerank,aspartate family amino acid catabolic process (GO:0009068),0.25195370556960717,0.579686243674767,0.9438775510204082,0.9884314462676295,1.0,4/19,20.39%,SDS;SLC25A21;CRYM;GOT1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.27096434268458514,0.5795229522575842,0.9482758620689655,0.9881710012266176,1.0,2/14,15.24%,ANK3;ATP1B1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.27180465652321667,0.578300885001322,0.9378378378378378,0.9884200507742524,1.0,4/12,30.14%,ADCY8;STX4;PLA2G6;C2CD2L
prerank,regulation of urine volume (GO:0035809),0.27895934694079877,0.5765784547884157,0.9304964539007092,0.9889226677672872,1.0,2/10,19.55%,HYAL2;TFAP2B
prerank,quinone biosynthetic process (GO:1901663),-0.21760664538718982,-0.5755498764978388,0.9646017699115044,0.9940891547677846,1.0,7/14,25.63%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,polarized epithelial cell differentiation (GO:0030859),0.269673217551268,0.5750412805058484,0.940677966101695,0.989343718607164,1.0,5/13,31.37%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2727521278984243,0.5747512380465889,0.9533954727030626,0.9891541961571291,1.0,1/12,4.36%,CHEK2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.20713975357316083,-0.5747409914443737,0.9831223628691983,0.9931032517174914,1.0,4/16,15.57%,TOP2B;SLX4;HFM1;FANCM
prerank,endochondral bone morphogenesis (GO:0060350),-0.22325661813420328,-0.5726973280448844,0.9454545454545454,0.9925588774534949,1.0,3/11,16.29%,COL13A1;BMP4;BMPR2
prerank,nuclear pore complex assembly (GO:0051292),0.28106450477828565,0.5724629852162885,0.9473684210526315,0.9899028699028826,1.0,1/10,4.80%,RTN4
prerank,DNA catabolic process (GO:0006308),-0.22313611924528165,-0.5713237047754918,0.9269102990033222,0.9917222364890411,1.0,2/11,9.95%,FBH1;DNASE1L1
prerank,negative regulation of dephosphorylation (GO:0035305),0.2510490377166026,0.5711805265740854,0.9462647444298821,0.9901485725027345,1.0,8/18,32.33%,YWHAB;PPP1R35;ARPP19;PPP1R15A;MFHAS1;CHP1;PTPA;PPP1R16B
prerank,GPI anchor metabolic process (GO:0006505),0.23336738483504754,0.5697683435106766,0.9627403846153846,0.9904506183231645,1.0,4/26,16.85%,PIGZ;PIGQ;DPM3;DPM2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22844866234097175,0.5686390040804015,0.9665871121718377,0.9906341564523455,1.0,1/29,4.14%,SYCP2
prerank,ncRNA export from nucleus (GO:0097064),0.21873549566363262,0.5668837458696523,0.979498861047836,0.9911195321124147,1.0,12/36,30.80%,NPM1;RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,steroid biosynthetic process (GO:0006694),0.20968794982990455,0.5666634000380943,0.9845814977973568,0.9908716774810837,1.0,11/56,23.30%,SCP2;LSS;HSD17B4;OSBPL6;SC5D;HSD3B2;OSBPL3;CH25H;OSBPL1A;PMVK;PRLR
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.20045566338535983,0.5663480238271122,0.9927536231884058,0.9906747829917278,1.0,32/96,32.54%,MAGOHB;MAGOH;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP205;NUP188;DDX25;HNRNPA2B1;NUP43;NUP210;SEH1L;UPF1;POLDIP3;U2AF1
prerank,endosome organization (GO:0007032),0.2175772310172949,0.5659584594924923,0.9785067873303167,0.9904982660183306,1.0,10/41,27.58%,CHMP2B;CORO1C;SNX33;USP8;SQSTM1;HOOK1;EXOC8;DNM1;LAPTM4B;AKTIP
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.19043605016537146,0.5658973506945227,0.9989939637826962,0.9901841980224393,1.0,38/172,27.25%,CHKB;CSNK2B;CDIPT;CDS1;RAB14;DGKH;MFSD2A;PIK3C2G;PCYT2;MTMR9;CHAT;ABHD8;INPP5J;PTDSS1;ARF1;ACHE;CPNE6;PIK3CD;AGPAT5;RAB4A;SLC44A5;DGKB;STARD10;LPCAT2;INPP5D;ETNPPL;AGPAT2;SBF1;PLEKHA1;SLC44A2;PIK3R5;INPP4B;CPNE3;SLC44A1;MTMR6;MBOAT7;GPAM;PIP5K1C
prerank,manganese ion transport (GO:0006828),0.26412641382018487,0.5653740973603281,0.9507978723404256,0.9900749574271533,1.0,3/14,14.00%,TRPC7;SLC11A1;TRPC1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.2744288073421494,0.5637096630551605,0.9312242090784044,0.9904683641037564,1.0,4/11,25.11%,PF4;TGFB1;ID2;PRKCA
prerank,positive regulation of nuclear division (GO:0051785),0.23663970563615117,0.5635265778761313,0.9671931956257594,0.9902103028425389,1.0,6/25,23.89%,PDGFB;IGF2;EDN3;SIRT2;TGFA;CD28
prerank,regulation of DNA metabolic process (GO:0051052),0.21462674481916236,0.5634982752278743,0.9797297297297297,0.9898904670919694,1.0,12/44,22.67%,NUCKS1;UBE2V1;KDM1B;PDGFA;SUB1;TERF2IP;ALYREF;MYC;CDK9;RADX;GRHL2;MPV17
prerank,positive regulation of keratinocyte migration (GO:0051549),0.2720989030198658,0.5620951160477639,0.9440559440559441,0.9901404674313486,1.0,2/10,16.56%,ARF6;EPB41L4B
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.22247911918801982,-0.5620081127535419,0.9769230769230769,0.9936962276353553,1.0,1/11,2.94%,ACTN2
prerank,mitotic chromosome condensation (GO:0007076),0.2265005725897607,0.5607803015889434,0.9706959706959707,0.9903740753961218,1.0,3/26,13.98%,CSNK2B;SET;NCAPG
prerank,ubiquinone metabolic process (GO:0006743),-0.20429436423091085,-0.5605649190442821,0.9634703196347032,0.9928978543366825,1.0,7/15,25.63%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24047647868084895,0.5598097489174232,0.9446540880503145,0.9904407265921694,1.0,8/21,27.55%,JUN;MED30;SUB1;TWIST1;SRF;PAXIP1;MED16;MED12
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2735429172708708,0.5590919115100496,0.9438202247191011,0.9903892243401847,1.0,1/10,5.11%,PPP2R1A
prerank,snRNA 3'-end processing (GO:0034472),0.24164457442627668,0.5569847601651721,0.9609571788413098,0.990917182483728,1.0,9/19,33.90%,EXOSC2;TOE1;EXOSC9;USB1;EXOSC4;INTS12;INTS5;INTS6L;EXOSC3
prerank,positive regulation of transporter activity (GO:0032411),-0.20338949638338405,-0.5542090863452184,0.9656488549618321,0.9936033441081213,1.0,3/13,16.18%,KMT2A;TRPC6;STK39
prerank,protein heterotetramerization (GO:0051290),0.26001028505065676,0.5539287749457227,0.9511854951185496,0.9918101048906997,1.0,2/13,18.26%,GRIN1;GRIN2B
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.2518074349669274,0.5538518461287614,0.9581646423751687,0.9915004014922044,1.0,2/15,13.94%,NME2;SFRP4
prerank,microtubule anchoring (GO:0034453),0.25957086233254634,0.5537699550171102,0.9723756906077348,0.991202802627126,1.0,6/12,36.50%,CLASP1;CAMSAP3;CLASP2;PEX14;GCC2;BICD2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.21601679594112488,0.5527158925589788,0.9799054373522459,0.9912829075035373,1.0,7/37,22.14%,RNASEH2A;ENTPD3;RNASEH1;SND1;NUDT16;NUDT9;ISG20
prerank,sulfate transport (GO:0008272),0.2522461226174494,0.5518384062572065,0.9665775401069518,0.9913041894177825,1.0,2/14,9.20%,SLC26A4;SLC25A11
prerank,negative regulation of interleukin-12 production (GO:0032695),0.25167204426880396,0.5517726284873959,0.9644322845417237,0.9909947488116473,1.0,2/14,13.39%,LILRA5;LILRB1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.2261700956582483,-0.5517137810558341,0.9702970297029703,0.9930469300172308,1.0,5/10,31.27%,NUMA1;MED1;NCOA3;PRKCH;VDR
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.27023206817268813,0.5509081605390191,0.9459459459459459,0.9909923587666418,1.0,5/10,32.28%,SOX9;PDGFA;MYC;CHRD;SHH
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22622251999639728,0.5488711661180571,0.9719169719169719,0.9914081869491406,1.0,9/26,31.00%,TNFAIP3;SIGIRR;TYRO3;SIRT2;C1QBP;PCBP2;TRIB1;ACOD1;TRAFD1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2511901088769678,0.5463564333788196,0.948069241011984,0.9920037555091922,1.0,2/14,15.15%,ZDHHC5;TLR5
prerank,ncRNA catabolic process (GO:0034661),0.22229331385231063,0.5449851194821185,0.9783653846153846,0.9921635183047203,1.0,7/28,21.53%,LIN28B;EXOSC2;SND1;NUDT16;EXOSC9;RBM7;EXOSC4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22115142545707364,0.5420308631317192,0.9775413711583925,0.9928635333263744,1.0,8/29,26.39%,GABARAPL2;NAPA;TRAPPC3;RAB6B;COPB2;COPG1;COG8;COPE
prerank,cytoplasmic microtubule organization (GO:0031122),0.20180475057819477,0.5401261626830203,0.9890829694323144,0.9931816556714248,1.0,14/54,28.63%,STMN3;CLASP1;MAPT;DCTN1;RHOA;CLIP3;CCDC88A;HOOK1;KATNA1;KPNB1;CHP1;KATNAL1;CCDC88C;CAMSAP3
prerank,homologous chromosome segregation (GO:0045143),-0.17577017008920476,-0.5399639192919001,0.9901477832512315,0.9949503697531907,1.0,7/20,25.97%,CENPC;PRDM9;SIRT7;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.24223614933874452,0.5399296459965887,0.9626288659793815,0.9929095198239647,1.0,10/18,37.03%,KCNE5;CBARP;CAV1;SLC43A2;COMMD1;PPIF;CAB39;BIN1;KCNH2;SLC43A1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.21497764579601522,-0.5399031843645962,0.9755244755244755,0.9936464964691893,1.0,5/10,26.29%,MTHFR;MTHFD1L;SHMT1;MTHFD1;TYMS
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.21654916099553198,-0.5392287540443084,0.979933110367893,0.9925340968452431,1.0,5/11,28.65%,RIPK1;CASP8;COLEC12;SCARA3;TLR3
prerank,tryptophan metabolic process (GO:0006568),0.26221642552830227,0.5391162812142294,0.9583911234396671,0.9928541512314292,1.0,1/11,11.01%,IDO2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.20141630085202075,0.5388291035814519,0.9934282584884995,0.9926066597882154,1.0,17/52,32.90%,MDH1;SLC19A1;FOLR2;ACOT4;D2HGDH;GOT1;SHMT2;MTHFS;SDHA;ACLY;IDH1;DHFR;ASS1;L2HGDH;ALDH1L1;MTHFD2L;MTRR
prerank,glutathione biosynthetic process (GO:0006750),-0.20480793371830278,-0.538356575966306,0.9773462783171522,0.991475300756534,1.0,11/11,79.54%,GGCT;GGT1;GCLC;MGST2;GCLM;GSS;CHAC1;CNDP2;HAGH;CHAC2;OPLAH
prerank,tetrapyrrole metabolic process (GO:0033013),0.23060719784046962,0.5346823967989119,0.9665379665379665,0.9936263754489226,1.0,1/18,5.32%,ABCB6
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2476663877523559,0.5338752791664161,0.9646596858638743,0.9935619423029227,1.0,3/15,19.19%,NPM1;FAM83D;DDRGK1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2511333325789139,0.5338289114087376,0.9633649932157394,0.9932375450031411,1.0,2/13,15.19%,AMDHD2;SLC35A3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.18689351937162788,-0.5332721562941978,0.991304347826087,0.991526661379429,1.0,4/17,25.41%,PLA2G4A;CRLS1;SERAC1;PLA2G5
prerank,metanephric mesenchyme development (GO:0072075),0.26135342111298515,0.5271063927021924,0.9393491124260355,0.9949365356240126,1.0,1/10,8.19%,BASP1
prerank,maturation of 5.8S rRNA (GO:0000460),0.23152417934035688,0.5238236581616502,0.9765013054830287,0.9955431488130205,1.0,8/17,33.67%,EXOSC4;FTSJ3;RRP15;EIF6;NOL9;URB1;PES1;LAS1L
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25079479289755374,0.5228751376376509,0.9714673913043478,0.9954712589412065,1.0,3/12,25.11%,CTDNEP1;VRK1;PRKCA
prerank,regulation of telomere capping (GO:1904353),0.21872459563294808,0.5203536165315202,0.9786432160804021,0.9958468405594331,1.0,1/23,1.89%,MAPK3
prerank,muscle cell migration (GO:0014812),0.25464959867848613,0.5179331612052123,0.9712556732223904,0.996149318569945,1.0,3/10,21.70%,AAMP;PLAT;CCN3
prerank,outer dynein arm assembly (GO:0036158),-0.18983826158693204,-0.5173120891240147,0.991701244813278,0.9936128305464084,1.0,7/14,29.09%,ODAD1;DNAAF5;ODAD2;ODAD3;ODAD4;DNAAF4;CCDC63
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2423688721993974,0.5161099134736654,0.963855421686747,0.996280354561874,1.0,3/11,27.81%,PF4;TMEM106A;XBP1
prerank,ubiquinone biosynthetic process (GO:0006744),0.2317965506116459,0.5156566493872501,0.9676584734799483,0.9960495943580158,1.0,5/15,26.80%,COQ6;NDUFA9;PDSS1;COQ10A;COQ2
prerank,rRNA catabolic process (GO:0016075),0.23014886053352707,0.5149773649204297,0.9773030707610146,0.9958822592073531,1.0,7/16,35.60%,EXOSC2;EXOSC9;EXOSC4;TRIR;PELO;EXOSC3;DEDD2
prerank,lysine catabolic process (GO:0006554),0.23900193941597156,0.5111157823846303,0.9782903663500678,0.9961723312956982,1.0,2/12,13.43%,SLC25A21;CRYM
prerank,lysine metabolic process (GO:0006553),0.23900193941597156,0.5111157823846303,0.9782903663500678,0.9961723312956982,1.0,2/12,13.43%,SLC25A21;CRYM
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.20828321179876952,0.5110360464027979,0.9903498190591074,0.9958561167096516,1.0,8/29,22.34%,SPRY1;DAB2IP;VASN;EFNA1;FOXA2;SFRP1;FOXA1;ADIPOR1
prerank,response to X-ray (GO:0010165),0.2342228746635162,0.5096251058042283,0.9828947368421053,0.9958638923284767,1.0,4/14,28.69%,NUCKS1;BLM;IKBIP;XRCC6
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.22259566619490662,0.5091795488015365,0.9855072463768116,0.9956458478510527,1.0,4/18,22.31%,CCND1;FBXO5;CDC25A;RCC2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.15134664327336175,-0.5014008687652531,1.0,0.9949690908785132,1.0,5/29,18.75%,DDO;PRODH;HOGA1;ACADSB;GSTZ1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.24842666566507937,0.49974357984417767,0.9696969696969697,0.9970881062827048,1.0,4/10,33.96%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.24842666566507937,0.49974357984417767,0.9696969696969697,0.9970881062827048,1.0,4/10,33.96%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,recombinational repair (GO:0000725),0.17818743897246161,0.49868109554228257,1.0,0.9969695858445402,1.0,22/77,33.42%,SEM1;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;SFR1;RPA3;RAD51;RMI1;SMC6;AP5Z1;POLN;PSMD14;RHNO1;RAD51C;SWI5
prerank,glycerolipid metabolic process (GO:0046486),0.23591599691063697,0.49833824020369644,0.9789915966386554,0.996705380126219,1.0,6/11,34.98%,GAL3ST1;PGP;DGKB;DGKZ;DGKG;PLA2G15
prerank,positive regulation of immune system process (GO:0002684),-0.1720243472318177,-0.4964364018975631,0.991869918699187,0.9944241335242856,1.0,2/16,14.01%,IL15;LGALS9
prerank,exit from mitosis (GO:0010458),0.23046452732607675,0.49596162988179116,0.9821917808219178,0.9968641246000542,1.0,4/12,32.42%,CLASP1;CHMP7;CLASP2;CHMP4B
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17631993747097133,0.49585897839503074,0.9989743589743589,0.9965478747958102,1.0,23/95,29.99%,SEM1;MCM5;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;MUS81;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;CDC45;SFR1;RPA3;RAD51;RMI1;MCM7;MCM2;SMC6;AP5Z1;POLN
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.21591912353049963,0.49203790296427585,0.9847522236340533,0.9969390319742312,1.0,8/16,35.67%,SRSF1;SNRNP200;SART1;WBP4;WBP11;CWC15;DCPS;PSIP1
prerank,establishment of mitotic spindle localization (GO:0040001),0.2000984180779034,0.4913391599085211,0.988929889298893,0.9967365526111509,1.0,9/28,30.50%,CLASP1;DCTN1;GJA1;INSC;KPNB1;ITGB1;ESPL1;CLASP2;NSFL1C
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2115398592054141,0.48971230262056015,0.9847133757961783,0.9966869076241396,1.0,8/19,31.95%,APRT;PNP;CDA;POLD1;ADA;POLD3;DGUOK;DCK
prerank,tRNA export from nucleus (GO:0006409),0.19221017364306026,0.48677257051104905,0.9918032786885246,0.9965586983474823,1.0,11/32,30.80%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.19221017364306026,0.48677257051104905,0.9918032786885246,0.9965586983474823,1.0,11/32,30.80%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,tRNA modification (GO:0006400),0.1770653473068181,0.48576179983204915,0.9945175438596491,0.9963989919041183,1.0,13/62,26.12%,METTL1;TRMT112;AARS2;CTU1;PUSL1;PUS7;ADAT2;URM1;THUMPD1;CTU2;WDR6;LCMT2;TYW3
prerank,regulation of interleukin-13 production (GO:0032656),0.22461040825257342,0.48551868008107424,0.9851951547779273,0.996110033849148,1.0,3/13,26.78%,LILRA5;SPHK2;LEF1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2020986482033985,0.4853308797332838,0.9899623588456713,0.9958069374123703,1.0,9/24,38.03%,PLA2G4F;PLA2G3;ABCA3;GPAM;CDS2;PNPLA8;PLA2G15;LPCAT1;LPGAT1
prerank,regulation of interferon-alpha production (GO:0032647),0.20517515664879496,0.4849037781494316,0.9832474226804123,0.9955408395049173,1.0,8/23,32.13%,HSPD1;RIPK2;IRF7;IRF5;TLR7;DHX9;MAVS;DDX3X
prerank,positive regulation of telomere maintenance (GO:0032206),0.19386299682568026,0.48120063498390236,0.995221027479092,0.9958458699604937,1.0,11/31,33.05%,MAPK3;MAPK15;ERCC1;MAP2K7;NAF1;PNKP;PRKCQ;AURKB;HNRNPA2B1;HNRNPD;PKIB
prerank,mitotic metaphase plate congression (GO:0007080),0.1797220511912053,0.480644430257988,0.9978118161925602,0.9956095490708095,1.0,11/51,25.87%,CHMP2B;CHMP5;CHMP6;DCTN2;CHMP1B;NUDC;VPS4A;CHMP7;CHMP1A;KPNB1;CHMP4C
prerank,sarcomere organization (GO:0045214),0.19228165372030653,0.47668973693439903,0.9976387249114522,0.9958951597981857,1.0,7/27,30.25%,CSRP1;FHOD3;CAPN3;KRT19;TCAP;WDR1;SYNPO2L
prerank,retinal metabolic process (GO:0042574),0.22893937915872625,0.4763341602046072,0.9836289222373806,0.9956121538285374,1.0,2/12,18.13%,DHRS13;BCO2
prerank,regulation of sensory perception of pain (GO:0051930),0.2283704275048476,0.4715087835362639,0.9888111888111888,0.9959885941731038,1.0,3/11,28.06%,CCL3;CCN3;MGLL
prerank,monosaccharide transmembrane transport (GO:0015749),0.20760272177634037,0.4636460364587517,0.9973787680209698,0.9967193233786377,1.0,2/16,16.51%,SLC50A1;SLC2A2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.1912688092263367,0.4591115469670016,0.9927710843373494,0.9969460309309941,1.0,10/23,35.70%,SLC12A5;SLC26A4;TFAP2B;PDK2;SLC12A9;SLC12A6;SLC9A7;CLCN3;SLC12A2;KCNH2
prerank,neural tube development (GO:0021915),0.20829948758619993,0.45516916362063353,0.9904371584699454,0.9970689912241113,1.0,4/15,22.29%,PROX1;SOX11;TGFB1;GRHL2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.20421901898778083,0.4473222653013076,0.9874301675977654,0.9975713767162054,1.0,5/13,36.05%,UNC93B1;TLR7;IRAK2;PIK3AP1;MYD88
prerank,phasic smooth muscle contraction (GO:0014821),0.21672284175161846,0.445478551089399,0.9901823281907434,0.9974133237409337,1.0,3/10,31.52%,EDN3;HTR2B;DRD2
prerank,signal transduction in response to DNA damage (GO:0042770),0.1657260258205139,0.4375360495462909,1.0,0.9977819195848299,1.0,11/49,26.95%,CHEK2;NDRG1;PRPF19;ERCC6;GADD45A;CDC5L;STK33;ATRIP;DOT1L;PAXIP1;RAD9A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.19308049730001253,0.43617389943478047,0.9932157394843962,0.9975548222115097,1.0,17/17,80.71%,BUB3;AURKB;BOD1;IK;CENPA;ZW10;MTBP;HASPIN;CHAMP1;CTCF;RB1;SPDL1;KNL1;CDK1;MIS12;ZWILCH;TTK
prerank,protein localization to condensed chromosome (GO:1903083),0.20178379171882077,0.4302456941465306,0.9944827586206897,0.9976734835838784,1.0,1/12,11.18%,BUB3
prerank,response to light stimulus (GO:0009416),0.14798497986117135,0.3976634355443939,1.0,0.9991176394795268,1.0,20/55,35.34%,MAPK10;CIRBP;TRIM32;ERCC6;CCAR2;MEN1;MAP2K7;AANAT;POLD1;UBE2A;ERCC2;USF1;FECH;DRD2;CLOCK;TYR;CPT1B;ERCC4;DTL;GPR88
prerank,protein localization to kinetochore (GO:0034501),0.16020793624741297,0.35230878612806593,0.9986754966887417,0.9997511733408154,1.0,3/14,28.98%,BUB3;RCC2;AURKB
